Citrus Sinensis ID: 005916
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 670 | 2.2.26 [Sep-21-2011] | |||||||
| Q8S8Y8 | 567 | Probable serine/threonine | yes | no | 0.752 | 0.888 | 0.729 | 0.0 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.713 | 0.858 | 0.741 | 0.0 | |
| Q6EU49 | 612 | Probable serine/threonine | yes | no | 0.614 | 0.673 | 0.637 | 1e-159 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.617 | 0.666 | 0.577 | 1e-143 | |
| Q944Q0 | 563 | Serine/threonine-protein | no | no | 0.638 | 0.760 | 0.569 | 1e-137 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.567 | 0.736 | 0.563 | 1e-136 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.640 | 0.612 | 0.535 | 1e-135 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.610 | 0.580 | 0.549 | 1e-135 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.610 | 0.580 | 0.549 | 1e-135 | |
| Q2RA93 | 439 | Probable serine/threonine | no | no | 0.622 | 0.949 | 0.529 | 1e-132 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 764 bits (1973), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/522 (72%), Positives = 428/522 (81%), Gaps = 18/522 (3%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
ME ++D +A EPPDP+VLE DPT RYIRYKEVIGKGAFKTVYKAFDEV+G+EVAW QVR
Sbjct: 1 MEGTDDASALQEPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVR 60
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
IDDVLQSP LERLYSEV LLKSLKHNNIIRFYNSWIDD+NKTVNIITELFTSGSLR YR
Sbjct: 61 IDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYR 120
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
KKH+KV+MKAVK WARQIL GL YLH +PPIIHRDLKCDNIFINGN GEVKIGDLGLAT
Sbjct: 121 KKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLAT 180
Query: 181 IMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTF+YPY EC+NSAQIYK
Sbjct: 181 VMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYK 240
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
KVSSGIKPA+LS+VKDPEVK FIEKCL+PAS+RLSAKELL+DPFLQ+NG T N PLPLPD
Sbjct: 241 KVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLTMNNPLPLPD 300
Query: 301 IVLPRVGAFGDRCLMSEGPASVR-NKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVR 359
IV+P+ GAFGDRCLMSEGP + R +K S+D D D+ LP++T DNSG S IEVR
Sbjct: 301 IVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSG-----SRCIEVR 355
Query: 360 RSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLEL 419
R+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLFY + DTA VSSEMVEQLEL
Sbjct: 356 RAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLEL 415
Query: 420 ADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHE--KDALSLERV--D 475
DQNVTFIAELID+LL+N+IP WK V +DHLI + + S H K E V D
Sbjct: 416 TDQNVTFIAELIDILLVNMIPTWKTDVTVDHLIHSQLNQNSRSHHNEAKPQKQEETVFHD 475
Query: 476 NSSGLSH-------RSYEADNHS-RSSDGQDSTSLKEGIQTT 509
+SH RS E D ++ G+D +S++E + T
Sbjct: 476 TCELVSHSCNSDCPRSDEEDKQCVDATKGEDKSSIQEVEEAT 517
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 761 bits (1966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/495 (74%), Positives = 419/495 (84%), Gaps = 17/495 (3%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
ME SED +A +EPPDP+VLE DPTCRYIRYKEVIGKGA KTV+K FDEV+G+EVAW QVR
Sbjct: 1 MEGSEDASAIVEPPDPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVR 60
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
IDD+LQSP+ LERLYSEV LLKSLKH NIIRFYNSWIDD+NKTVNIITELFTSGSLRQYR
Sbjct: 61 IDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYR 120
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
KKH+KV+MKAVK WARQIL+GL YLHS DPPIIHRD+KCDNIFINGN GEVKIGDLGLAT
Sbjct: 121 KKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLAT 180
Query: 181 IMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPY ECRNSAQIYK
Sbjct: 181 VMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYK 240
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
KVSSGIKPA+LSKVKDPEV FIEKCL+PAS+RLSA+ELL+D FL VNG N PLPLPD
Sbjct: 241 KVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFLNVNGLVMNNPLPLPD 300
Query: 301 IVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRR 360
IV+P+ G+FG+RCLMSEGP + RN+ SM+ D D LP++ S +NSG + IEVRR
Sbjct: 301 IVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSG-----TNCIEVRR 355
Query: 361 SKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELA 420
+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLF+ + DTA +VSSEMVEQLEL
Sbjct: 356 AKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELT 415
Query: 421 DQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHEKDALSLERVDNSSGL 480
D+NV FIAELID+LL+NLIP WK V +DHLI + + S ++H+ +G
Sbjct: 416 DKNVKFIAELIDVLLVNLIPNWKTDVAVDHLIHPQQNQSSKDNHQ------------NGA 463
Query: 481 SHRSYEADNHSRSSD 495
S ++ E+ +HS SSD
Sbjct: 464 SSQAGESISHSLSSD 478
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1447), Expect = e-159, Method: Compositional matrix adjust.
Identities = 272/427 (63%), Positives = 326/427 (76%), Gaps = 15/427 (3%)
Query: 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERL 74
D + +E DPT RYIRY EV+G+GA KTVYKAFDEV G+EVAW QV ID+V+QSP++LERL
Sbjct: 12 DAECVEVDPTRRYIRYNEVLGRGAMKTVYKAFDEVEGIEVAWSQVEIDEVMQSPDNLERL 71
Query: 75 YSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW 134
YSEVHLLKSLKH N+++FYN W+DDQ KT+N+ITELFTSGSLRQYR+KH +VD+KA+K W
Sbjct: 72 YSEVHLLKSLKHENVMKFYNYWVDDQKKTINVITELFTSGSLRQYRQKHPRVDLKAIKNW 131
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP 194
ARQ+L GL YLH+H PPIIHRDLKCDNIF+NGN GEVKIGDLGLAT+M AKSVIGTP
Sbjct: 132 ARQVLRGLDYLHTHQPPIIHRDLKCDNIFVNGNHGEVKIGDLGLATVMLTPRAKSVIGTP 191
Query: 195 EFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV 254
EFMAPELYDENY+EL DIYSFGMCMLEM T EYPYSEC N+AQI+KKVS G+KPAAL+K+
Sbjct: 192 EFMAPELYDENYDELVDIYSFGMCMLEMFTLEYPYSECTNAAQIFKKVSKGVKPAALAKI 251
Query: 255 KDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCL 314
+ + K FI+KCLVPAS+RLSAKELL DPFL + ++ P LP+
Sbjct: 252 TNIQAKQFIDKCLVPASERLSAKELLQDPFLCSDNSSVLVGTKFPS-SLPK--------- 301
Query: 315 MSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESN 374
V + MD D++ + T N GG + +E R+ + L GE
Sbjct: 302 ----SVDVSLEALHMDVDTNESMCTSTCKRNDLGG-PHRSVLEFTRTNKNTELKLTGEKL 356
Query: 375 DEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLL 434
D+ SVSL+LRIAD G RNIHFLFYLDSDTA SV++EMVEQLELAD +VTFIA+ IDLL
Sbjct: 357 DDNSVSLVLRIADLCGHARNIHFLFYLDSDTAMSVAAEMVEQLELADCDVTFIADFIDLL 416
Query: 435 LLNLIPG 441
++NL+PG
Sbjct: 417 IVNLVPG 423
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 507 bits (1306), Expect = e-143, Method: Compositional matrix adjust.
Identities = 250/433 (57%), Positives = 315/433 (72%), Gaps = 19/433 (4%)
Query: 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERL 74
+P+ E DPT RY RY EV+GKGAFKTVYKAFD++ GLEVAW Q+++ D+L++ +DLERL
Sbjct: 15 EPEFAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLERL 74
Query: 75 YSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW 134
SEV LLK+LKH NII+FYNSW+D +N +N ITE+FTSG+LRQYR KHKKVD++A+K W
Sbjct: 75 RSEVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALKKW 134
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVIGT 193
+RQILSGL+YLHSHDPP+IHRDLKCDNIF+NGNQGEVKIGDLGLATI++ A +A S+IGT
Sbjct: 135 SRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSIIGT 194
Query: 194 PEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253
PEFMAPELYDE YNEL DIY+FGMC+LE+VTFEYPY EC N+AQIYKKVS G KP++L+K
Sbjct: 195 PEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSLAK 254
Query: 254 VKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRC 313
++DPEV+ FIEKC+ ASQRLSA+ELLMDPFL+ +G PL
Sbjct: 255 IEDPEVRFFIEKCIAKASQRLSAQELLMDPFLRDDGEKIFYPL-------------QSNT 301
Query: 314 LMSEGPASVRNKHPSMDFDSDAELPVIT----SLDNSGGGDSYSPSIEVRRSKRGNFFLL 369
S+G S N +D DA I S D Y S ++ G +
Sbjct: 302 KASDGAGS-SNSSMGYKYDRDASSMAIREHTGSFAEEHPSDRYIHSTMDPQAAAGRIITV 360
Query: 370 KGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAE 429
+ + D ++ L LRIAD +G +NIHF F +++DT+ SV++EMV QL+L DQ+VT IAE
Sbjct: 361 ESQMKDLNTIFLKLRIADSTGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIAE 420
Query: 430 LIDLLLLNLIPGW 442
+ID + IP W
Sbjct: 421 MIDAEIRAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1258), Expect = e-137, Method: Compositional matrix adjust.
Identities = 257/451 (56%), Positives = 321/451 (71%), Gaps = 23/451 (5%)
Query: 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERL 74
+ D E DP+ RYIRY +V+G+GAFKTVYKAFDEV+G+EVAW V I+DV+Q P LERL
Sbjct: 16 EADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERL 75
Query: 75 YSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW 134
YSEVHLLK+LKH NII+ + SW+D++NKT+N+ITELFTSGSLR YRKKH+KVD KA+K W
Sbjct: 76 YSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNW 135
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP 194
ARQIL GL YLHS +PP+IHRDLKCDNIF+NGN GEVKIGDLGLAT+++Q A+SVIGTP
Sbjct: 136 ARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTARSVIGTP 195
Query: 195 EFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV 254
EFMAPELY+E YNEL DIYSFGMCMLEMVT EYPY+ECRN AQIYKKV+S IKP +L KV
Sbjct: 196 EFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKV 255
Query: 255 KDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCL 314
DP+V+ FIEKCL+PAS R +A EL DPFL +G + L V
Sbjct: 256 DDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSALLASSSTSSKYV-------- 307
Query: 315 MSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESN 374
P + +H MD D + V ++ D +S +IE++R F L+GE +
Sbjct: 308 ---RPPQL--EHLPMDVDHNENKSVSSNEDY-----PWSQTIELQRIAENKEFRLRGERS 357
Query: 375 DEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLL 434
D+ + S++LRIAD SG+ R +HF FYL+SDTA +++ EMVE+L L Q V IA++ID
Sbjct: 358 DDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEELHLTSQEVVVIADMIDDF 417
Query: 435 LLNLIPGWKPCVRIDHLIPQKSRRQSPEDHE 465
++ L+ R Q S R + EDHE
Sbjct: 418 IMQLLSD-----RTSSHHNQNSPRLTHEDHE 443
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1248), Expect = e-136, Method: Compositional matrix adjust.
Identities = 243/431 (56%), Positives = 313/431 (72%), Gaps = 51/431 (11%)
Query: 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS 76
+ +E DPT RY RYKEV+GKGAFK VY+AFD++ G+EVAW QV++DD S EDL+RLYS
Sbjct: 11 EFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYS 70
Query: 77 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 136
EVHLLK+LKH +II+FY SWID Q+ T+N+ITE+FTSG+LRQYRKKHK VD++A+K W+R
Sbjct: 71 EVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALKKWSR 130
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVIGTPE 195
QIL GL+YLHSHDPP+IHRDLKCDNIFINGNQGEVKIGDLGLA I+ +A +A SVIGTPE
Sbjct: 131 QILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVIGTPE 190
Query: 196 FMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255
FMAPELY+E+YN L DIY+FGMC+LE+VTFEYPYSEC N+AQIY+KV+SGIKPAAL V
Sbjct: 191 FMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVT 250
Query: 256 DPEVKSFIEKCLVPASQRLSAKELLMDPFLQV-NGTTKNRPLPLPDIVLPRVGAFGDRCL 314
DP+V++FIEKC+ SQRLSAKELL DPFL+ T+N
Sbjct: 251 DPQVRAFIEKCIAKVSQRLSAKELLDDPFLKCYKENTEN--------------------- 289
Query: 315 MSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESN 374
+S + N + +D SD+E+ ++T ++G+
Sbjct: 290 VSSHKENGYNGNGIVDKLSDSEVGLLT---------------------------VEGQRK 322
Query: 375 DEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELA-DQNVTFIAELIDL 433
D ++ L LRI D G++RNIHF F +++DT+FSV+ EMVE+L+L DQ+++ IA++ID
Sbjct: 323 DLNTIFLKLRITDSKGQIRNIHFPFNIETDTSFSVAIEMVEELDLTDDQDISTIAKMIDT 382
Query: 434 LLLNLIPGWKP 444
+ + IP W P
Sbjct: 383 EIHSHIPDWTP 393
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1246), Expect = e-135, Method: Compositional matrix adjust.
Identities = 250/467 (53%), Positives = 328/467 (70%), Gaps = 38/467 (8%)
Query: 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
+EP + +E DPT RY RY EV+GKGA KTVY+AFDE G+EVAW QV++ D LQSPED
Sbjct: 7 LEPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED 66
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA 130
LERLY E+HLLK+LKH NI++FY SW+D N+ +N +TELFTSG+LRQYR +HK+V+++A
Sbjct: 67 LERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRA 126
Query: 131 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 190
+K W RQIL GL YLHSHDPP+IHRDLKCDNIF+NGNQGEVKIGDLGLA I+ +++A
Sbjct: 127 MKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC 186
Query: 191 IGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250
+GTPEFMAPE+Y+E YNEL DIYSFGMC+LEMVTF+YPYSEC + AQIYKKV SG KP A
Sbjct: 187 VGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDA 246
Query: 251 LSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQV-NGTTKNRPLPLPDIVLP---RV 306
L KVKDPEVK FIEKCL S R+SA+ELL DPFL++ +G R + + D V P +
Sbjct: 247 LYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDMEDSVGPLYRQP 306
Query: 307 GAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDN--SGG---------GDSYSPS 355
D +S+ ++ + ++ S++ +SL+ S G G +Y+P+
Sbjct: 307 HHLPDYYNYPSNSSSLNRQYSNGNYPSNS-----SSLNRQYSNGYNSHHEYQNGWAYNPA 361
Query: 356 -------IEVRRS----------KRGNF-FLLKGESNDEYSVSLILRIADQSGRLRNIHF 397
IE+ S K GN +KG+ D+ + L LRIAD+ GR+RNI+F
Sbjct: 362 ETEETHGIELFESRNNDDQEEEKKSGNVDITIKGKRRDDGGLFLRLRIADKEGRVRNIYF 421
Query: 398 LFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKP 444
F +++DTA SV++EMV +L++ D VT IA +ID + +L+P W+P
Sbjct: 422 PFDIETDTALSVATEMVAELDMDDHGVTKIANMIDGEISSLVPSWRP 468
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 483 bits (1244), Expect = e-135, Method: Compositional matrix adjust.
Identities = 246/448 (54%), Positives = 313/448 (69%), Gaps = 39/448 (8%)
Query: 16 PDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLY 75
P+ E DPT RY RY +V+GKGA KTVY+AFDE G+EVAW QV++ D LQSPEDLERLY
Sbjct: 15 PEYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLY 74
Query: 76 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWA 135
E+HLLK+LKH NI++FY SW+D + +N ITE+FTSG+LRQYR+KH +V++ AVK W
Sbjct: 75 CEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWC 134
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE 195
RQILSGL+YLHSHDPPIIHRDLKCDNIF+NGNQGEVKIGDLGLA I+ +++A +GTPE
Sbjct: 135 RQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPE 194
Query: 196 FMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255
FMAPE+Y+E YNEL DIYSFGMC+LEMVTFEYPYSEC + QIYKKV SG KP AL KVK
Sbjct: 195 FMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVK 254
Query: 256 DPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVL-PRVG------- 307
DP V+ F+EKCL AS+RLSA+ELL DPFLQV+ D+V P G
Sbjct: 255 DPMVRQFVEKCLATASRRLSARELLKDPFLQVD-----------DLVFCPGDGDYSLMNY 303
Query: 308 --------AFGDRCLMSEGPA-SVRNKHPSMD-FDSDAELPVITSLDNSGGGDSYSPSIE 357
A+ + +MS G + S+ P+ D +D + + +D G +
Sbjct: 304 LRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHED------ 357
Query: 358 VRRSKRGNF-FLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQ 416
GN +KG +++ S+ L LRIAD G +RNI+F F +++DTA SV++EMV +
Sbjct: 358 ---EPLGNVDITIKGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAE 414
Query: 417 LELADQNVTFIAELIDLLLLNLIPGWKP 444
L++ D VT IAE+ID + L+P W+P
Sbjct: 415 LDITDHEVTRIAEMIDGEVSALVPDWRP 442
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 483 bits (1244), Expect = e-135, Method: Compositional matrix adjust.
Identities = 246/448 (54%), Positives = 313/448 (69%), Gaps = 39/448 (8%)
Query: 16 PDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLY 75
P+ E DPT RY RY +V+GKGA KTVY+AFDE G+EVAW QV++ D LQSPEDLERLY
Sbjct: 15 PEYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLY 74
Query: 76 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWA 135
E+HLLK+LKH NI++FY SW+D + +N ITE+FTSG+LRQYR+KH +V++ AVK W
Sbjct: 75 CEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWC 134
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE 195
RQILSGL+YLHSHDPPIIHRDLKCDNIF+NGNQGEVKIGDLGLA I+ +++A +GTPE
Sbjct: 135 RQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPE 194
Query: 196 FMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255
FMAPE+Y+E YNEL DIYSFGMC+LEMVTFEYPYSEC + QIYKKV SG KP AL KVK
Sbjct: 195 FMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVK 254
Query: 256 DPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVL-PRVG------- 307
DP V+ F+EKCL AS+RLSA+ELL DPFLQV+ D+V P G
Sbjct: 255 DPMVRQFVEKCLATASRRLSARELLKDPFLQVD-----------DLVFCPGDGDYSLMNY 303
Query: 308 --------AFGDRCLMSEGPA-SVRNKHPSMD-FDSDAELPVITSLDNSGGGDSYSPSIE 357
A+ + +MS G + S+ P+ D +D + + +D G +
Sbjct: 304 LRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHED------ 357
Query: 358 VRRSKRGNF-FLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQ 416
GN +KG +++ S+ L LRIAD G +RNI+F F +++DTA SV++EMV +
Sbjct: 358 ---EPLGNVDITIKGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAE 414
Query: 417 LELADQNVTFIAELIDLLLLNLIPGWKP 444
L++ D VT IAE+ID + L+P W+P
Sbjct: 415 LDITDHEVTRIAEMIDGEVSALVPDWRP 442
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RA93|WNK6_ORYSJ Probable serine/threonine-protein kinase WNK6 OS=Oryza sativa subsp. japonica GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1212), Expect = e-132, Method: Compositional matrix adjust.
Identities = 239/451 (52%), Positives = 305/451 (67%), Gaps = 34/451 (7%)
Query: 12 EPPD--PDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDD-VLQSP 68
EPPD PDV E DPT RY+RY+E+IG G+ KTVYKAFD V+G+EVAW +V I++ ++ S
Sbjct: 17 EPPDEDPDVAEADPTGRYLRYREIIGSGSSKTVYKAFDAVDGIEVAWGKVEINERIMGSS 76
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM 128
++L+RL +E+ LLKSL+H +I++ Y SW+D +TVNI+TELFTSG+LR+YR KHKKVDM
Sbjct: 77 KELQRLRTEIQLLKSLQHKHILKLYASWVDTNRRTVNIVTELFTSGNLREYRTKHKKVDM 136
Query: 129 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 188
KA++ WA+QIL+GL YLHS PPIIHRDLKCDNIFINGN G+VKIGD GLA +M+Q +
Sbjct: 137 KAMRRWAKQILTGLEYLHSQKPPIIHRDLKCDNIFINGNHGKVKIGDFGLAMVMQQRKTR 196
Query: 189 SVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248
S+ GT EFMAPEL+ ENYNEL DIYSFGMCMLEMVT E PYSEC+ QIYKK++ G+KP
Sbjct: 197 SIQGTIEFMAPELFGENYNELVDIYSFGMCMLEMVTCECPYSECKGFIQIYKKITEGVKP 256
Query: 249 AALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGA 308
AALSKVKD EV+ FIE CL S RL A ELL PFLQ +
Sbjct: 257 AALSKVKDAEVRGFIESCLASVSDRLPASELLKSPFLQSD-------------------- 296
Query: 309 FGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSGG---GDSYSPSIEVRRSKRGN 365
D S K P +F D P+ SL + G G S + +++S
Sbjct: 297 --DANHRSSNSVQEPVKFPENNFTKDE--PIFVSLAPNNGTVNGKEQSFILVLQKSD--- 349
Query: 366 FFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVT 425
FLL+G + V L LR G+ +N+ F F ++ DT+ SVS+EMVEQLEL + N
Sbjct: 350 -FLLEGNMSTTNPVMLFLRFPGPDGKFKNVQFPFDMEKDTSLSVSTEMVEQLELPEWNNP 408
Query: 426 FIAELIDLLLLNLIPGWKPCVRIDHLIPQKS 456
+AELID LL+++P WKPCV++ ++P S
Sbjct: 409 VLAELIDAFLLHILPSWKPCVKVGKMLPSSS 439
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 670 | ||||||
| 225431547 | 677 | PREDICTED: probable serine/threonine-pro | 0.991 | 0.980 | 0.662 | 0.0 | |
| 255585425 | 662 | kinase, putative [Ricinus communis] gi|2 | 0.974 | 0.986 | 0.658 | 0.0 | |
| 10241605 | 666 | protein kinase [Fagus sylvatica] | 0.913 | 0.918 | 0.601 | 0.0 | |
| 224131198 | 583 | predicted protein [Populus trichocarpa] | 0.805 | 0.926 | 0.726 | 0.0 | |
| 357464557 | 675 | Protein kinase [Medicago truncatula] gi| | 0.953 | 0.946 | 0.613 | 0.0 | |
| 15230184 | 567 | putative serine/threonine-protein kinase | 0.752 | 0.888 | 0.729 | 0.0 | |
| 297852562 | 557 | hypothetical protein ARALYDRAFT_474058 [ | 0.731 | 0.879 | 0.742 | 0.0 | |
| 30694495 | 557 | putative serine/threonine-protein kinase | 0.713 | 0.858 | 0.741 | 0.0 | |
| 297834790 | 571 | hypothetical protein ARALYDRAFT_318635 [ | 0.725 | 0.851 | 0.748 | 0.0 | |
| 9293898 | 571 | MAP (mitogen activated protein) kinase-l | 0.752 | 0.882 | 0.724 | 0.0 |
| >gi|225431547|ref|XP_002275565.1| PREDICTED: probable serine/threonine-protein kinase WNK6-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2215), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/667 (66%), Positives = 519/667 (77%), Gaps = 3/667 (0%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
+ES E+G EPPDPDVLE DPT RYIR+K+++GKGAFKTVYKAFD+V+G+EVAW QVR
Sbjct: 6 VESGEEGIGHSEPPDPDVLEIDPTSRYIRFKDILGKGAFKTVYKAFDQVDGIEVAWNQVR 65
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
ID+VLQSP++LERLYSEVHLLKSLKH NII+FYNSWIDD NKTVNIITELFTSGSLRQYR
Sbjct: 66 IDEVLQSPDELERLYSEVHLLKSLKHKNIIKFYNSWIDDGNKTVNIITELFTSGSLRQYR 125
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
KKHKKVDMKAVKGWARQIL GL YLH+H+PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT
Sbjct: 126 KKHKKVDMKAVKGWARQILMGLNYLHNHNPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 185
Query: 181 IMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
+M+QANA++VIGTPEFMAPELYDENYNELADIYSFGMCMLEMVT EYPYSECRNSAQIYK
Sbjct: 186 VMQQANARTVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTLEYPYSECRNSAQIYK 245
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
KVS+GIKPAALSK+KD EVK FIEKCLVPASQRLSAK+LL DPF QV+G TKN PL LPD
Sbjct: 246 KVSNGIKPAALSKIKDLEVKMFIEKCLVPASQRLSAKKLLNDPFFQVDGLTKNHPLQLPD 305
Query: 301 IVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDS--DAELPVITSLDNSGGGDSYSPSIEV 358
IV+P+ GAFGDRCL+SEGP S++N+ +MD D+ D ELP+ITS+DNS G YS +EV
Sbjct: 306 IVIPKTGAFGDRCLLSEGPTSLQNRPLAMDLDAVDDDELPIITSMDNSVDGGPYSLCMEV 365
Query: 359 RRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLE 418
+R+K GNFFLLKGE NDE S+SLILRIADQ+GRLRNIHF+FYLDSDTA SVSSEMVEQLE
Sbjct: 366 QRAKGGNFFLLKGEGNDENSISLILRIADQNGRLRNIHFMFYLDSDTALSVSSEMVEQLE 425
Query: 419 LADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHEKDALSLERVDNSS 478
LADQNVTFIAELIDLLL+ LIP WKPCV IDHL+ +R Q+ H +D E +
Sbjct: 426 LADQNVTFIAELIDLLLIMLIPTWKPCVPIDHLVAL-NRMQTSNGHHEDLQCPEHGECLV 484
Query: 479 GLSHRSYEADNHSRSSDGQDSTSLKEGIQTTVLGPDFMKPDEKRSHNDFSCQGKATADDQ 538
G E DN +STS + I+T P + DE ++H D AT +D
Sbjct: 485 GSFEGVCETDNLLSPHVYPNSTSFEGYIETMQENPKHLSLDEIKTHADLGLPSSATVEDH 544
Query: 539 TSEKSNVSASSSEQNEKKYCFSSDIFPEPGTMDFDGHAFVVRTSESPARMGLGETPDEKS 598
S+ S VSA+S+E ++KKY ++ + E G MD++ + +S + + +K
Sbjct: 545 GSDMSYVSATSNEGSDKKYSHNAYLSAESGCMDYNEYGSKRGVRQSLSAVQTSSCNLDKG 604
Query: 599 NIMDICSNGVVDTSSGLTISSLSDLEIDEEIRMKLEMIDLQYQEEFKAISKRRHDAILDT 658
DI SNG V +S SSLSD E + ++LEMI+LQY E K I+KRR +AI +T
Sbjct: 605 KATDIGSNGAVTSSDYPIDSSLSDQVESENMILELEMIELQYHEAVKEIAKRRQEAIRET 664
Query: 659 KKSMKKK 665
KK + +K
Sbjct: 665 KKRLSQK 671
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585425|ref|XP_002533407.1| kinase, putative [Ricinus communis] gi|223526752|gb|EEF28980.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2163), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/670 (65%), Positives = 511/670 (76%), Gaps = 17/670 (2%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
ME+ EDG A EPPDPDVLE DPT RYIRYKE++GKGAFK VYKAFDEVNGLEVAW QVR
Sbjct: 1 MENCEDGGAHSEPPDPDVLEVDPTGRYIRYKEMLGKGAFKRVYKAFDEVNGLEVAWNQVR 60
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
ID+VLQSPEDLERLYSEVHLLKSLKH NI+RFYNSWIDD+NKTVNIITELFTSG+LR+Y
Sbjct: 61 IDEVLQSPEDLERLYSEVHLLKSLKHGNIVRFYNSWIDDKNKTVNIITELFTSGNLREYC 120
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
KK++ V+MKAVKGWARQIL GL YLH H PP+IHRDLKCDNIFINGNQGEVKIGDLGLAT
Sbjct: 121 KKYRNVEMKAVKGWARQILMGLSYLHGHKPPVIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
Query: 181 IMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
IMEQ+NAKSVIGTPEFMAPELYDE+YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK
Sbjct: 181 IMEQSNAKSVIGTPEFMAPELYDEDYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
KVSSGIKPAALSKVKDPEVK FI+KC+V ASQRLSAKELLMDPFL+VNG KNRPL LPD
Sbjct: 241 KVSSGIKPAALSKVKDPEVKLFIQKCIVSASQRLSAKELLMDPFLEVNGLAKNRPLSLPD 300
Query: 301 IVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRR 360
IV+P++ AFGDRCLMSEGPA+ RNK PSMD D+D E+P+I + NS G S +EVRR
Sbjct: 301 IVMPKLSAFGDRCLMSEGPANARNKPPSMDLDNDPEMPIIKAFKNSFGRHFNSTFVEVRR 360
Query: 361 SKRGNFFLLKGESNDEYSVSLILRIADQSG-RLRNIHFLFYLDSDTAFSVSSEMVEQLEL 419
+K+GN F LKGE +DE SVSLILRIADQ+G R+RNIHFLFYLD DTA VSSEMVEQLEL
Sbjct: 361 AKKGNIFFLKGEKHDENSVSLILRIADQNGSRVRNIHFLFYLDGDTALLVSSEMVEQLEL 420
Query: 420 ADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHEKDALSLERVDN--S 477
DQN+TFIAELIDLLLL LIP WKPCVRI+HL+P+ + S + + S D
Sbjct: 421 EDQNITFIAELIDLLLLKLIPNWKPCVRIEHLVPRNATNSSKGNLKSHKSSENYKDQIVV 480
Query: 478 SGLSHRSYEADNHSRSSDGQDSTSLKEGIQTTVLGPD----FMKPDEKRSHNDFSCQGK- 532
+G + + +SR+S DS S I + D +K + S + S +
Sbjct: 481 AGSAQDIRQIATYSRTSSCLDSCSQGGSIPRSEADQDGSAGIIKLSDMPSQTNESGNYRM 540
Query: 533 ATADDQTSEKSNVSASSSEQNEKKYCFSSDIFPEPGTMDFDGHAFVVRTSESPARMGLGE 592
A +D SEKS SA+SSE N+K+ F+S + E G ++FDGH F + A M G+
Sbjct: 541 AMVEDLVSEKSYTSAASSEWNDKRLSFNSCVTAESGLVNFDGHGFKGSQGDLLASMEAGQ 600
Query: 593 TPDEKSNIMDICSNGVVDTSSGLTISSLSDLEIDEEIRMKLEMIDLQYQEEFKAISKRRH 652
PD M+I S+ +IS LS+ E+R +LE I+LQYQE K I ++RH
Sbjct: 601 PPDSH---MEISSDYPT------SISFLSNKNESNELREELEKIELQYQEAIKEIIRQRH 651
Query: 653 DAILDTKKSM 662
AI++T K +
Sbjct: 652 KAIIETTKRL 661
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10241605|emb|CAC09581.1| protein kinase [Fagus sylvatica] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2038), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/697 (60%), Positives = 484/697 (69%), Gaps = 85/697 (12%)
Query: 2 ESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI 61
ESSEDG+ EPPDPDVLE DPTCRYIRYK+V+GKGAFKTV+KAFDE +GLEVAW QVRI
Sbjct: 7 ESSEDGSGHAEPPDPDVLEIDPTCRYIRYKDVLGKGAFKTVFKAFDEADGLEVAWNQVRI 66
Query: 62 DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR- 120
DDVLQSP+DLERLYSEVHLLKSLKH+NI++FYNSWIDD+NKTVNIITELFTSG+LRQY
Sbjct: 67 DDVLQSPDDLERLYSEVHLLKSLKHSNIVKFYNSWIDDKNKTVNIITELFTSGNLRQYVS 126
Query: 121 -------------------------------KKHKKVDMKAVKGWARQILSGLIYLHSHD 149
KKHKKVDMKA+KGWARQIL+GL YLHSH
Sbjct: 127 FLLIALLKFLILFYGDISLVVSGCNPWFRYCKKHKKVDMKALKGWARQILTGLNYLHSHS 186
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNEL 209
PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT+MEQANAKSVIGTPEFMAPELYDE+YNEL
Sbjct: 187 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDEDYNEL 246
Query: 210 ADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP 269
ADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP ALSKVKDP +K FIEKCLVP
Sbjct: 247 ADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPVALSKVKDPAMKQFIEKCLVP 306
Query: 270 ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSM 329
ASQRLSAKELLMDPFLQVN KNRPLPLPDIVLP++GAF
Sbjct: 307 ASQRLSAKELLMDPFLQVNRLAKNRPLPLPDIVLPKMGAF-------------------- 346
Query: 330 DFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQS 389
DNS G SY +E++R+K+GNFF +KGE NDE SVSLILRIADQ+
Sbjct: 347 --------------DNSVYGGSYPVCVEIQRAKKGNFFWIKGEGNDEDSVSLILRIADQN 392
Query: 390 GRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPCVRID 449
GR RNIHFLFYL SDTA SVSSEMVEQLELADQNV FIAELIDLLL+NL+P WKPCVRID
Sbjct: 393 GRARNIHFLFYLVSDTAISVSSEMVEQLELADQNVMFIAELIDLLLMNLVPKWKPCVRID 452
Query: 450 HLIPQKSRRQSPEDHEKDALS------LERVDNSSGLSHRSYEADNHSRSSDGQDSTSLK 503
HL+ R E L ++ N ++H S + + S G +
Sbjct: 453 HLVAPNGIRTHEAHQEASQLPKHGEKLVKSHQNVCAVAHPSSPPSSTNSISSGGSIQPVP 512
Query: 504 EGIQTTVL---------GPDFMKPDEKRSHNDFSCQGKATADDQTSEKSNVSASSSEQNE 554
+ PD +K +E SH++F Q +DQ SE S +SA+S+E ++
Sbjct: 513 SSTNSISSGGSIQSVRESPDNVKLEEIMSHDNFGLQSATVTEDQCSEMSYISATSTEFDD 572
Query: 555 KKYCFSSDIFPEPGTMDFDGHAFVVRTSESPARMGLGETPDEKSNIMDICSNGVVDTSSG 614
K S + E G +D + + ESP++ +G +PD S MD+ S+ V T S
Sbjct: 573 KNSSIDSYMSAEMGPVDLNRYRLDRGVRESPSKAEMGASPDYNSKDMDLESSLV--TFSA 630
Query: 615 LTISSLSDLEIDEEIRMKLEMIDLQYQEEFKAISKRR 651
I+ +D EE+RM+LE+I+LQYQE K +S+ +
Sbjct: 631 YPIN--ADQGGVEELRMELEVIELQYQEAIKEMSQEK 665
|
Source: Fagus sylvatica Species: Fagus sylvatica Genus: Fagus Family: Fagaceae Order: Fagales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224131198|ref|XP_002328479.1| predicted protein [Populus trichocarpa] gi|222838194|gb|EEE76559.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2011), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/545 (72%), Positives = 450/545 (82%), Gaps = 5/545 (0%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
MESSEDG + EPPDPDVLE DPTCRYIRYKEV+GKGAFKTVYKAFDEVNG+EVAW QVR
Sbjct: 1 MESSEDGGSHSEPPDPDVLEIDPTCRYIRYKEVLGKGAFKTVYKAFDEVNGIEVAWNQVR 60
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
ID+VLQSP+DLERLYSE+HLLK+LK++NI+RFYNSWIDD+ KTVNIITELFTSGSLRQY
Sbjct: 61 IDEVLQSPDDLERLYSEMHLLKTLKNSNIVRFYNSWIDDKKKTVNIITELFTSGSLRQYC 120
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
KKH+K++MKAVKGWARQIL+GL YLH+HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT
Sbjct: 121 KKHRKIEMKAVKGWARQILNGLNYLHNHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
Query: 181 IMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK
Sbjct: 181 VMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
KVSSGIKPA+LSKVKDP++K FIEKCL+PAS+RL AKELLMDPFL VNG +N +P D
Sbjct: 241 KVSSGIKPASLSKVKDPDLKQFIEKCLLPASERLPAKELLMDPFLDVNGFARNSSIPRSD 300
Query: 301 IVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRR 360
I++ ++ A GDRCLMSEGPA+ RNK PSMD D E+P ITS +NS D++S +EVRR
Sbjct: 301 ILMSKMTAIGDRCLMSEGPATARNKPPSMDLSHDPEMPTITSFNNSVDEDTHSLCLEVRR 360
Query: 361 SKRGNFFLLKGESNDEYSVSLILRIADQSG-RLRNIHFLFYLDSDTAFSVSSEMVEQLEL 419
+KRGN FLL+GE NDE SVSLILR+ADQ+G R+RNIHFLFYLD DTA SVSSEMVEQLEL
Sbjct: 361 AKRGNVFLLRGEGNDENSVSLILRMADQNGARVRNIHFLFYLDGDTALSVSSEMVEQLEL 420
Query: 420 ADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHEKDALSLERVDNSSG 479
+NV FIAELIDLLLL LIP WKP V I+HL+P SR Q+P KD SL +
Sbjct: 421 EVENVKFIAELIDLLLLKLIPNWKPGVHIEHLVP-PSREQTPRVQSKDFHSLGNGKMAVA 479
Query: 480 LSHRSYEADNHSRSSDGQDSTSLKEGIQTTVLGPDFMKPDEKRSH-NDFSCQGKATADDQ 538
+++A NHSR S + SL I T P +K D+ S+ +DF Q A+D+
Sbjct: 480 PFQNAHDAANHSRCSSRPN--SLGGSIPTVGESPSTVKLDDLMSNLDDFDSQNPPAAEDR 537
Query: 539 TSEKS 543
SE S
Sbjct: 538 HSEMS 542
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357464557|ref|XP_003602560.1| Protein kinase [Medicago truncatula] gi|355491608|gb|AES72811.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1987), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/665 (61%), Positives = 485/665 (72%), Gaps = 26/665 (3%)
Query: 5 EDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV 64
E+G+A +EPPDPDV+E DPTCRY+RYKEVIGKGAFKTVYKAFDEV GLEVAW QVRID+V
Sbjct: 28 EEGSALLEPPDPDVVEIDPTCRYLRYKEVIGKGAFKTVYKAFDEVTGLEVAWSQVRIDEV 87
Query: 65 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK 124
LQSP DLERLYSEVHLL+SLKH+NIIRFYNSWIDD++ VN+ITELFTSGSLRQYRKKHK
Sbjct: 88 LQSPGDLERLYSEVHLLRSLKHSNIIRFYNSWIDDKHGNVNMITELFTSGSLRQYRKKHK 147
Query: 125 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184
KVD+KAVKGWARQIL GL+YLH+H+PPIIHRD+KCDNIFING+QGEVKIGDLGLAT+++Q
Sbjct: 148 KVDVKAVKGWARQILMGLVYLHNHNPPIIHRDVKCDNIFINGHQGEVKIGDLGLATLLKQ 207
Query: 185 ANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS 244
NAKSVIGTPEFMAPELYDE+YNELADIYSFGMCMLE+ T +YPY ECRNSAQIYKKVSS
Sbjct: 208 NNAKSVIGTPEFMAPELYDEDYNELADIYSFGMCMLELATSQYPYRECRNSAQIYKKVSS 267
Query: 245 GIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLP 304
GIKP +LS +KDPE+KSFIEKCLVPASQRLSAKELLMDPFL+VN + KNRPLPLPDIVLP
Sbjct: 268 GIKPVSLSTIKDPEIKSFIEKCLVPASQRLSAKELLMDPFLEVNFSVKNRPLPLPDIVLP 327
Query: 305 RVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRG 364
+ G F +RCLMSEGPAS R SM+ E PVIT NS SP +E+RR
Sbjct: 328 KFGGFENRCLMSEGPASARIGSSSMELGDTNEQPVITVSYNSVDDAPPSPCVEIRRLMGV 387
Query: 365 NFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNV 424
+ F LKGE+ND S+SL+LRI DQ GR RNIHF+FYLDSDTA SVSSEMVEQLELA+ NV
Sbjct: 388 DRFFLKGEANDTNSISLVLRIIDQGGRARNIHFIFYLDSDTAMSVSSEMVEQLELAEHNV 447
Query: 425 TFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRR----QSPEDHEKDALSLERVDNSSGL 480
FIAELIDLLL LIP WKPCV IDHLI RR Q + + +D+S +
Sbjct: 448 KFIAELIDLLLTTLIPDWKPCVAIDHLISPNGRRTHMSQQKQLSQLAKYKQNSIDSSQIM 507
Query: 481 SHRSYEADNHSRSSDGQDSTSLKEGIQTTVLGPDFMKPDEKRSHNDFSCQGKATADDQTS 540
+ +H R ++ KE I D M ++ SH Q DD S
Sbjct: 508 REYVGPSTSHERLAE-------KENI-------DNMNFEDVFSHASIGLQRTTKTDDLYS 553
Query: 541 EKSNVSASSSEQNEKKYCFSSDIFPEPGTMDFDGHAFVVRTSESPARMGLGETPDEKSNI 600
S SA +S+ N+K + S + G DF+ S+S +G + D+KS
Sbjct: 554 MTSYTSA-TSDYNDKNFSTVSFMSARSGFTDFNFPTVNGWGSQSSLASEIGASYDKKSKF 612
Query: 601 MDICSNGVVDTSSGLTISSLSDLEIDEEIRMKLEMIDLQYQEEFKAISKRRHDAILDTKK 660
+ +N +S+ S E ++E+R++LE I+ QYQE K + KRRHDA+++T+K
Sbjct: 613 PCMENN-------NYPLSTSSFHEAEDELRIELEKIERQYQEAMKDLCKRRHDAMMETRK 665
Query: 661 SMKKK 665
+ +K
Sbjct: 666 RLSQK 670
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15230184|ref|NP_188505.1| putative serine/threonine-protein kinase WNK6 [Arabidopsis thaliana] gi|334185446|ref|NP_001189928.1| putative serine/threonine-protein kinase WNK6 [Arabidopsis thaliana] gi|75248034|sp|Q8S8Y8.1|WNK6_ARATH RecName: Full=Probable serine/threonine-protein kinase WNK6; Short=AtWNK6; AltName: Full=Protein kinase with no lysine 6 gi|20302604|dbj|BAB91129.1| Ser/Thr kinase [Arabidopsis thaliana] gi|51970136|dbj|BAD43760.1| putative mitogen activated protein kinase kinase [Arabidopsis thaliana] gi|133778828|gb|ABO38754.1| At3g18750 [Arabidopsis thaliana] gi|332642618|gb|AEE76139.1| putative serine/threonine-protein kinase WNK6 [Arabidopsis thaliana] gi|332642620|gb|AEE76141.1| putative serine/threonine-protein kinase WNK6 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1973), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/522 (72%), Positives = 428/522 (81%), Gaps = 18/522 (3%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
ME ++D +A EPPDP+VLE DPT RYIRYKEVIGKGAFKTVYKAFDEV+G+EVAW QVR
Sbjct: 1 MEGTDDASALQEPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVR 60
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
IDDVLQSP LERLYSEV LLKSLKHNNIIRFYNSWIDD+NKTVNIITELFTSGSLR YR
Sbjct: 61 IDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYR 120
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
KKH+KV+MKAVK WARQIL GL YLH +PPIIHRDLKCDNIFINGN GEVKIGDLGLAT
Sbjct: 121 KKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLAT 180
Query: 181 IMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTF+YPY EC+NSAQIYK
Sbjct: 181 VMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYK 240
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
KVSSGIKPA+LS+VKDPEVK FIEKCL+PAS+RLSAKELL+DPFLQ+NG T N PLPLPD
Sbjct: 241 KVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLTMNNPLPLPD 300
Query: 301 IVLPRVGAFGDRCLMSEGPASVR-NKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVR 359
IV+P+ GAFGDRCLMSEGP + R +K S+D D D+ LP++T DNSG S IEVR
Sbjct: 301 IVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSG-----SRCIEVR 355
Query: 360 RSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLEL 419
R+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLFY + DTA VSSEMVEQLEL
Sbjct: 356 RAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLEL 415
Query: 420 ADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHE--KDALSLERV--D 475
DQNVTFIAELID+LL+N+IP WK V +DHLI + + S H K E V D
Sbjct: 416 TDQNVTFIAELIDILLVNMIPTWKTDVTVDHLIHSQLNQNSRSHHNEAKPQKQEETVFHD 475
Query: 476 NSSGLSH-------RSYEADNHS-RSSDGQDSTSLKEGIQTT 509
+SH RS E D ++ G+D +S++E + T
Sbjct: 476 TCELVSHSCNSDCPRSDEEDKQCVDATKGEDKSSIQEVEEAT 517
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852562|ref|XP_002894162.1| hypothetical protein ARALYDRAFT_474058 [Arabidopsis lyrata subsp. lyrata] gi|297340004|gb|EFH70421.1| hypothetical protein ARALYDRAFT_474058 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1968), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/500 (74%), Positives = 420/500 (84%), Gaps = 10/500 (2%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
ME SED +A +EPPDP+VLE DPTCRYIRYKEVIGKGA KTV+K FDEV+G+EVAW QVR
Sbjct: 1 MEGSEDASAIVEPPDPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVR 60
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
IDD+LQSP+ LERLYSEV LLKSLKH NIIRFYNSWIDD+NKTVNIITELFTSGSLRQYR
Sbjct: 61 IDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYR 120
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
KKH+KV+MKAVK WARQIL+GL YLHS DPPIIHRD+KCDNIFINGN GEVKIGDLGLAT
Sbjct: 121 KKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLAT 180
Query: 181 IMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPY ECRNSAQIYK
Sbjct: 181 VMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYK 240
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
KVSSGIKPA+LSKVKDPEV FIEKCL+PAS+RLSA+ELL+D FL VNG N PLPLPD
Sbjct: 241 KVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFLNVNGLVMNNPLPLPD 300
Query: 301 IVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRR 360
IV+P+ G+FG+RCLMSEGP + RN+ SM+ D D LP++ S +NSG S IEVRR
Sbjct: 301 IVMPKEGSFGERCLMSEGPPNARNRPMSMNLDEDNNLPIVISSNNSG-----SKCIEVRR 355
Query: 361 SKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELA 420
+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLF+ + DTA +VSSEMVEQLEL
Sbjct: 356 AKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELT 415
Query: 421 DQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHEKDALSLERVDNSSGL 480
DQNV FIAELID+LL+NLIP WK V +DHLI + + S ++H+ A S + +
Sbjct: 416 DQNVKFIAELIDVLLVNLIPNWKTDVTVDHLIHPQQNQSSKDNHQNGANS----QDGESI 471
Query: 481 SHRSYEADNHSRSSDGQDST 500
SH S +D RS D + T
Sbjct: 472 SH-SLSSDYCPRSDDEANPT 490
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30694495|ref|NP_849787.1| putative serine/threonine-protein kinase WNK7 [Arabidopsis thaliana] gi|75246559|sp|Q8LST2.1|WNK7_ARATH RecName: Full=Probable serine/threonine-protein kinase WNK7; Short=AtWNK7; AltName: Full=Protein kinase with no lysine 7 gi|21039014|dbj|BAB92986.1| protein kinase [Arabidopsis thaliana] gi|222423633|dbj|BAH19785.1| AT1G49160 [Arabidopsis thaliana] gi|332194277|gb|AEE32398.1| putative serine/threonine-protein kinase WNK7 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/495 (74%), Positives = 419/495 (84%), Gaps = 17/495 (3%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
ME SED +A +EPPDP+VLE DPTCRYIRYKEVIGKGA KTV+K FDEV+G+EVAW QVR
Sbjct: 1 MEGSEDASAIVEPPDPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVR 60
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
IDD+LQSP+ LERLYSEV LLKSLKH NIIRFYNSWIDD+NKTVNIITELFTSGSLRQYR
Sbjct: 61 IDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYR 120
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
KKH+KV+MKAVK WARQIL+GL YLHS DPPIIHRD+KCDNIFINGN GEVKIGDLGLAT
Sbjct: 121 KKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLAT 180
Query: 181 IMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPY ECRNSAQIYK
Sbjct: 181 VMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYK 240
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
KVSSGIKPA+LSKVKDPEV FIEKCL+PAS+RLSA+ELL+D FL VNG N PLPLPD
Sbjct: 241 KVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFLNVNGLVMNNPLPLPD 300
Query: 301 IVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRR 360
IV+P+ G+FG+RCLMSEGP + RN+ SM+ D D LP++ S +NSG + IEVRR
Sbjct: 301 IVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSG-----TNCIEVRR 355
Query: 361 SKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELA 420
+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLF+ + DTA +VSSEMVEQLEL
Sbjct: 356 AKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELT 415
Query: 421 DQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHEKDALSLERVDNSSGL 480
D+NV FIAELID+LL+NLIP WK V +DHLI + + S ++H+ +G
Sbjct: 416 DKNVKFIAELIDVLLVNLIPNWKTDVAVDHLIHPQQNQSSKDNHQ------------NGA 463
Query: 481 SHRSYEADNHSRSSD 495
S ++ E+ +HS SSD
Sbjct: 464 SSQAGESISHSLSSD 478
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297834790|ref|XP_002885277.1| hypothetical protein ARALYDRAFT_318635 [Arabidopsis lyrata subsp. lyrata] gi|297331117|gb|EFH61536.1| hypothetical protein ARALYDRAFT_318635 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1960), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/500 (74%), Positives = 419/500 (83%), Gaps = 14/500 (2%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVY----KAFDEVNGLEVAW 56
ME ++D A EPPDP+VLE DPT RYIRYKEVIGKGAFKTVY KAFDEV+G+EVAW
Sbjct: 1 MEGTDDACALQEPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYPFRYKAFDEVDGIEVAW 60
Query: 57 CQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL 116
QVRIDDVLQSP LERLYSEV LLKSLKHNNIIRFYNSWIDD+NKTVNIITELFTSGSL
Sbjct: 61 NQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSL 120
Query: 117 RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176
R YRKKH+KV+MKAVK WARQIL GL YLH +PPIIHRDLKCDNIFINGN GEVKIGDL
Sbjct: 121 RHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDL 180
Query: 177 GLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSA 236
GLAT+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPY EC+NSA
Sbjct: 181 GLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECKNSA 240
Query: 237 QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPL 296
QIYKKVSSGIKPA+LS+VKDPEVK FIEKCL+PAS+RLSAKELL+DPFLQ+NG T N PL
Sbjct: 241 QIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLTMNNPL 300
Query: 297 PLPDIVLPRVGAFGDRCLMSEGPASVR-NKHPSMDFDSDAELPVITSLDNSGGGDSYSPS 355
PLPDIV+P+ GAFGDRCLMSEGP + R +K S+D D D+ LP++T DNSG S
Sbjct: 301 PLPDIVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSG-----SRC 355
Query: 356 IEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVE 415
IEVRR+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLFY + DTA VSSEMVE
Sbjct: 356 IEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVE 415
Query: 416 QLELADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHEKDALSLERVD 475
QLEL DQNVTFIAELID+LL+N+IP WK V +DHLI Q+ H +A ++ +
Sbjct: 416 QLELTDQNVTFIAELIDILLVNMIPTWKTDVTVDHLI-HSQLNQNSRSHHNEAKPQKQEE 474
Query: 476 NSSGLSHRSYEADNHSRSSD 495
+ H + E+ +HS +SD
Sbjct: 475 TT---FHDACESVSHSWNSD 491
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|9293898|dbj|BAB01801.1| MAP (mitogen activated protein) kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1955), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/526 (72%), Positives = 428/526 (81%), Gaps = 22/526 (4%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVY----KAFDEVNGLEVAW 56
ME ++D +A EPPDP+VLE DPT RYIRYKEVIGKGAFKTVY KAFDEV+G+EVAW
Sbjct: 1 MEGTDDASALQEPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYPFRYKAFDEVDGIEVAW 60
Query: 57 CQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL 116
QVRIDDVLQSP LERLYSEV LLKSLKHNNIIRFYNSWIDD+NKTVNIITELFTSGSL
Sbjct: 61 NQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSL 120
Query: 117 RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176
R YRKKH+KV+MKAVK WARQIL GL YLH +PPIIHRDLKCDNIFINGN GEVKIGDL
Sbjct: 121 RHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDL 180
Query: 177 GLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSA 236
GLAT+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTF+YPY EC+NSA
Sbjct: 181 GLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSA 240
Query: 237 QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPL 296
QIYKKVSSGIKPA+LS+VKDPEVK FIEKCL+PAS+RLSAKELL+DPFLQ+NG T N PL
Sbjct: 241 QIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLTMNNPL 300
Query: 297 PLPDIVLPRVGAFGDRCLMSEGPASVR-NKHPSMDFDSDAELPVITSLDNSGGGDSYSPS 355
PLPDIV+P+ GAFGDRCLMSEGP + R +K S+D D D+ LP++T DNSG S
Sbjct: 301 PLPDIVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSG-----SRC 355
Query: 356 IEVRRSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVE 415
IEVRR+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLFY + DTA VSSEMVE
Sbjct: 356 IEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVE 415
Query: 416 QLELADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPEDHE--KDALSLER 473
QLEL DQNVTFIAELID+LL+N+IP WK V +DHLI + + S H K E
Sbjct: 416 QLELTDQNVTFIAELIDILLVNMIPTWKTDVTVDHLIHSQLNQNSRSHHNEAKPQKQEET 475
Query: 474 V--DNSSGLSH-------RSYEADNHS-RSSDGQDSTSLKEGIQTT 509
V D +SH RS E D ++ G+D +S++E + T
Sbjct: 476 VFHDTCELVSHSCNSDCPRSDEEDKQCVDATKGEDKSSIQEVEEAT 521
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 670 | ||||||
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.725 | 0.857 | 0.717 | 4.8e-194 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.731 | 0.879 | 0.702 | 4.4e-191 | |
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.410 | 0.488 | 0.694 | 2.8e-131 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.438 | 0.42 | 0.654 | 1.7e-123 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.405 | 0.527 | 0.699 | 2.2e-120 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.601 | 0.769 | 0.554 | 1.1e-118 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.632 | 0.861 | 0.501 | 2.5e-106 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.435 | 0.531 | 0.610 | 2.5e-104 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.401 | 0.471 | 0.644 | 9.6e-101 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.420 | 0.898 | 0.565 | 4.4e-84 |
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1803 (639.7 bits), Expect = 4.8e-194, Sum P(2) = 4.8e-194
Identities = 356/496 (71%), Positives = 397/496 (80%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
ME ++D +A EPPDP+VLE DPT RYIRYKEVIGKGAFKTVYKAFDEV+G+EVAW QVR
Sbjct: 1 MEGTDDASALQEPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVR 60
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
IDDVLQSP LERLYSEV LLKSLKHNNIIRFYNSWIDD+NKTVNIITELFTSGSLR YR
Sbjct: 61 IDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYR 120
Query: 121 XXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
WARQIL GL YLH +PPIIHRDLKCDNIFINGN GEVKIGDLGLAT
Sbjct: 121 KKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLAT 180
Query: 181 IMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTF+YPY EC+NSAQIYK
Sbjct: 181 VMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYK 240
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
KVSSGIKPA+LS+VKDPEVK FIEKCL+PAS+RLSAKELL+DPFLQ+NG T N PLPLPD
Sbjct: 241 KVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLTMNNPLPLPD 300
Query: 301 IVLPRVGAFGDRCLMSEGPASVR-NKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVR 359
IV+P+ GAFGDRCLMSEGP + R +K S+D D D+ LP++T DNSG S IEVR
Sbjct: 301 IVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSG-----SRCIEVR 355
Query: 360 RSKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLEL 419
R+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLFY + DTA VSSEMVEQLEL
Sbjct: 356 RAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLEL 415
Query: 420 ADQNVTFIAEXXXXXXXXXXPGWKPCVRIDHLIPQKSRRQSPEDHEKDALSLERVDNSSG 479
DQNVTFIAE P WK V +DHLI Q+ H +A ++ +
Sbjct: 416 TDQNVTFIAELIDILLVNMIPTWKTDVTVDHLI-HSQLNQNSRSHHNEAKPQKQEET--- 471
Query: 480 LSHRSYEADNHSRSSD 495
+ H + E +HS +SD
Sbjct: 472 VFHDTCELVSHSCNSD 487
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1782 (632.4 bits), Expect = 4.4e-191, Sum P(2) = 4.4e-191
Identities = 351/500 (70%), Positives = 397/500 (79%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
ME SED +A +EPPDP+VLE DPTCRYIRYKEVIGKGA KTV+K FDEV+G+EVAW QVR
Sbjct: 1 MEGSEDASAIVEPPDPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVR 60
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
IDD+LQSP+ LERLYSEV LLKSLKH NIIRFYNSWIDD+NKTVNIITELFTSGSLRQYR
Sbjct: 61 IDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYR 120
Query: 121 XXXXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
WARQIL+GL YLHS DPPIIHRD+KCDNIFINGN GEVKIGDLGLAT
Sbjct: 121 KKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLAT 180
Query: 181 IMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
+MEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPY ECRNSAQIYK
Sbjct: 181 VMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYK 240
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
KVSSGIKPA+LSKVKDPEV FIEKCL+PAS+RLSA+ELL+D FL VNG N PLPLPD
Sbjct: 241 KVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFLNVNGLVMNNPLPLPD 300
Query: 301 IVLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRR 360
IV+P+ G+FG+RCLMSEGP + RN+ SM+ D D LP++ S +NSG + IEVRR
Sbjct: 301 IVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSG-----TNCIEVRR 355
Query: 361 SKRGNFFLLKGESNDEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELA 420
+KRGNFF+LKGE NDE SVSLILRI D++GR+RNIHFLF+ + DTA +VSSEMVEQLEL
Sbjct: 356 AKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELT 415
Query: 421 DQNVTFIAEXXXXXXXXXXPGWKPCVRIDHLIPQKSRRQSPEDHEKDALSLERVDNSSGL 480
D+NV FIAE P WK V +DHLI + + S ++H+ A S +
Sbjct: 416 DKNVKFIAELIDVLLVNLIPNWKTDVAVDHLIHPQQNQSSKDNHQNGASS----QAGESI 471
Query: 481 SHRSYEADNHSRSSDGQDST 500
SH S +D RS D + T
Sbjct: 472 SH-SLSSDYCPRSDDEANPT 490
|
|
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1026 (366.2 bits), Expect = 2.8e-131, Sum P(3) = 2.8e-131
Identities = 191/275 (69%), Positives = 224/275 (81%)
Query: 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERL 74
+ D E DP+ RYIRY +V+G+GAFKTVYKAFDEV+G+EVAW V I+DV+Q P LERL
Sbjct: 16 EADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERL 75
Query: 75 YSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRXXXXXXXXXXXXGW 134
YSEVHLLK+LKH NII+ + SW+D++NKT+N+ITELFTSGSLR YR W
Sbjct: 76 YSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNW 135
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP 194
ARQIL GL YLHS +PP+IHRDLKCDNIF+NGN GEVKIGDLGLAT+++Q A+SVIGTP
Sbjct: 136 ARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTARSVIGTP 195
Query: 195 EFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV 254
EFMAPELY+E YNEL DIYSFGMCMLEMVT EYPY+ECRN AQIYKKV+S IKP +L KV
Sbjct: 196 EFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKV 255
Query: 255 KDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNG 289
DP+V+ FIEKCL+PAS R +A EL DPFL +G
Sbjct: 256 DDPQVRQFIEKCLLPASSRPTALELSKDPFLARDG 290
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1024 (365.5 bits), Expect = 1.7e-123, Sum P(3) = 1.7e-123
Identities = 193/295 (65%), Positives = 229/295 (77%)
Query: 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
+EP + +E DPT RY RY EV+GKGA KTVY+AFDE G+EVAW QV++ D LQSPED
Sbjct: 7 LEPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED 66
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRXXXXXXXXXX 130
LERLY E+HLLK+LKH NI++FY SW+D N+ +N +TELFTSG+LRQYR
Sbjct: 67 LERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRA 126
Query: 131 XXGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 190
W RQIL GL YLHSHDPP+IHRDLKCDNIF+NGNQGEVKIGDLGLA I+ +++A
Sbjct: 127 MKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC 186
Query: 191 IGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250
+GTPEFMAPE+Y+E YNEL DIYSFGMC+LEMVTF+YPYSEC + AQIYKKV SG KP A
Sbjct: 187 VGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDA 246
Query: 251 LSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVN-GTTKNRPLPLPDIVLP 304
L KVKDPEVK FIEKCL S R+SA+ELL DPFL+++ G R + + D V P
Sbjct: 247 LYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDMEDSVGP 301
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 2.2e-120, Sum P(2) = 2.2e-120
Identities = 191/273 (69%), Positives = 229/273 (83%)
Query: 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERL 74
+ + +E DPT RY RYKEV+GKGAFK VY+AFD++ G+EVAW QV++DD S EDL+RL
Sbjct: 9 EEEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRL 68
Query: 75 YSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRXXXXXXXXXXXXGW 134
YSEVHLLK+LKH +II+FY SWID Q+ T+N+ITE+FTSG+LRQYR W
Sbjct: 69 YSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALKKW 128
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVIGT 193
+RQIL GL+YLHSHDPP+IHRDLKCDNIFINGNQGEVKIGDLGLA I+ +A +A SVIGT
Sbjct: 129 SRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVIGT 188
Query: 194 PEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253
PEFMAPELY+E+YN L DIY+FGMC+LE+VTFEYPYSEC N+AQIY+KV+SGIKPAAL
Sbjct: 189 PEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAALLN 248
Query: 254 VKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQ 286
V DP+V++FIEKC+ SQRLSAKELL DPFL+
Sbjct: 249 VTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLK 281
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1134 (404.2 bits), Expect = 1.1e-118, Sum P(2) = 1.1e-118
Identities = 230/415 (55%), Positives = 286/415 (68%)
Query: 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERL 74
+ D ++ DPT RYIRY +V+G+GAFKTVYKAFDEV G+EVAW + I+DVLQ P L+RL
Sbjct: 3 EADFVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRL 62
Query: 75 YSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRXXXXXXXXXXXXGW 134
YSEVHLL SLKH+NII+ + SW+DD NK++N+ITELFTSGSL YR W
Sbjct: 63 YSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNW 122
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP 194
ARQIL GL YLHS PP+IHRDLKCDNIF+NGN G+VKIGDLGLA +M+Q A+SVIGTP
Sbjct: 123 ARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTP 182
Query: 195 EFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV 254
EFMAPELY+E YNEL DIYSFGMCMLEMVT EYPY ECRN AQIYKKV+SGIKP +LSKV
Sbjct: 183 EFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKV 242
Query: 255 KDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCL 314
DP+VK FIEKCL+PA R +A ELL D L V+G K+ L A +
Sbjct: 243 DDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGA-KDSTLT----------ASSNTTF 291
Query: 315 MSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESN 374
P + +++ + + + +S +S + ++EV+R F L GE
Sbjct: 292 KPAMPPQCEYRPMDVEYKKNTSVSICSSAKSSQEC-ALLQTMEVQRVAESTEFKLSGERR 350
Query: 375 DEYSVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAE 429
D+ + S+ LRIA SG+ R + F F L +DTA +V+ EMVE+L+L+ VT IAE
Sbjct: 351 DDVAASMALRIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAE 405
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1052 (375.4 bits), Expect = 2.5e-106, P = 2.5e-106
Identities = 221/441 (50%), Positives = 287/441 (65%)
Query: 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
+E + +E DPT RY RY EV+GKG+ KTVY+ FDE G+EVAW QV++ D LQSP++
Sbjct: 8 LESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQE 67
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRXXXXXXXXXX 130
LERLY E+HLLK+LKH +I++FY SW+D N+ +N +TE+FTSG+LRQYR
Sbjct: 68 LERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRA 127
Query: 131 XXGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 190
W RQIL GL YLH+HDPP+IHRDLKCDNIFINGNQGEVKIGDLGLA ++ ++A
Sbjct: 128 VKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHC 187
Query: 191 IGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250
+GTPEFMAPE+Y E YN+L DIYSFGMC+LEMVTF+YPYSEC + AQIYK+V SG KP
Sbjct: 188 VGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDG 247
Query: 251 LSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFG 310
L KVKDPEV+ FIEKCL S RLSA ELL D FL ++ + R + ++ G
Sbjct: 248 LDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCIDESDMRR-VESEKGLIDEAGTPL 306
Query: 311 DRCL----MSEGPASVRNKHPSMDFDSD--AELPVITSLDNSGGGDSYSPSIEVRRSKR- 363
S G S+ N++ D++ D E I L+ D E KR
Sbjct: 307 RHSYHIPHYSNGYYSLYNQN-QWDYNGDETVESHEIDLLEFQNDDD------EEEEDKRF 359
Query: 364 GNFFL-LKGESNDEYS-VSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELAD 421
G+ + +KG+ D + L L+ ++ G +RNI+F F +++DTA SV+ EMVE+LE+ D
Sbjct: 360 GSVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVEELEMDD 419
Query: 422 QNVTFIAEXXXXXXXXXXPGW 442
++VT IA P W
Sbjct: 420 RDVTKIANMIDGEIASLVPNW 440
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 927 (331.4 bits), Expect = 2.5e-104, Sum P(2) = 2.5e-104
Identities = 180/295 (61%), Positives = 220/295 (74%)
Query: 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEV 78
+ETDP+ RY R++EV+GKGA KTVYKAFD+V G+EVAW QV++++V +SPE L+RLYSEV
Sbjct: 16 VETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSEV 75
Query: 79 HLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRXXXXXXXXXXXXGWARQI 138
HLLK+L H +IIR+ SWID +T N ITELFTSG+LR+YR WARQI
Sbjct: 76 HLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQI 135
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVIGTPEFM 197
L+GL YLH HDPP+IHRDLKCDNIF+NG+ G+VKIGDLGLA I+ + NA SVIGTPEFM
Sbjct: 136 LNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEFM 195
Query: 198 APELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257
APELY+E+YNEL DIYSFGMC+LEM+T EYPYSEC N AQIYKKV+SG P + ++
Sbjct: 196 APELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQHT 255
Query: 258 EVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPL-PLPD-IVLPRVGAFG 310
E + F+ KCL S+RL AKELL DPFL PL LP + + + A G
Sbjct: 256 EAQRFVGKCLETVSRRLPAKELLADPFLAATDERDLAPLFRLPQQLAIQNLAANG 310
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 9.6e-101, Sum P(2) = 9.6e-101
Identities = 174/270 (64%), Positives = 209/270 (77%)
Query: 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS 76
+ +ETDPT RY R+ E++G+GA KTVYKA DE G+EVAW QV++ +VL+S DL+RLYS
Sbjct: 8 EYVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYS 67
Query: 77 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRXXXXXXXXXXXXGWAR 136
EVHLL +L H +IIRFY SWID N T+N ITELFTSG+LRQY+ WAR
Sbjct: 68 EVHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWAR 127
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPE 195
QIL GL+YLH HDPP+IHRDLKCDNIF+NG+ G+VKIGDLGLA ++ + A S+IGTPE
Sbjct: 128 QILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPE 187
Query: 196 FMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255
FMAPELY+ENYNEL D+YSFGMC LEM+T E+PYSEC + AQIYKKV G P A +V
Sbjct: 188 FMAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVG 247
Query: 256 DPEVKSFIEKCLVPASQRLSAKELLMDPFL 285
D E + FI KCLV AS+R+SAKELL DPFL
Sbjct: 248 DIEAQRFIGKCLVSASKRVSAKELLQDPFL 277
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 842 (301.5 bits), Expect = 4.4e-84, P = 4.4e-84
Identities = 160/283 (56%), Positives = 204/283 (72%)
Query: 3 SSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID 62
SS+D ++ + +E DPT RY RY E++G GA K VY+AFD+ G+EVAW QV++
Sbjct: 6 SSDDNESEKDKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 65
Query: 63 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRXX 122
P ERLYSEV LLK+LK++NII Y W D++N T+N ITE+ TSG+LR+YR
Sbjct: 66 CFSDDPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKK 125
Query: 123 XXXXXXXXXXGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182
W++QIL GL YLH+HDP IIHRDL C NIF+NGN G+VKIGDLGLA I+
Sbjct: 126 HRHVSMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIV 185
Query: 183 EQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 241
+ + A S++GTPEFMAPELY+ENY E+ DIYS+GMC+LE+V+ E PYSEC + A+IYK+
Sbjct: 186 GKNHLAHSILGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKR 245
Query: 242 VSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPF 284
VS G+KP AL+KV DPE K+FIEKC+ R SA ELL DPF
Sbjct: 246 VSKGLKPEALNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPF 288
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q8S8Y8 | WNK6_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7298 | 0.7522 | 0.8888 | yes | no |
| Q6EU49 | WNK4_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6370 | 0.6149 | 0.6732 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| gw1.70.94.1 | hypothetical protein (583 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 670 | |||
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-75 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-69 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-57 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-55 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-53 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-53 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-52 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-50 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-48 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-46 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-45 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-44 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-42 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-41 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-40 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-40 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-39 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-38 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-38 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-36 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-36 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-36 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-35 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-34 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-34 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-33 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-33 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-31 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-31 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-30 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-28 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-28 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-28 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-24 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-23 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-20 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-18 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 240 bits (615), Expect = 9e-75
Identities = 100/260 (38%), Positives = 144/260 (55%), Gaps = 11/260 (4%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E++G+G+F +VY A D+ G +A V + S E+LE L E+ +L SL+H NI+R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSG--DSEEELEALEREIRILSSLQHPNIVR 63
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+Y S D++ T+NI E + GSL KK K+ ++ + RQIL GL YLHS+
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA----KSVIGTPEFMAPELY-DENY 206
I+HRD+K NI ++ + G VK+ D G A + SV GTP +MAPE+ E Y
Sbjct: 122 IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 266
ADI+S G ++EM T + P+SE N K+ S +P + + E K F+ KC
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240
Query: 267 LVP-ASQRLSAKELLMDPFL 285
L +R +A ELL PFL
Sbjct: 241 LRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 5e-69
Identities = 87/258 (33%), Positives = 136/258 (52%), Gaps = 12/258 (4%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E +G+G+F VY A D+ G VA ++ + + E + R E+ +LK LKH NI+R
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR---EIKILKKLKHPNIVR 61
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
Y+ + D+ + ++ E G L KK ++ + + RQILS L YLHS
Sbjct: 62 LYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIM-EQANAKSVIGTPEFMAPELYDEN-YNEL 209
I+HRDLK +NI ++ + G VK+ D GLA + + +GTPE+MAPE+ Y +
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 210 ADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFIEKCLV 268
DI+S G+ + E++T + P+ +++KK+ P + PE K I K LV
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 269 P-ASQRLSAKELLMDPFL 285
+RL+A+E L PF
Sbjct: 237 KDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 4e-60
Identities = 82/267 (30%), Positives = 132/267 (49%), Gaps = 16/267 (5%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
+G G+F TVYKA + G VA ++ + + + E+ +L+ L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHP 58
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
NI+R +++ D + + ++ E G L Y + + K A QIL GL YLHS
Sbjct: 59 NIVRLIDAFEDKDH--LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTPEFMAPE--LYD 203
+ IIHRDLK +NI ++ N G VKI D GLA + ++ + +GTP +MAPE L
Sbjct: 117 NG--IIHRDLKPENILLDEN-GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 204 ENYNELADIYSFGMCMLEMVTFEYPYSEC--RNSAQIYKKVSSGIKPAALSKV--KDPEV 259
Y D++S G+ + E++T + P+S + Q+ +++ K E
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233
Query: 260 KSFIEKCLVP-ASQRLSAKELLMDPFL 285
K I+KCL S+R +A+E+L P+
Sbjct: 234 KDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 3e-57
Identities = 81/253 (32%), Positives = 127/253 (50%), Gaps = 47/253 (18%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+G+G F TVY A D+ G +VA ++ +D S LE L E+ +LK L H NI++ Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED---SSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
+ D+ + + ++ E GSL+ ++ K+ + QIL GL YLHS+ I
Sbjct: 58 GVFEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--GI 113
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELYDEN--YNE 208
IHRDLK +NI ++ + G+VK+ D GL+ ++ K+++GTP +MAPE+ Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268
+DI+S G+ + E+ PE+K I K L
Sbjct: 174 KSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199
Query: 269 P-ASQRLSAKELL 280
+R SAKE+L
Sbjct: 200 KDPEKRPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 2e-55
Identities = 89/263 (33%), Positives = 146/263 (55%), Gaps = 15/263 (5%)
Query: 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
E IGKG F VYKA + G EVA +++ L+S E E++ +E+ +LK KH
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVA---IKVIK-LESKEKKEKIINEIQILKKCKH 56
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ-YRKKHKKVDMKAVKGWARQILSGLIYL 145
NI+++Y S++ + I+ E + GSL+ + ++ + + +++L GL YL
Sbjct: 57 PNIVKYYGSYLK--KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYD 203
HS+ IIHRD+K NI + + GEVK+ D GL+ + A +++GTP +MAPE +
Sbjct: 115 HSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING 171
Query: 204 ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSF 262
+ Y+ ADI+S G+ +E+ + PYSE ++K ++G P + K E K F
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDF 230
Query: 263 IEKCLVPA-SQRLSAKELLMDPF 284
++KCL +R +A++LL PF
Sbjct: 231 LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 1e-53
Identities = 81/265 (30%), Positives = 137/265 (51%), Gaps = 17/265 (6%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
+ IGKG+F VY + +G ++ + + S ++ E +EV +LK L H N
Sbjct: 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNHPN 60
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM----KAVKGWARQILSGLIY 144
II++Y S+ + + I+ E G L Q KK KK + + W Q+ L Y
Sbjct: 61 IIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTPEFMAPELY 202
LHS I+HRD+K NIF+ N G VK+GD G++ ++ AK+V+GTP +++PEL
Sbjct: 119 LHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 203 -DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
++ YN +DI+S G + E+ T ++P+ E N ++ K+ G + + E+++
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKG-QYPPIPSQYSSELRN 233
Query: 262 FIEKCLVP-ASQRLSAKELLMDPFL 285
+ L +R S ++L PF+
Sbjct: 234 LVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 7e-53
Identities = 94/262 (35%), Positives = 143/262 (54%), Gaps = 17/262 (6%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRI-DDVLQSPEDLERLYSEVHLLKSLKHNNII 90
E++G G+F +VY+ + +G A +V + DD E +++L E+ LL L+H NI+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
++ + ++ N + I EL GSL + KK+ ++ + RQIL GL YLH +
Sbjct: 66 QYLGTEREEDN--LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN- 122
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLAT-IMEQANAKSVIGTPEFMAPELYDE--NYN 207
+HRD+K NI ++ N G VK+ D G+A ++E + AKS G+P +MAPE+ + Y
Sbjct: 123 -TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 208 ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA---ALSKVKDPEVKSFIE 264
ADI+S G +LEM T + P+S+ A ++K S P LS E K FI
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS----DEAKDFIL 236
Query: 265 KCL-VPASQRLSAKELLMDPFL 285
KCL S R +A ELL PF+
Sbjct: 237 KCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 99/278 (35%), Positives = 146/278 (52%), Gaps = 24/278 (8%)
Query: 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSE 77
V E DP Y E IG+GA VYKA D G EVA ++R+ ++ E + +E
Sbjct: 12 VSEGDPRELYKNL-EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-----QNKELIINE 65
Query: 78 VHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL----RQYRKKHKKVDMKAVKG 133
+ ++K KH NI+ +Y+S++ + ++ E GSL Q + + + V
Sbjct: 66 ILIMKDCKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-- 121
Query: 134 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVI 191
R++L GL YLHS +IHRD+K DNI ++ G VK+ D G A + E++ SV+
Sbjct: 122 -CREVLQGLEYLHSQ--NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVV 177
Query: 192 GTPEFMAPELY-DENYNELADIYSFG-MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA 249
GTP +MAPE+ ++Y DI+S G MC+ EM E PY ++ + GI P
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCI-EMAEGEPPYLREPPLRALFLITTKGIPPL 236
Query: 250 ALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+ PE K F+ KCLV +R SA+ELL PFL+
Sbjct: 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 6e-50
Identities = 89/259 (34%), Positives = 141/259 (54%), Gaps = 13/259 (5%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
++IG+GAF VYK + G VA Q+ ++ + E L+ + E+ LLK+LKH NI+
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIV 62
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
++ S I+ + ++ II E +GSLRQ KK V + Q+L GL YLH
Sbjct: 63 KYIGS-IETSD-SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG- 119
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPE-LYDENYN 207
+IHRD+K NI + G VK+ D G+AT + + SV+GTP +MAPE + +
Sbjct: 120 -VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 208 ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267
+DI+S G ++E++T PY + A +++ V P L + PE+K F+ +C
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCF 235
Query: 268 VP-ASQRLSAKELLMDPFL 285
+ R +AK+LL P++
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 81/260 (31%), Positives = 134/260 (51%), Gaps = 13/260 (5%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
V+G+G+ VYK + G A ++ V E ++L E+ L+S + +++
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYA---LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
Y ++ ++I+ E GSL KK K+ + ARQIL GL YLH I
Sbjct: 65 YGAFYK--EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH-TKRHI 121
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKSVIGTPEFMAPELYD-ENYNEL 209
IHRD+K N+ IN ++GEVKI D G++ ++E + +GT +M+PE E+Y+
Sbjct: 122 IHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 210 ADIYSFGMCMLEMVTFEYPYS--ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267
ADI+S G+ +LE ++P+ + ++ + + G P+ ++ PE + FI CL
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240
Query: 268 VP-ASQRLSAKELLMDPFLQ 286
+R SA ELL PF++
Sbjct: 241 QKDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 89/265 (33%), Positives = 144/265 (54%), Gaps = 16/265 (6%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E IGKG+F TV K + +G + W + ID + ++ ++L SEV++L+ LKH NI+R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKE--IDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 92 FYNSWIDDQNKTVNIITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
+Y+ ID N+T+ I+ E G L ++ +K+ K ++ + + Q+L L H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 148 HDPP---IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPE-L 201
P ++HRDLK NIF++ N VK+GD GLA I+ + AK+ +GTP +M+PE L
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 202 YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
+Y+E +DI+S G + E+ P+ RN Q+ K+ G + E+
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASKIKEGKFR-RIPYRYSSELNE 240
Query: 262 FIEKCL-VPASQRLSAKELLMDPFL 285
I+ L V +R S +ELL P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 7e-45
Identities = 90/265 (33%), Positives = 137/265 (51%), Gaps = 26/265 (9%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
E +G+G++ +VYKA + G VA V ++ EDL+ + E+ +LK I+
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIV 61
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSGLIYLHSHD 149
++Y S+ +N + I+ E +GS+ K K + + Q L GL YLHS+
Sbjct: 62 KYYGSYF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELYDE-NY 206
IHRD+K NI +N +G+ K+ D G++ + AK +VIGTP +MAPE+ E Y
Sbjct: 120 --KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK---PAALSKVKD--PEVKS 261
N ADI+S G+ +EM + PYS+ I+ I P LS + PE
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTLSDPEKWSPEFND 231
Query: 262 FIEKCLV-PASQRLSAKELLMDPFL 285
F++KCLV +R SA +LL PF+
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 3e-44
Identities = 93/265 (35%), Positives = 143/265 (53%), Gaps = 21/265 (7%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
IG G F VY A + G +A ++RI D P+ ++ + E+ +L+ LKH N++++Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 153
++ + V I E + G+L + + + +D ++ + Q+L GL YLHSH I+
Sbjct: 66 G--VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 154 HRDLKCDNIFINGNQGEVKIGDLGLA------TIMEQANAKSVIGTPEFMAPELYDEN-- 205
HRD+K NIF++ N G +K+GD G A T +S+ GTP +MAPE+
Sbjct: 122 HRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 206 --YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA-LSKVKDPEVKSF 262
+ ADI+S G +LEM T + P+SE N QI V +G KP S PE K F
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240
Query: 263 IEKCLV--PASQRLSAKELLMDPFL 285
+++CL P +R +A ELL PF+
Sbjct: 241 LDRCLESDP-KKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 9e-42
Identities = 94/264 (35%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID-DVLQSPEDLERLYSEVHLLKSLKHN 87
R +++G+GAF VY +D G E+A QV D D ++ +++ L E+ LLK+L+H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
I+++Y DD+ T++I E GS++ K + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDDE--TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLG----LATI-MEQANAKSVIGTPEFMAPELY 202
+ I+HRD+K NI + G VK+GD G L TI KSV GTP +M+PE+
Sbjct: 123 NM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 203 D-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
E Y AD++S G ++EM+T + P++E A I+K + P S V P+ ++
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARN 238
Query: 262 FIEKCLV-PASQRLSAKELLMDPF 284
F+ + V A +R SA+ELL F
Sbjct: 239 FLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 6e-41
Identities = 93/266 (34%), Positives = 146/266 (54%), Gaps = 11/266 (4%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID-DVLQSPEDLERLYSEVHLLKSLKHN 87
R +++G+GAF VY +D G E+A QV+ D + ++ +++ L E+ LLK+L+H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
I+++Y D KT+ I E GS++ K + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLG----LATI-MEQANAKSVIGTPEFMAPELY 202
+ I+HRD+K NI + + G VK+GD G L TI M +SV GTP +M+PE+
Sbjct: 125 N--MIVHRDIKGANI-LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 203 D-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
E Y AD++S G ++EM+T + P++E A I+K + P S + + +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARD 240
Query: 262 FIEKCLVPASQRLSAKELLMDPFLQV 287
F+ V A R SA+ELL PF Q+
Sbjct: 241 FLGCIFVEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 2e-40
Identities = 95/267 (35%), Positives = 144/267 (53%), Gaps = 15/267 (5%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPE---DLERLYSEVHLLKSLK 85
R +++G+GAF VY +D G E+A QV+ D +SPE ++ L E+ LLK+L
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDP--ESPETSKEVNALECEIQLLKNLL 62
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL 145
H I+++Y D +T++I E GS++ K + + + + RQIL G+ YL
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG----LATI-MEQANAKSVIGTPEFMAPE 200
HS+ I+HRD+K NI + + G VK+GD G L TI + KSV GTP +M+PE
Sbjct: 123 HSN--MIVHRDIKGANI-LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 201 LYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259
+ E Y ADI+S G ++EM+T + P++E A I+K + P V D
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HC 238
Query: 260 KSFIEKCLVPASQRLSAKELLMDPFLQ 286
+ F+++ V A R SA ELL F+
Sbjct: 239 RDFLKRIFVEAKLRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 84/256 (32%), Positives = 134/256 (52%), Gaps = 15/256 (5%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
IGKG F VYKA ++G VA +V+I +++ + + E+ LLK L H N+I++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKK----VDMKAVKGWARQILSGLIYLHSHD 149
S+I+ N +NI+ EL +G L + K KK + + + + Q+ S L ++HS
Sbjct: 69 ASFIE--NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELYDEN-Y 206
I+HRD+K N+FI G VK+GDLGL + A S++GTP +M+PE EN Y
Sbjct: 127 --IMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 207 NELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265
N +DI+S G + EM + P Y + N + KK+ P + E++ + +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243
Query: 266 CLVP-ASQRLSAKELL 280
C+ P +R +L
Sbjct: 244 CINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 5e-39
Identities = 79/261 (30%), Positives = 138/261 (52%), Gaps = 15/261 (5%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
IGKG+F V+K + + A Q+ + + + + E E +L L + II
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYII 62
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR--QILSGLIYLHSH 148
R+Y S++D +NI+ E +G L + K + + + W QIL GL +LHS
Sbjct: 63 RYYESFLDKGK--LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPEL-YDEN 205
I+HRD+K N+F++ VKIGDLG+A ++ A +++GTP +++PEL D+
Sbjct: 121 K--ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 206 YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265
YNE +D+++ G+ + E T ++P+ + N + K+ G+ P +S++ ++ I++
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQ 235
Query: 266 CL-VPASQRLSAKELLMDPFL 285
CL QR +LL +P L
Sbjct: 236 CLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 86/274 (31%), Positives = 134/274 (48%), Gaps = 24/274 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E IGKG+F VYKA D+ VA +++ D+ ++ +++E + E+ L + I +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVA---IKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+Y S++ + II E GS K K+D + R++L GL YLH
Sbjct: 64 YYGSFLKGSK--LWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGK- 119
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTPEFMAPELY-DENYNE 208
IHRD+K NI ++ +G+VK+ D G++ + + + +GTP +MAPE+ Y+E
Sbjct: 120 -IHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 209 LADIYSFGMCMLEMVTFEYPYSE---CRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFIE 264
ADI+S G+ +E+ E P S+ R I K P +L K K F+
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-----NPPSLEGNKFSKPFKDFVS 232
Query: 265 KCLV--PASQRLSAKELLMDPFLQVNGTTKNRPL 296
CL P +R SAKELL F++ T L
Sbjct: 233 LCLNKDPK-ERPSAKELLKHKFIKKAKKTSYLTL 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 90/263 (34%), Positives = 145/263 (55%), Gaps = 11/263 (4%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID-DVLQSPEDLERLYSEVHLLKSLKHN 87
R +++G+GAF VY +D G E+A QV D D ++ +++ L E+ LLK+L+H+
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
I+++Y D + K ++I E GS++ K + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLG----LATI-MEQANAKSVIGTPEFMAPELY 202
+ I+HRD+K NI + + G VK+GD G + TI M KSV GTP +M+PE+
Sbjct: 125 N--MIVHRDIKGANI-LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 203 D-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
E Y AD++S ++EM+T + P++E A I+K + KP V D +
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRD 240
Query: 262 FIEKCLVPASQRLSAKELLMDPF 284
F+++ V +R +A+ LL PF
Sbjct: 241 FLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 1e-36
Identities = 91/267 (34%), Positives = 135/267 (50%), Gaps = 27/267 (10%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
V+GKG + VY A D + +A ++ D ++ L+ E+ L LKH NI+++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMK--AVKGWARQILSGLIYLHSHD 149
S D +N I E GSL R K + + + +QIL GL YLH +
Sbjct: 71 LGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELYDE--- 204
I+HRD+K DN+ +N G VKI D G + + N ++ GT ++MAPE+ D+
Sbjct: 129 --IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 205 NYNELADIYSFGMCMLEMVTFEYPYSECRN-SAQIYK----KVSSGIKPAALSKVKDPEV 259
Y ADI+S G ++EM T + P+ E A ++K K+ I P +LS E
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-PESLSA----EA 241
Query: 260 KSFIEKCLVP-ASQRLSAKELLMDPFL 285
K+FI +C P +R SA +LL DPFL
Sbjct: 242 KNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 79/264 (29%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+ IG G + VYKA D G VA ++++ +D E + E+ +LK +H NI+
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVA 64
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQ-YRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
++ S++ + + I+ E GSL+ Y+ + + R+ L GL YLH
Sbjct: 65 YFGSYL--RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG- 121
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELYDEN--- 205
IHRD+K NI + G+VK+ D G++ + AK S IGTP +MAPE+
Sbjct: 122 -KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 206 -YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD---PEVKS 261
Y+ DI++ G+ +E+ + P + ++ S P L K K+ P
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKL-KDKEKWSPVFHD 238
Query: 262 FIEKCLVPA-SQRLSAKELLMDPF 284
FI+KCL +R +A +LL PF
Sbjct: 239 FIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 32/270 (11%)
Query: 28 IRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS 83
+ + +G+GAF VYK + +EVA ++ D S + +E E +++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA---SEQQIEEFLREARIMRK 57
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSG 141
L H NI++ +++ I+ E G L Y +K++ + + + +A QI G
Sbjct: 58 LDHPNIVKLLGVCTEEEPLM--IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA------TIMEQANAKSVIGTPE 195
+ YL S IHRDL N + N VKI D GL+ + K I
Sbjct: 116 MEYLESK--NFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYKVKGGKLPI---R 169
Query: 196 FMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSK 253
+MAPE E + +D++SFG+ + E+ T E PY N A++ + + G + L K
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYR---LPK 225
Query: 254 VKD--PEVKSFIEKCLVP-ASQRLSAKELL 280
+ PE+ + +C R + EL+
Sbjct: 226 PPNCPPELYKLMLQCWAEDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 83/260 (31%), Positives = 132/260 (50%), Gaps = 19/260 (7%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS--EVHLLKSLKHNNIIR 91
+GKG++ +VYK + A +V L S ER + E+ +L S+ H NII
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVD----LGSMSQKEREDAVNEIRILASVNHPNIIS 63
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK----VDMKAVKGWARQILSGLIYLHS 147
+ +++D NK I+ E G L + K KK + + + Q+L GL LH
Sbjct: 64 YKEAFLDG-NKLC-IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENY 206
I+HRDLK NI + N VKIGDLG++ ++++ AK+ IGTP +MAPE++ Y
Sbjct: 122 QK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 266
+ +DI+S G + EM TF P+ E R+ + KV G P + + ++++FI
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSM 236
Query: 267 LVP-ASQRLSAKELLMDPFL 285
L R + ++L P +
Sbjct: 237 LQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 9e-36
Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 22/267 (8%)
Query: 28 IRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS 83
+ + +G+GAF VYK E +VA ++ S E+ E E ++K
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA---SEEEREEFLEEASIMKK 57
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGL 142
L H NI+R + + I+TE G L + +KH K+ +K + A QI G+
Sbjct: 58 LSHPNIVRLLGVCTQGE--PLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-TIMEQANAKSVIGTPE---FMA 198
YL S +HRDL N + VKI D GL+ I E + G +MA
Sbjct: 116 EYLESK--NFVHRDLAARNCLV-TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA 172
Query: 199 PELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256
PE + + +D++SFG+ + E+ T E PY N ++ + + G +
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE-EVLELLEDGYRLPRPENC-P 230
Query: 257 PEVKSFIEKCLVP-ASQRLSAKELLMD 282
E+ + +C R + EL+ D
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 9e-36
Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 27/267 (10%)
Query: 28 IRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS 83
+ + +G+GAF VYK +EVA V+ S + +E E +++
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVA---VKTLKEDASEQQIEEFLREARIMRK 57
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGL 142
L H N+++ +++ I+ E G L Y RK K+ + + +A QI G+
Sbjct: 58 LDHPNVVKLLGVCTEEEPLY--IVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA------TIMEQANAKSVIGTPEF 196
YL S IHRDL N + N VKI D GL+ + K I +
Sbjct: 116 EYLESK--NFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYRKRGGKLPI---RW 169
Query: 197 MAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKV 254
MAPE E + +D++SFG+ + E+ T E PY N ++ + + +G +
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRL-PQPPN 227
Query: 255 KDPEVKSFIEKCLVP-ASQRLSAKELL 280
PE+ + +C R + EL+
Sbjct: 228 CPPELYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 6e-35
Identities = 88/268 (32%), Positives = 139/268 (51%), Gaps = 22/268 (8%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED-----LERLYSEVHLLKSLKHN 87
+IG G+F +VY + +G +A QV + V S +D L+ L E+ LLK L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
NI+++ S +D + +NI E GS+ + + V+ + RQIL GL YLH+
Sbjct: 67 NIVQYLGSSLDADH--LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--------QANAKSVIGTPEFMAP 199
IIHRD+K NI ++ N+G +KI D G++ +E S+ G+ +MAP
Sbjct: 125 RG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 200 ELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258
E+ + Y ADI+S G ++EM+T ++P+ +C I+ K+ P S + E
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSNISS-E 239
Query: 259 VKSFIEKCLVP-ASQRLSAKELLMDPFL 285
F+EK ++R +A ELL PFL
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 63/249 (25%), Positives = 122/249 (48%), Gaps = 13/249 (5%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+GKG+F V + G A ++ +++ E +E +E ++L + H I++ +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE-VEHTLTERNILSRINHPFIVKLH 59
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 153
++ ++ + ++ E G L + K + + + +A +I+ L YLHS II
Sbjct: 60 YAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--II 115
Query: 154 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELYDEN-YNELA 210
+RDLK +NI ++ G +K+ D GLA + ++ + GTPE++APE+ Y +
Sbjct: 116 YRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 211 DIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP- 269
D +S G+ + EM+T + P+ + +IY+K+ P + PE + I L
Sbjct: 175 DWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKD 231
Query: 270 ASQRLSAKE 278
++RL +
Sbjct: 232 PTKRLGSGG 240
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 78/272 (28%), Positives = 127/272 (46%), Gaps = 25/272 (9%)
Query: 30 YK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
Y+ EVIG GA VY A N +VA ++ D+ + ++ L EV + H
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVA---IKRIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLR---QYRKKHKKVDMKAVKGWARQILSGLIY 144
N++++Y S++ + ++ + GSL + +D + +++L GL Y
Sbjct: 60 NVVKYYTSFVVGD--ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA------TIMEQANAKSVIGTPEFMA 198
LHS+ IHRD+K NI + G G VKI D G++ + K+ +GTP +MA
Sbjct: 118 LHSNG--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 199 PELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV---SSGIKPAALSK 253
PE+ Y+ ADI+SFG+ +E+ T PYS+ + + ++ A K
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 254 VKDPEVKSFIEKCLVP-ASQRLSAKELLMDPF 284
+ I CL S+R +A+ELL F
Sbjct: 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 91/300 (30%), Positives = 137/300 (45%), Gaps = 59/300 (19%)
Query: 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLK 82
Y + E +G+G + VYKA D+ G VA ++R+D + E + S E+ LLK
Sbjct: 1 YEK-LEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTALREISLLK 53
Query: 83 SLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSG 141
LKH NI++ + + + + ++ E + L++Y K+ + +K Q+L G
Sbjct: 54 ELKHPNIVKLLD--VIHTERKLYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSVIGTPEFMA 198
L Y HSH I+HRDLK NI IN + G +K+ D GLA I + V+ T + A
Sbjct: 111 LAYCHSHR--ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVV-TLWYRA 166
Query: 199 PELY--DENYNELADIYSFGMCMLEMVTFEYPY---SECRNSAQI--------------- 238
PE+ ++Y+ DI+S G EM+T + + SE Q+
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE---IDQLFKIFQILGTPTEESW 223
Query: 239 --------YKKVSSGIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFL 285
YK P L KV DPE + K L PA +R+SAKE L P+
Sbjct: 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPA-KRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 71/266 (26%), Positives = 132/266 (49%), Gaps = 14/266 (5%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
+ Y +G G V K G +A +R++ + +++ E+ +L
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE---INEAIQKQILRELDILHKCNSP 59
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLH 146
I+ FY ++ + N ++I E GSL + K+ + + + + A +L GL YLH
Sbjct: 60 YIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYD-EN 205
IIHRD+K NI +N ++G++K+ D G++ + + AK+ +GT +MAPE +
Sbjct: 118 -EKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGND 175
Query: 206 YNELADIYSFGMCMLEMVTFEYPYSECRNSA----QIYKKVSSGIKPAALSKVKDPEVKS 261
Y+ +DI+S G+ ++E+ T +PY + ++ + + + P S P+ +
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235
Query: 262 FIEKCLVP-ASQRLSAKELLMDPFLQ 286
F+ CL+ +R S KELL PF++
Sbjct: 236 FVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 76/267 (28%), Positives = 125/267 (46%), Gaps = 22/267 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED--LERLYSEVHLLKSLKHNNI 89
+ +G GAF + Y+A D G +A QV S ++ +E L E+ L+ L H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
IR + +D + N+ E GS+ K+ + + Q+L GL YLH +
Sbjct: 66 IRMLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH--E 121
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK---------SVIGTPEFMAPE 200
IIHRD+K N+ I+ ++I D G A + AK ++GT FMAPE
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAA---RLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 201 -LYDENYNELADIYSFGMCMLEMVTFEYPYS--ECRNSAQIYKKVSSGIKPAALSKVKDP 257
L E Y D++S G ++EM T + P++ + N + K++S ++ + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 258 EVKSFIEKCL-VPASQRLSAKELLMDP 283
++ +CL + R ++ELL P
Sbjct: 239 GLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 88/267 (32%), Positives = 137/267 (51%), Gaps = 20/267 (7%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRID--DVLQSPEDLERLYSEVHLLKSLKHNNI 89
EV+GKGA+ TVY L +A QV +D +VL + ++ E+L EV LLKSLKH NI
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
+++ + +DD T++I E GS+ + + + +QIL G+ YLH++
Sbjct: 65 VQYLGTCLDDN--TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA--------KSVIGTPEFMAPEL 201
++HRD+K +N+ + N G +K+ D G A + KS+ GTP +MAPE+
Sbjct: 123 --VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 202 YDEN-YNELADIYSFGMCMLEMVTFEYPYSEC-RNSAQIYKKVSSGIKPAALSKVKDPEV 259
+E+ Y +DI+S G + EM T + P + R +A Y G+ P +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239
Query: 260 KSFIEKCLV-PASQRLSAKELLMDPFL 285
F+ CL +R SA +LL FL
Sbjct: 240 -DFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 89/271 (32%), Positives = 140/271 (51%), Gaps = 25/271 (9%)
Query: 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED-LERLYSEVHLLKSLK 85
Y R E+IG+GA+ VY+ G VA ++I + L +P+D + + EV LL L+
Sbjct: 3 YQRL-ELIGRGAYGAVYRGKHVPTGRVVA---LKIIN-LDTPDDDVSDIQREVALLSQLR 57
Query: 86 HN---NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
+ NI ++Y S++ + II E GS+R K + K + R++L L
Sbjct: 58 QSQPPNITKYYGSYLKGPR--LWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVAL 114
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPE 200
Y+H +IHRD+K NI + N G VK+ D G+A ++ Q ++K + +GTP +MAPE
Sbjct: 115 KYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE 171
Query: 201 LYDEN--YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS-KVKDP 257
+ E Y+ ADI+S G+ + EM T PYS+ + S KP L
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSK 229
Query: 258 EVKSFIEKCL--VPASQRLSAKELLMDPFLQ 286
++ F+ CL P +RLSA+ELL +++
Sbjct: 230 LLREFVAACLDEEPK-ERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 64/258 (24%), Positives = 109/258 (42%), Gaps = 38/258 (14%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQV-----RIDDVLQSPEDLERLYSEVHLLKSLKH 86
+ +G+GAF VYK ++ G + +V + D S E+ + E ++K L H
Sbjct: 1 KKLGEGAFGEVYKG--KLKGKDGKTTEVAVKTLKEDA---SEEERKDFLKEARVMKKLGH 55
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKG---------WARQ 137
N++R +++ + ++ E G L Y +K + V K +A Q
Sbjct: 56 PNVVRLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-------TIMEQANAKSV 190
I G+ YL S +HRDL N + + VKI D GL+ ++ K
Sbjct: 114 IAKGMEYLASK--KFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLP 170
Query: 191 IGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKP 248
I +MAPE L D + +D++SFG+ + E+ T PY N ++ + + G +
Sbjct: 171 I---RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-EVLEYLRKGYRL 226
Query: 249 AALSKVKDPEVKSFIEKC 266
D E+ + C
Sbjct: 227 PKPEYCPD-ELYELMLSC 243
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (323), Expect = 2e-32
Identities = 81/346 (23%), Positives = 137/346 (39%), Gaps = 35/346 (10%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-N 87
R +G+G+F VY A D VA +V + +++ER E+ +L SL H
Sbjct: 3 RILRKLGEGSFGEVYLARDR---KLVA-LKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH---KKVDMKAVKGWARQILSGLIY 144
NI++ Y+ + D+ + + ++ E GSL KK + QILS L Y
Sbjct: 59 NIVKLYDFFQDEGS--LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--------AKSVIGTPEF 196
LHS IIHRD+K +NI ++ + VK+ D GLA ++ + +GTP +
Sbjct: 117 LHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 197 MAPELY----DENYNELADIYSFGMCMLEMVTFEYPY---SECRNSAQIYKKVSSGIKPA 249
MAPE+ + +DI+S G+ + E++T P+ ++Q K + P+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 250 ALSKVK-------DPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDI 301
S + ++K L RLS+ L L ++ L
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294
Query: 302 VLPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSG 347
+ +S+ + S + L +G
Sbjct: 295 DDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNG 340
|
Length = 384 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 83/253 (32%), Positives = 138/253 (54%), Gaps = 14/253 (5%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
R ++ IG+G F VY+A ++G+ VA +V+I D++ + + + E+ LLK L H N
Sbjct: 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPN 63
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLIY 144
+I++Y S+I+D +NI+ EL +G L + ++K+ + + K V + Q+ S L +
Sbjct: 64 VIKYYASFIEDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELY 202
+HS ++HRD+K N+FI G VK+GDLGL A S++GTP +M+PE
Sbjct: 122 MHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 203 DEN-YNELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260
EN YN +DI+S G + EM + P Y + N + KK+ P S E++
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 261 SFIEKCLVPASQR 273
+ C+ P ++
Sbjct: 239 QLVNMCINPDPEK 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 21/270 (7%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+G GAF VYKA + GL A ++I +S E+LE E+ +L KH NI+ Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQI----ESEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSGLIYLHSHDPPI 152
++ + I+ E G+L + ++ ++ RQ+L L +LHSH +
Sbjct: 69 EAYFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--V 124
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELY------DE 204
IHRDLK NI + G+VK+ D G++ + K + IGTP +MAPE+ D
Sbjct: 125 IHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 205 NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFI 263
Y+ ADI+S G+ ++E+ E P+ E N ++ K+ P K F+
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSSFNDFL 242
Query: 264 EKCLVP-ASQRLSAKELLMDPFLQVNGTTK 292
+ CLV R +A ELL PF+ K
Sbjct: 243 KSCLVKDPDDRPTAAELLKHPFVSDQSDNK 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 90/270 (33%), Positives = 141/270 (52%), Gaps = 15/270 (5%)
Query: 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
DP +Y R+ E IG+GA TVY A D G EVA Q+ + Q P+ E + +E+ ++
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
+ KH NI+ + +S++ + ++ E GSL + +D + R+ L
Sbjct: 71 RENKHPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL-ATIM-EQANAKSVIGTPEFMAP 199
L +LHS+ +IHRD+K DNI + G G VK+ D G A I EQ+ +++GTP +MAP
Sbjct: 128 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 200 ELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258
E+ + Y DI+S G+ +EMV E PY +Y ++G +
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 244
Query: 259 VKSFIEKCL-VPASQRLSAKELLMDPFLQV 287
+ F+ +CL + +R SAKELL PFL++
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 89/270 (32%), Positives = 139/270 (51%), Gaps = 15/270 (5%)
Query: 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
DP +Y RY E IG+GA TV+ A D G EVA Q+ LQ E + +E+ ++
Sbjct: 16 DPKKKYTRY-EKIGQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVM 70
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
K LK+ NI+ F +S++ + ++ E GSL + +D + R+ L
Sbjct: 71 KELKNPNIVNFLDSFL--VGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQA 127
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAP 199
L +LH++ +IHRD+K DN+ + G G VK+ D G + EQ+ +++GTP +MAP
Sbjct: 128 LEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 200 ELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258
E+ Y DI+S G+ +EMV E PY +Y ++G + P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244
Query: 259 VKSFIEKCL-VPASQRLSAKELLMDPFLQV 287
+ F+ +CL + +R SAKELL PFL++
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 82/294 (27%), Positives = 134/294 (45%), Gaps = 62/294 (21%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVA---------WCQVRIDDVLQSPEDLERLYSEVHLLK 82
++IG+G+F TV A ++ E A + ++ V E+ EV L +
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI-----EK---EV-LTR 57
Query: 83 SLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
H II+ Y ++ D++N + + E +G L QY +K+ +D K + +A +IL L
Sbjct: 58 LNGHPGIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLAL 115
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM-------------------- 182
YLHS IIHRDLK +NI ++ + +KI D G A ++
Sbjct: 116 EYLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 183 --EQANAKSVIGTPEFMAPELYDENY-NELADIYSFGMCML-EMVTFEYPYSECRNSAQI 238
+ S +GT E+++PEL +E + +D+++ G C++ +M+T + P+ N
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNEYLT 230
Query: 239 YKKVSSGIKPAALS--KVKDPEVKSFIEKCLV--PASQRLSAK----ELLMDPF 284
++K I S P+ K IEK LV P RL EL PF
Sbjct: 231 FQK----ILKLEYSFPPNFPPDAKDLIEKLLVLDP-QDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 85/268 (31%), Positives = 143/268 (53%), Gaps = 20/268 (7%)
Query: 26 RYIRYKEVIGKGAF--KTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS 83
YI + V+GKGAF T+Y+ E + L V W +V + + S ++ +E+ +L
Sbjct: 1 HYIPIR-VLGKGAFGEATLYRR-TEDDSL-VVWKEVNLTRL--SEKERRDALNEIVILSL 55
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ--YRKKHKKVDMKAVKGWARQILSG 141
L+H NII +YN ++DD T+ I E G+L R+K + + + V + QI+S
Sbjct: 56 LQHPNIIAYYNHFMDDN--TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAP 199
+ Y+H I+HRD+K NIF+ G +K+GD G++ I+ E + A++V+GTP +M+P
Sbjct: 114 VSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSP 170
Query: 200 ELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258
EL YN +DI++ G + E++T + + + N + K+ G +S V E
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVVS-VYSSE 228
Query: 259 VKSFIEKCL-VPASQRLSAKELLMDPFL 285
+ S + L +R +A E+L P L
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 84/274 (30%), Positives = 141/274 (51%), Gaps = 19/274 (6%)
Query: 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSE 77
V DP + + IG+G+ V A D+ G +VA V+ D L+ + E L++E
Sbjct: 12 VDPGDPRSYLDNFVK-IGEGSTGIVCIATDKSTGRQVA---VKKMD-LRKQQRRELLFNE 66
Query: 78 VHLLKSLKHNNIIRFYNSW-IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 136
V +++ +H NI+ Y+S+ + D+ + ++ E G+L H +++ + +
Sbjct: 67 VVIMRDYQHPNIVEMYSSYLVGDE---LWVVMEFLEGGALTDI-VTHTRMNEEQIATVCL 122
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTP 194
+L L +LH+ +IHRD+K D+I + + G VK+ D G E KS++GTP
Sbjct: 123 AVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSLVGTP 179
Query: 195 EFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253
+MAPE+ Y DI+S G+ ++EMV E PY Q K++ + P +
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNL 238
Query: 254 VK-DPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285
K P ++SF+++ LV +QR +A ELL PFL
Sbjct: 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 77/270 (28%), Positives = 126/270 (46%), Gaps = 22/270 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED------LERLYSEVHLLKSLK 85
E+IGKG + VY A + G +A QV + + D ++ L SE+ LK L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL 145
H NI+++ + + ++I E GS+ + + + + + V+ + Q+L GL YL
Sbjct: 67 HLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL----ATIMEQANAKSVIGTPEFMAPE- 200
HS I+HRDLK DN+ ++ G KI D G+ I + S+ G+ +MAPE
Sbjct: 125 HSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 201 --LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK----KVSSGIKPAALSKV 254
Y + Y+ DI+S G +LEM P+S+ A ++K + + I P +
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 255 KDPEVKSFIEKCLVPASQRLSAKELLMDPF 284
+ + R +A+ELL PF
Sbjct: 242 SPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 75/244 (30%), Positives = 133/244 (54%), Gaps = 14/244 (5%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
IG+G F VY+A ++ VA +V+I +++ + + + E+ LLK L H N+I++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA-KARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQ----YRKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
+S+I+D +NI+ EL +G L Q ++K+ + + + V + Q+ S + ++HS
Sbjct: 69 DSFIEDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELYDEN-Y 206
++HRD+K N+FI G VK+GDLGL + A S++GTP +M+PE EN Y
Sbjct: 127 --VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 207 NELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265
N +DI+S G + EM + P Y + N + +K+ P ++ +++ +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243
Query: 266 CLVP 269
C+ P
Sbjct: 244 CIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 86/286 (30%), Positives = 143/286 (50%), Gaps = 35/286 (12%)
Query: 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
DPT + EVIG+G + VYKA + G VA ++I D++ ++ E + E ++L
Sbjct: 3 DPTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVA---IKIMDII--EDEEEEIKEEYNIL 56
Query: 82 KSL-KHNNIIRFYNSWI--DDQNKTVNI--ITELFTSGS----LRQYRKKHKKVDMKAVK 132
+ H NI FY ++I + + + EL GS ++ RKK K++ + +
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 133 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SV 190
R+ L GL YLH + +IHRD+K NI + N EVK+ D G++ ++ + +
Sbjct: 117 YILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 191 IGTPEFMAPEL------YDENYNELADIYSFGMCMLEMVTFEYPYSE---CRNSAQIYKK 241
IGTP +MAPE+ D +Y+ +D++S G+ +E+ + P + R +I +
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233
Query: 242 VSSGIK-PAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFL 285
+K P SK + FI +CL+ QR +ELL PF+
Sbjct: 234 PPPTLKSPENWSK----KFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 78/258 (30%), Positives = 142/258 (55%), Gaps = 17/258 (6%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERL--YSEVHLLKSLKHNNII 90
V+G+GAF V+ + + V Q+ ++ Q +D ERL +E +LK L H NII
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVE---QMTKD-ERLAAQNECQVLKLLSHPNII 62
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSH 148
+Y ++++D K + I+ E G+L +Y +K +D + + QIL L ++H+
Sbjct: 63 EYYENFLED--KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM-EQANAKSVIGTPEFMAPELYD-ENY 206
I+HRDLK NI ++ ++ VKIGD G++ I+ ++ A +V+GTP +++PEL + + Y
Sbjct: 121 L--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPY 178
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 266
N+ +DI++ G + E+ + + + E N + K+ SG A +S P+++ I
Sbjct: 179 NQKSDIWALGCVLYELASLKRAF-EAANLPALVLKIMSG-TFAPISDRYSPDLRQLILSM 236
Query: 267 L-VPASQRLSAKELLMDP 283
L + S+R +++ P
Sbjct: 237 LNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 75/262 (28%), Positives = 117/262 (44%), Gaps = 19/262 (7%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
VIGKGAF V A + + + + +E +L+ L H ++
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNL 65
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
+ S+ D++N + ++ +L G LR + + K + VK W +I+ L YLHS I
Sbjct: 66 WYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--I 121
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIME-QANAKSVIGTPEFMAPELY-DENYNELA 210
IHRD+K DNI ++ QG V I D +AT + S GTP +MAPE+ + Y+
Sbjct: 122 IHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAV 180
Query: 211 DIYSFGMCMLEMVTFEYPY---SECRNSAQIYKKVSSGIK-PAALSKVKDPEVKSFIEKC 266
D +S G+ E + + PY S K+ ++ + PA S E I K
Sbjct: 181 DWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWST----EAIDAINKL 236
Query: 267 L-VPASQRLS--AKELLMDPFL 285
L +RL K+L P+
Sbjct: 237 LERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 91/274 (33%), Positives = 140/274 (51%), Gaps = 23/274 (8%)
Query: 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
DP +Y R+ E IG+GA TVY A D G EVA Q+ LQ E + +E+ ++
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMN----LQQQPKKELIINEILVM 70
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
+ K+ NI+ + +S++ + ++ E GSL + +D + R+ L
Sbjct: 71 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAP 199
L +LHS+ +IHRD+K DNI + G G VK+ D G + EQ+ +++GTP +MAP
Sbjct: 128 LDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 200 ELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI----KPAALSKV 254
E+ Y DI+S G+ +EMV E PY +Y ++G P LS V
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244
Query: 255 KDPEVKSFIEKCL-VPASQRLSAKELLMDPFLQV 287
+ F+ +CL + +R SAKELL PFL++
Sbjct: 245 ----FRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 89/306 (29%), Positives = 130/306 (42%), Gaps = 61/306 (19%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLK 85
RY+ + IG GA+ V A D+ G +VA + +I +V D +R+ E+ LL+ L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVA---IKKISNVFDDLIDAKRILREIKLLRHLR 57
Query: 86 HNNIIRFYNSWIDDQN---KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
H NII + V I+TEL + L + K + + ++ + QIL GL
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM----- 197
YLHS + +IHRDLK NI +N N ++KI D GLA ++ F+
Sbjct: 117 KYLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED-----EKGFLTEYVV 168
Query: 198 -----APE--LYDENYNELADIYSFGMCMLEMVT----F--------------------- 225
APE L Y + DI+S G E++T F
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 226 EYPYSECRNSAQIYKKVSSGIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELL 280
E A+ Y K LSK+ PE +EK LV P +R++A E L
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPK-KRITADEAL 287
Query: 281 MDPFLQ 286
P+L
Sbjct: 288 AHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 88/274 (32%), Positives = 142/274 (51%), Gaps = 23/274 (8%)
Query: 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
DP +Y R+ E IG+GA TVY A D G EVA +R ++ Q P+ E + +E+ ++
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKK-ELIINEILVM 71
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
+ K+ NI+ + +S++ + ++ E GSL + +D + R+ L
Sbjct: 72 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAP 199
L +LHS+ +IHRD+K DNI + G G VK+ D G + EQ+ +++GTP +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 200 ELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI----KPAALSKV 254
E+ Y DI+S G+ +EM+ E PY +Y ++G P LS +
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 255 KDPEVKSFIEKCL-VPASQRLSAKELLMDPFLQV 287
+ F+ +CL + +R SAKELL FL++
Sbjct: 246 ----FRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 75/296 (25%), Positives = 124/296 (41%), Gaps = 61/296 (20%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLER------LYSEVHLLKSLKHN 87
IG+G + VYKA ++ G VA ++R+++ E+ E+ LL+ L+H
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMEN--------EKEGFPITAIREIKLLQKLRHP 58
Query: 88 NIIRFYNSWIDDQNKTVNIITELFT---SGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
NI+R ++ ++ E +G L K +K + +Q+L GL Y
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQY 115
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS----VIGTPEFMAPE 200
LHS+ I+HRD+K NI IN N G +K+ D GLA + N+ VI T + PE
Sbjct: 116 LHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171
Query: 201 LY--DENYNELADIYSFGMCMLEMVTFEYPY---SECRNSAQIYKKVSS----------- 244
L Y D++S G + E+ + + +E +I++ S
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 245 -----GIKPAA---------LSKVKDPEVKSFIEK--CLVPASQRLSAKELLMDPF 284
+KP + DP ++K L P +R+SA + L +
Sbjct: 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDP-KKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 89/299 (29%), Positives = 138/299 (46%), Gaps = 42/299 (14%)
Query: 15 DPDVLE----TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL----Q 66
DP++ E DP + +E IG G+F VY A D VA I + Q
Sbjct: 1 DPEIAELFSKDDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVA-----IKKMSYSGKQ 54
Query: 67 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK- 125
S E + + EV L+ L+H N I + ++ + T ++ E + GS + HKK
Sbjct: 55 SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH--TAWLVME-YCLGSASDILEVHKKP 111
Query: 126 ---VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182
V++ A+ L GL YLHSH+ IHRD+K NI + G VK+ D G A+++
Sbjct: 112 LQEVEIAAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGSASLV 165
Query: 183 EQANAKSVIGTPEFMAPEL---YDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 238
AN S +GTP +MAPE+ DE Y+ D++S G+ +E+ + P + +
Sbjct: 166 SPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 239 YKKVSSGIKPAALSKVK-DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTKNRP 295
Y + LS ++F++ CL R S++ELL F+ + RP
Sbjct: 224 YHIAQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV-----LRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 79/261 (30%), Positives = 131/261 (50%), Gaps = 16/261 (6%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP-EDLERLYSEVHLLKSLKHNNII 90
+ IG+G+F +Y A + + C ++ D+ + P ++ E EV LL +KH NI+
Sbjct: 6 KKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV--DMKAVKGWARQILSGLIYLHSH 148
F+ S+ +N + I+ E G L + + + V + W QI GL H H
Sbjct: 63 TFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL--KHIH 118
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPEL-YDEN 205
D I+HRD+K NIF++ N K+GD G+A + + A + +GTP +++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178
Query: 206 YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265
YN DI+S G + E+ T ++P+ E N Q+ K+ G A +S +++S I +
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQG-YFAPISPNFSRDLRSLISQ 236
Query: 266 CL-VPASQRLSAKELLMDPFL 285
V R S +L PFL
Sbjct: 237 LFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 74/275 (26%), Positives = 139/275 (50%), Gaps = 25/275 (9%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
I +G+GA +V K + G+ A + D +P+ +++ E+ + KS K
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSP 59
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLI 143
I+++Y +++D+ + ++ I E GSL ++ +K+ ++ K + A +L GL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LY 202
YLHS IIHRD+K NI + +G+VK+ D G++ + + A + GT +MAPE +
Sbjct: 120 YLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQ 176
Query: 203 DENYNELADIYSFGMCMLEMVT--FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD-PEV 259
+ Y+ +D++S G+ +LE+ F +P I ++ S I ++KD P
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI--ELLSYIVNMPNPELKDEPGN 234
Query: 260 --------KSFIEKCL-VPASQRLSAKELLMDPFL 285
K FI++CL ++R + ++L P++
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 59/246 (23%), Positives = 110/246 (44%), Gaps = 12/246 (4%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+G G F V + A V+ ++++ + E ++SE +L+ H I++ Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKLY 59
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 153
++ D K + ++ E G L + D + + ++ YLH+ II
Sbjct: 60 RTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--II 115
Query: 154 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPE-LYDENYNELAD 211
+RDLK +N+ ++ + G VK+ D G A ++ + GTPE++APE + ++ Y+ D
Sbjct: 116 YRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVD 174
Query: 212 IYSFGMCMLEMVTFEYPYSECRNSAQ-IYKKVSSGIKPAALSKVKDPEVKSFIEK--CLV 268
+S G+ + E++T P+ E IY + G D K I++
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234
Query: 269 PASQRL 274
P +RL
Sbjct: 235 PE-ERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 67/215 (31%), Positives = 114/215 (53%), Gaps = 12/215 (5%)
Query: 77 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL--RQYRKKHKKVDMKAVKGW 134
E LL LKH NI+ + SW + ++ + I+ G L + +K K + V W
Sbjct: 49 EAQLLSQLKHPNIVAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIG 192
QI L YLH + I+HRDLK N+F+ +K+GDLG+A ++E A ++IG
Sbjct: 108 FVQIAMALQYLH--EKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIG 164
Query: 193 TPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 251
TP +M+PEL+ ++ YN +D+++ G C+ EM T ++ ++ ++ +Y+ + + P +
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--M 222
Query: 252 SKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFL 285
K PE+ I L +R S K +L P++
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 82/274 (29%), Positives = 138/274 (50%), Gaps = 24/274 (8%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+G GAF VYKA ++ G+ A ++ D +S E+LE E+ +L S H NI++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA---AKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
+++ + N + I+ E G++ + + + ++ +Q L L YLH + I
Sbjct: 69 DAFYYENN--LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH--ENKI 124
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELY------DE 204
IHRDLK NI + G++K+ D G++ + + S IGTP +MAPE+ D
Sbjct: 125 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 205 NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFI 263
Y+ AD++S G+ ++EM E P+ E N ++ K++ P + E K F+
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242
Query: 264 EKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL 296
+KCL R + +LL PF+ VN N+P+
Sbjct: 243 KKCLEKNVDARWTTTQLLQHPFVTVN---SNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 81/273 (29%), Positives = 138/273 (50%), Gaps = 26/273 (9%)
Query: 26 RYIRYKEVIGKGAFKTVY----KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
RYI ++ +GKG+F TVY K L+V ++ + ++ +P + + E LL
Sbjct: 1 RYI-LQQRLGKGSFGTVYLVKDKKAVAEERLKVLK-EIPVGEL--NPNETVQANQEAQLL 56
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG-----SLRQYRKKHKKVDMKAVKGWAR 136
L H I++F+ S++ + IITE + G L + + K + V W
Sbjct: 57 SKLDHPAIVKFHASFL--ERDAFCIITE-YCEGRDLDCKLEELKHTGKTLSENQVCEWFI 113
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTP 194
Q+L G+ Y+H I+HRDLK NIF+ N +KIGD G++ ++ + A + GTP
Sbjct: 114 QLLLGVHYMHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTP 169
Query: 195 EFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253
+M+PE L + Y+ +DI+S G + EM + + E +N + ++ G P +L +
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP-SLPE 227
Query: 254 VKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFL 285
++ S ++ L S R SA E+L +PF+
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 85/298 (28%), Positives = 126/298 (42%), Gaps = 53/298 (17%)
Query: 30 YKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRI----DDVLQSPEDLERLYSEVHLLKS 83
Y+E+ IG+GA+ TVYKA D G VA +VR+ + + S E+ LLK
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS------TLREIALLKQ 54
Query: 84 LK---HNNIIRFYN---SWIDDQNKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWA 135
L+ H NI+R + D+ + ++ E L Y K K + + +K
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKDLM 113
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTP 194
RQ+L G+ +LHSH I+HRDLK NI + + G+VKI D GLA I A SV+ T
Sbjct: 114 RQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTL 170
Query: 195 EFMAPE-LYDENYNELADIYSFGMCMLEMVTFE---YPYSECRNSAQIYKKV-------- 242
+ APE L +Y D++S G E+ SE +I+ +
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230
Query: 243 -------------SSGIKPAALSKVKDPEVKSFIEKCLV--PASQRLSAKELLMDPFL 285
+ + E ++K L P R+SA E L P+
Sbjct: 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHK-RISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 85/285 (29%), Positives = 132/285 (46%), Gaps = 30/285 (10%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLER--LYSEVHLLKSLKHNNIIR 91
IG GA TVYK G A + + + ED R + E+ +L+ + H N+++
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYA-----LKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
++ + D N + ++ E GSL ++ + ARQILSG+ YLH
Sbjct: 137 CHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQ----FLADVARQILSGIAYLHRRH-- 188
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKSVIGTPEFMAPE-----LYDE 204
I+HRD+K N+ IN + VKI D G++ I+ Q S +GT +M+PE L
Sbjct: 189 IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247
Query: 205 NYNELA-DIYSFGMCMLEMVTFEYPYSECRNS--AQIYKKVSSGIKPAALSKVKDPEVKS 261
Y+ A DI+S G+ +LE +P+ R A + + P A + E +
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS-REFRH 306
Query: 262 FIEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLP 304
FI CL PA +R SA +LL PF+ + + P +LP
Sbjct: 307 FISCCLQREPA-KRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLP 350
|
Length = 353 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 5e-24
Identities = 81/262 (30%), Positives = 129/262 (49%), Gaps = 15/262 (5%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E IGKG+F V+K D VA ++I D+ ++ +++E + E+ +L + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+Y S++ D + II E GS + +D + R+IL GL YLHS
Sbjct: 67 YYGSYLKDTK--LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK- 122
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS--VIGTPEFMAPELYDEN-YNE 208
IHRD+K N+ ++ GEVK+ D G+A + K +GTP +MAPE+ ++ Y+
Sbjct: 123 -IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL- 267
ADI+S G+ +E+ E P+SE ++ + P L +K F+E CL
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NPPTLEGNYSKPLKEFVEACLN 238
Query: 268 VPASQRLSAKELLMDPFLQVNG 289
S R +AKELL F+
Sbjct: 239 KEPSFRPTAKELLKHKFIVRFA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 19/213 (8%)
Query: 25 CRYIRYKEVIGKGAFKTVYKAFDEVN----GLEVAWCQVRIDDVLQSPEDLERLYSEVHL 80
R++++ + +G+G F V + G +VA + Q D ER E+ +
Sbjct: 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEI 59
Query: 81 LKSLKHNNIIRFYNSWIDDQN-KTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQI 138
L++L H NI++ Y + +++ +I E SGSLR Y ++H+ ++++K + ++ QI
Sbjct: 60 LRTLDHENIVK-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTP 194
G+ YL S IHRDL NI + ++ VKI D GLA ++ + K +P
Sbjct: 119 CKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 195 EF-MAPE-LYDENYNELADIYSFGMCMLEMVTF 225
F APE L ++ +D++SFG+ + E+ T+
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 22/267 (8%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
I KGA+ V+ A + G A ++ D + ++++ +E +L + +++ Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-MIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 153
S+ +N + ++ E G L + +D + + +I+ L YLHS+ II
Sbjct: 60 YSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--II 115
Query: 154 HRDLKCDNIFINGNQGEVKIGDLGLATI--------MEQANAKS--VIGTPEFMAPE-LY 202
HRDLK DNI I+ N G +K+ D GL+ + + + ++GTP+++APE +
Sbjct: 116 HRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262
+ +++ D +S G + E + P+ +I++ + +G E
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 263 IEKCLVP-ASQRL---SAKELLMDPFL 285
I K LVP +RL S +E+ PF
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 68/252 (26%), Positives = 127/252 (50%), Gaps = 26/252 (10%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+ +G G+F V + +G A + +++ + +E + +E +L+S++H ++
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVN 65
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
Y S+ DD N + ++ E G L + +K + + +A Q++ L YLHS D
Sbjct: 66 LYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD-- 121
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELA 210
I++RDLK +N+ + + G +KI D G A ++ ++ GTPE++APE + + Y +
Sbjct: 122 IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKG-RTYTLCGTPEYLAPEIILSKGYGKAV 179
Query: 211 DIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSGIKPAALSKVK-----DPEVKSFI 263
D ++ G+ + EM+ YP + + N QIY+K+ G KV+ P+ K I
Sbjct: 180 DWWALGILIYEMLA-GYPPFFDD--NPIQIYEKILEG-------KVRFPSFFSPDAKDLI 229
Query: 264 EKCLVP-ASQRL 274
L ++RL
Sbjct: 230 RNLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 78/272 (28%), Positives = 135/272 (49%), Gaps = 32/272 (11%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
I+Y+E++G G TVYKA+ + +A V++ + + E +++ SE+ +L
Sbjct: 3 IQYQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
II FY ++ + ++I TE GSL YRK + V + A ++ GL YL S
Sbjct: 60 YIIGFYGAFFVENR--ISICTEFMDGGSLDVYRKIPEHVLGRI----AVAVVKGLTYLWS 113
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENY 206
I+HRD+K N+ +N +G+VK+ D G++T + + AK+ +GT +MAPE + E Y
Sbjct: 114 LK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQY 170
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD---------- 256
+D++S G+ +E+ +PY QI K S + L + D
Sbjct: 171 GIHSDVWSLGISFMELALGRFPY------PQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224
Query: 257 --PEVKSFIEKCL-VPASQRLSAKELLMDPFL 285
+ FI +C+ +R + + L+ PF+
Sbjct: 225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 81/258 (31%), Positives = 129/258 (50%), Gaps = 15/258 (5%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E IGKG+F VYK D VA ++I D+ ++ +++E + E+ +L I R
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+Y S++ + + II E GS K ++ + R+IL GL YLHS
Sbjct: 67 YYGSYL--KGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERK- 122
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELYDEN-YNE 208
IHRD+K N+ ++ QG+VK+ D G+A + K + +GTP +MAPE+ ++ Y+
Sbjct: 123 -IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268
ADI+S G+ +E+ E P S+ ++ + P L K F+E CL
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--SPPTLEGQYSKPFKEFVEACLN 238
Query: 269 PASQ-RLSAKELLMDPFL 285
+ R +AKELL F+
Sbjct: 239 KDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 84/313 (26%), Positives = 142/313 (45%), Gaps = 49/313 (15%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLER-LYSEVHLLKSL 84
RY + + +G+G + VYKA D+ G VA ++++ + ++ + + E+ LL+ L
Sbjct: 1 RYEK-GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL 59
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA-VKGWARQILSGLI 143
KH NII + + N +N++ E F L + K V A +K + L GL
Sbjct: 60 KHPNIIGLLDVFGHKSN--INLVFE-FMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK---SVIGTPEFMAPE 200
YLHS+ I+HRDLK +N+ I + G +K+ D GLA N K V+ T + APE
Sbjct: 117 YLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172
Query: 201 LY--DENYNELADIYSFGMCMLEM---VTFEYPYSECRNSAQIYKKVSSGIK--PAALSK 253
L +Y D++S G E+ V F S+ +I++ + + + ++
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 254 VKDP-EVKSF-------------------IEKCLV--PASQRLSAKELLMDPFLQVNGTT 291
+ D E K F +++ L P ++R++A++ L P+
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP-NKRITARQALEHPYF------ 285
Query: 292 KNRPLPLPDIVLP 304
N P P P LP
Sbjct: 286 SNDPAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 83/274 (30%), Positives = 135/274 (49%), Gaps = 23/274 (8%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+G GAF VYKA ++ G A ++ + +S E+LE E+ +L + H I++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAA---AKVIET-KSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
++ D + I+ E G++ + + + ++ RQ+L L YLHS I
Sbjct: 76 GAFYWDGK--LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--I 131
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPE------LYDE 204
IHRDLK N+ + G++K+ D G++ + + S IGTP +MAPE + D
Sbjct: 132 IHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 205 NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFI 263
Y+ ADI+S G+ ++EM E P+ E N ++ K++ P K E + F+
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQPSKWSMEFRDFL 249
Query: 264 EKCLVPASQ-RLSAKELLMDPFLQVNGTTKNRPL 296
+ L + R SA +LL PF V+ T NRPL
Sbjct: 250 KTALDKHPETRPSAAQLLEHPF--VSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 78/261 (29%), Positives = 134/261 (51%), Gaps = 16/261 (6%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
IG+G+ V A ++ G +VA V+ D L+ + E L++EV +++ H N++ Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVA---VKKMD-LRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 153
NS++ + ++ E G+L H +++ + + +L L YLH+ +I
Sbjct: 86 NSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQG--VI 140
Query: 154 HRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELYDE-NYNELA 210
HRD+K D+I + + G +K+ D G + E KS++GTP +MAPE+ Y
Sbjct: 141 HRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 211 DIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV-KSFIEKCLV- 268
DI+S G+ ++EM+ E PY Q +++ + P K V + F++ LV
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR 258
Query: 269 PASQRLSAKELLMDPFLQVNG 289
SQR +A+ELL PFL++ G
Sbjct: 259 EPSQRATAQELLQHPFLKLAG 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 7e-23
Identities = 72/231 (31%), Positives = 118/231 (51%), Gaps = 14/231 (6%)
Query: 65 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK 124
L+ + E L++EV +++ +H N++ YNS++ + ++ E G+L H
Sbjct: 55 LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHT 111
Query: 125 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM-- 182
+++ + + +L L LH+ +IHRD+K D+I + + G VK+ D G +
Sbjct: 112 RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSK 168
Query: 183 EQANAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 241
E KS++GTP +MAPEL Y DI+S G+ ++EMV E PY + K
Sbjct: 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKM 227
Query: 242 VSSGIKP--AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289
+ + P L KV P +K F+++ LV +QR +A ELL PFL G
Sbjct: 228 IRDNLPPKLKNLHKVS-PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 1e-22
Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 31/273 (11%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN-NII 90
E++G G + VYK G A +++ DV E E + E+++LK H+ NI
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTGDEE--EEIKQEINMLKKYSHHRNIA 66
Query: 91 RFYNSWI-------DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA--VKGWARQILSG 141
+Y ++I DDQ + ++ E +GS+ K K +K + R+IL G
Sbjct: 67 TYYGAFIKKNPPGMDDQ---LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAP 199
L +LH H +IHRD+K N+ + N EVK+ D G++ +++ + + IGTP +MAP
Sbjct: 124 LSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
Query: 200 ELY--DEN----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253
E+ DEN Y+ +D++S G+ +EM P + ++ + P SK
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSK 239
Query: 254 VKDPEVKSFIEKCLVPA-SQRLSAKELLMDPFL 285
+ +SFIE CLV SQR + ++L+ PF+
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-22
Identities = 79/260 (30%), Positives = 128/260 (49%), Gaps = 18/260 (6%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
IG G + VYKA + VN E+A +V L+ ED + E+ ++K KH+NI+ ++
Sbjct: 17 IGSGTYGDVYKARN-VNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 153
S++ + + I E GSL+ + + +R+ L GL YLHS +
Sbjct: 73 GSYL--RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--M 128
Query: 154 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKSVIGTPEFMAPEL----YDENYN 207
HRD+K NI + N G VK+ D G++ + A KS IGTP +MAPE+ YN
Sbjct: 129 HRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 208 ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS-KVK-DPEVKSFIEK 265
+L DI++ G+ +E+ + P + ++ S +P L K+K F++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKM 247
Query: 266 CLVP-ASQRLSAKELLMDPF 284
L +R +A++LL PF
Sbjct: 248 ALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 80/278 (28%), Positives = 143/278 (51%), Gaps = 24/278 (8%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
IG+G+ V A ++ +G +VA V++ D L+ + E L++EV +++ +H N++ Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 153
S++ + + ++ E G+L + +++ + + +L L YLHS +I
Sbjct: 85 KSYL--VGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VI 139
Query: 154 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKSVIGTPEFMAPELYDEN-YNELA 210
HRD+K D+I + + G VK+ D G + + KS++GTP +MAPE+ Y
Sbjct: 140 HRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 211 DIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFIEKCLV- 268
DI+S G+ ++EMV E PY + Q K++ P + K P ++ F+E+ L
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257
Query: 269 PASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRV 306
+R +A+ELL PFL G LP+ ++P +
Sbjct: 258 EPQERATAQELLDHPFLLQTG--------LPECLVPLI 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 85/275 (30%), Positives = 136/275 (49%), Gaps = 35/275 (12%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN-NII 90
EV+G G + VYK G A +++ DV + E E + E+++LK H+ NI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTEDEE--EEIKLEINMLKKYSHHRNIA 76
Query: 91 RFYNSWI-------DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW----ARQIL 139
+Y ++I DDQ + ++ E +GS+ K K +K + W R+IL
Sbjct: 77 TYYGAFIKKSPPGHDDQ---LWLVMEFCGAGSVTDLVKNTKGNALK--EDWIAYICREIL 131
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFM 197
GL +LH+H +IHRD+K N+ + N EVK+ D G++ +++ + + IGTP +M
Sbjct: 132 RGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188
Query: 198 APELY--DEN----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 251
APE+ DEN Y+ +DI+S G+ +EM P + ++ + P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPPPKLK 247
Query: 252 SKVKDPEVKSFIEKCLVPAS-QRLSAKELLMDPFL 285
SK + FIE CLV R S ++LL PF+
Sbjct: 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-22
Identities = 95/295 (32%), Positives = 145/295 (49%), Gaps = 32/295 (10%)
Query: 15 DPDVLE----TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
DPDV E DP + +E IG G+F VY A D N VA ++ QS E
Sbjct: 1 DPDVAELFFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEK 58
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK----V 126
+ + EV L+ L+H N I++ ++ + T ++ E + GS + HKK V
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLVME-YCLGSASDLLEVHKKPLQEV 115
Query: 127 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186
++ AV A L GL YLHSH+ +IHRD+K NI ++ G VK+GD G A+IM AN
Sbjct: 116 EIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN 169
Query: 187 AKSVIGTPEFMAPEL---YDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242
+GTP +MAPE+ DE Y+ D++S G+ +E+ + P + +Y +
Sbjct: 170 --XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HI 226
Query: 243 SSGIKPAALSKVKDPEVKSFIEKCLVPASQ-RLSAKELLMDPFLQVNGTTKNRPL 296
+ PA S ++F++ CL Q R +++ LL F+ + RP
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL-----RERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 7e-22
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 30 YKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV---LQSPEDLERLYSEVHLLKSL 84
YK + +G G F +VY A ++ G VA I + S E+ L EV L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVA-----IKKMKKKFYSWEECMNL-REVKSLRKL 54
Query: 85 K-HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM--KAVKGWARQILSG 141
H NI++ + + N + + E + G+L Q K K ++ QIL G
Sbjct: 55 NEHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-TIMEQANAKSVIGTPEFMAPE 200
L ++H H HRDLK +N+ ++G VKI D GLA I + + T + APE
Sbjct: 112 LAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPE 168
Query: 201 --LYDENYNELADIYSFGMCMLEMVTFE 226
L +Y+ DI++ G M E+ T
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 87/297 (29%), Positives = 136/297 (45%), Gaps = 49/297 (16%)
Query: 28 IRYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
RY+ + +G GA+ V AFD G +VA ++ QS +R Y E+ LLK +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVA--IKKLSRPFQSAIHAKRTYRELRLLKHMD 72
Query: 86 HNNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
H N+I + + + + V ++T L + L K +K+ ++ QIL G
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNI-VKCQKLSDDHIQFLVYQILRG 130
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAP 199
L Y+HS IIHRDLK NI +N + E+KI D GLA + + + T + AP
Sbjct: 131 LKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGLA---RHTDDEMTGYVATRWYRAP 184
Query: 200 E--LYDENYNELADIYSFGMCMLEMVTFE--YPYSECRN------------SAQIYKKVS 243
E L +YN+ DI+S G M E++T + +P S+ + ++ +K+S
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244
Query: 244 SG-----IKPAALSKVKD---------PEVKSFIEKCLV-PASQRLSAKELLMDPFL 285
S I+ KD P +EK LV +R++A E L P+L
Sbjct: 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 66/248 (26%), Positives = 126/248 (50%), Gaps = 22/248 (8%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+G G F V+ D ++ A + I +V++ ++ + +++E +LK + H IIR +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHNEKRVLKEVSHPFIIRLF 67
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 153
+ D + + ++ E G L Y + + +A +I+ L YLHS + I+
Sbjct: 68 WTEHDQRF--LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IV 123
Query: 154 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADI 212
+RDLK +NI ++ +G +K+ D G A + ++ GTPE++APE + + +N+ D
Sbjct: 124 YRDLKPENILLD-KEGHIKLTDFGFAKKLRD-RTWTLCGTPEYLAPEVIQSKGHNKAVDW 181
Query: 213 YSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-----DPEVKSFIEKCL 267
++ G+ + EM+ P+ + N IY+K+ +G K++ D K I+K L
Sbjct: 182 WALGILIYEMLVGYPPFFD-DNPFGIYEKILAG-------KLEFPRHLDLYAKDLIKKLL 233
Query: 268 V-PASQRL 274
V ++RL
Sbjct: 234 VVDRTRRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 87/297 (29%), Positives = 141/297 (47%), Gaps = 32/297 (10%)
Query: 13 PPDPDVLE----TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP 68
DP++ + DP ++ E IG G+F VY A + VA ++ Q+
Sbjct: 5 VKDPEIADLFYKDDPEEIFVGLHE-IGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTN 62
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK--- 125
E + + EV L+ LKH N I + ++ + T ++ E + GS + HKK
Sbjct: 63 EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--TAWLVME-YCLGSASDLLEVHKKPLQ 119
Query: 126 -VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184
V++ A+ A L GL YLHSH+ +IHRD+K NI + G+VK+ D G A+
Sbjct: 120 EVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSSP 173
Query: 185 ANAKSVIGTPEFMAPEL---YDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
AN S +GTP +MAPE+ DE Y+ D++S G+ +E+ + P + +Y
Sbjct: 174 AN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY- 230
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLVPASQ-RLSAKELLMDPFLQVNGTTKNRPL 296
++ P S + F++ CL Q R ++ ELL F++ ++RP
Sbjct: 231 HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR-----RDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 27/203 (13%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
IG+G + VYKA D++ G VA ++++ +S + E+ LLK L H NII+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 153
+ + + + ++ E + + + + + + +K + Q+L GL + HSH I+
Sbjct: 65 DVFRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--IL 120
Query: 154 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM----------APELY- 202
HRDLK +N+ IN G +K+ D GL A+S APEL
Sbjct: 121 HRDLKPENLLINTE-GVLKLADFGL--------ARSFGSPVRPYTHYVVTRWYRAPELLL 171
Query: 203 -DENYNELADIYSFGMCMLEMVT 224
D+ Y+ DI+S G E+++
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 78/258 (30%), Positives = 129/258 (50%), Gaps = 15/258 (5%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E IGKG+F V+K D VA ++I D+ ++ +++E + E+ +L + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+Y S++ + + II E GS + D + ++IL GL YLHS
Sbjct: 67 YYGSYL--KGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKK- 122
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELYDEN-YNE 208
IHRD+K N+ ++ QG+VK+ D G+A + K + +GTP +MAPE+ ++ Y+
Sbjct: 123 -IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL- 267
ADI+S G+ +E+ E P S+ ++ + P L+ K FI+ CL
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDMHPMRVLF--LIPKNNPPTLTGEFSKPFKEFIDACLN 238
Query: 268 VPASQRLSAKELLMDPFL 285
S R +AKELL F+
Sbjct: 239 KDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 7e-21
Identities = 89/284 (31%), Positives = 139/284 (48%), Gaps = 27/284 (9%)
Query: 15 DPDVLE----TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
DP++ E DP + +E IG G+F VY A D V EV + QS E
Sbjct: 11 DPEIAELFFKEDPEKLFTDLRE-IGHGSFGAVYFARD-VRTNEVVAIKKMSYSGKQSNEK 68
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK----V 126
+ + EV L+ +KH N I + ++ + T ++ E + GS + HKK V
Sbjct: 69 WQDIIKEVKFLQRIKHPNSIEYKGCYLREH--TAWLVME-YCLGSASDLLEVHKKPLQEV 125
Query: 127 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186
++ A+ A L GL YLHSH+ +IHRD+K NI + G+VK+ D G A+I AN
Sbjct: 126 EIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIASPAN 179
Query: 187 AKSVIGTPEFMAPEL---YDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242
S +GTP +MAPE+ DE Y+ D++S G+ +E+ + P + +Y +
Sbjct: 180 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HI 236
Query: 243 SSGIKPAALSKVKDPEVKSFIEKCLVPASQ-RLSAKELLMDPFL 285
+ P S ++F++ CL Q R +++ELL F+
Sbjct: 237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 8e-21
Identities = 82/277 (29%), Positives = 133/277 (48%), Gaps = 19/277 (6%)
Query: 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS 76
D+L +P Y + V G G + VYKA + G E+A V+I L+ +D +
Sbjct: 1 DILRRNPQHDYELIQRV-GSGTYGDVYKARNLHTG-ELA--AVKIIK-LEPGDDFSLIQQ 55
Query: 77 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 136
E+ ++K KH NI+ ++ S++ + + I E GSL+ + + R
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREK--LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR 113
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKSVIGTP 194
+ L GL YLHS +HRD+K NI + N G+VK+ D G+A + A KS IGTP
Sbjct: 114 ETLQGLAYLHSKGK--MHRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGTP 170
Query: 195 EFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250
+MAPE+ + YN+L DI++ G+ +E+ + P + ++ S +P
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK 230
Query: 251 LS-KVK-DPEVKSFIEKCLVP-ASQRLSAKELLMDPF 284
L K K +F++ L +R +A+ LL F
Sbjct: 231 LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 18/201 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E +G+G + TVYK + G VA ++ +D +P R E+ L+K LKH NI+R
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVR 62
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKH---KKVDMKAVKGWARQILSGLIYLHSH 148
++ I +NK + ++ E + L++Y H +D VK + Q+L G+ + H +
Sbjct: 63 LHDV-IHTENKLM-LVFE-YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT---IMEQANAKSVIGTPEFMAPE--LYD 203
++HRDLK N+ IN +GE+K+ D GLA I + V+ T + AP+ L
Sbjct: 120 R--VLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGS 175
Query: 204 ENYNELADIYSFGMCMLEMVT 224
Y+ DI+S G M EM+T
Sbjct: 176 RTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 58/153 (37%), Positives = 88/153 (57%), Gaps = 17/153 (11%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLKSLKHN 87
E IG+G + TV+KA + VA +VR+DD D E + S E+ LLK LKH
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD------DDEGVPSSALREICLLKELKHK 59
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLH 146
NI+R Y+ + +K + ++ E + L++Y + +D + VK + Q+L GL + H
Sbjct: 60 NIVRLYD--VLHSDKKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179
SH+ ++HRDLK N+ IN N GE+K+ D GLA
Sbjct: 117 SHN--VLHRDLKPQNLLINKN-GELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 73/256 (28%), Positives = 121/256 (47%), Gaps = 27/256 (10%)
Query: 32 EVIGKGAFKTVYK-----------AFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHL 80
E +G GAF VYK A E+N A+ + D + + + + SEV +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGK----DKRERDKSIGDIVSEVTI 61
Query: 81 LK-SLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWAR- 136
+K L+H NI+R+Y +++ +N + I+ +L L ++ K KK + W
Sbjct: 62 IKEQLRHPNIVRYYKTFL--ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 137 -QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-TIMEQANAKSVIGTP 194
Q++ L YLH + I+HRDL +NI + G +V I D GLA ++ SV+GT
Sbjct: 120 VQMVLALRYLHK-EKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 195 EFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253
+ PE + +E Y E AD+++FG + +M T + P+ N + K+ +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEG 236
Query: 254 VKDPEVKSFIEKCLVP 269
+ +V I CL P
Sbjct: 237 MYSEDVTDVITSCLTP 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 18/211 (8%)
Query: 26 RYIRYKEVIGKGAFKTV----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
R++++ + +GKG F +V Y + G VA +++ + E L E+ +L
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEIL 59
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILS 140
KSL+H+NI+++ + + ++ E GSLR Y +KH+ ++D + + +A QI
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 141 GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE----- 195
G+ YL S +HRDL NI + ++ VKIGD GL ++ Q + P
Sbjct: 120 GMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 196 FMAPE-LYDENYNELADIYSFGMCMLEMVTF 225
+ APE L + ++ +D++SFG+ + E+ T+
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFTY 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 65/228 (28%), Positives = 118/228 (51%), Gaps = 14/228 (6%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
+Y++ K+ IG+G+F + +G + ++ I + SP++ E EV +L ++K
Sbjct: 1 KYVKVKK-IGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMK 57
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV--DMKAVKGWARQILSGLI 143
H NI+++ S+ ++N + I+ + G L + + V + W QI L
Sbjct: 58 HPNIVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL- 114
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPEL 201
H HD I+HRD+K NIF+ G +K+GD G+A ++ A++ IGTP +++PE+
Sbjct: 115 -KHVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172
Query: 202 YDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248
+ YN +DI++ G + EM T ++ + E N + K+ G P
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 70/266 (26%), Positives = 127/266 (47%), Gaps = 23/266 (8%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+GKG + +VYK G+ +A ++R++ ++ E+ +L I+ FY
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQY---RKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
++ V + E +GSL + + + ++ ++ GL +L +
Sbjct: 66 GAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-KEEH 122
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDE------ 204
IIHRD+K N+ +NGN G+VK+ D G++ + + AK+ IG +MAPE
Sbjct: 123 NIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 205 -NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKS 261
Y +D++S G+ +LEM YPY A I+ ++S+ + P L + +
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDDAQD 240
Query: 262 FIEKCL--VPASQRLSAKELLMDPFL 285
F+ KCL +P ++R + +LL P+L
Sbjct: 241 FVAKCLNKIP-NRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLKSLKHN 87
E IG+G + VYKA D++ G VA ++R++ ED E + S E+ LLK L H
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLET-----ED-EGVPSTAIREISLLKELNHP 58
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYL 145
NI+R + + + ++ E F L++Y +D +K + Q+L G+ Y
Sbjct: 59 NIVRLLDVVHSENK--LYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT---IMEQANAKSVIGTPEFMAPE-- 200
HSH ++HRDLK N+ I+ +G +K+ D GLA + + V+ T + APE
Sbjct: 116 HSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 171
Query: 201 LYDENYNELADIYSFGMCMLEMVT 224
L Y+ DI+S G EMV
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 20/268 (7%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHL-LKSLKHNNII 90
E +G+GA+ V K G +A RI + S E +RL ++ + ++S+ +
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMA--VKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTV 63
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK----AVKGWARQILSGLIYLH 146
FY + + V I E+ + SL ++ KK + + A I+ L YLH
Sbjct: 64 TFYGALF--REGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV-IGTPEFMAPELYD-- 203
S +IHRD+K N+ IN G+VK+ D G++ + + AK++ G +MAPE +
Sbjct: 121 SK-LSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 204 ---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260
+ Y+ +D++S G+ M+E+ T +PY + Q K+V P ++ PE +
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ 238
Query: 261 SFIEKCLVP-ASQRLSAKELLMDPFLQV 287
F+ KCL +R + ELL PF ++
Sbjct: 239 DFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
+ T RY+ + V G GAF V A D++ G VA +I +P +R Y E+ LL
Sbjct: 7 EITNRYVDLQPV-GMGAFGLVCSARDQLTGQNVA--IKKIMKPFSTPVLAKRTYRELKLL 63
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
K L+H NII + +I + + +TEL + R + ++ + ++ + QIL G
Sbjct: 64 KHLRHENIISLSDIFISPL-EDIYFVTELLGTDLHRLL--TSRPLEKQFIQYFLYQILRG 120
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE- 200
L Y+HS ++HRDLK NI IN N ++KI D GLA I + + T + APE
Sbjct: 121 LKYVHSAG--VVHRDLKPSNILINEN-CDLKICDFGLARIQD-PQMTGYVSTRYYRAPEI 176
Query: 201 -LYDENYNELADIYSFGMCMLEMV 223
L + Y+ DI+S G EM+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 65/268 (24%), Positives = 130/268 (48%), Gaps = 24/268 (8%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+G G +V K G +A V I +++ E+ ++ + I+ FY
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIG---AKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPI 152
+++++ N + + E GSL + KK + ++ + A ++ GL YL++ H I
Sbjct: 70 GAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELAD 211
+HRD+K NI +N +G++K+ D G++ + + A + +GT +M+PE + Y +D
Sbjct: 126 MHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 212 IYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI----------KPAALSKVKDPEV-K 260
++S G+ ++E+ ++P++ N + GI P L PE +
Sbjct: 185 VWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243
Query: 261 SFIEKCLV-PASQRLSAKELL-MDPFLQ 286
F++ CL+ ++R + ++L M PF+Q
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 28 IRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS 83
+ +V+G GAF TVYK E + VA +R + SP+ + + E +++ S
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE---TSPKANKEILDEAYVMAS 65
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGL 142
+ H +++R + + V +IT+L G L Y + HK + + + W QI G+
Sbjct: 66 VDHPHVVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGT----P-EFM 197
YL ++HRDL N+ + Q VKI D GLA +++ + K P ++M
Sbjct: 123 SYLEEKR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLD-VDEKEYHAEGGKVPIKWM 178
Query: 198 APE-LYDENYNELADIYSFGMCMLEMVTF-EYPY 229
A E + Y +D++S+G+ + E++TF PY
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 52/159 (32%), Positives = 88/159 (55%), Gaps = 10/159 (6%)
Query: 74 LYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVK 132
L E+ +L++L H NI+++ +D + +I E SGSL++Y ++K K+++K
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112
Query: 133 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA----TIMEQANAK 188
+A QI G+ YL S +HRDL N+ + ++ +VKIGD GL T E K
Sbjct: 113 KYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 189 SVIGTPEF-MAPE-LYDENYNELADIYSFGMCMLEMVTF 225
+ +P F APE L + +D++SFG+ + E++T+
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 43/236 (18%)
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS- 147
I+ FY ++ D ++I E GSL Q KK ++ + + +L GL YL
Sbjct: 61 IVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENY 206
H I+HRD+K NI +N GE+K+ D G++ + + A S +GT +M+PE L +Y
Sbjct: 119 HK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 207 NELADIYSFGMCMLEMVTFEYP---------------YSECRNSAQIYKKVSSGI----K 247
+DI+S G+ ++EM YP + + ++ VS +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
Query: 248 PAAL----------------SKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
P A+ S E + F++KCL +R KEL PF++
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 26 RYIRYKEVIGKGAF-KTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
RY++ V+G+G F K +D N G VA ++ + ++ E+++L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINIL 60
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
K+L H NI+++ + K + +I E GSLR Y KH K+++ + +A+QI G
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEG 119
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG----TPEF- 196
+ YLHS IHRDL N+ ++ N VKIGD GLA + + + + +P F
Sbjct: 120 MAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 197 MAPELYDEN-YNELADIYSFGMCMLEMVT 224
A E EN ++ +D++SFG+ + E++T
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 6e-19
Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 53/306 (17%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY ++ +G G+ V+ A D VA ++ VL P+ ++ E+ +++ L H
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI----VLTDPQSVKHALREIKIIRRLDH 61
Query: 87 NNIIRFYNSWID---DQNKTVNIITELFTSGSLRQYRK-------KHKKVDMKAVKGWAR 136
+NI++ Y D + V +TEL + +++Y + + + + + +
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMY 121
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS-----VI 191
Q+L GL Y+HS + ++HRDLK N+FIN +KIGD GLA I++ + +
Sbjct: 122 QLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 192 GTPEFMAPE--LYDENYNELADIYSFGMCMLEMVT------------------------F 225
T + +P L NY + D+++ G EM+T
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239
Query: 226 EYPYSECRNSAQIYKKVSSGIKPAALSKV---KDPEVKSFIEKCLVPA-SQRLSAKELLM 281
E +E N + + G L + +PE F+E+ L RL+A+E LM
Sbjct: 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299
Query: 282 DPFLQV 287
P++
Sbjct: 300 HPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 15/222 (6%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
V+G+G+F + + A ++R+ +S +E E LL +KH NI+ F
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLP---KSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRK--KHKKVDMKAVKGWARQILSGLIYLHSHDP 150
S+ D + + I+ E G L Q K + K + W Q+ G+ H H+
Sbjct: 64 KESFEADGH--LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV--QHIHEK 119
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKSVIGTPEFMAPELYDEN--Y 206
++HRD+K NIF+ N G+VK+GD G A ++ A A + +GTP ++ PE++ EN Y
Sbjct: 120 RVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW-ENMPY 177
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248
N +DI+S G + E+ T ++P+ I K KP
Sbjct: 178 NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 18/201 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNII 90
E IG+G + VYKA +++ G VA ++R+D + P R E+ LLK L H NI+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 62
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSH 148
+ + I +NK + ++ E F L+++ + + +K + Q+L GL + HSH
Sbjct: 63 KLLDV-IHTENK-LYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT---IMEQANAKSVIGTPEFMAPE--LYD 203
++HRDLK N+ IN +G +K+ D GLA + + V+ T + APE L
Sbjct: 120 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 175
Query: 204 ENYNELADIYSFGMCMLEMVT 224
+ Y+ DI+S G EMVT
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 71/230 (30%), Positives = 109/230 (47%), Gaps = 31/230 (13%)
Query: 34 IGKGAFKTVYKAFDEVN--GLEVAWCQVRIDDVLQSPEDLERL----YSEVHLLKSLKHN 87
IG+G + VYKA + G E A I E + E+ LL+ LKH
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYA-----IKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQ-----YRKKHKKVDMKAVKGWARQILSGL 142
N++ +++ +K+V ++ + + L Q + K + VK QIL+G+
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGN---QGEVKIGDLGLATIMEQ-----ANAKSVIGTP 194
YLHS+ ++HRDLK NI + G +G VKIGDLGLA + A+ V+ T
Sbjct: 122 HYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 195 EFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242
+ APEL +Y + DI++ G E++T E P + R A+I K
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PIFKGRE-AKIKKSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 30/227 (13%)
Query: 32 EVIGKGAFKTVYKA-FDEVNG--LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
+ +G G+F V + + G + VA ++ D + +D + E ++ SL H N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK---EAAIMHSLDHEN 57
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLH 146
+IR Y + V TEL GSL +K + + +A QI +G+ YL
Sbjct: 58 LIRLYGVVLTHPLMMV---TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT---------IMEQANAKSVIGTPEFM 197
S IHRDL NI + + +VKIGD GL +M + + K +
Sbjct: 115 SKR--FIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVM-EEHLKVPFA---WC 167
Query: 198 APE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKV 242
APE L ++ +D++ FG+ + EM T+ E P++ + +QI KK+
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+ +G+G++ TVYK ++ G VA ++R++ +P R E LLK LKH NI+
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVT 67
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDP 150
++ I KT+ ++ E + L+QY + M V+ + Q+L GL Y H
Sbjct: 68 LHD--IIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV--------IGTPEFMAPE-- 200
++HRDLK N+ I+ +GE+K+ D GL A AKSV + T + P+
Sbjct: 124 -VLHRDLKPQNLLIS-ERGELKLADFGL------ARAKSVPSKTYSNEVVTLWYRPPDVL 175
Query: 201 LYDENYNELADIYSFGMCMLEMVT 224
L Y+ D++ G EM T
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 73/276 (26%), Positives = 135/276 (48%), Gaps = 35/276 (12%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNII 90
E IGKG + V+K ++ NG + A V+I D + + E + +E ++LK+L H N++
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAA---VKILDPIHDID--EEIEAEYNILKALSDHPNVV 78
Query: 91 RFYNSWIDDQNKTVN---IITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLI 143
+FY + K + ++ EL GS+ + + K+ ++++ + + L GL
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPEL 201
+LH + IHRD+K +NI + +G VK+ D G++ + + + +GTP +MAPE+
Sbjct: 139 HLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 202 ------YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255
D Y+ D++S G+ +E+ + P ++ ++K I +
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-----IPRNPPPTLH 250
Query: 256 DPEVKS-----FIEKCLVPA-SQRLSAKELLMDPFL 285
PE+ S FI KCL +R + +LL F+
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 53/188 (28%), Positives = 94/188 (50%), Gaps = 20/188 (10%)
Query: 67 SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHK 124
P+D E ++K L+H +I+ Y ++ + I+TEL GSL +Y +
Sbjct: 44 DPKDFLA---EAQIMKKLRHPKLIQLYAVCTLEE--PIYIVTELMKYGSLLEYLQGGAGR 98
Query: 125 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184
+ + + A Q+ SG+ YL + + IHRDL N+ + G K+ D GLA ++++
Sbjct: 99 ALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLARVIKE 155
Query: 185 ANAKSVIGTP---EFMAPELYDENYNEL---ADIYSFGMCMLEMVTF-EYPYSECRNSAQ 237
++ G ++ APE YN +D++SFG+ + E+VT+ PY N A+
Sbjct: 156 DIYEAREGAKFPIKWTAPEA--ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AE 212
Query: 238 IYKKVSSG 245
+ ++V G
Sbjct: 213 VLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNII 90
E IGKG + VYK ++ +G A V+I D + + E + +E ++L+SL H N++
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAA---VKILDPISDVD--EEIEAEYNILQSLPNHPNVV 82
Query: 91 RFYNSWIDDQNKT---VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG--LIYL 145
+FY + + ++ EL GS+ + K + + IL G L
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPEL-- 201
H H+ IIHRD+K +NI + +G VK+ D G++ + + + +GTP +MAPE+
Sbjct: 143 HLHNNRIIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 202 ----YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-D 256
YD +Y+ D++S G+ +E+ + P + ++ K+ P L K
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRNPPPTLLHPEKWC 260
Query: 257 PEVKSFIEKCLVPA-SQRLSAKELLMDPFLQ 286
FI +CL+ R S LL PF++
Sbjct: 261 RSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 75/246 (30%), Positives = 119/246 (48%), Gaps = 18/246 (7%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ + +G GA+ +V AFD GL VA ++ QS +R Y E+ LLK +KH
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVA--VKKLSRPFQSIIHAKRTYRELRLLKHMKH 75
Query: 87 NNIIRFYNSWID----DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
N+I + + ++ V ++T L L K K D V+ QIL GL
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 133
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY 202
Y+HS D IIHRDLK N+ +N E+KI D GLA + + T + APE+
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIM 189
Query: 203 DE--NYNELADIYSFGMCMLEMVTFE--YPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258
+YN+ DI+S G M E++T +P ++ + ++ ++ L K+
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 259 VKSFIE 264
+++I+
Sbjct: 250 ARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 58/206 (28%), Positives = 107/206 (51%), Gaps = 20/206 (9%)
Query: 33 VIGKGAFKTV----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK-SLKHN 87
V+GKG+F V K DE+ ++V ++ D +LQ +D+E +E +L + KH
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV----LKKDVILQD-DDVECTMTEKRVLALAGKHP 56
Query: 88 NIIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
+ + ++ + Q K + + E G L + ++ + D + +A +I+ GL +LH
Sbjct: 57 FLTQLHSCF---QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYD 203
II+RDLK DN+ ++ +G +KI D G+ I+ + GTP+++APE L
Sbjct: 114 ERG--IIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170
Query: 204 ENYNELADIYSFGMCMLEMVTFEYPY 229
+ Y D ++ G+ + EM+ + P+
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED---LERLYSEVHLLKS 83
+Y+ V+G+GA+ V K ++ G VA I +S +D + EV +L+
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVA-----IKKFKESEDDEDVKKTALREVKVLRQ 56
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
L+H NI+ ++ + ++ E L + AV+ + Q+L +
Sbjct: 57 LRHENIVNLKEAFRRK--GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK---SVIGTPEFMAPE 200
Y HSH+ IIHRD+K +NI ++ + G +K+ D G A + A + T + APE
Sbjct: 115 YCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 201 LY--DENYNELADIYSFGMCMLEMVT 224
L D NY + D+++ G M E++
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 1e-17
Identities = 71/238 (29%), Positives = 125/238 (52%), Gaps = 32/238 (13%)
Query: 73 RLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL-RQYRKKHK---KVDM 128
+L EV++++ LKH NI+R+ + +++ N+ + I+ E +G L R +K +K K++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 129 KAVKGWARQILSGLIYLHS-HDPP----IIHRDLKCDNIFI--------------NGNQG 169
A+ RQ+L L Y H+ D P ++HRDLK NIF+ N G
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 170 E--VKIGDLGLA-TIMEQANAKSVIGTPEFMAPELY---DENYNELADIYSFGMCMLEMV 223
KIGD GL+ I ++ A S +GTP + +PEL ++Y++ +D+++ G + E+
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 224 TFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKELL 280
+ + P+ + N +Q+ ++ G P K K E+ I+ L + A +R SA + L
Sbjct: 238 SGKTPFHKANNFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 33 VIGKGAFKTVYKA-FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK-SLKHNNII 90
V+GKG+F V A N + DV+ +D+E E +L + +H +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKK--DVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
+ ++ + + + E G L + + + D + +A +I+ GL +LH
Sbjct: 60 HLFCTF--QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG- 116
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYDENYN 207
II+RDLK DN+ ++ G +KI D G+ + + A + GTP+++APE L + YN
Sbjct: 117 -IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 208 ELADIYSFGMCMLEMVTFEYPYSEC 232
E D +SFG+ + EM+ + P+
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 34 IGKGAFKTVYKAF-----DEVNGLEVAWCQVRIDDVLQSPEDLERL--YSEVHLLKSLKH 86
+G+G+F VY+ VA I V ++ ER+ +E ++K
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVA-----IKTVNENASMRERIEFLNEASVMKEFNC 68
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKG----------WAR 136
++++R + T+ ++ EL G L+ Y + + A
Sbjct: 69 HHVVRLLGV-VSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGT--- 193
+I G+ YL + +HRDL N + + VKIGD G+ + + + G
Sbjct: 127 EIADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 194 P-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPY 229
P +MAPE L D + +D++SFG+ + EM T E PY
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 69/216 (31%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIR 91
IG+G + VYKA D+ G VA +VR+D+ + P R E+ +L+ L H NI+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVN 70
Query: 92 FYNSWIDDQNKT--------VNIITE--------LFTSGSLRQYRKKHKKVDMKAVKGWA 135
D Q+ ++ E L SG L + + H K MK
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMK------ 123
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK----SVI 191
Q+L GL Y H + +HRD+KC NI +N N+G++K+ D GLA + ++ VI
Sbjct: 124 -QLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 192 GTPEFMAPELY--DENYNELADIYSFGMCML-EMVT 224
T + PEL +E Y D++S G C+L E+ T
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 79/321 (24%), Positives = 135/321 (42%), Gaps = 60/321 (18%)
Query: 33 VIGKGAF--KTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
+IGK V+ A + VA ++ +D S EDL+ L E+ + L+H NI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK--AVKGWARQILSGLIYLHSH 148
+ S+I D + +++ L GS K H + A+ + +L+ L Y+HS
Sbjct: 63 PYVTSFIVDSE--LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-TIMEQANAKSVI-GTPEF-------MAP 199
IHR +K +I ++G+ G+V + L + ++++ + V+ P+ ++P
Sbjct: 121 G--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 200 ELYDEN---YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV-------------- 242
E+ +N YNE +DIYS G+ E+ P+ + + + +KV
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237
Query: 243 ----------SSGIKPAALSKVKDPEVKSF-------IEKCL-VPASQRLSAKELLMDPF 284
SS P V P ++F +E CL R SA +LL F
Sbjct: 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297
Query: 285 L-QVNGTTKNRPLPLPDIVLP 304
Q K R L D++ P
Sbjct: 298 FKQC----KRRNTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 28 IRYKEVIGKGAFKTVYKA-FDEVNG--LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL 84
I IG+G F VY+ + + VA + SP E+ E ++++
Sbjct: 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQF 64
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLI 143
H +I++ ++ V I+ EL G LR Y + +K +D+ ++ ++ Q+ + L
Sbjct: 65 DHPHIVKLIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTP-EFMAPE 200
YL S +HRD+ N+ ++ VK+GD GL+ +E + S P ++MAPE
Sbjct: 122 YLESKR--FVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 201 LYD-ENYNELADIYSFGMCMLEMVTF 225
+ + +D++ FG+CM E++
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 92/294 (31%), Positives = 137/294 (46%), Gaps = 54/294 (18%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLKSLKHN 87
E IG+G + VYK ++ G VA ++R L+S E E + S E+ LLK L+H
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIR----LESEE--EGVPSTAIREISLLKELQHP 59
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR---KKHKKVDMKAVKGWARQILSGLIY 144
NI+ + + Q + +I E F S L++Y K + +D + VK + QIL G+++
Sbjct: 60 NIVCLQDVLM--QESRLYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT---IMEQANAKSVIGTPEFMAPE- 200
HS ++HRDLK N+ I+ N+G +K+ D GLA I + V+ T + APE
Sbjct: 117 CHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEV 172
Query: 201 -LYDENYNELADIYSFGMCMLEMVT-----------------FEY---PYSECRN---SA 236
L Y+ DI+S G EM T F P + S
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232
Query: 237 QIYKKVSSGIKPAAL-SKVK--DPEVKSFIEKCLV--PASQRLSAKELLMDPFL 285
YK K +L S VK D + +EK L+ PA +R+SAK+ L P+
Sbjct: 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPA-KRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 13/198 (6%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRF 92
IG+G F V KA G A + + +S E + L E+ L+ L H NI+R
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYA-IK-CMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPP 151
D + + ++ EL +L + K K+ + K VK + Q+L L ++H +
Sbjct: 64 IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLG-LATIMEQANAKSVIGTPEFMAPE--LYDENYNE 208
I HRD+K +NI I +K+ D G I + I T + APE L D Y
Sbjct: 121 IFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP 178
Query: 209 LADIYSFGMCMLEMVTFE 226
DI++ G E+++
Sbjct: 179 KMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 63/244 (25%), Positives = 117/244 (47%), Gaps = 28/244 (11%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+G G F V++ + N + VA ++ DD+L+ + EV LK L+H ++I +
Sbjct: 14 LGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLK----QQDFQKEVQALKRLRHKHLISLF 68
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRK--KHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+ + V IITEL GSL + + + + + + ++ A Q+ G+ YL +
Sbjct: 69 A--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN-- 124
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE-------FMAPE-LYD 203
IHRDL NI + G K+ D GLA ++ K + + APE
Sbjct: 125 SIHRDLAARNILV-GEDLVCKVADFGLARLI-----KEDVYLSSDKKIPYKWTAPEAASH 178
Query: 204 ENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262
++ +D++SFG+ + EM T+ + PY N+ ++Y ++++G + +K E+
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRMPCPAKCP-QEIYKI 236
Query: 263 IEKC 266
+ +C
Sbjct: 237 MLEC 240
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 75/208 (36%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS--EVHLLKSL 84
+Y+ V IG GA+ TVYKA D +G VA VR+ Q+ ED L + EV LLK L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----QTNEDGLPLSTVREVALLKRL 56
Query: 85 K---HNNIIRFYN---SWIDDQNKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWAR 136
+ H NI+R + + D+ V ++ E LR Y K + + +K R
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFE-HVDQDLRTYLDKVPPPGLPAETIKDLMR 115
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME-QANAKSVIGTPE 195
Q L GL +LH++ I+HRDLK +NI + + G+VK+ D GLA I Q V+ T
Sbjct: 116 QFLRGLDFLHAN--CIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLW 172
Query: 196 FMAPE-LYDENYNELADIYSFGMCMLEM 222
+ APE L Y D++S G EM
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 29 RYKE--VIGKGAFKTVYKAFDEVNGLEVAWCQV---RIDDVLQSPEDLERLYSEVHLLKS 83
RYK IG+GA V+KA D G VA +V R++ + P R E+ L++
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI--PNQALR---EIKALQA 55
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
+H +++ + + ++ E S R + + + VK + R +L G+
Sbjct: 56 CQHPYVVKLLDVFPHGSG--FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV---IGTPEFMAPE 200
Y+H++ I+HRDLK N+ I G +KI D GLA + + + + T + APE
Sbjct: 114 YMHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
Query: 201 LY--DENYNELADIYSFGMCMLEM 222
L Y+ D+++ G E+
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 48/290 (16%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN-IIR 91
VIG+GAF V+ D+ G A +R D+++ + + + + I++
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ--IAHVRAERDILADADSPWIVK 65
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
Y S+ D+++ + ++ E G L + + + + +++ L +H
Sbjct: 66 LYYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG-- 121
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-------------------------- 185
IHRD+K DNI I G +K+ D GL M +A
Sbjct: 122 FIHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 186 -----NAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQ 237
A S +GTP+++APE L Y D +S G+ + EM+ + +P YS+ +
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML-YGFPPFYSD--TLQE 237
Query: 238 IYKKVSSGIKPAALSKVKD--PEVKSFIEKCLVPASQRL-SAKELLMDPF 284
Y K+ + + PE I + L RL S +E+ PF
Sbjct: 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLK 85
RYK E IG GA+ V A D +G +VA ++ DV + R E+ +L+ K
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK---RTLRELKILRHFK 62
Query: 86 HNNIIRFYNSWIDDQN--KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
H+NII + K V ++ +L S L + + + ++ + Q+L GL
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLK 121
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK------SVIGTPEFM 197
Y+HS + +IHRDLK N+ +N + E++IGD G+A + + + + T +
Sbjct: 122 YIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 198 APEL---YDENYNELADIYSFGMCMLEMV 223
APEL E Y D++S G EM+
Sbjct: 179 APELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 50/295 (16%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRI--DDVLQSPEDLERLYSEVHLLKSLKHNN- 88
E IG+G + VYKA D+ G VA + R+ D+ P L E+ LL+ L +
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQMLSESIY 62
Query: 89 IIRFYN--SWIDDQNKTVNIITELFTSGSLRQY-----RKKHKKVDMKAVKGWARQILSG 141
I+R + + K + + L+++ R + + K +K + Q+L G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSVIGTPEFMA 198
+ + H H ++HRDLK N+ ++ +G +KI DLGL +I ++ ++ T + A
Sbjct: 123 VAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRA 179
Query: 199 PE--LYDENYNELADIYSFGMCMLEMVTFEYPY---SECRNSAQIYK-------KVSSGI 246
PE L +Y+ DI+S G EM + + SE + I+K +V G+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239
Query: 247 ------------KPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPF 284
KP LS+ PE ++K L PA +R+SAK L P+
Sbjct: 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA-KRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 25/228 (10%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNG-LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
++ + +G G F V+ NG +VA + + E E ++K L+H
Sbjct: 8 LKLERKLGAGQFGEVWMGT--WNGTTKVA-----VKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIY 144
+ +++ Y + + + + I+TE + GSL + K KK+ + + A QI G+ Y
Sbjct: 61 DKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTP-EFMAPEL 201
L S + IHRDL NI + G KI D GLA ++E + A+ P ++ APE
Sbjct: 119 LESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA 175
Query: 202 YDENYNEL---ADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
NY +D++SFG+ + E+VT+ PY + ++ ++V G
Sbjct: 176 --ANYGRFTIKSDVWSFGILLTEIVTYGRVPY-PGMTNREVLEQVERG 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 37/275 (13%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRF 92
IG+GAF TV K + +G +A ++R ++ +RL ++ +++S I++F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 93 Y-------NSWIDDQNKTVNIITELFTSGSL-----RQYRKKHKKVDMKAVKGWARQILS 140
Y + WI EL SL Y + + + A +
Sbjct: 69 YGALFREGDCWI---------CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 141 GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV-IGTPEFMAP 199
L YL + IIHRD+K NI ++ N G +K+ D G++ + + AK+ G +MAP
Sbjct: 119 ALNYLKE-ELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 176
Query: 200 ELYDEN----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG---IKPAALS 252
E D + Y+ +D++S G+ + E+ T ++PY + + +V G I +
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236
Query: 253 KVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+ P +FI CL+ S+R KELL PF++
Sbjct: 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E IGKG F VYK + N EVA R P+ + E +LK H NI++
Sbjct: 1 EKIGKGNFGDVYKGVLKGNT-EVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVK 56
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
+ Q + + I+ EL GSL + RKK ++ +K + + +G+ YL S +
Sbjct: 57 LIG--VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE----FMAPE-LYDEN 205
IHRDL N + G +KI D G++ E G + + APE L
Sbjct: 114 -CIHRDLAARNCLV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 206 YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
Y +D++S+G+ + E + + PY N Q +++ SG
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QTRERIESG 211
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 59/250 (23%), Positives = 111/250 (44%), Gaps = 16/250 (6%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN-NIIRF 92
I KGAF +VY A G A ++ D + + + + +E ++ + + +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSD-MIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 93 YNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
Y S+ Q+K + ++ E G K + K + +++ G+ LH
Sbjct: 63 YYSF---QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH--QRG 117
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELA 210
IIHRD+K +N+ I+ G +K+ D GL+ + K +GTP+++APE + ++++
Sbjct: 118 IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKFVGTPDYLAPETILGVGDDKMS 174
Query: 211 DIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIEKCLV 268
D +S G + E + F YP ++ + S P + + PE I + L
Sbjct: 175 DWWSLGCVIFEFL-FGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233
Query: 269 P-ASQRLSAK 277
++RL A
Sbjct: 234 MDPAKRLGAN 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 38/224 (16%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS--EVHLLKSL 84
Y+ + +G+G F VYKA G VA ++ ++ + +D + + E+ +LK L
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKI----LMHNEKDGFPITALREIKILKKL 64
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFT---------SGSLRQYRKKHKKVDMKAVKGWA 135
KH N++ + ++ +K+ ++ SG L K + +K +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCYM 121
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI-------------M 182
Q+L G+ YLH + I+HRD+K NI I+ NQG +KI D GLA
Sbjct: 122 LQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 183 EQANAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVT 224
+++ T + PEL + Y DI+ G EM T
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-16
Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+++ +G GA+ TV A D G +VA ++ QS +R Y E+ LLK +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAI--KKLYRPFQSELFAKRAYRELRLLKHMKH 73
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFT----SGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
N+I + + D + ++ + + G+ KH+K+ ++ Q+L GL
Sbjct: 74 ENVIGLLDVFTPDLS--LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-- 200
Y+H+ IIHRDLK N+ +N E+KI D GLA + V+ T + APE
Sbjct: 132 KYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEMTGYVV-TRWYRAPEVI 187
Query: 201 LYDENYNELADIYSFGMCMLEMVT 224
L +Y + DI+S G M EM+T
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 26/267 (9%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRF 92
IG G VYK + G +A Q+R E+ +R+ ++ +LKS I++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKG-WARQILSGLIYL---HSH 148
Y +I D + V I EL S L + K+ + + + G I+ L YL H
Sbjct: 80 YGYFITDSD--VFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG- 135
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELYD--- 203
+IHRD+K NI ++ + G VK+ D G++ + +A +S G +MAPE D
Sbjct: 136 ---VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSA-GCAAYMAPERIDPPD 190
Query: 204 --ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVKDPEVK 260
Y+ AD++S G+ ++E+ T ++PY C+ ++ K+ P+ ++ P+
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC 250
Query: 261 SFIEKCLVPASQ-RLSAKELLMDPFLQ 286
SF++ CL + R +ELL PF++
Sbjct: 251 SFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 64/241 (26%), Positives = 116/241 (48%), Gaps = 17/241 (7%)
Query: 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH 79
E P+ I ++VIG G F V++ ++ G + ++ + + + SE
Sbjct: 1 EIHPSH--ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEAS 58
Query: 80 LLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQI 138
++ H+NIIR + + K IITE +G+L +Y + H + + G R I
Sbjct: 59 IMGQFSHHNIIRLEG--VVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP---- 194
+G+ YL D +HRDL NI +N + E K+ D GL+ ++E + +
Sbjct: 117 AAGMKYLS--DMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 195 -EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIK-PAA 250
+ APE + + +D++SFG+ M E+++F E PY + N ++ K ++ G + PA
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-EVMKAINDGFRLPAP 232
Query: 251 L 251
+
Sbjct: 233 M 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLER----LYS--EVHLLKSLKHN 87
IG+G + VY+A D +G VA +VR+D+ ER + S E+ LL +L+H
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDN--------ERDGIPISSLREITLLLNLRHP 66
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTS--GSLRQYRKKHKKVDMKA------VKGWARQIL 139
NI+ + ++ ++ E SL +M VK Q+L
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLD--------NMPTPFSESQVKCLMLQLL 118
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTPEFM 197
GL YLH + IIHRDLK N+ + G +KI D GLA + T +
Sbjct: 119 RGLQYLHEN--FIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPAKPMTPKVVTLWYR 175
Query: 198 APELY--DENYNELADIYSFGMCMLEMVTFE 226
APEL Y D+++ G + E++ +
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 50/139 (35%), Positives = 71/139 (51%), Gaps = 9/139 (6%)
Query: 134 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVI 191
+ QI+SGL +LH II+RDLK +N+ ++ N G V+I DLGLA ++ Q+ K
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 192 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KP 248
GTP FMAPE L E Y+ D ++ G+ + EM+ P+ R K++ I
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRILNDS 217
Query: 249 AALSKVKDPEVKSFIEKCL 267
P KSF E L
Sbjct: 218 VTYPDKFSPASKSFCEALL 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 67/245 (27%), Positives = 122/245 (49%), Gaps = 23/245 (9%)
Query: 32 EVIGKGAFKTVY----KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK-SLKH 86
+V+GKG+F V K DEV ++V ++ D +LQ +D++ +E +L + KH
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKV----LKKDVILQD-DDVDCTMTEKRILALAAKH 55
Query: 87 NNIIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL 145
+ + + Q K + + E G L ++ +K D + +A ++ L++L
Sbjct: 56 PFLTALHCCF---QTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPELYD 203
H H +I+RDLK DNI ++ +G K+ D G+ I+ + GTP+++APE+
Sbjct: 113 HRHG--VIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 204 E-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV--SSGIKPAALSKVKDPEVK 260
E Y D ++ G+ M EM+ + P+ E N +++ + + P LSK +K
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILK 228
Query: 261 SFIEK 265
+F+ K
Sbjct: 229 AFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 78/311 (25%), Positives = 130/311 (41%), Gaps = 72/311 (23%)
Query: 29 RY--KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK- 85
+Y + +GKGA+ V+KA D VA +I D ++ D +R + E+ L+ L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVAL--KKIFDAFRNATDAQRTFREIMFLQELGD 65
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-----HKKVDMKAVKGWARQILS 140
H NI++ N + +K + ++ E + R HK+ M Q+L
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIM-------YQLLK 118
Query: 141 GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSV----IGT 193
L Y+HS + +IHRDLK NI +N + VK+ D GLA + +E+ V + T
Sbjct: 119 ALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 194 PEFMAPE--LYDENYNELADIYSFGMCML-EMVT----F--------------------- 225
+ APE L Y + D++S G C+L EM+ F
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVG-CILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234
Query: 226 --------EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV--PASQRLS 275
+ + + +K + P A + ++K LV P ++RL+
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKA-----SDDALDLLKKLLVFNP-NKRLT 288
Query: 276 AKELLMDPFLQ 286
A+E L P++
Sbjct: 289 AEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDL-ERLYSEVHLLKSLKHNNII 90
E IG+G + VYKA D V +A ++R++ Q E + E+ LLK ++H NI+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV------DMKAVKGWARQILSGLIY 144
R + + K + ++ E L KKH + + +K + QIL G+ Y
Sbjct: 65 RLQD--VVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT---IMEQANAKSVIGTPEFMAPE- 200
HSH ++HRDLK N+ I+ +K+ D GLA I + V+ T + APE
Sbjct: 118 CHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEI 174
Query: 201 -LYDENYNELADIYSFGMCMLEMVT 224
L +Y+ DI+S G EMV
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 34/233 (14%)
Query: 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS--- 76
+ RYI+ +G+G + V KA+D + G VA +V+I ++ +L
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 77 -------EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK 129
E+ ++ +KH NI+ + ++ + +N++ ++ + L++ + ++
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYV--EGDFINLVMDIM-ASDLKKVVDRKIRLTES 119
Query: 130 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA---------- 179
VK QIL+GL LH +HRDL NIFIN ++G KI D GLA
Sbjct: 120 QVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSD 176
Query: 180 -TIMEQANAKSVIGTPE-----FMAPELY--DENYNELADIYSFGMCMLEMVT 224
++ + T + + APEL E Y+ D++S G E++T
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 52/295 (17%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
IG GAF V+ D +G VA ++ +V Q+ +R++ E+ +L KH+N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVAL--KKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL--- 62
Query: 94 NSWID-------DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
S +D D + + ++TEL S L + + + VK + QIL GL YLH
Sbjct: 63 -SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV---IGTPEFMAPELY- 202
S I+HRD+K N+ +N N +KI D GLA + E +K + + T + APE+
Sbjct: 121 SAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177
Query: 203 -DENYNELADIYSFGMCMLEMV-------------------------TFEYPYSECRNS- 235
+Y DI+S G E++ + E S C +
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237
Query: 236 AQIYKKVSSGIKPAALSKVKDP---EVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286
A I + L + E + + LV +R+SA + L P+L
Sbjct: 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+G G V+K + +GL +A + ++ P ++ E+ +L I+ FY
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPII 153
++ D ++I E GSL Q KK ++ + + + ++ GL YL I+
Sbjct: 70 GAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 126
Query: 154 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADI 212
HRD+K NI +N ++GE+K+ D G++ + + A S +GT +M+PE L +Y+ +DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 213 YSFGMCMLEMVTFEYP 228
+S G+ ++EM YP
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 10/202 (4%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK-SLKHNNII 90
+++GKG+F V+ A + A ++ D VL +D+E E +L + +H +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLT 59
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
Y ++ +N + + E G L + + K D+ +A +I+ GL +LHS
Sbjct: 60 HLYCTFQTKEN--LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG- 116
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYDENYN 207
I++RDLK DNI ++ G +KI D G+ ++ A + GTP+++APE L + YN
Sbjct: 117 -IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 208 ELADIYSFGMCMLEMVTFEYPY 229
D +SFG+ + EM+ + P+
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 46/287 (16%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDL---ERLYSEVHLLKSLKHNNII 90
IG+G++ V+K + G VA I ++S +D + E+ +LK LKH N++
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVA-----IKKFVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
+ + + ++++ E L + K + V +K Q L + + H H+
Sbjct: 64 NLIEVF--RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN- 120
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTPEFMAPELY--DENY 206
IHRD+K +NI I QG++K+ D G A I+ + + T + APEL D Y
Sbjct: 121 -CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK-------------------KVSSGIK 247
D+++ G E++T + + + Q+Y + G+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238
Query: 248 PAALSKVKDPEVK---------SFIEKCLVP-ASQRLSAKELLMDPF 284
+ E K SF++ CL ++RLS +ELL P+
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 77 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWA 135
E ++ L H N+++ Y + + + I+TE +G L Y ++ K + +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCT--KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP- 194
+ + YL S+ IHRDL N + G VK+ D GLA + S GT
Sbjct: 107 SDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163
Query: 195 --EFMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGI---K 247
++ PE++D + ++ +D++SFG+ M E+ + + PY NS ++ + VS+G +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVVESVSAGYRLYR 222
Query: 248 PAALSKVKDPEVKSFIEKCLVPASQ-RLSAKELL 280
P K+ EV + + C + R + K+LL
Sbjct: 223 P----KLAPTEVYTIMYSCWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 74/277 (26%), Positives = 130/277 (46%), Gaps = 25/277 (9%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RYK EVIGKG++ V A D G +VA +I+DV + D R+ E+ LL+ L+H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAI--KKINDVFEHVSDATRILREIKLLRLLRH 58
Query: 87 NNIIRFYNSWIDDQNKTVN---IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
+I+ + + + ++ EL S L Q K + + + + + Q+L L
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV-----IGTPEFMA 198
Y+H+ + + HRDLK NI N + ++KI D GLA + ++ + T + A
Sbjct: 118 YIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 199 PEL---YDENYNELADIYSFGMCMLEMVTFE--YPYSECRNSAQIYKKVSSGIKPAALSK 253
PEL + Y DI+S G E++T + +P + + + P +S+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 254 VKDPEVKSFI----EKCLVPASQRLSAKELLMDPFLQ 286
V++ + + ++ +K VP SQ+ + L L+
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLE 271
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 34 IGKGAFKTVYKAFDEVNGLE-VAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIR 91
IG+GA+ V+KA D NG VA +VR+ + P R + + L++ +H N++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 92 FYNSWIDDQNKTVNIITELF--TSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHS 147
++ + +T +F L Y K V + +K Q+L GL +LHS
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME-QANAKSVIGTPEFMAPE-LYDEN 205
H ++HRDLK NI + + G++K+ D GLA I Q SV+ T + APE L +
Sbjct: 129 HR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185
Query: 206 YNELADIYSFGMCMLEM 222
Y D++S G EM
Sbjct: 186 YATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 9e-15
Identities = 49/162 (30%), Positives = 87/162 (53%), Gaps = 5/162 (3%)
Query: 68 PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVD 127
P ++ E+ +L I+ FY ++ D ++I E GSL Q K+ K++
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKRIP 101
Query: 128 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 187
+ + + +L GL YL I+HRD+K NI +N ++GE+K+ D G++ + + A
Sbjct: 102 EEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 188 KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP 228
S +GT +M+PE L +Y+ +DI+S G+ ++E+ YP
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E +G+G++ TVYK +VNG VA +R+ + +P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVL 67
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDP 150
++ I +T+ ++ E + L QY KH + + VK + Q+L GL Y+H
Sbjct: 68 LHD--IIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR-- 122
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSVIGTPEFMAPE--LYDEN 205
I+HRDLK N+ I+ + GE+K+ D GLA ++ + V+ T + P+ L
Sbjct: 123 YILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTE 180
Query: 206 YNELADIYSFGMCMLEMV 223
Y+ D++ G +EM+
Sbjct: 181 YSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAW-CQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
+V+G GAF TVYK G V ++I + P+ E ++ S+ H +++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHD 149
R + + T+ ++T+L G L Y +HK + + + W QI G++YL
Sbjct: 73 RLLGVCL---SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME----QANAKSVIGTPEFMAPE-LYDE 204
++HRDL N+ + + VKI D GLA ++E + NA ++MA E ++
Sbjct: 130 --LVHRDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 205 NYNELADIYSFGMCMLEMVTF 225
+ +D++S+G+ + E++TF
Sbjct: 187 KFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
YI+ + +G+G + TVYK ++ VA ++R++ +P R EV LLK LKH
Sbjct: 8 YIKLDK-LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKH 63
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYL 145
NI+ ++ I K++ ++ E + L+QY ++M VK + Q+L GL Y
Sbjct: 64 ANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSVIGTPEFMAPE-- 200
H ++HRDLK N+ IN +GE+K+ D GLA +I + + V+ T + P+
Sbjct: 121 HRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDIL 176
Query: 201 LYDENYNELADIYSFGMCMLEMVT 224
L +Y+ D++ G EM T
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 79/259 (30%), Positives = 123/259 (47%), Gaps = 42/259 (16%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
RY K+V G GA+ +V A D+ G +VA ++ QS +R Y E+ LLK ++
Sbjct: 16 RYTSLKQV-GSGAYGSVCSAIDKRTGEKVAI--KKLSRPFQSEIFAKRAYRELTLLKHMQ 72
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSG-SLRQYRK-----KHKKVDMKAVKGW----- 134
H N+I +D +FTS S +++ + + D++ + G
Sbjct: 73 HENVIG----LLD-----------VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED 117
Query: 135 -----ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 189
Q+L GL Y+HS IIHRDLK N+ +N E+KI D GLA + A
Sbjct: 118 KVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHAD-AEMTG 173
Query: 190 VIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK--KVSSG 245
+ T + APE L +YN+ DI+S G M EM+T + + Q+ + KV+
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233
Query: 246 IKPAALSKVKDPEVKSFIE 264
P + K++D KS+I+
Sbjct: 234 PGPEFVQKLEDKAAKSYIK 252
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 68/264 (25%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+++GKG F V ++ G A +R +V+ + +++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
++ + + + E G L + + + + + + +I+S L YLHS D
Sbjct: 60 LKYAF--QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 115
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDENYNE 208
+++RD+K +N+ ++ G +KI D GL I + A K+ GTPE++APE L D +Y
Sbjct: 116 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKDPEVKSFIEKCL 267
D + G+ M EM+ P+ + + I+ P LS PE KS + L
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS----PEAKSLLAGLL 230
Query: 268 VP-ASQRL-----SAKELLMDPFL 285
QRL AKE++ F
Sbjct: 231 KKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 68/255 (26%), Positives = 123/255 (48%), Gaps = 12/255 (4%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+VIGKG+F V A + A ++ +L+ E+ + LLK++KH ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+ S+ + + + G L + ++ + + +A +I S L YLHS +
Sbjct: 61 LHFSF--QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN-- 116
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYDENYNE 208
I++RDLK +NI ++ +QG + + D GL I + GTPE++APE L+ + Y+
Sbjct: 117 IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268
D + G + EM+ + P RN+A++Y + + KP L + +E L
Sbjct: 176 TVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHLLEGLLQ 232
Query: 269 P-ASQRLSAKELLMD 282
++RL AK+ M+
Sbjct: 233 KDRTKRLGAKDDFME 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED----LERLYSEVHLLK 82
RY+ IG+GA+ V A + G++VA ++ SP + +R E+ +L+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREIKILR 58
Query: 83 SLKHNNIIRFYNSWID---DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQIL 139
KH NII + + V I+ EL + + + +H D ++ + QIL
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH--IQYFLYQIL 116
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS-----VIGTP 194
GL Y+HS + ++HRDLK N+ +N N ++KI D GLA I + + + + T
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 195 EFMAPE--LYDENYNELADIYSFGMCMLEMVT 224
+ APE L + Y + DI+S G + EM++
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 26/202 (12%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+G+G + TV+K ++ VA ++R++ +P R EV LLK+LKH NI+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVTLH 69
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSGLIYLHSHDPPI 152
+ I + + ++ E S L+QY + M VK + Q+L GL Y H I
Sbjct: 70 D--IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--I 124
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV--------IGTPEFMAPE--LY 202
+HRDLK N+ IN +GE+K+ D GL A AKSV + T + P+ L
Sbjct: 125 LHRDLKPQNLLIN-EKGELKLADFGL------ARAKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 203 DENYNELADIYSFGMCMLEMVT 224
Y+ D++ G + EM T
Sbjct: 178 STEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 53/220 (24%), Positives = 101/220 (45%), Gaps = 16/220 (7%)
Query: 34 IGKGAFKTVYKA-FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
+G G F +V K + +G EV V+ + E ++ L H I+R
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE-VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
+ + ++ EL G L +Y KK +++ + +K A Q+ G+ YL S
Sbjct: 62 IGVCKGEP---LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--F 116
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTP-EFMAPE-LYDENY 206
+HRDL N+ + N+ + KI D G++ + + A + P ++ APE + +
Sbjct: 117 VHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 207 NELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
+ +D++S+G+ + E ++ PY E + A++ + SG
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 70/255 (27%), Positives = 123/255 (48%), Gaps = 14/255 (5%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
VIGKG+F V A + +G A ++ +L+ E + LLK++KH ++
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 93 YNSWIDDQNK-TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+ S+ Q + + + G L + ++ + + +A +I S L YLHS +
Sbjct: 62 HYSF---QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN-- 116
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDENYNE 208
II+RDLK +NI ++ +QG V + D GL I + GTPE++APE L + Y+
Sbjct: 117 IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268
D + G + EM+ + P R++A++Y + + KP L + +E L
Sbjct: 176 TVDWWCLGAVLYEML-YGLPPFYSRDTAEMYDNILN--KPLRLKPNISVSARHLLEGLLQ 232
Query: 269 P-ASQRLSAKELLMD 282
++RL AK+ ++
Sbjct: 233 KDRTKRLGAKDDFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 21/235 (8%)
Query: 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHL 80
DP+ + ++VIG G F V + ++ G + ++ S + +E +
Sbjct: 1 IDPSY--VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASI 58
Query: 81 LKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQIL 139
+ H NIIR + +++ V IITE +GSL ++ R+ K + + G R I
Sbjct: 59 MGQFDHPNIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIA 116
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-------KSVIG 192
SG+ YL + +HRDL NI +N + K+ D GL+ +E + A K I
Sbjct: 117 SGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI- 172
Query: 193 TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
+ APE + + +D++SFG+ M E++++ E PY + N + K V G
Sbjct: 173 --RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-DVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 27/233 (11%)
Query: 34 IGKGAFKTVYK--AFDEVNGLEVAWCQVRIDDVLQSPEDLER--LYSEVHLLKSLKHNNI 89
+G GAF VY+ A D + G +V + + + D E+ E HL+ + H NI
Sbjct: 3 LGSGAFGEVYEGTATDIL-GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-------VDMKAVKGWARQILSGL 142
++ + N+ II EL G L Y + + + +K + + G
Sbjct: 62 VKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGE----VKIGDLGLATIMEQANAKSVIGTP---- 194
+YL IHRDL N ++ + VKIGD GLA + +++ G
Sbjct: 120 VYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 195 EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
+MAPE L D + +D++SFG+ M E++T + PY N+ ++ + V++G
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP-ALNNQEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 9/214 (4%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+VIGKG+F V A + +G A ++ +L+ E + LLK+LKH ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+ S+ + + + + G L + ++ + + +A ++ S + YLHS +
Sbjct: 61 LHYSF--QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN-- 116
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDENYNE 208
II+RDLK +NI ++ +QG V + D GL + + + GTPE++APE L E Y+
Sbjct: 117 IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242
D + G + EM+ + P R+ +Q+Y +
Sbjct: 176 TVDWWCLGAVLYEML-YGLPPFYSRDVSQMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 66/241 (27%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN--I 89
V+GKG+F V A + +G A ++ D +LQ +D+E +E +L SL N+ +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-DDVECTMTEKRIL-SLARNHPFL 58
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
+ Y + + + E G L + +K ++ D + +A +I S L++LH D
Sbjct: 59 TQLYCCF--QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH--D 114
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDENY 206
II+RDLK DN+ ++ ++G K+ D G+ I + GTP+++APE L + Y
Sbjct: 115 KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAALSKVKDPEVKSFIE 264
D ++ G+ + EM+ P+ E N +++ + + + P LS+ +K+F+
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMT 232
Query: 265 K 265
K
Sbjct: 233 K 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-14
Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+++GKG F V ++ +G A ++ +V+ + +++ +E +LK+ +H +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAM-KILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
S+ + + E G L + + + + + +I+S L YLHS
Sbjct: 60 LKYSF--QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDENYNE 208
I++RDLK +N+ ++ + G +KI D GL I + A K+ GTPE++APE L D +Y
Sbjct: 116 IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 209 LADIYSFGMCMLEMVTFEYPY 229
D + G+ M EM+ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 64/267 (23%), Positives = 116/267 (43%), Gaps = 41/267 (15%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
IG+GA+ V A + +VA +I + + D +R E+ LL+ L H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAI--KKIANAFDNRIDAKRTLREIKLLRHLDHENVI--- 67
Query: 94 NSWID-------DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
+ D + V I+ EL + L Q + + + + + Q+L GL Y+H
Sbjct: 68 -AIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM--------- 197
S + ++HRDLK N+ +N N ++KI D GL A++ +FM
Sbjct: 126 SAN--VLHRDLKPSNLLLNAN-CDLKICDFGL--------ARTTSEKGDFMTEYVVTRWY 174
Query: 198 -APELY--DENYNELADIYSFGMCMLEMVTFE--YPYSECRNSAQIYKKVSSGIKPAALS 252
APEL Y D++S G E++ + +P + + ++ ++ L
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234
Query: 253 KVKDPEVKSFIEKCLVPASQRLSAKEL 279
+++ + + +I +P + R S L
Sbjct: 235 FIRNEKARRYIRS--LPYTPRQSFARL 259
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 68/264 (25%), Positives = 129/264 (48%), Gaps = 22/264 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+++GKG F V ++ G A ++ +V+ + +++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYA-MKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
S+ + + + E G L + + + + + +I+S L YLHS D
Sbjct: 60 LKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPELYDEN-YNE 208
+++RDLK +N+ ++ + G +KI D GL I + A K+ GTPE++APE+ ++N Y
Sbjct: 116 VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IK-PAALSKVKDPEVKSFIEKC 266
D + G+ M EM+ P+ ++ ++++ + I+ P LS PE KS +
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLS----PEAKSLLAGL 229
Query: 267 LVP-ASQRL-----SAKELLMDPF 284
L QRL AKE++ F
Sbjct: 230 LKKDPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 91/342 (26%), Positives = 152/342 (44%), Gaps = 37/342 (10%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+VIGKG+F V A +++G A ++ VL E + LLK++KH ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+ S+ + + + + G L + ++ + + +A +I S L YLHS +
Sbjct: 61 LHYSF--QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN-- 116
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDENYNE 208
I++RDLK +NI ++ +QG V + D GL I + + GTPE++APE + + Y+
Sbjct: 117 IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268
D + G + EM+ + P CR+ A++Y + KP L S +E+ L
Sbjct: 176 TVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTAWSILEELLE 232
Query: 269 PASQ-RLSAKELLMD----PFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEGPASVR 323
Q RL AKE ++ PF + T +P P V EGP +
Sbjct: 233 KDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNV----------EGPDDIS 282
Query: 324 NKHP---------SMDFDSDAEL--PVITSLDNSGGGDSYSP 354
N S+ F SD + + D++ G SY+P
Sbjct: 283 NFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYAP 324
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 28/232 (12%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
I K +G G + VY+ + L VA ++ D + ++E E ++K +KH
Sbjct: 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHP 62
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVK--GWARQILSGLIYL 145
N+++ + + IITE T G+L Y ++ + ++ AV A QI S + YL
Sbjct: 63 NLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME------QANAKSVIGTPEFMAP 199
+ IHRDL N + G VK+ D GL+ +M A AK I ++ AP
Sbjct: 121 EKKN--FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAP 174
Query: 200 E-LYDENYNELADIYSFGMCMLEMVTF---EYPYSECRNSAQIYKKVSSGIK 247
E L ++ +D+++FG+ + E+ T+ YP + +Q+Y+ + G +
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGYR 223
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E +G+G++ TVYK +NG VA + + P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVL 67
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDP 150
++ I +T+ + E + L QY +H + V+ + Q+L GL Y+H
Sbjct: 68 LHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSVIGTPEFMAPE--LYDEN 205
I+HRDLK N+ I+ GE+K+ D GLA +I Q + V+ T + P+ L +
Sbjct: 124 -ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATD 180
Query: 206 YNELADIYSFGMCMLEMV 223
Y+ DI+ G +EM+
Sbjct: 181 YSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 78/263 (29%), Positives = 120/263 (45%), Gaps = 19/263 (7%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+++ IG GA V AFD V G+ VA ++ Q+ +R Y E+ LLK + H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVA--VKKLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 87 NNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
NII N + ++ + V ++ EL + + H ++D + + Q+L G+
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGI 136
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-TIMEQANAKSVIGTPEFMAPE- 200
+LHS IIHRDLK NI + + +KI D GLA T + T + APE
Sbjct: 137 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 201 LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKPAALSKVKDPEV 259
+ Y E DI+S G M E+V + + Q K + G A P V
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253
Query: 260 KSFIEKCLVPASQRLSAKELLMD 282
++++E P +S +EL D
Sbjct: 254 RNYVEN--RPQYPGISFEELFPD 274
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ--SPEDLERLYSEVHLLKSLKHNNI 89
+V+G GAF TVYK G +V V I ++ + SP+ + + E +++ S+ + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHV 71
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSH 148
R + TV +IT+L G L Y ++HK + + + W QI G+ YL
Sbjct: 72 CRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL--E 126
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM---EQANAKSVIGTP-EFMAPE-LYD 203
+ ++HRDL N+ + Q VKI D GLA ++ E+ P ++MA E +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 204 ENYNELADIYSFGMCMLEMVTF-EYPY 229
Y +D++S+G+ + E++TF PY
Sbjct: 186 RIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
RY K IG GA V A+D V G VA ++ Q+ +R Y E+ L+K +
Sbjct: 17 RYQNLK-PIGSGAQGIVCAAYDTVTGQNVAI--KKLSRPFQNVTHAKRAYRELVLMKLVN 73
Query: 86 HNNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
H NII N + ++ + V ++ EL + +L Q +D + + Q+L G
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQV--IQMDLDHERMSYLLYQMLCG 130
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE-----F 196
+ +LHS IIHRDLK NI + + +KI D GLA + S + TP +
Sbjct: 131 IKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYY 183
Query: 197 MAPEL-----YDENYNELADIYSFGMCMLEMV 223
APE+ Y EN DI+S G M EM+
Sbjct: 184 RAPEVILGMGYKEN----VDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
YI+ E +G+G + TV+K ++ VA ++R++ +P R EV LLK LKH
Sbjct: 8 YIKL-EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKH 63
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSGLIYL 145
NI+ ++ I +K++ ++ E + L+QY + M VK + QIL GL Y
Sbjct: 64 ANIVTLHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV--------IGTPEFM 197
H ++HRDLK N+ IN +GE+K+ D GL A AKSV + T +
Sbjct: 121 HRRK--VLHRDLKPQNLLIN-ERGELKLADFGL------ARAKSVPTKTYSNEVVTLWYR 171
Query: 198 APE--LYDENYNELADIYSFGMCMLEMVT 224
P+ L Y+ D++ G EM +
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 56/216 (25%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
E +G G+F V A + G A ++ ++L+ + ++ + E +L L H I+
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPFIV 81
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
S+ D+ V + E G L + +K + K + +++ YLHS D
Sbjct: 82 NMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD- 138
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNEL 209
II+RDLK +N+ ++ N+G VK+ D G A + ++ GTPE++APE + + + +
Sbjct: 139 -IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPD-RTFTLCGTPEYLAPEVIQSKGHGKA 195
Query: 210 ADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 245
D ++ G+ + E + P+ + +IY+K+ +G
Sbjct: 196 VDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG 230
|
Length = 329 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+ +G G F V+ + + +V I + Q E +E +L+K L+H ++R
Sbjct: 12 KKLGAGQFGEVWMGYYNGH------TKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVR 65
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVK--GWARQILSGLIYLHSHD 149
Y + + IITE +GSL + K + + + K A QI G+ ++ +
Sbjct: 66 LYAVV---TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME------QANAKSVIGTPEFMAPELYD 203
IHRDL+ NI ++ KI D GLA ++E + AK I ++ APE
Sbjct: 123 --YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAI- 175
Query: 204 ENYNEL---ADIYSFGMCMLEMVTF-EYPYSECRNSAQI 238
NY +D++SFG+ + E+VT+ PY N I
Sbjct: 176 -NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 6/100 (6%)
Query: 134 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI-MEQANAKSVI- 191
+A ++ GL YLH + I++RDLK DN+ ++ +G VKI D GL M + S
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFC 162
Query: 192 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYS 230
GTPEF+APE L + +Y D + G+ + EM+ E P+
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 73/249 (29%), Positives = 124/249 (49%), Gaps = 24/249 (9%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ + +G GA+ +V A+D +VA ++ QS R Y E+ LLK +KH
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVA--VKKLSRPFQSLIHARRTYRELRLLKHMKH 73
Query: 87 NNIIRFYNSW-----IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
N+I + + I++ N+ V ++T L G+ K +K+ + V+ Q+L G
Sbjct: 74 ENVIGLLDVFTPATSIENFNE-VYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAP 199
L Y+HS IIHRDLK N+ +N E++I D GLA QA+ + + T + AP
Sbjct: 131 LKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLA---RQADDEMTGYVATRWYRAP 184
Query: 200 ELYDE--NYNELADIYSFGMCMLEMVTFE--YPYSECRNSAQIYKKVSSGIKPAALSKVK 255
E+ +YN+ DI+S G M E++ + +P ++ + + +V P L K+
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244
Query: 256 DPEVKSFIE 264
+ +I+
Sbjct: 245 SEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 52/156 (33%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 77 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 136
E LL+++ H ++IR ++ + ++ ++S K+ + + + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI-MEQANAKSVIGTPE 195
QIL GL YLH+ IIHRD+K +NIFIN + +V IGDLG A + + GT E
Sbjct: 165 QILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 196 FMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYS 230
APE L + YN ADI+S G+ + EM+ YP +
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPST 255
|
Length = 357 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 39/230 (16%)
Query: 33 VIGKGAFKTVYKAFD-EVNGLE-VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
+G+G F V KA + G V++ S +L L SE +LLK + H ++I
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVD----------------------- 127
+ Y + Q+ + +I E GSLR + ++ +KV
Sbjct: 67 KLYGAC--SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 128 -MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186
M + +A QI G+ YL + ++HRDL N+ + + ++KI D GL+ + + +
Sbjct: 125 TMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGR-KMKISDFGLSRDVYEED 181
Query: 187 A---KSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF---EYP 228
+ +S P ++MA E L+D Y +D++SFG+ + E+VT YP
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 18/194 (9%)
Query: 106 IITELFTSGSLRQ--YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 163
++ L G L+ Y +A QI+ GL H H I++RDLK +N+
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL--EHLHQRRIVYRDLKPENVL 127
Query: 164 INGNQGEVKIGDLGLATIM-EQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 221
++ + G V+I DLGLA + K GTP +MAPE L E Y+ D ++ G + E
Sbjct: 128 LD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYE 186
Query: 222 MVTFEYP---YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL--- 274
M+ P E ++ ++ PE K E L +RL
Sbjct: 187 MIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCR 244
Query: 275 --SAKELLMDPFLQ 286
SA E+ P +
Sbjct: 245 GGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 68/246 (27%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
D +C I+ ++VIG G F V ++ G ++ + + SE ++
Sbjct: 2 DASC--IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIM 59
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILS 140
H NII + ++K V I+TE +GSL + +KH + + + G R I S
Sbjct: 60 GQFDHPNIIHLEG--VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS 117
Query: 141 GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP------ 194
G+ YL D +HRDL NI +N N K+ D GL+ ++E + ++ T
Sbjct: 118 GMKYL--SDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLED-DPEAAYTTRGGKIPI 173
Query: 195 EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIK----- 247
+ APE + + +D++S+G+ M E++++ E PY E N I K + G +
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-KAIEEGYRLPAPM 232
Query: 248 --PAAL 251
PAAL
Sbjct: 233 DCPAAL 238
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 32/224 (14%)
Query: 32 EVIGKGAFKTVYKA--FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNN 88
+ +G+GAF V KA N E + V++ + +DL L SE+ ++K + KH N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVK---------------- 132
II + Q + ++ E G+LR + + + A
Sbjct: 78 IINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 133 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSV 190
+A Q+ G+ +L S IHRDL N+ + +KI D GLA + + K+
Sbjct: 136 SFAYQVARGMEFLASKK--CIHRDLAARNVLV-TEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 191 IGT-P-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF---EYP 228
G P ++MAPE L+D Y +D++SFG+ + E+ T YP
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
I+ + +G G F V+ + N +VA + + ++ E +L+K+L+H+
Sbjct: 8 IKLVKKLGAGQFGEVWMGYYN-NSTKVA-----VKTLKPGTMSVQAFLEEANLMKTLQHD 61
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYL 145
++R Y + + + + IITE GSL + K + KV + + ++ QI G+ Y+
Sbjct: 62 KLVRLYA--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAKSVIGTP-EFMAPELY 202
+ IHRDL+ N+ ++ KI D GLA ++E + A+ P ++ APE
Sbjct: 120 ERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176
Query: 203 DENYNEL---ADIYSFGMCMLEMVTF-EYPYSECRNS 235
N+ +D++SFG+ + E+VT+ + PY NS
Sbjct: 177 --NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 73/303 (24%), Positives = 121/303 (39%), Gaps = 65/303 (21%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRF 92
IG+G F V+KA + VA +V +++ + P R E+ +L+ LKH N++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR---EIKILQLLKHENVVNL 76
Query: 93 Y---NSWIDDQNK---TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
+ N+ + ++ E K+ K + +K + +L+GL Y+H
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-----TIMEQANAKS--VIGTPEFMAP 199
+ I+HRD+K NI I + G +K+ D GLA + + N + V+ T + P
Sbjct: 137 RNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPP 192
Query: 200 ELY--DENYNELADIYSFGMCMLEMVTFEYP----------------------------- 228
EL + +Y D++ G M EM T P
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLISQLCGSITPEVWPGV 251
Query: 229 -----YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV--PASQRLSAKELLM 281
+ + +KV +KP VKDP I+K LV P ++R+ A L
Sbjct: 252 DKLELFKKMELPQGQKRKVKERLKP----YVKDPHALDLIDKLLVLDP-AKRIDADTALN 306
Query: 282 DPF 284
F
Sbjct: 307 HDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-13
Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 40/235 (17%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY + IGKG VY A+D V VA ++R +D+ ++P +R E + L H
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLIH 61
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-----------HKKVDMKAVKGWA 135
I+ Y+ I V +L+ K +K + A
Sbjct: 62 PGIVPVYS--ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ---------AN 186
+I + + Y+HS ++HRDLK DNI + G GEV I D G A + +
Sbjct: 120 HKICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 187 AKS-----------VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY 229
++ ++GTP++MAPE L +E DIY+ G+ + +M+T +PY
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 66/244 (27%), Positives = 115/244 (47%), Gaps = 23/244 (9%)
Query: 32 EVIGKGAFKTVYKA-FDEVNGLEVAWCQVRIDDVLQSPEDLE-RLYSEVHLLKSLKHNNI 89
E++GKG F V+K + + V C+ +D+ P++L+ + SE +LK H NI
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCK---EDL---PQELKIKFLSEARILKQYDHPNI 54
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSH 148
++ + Q + + I+ EL G + RKK ++ K + +A +G+ YL S
Sbjct: 55 VKLIG--VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE----FMAPE-LYD 203
+ IHRDL N + G +KI D G++ E S G + + APE L
Sbjct: 113 N--CIHRDLAARNCLV-GENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 204 ENYNELADIYSFGMCMLEMVTFEY-PYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262
Y+ +D++S+G+ + E + PY N Q ++V G + + K D +V
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAREQVEKGYRMSCPQKCPD-DVYKV 226
Query: 263 IEKC 266
+++C
Sbjct: 227 MQRC 230
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 168
ELFT R++ + V+ + +I+ L +LH II+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTES------EVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE- 141
Query: 169 GEVKIGDLGLATIM---EQANAKSVIGTPEFMAPELY---DENYNELADIYSFGMCMLEM 222
G V + D GL+ E+ A S GT E+MAPE+ +++ D +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 223 VTFEYPYS---ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL---S 275
+T P++ E + ++I +++ P K E + FI+K L +RL
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 276 AKELLMDPFLQ----VNGTTKNRPLP 297
A E+ PF Q + K P P
Sbjct: 260 ADEIKNHPFFQGIDWDDLAAKRIPAP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 64/263 (24%), Positives = 126/263 (47%), Gaps = 17/263 (6%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+++GKG F V ++ G A ++ +V+ + +++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYA-MKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
S+ + + + E G L + + + + + +I+S L YLHS +
Sbjct: 60 LKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-EKN 116
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDENYNE 208
+++RDLK +N+ ++ + G +KI D GL I + A K+ GTPE++APE L D +Y
Sbjct: 117 VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268
D + G+ M EM+ P+ ++ ++++ + ++ + PE KS + L
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLK 232
Query: 269 P-ASQRL-----SAKELLMDPFL 285
QRL AKE++ F
Sbjct: 233 KDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 83/299 (27%), Positives = 130/299 (43%), Gaps = 45/299 (15%)
Query: 19 LETDPTCRYIRYKEVIGK----GAFKTVYKA----FDEVNGLEVAWCQVRIDDVLQSPED 70
L DP + R K +GK G F V A D+ E V++ + +D
Sbjct: 4 LPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD 63
Query: 71 LERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK 129
L L SE+ ++K + KH NII + Q+ + +I E + G+LR+Y + + M+
Sbjct: 64 LSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGME 121
Query: 130 AVKGWAR----------------QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 173
AR Q+ G+ YL S IHRDL N+ + N +KI
Sbjct: 122 YSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMKI 178
Query: 174 GDLGLATIMEQAN--AKSVIG--TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF--- 225
D GLA + + K+ G ++MAPE L+D Y +D++SFG+ M E+ T
Sbjct: 179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238
Query: 226 EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC--LVPASQRLSAKELLMD 282
YP ++ K+ KPA + E+ + C +P S R + K+L+ D
Sbjct: 239 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAIP-SHRPTFKQLVED 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLER---LYSEVHLLKSLKHNN 88
++G+G++ V K + G VA I L+S +D E+ +LK L+H N
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVA-----IKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 148
++ + + K + ++ E L K +D V+ + QIL G+ + HSH
Sbjct: 62 LVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA--KSVIGTPEFMAPELY--DE 204
+ IIHRD+K +NI ++ + G VK+ D G A + + T + APEL D
Sbjct: 120 N--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 205 NYNELADIYSFGMCMLEMVTFE 226
Y DI++ G + EM+T E
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 34/239 (14%)
Query: 26 RYIRYKEVIGKGAFKTVYKA----FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
R I K +G+GAF V+ A + + D L + +D +R E LL
Sbjct: 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELL 61
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW------- 134
+L+H +I++FY D + ++ E G L ++ + H M V G
Sbjct: 62 TNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 135 ---------ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185
A QI SG++YL S +HRDL N + G VKIGD G++ +
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSRDVYST 176
Query: 186 NAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQI 238
+ V G +M PE + + +D++SFG+ + E+ T+ + P+ + N+ I
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
IG G F V+ + + +VA +R + S ED E ++ L H +++ Y
Sbjct: 12 IGSGQFGLVWLGY-WLEKRKVAIKTIR--EGAMSEEDFIE---EAQVMMKLSHPKLVQLY 65
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
+ + + ++ E G L Y R + K + + G + G+ YL S + +
Sbjct: 66 G--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--V 121
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP---EFMAPELYD-ENYNE 208
IHRDL N + NQ VK+ D G+ + S GT ++ +PE++ Y+
Sbjct: 122 IHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 209 LADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSG---IKPAALSK 253
+D++SFG+ M E+ + + PY E R+++++ + +++G KP S+
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPY-ENRSNSEVVETINAGFRLYKPRLASQ 228
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 57/223 (25%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
D +C ++ +EVIG G F V + ++ G + ++ + + SE ++
Sbjct: 2 DVSC--VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 59
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILS 140
H NII + +++ V IITE +G+L + R+ + + + G R I +
Sbjct: 60 GQFDHPNIIHLEG--VVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA 117
Query: 141 GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK----SVIGTP-- 194
G+ YL + +HRDL NI +N N K+ D GL+ +E + S +G
Sbjct: 118 GMKYLS--EMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 195 -EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRN 234
+ APE + + +D++S+G+ M E++++ E PY + N
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 55/215 (25%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 28 IRYKEVIGKGAFKTVYKAF--DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
+R +++G G F TV+K E + +++ I D + + + + + SL
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD-RSGRQTFQEITDHMLAMGSLD 67
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIY 144
H I+R ++ ++T+L GSL + ++H+ +D + + W QI G+ Y
Sbjct: 68 HAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK---SVIGTP-EFMAPE 200
L H ++HR+L NI + + V+I D G+A ++ + K S TP ++MA E
Sbjct: 125 LEEHR--MVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 201 -LYDENYNELADIYSFGMCMLEMVTF-EYPYSECR 233
+ Y +D++S+G+ + EM+++ PY+ R
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRI--DDVLQSPEDLERLYSEVHLLKSLKHNNI 89
+V+GKG+F V A E+ G + + V+ DV+ +D+E E +L N
Sbjct: 1 KVLGKGSFGKVLLA--ELKG-KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
+ + + E G L + + + D+ +A +I+ GL +LHS
Sbjct: 58 LTHLYCTFQTKEHLF-FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYDENY 206
II+RDLK DN+ ++ + G +KI D G+ + A + GTP+++APE L Y
Sbjct: 117 --IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 207 NELADIYSFGMCMLEMVTFEYPY 229
D +SFG+ + EM+ + P+
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 31/272 (11%)
Query: 15 DPDVLETDPTCRYIR----YKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
DP L D + R + + +G GAF V +A A +V + +L+
Sbjct: 20 DPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK-MLKPTAH 78
Query: 71 L---ERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHK 124
E L SE+ ++ L H NI+ + + +ITE G L + RK+
Sbjct: 79 SSEREALMSELKIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRES 136
Query: 125 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV-KIGDLGLA-TIM 182
+ ++ + ++ Q+ G+ +L S + IHRDL N+ + G++ KI D GLA IM
Sbjct: 137 FLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT--HGKIVKICDFGLARDIM 192
Query: 183 EQAN--AKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQ 237
+N K P ++MAPE +++ Y +D++S+G+ + E+ + PY ++
Sbjct: 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK 252
Query: 238 IYKKVSSGI---KPAALSKVKDPEVKSFIEKC 266
YK + G +P E+ ++ C
Sbjct: 253 FYKLIKEGYRMAQPEHAPA----EIYDIMKTC 280
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-12
Identities = 90/363 (24%), Positives = 154/363 (42%), Gaps = 56/363 (15%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
+IG G+F VY+A ++ E +V I VLQ P+ R E+ ++K+L H NII
Sbjct: 73 IIGNGSFGVVYEAIC-IDTSE----KVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFL 124
Query: 93 YNSWI------DDQNKTVNIITELF---TSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
+ + +++N +N++ E ++ Y + + + + VK ++ Q+ L
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-TIMEQANAKSVIGTPEFMAPELY 202
Y+HS I HRDLK N+ I+ N +K+ D G A ++ + S I + + APEL
Sbjct: 185 YIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELM 242
Query: 203 --DENYNELADIYSFGMCMLEMVTFEYPYSECRNSA-QIYKKVSSGIKPAA--------- 250
NY D++S G + EM+ YP ++S Q+ + + P
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMI-LGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN 301
Query: 251 LSKVKDPEVKSFIEKCLVPAS------------------QRLSAKELLMDPFLQVNGTTK 292
+ +K P+VK K + P +RL+ E L DPF +
Sbjct: 302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD---DLR 358
Query: 293 NRPLPLPDIV--LPRVGAFGDRCLMSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGD 350
+ + LP + LP + F D + A R P +++ E + D + D
Sbjct: 359 DPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCTYEAYKEFLMSDENDANIIAD 418
Query: 351 SYS 353
S
Sbjct: 419 KIS 421
|
Length = 440 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 47/182 (25%), Positives = 90/182 (49%), Gaps = 12/182 (6%)
Query: 72 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKA 130
+ E ++ L H +++ Y + + + + I+TE ++G L Y ++H K+
Sbjct: 44 DEFIEEAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ 101
Query: 131 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 190
+ + + G+ YL S IHRDL N ++ +QG VK+ D GL+ + S
Sbjct: 102 LLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSS 158
Query: 191 IGTP---EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
+G+ + PE L ++ +D+++FG+ M E+ + + PY NS + +KVS G
Sbjct: 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-ETVEKVSQG 217
Query: 246 IK 247
++
Sbjct: 218 LR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 72/274 (26%), Positives = 127/274 (46%), Gaps = 33/274 (12%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL-QSPEDLERLYSEVHLLKSLKHNNI 89
V+G GA TV A +G A V++ D+ S D R +EV L + +I
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFA---VKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 90 IRFYNSWI--DDQNK----TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
++ + + D +N + ++ + +G LRQ K K + + A GL+
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEA-----GLL 148
Query: 144 YL-------HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL-----ATIMEQANAKSVI 191
++ H H +IHRD+K NI + N G VK+GD G AT+ + ++
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDV-GRTFC 206
Query: 192 GTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250
GTP ++APE++ Y++ AD++S G+ + E++T + P+ ++K ++ P
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP-- 264
Query: 251 LSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDP 283
L PE++ + L +R S+ +LL P
Sbjct: 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 20/143 (13%)
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-IMEQANAKSVIGTPEFMAPE-LYDEN 205
H+ IHRDLK +N F+ G +K+ D GL+ I+ AN SV+G+P++MAPE L +
Sbjct: 118 HELGYIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTYAN--SVVGSPDYMAPEVLRGKG 174
Query: 206 YNELADIYSFGMCMLEMVTFEYP----------YSECRNSAQIYKKVSSGIKPAALSKVK 255
Y+ D +S G CML +P + + + ++ LS
Sbjct: 175 YDFTVDYWSLG-CMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD-- 231
Query: 256 DPEVKSFIEKCLVPASQRLSAKE 278
E I K + S+R + E
Sbjct: 232 --EAWDLITKLINDPSRRFGSLE 252
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 35/100 (35%), Positives = 59/100 (59%), Gaps = 8/100 (8%)
Query: 134 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVI 191
+A +I GL +LHS II+RDLK DN+ ++ +G +KI D G+ I ++
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFC 162
Query: 192 GTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTFEYPY 229
GTP+++APE Y + Y + D ++FG+ + EM+ + P+
Sbjct: 163 GTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 69/245 (28%), Positives = 111/245 (45%), Gaps = 42/245 (17%)
Query: 19 LETDPTCRYIRYKEVIGK----GAFKTVYKAFDEVNGLEVAW------CQVRIDDVLQSP 68
L DP + R + V+GK G F V +A E G++ + V++ +
Sbjct: 1 LPLDPKWEFPRDRLVLGKPLGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATD 58
Query: 69 EDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-------- 119
+DL L SE+ L+K + KH NII + Q + +I E G+LR++
Sbjct: 59 KDLADLISEMELMKLIGKHKNIINLLG--VCTQEGPLYVIVEYAAKGNLREFLRARRPPG 116
Query: 120 --------RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 171
+ +++ K + A Q+ G+ YL S IHRDL N+ + + +
Sbjct: 117 PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VM 173
Query: 172 KIGDLGLATIMEQAN--AKSVIG--TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF- 225
KI D GLA + + K+ G ++MAPE L+D Y +D++SFG+ M E+ T
Sbjct: 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG 233
Query: 226 --EYP 228
YP
Sbjct: 234 GSPYP 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 36/221 (16%)
Query: 72 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRK--KHKKVDMK 129
E E ++K L+H+ +++ Y + + I+TE + GSL + K + + + +
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLP 102
Query: 130 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 189
+ A Q+ +G+ Y+ + IHRDL+ NI + G+ KI D GLA ++E +
Sbjct: 103 NLVDMAAQVAAGMAYIERMN--YIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTA 159
Query: 190 VIGTP---EFMAPE--LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVS 243
G ++ APE LY + +D++SFG+ + E+VT PY N+ ++ ++V
Sbjct: 160 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVE 217
Query: 244 SGIK-------PAALSKV------KDPE-------VKSFIE 264
G + P +L ++ KDPE ++SF+E
Sbjct: 218 RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 33 VIGKGAFKTVY----KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
VIG+G++ V K D++ ++V ++ DD ED++ + +E H+ + N
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD-----EDIDWVQTEKHVFEQASSNP 56
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 148
+ +S ++ +I E G L + ++ +K+ + + +A +I L +LH
Sbjct: 57 FLVGLHSCFQTTSRLFLVI-EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDEN 205
II+RDLK DN+ ++ + G +K+ D G+ + + GTP ++APE L E
Sbjct: 116 G--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 206 YNELADIYSFGMCMLEMVTFEYPY 229
Y D ++ G+ M EM+ P+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 34 IGKGAFKTVYKAF--DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+G+G + VYKA D + E A Q+ + S E+ LL+ LKH N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA------CREIALLRELKHPNVIA 62
Query: 92 FYNSWIDDQNKTVNIITE--------LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
++ ++ V ++ + + + KK ++ VK QIL G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 144 YLHSHDPPIIHRDLKCDNIFING---NQGEVKIGDLGLATIMEQ-----ANAKSVIGTPE 195
YLH++ ++HRDLK NI + G +G VKI D+G A + A+ V+ T
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 196 FMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECR 233
+ APEL +Y + DI++ G E++T E P CR
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 49/175 (28%), Positives = 84/175 (48%), Gaps = 9/175 (5%)
Query: 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166
I +L G L + +H K ++ +A +I+ GL H H+ +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGL--EHMHNRFVVYRDLKPANILLD- 131
Query: 167 NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDEN--YNELADIYSFGMCMLEMVT 224
G V+I DLGLA + + +GT +MAPE+ + Y+ AD +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 225 FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKEL 279
P+ + + + + L PE+KS +E L QR +K L
Sbjct: 192 GHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL----QRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 20/215 (9%)
Query: 77 EVHLLKSLKHNNIIRFYNSWID--DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW 134
E+ L+ + NNI++ Y ID D +++I E T G LR+ K K + K
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 135 ARQILSGLIYLHSHD--PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG 192
A GL L+ + P +++L + + N ++KI GL I+ K+V
Sbjct: 128 AIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTEN-YKLKIICHGLEKILSSPPFKNV-- 181
Query: 193 TPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI 246
FM Y Y DIYS G+ + E+ T + P+ E + +IY + +
Sbjct: 182 --NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF-ENLTTKEIYDLIINKN 238
Query: 247 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL 280
L E+K +E C + +R + KE+L
Sbjct: 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 50/200 (25%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM 128
+ ++ ++SE +L + H + Y S+ D+ + ++ E G + +++K+
Sbjct: 73 KQVDHVFSERKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRFPN 130
Query: 129 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 188
+A QI+ YL S + I++RDLK +N+ ++ + G +K+ D G A +++
Sbjct: 131 DVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVD-TRTY 186
Query: 189 SVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK 247
++ GTPE++APE L + + + AD ++ G+ + E++ P+ IY+K+ GI
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEGI- 244
Query: 248 PAALSKVKDPEVKSFIEKCL 267
K D K ++K L
Sbjct: 245 -IYFPKFLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 64/254 (25%), Positives = 104/254 (40%), Gaps = 50/254 (19%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP------EDLERLYSEVH 79
I K +G+GAF V+ E V + L+ +D ER E
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVK-TLKETASNDARKDFER---EAE 60
Query: 80 LLKSLKHNNIIRFY------NSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-----VDM 128
LL + +H NI++FY + I ++ E G L ++ + H
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPI--------MVFEYMEHGDLNKFLRSHGPDAAFLKSP 112
Query: 129 KAVKG---------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179
+ G A QI SG++YL S +HRDL N + G VKIGD G++
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMS 169
Query: 180 TIMEQANAKSVIGTP----EFMAPE--LYDENYNELADIYSFGMCMLEMVTF-EYPYSEC 232
+ + V G +M PE +Y + E +D++SFG+ + E+ T+ + P+
Sbjct: 170 RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGL 228
Query: 233 RNSAQIYKKVSSGI 246
N I + ++ G
Sbjct: 229 SNEEVI-ECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 51/204 (25%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 33 VIGKGAFKTVY----KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
VIG+G++ V K + + ++V ++ DD ED++ + +E H+ + ++
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHP 56
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 148
+ +S +++ +I E G L + ++ +K+ + + ++ +I L YLH
Sbjct: 57 FLVGLHSCFQTESRLFFVI-EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDEN 205
II+RDLK DN+ ++ ++G +K+ D G+ + + GTP ++APE L E+
Sbjct: 116 G--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 206 YNELADIYSFGMCMLEMVTFEYPY 229
Y D ++ G+ M EM+ P+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
++ IGKG F V + G +VA ++ DD + +E ++ +L+H
Sbjct: 8 LKLGATIGKGEFGDVMLG--DYRGQKVAVKCLK-DDS----TAAQAFLAEASVMTTLRHP 60
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKA-VKGWARQILSGLIYL 145
N+++ + + I+TE GSL Y R + + V A G+A + G+ YL
Sbjct: 61 NLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPELYD 203
+ +HRDL N+ ++ K+ D GLA Q + K + ++ APE
Sbjct: 119 EEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEALR 172
Query: 204 EN-YNELADIYSFGMCMLEMVTF-EYPY 229
E ++ +D++SFG+ + E+ +F PY
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 50/163 (30%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 76 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL----RQYRKKHKKVDMKAV 131
SE+H L + H I++ ++ + D + +I E + G L +Q K+H V
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 132 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----NA 187
QI+ L +HS ++HRDLK NIF+ G +K+GD G + + A
Sbjct: 172 GLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVA 228
Query: 188 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPY 229
S GTP ++APEL++ + Y++ AD++S G+ + E++T P+
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLE--RLYSEVHLLKSLKH 86
R+ V+GKG F EV CQVR + + + LE R+ +L
Sbjct: 3 RHYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 50
Query: 87 NNIIRFYNS-------WIDDQNKTVNIITELFTSGSLR--QYRKKHKKVDMKAVKGWARQ 137
I+ NS + + + ++ L G L+ Y + D + +A +
Sbjct: 51 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE 110
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-IMEQANAKSVIGTPEF 196
I GL LH I++RDLK +NI ++ + G ++I DLGLA I E + +GT +
Sbjct: 111 ITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGY 167
Query: 197 MAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY 229
MAPE + +E Y D + G + EM+ + P+
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 34 IGKGAFKTVYKAF--DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+G+G + VYKA D + + A Q+ + S E+ LL+ LKH N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA------CREIALLRELKHPNVIS 62
Query: 92 FYNSWIDDQNKTVNII-----TELFTSGSLRQYRKKHKK---VDMKAVKGWARQILSGLI 143
++ ++ V ++ +L+ + K +KK + VK QIL G+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 144 YLHSHDPPIIHRDLKCDNIFING---NQGEVKIGDLGLATIMEQ-----ANAKSVIGTPE 195
YLH++ ++HRDLK NI + G +G VKI D+G A + A+ V+ T
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 196 FMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECR 233
+ APEL +Y + DI++ G E++T E P CR
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAW-CQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
++ +V+G GAF TVYK +G V +++ SP+ + + E +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYL 145
+ R + TV ++T+L G L Y +++K ++ + + W QI G+ YL
Sbjct: 69 PYVCRLLGICL---TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME------QANAKSVIGTPEFMAP 199
+ ++HRDL N+ + + VKI D GLA +++ A+ V ++MA
Sbjct: 126 --EEVRLVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMAL 180
Query: 200 E-LYDENYNELADIYSFGMCMLEMVTF 225
E + + +D++S+G+ + E++TF
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 40/145 (27%), Positives = 78/145 (53%), Gaps = 10/145 (6%)
Query: 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 165
++T+ + G L + +K + K + +++ L +LH +D I++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 166 GNQGEVKIGDLGL--ATIMEQANAKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLE 221
G + + D GL A + + + GT E++APE L ++ Y + D +S G+ + E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 222 MVTFEYP-YSECRNSAQIYKKVSSG 245
M P Y+E ++ Q+Y+ ++ G
Sbjct: 190 MCCGWSPFYAE--DTQQMYRNIAFG 212
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 49/188 (26%), Positives = 90/188 (47%), Gaps = 11/188 (5%)
Query: 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166
I +L G L + +H ++ +A +I+ GL H H+ +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGL--EHMHNRFVVYRDLKPANILLDE 132
Query: 167 NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDEN--YNELADIYSFGMCMLEMVT 224
+ G V+I DLGLA + + +GT +MAPE+ + Y+ AD +S G + +++
Sbjct: 133 H-GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 225 FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRL-----SAKE 278
P+ + + + + L PE++S +E L ++RL A+E
Sbjct: 192 GHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 251
Query: 279 LLMDPFLQ 286
+ PF +
Sbjct: 252 VKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 62/250 (24%), Positives = 112/250 (44%), Gaps = 47/250 (18%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+VIG+GAF V + G A +R D+L+ E + + +E +L +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-EQVGHIRAERDILVEADSLWVVK 65
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+ S+ D N + +I E G + K + + + + + + + +H
Sbjct: 66 MFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG-- 121
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN------------------------- 186
IHRD+K DN+ ++ ++G VK+ D GL T +++A+
Sbjct: 122 FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 187 ------------AKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECR 233
A S +GTP+++APE++ + YN+L D +S G+ M EM+ P+ C
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF--CS 238
Query: 234 NSAQ-IYKKV 242
+ Q YKKV
Sbjct: 239 ETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 83/301 (27%), Positives = 134/301 (44%), Gaps = 49/301 (16%)
Query: 19 LETDPTCRYIRYKEVIGK----GAFKTVYKAFDEVNGLE------VAWCQVRIDDVLQSP 68
L DP R + V+GK G F V A E GL+ V V++ +
Sbjct: 7 LPEDPRWEVPRDRLVLGKPLGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATE 64
Query: 69 EDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK--- 124
+DL L SE+ ++K + KH NII + Q+ + +I E + G+LR+Y + +
Sbjct: 65 KDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPG 122
Query: 125 -------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 171
++ K + A Q+ G+ YL S IHRDL N+ + + +
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VM 179
Query: 172 KIGDLGLATIMEQAN--AKSVIG--TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF- 225
KI D GLA + + K+ G ++MAPE L+D Y +D++SFG+ + E+ T
Sbjct: 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 239
Query: 226 --EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC--LVPASQRLSAKELLM 281
YP ++ K+ KP+ + E+ + C VP SQR + K+L+
Sbjct: 240 GSPYPGVPVEELFKLLKEGHRMDKPSNCTN----ELYMMMRDCWHAVP-SQRPTFKQLVE 294
Query: 282 D 282
D
Sbjct: 295 D 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 33 VIGKGAFKTVY----KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
V+GKG+F V K DE+ +++ V I D +D+E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALSGKPP 61
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 148
+ +S ++ + + E G L ++ + +A +I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPELYD-EN 205
II+RDLK DN+ ++ ++G +KI D G+ + + K+ GTP+++APE+ +
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 206 YNELADIYSFGMCMLEMVTFEYPY 229
Y + D ++FG+ + EM+ + P+
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 47/186 (25%), Positives = 96/186 (51%), Gaps = 18/186 (9%)
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVDM 128
+E +E +++K+L+H+ +++ ++ + + + IITE GSL + K + K +
Sbjct: 45 VEAFLAEANVMKTLQHDKLVKL-HAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 101
Query: 129 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 188
+ ++ QI G+ ++ + IHRDL+ NI ++ + KI D GLA ++E
Sbjct: 102 PKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 158
Query: 189 SVIGTP---EFMAPELYDENYNEL---ADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKK 241
+ G ++ APE N+ +D++SFG+ ++E+VT+ PY N ++ +
Sbjct: 159 AREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRA 215
Query: 242 VSSGIK 247
+ G +
Sbjct: 216 LERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 8e-11
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
+R + +G+G F V+ NG +V I + E E ++K L+H
Sbjct: 8 LRLEVKLGQGCFGEVWMG--TWNGTT----RVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYL 145
+++ Y ++ + I+TE + GSL + K K + + + A QI SG+ Y+
Sbjct: 62 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP---EFMAPE-- 200
+ +HRDL+ NI + G K+ D GLA ++E + G ++ APE
Sbjct: 119 ERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 201 LYDENYNELADIYSFGMCMLEMVT 224
LY + +D++SFG+ + E+ T
Sbjct: 176 LYGR-FTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 47/137 (34%), Positives = 68/137 (49%), Gaps = 12/137 (8%)
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LY 202
H H II+RDLK +NI ++ QG VK+ D GL +I E + GT E+MAPE L
Sbjct: 115 HLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAALSKVKDPEVK 260
+ + D +S G M +M+T P++ N + K+ G P L+ PE +
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPYLT----PEAR 228
Query: 261 SFIEKCLV-PASQRLSA 276
++K L S RL A
Sbjct: 229 DLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 8e-11
Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 76 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWA 135
+E H+L+++ H +II+ ++ NK +I + + L Y + + + +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFT--YNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIE 188
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV---IG 192
R +L + YLH + IIHRD+K +NIFIN + G+V +GD G A NA G
Sbjct: 189 RSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 193 TPEFMAPELYDEN-YNELADIYSFGMCMLEMVT 224
T APEL + Y DI+S G+ + EM T
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 74/322 (22%), Positives = 138/322 (42%), Gaps = 67/322 (20%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+VIG+GAF V + G A ++R ++L+ E + + +E +L + +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK-EQVAHVRAERDILAEADNPWVVK 65
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
Y S+ D+ + +I E G + K + + + + + + +H
Sbjct: 66 LYYSFQDENY--LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG-- 121
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN------------------------- 186
IHRD+K DN+ ++ +G +K+ D GL T +++++
Sbjct: 122 YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 187 ---------------AKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYP-- 228
A S +GTP+++APE++ + YN+ D +S G+ M EM+ YP
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV-GYPPF 239
Query: 229 YSECRNSAQIYKKV----SSGIKP--AALSKVKDPEVKSFIEKCLVPASQRL---SAKEL 279
S+ N + Y+K+ + P LS PE K I++ A +RL E+
Sbjct: 240 CSD--NPQETYRKIINWKETLQFPDEVPLS----PEAKDLIKRLCCEAERRLGNNGVNEI 293
Query: 280 LMDPFLQ-VN-GTTKNRPLPLP 299
PF + V+ + RP P+
Sbjct: 294 KSHPFFKGVDWEHIRERPAPII 315
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 35/87 (40%), Positives = 54/87 (62%), Gaps = 4/87 (4%)
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPELYD 203
H H II+RDLK +NI ++ +G +K+ D GL+ +I + A S GT E+MAPE+ +
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 204 -ENYNELADIYSFGMCMLEMVTFEYPY 229
+ + AD +SFG+ M EM+T P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 42/132 (31%), Positives = 76/132 (57%), Gaps = 11/132 (8%)
Query: 106 IITELFTSGSLRQ--YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 163
++ L G L+ Y + ++M+ V ++ QI G+++LHS D I++RD+K +N+
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVL 127
Query: 164 INGNQGEVKIGDLGLATIMEQANAKSVI---GTPEFMAPE-LYDENYNELADIYSFGMCM 219
++ +QG ++ DLGLA +E + K++ GT +MAPE L +E Y+ D ++ G +
Sbjct: 128 LD-DQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSI 184
Query: 220 LEMVTFEYPYSE 231
EMV P+ +
Sbjct: 185 YEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 87/320 (27%), Positives = 139/320 (43%), Gaps = 51/320 (15%)
Query: 19 LETDPTCRYIRYKEVIGK----GAFKTVYKA------FDEVNGLEVAWCQVRIDDVLQSP 68
L DP R + +GK G F V A D+ N ++ DD +
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TD 58
Query: 69 EDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVD 127
+DL L SE+ ++K + KH NII + Q+ + ++ E + G+LR+Y + +
Sbjct: 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVLVEYASKGNLREYLRARRPPG 116
Query: 128 M----------------KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 171
M K + A Q+ G+ YL S IHRDL N+ + +
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT-EDNVM 173
Query: 172 KIGDLGLATIMEQAN--AKSVIG--TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF- 225
KI D GLA + + K+ G ++MAPE L+D Y +D++SFG+ + E+ T
Sbjct: 174 KIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 233
Query: 226 --EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC--LVPASQRLSAKELL- 280
YP ++ K+ KPA + E+ + +C VP SQR + K+L+
Sbjct: 234 GSPYPGIPVEELFKLLKEGHRMDKPANCTH----ELYMIMRECWHAVP-SQRPTFKQLVE 288
Query: 281 -MDPFLQVNGTTKNRPLPLP 299
+D L V T + L +P
Sbjct: 289 DLDRVLTVTSTDEYLDLSVP 308
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 35/104 (33%), Positives = 62/104 (59%), Gaps = 7/104 (6%)
Query: 128 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--- 184
+K + +Q+L + Y+H D +IHRD+K +NIF+N + G++ +GD G A E+
Sbjct: 266 LKQTRAIMKQLLCAVEYIH--DKKLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKERE 322
Query: 185 ANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEY 227
A +GT +PE L + Y E+ DI+S G+ +L+M++ ++
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 62/250 (24%), Positives = 113/250 (45%), Gaps = 47/250 (18%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+VIG+GAF V + G A +R D+L+ E + + +E +L +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAHIRAERDILVEADGAWVVK 65
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+ S+ D +N + +I E G + K + +A + + + + + +H
Sbjct: 66 MFYSFQDKRN--LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG-- 121
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN------------------------- 186
IHRD+K DN+ ++ +G VK+ D GL T +++A+
Sbjct: 122 FIHRDIKPDNLLLDA-KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 187 ------------AKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECR 233
A S +GTP+++APE++ + YN+L D +S G+ M EM+ P+ C
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF--CS 238
Query: 234 NSAQ-IYKKV 242
+ Q Y+KV
Sbjct: 239 ETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 30/222 (13%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVA-WCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
+R+ E +G+ AF +YK + G++ A ++ + +P+ E L+ L H
Sbjct: 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY---RKKHKKVDMKA-----VKG----- 133
NI+ + Q + V ++ E G L ++ R H V + VK
Sbjct: 67 PNIVCLLG--VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 134 ----WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 189
A QI +G+ YL SH +H+DL NI I G Q VKI DLGL+ + A+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADYYR 181
Query: 190 VIGTP----EFMAPE--LYDENYNELADIYSFGMCMLEMVTF 225
V +M PE +Y + ++ +DI+SFG+ + E+ +F
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 33 VIGKGAFKTVY----KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
V+GKG+F V K DE+ +++ V I D +D+E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALQDKPP 61
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 148
+ +S ++ + + E G L + ++ K +A +I GL +LH
Sbjct: 62 FLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPELYD-EN 205
II+RDLK DN+ ++ ++G +KI D G+ +++ ++ GTP+++APE+ +
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 206 YNELADIYSFGMCMLEMVTFEYPY 229
Y + D +++G+ + EM+ + P+
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLE--RLYSEVHLLKSLKH 86
R V+GKG F EV CQVR + + + LE R+ +L
Sbjct: 3 RQYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGESMALNE 50
Query: 87 NNIIRFYNS-------WIDDQNKTVNIITELFTSGSLR--QYRKKHKKVDMKAVKGWARQ 137
I+ NS + + + ++ L G L+ Y + +A +
Sbjct: 51 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE 110
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-IMEQANAKSVIGTPEF 196
I GL LH I++RDLK +NI ++ + G ++I DLGLA + E K +GT +
Sbjct: 111 ICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 167
Query: 197 MAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSE 231
MAPE+ +E Y D ++ G + EM+ + P+ +
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 48/179 (26%), Positives = 90/179 (50%), Gaps = 13/179 (7%)
Query: 114 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 173
G L + ++ + D+ + + ++L L LH + +I+RDLK +NI ++ QG + +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134
Query: 174 GDLGLATI-MEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYS 230
D GL + M+ + + GTPE++APEL Y + D ++ G+ + EM+T P+
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
Query: 231 ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPA-SQRL---SAKELLMDPFL 285
+ N ++Y+K+ +P D + K + L ++RL A+E+ PF
Sbjct: 195 D-ENVNEMYRKILQ--EPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 145 LHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM---EQANAKSVIGTPEFMAPE 200
+HS H +HRD+K +N+ I+ G +K+ D G A + + N+K +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 201 LY-------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253
+ Y D +S G+ EM+ P+ E SA+ Y + + L
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN--FQRFLKF 230
Query: 254 VKDPEVKS----FIEKCLVPASQRLSAKELLMDPF 284
+DP+V S I+ L +RL + L PF
Sbjct: 231 PEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 51/204 (25%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 33 VIGKGAFKTV----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
VIG+G++ V K + ++V ++ DD ED++ + +E H+ ++ ++
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD-----EDIDWVQTEKHVFETASNHP 56
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 148
+ +S +++ +I E + G L + ++ +K+ + + ++ +I L +LH
Sbjct: 57 FLVGLHSCFQTESRLFFVI-EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--IMEQANAKSVIGTPEFMAPE-LYDEN 205
II+RDLK DN+ ++ +G +K+ D G+ I + GTP ++APE L E+
Sbjct: 116 G--IIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 206 YNELADIYSFGMCMLEMVTFEYPY 229
Y D ++ G+ M EM+ P+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 70/249 (28%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ + IG GA V A+D + LE ++ Q+ +R Y E+ L+K + H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAI--LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 87 NNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
NII N + ++ + V I+ EL + + + + +D + + Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE-----FM 197
+LHS IIHRDLK NI + + +KI D GLA + S + TP +
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 198 APE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKPAALSKVK 255
APE + Y E DI+S G M EM+ + + Q K + G K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
Query: 256 DPEVKSFIE 264
P V++++E
Sbjct: 253 QPTVRTYVE 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 5e-10
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 78 VHLLKSLKHN-NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 136
VH L +K N N I+ Y S K +I + G L KK K+ VK R
Sbjct: 61 VHQL--MKDNPNFIKLYYSV--TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIR 116
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI-GTPE 195
Q++ L LH H+ IIH D+K +N+ + + + + D GL I+ S GT +
Sbjct: 117 QLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTPSCYDGTLD 171
Query: 196 FMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSE 231
+ +PE + NY+ D ++ G+ E++T ++P+ E
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 7e-10
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 39/210 (18%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRF 92
I +G + VY+A D+ G VA +++++ + P R E+++L L+H NI+
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR---EINILLKLQHPNIVTV 69
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA-------------VKGWARQIL 139
+ + ++ E +H D+K+ VK Q+L
Sbjct: 70 KEVVVGSNLDKIYMVMEYV----------EH---DLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK---SVIGTPEF 196
SG+ +LH + I+HRDLK N+ +N N+G +KI D GLA + K ++ T +
Sbjct: 117 SGVAHLHDN--WILHRDLKTSNLLLN-NRGILKICDFGLAREY-GSPLKPYTQLVVTLWY 172
Query: 197 MAPELY--DENYNELADIYSFGMCMLEMVT 224
APEL + Y+ D++S G E++T
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 72 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMK 129
E E ++K L+H+ ++ Y ++ + I+TE GSL + K+ K + +
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLP 102
Query: 130 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 189
+ A QI G+ Y+ + IHRDL+ NI + N KI D GLA ++E +
Sbjct: 103 QLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTA 159
Query: 190 VIGTP---EFMAPE--LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVS 243
G ++ APE LY + +D++SFG+ + E+VT PY N ++ ++V
Sbjct: 160 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLEQVE 217
Query: 244 SGIK-------PAALSKV------KDPE-------VKSFIE 264
G + P +L ++ KDP+ ++SF+E
Sbjct: 218 RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 70/243 (28%), Positives = 113/243 (46%), Gaps = 43/243 (17%)
Query: 26 RYIRYKEVIGKGAFKTVYKA-----FDEVNGLEVAWCQVRIDDVLQSP-EDLERLYSEVH 79
R I K +G+GAF V+ A E + + VA ++ + +S +D +R E
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESARQDFQR---EAE 59
Query: 80 LLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW----- 134
LL L+H +I+RFY + + + ++ E G L ++ + H D K + G
Sbjct: 60 LLTVLQHQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGP-DAKILAGGEDVAP 116
Query: 135 -----------ARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182
A QI SG++YL S H +HRDL N + G VKIGD G++ +
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLV-GQGLVVKIGDFGMSRDI 172
Query: 183 EQANAKSVIGTP----EFMAPE--LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNS 235
+ V G +M PE LY + E +DI+SFG+ + E+ T+ + P+ + N+
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNT 231
Query: 236 AQI 238
I
Sbjct: 232 EAI 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 32/196 (16%)
Query: 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL---HSHDPPIIHRDLKCDNIFIN 165
ELFT S R+ K+ + QI SG I L H H II+RD+K +NI ++
Sbjct: 91 ELFTHLSQRERFKEQEV-----------QIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139
Query: 166 GNQGEVKIGDLGLATIM---EQANAKSVIGTPEFMAPELY---DENYNELADIYSFGMCM 219
N G V + D GL+ E A S GT E+MAP++ D +++ D +S G+ M
Sbjct: 140 SN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198
Query: 220 LEMVTFEYPYS---ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL- 274
E++T P++ E + A+I +++ P + K I++ L+ +RL
Sbjct: 199 YELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLG 256
Query: 275 ----SAKELLMDPFLQ 286
A E+ PF Q
Sbjct: 257 CGPSDADEIKKHPFFQ 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 9e-10
Identities = 72/251 (28%), Positives = 118/251 (47%), Gaps = 29/251 (11%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ + IG GA V A+D V VA ++ Q+ +R Y E+ L+K + H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAI--KKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 87 NNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
NII N + ++ + V ++ EL + + + + +D + + Q+L G+
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 132
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP-----EFM 197
+LHS IIHRDLK NI + + +KI D GLA + S + TP +
Sbjct: 133 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 185
Query: 198 APE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK---PAALSK 253
APE + Y E DI+S G M EMV + + R+ + KV + P + K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 254 VKDPEVKSFIE 264
++ P V++++E
Sbjct: 245 LQ-PTVRNYVE 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 53/218 (24%), Positives = 104/218 (47%), Gaps = 18/218 (8%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93
+G G F V+ G A +V I + + E E ++ L H +++ Y
Sbjct: 12 LGSGQFGVVHL------GKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 94 NSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
Q K + I+TE +G L Y R++ K+ + + + G+ YL +
Sbjct: 66 GVCT--QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--F 121
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTP-EFMAPELYDEN-YNE 208
IHRDL N ++ + G VK+ D G+ + ++ + S P ++ PE+++ + Y+
Sbjct: 122 IHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 209 LADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSG 245
+D++SFG+ M E+ T + P+ E +++ ++ + +S G
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 49/209 (23%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
+ ++ + IGKG F V + G +VA ++ D Q+ +E ++ L+
Sbjct: 6 KELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQA------FLAEASVMTQLR 57
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKV-DMKAVKGWARQILSGLI 143
H+N+++ +++ + I+TE GSL Y R + + V + ++ + +
Sbjct: 58 HSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP-EFMAPE-L 201
YL +++ +HRDL N+ ++ K+ D GL E ++ + P ++ APE L
Sbjct: 117 YLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEAL 171
Query: 202 YDENYNELADIYSFGMCMLEMVTF-EYPY 229
++ ++ +D++SFG+ + E+ +F PY
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLE--RLYSEVHLLKSLKH 86
R V+GKG F EV CQVR + + + LE R+ +L
Sbjct: 3 RQYRVLGKGGFG------------EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNE 50
Query: 87 NNIIRFYNS-------WIDDQNKTVNIITELFTSGSLR--QYRKKHKKVDMKAVKGWARQ 137
I+ NS + + + ++ + G L+ Y + + + +A +
Sbjct: 51 KQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE 110
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-IMEQANAKSVIGTPEF 196
IL GL LH + ++RDLK +NI ++ + G ++I DLGLA I E + + +GT +
Sbjct: 111 ILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGY 167
Query: 197 MAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY 229
MAPE L ++ Y D + G + EM+ + P+
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 27/223 (12%)
Query: 28 IRYKEVIGKGAFKTVYKAF--DEVNGLEVAWCQVRIDDVLQ--SPEDLERLYSEVHLLKS 83
+ +++ +G F ++ DE G E +V + V S + L E LL
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKE---EEVFVKTVKDHASEIQVTLLLQESCLLYG 64
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKG--------WA 135
L H NI+ + I+D ++ G+L+ + ++ + + + A
Sbjct: 65 LSHQNILPILHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE 195
QI G+ YLH +IH+D+ N I+ + +VKI D L+ + + +G E
Sbjct: 124 IQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNALSRDLFPMDYHC-LGDNE 179
Query: 196 -----FMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSE 231
+MA E L ++ Y+ +D++SFG+ + E++T + PY E
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 57/236 (24%), Positives = 90/236 (38%), Gaps = 40/236 (16%)
Query: 29 RYKEVIGKGAFKTVY-------KAFDEVNGLEVAW-CQVRI-------DDVLQSPEDLER 73
+ E +G+G F V+ + F E E + D S E
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNARED 65
Query: 74 LYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKG 133
EV +L L NI R D + +I E +G L Q+ +KH
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 134 -----------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182
A QI SG+ YL S + +HRDL N + N +KI D G++ +
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNY-TIKIADFGMSRNL 180
Query: 183 EQANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF--EYPYSE 231
++ V G +MA E + + +D+++FG+ + E++T E PY
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 16/198 (8%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRF 92
+G+GA+ V A + E +I +V +R E+ LL+ + H NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 93 YNSWI--DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
Y+ I + + EL + L Q + + + + + QIL GL Y+HS +
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN- 125
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLA------TIMEQANAKSVIGTPEFMAPE--LY 202
++HRDLK N+ +N + E+KI D GLA + T + APE L
Sbjct: 126 -VLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183
Query: 203 DENYNELADIYSFGMCML 220
++Y + D++S G C+L
Sbjct: 184 FQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLE--RLYSEVHLLKSLKH 86
R+ V+GKG F EV CQVR + + + LE R+ +L
Sbjct: 3 RHYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 50
Query: 87 NNIIRFYNS-------WIDDQNKTVNIITELFTSGSLR--QYRKKHKKVDMKAVKGWARQ 137
I+ NS + + + ++ + G L+ Y + D + +A +
Sbjct: 51 KRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE 110
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-IMEQANAKSVIGTPEF 196
+ GL L I++RDLK +NI ++ ++G ++I DLGLA I E + +GT +
Sbjct: 111 LCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGY 167
Query: 197 MAPE-LYDENYNELADIYSFGMCMLEMVTFEYPY 229
MAPE + +E Y D + G + EM+ + P+
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 47/141 (33%), Positives = 78/141 (55%), Gaps = 12/141 (8%)
Query: 133 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE-VKIGDLGLA-TIMEQAN--AK 188
G++ Q+ +G+ +L S + +HRDL N+ I +G+ VKI D GLA IM +N +K
Sbjct: 243 GFSYQVANGMEFLASKN--CVHRDLAARNVLIC--EGKLVKICDFGLARDIMRDSNYISK 298
Query: 189 SVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
P ++MAPE +++ Y L+D++SFG+ + E+ T PY E + Q Y + G
Sbjct: 299 GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358
Query: 246 IKPAALSKVKDPEVKSFIEKC 266
+ A + D E+ ++KC
Sbjct: 359 YRMAKPAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-09
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 27/208 (12%)
Query: 51 GLEVAWCQVRIDDVLQSPED---LERLYSEVHLLKSLKHNNIIRFYNSWI--DDQNKTVN 105
G EVA +R D +PE+ R E L L H NI+ +S V
Sbjct: 3 GHEVAIKLLRTD----APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAV- 57
Query: 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 165
E +LR+ + Q+L L +H+ I+HRDLK NI ++
Sbjct: 58 --FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALA--CAHNQGIVHRDLKPQNIMVS 113
Query: 166 GNQGE--VKIGDLGLATIMEQANAK---------SVIGTPEFMAPE-LYDENYNELADIY 213
K+ D G+ T++ V+GTP + APE L E +D+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 214 SFGMCMLEMVTFEYPYSECRNSAQIYKK 241
++G+ LE +T + + + A+I +
Sbjct: 174 AWGLIFLECLTGQ-RVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 32 EVIGKGAFKTVYKA-FDEVNGLEVAWCQV----RIDDVLQSPEDLERLYSEVHLLKSLKH 86
VIGKG F VY + +G ++ C V RI D+ E++E+ E ++K H
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIH-CAVKSLNRITDL----EEVEQFLKEGIIMKDFSH 55
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYL 145
N++ + + + ++ G LR + R + +K + G+ Q+ G+ YL
Sbjct: 56 PNVLSLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA---------TIMEQANAKSVIGTPEF 196
S +HRDL N ++ + VK+ D GLA ++ AK + ++
Sbjct: 115 ASKK--FVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPV---KW 168
Query: 197 MAPE-LYDENYNELADIYSFGMCMLEMVT 224
MA E L + + +D++SFG+ + E++T
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 19/243 (7%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLE-RLYSEVHLLKSLKHNNII 90
E IG+G F V+ + VA R + L P DL+ + E +LK H NI+
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR--ETL--PPDLKAKFLQEARILKQYSHPNIV 56
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
R + Q + + I+ EL G + R + ++ +K + +G+ YL S
Sbjct: 57 RLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE----FMAPE-LYDE 204
IHRDL N + + +KI D G++ E S G + + APE L
Sbjct: 115 --CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 205 NYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263
Y+ +D++SFG+ + E + PY+ N Q + + G++ D V +
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-QTREAIEQGVRLPCPELCPD-AVYRLM 229
Query: 264 EKC 266
E+C
Sbjct: 230 ERC 232
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 33/235 (14%)
Query: 28 IRYKEVIGKGAFKTV-----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK 82
I K +G+GAF V Y E + + VA ++ D + +D R E LL
Sbjct: 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHR---EAELLT 62
Query: 83 SLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKG--------- 133
+L+H +I++FY + + + ++ E G L ++ + H + +G
Sbjct: 63 NLQHEHIVKFYGVCV--EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 134 ----WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 189
A+QI +G++YL S +HRDL N + G VKIGD G++ + +
Sbjct: 121 QMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSRDVYSTDYYR 177
Query: 190 VIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQI 238
V G +M PE + + +D++S G+ + E+ T+ + P+ + N+ I
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 35/271 (12%)
Query: 34 IGKGAFKTVYKAFDEVN-GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
IG G F V EVN G A V+ V S ++ + E +SL+H+N+++
Sbjct: 3 IGNGWFGKVI--LGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-----DMKAVKGWARQILSGLIYLHS 147
+ ++ E G L+ Y + +K D ++ A +I GL++LH
Sbjct: 61 LGQCT--EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELYD 203
++ IH DL N + + VKIGD GL+ + + + ++APEL D
Sbjct: 119 NN--FIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 204 ENYNEL--------ADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKV 254
E + L ++++S G+ + E+ PY + + V ++
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235
Query: 255 KDP------EVKSFIEKCLVPASQRLSAKEL 279
K P EV F C + QR SA+E+
Sbjct: 236 KLPLSDRWYEVMQF---CWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERL--YSEVHLLKSLKHNNIIR 91
+G+G+F VY+ + + +V I V ++ ER+ +E ++K ++++R
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVD----------MKAVKGWARQILSG 141
+ Q + +I EL T G L+ Y + + +K + A +I G
Sbjct: 74 LLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP----EFM 197
+ YL+++ +HRDL N + VKIGD G+ + + + G +M
Sbjct: 132 MAYLNANK--FVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 198 APE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
+PE L D + +D++SFG+ + E+ T E PY N Q+ + V G
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-QVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 32/223 (14%)
Query: 28 IRYKEVIGKGAFKTVYKA--FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
+R+ E +G+GAF VYK L ++ P+ + E L+ L+
Sbjct: 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY---RKKHKKVDMKAVKGW-------- 134
H NI+ + + + ++ E G L ++ H V ++
Sbjct: 67 HPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 135 -----ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--- 186
A QI +G+ YL SH +HRDL N + G VKI D GL+ + A+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYYR 181
Query: 187 --AKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTF 225
+KS++ +M PE LY + E +DI+SFG+ + E+ ++
Sbjct: 182 VQSKSLLPV-RWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 13/153 (8%)
Query: 76 SEVHLLKSLKHNNIIRFYNSWIDDQNK-TVNIITELFTSGSLRQYRKKHKKVDMKAVKGW 134
E+ +LK++ H II +++ + K TV ++ + L Y + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAY---RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITI 190
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV---- 190
R++L L YLH IIHRD+K +NIF++ +GD G A ++
Sbjct: 191 QRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGW 247
Query: 191 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEM 222
GT E +PEL + Y DI+S G+ + EM
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 33 VIGKGAFKTVYKAF---DEVNGLE----VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
+G+G F V+ A E G E V Q D+ LQS + R E+ + + L
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRR---ELDMFRKLS 66
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVD---------MKAVKGWAR 136
H N++R + + +I E G L+Q+ + K D K
Sbjct: 67 HKNVVRLLGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM---EQANAKSVIGT 193
QI G+ +L + +HRDL N ++ +Q EVK+ L L+ + E ++ +
Sbjct: 125 QIALGMDHLSNAR--FVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 194 PEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRN 234
++APE + +++++ +D++SFG+ M E+ T E P+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 27/227 (11%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGL--EVAWCQVRIDDV--LQSPEDLERLYSEVHLLKS 83
I +G GAF VY+ G + QV + + S +D E ++
Sbjct: 8 ITLLRALGHGAFGEVYEG--LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-------KVDMKAVKGWAR 136
H NI+R + + I+ EL G L+ + ++++ + MK + AR
Sbjct: 66 FNHQNIVRLIG--VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIMEQA-----NAKS 189
+ G YL + IHRD+ N + G KI D G+A + +A ++
Sbjct: 124 DVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 190 VIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEY-PYSECRN 234
++ ++M PE + + + D++SFG+ + E+ + Y PY N
Sbjct: 182 MLPI-KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 30 YKEVIGKGAFKTVYKAFDEVNGLE-VAWCQVRIDDVLQSP---------EDLER-----L 74
+KE +G+G F V+ E G+E +D P ED +
Sbjct: 9 FKEKLGEGQFGEVHLC--EAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 75 YSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK---------- 124
E+ ++ LK NIIR I + +ITE +G L Q+ +H+
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 125 -KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183
+ + A QI SG+ YL S + +HRDL N + G +KI D G++ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLY 181
Query: 184 QANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF--EYPYSE 231
+ + G +M+ E + + +D+++FG+ + E++T E PYS+
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 45/238 (18%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLE----------------VAWCQVRIDDVLQSPEDL 71
+R KE +G+G F V+ E GL VA +R D + D
Sbjct: 7 LRLKEKLGEGQFGEVHLC--EAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 72 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK------- 124
+ E+ ++ LK+ NIIR + D + +ITE +G L Q+ + +
Sbjct: 65 LK---EIKIMSRLKNPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 125 -----KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179
V + + A QI SG+ YL S + +HRDL N + GN +KI D G++
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV-GNHYTIKIADFGMS 176
Query: 180 TIMEQANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF--EYPYS 230
+ + + G +MA E + + +D+++FG+ + EM T E PYS
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 8/106 (7%)
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
+ + + + V ARQ+LS + Y+H IIHRD+K +N+ +NG + ++ +GD G A
Sbjct: 252 ARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAAC 308
Query: 181 IMEQANAK----SVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 221
+ + + GT + APE L + Y DI+S G+ + E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 66/261 (25%), Positives = 120/261 (45%), Gaps = 32/261 (12%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KH 86
I++++VIG+G F V +A + +GL++ +++ S D E+ +L L H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMN-AAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM---------KAVKGWARQ 137
NII + + + I E G+L + +K + ++ A ++Q
Sbjct: 63 PNIINLLGAC--ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 138 IL-------SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 190
+L +G+ YL + IHRDL N+ + G KI D GL+ E K++
Sbjct: 121 LLQFASDVATGMQYL--SEKQFIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKTM 177
Query: 191 IGTP-EFMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIK 247
P +MA E + + Y +D++SFG+ + E+V+ PY A++Y+K+ G +
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYR 236
Query: 248 PAALSKVK--DPEVKSFIEKC 266
+ K + D EV + +C
Sbjct: 237 ---MEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 19/148 (12%)
Query: 142 LIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ---ANAKSVIGTPEFM 197
++ +HS H +HRD+K DN+ ++ N G +++ D G M Q + +GTP+++
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI 170
Query: 198 APELYDE------NYNELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIK--- 247
+PE+ Y D +S G+CM EM+ E P Y+E + + Y K+ + +
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHEERFQ 228
Query: 248 -PAALSKVKDPEVKSFIEKCLVPASQRL 274
P+ ++ V + E K I++ + +RL
Sbjct: 229 FPSHITDVSE-EAKDLIQRLICSRERRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 16/140 (11%)
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLG-LATIMEQANAKS--VIGTPEFMAPELYDE 204
H +HRD+K DNI ++ N G +++ D G +ME +S +GTP++++PE+
Sbjct: 119 HQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 205 ------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK----PAALSKV 254
Y D +S G+CM EM+ E P+ + + Y K+ + + PA ++ V
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERFQFPAQVTDV 236
Query: 255 KDPEVKSFIEKCLVPASQRL 274
+ + K I + + RL
Sbjct: 237 SE-DAKDLIRRLICSREHRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 31/183 (16%)
Query: 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 168
E+FT R + V+ ++ +I+ L +LH I++RD+K +NI ++ ++
Sbjct: 91 EMFTHLYQRDNFSE------DEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SE 141
Query: 169 GEVKIGDLGLATIM---EQANAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMV 223
G V + D GL+ E+ S GT E+MAPE+ + + D +S G+ + E++
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 224 TFEYPYS---ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELL 280
T P++ E +++ +++ DP SFI P +Q L K L
Sbjct: 202 TGASPFTLEGERNTQSEVSRRILK----------CDPPFPSFIG----PEAQDLLHKLLR 247
Query: 281 MDP 283
DP
Sbjct: 248 KDP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 32 EVIGKGAFKTV----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
+VIG+GAF V +K+ +V +++ + + + +S D + E ++
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLL---SKFEMIKRS--DSAFFWEERDIMAFANSP 103
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
+++ + ++ DD K + ++ E G L + V K K + +++ L +HS
Sbjct: 104 WVVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA---NAKSVIGTPEFMAPELY-- 202
+IHRD+K DN+ ++ G +K+ D G M++ + +GTP++++PE+
Sbjct: 161 MG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 203 ---DENYNELADIYSFGMCMLEMVTFEYPY 229
D Y D +S G+ + EM+ + P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 21/96 (21%)
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI-----------------MEQAN 186
YLH++ I+HRDLK DN+ I + G +K+ D GL+ I +
Sbjct: 116 YLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 187 AKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 221
K V GTPE++APE + + Y + D ++ G+ + E
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 66/262 (25%), Positives = 115/262 (43%), Gaps = 34/262 (12%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KH 86
I++++VIG+G F V KA + +GL + R+ + S +D E+ +L L H
Sbjct: 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHH 67
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM----------------KA 130
NII + + + + E G+L + +K + ++ +
Sbjct: 68 PNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 131 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 190
+ +A + G+ YL IHRDL NI + G KI D GL+ E K++
Sbjct: 126 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTM 182
Query: 191 IGTP-EFMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGI- 246
P +MA E + + Y +D++S+G+ + E+V+ PY A++Y+K+ G
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYR 241
Query: 247 --KPAALSKVKDPEVKSFIEKC 266
KP D EV + +C
Sbjct: 242 LEKPLNC----DDEVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 33/182 (18%)
Query: 77 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW-- 134
EV +L LK NIIR +D+ + +ITE +G L Q+ H +D K G
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSH-HLDDKEENGNDA 125
Query: 135 ------------------ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176
A QI SG+ YL S + +HRDL N + N +KI D
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADF 182
Query: 177 GLATIMEQANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF--EYPY 229
G++ + + + G +MA E + + +D+++FG+ + E++ E PY
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 230 SE 231
E
Sbjct: 243 GE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 57/249 (22%), Positives = 109/249 (43%), Gaps = 37/249 (14%)
Query: 32 EVIGKGAFKTVYKAF---DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
+++G+G F +V + D+ + L+VA +++D S ++E SE +K H N
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS--EIEEFLSEAACMKDFDHPN 62
Query: 89 IIRFYNSWID--DQNKTVN--IITELFTSGSLRQY------RKKHKKVDMKAVKGWARQI 138
+++ + K +I G L + +K+ ++ + + I
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-------AKSVI 191
G+ YL + + IHRDL N + + V + D GL+ + + AK +
Sbjct: 123 ALGMEYLSNRN--FIHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 192 GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPA 249
+++A E L D Y +D+++FG+ M E+ T + PY N +IY + G
Sbjct: 180 ---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-EIYDYLRHG---- 231
Query: 250 ALSKVKDPE 258
+++K PE
Sbjct: 232 --NRLKQPE 238
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 45/137 (32%), Positives = 70/137 (51%), Gaps = 12/137 (8%)
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE-VKIGDLGLA-TIMEQANAKSVIGT- 193
Q+ G+ +L S + +HRDL N+ + QG+ VKI D GLA IM +N S T
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLLA--QGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 194 --PEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPA 249
++MAPE ++D Y L+D++S+G+ + E+ + PY + Y K+ SG + A
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
Query: 250 ALSKVKDPEVKSFIEKC 266
EV + KC
Sbjct: 361 KPDHATQ-EVYDIMVKC 376
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 62/250 (24%), Positives = 114/250 (45%), Gaps = 35/250 (14%)
Query: 34 IGKGAFKTVYKAFDEVNGLE--VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+G G F TV K ++ E VA ++ D+ P + L E ++++ L + I+R
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVR 60
Query: 92 FY-----NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
SW+ ++ EL G L ++ +K+K V K + Q+ G+ YL
Sbjct: 61 MIGICEAESWM--------LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-TIMEQAN---AKSVIGTP-EFMAPEL 201
+ +HRDL N+ + Q KI D GL+ + N AK+ P ++ APE
Sbjct: 113 ETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 202 YD-ENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIK---PAALSKVKD 256
+ ++ +D++SFG+ M E ++ + PY + + ++ + + SG + P
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQMIESGERMECPQRCP---- 224
Query: 257 PEVKSFIEKC 266
PE+ ++ C
Sbjct: 225 PEMYDLMKLC 234
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 40/151 (26%), Positives = 58/151 (38%), Gaps = 19/151 (12%)
Query: 134 WA--RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 191
WA Q L L LH K NI + + G +K+ G +
Sbjct: 20 WAVCLQCLGALRELHRQA--------KSGNILLTWD-GLLKLD--GSVAFKTPEQS---R 65
Query: 192 GTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250
P FMAPE+ +Y E ADIYS G+ + E + +E PY+E R + I + + +G A
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG--MPA 123
Query: 251 LSKVKDPEVKSFIEKCLVPASQRLSAKELLM 281
++ RL A L
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQ 154
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 34 IGKGAFKTVYKAFDEVN-GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
IG G F V E + G+ A V+ +P++ EV + L H N+++
Sbjct: 3 IGNGWFGKVLLG--EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKG----WARQILSGLIYLHS 147
I ++ ++ E G L+ Y R V A K A ++ SGL++LH
Sbjct: 61 LGQCI--ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA------TIMEQANAKSVIGTP-EFMAPE 200
D IH DL N + + VKIGD GLA + +V P ++APE
Sbjct: 119 AD--FIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAV---PLRWLAPE 172
Query: 201 LYDENYNEL--------ADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKV 242
L + +L ++I+S G+ M E+ T + PY + + Q+ K+V
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 37/136 (27%), Positives = 68/136 (50%), Gaps = 18/136 (13%)
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLG-LATIMEQANAKS--VIGTPEFMAPELYDE----- 204
+HRD+K DN+ ++ N G +++ D G ++ +S +GTP++++PE+
Sbjct: 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 205 -NYNELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIK----PAALSKVKDPE 258
Y D +S G+CM EM+ E P Y+E + + Y K+ + + P ++ V + E
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQFPPDVTDVSE-E 239
Query: 259 VKSFIEKCLVPASQRL 274
K I + + RL
Sbjct: 240 AKDLIRRLICSPETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 56/249 (22%), Positives = 97/249 (38%), Gaps = 49/249 (19%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGL-------EVAWCQVRIDDVLQSPEDLERLYSEVHL 80
I Y IG+GAF V++A GL VA ++ + D +R E L
Sbjct: 7 IEYVRDIGQGAFGRVFQA--RAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAAL 61
Query: 81 LKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGW----- 134
+ H NI++ + K + ++ E G L ++ R + +
Sbjct: 62 MAEFDHPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 135 ----------------ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178
A+Q+ +G+ YL + +HRDL N + N VKI D GL
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRNCLVGENM-VVKIADFGL 176
Query: 179 -----ATIMEQANAKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTFEY-PYS 230
+ +A+ I +M PE Y+ Y +D++++G+ + E+ ++ PY
Sbjct: 177 SRNIYSADYYKASENDAIPI-RWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYY 234
Query: 231 ECRNSAQIY 239
+ IY
Sbjct: 235 GMAHEEVIY 243
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 39/233 (16%)
Query: 34 IGKG--AFKTVYKAFDEVNGLEVAWCQVRIDDVLQ-SPEDLERLYSEVHLLKSLKHNNII 90
IG+G +VY A G V VRI D+ + E L+ L +EV L +H NI+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVT---VRITDLENCTEEHLKALQNEVVLSHFFRHPNIM 62
Query: 91 RFYN-----SWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI-- 143
+ SW+ +I+ GS K + M + IL G +
Sbjct: 63 TSWTVFTTGSWL-------WVISPFMAYGSANSLLKTYFPEGMS--EALIGNILFGALRG 113
Query: 144 --YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG--LATIMEQANAKSVIGTPEF--- 196
YLH + IHR++K +I I+G+ G V + L + + AK V P+F
Sbjct: 114 LNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS 170
Query: 197 ----MAPELYDEN---YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242
++PEL ++ YN +DIYS G+ E+ T P+ + + + +K+
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKL 223
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 64/255 (25%), Positives = 111/255 (43%), Gaps = 28/255 (10%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN-NII 90
+VIG+G F V KA + +GL + ++ S +D E+ +L L H+ NII
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM---------KAVKGWARQIL-- 139
+ + + + E G+L + +K + ++ A ++Q+L
Sbjct: 60 NLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 140 -----SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP 194
G+ YL IHRDL NI + N KI D GL+ E K++ P
Sbjct: 118 AADVARGMDYLS--QKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLP 174
Query: 195 -EFMAPELYDEN-YNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAAL 251
+MA E + + Y +D++S+G+ + E+V+ PY A++Y+K+ G +
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLEKP 233
Query: 252 SKVKDPEVKSFIEKC 266
D EV + +C
Sbjct: 234 LNCDD-EVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 36/265 (13%)
Query: 33 VIGKGAFKTVYKAF---DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI 89
++GKG F +V +A ++ + +VA ++ D + S D+E E +K H N+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD--IFSSSDIEEFLREAACMKEFDHPNV 63
Query: 90 IRFYNSWIDDQNK----TVNIITELFTSGSLRQYRKKHK------KVDMKAVKGWARQIL 139
I+ + + K +I G L + + + ++ + + I
Sbjct: 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---AKSVIGTP-E 195
SG+ YL S + IHRDL N +N N V + D GL+ + + P +
Sbjct: 124 SGMEYLSSKN--FIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 196 FMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSK 253
++A E L D Y +D+++FG+ M E++T + PY+ NS +IY + G ++
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-EIYNYLIKG------NR 233
Query: 254 VKDP-----EVKSFIEKCLVPASQR 273
+K P +V + +C P +
Sbjct: 234 LKQPPDCLEDVYELMCQCWSPEPKC 258
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 48/192 (25%), Positives = 92/192 (47%), Gaps = 12/192 (6%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
V+G+GA+ V K + VA + + D ++ E E E+ +L++LK NI+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
++ + + ++ E L + V + V+ + Q++ + + H +D I
Sbjct: 66 KEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--I 121
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ---ANAKSVIGTPEFMAPE-LYDENYNE 208
+HRD+K +N+ I+ N +K+ D G A + + AN + T + +PE L Y +
Sbjct: 122 VHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 209 LADIYSFGMCML 220
D++S G C+L
Sbjct: 181 AVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 52/207 (25%), Positives = 82/207 (39%), Gaps = 56/207 (27%)
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--------------------IMEQAN- 186
H IHRD+K DNI I+ + G +K+ D GL T ME ++
Sbjct: 118 HKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 187 ----------------------------AKSVIGTPEFMAPE-LYDENYNELADIYSFGM 217
A S++GTP ++APE L + Y +L D +S G+
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 218 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSFIEKCLVPASQRL-- 274
+ EM+ + P+ + K ++ +VK PE I K A +RL
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296
Query: 275 -SAKELLMDPFL-QVNGTTKNRPLPLP 299
A ++ PF +V+ ++ R P P
Sbjct: 297 NGADDIKAHPFFSEVDFSSDIRTQPAP 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 34/128 (26%), Positives = 51/128 (39%), Gaps = 47/128 (36%)
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--------------------------- 180
H IHRD+K DNI I+ G +K+ D GL T
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 181 ----------IMEQAN--------AKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLE 221
+E+ A S++GTP ++APE L Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 222 MVTFEYPY 229
M+ + P+
Sbjct: 237 MLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 31/108 (28%), Positives = 56/108 (51%), Gaps = 15/108 (13%)
Query: 134 WAR----QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME---QAN 186
WAR +++ L +HS IHRD+K DN+ ++ + G +K+ D G M+
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVR 199
Query: 187 AKSVIGTPEFMAPEL-----YDENYNELADIYSFGMCMLEMVTFEYPY 229
+ +GTP++++PE+ D Y D +S G+ + EM+ + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 134 WAR----QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ---AN 186
WAR +++ L +HS IHRD+K DN+ ++ G +K+ D G M +
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVR 199
Query: 187 AKSVIGTPEFMAPELY-----DENYNELADIYSFGMCMLEMVTFEYPY 229
+ +GTP++++PE+ D Y D +S G+ + EM+ + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 18/181 (9%)
Query: 76 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGW 134
+E L H+NI+R + + T+ I+TE ++G+L + +KH+ ++ + G
Sbjct: 55 AEALTLGQFDHSNIVRLEG--VITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG------LATIMEQANAK 188
+ SG+ YL +H+ L + +N + KI I + K
Sbjct: 113 LPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLV-CKISGFRRLQEDKSEAIYTTMSGK 169
Query: 189 SVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGI 246
S + + APE + +++ +D++SFG+ M E++++ E PY + + K V G
Sbjct: 170 SPV---LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DVIKAVEDGF 225
Query: 247 K 247
+
Sbjct: 226 R 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 49/228 (21%), Positives = 99/228 (43%), Gaps = 44/228 (19%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+++GKG V+ + G A +V + ++R+ +E +L +L H +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFA-LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 92 FYNSWIDDQNKTVNIITELFTSG----SLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
Y S+ + ++ + + G L Q R+ K + + + +A ++L L YLH
Sbjct: 66 LYASF--QTETYLCLVMD-YCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA---------------------------- 179
I++RDLK +NI ++ + G + + D L+
Sbjct: 122 LG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 180 -TIMEQANAK--SVIGTPEFMAPELYDENYNELA-DIYSFGMCMLEMV 223
T E+ + + S +GT E++APE+ + + A D ++ G+ + EM+
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 54/217 (24%), Positives = 75/217 (34%), Gaps = 57/217 (26%)
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME---QANAKSVIG 192
RQIL L LHS I+HRD+K NI + G KI DLG A + K +
Sbjct: 262 RQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL 319
Query: 193 TPEFMAPE-----------------------LYDENYNELADIYSFGMCMLEM------- 222
P + APE L+ N + DIYS G+ L+M
Sbjct: 320 DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRS 379
Query: 223 ----VTFEYPYSECRNSAQIYKKVSSGIKPAALSK---VKDPE-------VKSFIEKCLV 268
+ F ++K+ L + V D + +KS +
Sbjct: 380 DSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF--- 436
Query: 269 PASQRLSAKELLMDPFLQVNG-----TTKNRPLPLPD 300
QR+SAK L P+ G +N L L
Sbjct: 437 KGRQRISAKAALAHPYFDREGLLGLSVMQNLRLQLFR 473
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 26/60 (43%), Positives = 36/60 (60%), Gaps = 5/60 (8%)
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAP 199
L YLH H IIHRDLK DN+ I+ N+G +K+ D GL+ T+ + N ++ TP P
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 57/243 (23%), Positives = 105/243 (43%), Gaps = 43/243 (17%)
Query: 34 IGKGAF----KTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI 89
+G G F K VYK ++VA +++ + + E ++ L + I
Sbjct: 3 LGSGNFGCVKKGVYKM--RKKQIDVA---IKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHSH 148
+R + + + ++ E+ + G L ++ K ++ + V Q+ G+ YL
Sbjct: 58 VRMIGVC---EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTP-EFMAPE-LY 202
+ +HRDL N+ + NQ KI D GL+ + + A+S P ++ APE +
Sbjct: 115 N--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262
++ +D++S+G+ M E ++ G KP K+K PEV SF
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSY-------------------GQKP--YKKMKGPEVMSF 210
Query: 263 IEK 265
IE+
Sbjct: 211 IEQ 213
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 38/139 (27%), Positives = 70/139 (50%), Gaps = 16/139 (11%)
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-------TIMEQANAKS 189
Q+ G+ +L S IHRDL NI ++ N VKI D GLA + + +A+
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 190 VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIK 247
+ ++MAPE ++D+ Y +D++SFG+ + E+ + PY + + + +++ G +
Sbjct: 239 PL---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295
Query: 248 PAALSKVKDPEVKSFIEKC 266
A + PE+ + C
Sbjct: 296 MRA-PENATPEIYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 25/60 (41%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 123 HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182
K D+ +KG RQ+L+GL LH I+HRD+K +N+ + + G+VKI D G A M
Sbjct: 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 55/255 (21%), Positives = 97/255 (38%), Gaps = 57/255 (22%)
Query: 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL 84
+++ K +G GAF V A A +R DVL + + + +E +L
Sbjct: 1 SMFVKIK-TLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQ-VAHVKAERDILAEA 58
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
+ ++R Y S+ D N + + + G + + + + ++ +
Sbjct: 59 DNEWVVRLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVES 116
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT--------------------IMEQ 184
+H IHRD+K DNI I+ G +K+ D GL T M+
Sbjct: 117 VHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 185 AN-----------------------------AKSVIGTPEFMAPE-LYDENYNELADIYS 214
+N A S++GTP ++APE L Y +L D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 215 FGMCMLEMVTFEYPY 229
G+ + EM+ + P+
Sbjct: 234 VGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 17/103 (16%)
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-------TIMEQANAKS 189
Q+ G+ +L S IHRDL NI ++ N VKI D GLA + + +A+
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 190 VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF---EYP 228
+ ++MAPE ++D+ Y +D++SFG+ + E+ + YP
Sbjct: 238 PL---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 24/232 (10%)
Query: 32 EVIGKGAFKTVYKAF--DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI 89
+ +G+G F +V + + + L+VA ++I +S ++E SE +K H N+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--EMEDFLSEAVCMKEFDHPNV 62
Query: 90 IRFYNSWIDDQNK----TVNIITELFTSGSLRQYRKKHKKVDM------KAVKGWARQIL 139
+R + + +I G L + + D + + + I
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---AKSVIGTP-E 195
SG+ YL S IHRDL N +N N V + D GL+ + + + P +
Sbjct: 123 SGMEYLSSKS--FIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 196 FMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
++A E L D Y +D++SFG+ M E+ T + PY NS +IY + G
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-EIYDYLRQG 230
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 48/195 (24%), Positives = 77/195 (39%), Gaps = 63/195 (32%)
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-------------IMEQANAK------ 188
H IHRD+K DNI I+ G +K+ D GL+T +++ + K
Sbjct: 118 HKLGFIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 189 ------------------------------SVIGTPEFMAPELY-DENYNELADIYSFGM 217
S +GTP+++APE++ + Y + D +S G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236
Query: 218 CMLEMVTFEYPY-SECRNSAQIYKKVSSGIKPAALSKVKD----PEVKSFIEKCLVPASQ 272
M E + P+ SE NS + Y+K+ + + L D E + I + + A
Sbjct: 237 IMFECLIGWPPFCSE--NSHETYRKIINWRE--TLYFPDDIHLSVEAEDLIRRLITNAEN 292
Query: 273 RL---SAKELLMDPF 284
RL A E+ PF
Sbjct: 293 RLGRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-------TIMEQANAKS 189
Q+ G+ +L S IHRDL NI ++ N VKI D GLA + + +A+
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 190 VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIK 247
+ ++MAPE ++D Y +D++SFG+ + E+ + PY + + +++ G +
Sbjct: 244 PL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 300
Query: 248 PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL--MDPFLQVN 288
A PE+ + C SQR + EL+ + LQ N
Sbjct: 301 MRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 35/129 (27%), Positives = 65/129 (50%), Gaps = 11/129 (8%)
Query: 126 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV-KIGDLGLATIMEQ 184
+D + + ++ Q+ G+ +L S + IHRDL NI + G + KI D GLA +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRN 266
Query: 185 ANAKSVIGTP----EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQI 238
+ V G ++MAPE +++ Y +D++S+G+ + E+ + PY ++
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 239 YKKVSSGIK 247
YK + G +
Sbjct: 327 YKMIKEGYR 335
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 23/215 (10%)
Query: 33 VIGKG--AFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
VIG+G TV A + G V RI+ + E + L E+H+ K H NI+
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYV--TVRRINLEACTNEMVTFLQGELHVSKLFNHPNIV 62
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK--AVKGWARQILSGLIYLHSH 148
+ ++I D V +T GS + H M A+ + +L L Y+H
Sbjct: 63 PYRATFIADNELWV--VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDL--GLATIMEQANAKSVIGTPEF-------MAP 199
+HR +K +I I+ + G+V + L L+ I + V P++ ++P
Sbjct: 121 G--YVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177
Query: 200 ELYDEN---YNELADIYSFGMCMLEMVTFEYPYSE 231
E+ +N Y+ +DIYS G+ E+ P+ +
Sbjct: 178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 670 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.64 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.61 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.44 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.29 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.22 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.03 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.92 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.89 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.85 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.85 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.68 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.61 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.59 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.55 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.45 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.42 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.4 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.31 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.3 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.28 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.27 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.71 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.6 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.48 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.35 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.27 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.99 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.89 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.81 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.78 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.59 | |
| PLN02236 | 344 | choline kinase | 95.59 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.11 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 94.8 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.77 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.34 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.32 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.13 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.01 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.27 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 89.43 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 89.21 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.83 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 87.46 | |
| PTZ00296 | 442 | choline kinase; Provisional | 87.1 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 86.22 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-90 Score=759.71 Aligned_cols=454 Identities=58% Similarity=0.929 Sum_probs=388.4
Q ss_pred cCCCCCCCCCCCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC
Q 005916 7 GAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86 (670)
Q Consensus 7 ~~~~~~~~~~~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H 86 (670)
..+..++....+++++|+|||.++..+||+|+|.+||+|+|..+|.+|||..++..++.+++..+++|+.|+++|+.|+|
T Consensus 21 ~~~~~e~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H 100 (632)
T KOG0584|consen 21 QESESEPDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKH 100 (632)
T ss_pred hhhhhccccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCC
Confidence 33444567889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC
Q 005916 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166 (670)
Q Consensus 87 pNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~ 166 (670)
||||+||.+|++..++++.+|+|+|++|+|+.|++++++++.+.++.|++|||.||.|||++.||||||||||+||||++
T Consensus 101 ~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG 180 (632)
T KOG0584|consen 101 PNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG 180 (632)
T ss_pred CceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccchhhhcccccccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC
Q 005916 167 NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI 246 (670)
Q Consensus 167 ~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~ 246 (670)
+.|.|||||+|||+.++...+.+++|||.|||||++.+.|++.+||||||||++||+|+.+||++|.++++||++|.+|+
T Consensus 181 ~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi 260 (632)
T KOG0584|consen 181 NLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI 260 (632)
T ss_pred CcCceeecchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccCCCChHHHHHHHHcCCCCCCCCCHHHHhcCccccccCCCCCCCCCCCCCcCCCcc-cccccccccCCCCcccCC
Q 005916 247 KPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVG-AFGDRCLMSEGPASVRNK 325 (670)
Q Consensus 247 ~p~~~~~~~s~~~k~fI~kcL~dP~~RpSa~elL~hpf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~e~~~~~~~~ 325 (670)
+|..+.++.+|++++||++||...+.|+||.|||.||||..++... ...+.+....+.+. .+...+.....+......
T Consensus 261 KP~sl~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~-~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i 339 (632)
T KOG0584|consen 261 KPAALSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIV-ELAPEDDMSDPALSLSLRDEDGKKNKRPKANAI 339 (632)
T ss_pred CHHHhhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccccc-cccchhhcccccccccccccchhhcCCcccccc
Confidence 9999999999999999999998899999999999999999886653 44333333333333 222222222221211111
Q ss_pred CCCCCCCCCCCCccccccCCCCCCCCCCCchhhhhcccCccccccCCCCCcc-chhhhheeecCCCceeeeecccccCCC
Q 005916 326 HPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKGESNDEY-SVSLILRIADQSGRLRNIHFLFYLDSD 404 (670)
Q Consensus 326 ~~~~d~d~d~~~~~~~~~~~~~~~~~~~~~i~~~~l~~~~~~~~~g~~~~~~-~I~liLri~D~~g~i~~ieF~f~~d~D 404 (670)
...++.+.|...++..+.... .......+.++.++.....+.++|+..++. .+++.|||+|.+|+.++++|+|++..|
T Consensus 340 ~~~~~~~~D~~e~v~~em~~~-~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~d 418 (632)
T KOG0584|consen 340 QFDYNLNTDESEEVAQEMVEE-EIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGD 418 (632)
T ss_pred cceeecCCCchhHHHHHHHHh-ccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCc
Confidence 122233333222211111111 001223457788888888899999998877 999999999999999999999999999
Q ss_pred CcCcchHHHHhcccccccChHHHHHHHHHHHHHhCCCCCCCccccccccCCCCCCCcc
Q 005916 405 TAFSVSSEMVEQLELADQNVTFIAELIDLLLLNLIPGWKPCVRIDHLIPQKSRRQSPE 462 (670)
Q Consensus 405 ta~~Ia~EmV~~l~l~~~d~~~iA~~Id~~i~~l~p~w~~~~~~~~~~~~~~~~~~~~ 462 (670)
||..||.|||++|+++++++..||+|||++|..|+|.|+.....++.+...-...+.+
T Consensus 419 ta~~Va~eMv~el~~~dq~v~~ia~mid~~i~~L~p~~~~~~~~~~s~~~~~~~~~~s 476 (632)
T KOG0584|consen 419 TAPSVAHEMVEELEITDQPVVNIAEMIDGEISALVPNWKASTPNDESPHEQHTDNSVS 476 (632)
T ss_pred chhHHHHHHHhhcCCcccchhhHHHHHhchhhhcCCccCCCCCccccchhccCccccc
Confidence 9999999999999999999999999999999999999999876666555544444433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-55 Score=458.42 Aligned_cols=264 Identities=26% Similarity=0.376 Sum_probs=230.7
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCH---HHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP---EDLERLYSEVHLLKSLKHNNIIRFYNSWI 97 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~---~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~ 97 (670)
.....++|.+.+.||+|+||.|-+|+.+.+|+.||+|++.+....... .....+.+|+++|++|+|||||+++++|.
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 334678899999999999999999999999999999999876543321 23344689999999999999999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--CCcEEEee
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGD 175 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~g~vKL~D 175 (670)
.+. +.||||||+.||+|++++..++.+.+...+.+++|++.||.|||++| |+||||||+|||+..+ +..+||+|
T Consensus 247 ~~d--s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 247 VPD--SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred cCC--ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecc
Confidence 665 68999999999999999999999999999999999999999999999 9999999999999832 36799999
Q ss_pred ccchhhhccc-ccccccCCCccCCCccccC----CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc
Q 005916 176 LGLATIMEQA-NAKSVIGTPEFMAPELYDE----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 176 FGla~~~~~~-~~~~~~GTp~YmAPEvl~~----~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~ 250 (670)
||+|+..... ..++.||||.|.|||++.. .|..++|||||||+||.+++|.+||++......+.+.|..|..+..
T Consensus 323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 9999998764 3689999999999998843 3556899999999999999999999987666668889999885432
Q ss_pred --ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 251 --LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 251 --~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+...+.++++||.+||+ ||++|||+.|+|+||||+..
T Consensus 403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 344568999999999995 99999999999999999843
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-53 Score=461.96 Aligned_cols=263 Identities=35% Similarity=0.536 Sum_probs=238.2
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
.-.-+|+...+|..++.||+|||++||.+++..+|..||+|+|.++. +..+...+++.+||+|.++|+|||||+||++|
T Consensus 9 p~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~-l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 9 PEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKL-LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred CCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHH-hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence 33447778899999999999999999999999999999999998644 44567889999999999999999999999999
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
+|.. ++|||.|+|..|+|..++++.+.++|.+++.+++||+.||.|||+++ |||||||..|+|++ .+.+|||+||
T Consensus 88 EDs~--nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~-~~~~VKIgDF 162 (592)
T KOG0575|consen 88 EDSN--NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLN-ENMNVKIGDF 162 (592)
T ss_pred ecCC--ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeec-CcCcEEeccc
Confidence 8766 79999999999999999999999999999999999999999999999 99999999999999 5579999999
Q ss_pred cchhhhccc--ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 177 GLATIMEQA--NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 177 Gla~~~~~~--~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
|||+.+... ...+.||||.|+|||++ ..+++..+||||+||+||.||+|++||.. .+...+|.+|.... ..++.
T Consensus 163 GLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~--Y~~P~ 239 (592)
T KOG0575|consen 163 GLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNE--YSMPS 239 (592)
T ss_pred ceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcC--ccccc
Confidence 999998743 45789999999999977 46799999999999999999999999987 77889999998764 34455
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+.++++||.++|. +|.+|||++++|.|+||...
T Consensus 240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 788999999999996 79999999999999999544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-52 Score=433.34 Aligned_cols=255 Identities=31% Similarity=0.513 Sum_probs=231.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
..+....||+|+.|+||+|+|+.+++.+|+|.|... ..++...++.+|+++++.++||+||++|+.|..+.. .++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 466678999999999999999999999999999543 347778899999999999999999999999988764 6999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||.||+|.++++..++++|..+..++.+|+.||.|||. ++ ||||||||+|||++ ..|+|||||||.+..+...
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeec-cCCCEEeccccccHHhhhh
Confidence 99999999999999999999999999999999999999995 77 99999999999999 6799999999999999888
Q ss_pred ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCC----CCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 186 NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC----RNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 186 ~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~----~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
.+.+++||..|||||.+. +.|+.++||||||+.++||++|++||... .+...++..|..+..|.......+++++
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~ 312 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFR 312 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence 889999999999999775 57999999999999999999999999763 4677788888887655544446899999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+||..||. +|++|+|+.|||+|||++..
T Consensus 313 ~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 313 SFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 99999997 79999999999999999854
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=429.16 Aligned_cols=277 Identities=26% Similarity=0.431 Sum_probs=243.2
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
-..|.+.++||+|+||+||.++.+.+|+.||+|+++++.... ....+....|..+|..++||.||+++-+|++.. .+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~--kL 100 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE--KL 100 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--eE
Confidence 456999999999999999999999999999999999776654 366788999999999999999999999998765 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|||+||+.||+|+..+++.+.++|..++.|+..|+.||.|||++| ||||||||+|||++ .+|+|+|+||||++..-.
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhccc
Confidence 999999999999999999999999999999999999999999999 99999999999999 789999999999986533
Q ss_pred c--ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 185 A--NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 185 ~--~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
. .+.++|||+.|||||++ ..+|+..+|+||||+++|+|++|.+||.+ .+...++++|..+..+ ..+...++++++
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~-~~p~~ls~~ard 255 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLP-LPPGYLSEEARD 255 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCC-CCCccCCHHHHH
Confidence 2 46778999999999965 67899999999999999999999999987 7888999999887632 345567899999
Q ss_pred HHHHcCC-CCCCCC----CHHHHhcCccccccCCCCCCCCCCCCCcCCCcccc
Q 005916 262 FIEKCLV-PASQRL----SAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAF 309 (670)
Q Consensus 262 fI~kcL~-dP~~Rp----Sa~elL~hpf~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (670)
||+++|. +|.+|+ .+.++-.||||....|.......+.++..|.....
T Consensus 256 ll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~ 308 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGL 308 (357)
T ss_pred HHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCc
Confidence 9999996 899996 68999999999988776543333444555655443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-50 Score=405.42 Aligned_cols=257 Identities=25% Similarity=0.454 Sum_probs=233.7
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|.+.+.||.|+||.|.+++++.+|..||+|++.+.++.. -.+++...+|..+|+.+.||.+++++++|.|.. ++|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~--~ly 120 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS--NLY 120 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeeccCC--eEE
Confidence 35888999999999999999999999999999998776543 567888999999999999999999999998765 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||+.||.|+.++++.+++++..++.++.||+.||+|||+++ |++|||||+|||++ .+|.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCc
Confidence 99999999999999999999999999999999999999999999 99999999999999 7799999999999987654
Q ss_pred ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 186 NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 186 ~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
+.+.||||.|+|||++ ..+|+.++|+|+|||++|||+.|.+||.. .++.++|.+|..+.. .++...++++++||.
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLK 273 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHH
Confidence 7789999999999966 57899999999999999999999999988 677999999999864 456778899999999
Q ss_pred HcCC-CCCCCC-----CHHHHhcCccccccCCCC
Q 005916 265 KCLV-PASQRL-----SAKELLMDPFLQVNGTTK 292 (670)
Q Consensus 265 kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~~~ 292 (670)
++|+ |-.+|. ...++..||||+...|..
T Consensus 274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred HHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 9995 777884 678999999999776644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=416.09 Aligned_cols=256 Identities=28% Similarity=0.501 Sum_probs=226.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|.+.+.||+|+||+||+|+++.++..||||.|.++.+ .++.++.+..|+.+|+.|+|||||++++++.+.+ ++|
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~--~i~ 85 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD--FIY 85 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC--eEE
Confidence 347788889999999999999999999999999987654 4778889999999999999999999999887665 899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--C---CcEEEeeccchh
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--Q---GEVKIGDLGLAT 180 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~---g~vKL~DFGla~ 180 (670)
||||||.||+|.+|+++++.+++..++.++.||+.||++||+++ ||||||||+|||++.. . -.+||+|||+|+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999999999999999999999999999999 9999999999999843 1 358999999999
Q ss_pred hhcccc-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC-CCcccCCCCh
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKDP 257 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~-p~~~~~~~s~ 257 (670)
.+.... ..+.+|+|.|||||++ .++|+.|+|+||+|+|+|+|++|++||.. .+..+++..+..+.. ...++...+.
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhccC
Confidence 998754 5789999999999987 78999999999999999999999999987 567777777776653 3344555667
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...+++...|. +|..|.+..+-+.|+++...
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 77788888775 79999999999999999754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=422.70 Aligned_cols=259 Identities=29% Similarity=0.522 Sum_probs=226.6
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCH-HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP-EDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQ 100 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~-~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~ 100 (670)
...+.|++++.||+|+||+|++|.+..+|..||+|++..+...... ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456799999999999999999999999999999977654332122 34567779999999998 999999999987665
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+|||||.||+|++++..++++.|..++.+++||+.||+|||++| |+||||||+|||++.+.+.+||+|||++.
T Consensus 94 --~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 --KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred --eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 59999999999999999999999999999999999999999999999 99999999999999554899999999999
Q ss_pred hhc--ccccccccCCCccCCCccccC-C-CC-ccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCC
Q 005916 181 IME--QANAKSVIGTPEFMAPELYDE-N-YN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 181 ~~~--~~~~~~~~GTp~YmAPEvl~~-~-ys-~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
... .....+.+|||.|+|||++.+ . |+ .++||||+||+||.|++|..||.. .+...++.+|..+... ++...
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~--~p~~~ 246 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFK--IPSYL 246 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCcc--CCCCc
Confidence 883 345789999999999998865 4 64 789999999999999999999988 6777778888887543 34444
Q ss_pred -ChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 256 -DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 256 -s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++++++||.+||+ +|.+|+|+.+++.||||+..
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 8999999999996 89999999999999999964
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=427.15 Aligned_cols=260 Identities=27% Similarity=0.457 Sum_probs=231.7
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~ 102 (670)
+-..|.+++.||.|+|++|++|+++.++++||||++.++-+ .....+..+.+|-.+|..| .||.||+||-.|.|+.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I-ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-- 147 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI-IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-- 147 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH-HhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--
Confidence 44569999999999999999999999999999999985433 3345567788899999999 9999999999999877
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.+|+|+||+.+|+|.+++++.+.|++..++.++.||+.||+|||++| ||||||||+||||+ .+|++||+|||.|+.+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd-~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLD-KDGHIKITDFGSAKIL 224 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEc-CCCcEEEeeccccccC
Confidence 59999999999999999999999999999999999999999999999 99999999999999 6799999999999987
Q ss_pred cccc---------------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC
Q 005916 183 EQAN---------------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI 246 (670)
Q Consensus 183 ~~~~---------------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~ 246 (670)
.... ..+++||..|++||++. +..+..+|||+||||+|.|+.|.+||.+ .+.-.++++|+.-.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQALD 303 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHhc
Confidence 4321 14589999999999885 4578999999999999999999999988 78888999998754
Q ss_pred CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCCCC
Q 005916 247 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTK 292 (670)
Q Consensus 247 ~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~~~ 292 (670)
..++...++.+++||+++|+ +|++|+|+.+|..||||....|..
T Consensus 304 --y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 304 --YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred --ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 44566677999999999997 899999999999999998776654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=418.48 Aligned_cols=281 Identities=25% Similarity=0.401 Sum_probs=241.4
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
..+.|.++++||+|+||.||+|+.+.||..||+|++++.... ...+++.++.|-.+|...++|+||++|-+|.|.. +
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~--~ 215 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE--Y 215 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC--e
Confidence 455688999999999999999999999999999999976544 4678899999999999999999999999998766 8
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+||||||++||++..++.+.+.+++..++.|+.+++.|++-||.+| +|||||||+|+||+ ..|++||+||||++-+.
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLD 292 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhh
Confidence 9999999999999999999999999999999999999999999999 99999999999999 78999999999985331
Q ss_pred c-------------------------c-----c-------------------cccccCCCccCCCccc-cCCCCccceee
Q 005916 184 Q-------------------------A-----N-------------------AKSVIGTPEFMAPELY-DENYNELADIY 213 (670)
Q Consensus 184 ~-------------------------~-----~-------------------~~~~~GTp~YmAPEvl-~~~ys~~~DIW 213 (670)
. . . +.+.+|||.|||||++ ..+|+..||+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 0 0 0 1146899999999976 56799999999
Q ss_pred eccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCCChHHHHHHHHcCCCCCCCC---CHHHHhcCcccccc
Q 005916 214 SFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIEKCLVPASQRL---SAKELLMDPFLQVN 288 (670)
Q Consensus 214 SLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~s~~~k~fI~kcL~dP~~Rp---Sa~elL~hpf~~~~ 288 (670)
|||||+||||.|.+||.+ .++.+.+++|..... ..+-....++++++||.+||.+|.+|+ +++|+-.||||+..
T Consensus 373 SLG~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccC
Confidence 999999999999999988 788999999987652 222233457999999999999999998 59999999999988
Q ss_pred CCCCCCCCCCCCCcCCCcccccccc
Q 005916 289 GTTKNRPLPLPDIVLPRVGAFGDRC 313 (670)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (670)
.|......+ ++.+|.+....+..
T Consensus 452 ~W~~l~~~~--apfvP~v~~~~DT~ 474 (550)
T KOG0605|consen 452 DWDHLREMP--APFVPQVNSELDTQ 474 (550)
T ss_pred CcchhhcCC--CCCCCCCCCccccc
Confidence 876655433 44667666554443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-50 Score=403.33 Aligned_cols=252 Identities=31% Similarity=0.522 Sum_probs=223.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.++||+|+||+||++.+..+|..+|+|.+..... +....+.+..|+.+|++|+|||||++|+.-+.+++..++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 348899999999999999999999999999999985432 456778899999999999999999999955555666799
Q ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCC--eeeecCccccEEEeCCCCcEEEeeccch
Q 005916 106 IITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPP--IIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~--IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
||||||.+|+|.+.++. ++.++|+.++.++.|++.||..||+.-+. |+||||||.|||++ ..|.|||+||||+
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhH
Confidence 99999999999998764 46799999999999999999999995444 99999999999999 6789999999999
Q ss_pred hhhcccc--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 180 TIMEQAN--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 180 ~~~~~~~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
+.+.... +.+.+|||+||+||++ ..+|+.++||||+||++|||+...+||.+ .+-.++.++|.+|..|..+...++
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS 254 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYS 254 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhh
Confidence 9997654 6789999999999965 67899999999999999999999999998 588899999999987776668889
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
..+..+|..|+. +|..||+. +|+++
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t-----~~~v~ 280 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDT-----VPYVQ 280 (375)
T ss_pred hHHHHHHHHHccCCcccCCCc-----chHHH
Confidence 999999999995 89999986 55554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=407.09 Aligned_cols=257 Identities=35% Similarity=0.558 Sum_probs=220.3
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...+...+.||+|+||+||++.+..+|..+|+|.+.... +.. .+.+.+|+.+|++|+|||||++|+.........+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 455888999999999999999999999999999998652 222 6778999999999999999999996433322479
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+++|||+.+|+|.+++++.+ .+++..++.+.+||+.||.|||++| ||||||||+|||++..+|.+||+|||++....
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999999999987 7999999999999999999999998 99999999999999436899999999998876
Q ss_pred c-----cccccccCCCccCCCccccCCCC--ccceeeeccchhhhhhhccCCCCC-CCCHHHHHHHHhcCCCCCcccCCC
Q 005916 184 Q-----ANAKSVIGTPEFMAPELYDENYN--ELADIYSFGMCMLEMVTFEYPYSE-CRNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 184 ~-----~~~~~~~GTp~YmAPEvl~~~ys--~~~DIWSLGvilyeLltG~~Pf~~-~~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
. .....+.|||.|||||++...+. .++|||||||++.||+||.+||.. ......++........| .++...
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~l 248 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSL 248 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCccc
Confidence 3 12356899999999998875443 499999999999999999999987 34445555555555444 677778
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++++++||.+|+. +|.+||||.+||.|||++..
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 9999999999996 89999999999999999754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=425.21 Aligned_cols=261 Identities=25% Similarity=0.457 Sum_probs=233.1
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
.+.+..-|++++.||+|+.|.|.+|++..||+..|||+|.+... .+......+.+|+-||+-|.||||+++|++|.+..
T Consensus 7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccc-cccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 34455669999999999999999999999999999999986532 33455677889999999999999999999996544
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
++|+|.||+.||.|++|+.++|++++.+++++++||+.||.|||..+ |+||||||+|+|++. .+.|||+|||+|.
T Consensus 86 --~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~-~~nIKIADFGMAs 160 (786)
T KOG0588|consen 86 --HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDV-KNNIKIADFGMAS 160 (786)
T ss_pred --eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhc-ccCEeeeccceee
Confidence 89999999999999999999999999999999999999999999999 999999999999994 4569999999998
Q ss_pred hhcccc-cccccCCCccCCCcccc-CCC-CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELYD-ENY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl~-~~y-s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
.-..+. ..+.||+|.|.|||++. ..| +.++||||+|||||.||||.+||.+ .|...++.+|..|.+. ++..+++
T Consensus 161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~ 237 (786)
T KOG0588|consen 161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISS 237 (786)
T ss_pred cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCH
Confidence 766554 58899999999999764 456 5789999999999999999999986 8899999999999753 4577899
Q ss_pred HHHHHHHHcC-CCCCCCCCHHHHhcCccccccCC
Q 005916 258 EVKSFIEKCL-VPASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 258 ~~k~fI~kcL-~dP~~RpSa~elL~hpf~~~~~~ 290 (670)
++++||.+|| +||++|+|.+++++|||++....
T Consensus 238 eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 238 EAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 9999999999 59999999999999999986544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=396.87 Aligned_cols=266 Identities=27% Similarity=0.422 Sum_probs=230.5
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
...+--+....|.+.++||.|..++||+|++..++..||||++.+.+. ...++.+.+|++.|+.++||||+++|.+|
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc---~~~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC---NNDLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh---hhhHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 334445667789999999999999999999999999999999998875 34488999999999999999999999999
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
+... .+|+||.||.+|++.+.++.. ..++|..++.+++++|.||.|||.+| .||||||+.||||+ .+|.|||+
T Consensus 94 vv~~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLa 168 (516)
T KOG0582|consen 94 VVDS--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLA 168 (516)
T ss_pred Eecc--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEc
Confidence 8876 799999999999999998875 45999999999999999999999999 99999999999998 78999999
Q ss_pred eccchhhhcccc------cccccCCCccCCCccc-c--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC
Q 005916 175 DLGLATIMEQAN------AKSVIGTPEFMAPELY-D--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 245 (670)
Q Consensus 175 DFGla~~~~~~~------~~~~~GTp~YmAPEvl-~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g 245 (670)
|||.+..+.... .++++|||+|||||++ + .+|+.|+||||||+++.||.+|..||........+..++...
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~ 248 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND 248 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 999877664322 2677999999999985 3 479999999999999999999999999977777777766554
Q ss_pred CC-------CCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCC
Q 005916 246 IK-------PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 246 ~~-------p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~ 290 (670)
.. +....+..+..++.||..||+ ||.+||||.+||+|+||+....
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 32 222334456789999999997 8999999999999999986543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=414.57 Aligned_cols=256 Identities=33% Similarity=0.559 Sum_probs=227.3
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
.||..+ |.-.+.||+|+.|.||.|....++..||+|++.+... ...+-+.+|+.+|+.++|+|||.++++|...+
T Consensus 269 ~dP~~~-y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 269 GDPRSK-YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred CChhhh-hcchhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 455544 4555699999999999999999999999999987652 23567899999999999999999999998764
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+++||||++||+|.+.+... .++|.+++.+|+.++.||+|||.++ |||||||.+|||+. .+|.+||+|||++.
T Consensus 344 --eLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFca 417 (550)
T KOG0578|consen 344 --ELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCA 417 (550)
T ss_pred --eeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeee
Confidence 699999999999999987664 4999999999999999999999999 99999999999998 77899999999998
Q ss_pred hhccc--ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 181 IMEQA--NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 181 ~~~~~--~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
.+... +..+.+|||+|||||++. ..|++++||||||++++||+-|++||........+|..-..|......+...++
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~ 497 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSP 497 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCH
Confidence 87653 467899999999999875 579999999999999999999999998756666777777788777777888899
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
++++|+.+||+ |+.+|++|.+||+||||+.
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 99999999995 9999999999999999964
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=404.90 Aligned_cols=264 Identities=27% Similarity=0.462 Sum_probs=230.9
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQ 100 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~ 100 (670)
.....+|.+.+.||+|.||+||+|+++.+|..+|+|.+.+..... ....+.+.+|+.+|++|. |||||.++++|.+..
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 334567999999999999999999999999999999998765433 345678899999999997 999999999998766
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC---CCcEEEeecc
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN---QGEVKIGDLG 177 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~---~g~vKL~DFG 177 (670)
.+|+|||+|.||+|++++.+. .+++..+..+++||+.|+.|||+.| |+||||||+|+|+... .+.+|++|||
T Consensus 110 --~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 110 --SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred --eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 799999999999999998887 5999999999999999999999998 9999999999999743 3579999999
Q ss_pred chhhhccc-ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccC
Q 005916 178 LATIMEQA-NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSK 253 (670)
Q Consensus 178 la~~~~~~-~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~ 253 (670)
++...... .....+|||+|+|||++. ..|+..+||||+||++|.|++|.+||.+ .+...++..|..+.. +.....
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~ 263 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWD 263 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCcc
Confidence 99988763 467899999999999887 7899999999999999999999999988 556666667877764 333444
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCCCC
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTK 292 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~~~ 292 (670)
..+..+++||.+||. ||.+|+||.++|+|||++......
T Consensus 264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 264 DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 568999999999996 899999999999999998664443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=416.88 Aligned_cols=279 Identities=23% Similarity=0.397 Sum_probs=242.5
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~ 102 (670)
.-..|++.++||+|+||+|++|..+.+++.||||++++..++. .++++.++.|.+|+... +||.++.+|.+|+...
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~-- 442 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE-- 442 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccCC--
Confidence 3457999999999999999999999999999999999877765 56788899999999988 6999999999997665
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
++|+||||+.||++. .+.+.+.|++..++.|+..|+.||.|||.+| |||||||.+||||| ..|++||+|||+++.-
T Consensus 443 ~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEG 518 (694)
T ss_pred eEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEeccccccccc
Confidence 799999999999944 3445578999999999999999999999999 99999999999999 7799999999999864
Q ss_pred c--ccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 183 E--QANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 183 ~--~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
- ...+.+++|||.|||||++ ++.|+.++|+|||||+|||||.|+.||.+ .+.++++..|.... ..++...+.++
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~--~~yP~~ls~ea 595 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDE--VRYPRFLSKEA 595 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCC--CCCCCcccHHH
Confidence 3 2346889999999999987 56799999999999999999999999998 78889999888753 34566778999
Q ss_pred HHHHHHcCC-CCCCCCC-----HHHHhcCccccccCCCCCCCCCCCCCcCCCccccccc
Q 005916 260 KSFIEKCLV-PASQRLS-----AKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDR 312 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpS-----a~elL~hpf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (670)
.++++++|. +|.+|+. +.++..||||+...|........+++..|.++...+.
T Consensus 596 ~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~ 654 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDV 654 (694)
T ss_pred HHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhh
Confidence 999999996 8999994 6899999999988886655555666677877655443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=386.68 Aligned_cols=256 Identities=27% Similarity=0.471 Sum_probs=225.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|.+.++||+|.|+.||++.+..+|+.+|+|+|..+++... .-+.+.+|+.|-+.|+|||||++++.+... .+.|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~~~--~~~y 86 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHY 86 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhccc--ceeE
Confidence 347788999999999999999999999999999987766443 567889999999999999999999988554 4899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DFGla~~~~ 183 (670)
+|+|+++||+|..-+.++-.++|..+-.+++||+.||.|||.++ |||||+||+|+|+-. +..-+||+|||+|..+.
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999999887777778999999999999999999999999 999999999999973 23469999999999887
Q ss_pred ccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCCChHH
Q 005916 184 QAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEV 259 (670)
Q Consensus 184 ~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~s~~~ 259 (670)
.+. ....+|||.|||||++. ..|+..+|||+.|||||.|+.|.+||++ .+...+|..|..|.. +.......++++
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 543 46789999999999885 5799999999999999999999999998 677889999998873 333445568999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+++|++||. ||.+|+||.|+|+|||+...
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999995 99999999999999999743
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=386.61 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=222.2
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|+.+|+.++||||++++++|.+.. .+|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~ 94 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN--RVY 94 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC--EEE
Confidence 4589999999999999999999999999999999754322 2345677899999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCCC
Confidence 99999999999999999899999999999999999999999998 99999999999998 6789999999999866443
Q ss_pred ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 186 NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 186 ~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...+..+++||.
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDLVK 247 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHHHH
Confidence 34568999999999764 5689999999999999999999999977 566777777777643 345557889999999
Q ss_pred HcCC-CCCCCCC-----HHHHhcCccccccCC
Q 005916 265 KCLV-PASQRLS-----AKELLMDPFLQVNGT 290 (670)
Q Consensus 265 kcL~-dP~~RpS-----a~elL~hpf~~~~~~ 290 (670)
+||. +|.+|++ +.+++.||||....+
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 9996 8999997 799999999986443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=380.68 Aligned_cols=252 Identities=25% Similarity=0.430 Sum_probs=211.9
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|....++|+|+||+||+|+++.||+.||||++.... .++...+..++|+++|++|+|||+|.+.++|.. ++.+++|
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 555678999999999999999999999999987432 345666778999999999999999999999854 4579999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc-c-
Q 005916 108 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ-A- 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~-~- 185 (670)
+|||...-|.++-.....++...++.+++|++.|+.|||+++ +|||||||+|||++ .+|.+||||||+|+.+.. +
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcCCcc
Confidence 999987555544444457999999999999999999999999 99999999999998 678999999999999873 2
Q ss_pred ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-------------------
Q 005916 186 NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS------------------- 244 (670)
Q Consensus 186 ~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~------------------- 244 (670)
..+..+-|.+|+|||++- .+|+..+|||++||++.||++|++-|++..+..++|.....
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 246778899999999763 57999999999999999999999999998999998865542
Q ss_pred CC-CC-----Cccc---CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 245 GI-KP-----AALS---KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 245 g~-~p-----~~~~---~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
|. .| ..+. ...+..+.+|+++||. ||.+|++.+|+|.||||.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 11 01 1111 1134578899999996 999999999999999994
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=383.59 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=220.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.++.+|..||+|++...... .....+.+.+|+.+++.++||||+++++++.+.. .+|+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~l 78 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR--FLYM 78 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC--eEEE
Confidence 478899999999999999999999999999999754321 2344567889999999999999999999886543 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC-
Confidence 9999999999999999899999999999999999999999998 99999999999998 6789999999999876542
Q ss_pred cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHH
Q 005916 187 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~k 265 (670)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...++.+++||++
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 231 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKK 231 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHHH
Confidence 34567999999999764 5689999999999999999999999987 566777777776542 3455568999999999
Q ss_pred cCC-CCCCCCC-----HHHHhcCccccccCCC
Q 005916 266 CLV-PASQRLS-----AKELLMDPFLQVNGTT 291 (670)
Q Consensus 266 cL~-dP~~RpS-----a~elL~hpf~~~~~~~ 291 (670)
||. +|.+|++ +.+++.||||+...+.
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 996 8999995 9999999999865443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=383.83 Aligned_cols=250 Identities=24% Similarity=0.429 Sum_probs=215.2
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 111 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~ 111 (670)
++||+|+||+||+|.++.+|..||+|+++.... .......++.+|+.+++.++||||++++++|.... .+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEEEeCC
Confidence 479999999999999999999999999985432 23445667889999999999999999999887644 799999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc--cccc
Q 005916 112 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKS 189 (670)
Q Consensus 112 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~--~~~~ 189 (670)
.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccc
Confidence 99999999999899999999999999999999999998 99999999999998 6789999999998754222 2345
Q ss_pred ccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC
Q 005916 190 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268 (670)
Q Consensus 190 ~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~ 268 (670)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...++..+..+. ..++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 68999999999774 5699999999999999999999999977 55666666665543 23455678999999999996
Q ss_pred -CCCCCC-----CHHHHhcCccccccCC
Q 005916 269 -PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 269 -dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
+|.+|| ++.++++||||+...+
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 899999 8999999999986544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=387.89 Aligned_cols=257 Identities=25% Similarity=0.449 Sum_probs=217.9
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.+..+|..||+|++...... .......+.+|+.+|+.++||||++++++|.+.. .+|+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~l 78 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN--YLYL 78 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--eEEE
Confidence 488999999999999999999999999999999854322 2345667889999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||||.||+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceeccccc
Confidence 9999999999999998889999999999999999999999998 99999999999998 67899999999987543211
Q ss_pred ----------------------------------------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhc
Q 005916 187 ----------------------------------------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTF 225 (670)
Q Consensus 187 ----------------------------------------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG 225 (670)
....+||+.|+|||++ ...|+.++|||||||++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 1135799999999976 45799999999999999999999
Q ss_pred cCCCCCCCCHHHHHHHHhcCCCCCccc--CCCChHHHHHHHHcCCCCCCCCC---HHHHhcCccccccCC
Q 005916 226 EYPYSECRNSAQIYKKVSSGIKPAALS--KVKDPEVKSFIEKCLVPASQRLS---AKELLMDPFLQVNGT 290 (670)
Q Consensus 226 ~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~~~s~~~k~fI~kcL~dP~~RpS---a~elL~hpf~~~~~~ 290 (670)
.+||.. .+....+..+.........+ ...++++++||.+||.+|.+|++ +.++|.||||+...+
T Consensus 236 ~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 236 YPPFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 999987 45566666665543322222 24578999999999988999997 999999999986544
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=399.09 Aligned_cols=257 Identities=29% Similarity=0.398 Sum_probs=218.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~~ 104 (670)
.+|.+.+.||.|+||.||+|+.+.+|..||||+++.+- .+-++ ..-++|++.|++|+ |||||++++++.+.++ .+
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf--~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~-~L 85 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF--YSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-IL 85 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh--ccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eE
Confidence 45778889999999999999999999999999987532 22222 23368999999997 9999999999988765 89
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
|||||||.. +|.++++.+ +.|++..++.|+.||+.||+|+|.|| +.||||||+|||+.+. ..|||+|||+|+...
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGLAREVR 161 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEecccccccccc
Confidence 999999965 999998865 56999999999999999999999999 9999999999999854 489999999999887
Q ss_pred ccc-cccccCCCccCCCccc--cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC---------------
Q 005916 184 QAN-AKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--------------- 245 (670)
Q Consensus 184 ~~~-~~~~~GTp~YmAPEvl--~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g--------------- 245 (670)
... .+..+.|.+|+|||++ .+.|+.++|+|++|||++|+.+.++-|++....++||+...--
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 654 5778999999999976 4679999999999999999999999999988889998765320
Q ss_pred -----CCCC----c---ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCC
Q 005916 246 -----IKPA----A---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 246 -----~~p~----~---~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~ 290 (670)
.+|. . +-...++++.++|.+||. ||.+||||.|+|+||||+....
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 0110 1 112257899999999997 9999999999999999986543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=386.22 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=214.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.++.+|..||+|++...... .....+++.+|+.+++.++|||||+++++|.+.. ++|+
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~l 78 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ--YLYL 78 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--eeEE
Confidence 478899999999999999999999999999998754322 2445678899999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||||.||+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeeccccccccccc
Confidence 9999999999999998889999999999999999999999998 99999999999998 67899999999986331100
Q ss_pred -------------------------------------------------cccccCCCccCCCccc-cCCCCccceeeecc
Q 005916 187 -------------------------------------------------AKSVIGTPEFMAPELY-DENYNELADIYSFG 216 (670)
Q Consensus 187 -------------------------------------------------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLG 216 (670)
....+||+.|+|||++ ...|+.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0135799999999976 45799999999999
Q ss_pred chhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccC--CCChHHHHHHHHcCCCCCC---CCCHHHHhcCccccccCC
Q 005916 217 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK--VKDPEVKSFIEKCLVPASQ---RLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 217 vilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~--~~s~~~k~fI~kcL~dP~~---RpSa~elL~hpf~~~~~~ 290 (670)
|++|+|++|.+||.. .+....+..+........++. ..++++++||.+||.+|.+ |+++.+++.||||+...+
T Consensus 236 vil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 236 AIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 999999999999977 455566666655332222222 4678999999999986654 569999999999986443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=399.22 Aligned_cols=251 Identities=30% Similarity=0.493 Sum_probs=223.9
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||+|+||+||+|+.+.+...||+|.+.+.. ...+++..+.+|++|++.|+|||||.++++|.... .+++
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~--~~~v 78 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA--HLWV 78 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc--eEEE
Confidence 3667789999999999999999999999999997543 45678889999999999999999999999986544 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|+|||.| +|+.++...+.++|+.++.++.+++.||.|||+++ |+|||+||.|||+. ..|.+|+||||+|+.+....
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccCc
Confidence 9999987 99999999999999999999999999999999998 99999999999998 67899999999999887643
Q ss_pred --cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 187 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
.+++.|||.|||||++. +.|+..+|.||||||+|||++|++||.. ....++.+.|... |..++...+..++.|+
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl 231 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNFL 231 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHHH
Confidence 46788999999999774 6799999999999999999999999987 5566666666654 4455667889999999
Q ss_pred HHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 264 EKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 264 ~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+.+|. ||.+|+|..+|+.|||.+..
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhh
Confidence 99996 89999999999999999754
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=387.46 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=217.0
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.+..+|..||+|+++.... ........+.+|+.+++.++||||++++++|.+.. .+|+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~--~~~l 78 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL--NLYL 78 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--eEEE
Confidence 47889999999999999999999999999999975432 22345677889999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||||.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCcccccccc
Confidence 9999999999999999899999999999999999999999998 99999999999998 57899999999987543210
Q ss_pred -------------------------------------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCC
Q 005916 187 -------------------------------------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYP 228 (670)
Q Consensus 187 -------------------------------------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~P 228 (670)
....+||+.|+|||++ ...|+.++|||||||++|+|++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 1245899999999976 56799999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhcCCCCCccc--CCCChHHHHHHHHcCCCC---CCCCCHHHHhcCccccccCCC
Q 005916 229 YSECRNSAQIYKKVSSGIKPAALS--KVKDPEVKSFIEKCLVPA---SQRLSAKELLMDPFLQVNGTT 291 (670)
Q Consensus 229 f~~~~~~~~i~~~i~~g~~p~~~~--~~~s~~~k~fI~kcL~dP---~~RpSa~elL~hpf~~~~~~~ 291 (670)
|.+ .+....+..+........++ ...++++++||.+|+.+| ..||++.++++||||+...+.
T Consensus 236 f~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 236 FCS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred CCC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 987 55667777776543222222 235789999999977644 357899999999999876553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=381.34 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=218.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.+..+|..||+|+++..... .......+.+|+.+++.++||||++++++|.+.. ++|+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~l 78 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE--HLYL 78 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecCC--eEEE
Confidence 488999999999999999999999999999999864332 2245667889999999999999999999887654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||||.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+....
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCcccC
Confidence 9999999999999998889999999999999999999999998 99999999999998 67899999999997764432
Q ss_pred -------------------------------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCC
Q 005916 187 -------------------------------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN 234 (670)
Q Consensus 187 -------------------------------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~ 234 (670)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~-~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS-DT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC-CC
Confidence 23467999999999764 5689999999999999999999999987 44
Q ss_pred HHHHHHHHhcCCCCCcc--cCCCChHHHHHHHHcCCCCCCCCC-HHHHhcCccccccCC
Q 005916 235 SAQIYKKVSSGIKPAAL--SKVKDPEVKSFIEKCLVPASQRLS-AKELLMDPFLQVNGT 290 (670)
Q Consensus 235 ~~~i~~~i~~g~~p~~~--~~~~s~~~k~fI~kcL~dP~~RpS-a~elL~hpf~~~~~~ 290 (670)
....+..+........+ ....++.+++||.+||.+|.+|++ +.++|+||||+...+
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCH
Confidence 55566666552221222 223589999999999999999999 999999999986544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=379.18 Aligned_cols=255 Identities=21% Similarity=0.350 Sum_probs=217.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+++.++||||+++++++.+.. .+|+
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~l 78 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE--YLYL 78 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC--EEEE
Confidence 48899999999999999999999999999999985432 22345667889999999999999999999887544 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||||.||+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~-~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT-Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-c
Confidence 9999999999999998889999999999999999999999998 99999999999998 678999999999976644 3
Q ss_pred cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc------CCCChHH
Q 005916 187 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS------KVKDPEV 259 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~------~~~s~~~ 259 (670)
....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.. .+....+..+.........+ ...++++
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence 45678999999999764 5789999999999999999999999987 55666666555432111111 1347899
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
++||.+||. +|.+||++.++++||||....
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 999999997 578999999999999998543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=380.75 Aligned_cols=258 Identities=23% Similarity=0.413 Sum_probs=221.3
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCC-eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNG-LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg-~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
.-..|.+.+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-- 104 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDES-- 104 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC--
Confidence 3446899999999999999999876655 78999998754322 2345677889999999999999999999987654
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.+|+|||||.+|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeec
Confidence 79999999999999999999899999999999999999999999998 99999999999998 6789999999999876
Q ss_pred cccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 183 EQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 183 ~~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
.. ......||+.|||||++. ..++.++|||||||++|+|++|.+||.. .+...+++.+..+.. .++...++.+++
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 257 (340)
T PTZ00426 182 DT-RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKH 257 (340)
T ss_pred CC-CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 43 234678999999999764 5689999999999999999999999987 566677777777643 244557889999
Q ss_pred HHHHcCC-CCCCCC-----CHHHHhcCccccccCCC
Q 005916 262 FIEKCLV-PASQRL-----SAKELLMDPFLQVNGTT 291 (670)
Q Consensus 262 fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~~ 291 (670)
+|++||. +|.+|+ +++++++||||+...+.
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 9999996 799995 89999999999865443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=385.11 Aligned_cols=257 Identities=24% Similarity=0.361 Sum_probs=214.9
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.++||+|+||+||+|.+..++..||+|++..... ........+.+|+.+++.++|||||+++++|.+.. .+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~--~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--EEEE
Confidence 47889999999999999999999999999999975432 22455678899999999999999999999997654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
|||||.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCccccccc
Confidence 9999999999999988888999999999999999999999998 99999999999998 6789999999997532100
Q ss_pred ------------------------------------------------ccccccCCCccCCCccc-cCCCCccceeeecc
Q 005916 186 ------------------------------------------------NAKSVIGTPEFMAPELY-DENYNELADIYSFG 216 (670)
Q Consensus 186 ------------------------------------------------~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLG 216 (670)
...+.+||+.|+|||++ ...|+.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 01235799999999976 56799999999999
Q ss_pred chhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC--cccCCCChHHHHHHHHcCCCCCCCCC---HHHHhcCccccccCC
Q 005916 217 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALSKVKDPEVKSFIEKCLVPASQRLS---AKELLMDPFLQVNGT 290 (670)
Q Consensus 217 vilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~--~~~~~~s~~~k~fI~kcL~dP~~RpS---a~elL~hpf~~~~~~ 290 (670)
|++|+|++|.+||.. .+.......+....... ......+++++++|.+|+.+|.+|++ +.++++||||+...+
T Consensus 236 vil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 236 VILYEMLVGQPPFLA-QTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHHHHHHhCCCCCCC-CCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 999999999999987 44444444444432222 22234689999999999889999987 999999999986443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=375.15 Aligned_cols=247 Identities=24% Similarity=0.414 Sum_probs=213.2
Q ss_pred ecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 005916 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 113 (670)
Q Consensus 34 LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~g 113 (670)
||+|+||+||+|.+..++..||+|+++.... ........+.+|+.+++.++||||++++++|.+.. .+|+|||||.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--eEEEEEcCCCC
Confidence 7999999999999999999999999975432 23455677889999999999999999999887544 79999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc--cccccc
Q 005916 114 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKSVI 191 (670)
Q Consensus 114 GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~--~~~~~~ 191 (670)
|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...... .....+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCcccccc
Confidence 999999998889999999999999999999999998 99999999999998 6789999999998754322 234568
Q ss_pred CCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-C
Q 005916 192 GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 269 (670)
Q Consensus 192 GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-d 269 (670)
||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+....++.+..+. ..++...++++++||.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEP--LRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHcCCC
Confidence 999999999764 5689999999999999999999999987 45666677666543 34556678999999999996 8
Q ss_pred CCCCC---CHHHHhcCccccccC
Q 005916 270 ASQRL---SAKELLMDPFLQVNG 289 (670)
Q Consensus 270 P~~Rp---Sa~elL~hpf~~~~~ 289 (670)
|.+|| ++.++|.||||....
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCC
Confidence 99997 589999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=383.87 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=212.6
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||+|+||+||+|.+..++..||+|++...... .......+.+|+.+++.++||||++++++|.+.. .+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--EEEE
Confidence 478899999999999999999999999999999864432 2455678899999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
|||||.||+|.+++.+.+.+++..++.++.||+.||.|||.++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCccccccc
Confidence 9999999999999999889999999999999999999999998 99999999999998 6789999999997543100
Q ss_pred ------------------------------------------------ccccccCCCccCCCccc-cCCCCccceeeecc
Q 005916 186 ------------------------------------------------NAKSVIGTPEFMAPELY-DENYNELADIYSFG 216 (670)
Q Consensus 186 ------------------------------------------------~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLG 216 (670)
...+.+||+.|+|||++ ...|+.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 01245799999999976 45699999999999
Q ss_pred chhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCCChHHHHHHHHcCC---CCCCCCCHHHHhcCccccccCC
Q 005916 217 MCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIEKCLV---PASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 217 vilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~s~~~k~fI~kcL~---dP~~RpSa~elL~hpf~~~~~~ 290 (670)
|++|+|++|..||.... .......+..... ........++++++||.+||. ++..|+++.+++.||||+...+
T Consensus 236 ~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 236 VILFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred hHHHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 99999999999998743 4444444433221 112223468999999999663 3456999999999999986544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=380.90 Aligned_cols=258 Identities=25% Similarity=0.431 Sum_probs=217.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.++.+|..||+|+++..... .......+.+|+.++..++||||++++++|.+.. .+|+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~--~~~l 78 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR--NLYL 78 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEE
Confidence 478899999999999999999999999999999754322 2345677889999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||||.||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCccccccc
Confidence 9999999999999998889999999999999999999999998 99999999999998 67899999999987543210
Q ss_pred -------------------------------------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCC
Q 005916 187 -------------------------------------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYP 228 (670)
Q Consensus 187 -------------------------------------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~P 228 (670)
....+||+.|+|||++ ...|+.++|||||||++|+|++|.+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 1245799999999976 56799999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhcCCCCCccc--CCCChHHHHHHHHcCCCCCCCC---CHHHHhcCccccccCCC
Q 005916 229 YSECRNSAQIYKKVSSGIKPAALS--KVKDPEVKSFIEKCLVPASQRL---SAKELLMDPFLQVNGTT 291 (670)
Q Consensus 229 f~~~~~~~~i~~~i~~g~~p~~~~--~~~s~~~k~fI~kcL~dP~~Rp---Sa~elL~hpf~~~~~~~ 291 (670)
|.. .+....+..+........++ ...++++++||.+|+.+|.+|+ ++.+++.||||+...+.
T Consensus 236 f~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 236 FCS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred CCC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence 987 55666666666533222222 2357899999999888888888 58999999999876553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=395.27 Aligned_cols=251 Identities=32% Similarity=0.525 Sum_probs=223.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|+..+.||+|+||.||+|++..+++.||+|++.+.. .....+.+.+|+.+|.+++++||.++|++|+... .+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~g~--~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT--KLWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheeecc--cHHH
Confidence 3666699999999999999999999999999998764 3566888999999999999999999999998766 6999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
+||||.||++.+.++..+.+++..+..++++++.||.|||.++ .+|||||+.|||+. ..|.+||+|||.+..+....
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s-~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLS-ESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEe-ccCcEEEEecceeeeeechh
Confidence 9999999999999998888899999999999999999999999 99999999999998 45999999999998886643
Q ss_pred --cccccCCCccCCCccccC-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 187 --AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
..+++|||+|||||++.+ .|+.++||||||+++|||++|.+||..+.....++.. ....|+.+....++.+++||
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI--pk~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI--PKSAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec--cCCCCCccccccCHHHHHHH
Confidence 478999999999998765 8999999999999999999999999987664433322 22245666678899999999
Q ss_pred HHcCC-CCCCCCCHHHHhcCccccc
Q 005916 264 EKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 264 ~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
..||. +|..||||.+||+|+|++.
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHh
Confidence 99996 7999999999999999985
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=382.46 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=213.4
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.+..+|..||+|++...... .......+.+|+.+|+.++||||+++++.|.+.. .+|+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~l 78 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYF 78 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--EEEE
Confidence 488999999999999999999999999999998754321 1234567889999999999999999999987644 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
|||||.||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+...
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCccccccc
Confidence 9999999999999999889999999999999999999999998 99999999999998 6789999999997533100
Q ss_pred --------------------------------------------ccccccCCCccCCCcccc-CCCCccceeeeccchhh
Q 005916 186 --------------------------------------------NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCML 220 (670)
Q Consensus 186 --------------------------------------------~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvily 220 (670)
.....+||+.|||||++. ..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 012357999999999764 56899999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCCChHHHHHHHHcCCCCCCCC---CHHHHhcCccccccC
Q 005916 221 EMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIEKCLVPASQRL---SAKELLMDPFLQVNG 289 (670)
Q Consensus 221 eLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~s~~~k~fI~kcL~dP~~Rp---Sa~elL~hpf~~~~~ 289 (670)
+|++|..||.+. +.......+..... +.......++++++||.+|+.+|.+|+ ++.++++||||+...
T Consensus 236 ell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 236 EMLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred ehhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999999999873 44444444443322 122223467899999999888999999 999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=386.35 Aligned_cols=254 Identities=27% Similarity=0.346 Sum_probs=214.9
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|...+.||+|.||.||+|++..+|..||+|+|+.... .++......+||.||++|+|||||++.+...+.....+|+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 36667899999999999999999999999999997652 2445666789999999999999999999888776678999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|+|||.. +|.-++... -.|++.+++.+++||+.||+|||++| |+|||||+.||||| ++|.+||+|||||+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCC
Confidence 9999976 887776653 37999999999999999999999999 99999999999999 7899999999999987654
Q ss_pred c---cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC--Ccc-------
Q 005916 186 N---AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AAL------- 251 (670)
Q Consensus 186 ~---~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p--~~~------- 251 (670)
. .+..+-|.+|.|||++- ..|+.++|+||+||||.||++|++.|.+....+|+.+...-...| ..|
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3 56677899999999764 479999999999999999999999999977777665444321100 001
Q ss_pred -----------------cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 252 -----------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 252 -----------------~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
.+..++.+.+|+.+||. ||.+|.||.++|+|+||.
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 12356788899999996 999999999999999994
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=369.38 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=220.2
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC----HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCC
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS----PEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s----~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~ 102 (670)
|.-.++||+|..++|.++.++.+|.++|+|++.......+ ...++.-.+|+.||+++ .||+|+++.++|..+.
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s-- 96 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA-- 96 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc--
Confidence 5567899999999999999999999999999976443222 23455567899999999 8999999999996544
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
++++|+|+|..|.|++|+...-.++|+..+.+++|++.|++|||.++ ||||||||+|||++ ++.+|||+|||+++.+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILld-dn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLD-DNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeec-cccceEEeccceeecc
Confidence 89999999999999999999989999999999999999999999999 99999999999998 5679999999999999
Q ss_pred cccc-cccccCCCccCCCcccc-------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc--cc
Q 005916 183 EQAN-AKSVIGTPEFMAPELYD-------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LS 252 (670)
Q Consensus 183 ~~~~-~~~~~GTp~YmAPEvl~-------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~ 252 (670)
..+. ....||||+|+|||.+. .+|+..+|+|++|||||.|+.|.+||+. ...-...+.|+.|..... -+
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcch
Confidence 8764 67899999999999773 3689999999999999999999999986 333345577888875332 23
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
...+..++++|.+||+ ||.+|+|++|+|.||||+.
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 4567899999999995 9999999999999999964
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=375.01 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=218.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||+|+||+||+|.++.+|..||+|+++.... ........+.+|+.+++.++||||+++++++.+.. .+|+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~--~~~l 78 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD--NLYL 78 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--eEEE
Confidence 48899999999999999999999999999999985432 23345667889999999999999999999887644 7999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||||.+|+|.+++.+. +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCC
Confidence 99999999999999886 78999999999999999999999998 99999999999998 6789999999999876443
Q ss_pred c---cccccCCCccCCCcccc-------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc--C
Q 005916 186 N---AKSVIGTPEFMAPELYD-------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--K 253 (670)
Q Consensus 186 ~---~~~~~GTp~YmAPEvl~-------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~ 253 (670)
. .....||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+....+..+........++ .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 234 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPEDP 234 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC-CCHHHHHHHHHcCCCccCCCCCC
Confidence 2 23457999999999764 4578999999999999999999999987 44555666665543222222 2
Q ss_pred CCChHHHHHHHHcCCCCCCCCCHHHHhcCccccccCC
Q 005916 254 VKDPEVKSFIEKCLVPASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~dP~~RpSa~elL~hpf~~~~~~ 290 (670)
..++.+++||.+||.+|.+||++.+++.||||+...+
T Consensus 235 ~~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 235 KVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred CCCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCH
Confidence 4678999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=378.33 Aligned_cols=263 Identities=27% Similarity=0.385 Sum_probs=223.3
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
-+.|++.+.||+|.-|+||+|..+.++..+|+|++.+... .....+.|+..|-+||+.++||.++.+|..|..+. +.
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~--~~ 152 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK--YS 152 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH-hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc--ee
Confidence 3568888999999999999999999999999999986543 44667888999999999999999999999996554 89
Q ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
|+|||||.||+|...++++ +.|++..++.|+..|+.||+|||..| ||+|||||+||||. .+|+|.|+||.|+...
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccC
Confidence 9999999999999988876 57999999999999999999999999 99999999999998 7899999999986432
Q ss_pred c----------------------------------c-c-----------------------ccccccCCCccCCCcccc-
Q 005916 183 E----------------------------------Q-A-----------------------NAKSVIGTPEFMAPELYD- 203 (670)
Q Consensus 183 ~----------------------------------~-~-----------------------~~~~~~GTp~YmAPEvl~- 203 (670)
. . . ...+++||-+|+|||++.
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 0 0 0 012468999999999886
Q ss_pred CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCC----HHH
Q 005916 204 ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLS----AKE 278 (670)
Q Consensus 204 ~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpS----a~e 278 (670)
.+.+.++|+|+|||++|||+.|..||.+..+.+.++..+.+.. ...-....+..+++||+++|+ ||++|+. |.|
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-KFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-cCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 4799999999999999999999999999666555555554433 222222456899999999997 7999997 999
Q ss_pred HhcCccccccCCCCCC
Q 005916 279 LLMDPFLQVNGTTKNR 294 (670)
Q Consensus 279 lL~hpf~~~~~~~~~~ 294 (670)
+-+||||+...|...+
T Consensus 389 IK~HpFF~gVnWaLir 404 (459)
T KOG0610|consen 389 IKRHPFFEGVNWALIR 404 (459)
T ss_pred hhcCccccCCChhhee
Confidence 9999999988887443
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=380.74 Aligned_cols=257 Identities=21% Similarity=0.368 Sum_probs=215.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||.||+|.++.++..||+|++...... .......+.+|+.+++.++||||++++++|.+.. .+
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~--~~ 118 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK--YL 118 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EE
Confidence 45689999999999999999999999999999999753322 2334566788999999999999999999987654 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|+|||||.||+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceeccc
Confidence 9999999999999998765 5899999999999999999999998 99999999999998 678999999999987643
Q ss_pred cc---cccccCCCccCCCccccC-----CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc--CC
Q 005916 185 AN---AKSVIGTPEFMAPELYDE-----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KV 254 (670)
Q Consensus 185 ~~---~~~~~GTp~YmAPEvl~~-----~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~~ 254 (670)
.. ..+.+||+.|||||++.+ .++.++|||||||++|+|++|..||.. .+....+..+........++ ..
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCccc
Confidence 32 246789999999997743 378999999999999999999999987 45566666666543322233 24
Q ss_pred CChHHHHHHHHcCCCC---CCCCCHHHHhcCccccccC
Q 005916 255 KDPEVKSFIEKCLVPA---SQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 255 ~s~~~k~fI~kcL~dP---~~RpSa~elL~hpf~~~~~ 289 (670)
.+..++++|.+||.++ ..|+++.++++||||+...
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 5789999999999753 3488999999999998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=380.98 Aligned_cols=259 Identities=20% Similarity=0.359 Sum_probs=217.2
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||+||+|.+..+|..||+|++...... .....+.+.+|+.+++.++||||++++++|.+.. .
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~--~ 117 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK--Y 117 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--E
Confidence 345689999999999999999999999999999999753322 2334556788999999999999999999887544 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||.||+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeecc
Confidence 99999999999999988654 6899999999999999999999998 99999999999998 67899999999997764
Q ss_pred ccc---cccccCCCccCCCccccC-----CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccC--
Q 005916 184 QAN---AKSVIGTPEFMAPELYDE-----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK-- 253 (670)
Q Consensus 184 ~~~---~~~~~GTp~YmAPEvl~~-----~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~-- 253 (670)
... ....+||+.|||||++.. .++.++|||||||++|+|++|.+||.. .+....+..+........++.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcC
Confidence 322 245679999999997642 488999999999999999999999987 455667777766543333332
Q ss_pred CCChHHHHHHHHcCC-CCCC--CCCHHHHhcCccccccCC
Q 005916 254 VKDPEVKSFIEKCLV-PASQ--RLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~--RpSa~elL~hpf~~~~~~ 290 (670)
..+.++++||.+||. +|.+ |+|+.++++||||+...+
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 468999999999997 5765 999999999999986544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=383.12 Aligned_cols=260 Identities=23% Similarity=0.445 Sum_probs=219.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC------H----HHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS------P----EDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s------~----~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
.|++.+.||+|.||.|.+|++..++..||+|++.+...... + ...+++++||.||++|+|||||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 48889999999999999999999999999999986543211 1 2357899999999999999999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
-|+....+|||+|||..|.+...-.....+++.+++.|++.++.||+|||.+| ||||||||+|+||+ .+|+|||+||
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~-~~g~VKIsDF 254 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLS-SDGTVKISDF 254 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEc-CCCcEEeecc
Confidence 77777899999999999988654333333999999999999999999999999 99999999999998 5699999999
Q ss_pred cchhhhcccc-------cccccCCCccCCCccccC----C-CCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc
Q 005916 177 GLATIMEQAN-------AKSVIGTPEFMAPELYDE----N-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS 244 (670)
Q Consensus 177 Gla~~~~~~~-------~~~~~GTp~YmAPEvl~~----~-ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~ 244 (670)
|.+..+..+. ....+|||.|||||.+.+ . -+.+.||||+||+||.|+.|++||.+ .....++.+|..
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn 333 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVN 333 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhc
Confidence 9988763321 234789999999997744 1 35789999999999999999999987 667778888887
Q ss_pred CCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCC
Q 005916 245 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 245 g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~ 290 (670)
.....+-.....+.++++|.+||. ||.+|++..++..|||...++.
T Consensus 334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 654333334467899999999996 8999999999999999976543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=358.72 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=213.4
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
+|...++||+|.||+||+|++..+|+.||||+|+..+... .......+|+++|+.++|||||.+.++|-... .+.+
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~--~l~l 78 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVFPHKS--NLSL 78 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhccCCC--ceEE
Confidence 4666789999999999999999999999999999875432 22345789999999999999999999996554 6999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|+||+.. +|...++.. ..++...++.|+.|++.||+|||++. |+||||||.|+|++ .+|.+||+|||+|+.+...
T Consensus 79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGSP 154 (318)
T ss_pred EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccCCC
Confidence 9999965 999888765 56899999999999999999999999 99999999999998 7799999999999998764
Q ss_pred c--cccccCCCccCCCccc--cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC--CCCc---------
Q 005916 186 N--AKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAA--------- 250 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl--~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~--~p~~--------- 250 (670)
. ....+-|.+|.|||++ .+.|+..+|+||.|||+.||+-|.+-|.+..+.+|+...+..-. .+..
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 4 2334779999999976 45799999999999999999999999999888888765544311 1111
Q ss_pred --------------ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 251 --------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 251 --------------~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+....+..+.+|+.+||. +|.+|+||.|+|+|+||..
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 112245678999999997 8999999999999999974
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=373.24 Aligned_cols=250 Identities=24% Similarity=0.432 Sum_probs=213.7
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 111 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~ 111 (670)
++||+|+||.||+|.+..+|..||+|+++.... ........+.+|+.+++.++||||++++++|.+.. .+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEEEeCC
Confidence 479999999999999999999999999985432 23445667889999999999999999999887654 799999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc--cccc
Q 005916 112 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKS 189 (670)
Q Consensus 112 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~--~~~~ 189 (670)
.+|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCcccc
Confidence 99999999988889999999999999999999999998 99999999999998 6789999999998754221 2345
Q ss_pred ccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC
Q 005916 190 VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268 (670)
Q Consensus 190 ~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~ 268 (670)
..||+.|+|||++ .+.++.++|||||||++|+|++|..||.. .+....+..+.... ..++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 6799999999977 45789999999999999999999999976 45555555555433 23455678999999999996
Q ss_pred -CCCCCC-----CHHHHhcCccccccCC
Q 005916 269 -PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 269 -dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
+|.+|+ ++.++++||||....+
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 899998 8999999999986544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=373.01 Aligned_cols=262 Identities=30% Similarity=0.437 Sum_probs=219.4
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe---CCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID---DQN 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d---~~~ 101 (670)
.++|...+.||+|+||.|..|.++.+|..||+|++. +.+.+.-..++.++|+++|+.++|+|||.+++.+.. ..-
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 345666789999999999999999999999999886 344567788999999999999999999999998865 223
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+.+|+|+|+| +-+|.+.++.+..+++..+..++.|||.||.|+|+-+ |+||||||.|+|++ .+..+||+|||+|+.
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n-~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLN-ADCDLKICDFGLARY 174 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeec-cCCCEEeccccceee
Confidence 5799999999 5599999998888999999999999999999999999 99999999999999 668999999999998
Q ss_pred hc----ccccccccCCCccCCCccc--cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHH-------------
Q 005916 182 ME----QANAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV------------- 242 (670)
Q Consensus 182 ~~----~~~~~~~~GTp~YmAPEvl--~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i------------- 242 (670)
.. ....+..+-|.+|.|||++ ...|+.++||||+|||+.||++|++-|.+.....|+...+
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 85 3345677889999999976 3579999999999999999999999998855555543211
Q ss_pred -h---------c-CCC-CCc---ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCCCC
Q 005916 243 -S---------S-GIK-PAA---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTK 292 (670)
Q Consensus 243 -~---------~-g~~-p~~---~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~~~ 292 (670)
. + +.. +.. .....++.+.+|+++||+ ||.+|+|++|+|.||||.......
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 1 0 111 111 123467999999999997 999999999999999998654433
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=374.40 Aligned_cols=250 Identities=24% Similarity=0.429 Sum_probs=213.9
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 111 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~ 111 (670)
++||+|+||+||+|.+..+|..||+|++..... .......++.+|+.+++.++||||+++++++.+.. .+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEEEeCC
Confidence 479999999999999999999999999985432 23455677889999999999999999999887554 799999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--ccccc
Q 005916 112 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAKS 189 (670)
Q Consensus 112 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~~ 189 (670)
.+|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... .....
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCccccccc
Confidence 99999999988889999999999999999999999998 99999999999998 678999999999875432 22345
Q ss_pred ccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC
Q 005916 190 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268 (670)
Q Consensus 190 ~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~ 268 (670)
.+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+.+.+.... ..++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMED--IKFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCC--ccCCCCCCHHHHHHHHHHcC
Confidence 67999999999774 5789999999999999999999999977 45555665555433 23455678999999999996
Q ss_pred -CCCCCC-----CHHHHhcCccccccCC
Q 005916 269 -PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 269 -dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
+|.+|+ ++.++++||||....+
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 899997 8999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=381.46 Aligned_cols=246 Identities=35% Similarity=0.561 Sum_probs=208.5
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeE-EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLE-VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~-vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
..+.+.||+|+||+||+|.. .|.. ||+|++...... ....+.|.+|+.+|.+|+|||||+|++++..+.. .+++
T Consensus 43 l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~--~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~i 117 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFD--DESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCI 117 (362)
T ss_pred hhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEE
Confidence 34456699999999999965 4666 999999865432 3337889999999999999999999999876543 5899
Q ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC-cEEEeeccchhhhc
Q 005916 107 ITELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG-EVKIGDLGLATIME 183 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g-~vKL~DFGla~~~~ 183 (670)
||||+.+|+|.+++.+ .+.++...+..|+.||+.||+|||++++ ||||||||+|||++ .++ ++||+|||+++...
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~-~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVD-LKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEc-CCCCEEEECCCccceeec
Confidence 9999999999999987 6789999999999999999999999986 99999999999999 555 99999999998876
Q ss_pred cc--ccccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 184 QA--NAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 184 ~~--~~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
.. ......||+.|||||++.+ .|+.++||||||+++|||+||+.||.+....+..+..+..+..| ..+...++.
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp-~~p~~~~~~ 274 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP-PIPKECPPH 274 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-CCCccCCHH
Confidence 53 3445789999999999985 49999999999999999999999999976644444444455444 455558899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+..+|.+||. +|.+||+..+++.
T Consensus 275 l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 275 LSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999996 8999999998875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=365.83 Aligned_cols=256 Identities=21% Similarity=0.355 Sum_probs=212.3
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|+..+.||+|+||+||+|.+..+|..||+|.+...... .......+.+|+.+++.++||||++++++|.+.. .+++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~--~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD--ALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--eEEEE
Confidence 78889999999999999999999999999998754432 2233456788999999999999999999887654 79999
Q ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 108 TELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCC
Confidence 9999999999887643 46899999999999999999999998 99999999999998 6689999999999876433
Q ss_pred c-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCH---HHHHHHHhcCCCCCcccCCCChHHH
Q 005916 186 N-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNS---AQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 186 ~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~---~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
. .....||+.|||||++ ...|+.++|||||||++|+|++|..||...... ..+...+... ...++...++.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~ 233 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDAK 233 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHHH
Confidence 2 3456899999999977 457999999999999999999999999763322 2233333222 2234455688999
Q ss_pred HHHHHcCC-CCCCCCC-----HHHHhcCccccccCCC
Q 005916 261 SFIEKCLV-PASQRLS-----AKELLMDPFLQVNGTT 291 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpS-----a~elL~hpf~~~~~~~ 291 (670)
+||.+||. +|.+||+ ++++++||||....+.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 99999996 8999997 9999999999865543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=370.62 Aligned_cols=256 Identities=21% Similarity=0.359 Sum_probs=213.5
Q ss_pred EEEEEEecccCCeEEEEEEEc---CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 28 IRYKEVIGKGAFKTVYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~---~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
|++.+.||+|+||+||+|.+. .+|..||+|++............+.+..|+.+++.+ +||||+++++++.+.. .
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--~ 79 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA--K 79 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--E
Confidence 788999999999999998764 578999999997644333344567788999999999 6999999999886544 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||.+|+|.+++..++.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+.
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCcccc
Confidence 9999999999999999998889999999999999999999999998 99999999999998 66899999999997653
Q ss_pred cc---ccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCC---CCHHHHHHHHhcCCCCCcccCCC
Q 005916 184 QA---NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 184 ~~---~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~---~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
.. .....+||+.|||||++.+ .++.++|||||||++|+|++|..||... .....+...+.... ..++...
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 234 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFI 234 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCC
Confidence 32 2335679999999998754 4788999999999999999999999642 22334444444432 2344567
Q ss_pred ChHHHHHHHHcCC-CCCCCC-----CHHHHhcCccccccCC
Q 005916 256 DPEVKSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
++.+++||.+||. +|.+|| +++++++||||+...+
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 8999999999996 899999 8999999999986443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=370.91 Aligned_cols=250 Identities=24% Similarity=0.429 Sum_probs=213.0
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 111 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~ 111 (670)
++||+|+||+||+|.+..+|..||+|++..... .......++.+|+++++.++||||++++++|.+.. .+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--EEEEEEeCC
Confidence 479999999999999999999999999985432 23445667889999999999999999999886554 799999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 112 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 112 ~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
.+|+|..++...+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccc
Confidence 999999999888899999999999999999999997 67 99999999999998 678999999999875432 2234
Q ss_pred cccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC
Q 005916 189 SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 189 ~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL 267 (670)
...||+.|||||++ ...|+.++|||||||++|+|++|..||.. .+...++..+.... ..++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHh
Confidence 56799999999977 45789999999999999999999999977 45566666665443 2345567899999999999
Q ss_pred C-CCCCCC-----CHHHHhcCccccccCC
Q 005916 268 V-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 268 ~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
. +|.+|+ ++.++++||||....+
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 6 899997 9999999999986443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=375.53 Aligned_cols=252 Identities=24% Similarity=0.491 Sum_probs=226.7
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
.+|.+.+.||+|.||.|-+|++...|+.||||.|++.+. .+..++-++.+|++||..|+||||+++|++|...+ .+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd--KIv 129 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD--KIV 129 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc--eEE
Confidence 468889999999999999999999999999999997554 56788889999999999999999999999996544 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||||..+|.|.+|+...+.+++.+++.+++||++|+.|||.++ ++|||||.+|||++ .++++||+||||+..+...
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeec-CCCCeeeeccchhhhhccc
Confidence 99999999999999999999999999999999999999999998 99999999999999 6689999999999998876
Q ss_pred c-cccccCCCccCCCccccC-CC-CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 N-AKSVIGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 ~-~~~~~GTp~YmAPEvl~~-~y-s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
+ ..++||+|.|.+||++++ .| ++.+|.|||||+||.|+.|..||.+ .+...+.+.|..|....+ ..+..+.-|
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP---~~PSdA~gL 282 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREP---ETPSDASGL 282 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCC---CCCchHHHH
Confidence 5 589999999999998876 45 6889999999999999999999988 777788888888864322 234578899
Q ss_pred HHHcC-CCCCCCCCHHHHhcCccccc
Q 005916 263 IEKCL-VPASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 263 I~kcL-~dP~~RpSa~elL~hpf~~~ 287 (670)
|+.|| ++|.+|.|+.++..|=|+.-
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheeec
Confidence 99999 69999999999999988863
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=372.82 Aligned_cols=250 Identities=23% Similarity=0.410 Sum_probs=213.5
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
++||+|+||+||+|.++.++..||+|++...... .....+.+..|+.+++.+ +||||+++++++.+.. .+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--RLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--EEEEEEcC
Confidence 4799999999999999999999999999754322 234556778899998877 7999999999886554 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
|.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCccc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999875422 2234
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL 267 (670)
...||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...++..+..+.. ..+...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 567999999999775 5689999999999999999999999987 566677777766542 234557889999999999
Q ss_pred C-CCCCCCCH------HHHhcCccccccCC
Q 005916 268 V-PASQRLSA------KELLMDPFLQVNGT 290 (670)
Q Consensus 268 ~-dP~~RpSa------~elL~hpf~~~~~~ 290 (670)
. +|.+||++ +++++||||+...+
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 6 89999998 99999999986544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=385.05 Aligned_cols=256 Identities=30% Similarity=0.528 Sum_probs=225.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|.+.+++|+|+||.+++++++..+..|++|.|...... ....+...+|+.+++++.|||||.+++.|++.+ .++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t--~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT--EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC--chhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceE
Confidence 34688899999999999999999999999999999987643 333446789999999999999999999998765 359
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
+|||+||+||+|.+.+++.+ .++++.+..|+.||+.||.|||++. |+|||||+.|||++ .++.|||+|||+|+.+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLT-KDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcc-ccCceeecchhhhhhc
Confidence 99999999999999988754 6899999999999999999999887 99999999999999 5678899999999999
Q ss_pred ccc--ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 183 EQA--NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 183 ~~~--~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
... .+.+++|||+||+||++. ..|+.++||||||||+|||++-+++|.+ .+...+..+|..+. -.+++...+.++
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el 234 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSEL 234 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHH
Confidence 875 468899999999999885 5799999999999999999999999988 56666666666655 344677788999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+.+|+.||. +|..||+|.+||.+|.++..
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 999999996 79999999999999988743
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=369.48 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=207.0
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---Ce
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---KT 103 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~---~~ 103 (670)
+|++.++||+|+||.||+|.+..+|..||+|.+.... .......++.+|+.+++.++||||+++++++..... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 4889999999999999999999999999999987422 223345678899999999999999999998865432 35
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+||||| +++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 79 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCccccccc
Confidence 89999999 5699999988888999999999999999999999998 99999999999998 67899999999997653
Q ss_pred ccc-----cccccCCCccCCCcccc---CCCCccceeeeccchhhhhhhccCCCCCCCCHHHH--------------HHH
Q 005916 184 QAN-----AKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI--------------YKK 241 (670)
Q Consensus 184 ~~~-----~~~~~GTp~YmAPEvl~---~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i--------------~~~ 241 (670)
... ....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....++ ...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 13467999999999874 46899999999999999999999999764322211 011
Q ss_pred Hhc-----------CCCCCcc---cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 242 VSS-----------GIKPAAL---SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 242 i~~-----------g~~p~~~---~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+.. ...+..+ ....++.+.+||.+||. +|.+|||+.++|+||||+..
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 100 0011111 12346789999999996 89999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=361.30 Aligned_cols=252 Identities=20% Similarity=0.327 Sum_probs=206.9
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||+|+||+||+|+++.++..||+|++..... .....+.+.+|+.+++.++||||+++++++.... .+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 77 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRRG--KLYL 77 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecCC--EEEE
Confidence 58899999999999999999999999999999875432 2344567889999999999999999999886543 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.++.|..+......+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCcccccccc
Confidence 9999999887766665677999999999999999999999998 99999999999998 67899999999998764322
Q ss_pred ---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-CC---------------
Q 005916 187 ---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI--------------- 246 (670)
Q Consensus 187 ---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g~--------------- 246 (670)
.....||+.|+|||++ ...++.++|||||||++|+|++|.+||............... +.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 2346799999999976 456899999999999999999999999874433332221110 00
Q ss_pred ----CCC---------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 247 ----KPA---------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 247 ----~p~---------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.+. .+....+.++++||.+||. +|.+|||++++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112357789999999996 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=369.45 Aligned_cols=256 Identities=26% Similarity=0.453 Sum_probs=214.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||.||+|.+..+|..||+|.+.... .....+++.+|+++|+.++||||+++++++.+.. .+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EE
Confidence 456899999999999999999999999999999987542 3455678999999999999999999999987654 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
++||||+.+|+|.+++...+.+++..+..++.||+.||.|||+.+ +|+||||||+|||++ .++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEc-CCCcEEEccCcccccccc
Confidence 999999999999999998889999999999999999999999852 399999999999998 678999999999987755
Q ss_pred cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHh--------------------
Q 005916 185 ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS-------------------- 243 (670)
Q Consensus 185 ~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~-------------------- 243 (670)
.......||+.|+|||++. ..++.++|||||||++|+|++|..||... +...+...+.
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCccccc
Confidence 5556678999999999775 56899999999999999999999999652 2222222111
Q ss_pred --------------------------cCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 244 --------------------------SGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 244 --------------------------~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
....+.......++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 1111111122457899999999996 89999999999999999743
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=374.75 Aligned_cols=261 Identities=20% Similarity=0.347 Sum_probs=218.5
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
.......|++.+.||+|+||.||+|.++.++..||+|++...... .......+.+|+.+++.++||||++++++|.+.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~- 115 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD- 115 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-
Confidence 344457899999999999999999999999999999998753322 233456678899999999999999999998754
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.++|+|||||.||+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 116 -~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 -RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCM 190 (371)
T ss_pred -CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCcee
Confidence 3799999999999999998764 5899999999999999999999998 99999999999998 67899999999998
Q ss_pred hhcccc---cccccCCCccCCCccccC-----CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc
Q 005916 181 IMEQAN---AKSVIGTPEFMAPELYDE-----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS 252 (670)
Q Consensus 181 ~~~~~~---~~~~~GTp~YmAPEvl~~-----~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 252 (670)
.+.... ....+||+.|||||++.. .|+.++|||||||++|+|++|..||.. .+....+..+........++
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~ 269 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFP 269 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCC
Confidence 764322 245689999999998743 388999999999999999999999987 56667777777654322222
Q ss_pred --CCCChHHHHHHHHcCCCCC---CCCCHHHHhcCccccccC
Q 005916 253 --KVKDPEVKSFIEKCLVPAS---QRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 253 --~~~s~~~k~fI~kcL~dP~---~RpSa~elL~hpf~~~~~ 289 (670)
...+..++++|.+||.+|. .|+++.++++||||+...
T Consensus 270 ~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 3568999999999998643 378999999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=369.22 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=209.6
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~-iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
++||+|+||+||+|.+..+|..||+|++....... .....++..|.. +++.++||||++++++|.+.. .+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--EEEEEEcC
Confidence 47999999999999999999999999997543322 233345555554 568899999999999887654 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
|.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999875422 2234
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL 267 (670)
..+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+..+++..+..+.. .+....++.+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPL--RLKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 567999999999764 5689999999999999999999999986 566777777766532 234456899999999999
Q ss_pred C-CCCCCCCH----HHHhcCccccccCC
Q 005916 268 V-PASQRLSA----KELLMDPFLQVNGT 290 (670)
Q Consensus 268 ~-dP~~RpSa----~elL~hpf~~~~~~ 290 (670)
. +|.+||++ .+++.||||....+
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 6 89999987 69999999976443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=367.00 Aligned_cols=254 Identities=22% Similarity=0.366 Sum_probs=216.1
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCC-CeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN-NIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~Hp-NIVkl~~~~~d~~~~~~~l 106 (670)
|++.+.||+|+||.||+|.+..++..||+|++..... ......+.+..|+.+++.+.|+ +|++++++|.+.. .+|+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 78 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLYF 78 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC--EEEE
Confidence 7889999999999999999999999999999985432 2234567788999999999765 5888888886544 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc--c
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--Q 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~--~ 184 (670)
|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCC
Confidence 9999999999999998889999999999999999999999998 99999999999998 57899999999986532 2
Q ss_pred cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 185 ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 185 ~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+....+..+.... ..++...++++++||
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li 232 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSIC 232 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Confidence 2234567999999999775 5689999999999999999999999987 55666777776643 234556789999999
Q ss_pred HHcCC-CCCCCCCH-----HHHhcCccccccCC
Q 005916 264 EKCLV-PASQRLSA-----KELLMDPFLQVNGT 290 (670)
Q Consensus 264 ~kcL~-dP~~RpSa-----~elL~hpf~~~~~~ 290 (670)
.+||. +|.+|+++ .+++.||||+...+
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99996 89999976 89999999986544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=363.58 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=203.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||.|+||+||+|.+..++..||+|+++.... ......+.+|+.+++.++||||+++++++.+.. .++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTER--CLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC--eEE
Confidence 458889999999999999999999999999999975432 222345778999999999999999999886543 799
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+.+ +|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSV 155 (288)
T ss_pred EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeeccC
Confidence 99999975 9999887654 5799999999999999999999998 99999999999998 678999999999876533
Q ss_pred c--ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-CC-------------
Q 005916 185 A--NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI------------- 246 (670)
Q Consensus 185 ~--~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g~------------- 246 (670)
. ......||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+......+...+.. +.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 2 234567899999999764 45899999999999999999999999874333332221110 00
Q ss_pred ------CCC-------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 247 ------KPA-------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 247 ------~p~-------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.+. ......++++++||.+||. +|.+|||++|+|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 000 0012346789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=368.23 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=212.5
Q ss_pred EEecccCCeEEEEEEEc---CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 32 EVIGKGAFKTVYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~---~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
+.||+|+||.||+|.+. .+|..||+|+++.............+.+|+.+|+.++||||++++++|.+.. .+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG--KLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC--eEEEEE
Confidence 68999999999999864 5789999999986543333445567789999999999999999999887654 799999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc--c
Q 005916 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--N 186 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~--~ 186 (670)
||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCc
Confidence 99999999999999899999999999999999999999998 99999999999998 6789999999998654222 2
Q ss_pred cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHH
Q 005916 187 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~k 265 (670)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+..+.. .++...++.+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL--NLPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 34567999999999774 5688999999999999999999999987 455556666665542 3455678999999999
Q ss_pred cCC-CCCCCC-----CHHHHhcCccccccC
Q 005916 266 CLV-PASQRL-----SAKELLMDPFLQVNG 289 (670)
Q Consensus 266 cL~-dP~~Rp-----Sa~elL~hpf~~~~~ 289 (670)
||. +|.+|| ++.+++.||||....
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 996 899999 899999999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=364.02 Aligned_cols=254 Identities=23% Similarity=0.304 Sum_probs=215.9
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.....|++|+||.||+|+|+.|+..||+|+++...- ....--.-++||.+|.+++|||||.+-++.+..+-..+|+|
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 6667789999999999999999999999999987541 11222345789999999999999999999888777789999
Q ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 108 TELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+. +|...+...+ +|...+++.++.|+|.||.|||.+. |+||||||+|+|++ +.|.+||+|||+|+.+....
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcCCc
Confidence 999976 9999888775 8999999999999999999999999 99999999999998 88999999999999987652
Q ss_pred --cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC------CC--------
Q 005916 187 --AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI------KP-------- 248 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~------~p-------- 248 (670)
.+..+-|.+|.|||++- ..|+.++|+||+|||+.||+++.+-|.+.....|+.+.+.--. +|
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 46677799999999763 4699999999999999999999999999888888776654210 00
Q ss_pred --------------CcccCC-CChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 249 --------------AALSKV-KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 249 --------------~~~~~~-~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
..+... .+....+|+.++|. ||.+|+||.+.|+|.||..
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 001111 34677899999996 9999999999999999974
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=368.17 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=211.0
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHH---HhCCCCCeeeeeeEEEeCCCCeE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL---KSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iL---k~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
|++.+.||+|+||+||+|.+..+|..||+|+++..... .....+.+.+|++++ +.++||||++++++|.+.. .+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~--~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED--HV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC--EE
Confidence 67889999999999999999999999999999854322 234456677777665 4568999999999887544 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|+|||||.||+|..++.. +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 78 ~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCC
Confidence 999999999999988754 57999999999999999999999998 99999999999998 678999999999875432
Q ss_pred --cccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 185 --ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 185 --~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
......+||+.|||||++ ...++.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...++.+.+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 230 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAIS 230 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHH
Confidence 223457899999999976 45689999999999999999999999987 455666666655432 244556899999
Q ss_pred HHHHcCC-CCCCCC-----CHHHHhcCccccccC
Q 005916 262 FIEKCLV-PASQRL-----SAKELLMDPFLQVNG 289 (670)
Q Consensus 262 fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~ 289 (670)
||.+||. +|.+|| ++.++++||||+...
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 9999996 899999 799999999998644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=367.89 Aligned_cols=250 Identities=22% Similarity=0.372 Sum_probs=213.8
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
++||+|+||+||+|.+..+|..||+|++..... ......+.+..|..+++.+ +||||++++++|.+.. .+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEEEEeC
Confidence 469999999999999999999999999985432 2244566778899999876 8999999999987654 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc--ccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~--~~~ 188 (670)
|.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...... ...
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCcccc
Confidence 999999999998889999999999999999999999998 99999999999998 6789999999998754322 234
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL 267 (670)
...||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+....+..+..+.. ..+...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 567999999999774 5789999999999999999999999987 566677777766542 234456889999999999
Q ss_pred C-CCCCCC-------CHHHHhcCccccccCC
Q 005916 268 V-PASQRL-------SAKELLMDPFLQVNGT 290 (670)
Q Consensus 268 ~-dP~~Rp-------Sa~elL~hpf~~~~~~ 290 (670)
. +|.+|+ ++.++++||||....+
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 6 899999 9999999999976444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=354.64 Aligned_cols=257 Identities=24% Similarity=0.435 Sum_probs=230.1
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
-+-+.|.+++.||+|-||.||+|+.+.++-.||+|++.+..+.. .....++.+|++|-..|+||||+++|++|.|..
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~-- 95 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK-- 95 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheeccc--
Confidence 34456889999999999999999999999999999998766433 344567889999999999999999999998876
Q ss_pred eEEEEEecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 103 TVNIITELFTSGSLRQYRK--KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~--~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+++||...|+|+..+. ..+++++..++.+++|++.||.|||..+ ||||||||+|+|+. ..|.+||+|||.+.
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSV 172 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCcee
Confidence 6999999999999999998 6678999999999999999999999998 99999999999997 67899999999999
Q ss_pred hhcccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 181 IMEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 181 ~~~~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
........+.|||..|.+||..+ ..++..+|+|++|++.||++.|.+||.. .+....|+.|..... .++...+.++
T Consensus 173 ~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes-~~~~etYkrI~k~~~--~~p~~is~~a 249 (281)
T KOG0580|consen 173 HAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES-QSHSETYKRIRKVDL--KFPSTISGGA 249 (281)
T ss_pred ecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh-hhhHHHHHHHHHccc--cCCcccChhH
Confidence 88777788999999999999664 5799999999999999999999999987 458889999987543 3446778999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+++|.+||. +|.+|++..|++.|||+...
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999997 79999999999999999754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=365.83 Aligned_cols=253 Identities=27% Similarity=0.381 Sum_probs=204.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.++.+|..||+|+++.... ......+.+|+.+++.++||||+++++++.+.. .+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--eEE
Confidence 458899999999999999999999999999999875432 122345678999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+. ++|.+++..+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSV 155 (303)
T ss_pred EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceeccC
Confidence 9999995 6788777654 57899999999999999999999998 99999999999998 678999999999875432
Q ss_pred c--ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC---C-----------
Q 005916 185 A--NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG---I----------- 246 (670)
Q Consensus 185 ~--~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g---~----------- 246 (670)
. ......||+.|+|||++. ..|+.++|||||||++|+|++|..||.+..+.......+... .
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 2 234567899999999764 358899999999999999999999998755544333322110 0
Q ss_pred ---CCCcc------------c-CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 247 ---KPAAL------------S-KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 247 ---~p~~~------------~-~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.+..+ . ...++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 00000 0 0124678999999997 8999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=368.91 Aligned_cols=251 Identities=21% Similarity=0.388 Sum_probs=210.6
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
++||+|+||+||+|.+..++..||+|+++.... ........+..|..+++.+ +||||++++++|.+.. .+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEEEEeC
Confidence 479999999999999999999999999985432 2345567788999999999 7999999999987654 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
|.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccc
Confidence 999999999988889999999999999999999999998 99999999999998 678999999999875322 2234
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCC--------CCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC--------RNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~--------~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
..+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....+++.+.... ..++...++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHH
Confidence 578999999999764 56899999999999999999999999531 12233455555443 23455678899
Q ss_pred HHHHHHcCC-CCCCCCC------HHHHhcCccccccCC
Q 005916 260 KSFIEKCLV-PASQRLS------AKELLMDPFLQVNGT 290 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpS------a~elL~hpf~~~~~~ 290 (670)
+++|.+||. +|.+|++ +.++++||||....+
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999996 8999997 789999999975433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=368.46 Aligned_cols=251 Identities=28% Similarity=0.430 Sum_probs=213.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC---e
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK---T 103 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~---~ 103 (670)
.|+-.+++|+|+||+||+|....++..||||++-.+....+ +|+++|+.++|||||++.-+|...... +
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn--------rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN--------RELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc--------HHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 58888999999999999999999999999999987654433 699999999999999998888765554 6
Q ss_pred EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 104 VNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
.++||||++- +|.++++. +..++.-.++-+++||++||.|||+++ |+||||||.|+|+|.+.|.+||||||.|
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 7799999965 89888774 578999999999999999999999998 9999999999999988899999999999
Q ss_pred hhhcccc-cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc------------
Q 005916 180 TIMEQAN-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS------------ 244 (670)
Q Consensus 180 ~~~~~~~-~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~------------ 244 (670)
+.+..+. ..+...|.+|+|||++- ..|+.++||||.||++.||+-|++-|.+.....|+...+.-
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 9987654 35667899999999663 57999999999999999999999999996666665443321
Q ss_pred ----------CCCCCc----ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 245 ----------GIKPAA----LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 245 ----------g~~p~~----~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...+.. +....++++.+|+.++|+ +|.+|.++.|+|.||||..-
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 001111 345568999999999998 89999999999999999743
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=366.97 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=210.9
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
++||+|+||.||+|.++.+|..||+|.++..... .......+..|..+++.+ +||||++++++|.+.. ++|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--EEEEEECC
Confidence 4799999999999999999999999999854322 123455677788888765 9999999999987654 89999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc--ccccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~--~~~~~ 188 (670)
|.||+|..++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCcee
Confidence 999999999998889999999999999999999999998 99999999999998 66899999999986432 22235
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL 267 (670)
..+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...++..+..+. ..++...+.++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHc
Confidence 678999999999774 5789999999999999999999999986 45666666665543 2344557889999999999
Q ss_pred C-CCCCCCCH-HHHhcCccccccCC
Q 005916 268 V-PASQRLSA-KELLMDPFLQVNGT 290 (670)
Q Consensus 268 ~-dP~~RpSa-~elL~hpf~~~~~~ 290 (670)
. +|.+|+++ .++++||||....+
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCH
Confidence 6 89999997 58999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=377.27 Aligned_cols=257 Identities=24% Similarity=0.403 Sum_probs=223.2
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|.+.+.||+|-|++|-+|+|..+|..||||+|.+.++. .-.-..+.+|++.|+-+.|||||++|++.-... .+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD--~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT--Kl 92 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD--TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT--KL 92 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc--hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc--eE
Confidence 34688899999999999999999999999999999876642 333457899999999999999999999753333 69
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
|+|+|+-.+|+|++||-+| ..++|..+++|++||+.|+.|||... +|||||||+|+.+-...|.|||+|||++..+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999999998887 57999999999999999999999998 99999999999887788999999999999887
Q ss_pred ccc-cccccCCCccCCCccc-cCCCC-ccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 184 QAN-AKSVIGTPEFMAPELY-DENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 184 ~~~-~~~~~GTp~YmAPEvl-~~~ys-~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
++. ..+.||+..|-|||++ ...|+ +++||||||||||.|+||++||.... ..+..-.|+..+ ...+...+.+++
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-DSETLTmImDCK--YtvPshvS~eCr 247 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-DSETLTMIMDCK--YTVPSHVSKECR 247 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-chhhhhhhhccc--ccCchhhhHHHH
Confidence 754 6889999999999966 55676 68999999999999999999998854 444444555543 345667789999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCccccccCC
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~ 290 (670)
+||..||+ +|.+|.|.+++..|+|++....
T Consensus 248 dLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 248 DLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 99999997 8999999999999999996543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=365.18 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=216.5
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~l 106 (670)
|++.+.||+|+||+||+|.+..++..||+|+++.... ......+.+..|..++..+ +||+|+++++++.+.. .+|+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 78 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD--RLYF 78 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC--EEEE
Confidence 7889999999999999999999999999999985432 2234456677888888888 6899999999886544 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ-- 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~-- 184 (670)
||||+.+|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCC
Confidence 9999999999999998889999999999999999999999998 99999999999998 678999999999875432
Q ss_pred cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 185 ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 185 ~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
......+||+.|+|||++. +.|+.++|||||||++|+|++|..||.+ .+...++..+..... .++...+++++++|
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 232 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAIC 232 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHHH
Confidence 2234678999999999764 5699999999999999999999999987 556667777766432 34556789999999
Q ss_pred HHcCC-CCCCCCC-----HHHHhcCccccccCC
Q 005916 264 EKCLV-PASQRLS-----AKELLMDPFLQVNGT 290 (670)
Q Consensus 264 ~kcL~-dP~~RpS-----a~elL~hpf~~~~~~ 290 (670)
.+||. +|.+|++ ..++++||||+...+
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99996 8999997 489999999986544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=384.92 Aligned_cols=252 Identities=28% Similarity=0.391 Sum_probs=204.3
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC-----
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD----- 99 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~----- 99 (670)
.+.|++.++||+|+||+||+|.+..++..||+|++.... ....+|+.+|+.++|||||+++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 457999999999999999999999999999999886432 1234699999999999999999887542
Q ss_pred -CCCeEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 100 -QNKTVNIITELFTSGSLRQYRK----KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 100 -~~~~~~lVmEy~~gGsL~~~i~----~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
...++++|||||.+ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+||+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeee
Confidence 22357899999975 7766654 3467999999999999999999999998 99999999999998555679999
Q ss_pred eccchhhhcccc-cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC----
Q 005916 175 DLGLATIMEQAN-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK---- 247 (670)
Q Consensus 175 DFGla~~~~~~~-~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~---- 247 (670)
|||+++.+.... ....+||+.|||||++. ..|+.++|||||||++|+|++|.+||.+......+.+.+.....
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 999998765432 34568899999999764 36999999999999999999999999885555544443321100
Q ss_pred --------------C--------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 248 --------------P--------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 248 --------------p--------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
| ..++...++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 0 01122356799999999996 8999999999999999974
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=364.28 Aligned_cols=250 Identities=25% Similarity=0.439 Sum_probs=210.1
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
++||+|+||+||+|.+..++..||+|+++..... .....+.+..|..++..+ +||||+++++++.... .+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcC
Confidence 4799999999999999999999999999864322 233455566777777765 8999999999886543 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
+.||+|..++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999875432 2234
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL 267 (670)
..+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+..+++..+.... ..++...+.++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR--PHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHc
Confidence 568999999999764 5689999999999999999999999987 45566666665543 2345567889999999999
Q ss_pred C-CCCCCCCH-HHHhcCccccccCC
Q 005916 268 V-PASQRLSA-KELLMDPFLQVNGT 290 (670)
Q Consensus 268 ~-dP~~RpSa-~elL~hpf~~~~~~ 290 (670)
. +|.+||++ .+++.||||....+
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCH
Confidence 6 79999986 58999999986544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=364.10 Aligned_cols=251 Identities=22% Similarity=0.384 Sum_probs=210.0
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
++||+|+||+||+|.+..++..||+|+++.... ........+.+|+.++..+ +||||+++++++.+.. .+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEEEEeC
Confidence 479999999999999999999999999985432 3345567788999998887 8999999999987654 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
|.+|+|..++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccc
Confidence 999999999988889999999999999999999999998 99999999999998 678999999999875422 2234
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCC--------CCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC--------RNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~--------~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
...||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....+++.+.... ..++...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHH
Confidence 568999999999764 56899999999999999999999999521 12233444454432 23455678899
Q ss_pred HHHHHHcCC-CCCCCCC------HHHHhcCccccccCC
Q 005916 260 KSFIEKCLV-PASQRLS------AKELLMDPFLQVNGT 290 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpS------a~elL~hpf~~~~~~ 290 (670)
++||.+||. +|.+||+ +.++++||||+...+
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999996 8999998 589999999986543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=364.41 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=208.4
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~-iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
++||+|+||+||+|.+..+|..||+|++...... .......+..|.. +++.++||||++++++|.... .+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--EEEEEEcC
Confidence 4699999999999999999999999999754332 2233445556655 577789999999999887654 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
+.||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999875422 2234
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL 267 (670)
..+||+.|||||++. ..|+.++|||||||++|+|++|..||.. .+...++..+..... ......+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPL--VLRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCc--cCCCCCCHHHHHHHHHHh
Confidence 567999999999764 5689999999999999999999999987 566667776665432 233346789999999999
Q ss_pred C-CCCCCCCH----HHHhcCccccccCC
Q 005916 268 V-PASQRLSA----KELLMDPFLQVNGT 290 (670)
Q Consensus 268 ~-dP~~RpSa----~elL~hpf~~~~~~ 290 (670)
. +|.+||++ .+++.||||....+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 6 79999876 59999999986443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=363.49 Aligned_cols=250 Identities=26% Similarity=0.450 Sum_probs=210.7
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
+.||+|+||+||+|.+..++..||+|+++..... ..........|..+++.+ +||||+++++++.+.. .+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEEEEeC
Confidence 4799999999999999999999999999864321 123445667788888765 9999999999987654 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
+.||+|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCcee
Confidence 999999999988888999999999999999999999998 99999999999998 568999999999875322 2234
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL 267 (670)
...||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...+++.+.... ..++...+.++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDN--PCYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHh
Confidence 567999999999764 5689999999999999999999999987 45666666665543 2234457889999999999
Q ss_pred C-CCCCCCCHH-HHhcCccccccCC
Q 005916 268 V-PASQRLSAK-ELLMDPFLQVNGT 290 (670)
Q Consensus 268 ~-dP~~RpSa~-elL~hpf~~~~~~ 290 (670)
. +|.+||++. ++++||||+...+
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCH
Confidence 6 899999996 9999999987544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=363.12 Aligned_cols=250 Identities=23% Similarity=0.401 Sum_probs=213.5
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
++||+|+||+||+|.+..++..||+|+++.... ........+.+|+.+++.+ +||||+++++++.+.. .+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcC
Confidence 479999999999999999999999999985432 2234566778899999988 7999999999887654 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
|.||+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCccc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999865322 2234
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL 267 (670)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...++..+..... .++...+..+++||.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHc
Confidence 567999999999764 5789999999999999999999999976 556666666665432 344567899999999999
Q ss_pred C-CCCCCCCH-----HHHhcCccccccCC
Q 005916 268 V-PASQRLSA-----KELLMDPFLQVNGT 290 (670)
Q Consensus 268 ~-dP~~RpSa-----~elL~hpf~~~~~~ 290 (670)
. +|.+||++ .+++.||||+...+
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 6 89999999 99999999986544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=364.26 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=208.4
Q ss_pred ecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 34 LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L---~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
||+|+||+||+|.++.+|..||+|++....... .........|..++..+ +||||++++.+|.+.. .+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEEEEcC
Confidence 799999999999999999999999997543322 23344556677777765 7999999999887654 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCcc
Confidence 999999999998899999999999999999999999998 99999999999998 678999999999875432 2234
Q ss_pred cccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHc
Q 005916 189 SVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 266 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kc 266 (670)
..+||+.|||||++. ..|+.++|||||||++|+|++|..||.. .+..++++.+..+..... ....++.+++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRFP-KNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHHH
Confidence 678999999999774 3589999999999999999999999977 566777777776543221 234678999999999
Q ss_pred CC-CCCCCC----CHHHHhcCccccccC
Q 005916 267 LV-PASQRL----SAKELLMDPFLQVNG 289 (670)
Q Consensus 267 L~-dP~~Rp----Sa~elL~hpf~~~~~ 289 (670)
|. +|.+|| ++.++++||||....
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 96 899998 799999999997543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.46 Aligned_cols=255 Identities=26% Similarity=0.463 Sum_probs=212.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.+..+|..+|+|.+.... .......+.+|+++++.++||||++++++|.+.. .+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--EE
Confidence 456889999999999999999999999999999887542 2445677899999999999999999999988754 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
|+||||+.+|+|.+++...+.+++..+..++.||+.||.|||+. + |+||||||+|||++ .+|.+||+|||++..+.
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhhh
Confidence 99999999999999999888999999999999999999999974 5 99999999999998 67899999999998765
Q ss_pred ccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHH----------------------
Q 005916 184 QANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK---------------------- 240 (670)
Q Consensus 184 ~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~---------------------- 240 (670)
........||+.|+|||++. ..++.++|||||||++|+|++|..||.... ...+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred hhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCCc
Confidence 54445668999999999775 468999999999999999999999997522 222211
Q ss_pred ----------------------HHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 241 ----------------------KVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 241 ----------------------~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+.....+.......+.++++||.+||. +|.+|||+.+++.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 1111111111122356789999999996 89999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=359.09 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=210.4
Q ss_pred EEecccCCeEEEEEEE---cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 32 EVIGKGAFKTVYKAFD---EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d---~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
+.||+|+||+||++.+ ..+|..||+|++..... ......++.+|+.+|++++||||++++++|.+.. .+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--KLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--EEEEEE
Confidence 5799999999999876 46789999999985432 1234456788999999999999999999987644 799999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc--c
Q 005916 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--N 186 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~--~ 186 (670)
|||.+|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... .
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCc
Confidence 99999999999988888999999999999999999999998 99999999999998 6789999999998765433 2
Q ss_pred cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHH
Q 005916 187 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~k 265 (670)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+....+..+..... .++...++.+++||.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 34568999999999774 5689999999999999999999999987 455566666655432 3445578999999999
Q ss_pred cCC-CCCCCCC-----HHHHhcCccccccC
Q 005916 266 CLV-PASQRLS-----AKELLMDPFLQVNG 289 (670)
Q Consensus 266 cL~-dP~~RpS-----a~elL~hpf~~~~~ 289 (670)
||. +|.+||+ +.+++.||||+...
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 996 8999999 78899999998643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=361.41 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=208.7
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~-iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
++||+|+||+||+|.+..+|..||+|++....... .....++..|.. +++.++||||+++++++.+.. .+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEEEEcC
Confidence 47999999999999999999999999997543322 233444555554 678899999999999886544 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
|.||+|..++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccc
Confidence 999999999988888999999999999999999999998 99999999999998 678999999999875322 2234
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL 267 (670)
..+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+..+++..+.... ..++...+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKP--LQLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHc
Confidence 567999999999764 5689999999999999999999999987 56667777776543 3345556789999999999
Q ss_pred C-CCCCCCCH----HHHhcCccccccCC
Q 005916 268 V-PASQRLSA----KELLMDPFLQVNGT 290 (670)
Q Consensus 268 ~-dP~~RpSa----~elL~hpf~~~~~~ 290 (670)
. +|.+|+++ .++++||||....+
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 6 79999875 59999999975443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=363.14 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=207.8
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHH-HHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEV-HLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei-~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
+.||+|+||+||+|.+..++..||+|++........ .....+..|. .+++.++||||++++++|.+.. .+|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEEEEeC
Confidence 479999999999999999999999999985433222 2233444444 4578899999999999887654 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
|.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcc
Confidence 999999999998888999999999999999999999998 99999999999998 678999999999875432 2234
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL 267 (670)
..+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.. .+....+..+.... .......++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHc
Confidence 568999999999764 5689999999999999999999999987 55666666665543 2334456889999999999
Q ss_pred C-CCCCCCCHH----HHhcCccccccCC
Q 005916 268 V-PASQRLSAK----ELLMDPFLQVNGT 290 (670)
Q Consensus 268 ~-dP~~RpSa~----elL~hpf~~~~~~ 290 (670)
. +|.+|+++. ++++|+||....+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 6 799999876 8999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=361.52 Aligned_cols=257 Identities=19% Similarity=0.348 Sum_probs=212.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.+..++..||+|++...... .....+.+.+|+.+++.++||||++++++|.+.. .+|+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~l 78 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDEN--NLYL 78 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC--eEEE
Confidence 488999999999999999999999999999999753321 2344566889999999999999999999887554 7999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+.||+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCCC
Confidence 9999999999999976 467999999999999999999999998 99999999999998 6789999999998765433
Q ss_pred c---cccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcc---cC
Q 005916 186 N---AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL---SK 253 (670)
Q Consensus 186 ~---~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~---~~ 253 (670)
. .....||+.|||||++. +.++.++|||||||++|+|++|..||.. .+..+.+..+........+ ..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 234 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDVT 234 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCccC
Confidence 2 12357999999999874 3578899999999999999999999977 4555666666543321111 22
Q ss_pred CCChHHHHHHHHcCCCC---CCCCCHHHHhcCccccccCC
Q 005916 254 VKDPEVKSFIEKCLVPA---SQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~dP---~~RpSa~elL~hpf~~~~~~ 290 (670)
..+..+++||.+||..| ..|+++.++++||||....+
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 36789999999999643 34889999999999976443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=361.34 Aligned_cols=258 Identities=19% Similarity=0.338 Sum_probs=213.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.++.++..||+|++...... .......+.+|+.+++.++||||+++++++.+.. ++|+
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~--~~~l 78 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDEN--YLYL 78 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEE
Confidence 588999999999999999999999999999998753321 2334556788999999999999999999887654 7999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+.||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccCC
Confidence 9999999999999987 467999999999999999999999998 99999999999998 6789999999998766443
Q ss_pred c---cccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc---C
Q 005916 186 N---AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS---K 253 (670)
Q Consensus 186 ~---~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~---~ 253 (670)
. .....||+.|||||++. +.++.++|||||||++|+|++|..||.. .+....+..+........++ .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHIT 234 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCccc
Confidence 2 23457999999999875 3588999999999999999999999987 45556666665543222222 2
Q ss_pred CCChHHHHHHHHcCCCCCC---CCCHHHHhcCccccccCCC
Q 005916 254 VKDPEVKSFIEKCLVPASQ---RLSAKELLMDPFLQVNGTT 291 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~dP~~---RpSa~elL~hpf~~~~~~~ 291 (670)
..+.++++||.+||..+.+ |++++++++||||+...+.
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 3578999999999964333 5799999999999865443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=355.30 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=205.7
Q ss_pred ecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 005916 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 113 (670)
Q Consensus 34 LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~g 113 (670)
||+|+||+||+|.++.+|..||+|.+..... ......+.+..|+.+++.++||||++++++|.... .+|+||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT--DLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--eEEEEEeCCCC
Confidence 7999999999999999999999999875432 22334567788999999999999999999886543 79999999999
Q ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc--c
Q 005916 114 GSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 187 (670)
Q Consensus 114 GsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~--~ 187 (670)
|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..+.... .
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc
Confidence 999887643 356999999999999999999999998 99999999999998 67899999999997664432 3
Q ss_pred ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCH---HHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 188 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNS---AQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 188 ~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~---~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
....||+.|+|||++ ...++.++|||||||++|+|++|..||...... ..+...+... +...+...++.+++|+
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence 456799999999976 457899999999999999999999999753321 2233333222 2334455788999999
Q ss_pred HHcCC-CCCCCC-----CHHHHhcCccccccCCC
Q 005916 264 EKCLV-PASQRL-----SAKELLMDPFLQVNGTT 291 (670)
Q Consensus 264 ~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~~ 291 (670)
.+||. +|.+|| +++++++||||+...+.
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 99996 899999 89999999999864443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=376.25 Aligned_cols=252 Identities=35% Similarity=0.552 Sum_probs=220.8
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 111 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~ 111 (670)
-+||+|.||+||.|+|..+....|||-|..+. ....+-+..||.+.++|+|.|||+++|++ ..++++-|.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecC
Confidence 37999999999999999999999999987543 45667789999999999999999999986 3455899999999
Q ss_pred CCCCHHHHHHh-cCCC--CHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc--
Q 005916 112 TSGSLRQYRKK-HKKV--DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 186 (670)
Q Consensus 112 ~gGsL~~~i~~-~~~l--se~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~-- 186 (670)
+||+|..+++. .|++ +|.++..|.+||++||.|||.+. |||||||-+|+|++.-.|.+||+|||-++.+..-+
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 99999998765 4777 89999999999999999999998 99999999999999778999999999999886543
Q ss_pred cccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 187 AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
+.++.||..|||||++.+ +|+.++|||||||++.||.||++||.+..++...+-++---+..+..+...+.+++.||
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 578899999999999853 69999999999999999999999999877777665555443344556677789999999
Q ss_pred HHcCC-CCCCCCCHHHHhcCccccccCCC
Q 005916 264 EKCLV-PASQRLSAKELLMDPFLQVNGTT 291 (670)
Q Consensus 264 ~kcL~-dP~~RpSa~elL~hpf~~~~~~~ 291 (670)
.+|.. +|.+||+|.+||.+||++....+
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccCCCC
Confidence 99997 79999999999999999976443
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.90 Aligned_cols=251 Identities=21% Similarity=0.377 Sum_probs=211.6
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
++||+|+||+||+|.+..++..||+|+++.... ......+.+.+|+.+++.+ +||||+++++++.+.. .+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEEEEeC
Confidence 479999999999999999999999999985432 2345567788999999998 7999999999887654 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc--cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ--ANAK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~--~~~~ 188 (670)
|.||+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCcee
Confidence 999999999988889999999999999999999999998 99999999999998 678999999999875322 2234
Q ss_pred cccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCC------CCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 189 SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC------RNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 189 ~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~------~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
..+||+.|+|||++ ...|+.++|||||||++|+|++|..||... .....+++.+... +..++...++.+++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence 57899999999976 457899999999999999999999999532 2233455555443 33456667899999
Q ss_pred HHHHcCC-CCCCCCC------HHHHhcCccccccCC
Q 005916 262 FIEKCLV-PASQRLS------AKELLMDPFLQVNGT 290 (670)
Q Consensus 262 fI~kcL~-dP~~RpS------a~elL~hpf~~~~~~ 290 (670)
+|.+||. +|.+|++ ..+++.||||+...+
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 9999996 8999998 579999999986543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=353.39 Aligned_cols=256 Identities=23% Similarity=0.376 Sum_probs=211.1
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|++.++||+|+||+||++.+..++..||+|++...... .......+.+|+.+++.++||||+++++++.+.. .+++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--eEEEE
Confidence 77889999999999999999999999999999754321 2233456778999999999999999999886554 79999
Q ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 108 TELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCC
Confidence 9999999999887653 46999999999999999999999998 99999999999998 6689999999998776433
Q ss_pred c-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHH---HHHHHHhcCCCCCcccCCCChHHH
Q 005916 186 N-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSA---QIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 186 ~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~---~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
. ....+||+.|+|||++ ...++.++|||||||++|+|++|..||.+..... .+...+... +...+...++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAAR 233 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHH
Confidence 2 2456799999999976 4568999999999999999999999998633221 222223222 2234445688999
Q ss_pred HHHHHcCC-CCCCCC-----CHHHHhcCccccccCCC
Q 005916 261 SFIEKCLV-PASQRL-----SAKELLMDPFLQVNGTT 291 (670)
Q Consensus 261 ~fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~~ 291 (670)
+||.+||. +|.+|| ++.++++||||....+.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 99999996 899999 99999999999865444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.36 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=215.2
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~~~l 106 (670)
|.+.++||+|+||+||+|.++.+|..||+|++..... ......+.+..|+.+++.+. ||+|+++++++.+.. .+|+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD--RLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC--EEEE
Confidence 6788999999999999999999999999999985432 22345567788999999885 577888998876654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCC
Confidence 9999999999999999889999999999999999999999998 99999999999998 6789999999998754322
Q ss_pred -ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 186 -NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 186 -~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
......||+.|+|||++. +.++.++|||||||++|+|++|.+||.+ .+...+++.+..... .++...+.++++++
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li 232 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSIC 232 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHH
Confidence 234567999999999764 5689999999999999999999999987 556667777666432 34556788999999
Q ss_pred HHcCC-CCCCCCC-----HHHHhcCccccccCC
Q 005916 264 EKCLV-PASQRLS-----AKELLMDPFLQVNGT 290 (670)
Q Consensus 264 ~kcL~-dP~~RpS-----a~elL~hpf~~~~~~ 290 (670)
.+||. +|.+|++ ..++++||||+...+
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 233 KGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred HHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 99996 7999997 589999999986544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=350.74 Aligned_cols=253 Identities=29% Similarity=0.428 Sum_probs=200.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcC-CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEe---
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEV-NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWID--- 98 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~-tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L---~HpNIVkl~~~~~d--- 98 (670)
+.|++.+.||+|+||+||+|.+.. .|..||+|.++..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 358899999999999999999854 5788999998754322 12233455677777766 69999999998753
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
.....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Df 154 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADF 154 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccc
Confidence 22346899999996 6999988764 45899999999999999999999998 99999999999998 6789999999
Q ss_pred cchhhhcccc-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC-C--CC--
Q 005916 177 GLATIMEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-K--PA-- 249 (670)
Q Consensus 177 Gla~~~~~~~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~-~--p~-- 249 (670)
|++....... .....||+.|+|||++ ...++.++|||||||++|+|++|.+||.+......+ ..+.... . +.
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-~~i~~~~~~~~~~~~ 233 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDW 233 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHHhCCCChhhc
Confidence 9997664432 3456799999999976 567899999999999999999999999874443333 3332211 0 00
Q ss_pred --------------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 250 --------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 250 --------------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.+....++.+++||.+||. +|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112356788999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=362.77 Aligned_cols=251 Identities=29% Similarity=0.466 Sum_probs=205.4
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
-..|.+.+.||+|+||+||+|.+..+|..||+|++.... .......+.+|+.+++.++||||++++++|.+.. .+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 147 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG--EI 147 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC--eE
Confidence 345778899999999999999999999999999986432 3445677899999999999999999999886543 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|+|||||.+|+|... ...++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+..
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceeccc
Confidence 999999999998653 34678889999999999999999998 99999999999998 678999999999987654
Q ss_pred cc--cccccCCCccCCCccccC------CCCccceeeeccchhhhhhhccCCCCCCC--CHHHHHHHHhcCCCCCcccCC
Q 005916 185 AN--AKSVIGTPEFMAPELYDE------NYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~~------~ys~~~DIWSLGvilyeLltG~~Pf~~~~--~~~~i~~~i~~g~~p~~~~~~ 254 (670)
.. ....+||+.|+|||++.. .++.++|||||||++|+|++|..||.... ........+.... +......
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~ 299 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPAT 299 (353)
T ss_pred ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCc
Confidence 32 345689999999998732 23568999999999999999999997422 2222233332222 2233455
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+.++++||.+||. +|.+|||+.|+|+||||...
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 67899999999996 89999999999999999864
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=358.29 Aligned_cols=257 Identities=19% Similarity=0.336 Sum_probs=212.6
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.++||+|+||+||++.++.++..||+|++...... .......+..|+.+++.++||||+++++++.+.. .+|+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~l 78 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDEN--NLYL 78 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--EEEE
Confidence 488899999999999999999999999999998753321 2234456788999999999999999999887654 7999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+.+|+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccC
Confidence 9999999999999987 467999999999999999999999998 99999999999998 6789999999998765332
Q ss_pred c---cccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc---C
Q 005916 186 N---AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS---K 253 (670)
Q Consensus 186 ~---~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~---~ 253 (670)
. ....+||+.|||||++. +.|+.++|||||||++|+|++|..||.. .+....+..+........++ .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~ 234 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVT 234 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccc
Confidence 2 23457999999999774 3588999999999999999999999987 45666666666543222222 3
Q ss_pred CCChHHHHHHHHcCCC---CCCCCCHHHHhcCccccccCC
Q 005916 254 VKDPEVKSFIEKCLVP---ASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~d---P~~RpSa~elL~hpf~~~~~~ 290 (670)
..++++++||.+||.. +..|+++.++++||||+...+
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 4578999999999953 334789999999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=361.51 Aligned_cols=255 Identities=31% Similarity=0.410 Sum_probs=204.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--- 101 (670)
-+.|++.+.||+|+||+||+|.+..+|..||+|++.... .......++.+|+.+++.++||||++++++|.....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 356899999999999999999999999999999987432 234456678899999999999999999998865432
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 -~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
..+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCcc
Confidence 357999999965 6666653 35899999999999999999999998 99999999999998 67899999999997
Q ss_pred hhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHh---------------
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS--------------- 243 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~--------------- 243 (670)
...... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+..........+.
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 654322 34568899999999764 5799999999999999999999999986433222111110
Q ss_pred ------cC--CCC----------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 244 ------SG--IKP----------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 244 ------~g--~~p----------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.. ..+ .......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00 000 00112345789999999996 8999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=373.87 Aligned_cols=261 Identities=28% Similarity=0.451 Sum_probs=215.2
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CC-----Cee
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HN-----NII 90 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-Hp-----NIV 90 (670)
.++..|-.+.+|.+.++||+|+||.|.+|.+..|++.||||+|+.+ +....+-..|+.+|..|+ |. |+|
T Consensus 177 ~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~V 251 (586)
T KOG0667|consen 177 QLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIV 251 (586)
T ss_pred eEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEE
Confidence 3445555666788899999999999999999999999999999854 456667788999999996 43 899
Q ss_pred eeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe-CC
Q 005916 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN-GN 167 (670)
Q Consensus 91 kl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~-~~ 167 (670)
++|++|...+ ++|||+|++ +-+|.++++.+ ..++...++.+++|||.||.+||..+ |||+||||+||||. ..
T Consensus 252 rm~d~F~fr~--HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 252 RMLDYFYFRN--HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPK 326 (586)
T ss_pred Eeeecccccc--ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCC
Confidence 9999997655 799999999 56999999976 46899999999999999999999998 99999999999997 33
Q ss_pred CCcEEEeeccchhhhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-C
Q 005916 168 QGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-G 245 (670)
Q Consensus 168 ~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g 245 (670)
...|||+|||+|....+... +.+-+.+|+|||++ +..|+.+.||||||||++||++|.+.|.+.....++...+.- |
T Consensus 327 r~~vKVIDFGSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG 405 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG 405 (586)
T ss_pred cCceeEEecccccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence 45799999999998776554 78889999999965 778999999999999999999999999986555555432210 0
Q ss_pred C----------------------------------------------------CC-C------cccCCCChHHHHHHHHc
Q 005916 246 I----------------------------------------------------KP-A------ALSKVKDPEVKSFIEKC 266 (670)
Q Consensus 246 ~----------------------------------------------------~p-~------~~~~~~s~~~k~fI~kc 266 (670)
. .| . .+....+..+.+||.+|
T Consensus 406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 0 00 0 00012234678999999
Q ss_pred CC-CCCCCCCHHHHhcCcccccc
Q 005916 267 LV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 267 L~-dP~~RpSa~elL~hpf~~~~ 288 (670)
|. ||.+|+|+.++|+||||...
T Consensus 486 L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred hccCchhcCCHHHHhcCcccccc
Confidence 96 99999999999999999854
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=357.81 Aligned_cols=278 Identities=22% Similarity=0.394 Sum_probs=236.7
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|.+.++||+|.||.|.+++.+.+|+.||+|++++..+ ...+.+..-..|-++|+..+||.+..+.-+|+..+ .+|
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi-iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d--rlC 244 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI-IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD--RLC 244 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe-eehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc--eEE
Confidence 357788999999999999999999999999999986544 45677788889999999999999999887886544 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc-
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ- 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~- 184 (670)
+||||..||.|+-++.+...+++..++.+...|+.||.|||+++ ||+||||.+|+|++ .+|+|||+|||+++.--.
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhcccc
Confidence 99999999999999999999999999999999999999999998 99999999999999 789999999999875432
Q ss_pred -cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 185 -ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 185 -~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
....++||||.|+|||++. ..|+.++|+|.+||++|||+||++||.. .+...++..|..+. ..++...+++++.+
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed--~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMED--LKFPRTLSPEAKTL 398 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhh--ccCCccCCHHHHHH
Confidence 3467899999999999985 5799999999999999999999999987 66777777776653 34677788999999
Q ss_pred HHHcCC-CCCCCC-----CHHHHhcCccccccCCCCCCCCCCCCCcCCCccccccc
Q 005916 263 IEKCLV-PASQRL-----SAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDR 312 (670)
Q Consensus 263 I~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (670)
+..+|. ||.+|+ .|.|+.+|+||....|...-...++++..|....-.+.
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDT 454 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDT 454 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccch
Confidence 999996 899998 58999999999977764432223344455555444333
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=375.54 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=217.0
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCC-CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVN-GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~t-g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.+|....|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||+++++|...
T Consensus 62 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 62 NNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred CCCcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 455667799999999999999999998887 788888876543 244556778899999999999999999998765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEee
Q 005916 100 QNKTVNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 175 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~D 175 (670)
. .+|+|||||.||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 138 ~--~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~D 212 (478)
T PTZ00267 138 D--KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGD 212 (478)
T ss_pred C--EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEe
Confidence 4 79999999999999987653 456899999999999999999999998 99999999999998 678999999
Q ss_pred ccchhhhcccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc
Q 005916 176 LGLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 176 FGla~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~ 250 (670)
||++..+.... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...++..+..+..+ .
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~ 290 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-P 290 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-C
Confidence 99998764432 34567999999999774 5699999999999999999999999977 4555666666655432 2
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
++...++.+++||.+||. +|.+||++.++|.|||++.
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 344567899999999996 8999999999999999963
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=367.70 Aligned_cols=248 Identities=26% Similarity=0.348 Sum_probs=200.5
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+++|+.|+|||||+++++|.... .
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~ 157 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYNK--F 157 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC--e
Confidence 3456999999999999999999999999999999643 234678999999999999999999987644 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
.++|||++. ++|..++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++....
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPV 233 (391)
T ss_pred eEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCcccccc
Confidence 899999994 799999988888999999999999999999999998 99999999999998 66899999999997543
Q ss_pred cc---ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCC-------HHHHHHHHhc-CCC----
Q 005916 184 QA---NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN-------SAQIYKKVSS-GIK---- 247 (670)
Q Consensus 184 ~~---~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~-------~~~i~~~i~~-g~~---- 247 (670)
.. .....+||+.|+|||++ ...|+.++|||||||++|+|++|..||.+... ..++...+.. +..
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 22 23456899999999976 45799999999999999999999988753211 1111111100 000
Q ss_pred ----------------------CCc---cc--CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 248 ----------------------PAA---LS--KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 248 ----------------------p~~---~~--~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+.. +. ...+.++++||.+||. +|.+||||.|+|+||||+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 000 00 1134678999999996 8999999999999999974
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.55 Aligned_cols=256 Identities=34% Similarity=0.572 Sum_probs=215.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL-QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~-~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
.|++.+.||+|+||.||+|.+..+|..||+|.+...... ......+.+.+|+++++.++||||++++++|.+.....++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 478899999999999999999999999999998754322 2234567889999999999999999999998776556899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||+.+|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCccccccccc
Confidence 99999999999999998888999999999999999999999998 99999999999998 6789999999998765431
Q ss_pred -----ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 186 -----NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 186 -----~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
......|+..|+|||++ ...++.++|||||||++|+|++|..||........+.+ +.........+...+..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDHC 238 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHHH
Confidence 22345689999999976 45688999999999999999999999987544444443 333222233445567889
Q ss_pred HHHHHHcCCCCCCCCCHHHHhcCcccc
Q 005916 260 KSFIEKCLVPASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 260 k~fI~kcL~dP~~RpSa~elL~hpf~~ 286 (670)
.++|.+||.+|.+||++.++++|||+.
T Consensus 239 ~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 239 RDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=379.48 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=216.4
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
+|.+...||-|+||.||+|..+.++..-|.|+|..+ +.+.++.++-||.||..++||+||++|+.|+-++ .++|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~en--kLwi 106 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--KLWI 106 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--ceEE
Confidence 455667899999999999999999998898988754 4788999999999999999999999999887665 5999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+.|||.||-....+.. ...+.+.++..+|+|+|.||.|||+++ |||||||..|||++ -+|.|+|+|||.+......
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecccccccchhH
Confidence 9999999999876554 467999999999999999999999999 99999999999998 6799999999998765432
Q ss_pred --ccccccCCCccCCCccc------cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 186 --NAKSVIGTPEFMAPELY------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 186 --~~~~~~GTp~YmAPEvl------~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
...+++|||+|||||++ .+.|+.++||||||++|.+|..+.+|.........+.+.-.+.......+...+.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~ 263 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR 263 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence 35689999999999965 4689999999999999999999999998855555555544443322334556678
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.+++|+.+||+ +|..||++.+||+|||++.
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 99999999997 7999999999999999984
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=370.95 Aligned_cols=258 Identities=30% Similarity=0.500 Sum_probs=221.2
Q ss_pred cccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 19 ~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
...||... |.-.+.||+|+||.||.|++..+...||||++.... .++.+....+..|+..|++|+|||+|.+.++|.-
T Consensus 20 ~k~DPEkl-f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySG-KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 20 FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred ccCCHHHH-HHHHHHhcCCccceeEEeeccCccceeeeeeccccc-cccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 34555543 444678999999999999999999999999998643 3556778889999999999999999999999987
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
+. +.|+|||||- |+-.+.+.-+ +++.+.+++.|+.+.|.||.|||+++ .||||||..|||++ +.|.|||+|||
T Consensus 98 e~--TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLaDFG 171 (948)
T KOG0577|consen 98 EH--TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLADFG 171 (948)
T ss_pred cc--hHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeecccc
Confidence 65 7899999995 4877777644 67999999999999999999999999 99999999999998 77999999999
Q ss_pred chhhhcccccccccCCCccCCCccc----cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 178 LATIMEQANAKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 178 la~~~~~~~~~~~~GTp~YmAPEvl----~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
.|.+..+ +++++|||+|||||++ .+.|+-++||||||++..||.-.++|+........+|..-.. ..|.....
T Consensus 172 SAsi~~P--AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPtLqs~ 248 (948)
T KOG0577|consen 172 SASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQSN 248 (948)
T ss_pred chhhcCc--hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCCCCCc
Confidence 9988765 5789999999999965 578999999999999999999999998876666666765444 33444445
Q ss_pred CCChHHHHHHHHcCCC-CCCCCCHHHHhcCccccc
Q 005916 254 VKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~d-P~~RpSa~elL~hpf~~~ 287 (670)
..+..++.||..||.+ |.+|||++++|+|+|+..
T Consensus 249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 249 EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 5678999999999985 899999999999999963
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=373.03 Aligned_cols=254 Identities=19% Similarity=0.311 Sum_probs=200.0
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC------CCeeeeeeEEE
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH------NNIIRFYNSWI 97 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H------pNIVkl~~~~~ 97 (670)
..+.|++.++||+|+||+||+|.+..++..||+|+++.. .........|+.+++.+.| ++|++++++|.
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 356799999999999999999999999999999998642 1223345567777777754 45889999886
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCC--------
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQ-------- 168 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~-------- 168 (670)
... ..+|+|||++ |++|.+++.+++.+++..++.|+.||+.||.|||+ .+ ||||||||+|||++...
T Consensus 202 ~~~-~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NET-GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred cCC-ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccc
Confidence 543 4789999998 78999999988899999999999999999999998 47 99999999999998332
Q ss_pred -------CcEEEeeccchhhhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHH
Q 005916 169 -------GEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240 (670)
Q Consensus 169 -------g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~ 240 (670)
+.+||+|||++..... .....+||+.|||||++ ...|+.++|||||||++|+|++|++||.+..+...+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~- 355 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH- 355 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-
Confidence 2599999998764332 23467899999999976 4579999999999999999999999997744333221
Q ss_pred HHhc--CCCCCcc--------------------------------------cCCCChHHHHHHHHcCC-CCCCCCCHHHH
Q 005916 241 KVSS--GIKPAAL--------------------------------------SKVKDPEVKSFIEKCLV-PASQRLSAKEL 279 (670)
Q Consensus 241 ~i~~--g~~p~~~--------------------------------------~~~~s~~~k~fI~kcL~-dP~~RpSa~el 279 (670)
.+.. +..|..+ ....++.+.+||.+||. ||.+||||+|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 1111 1011000 01124667899999997 89999999999
Q ss_pred hcCcccccc
Q 005916 280 LMDPFLQVN 288 (670)
Q Consensus 280 L~hpf~~~~ 288 (670)
|+||||+..
T Consensus 436 L~Hp~~~~~ 444 (467)
T PTZ00284 436 TTHPYVLKY 444 (467)
T ss_pred hcCcccccc
Confidence 999999853
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=362.28 Aligned_cols=250 Identities=29% Similarity=0.533 Sum_probs=216.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|.+.+.||+|+||.||+|.|+.+|..+|+|+|... .+++.+..|+.||++++.|+||++|++|+-.. .++
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DLW 104 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DLW 104 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ceE
Confidence 3466778999999999999999999999999999753 45788999999999999999999999997554 599
Q ss_pred EEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+|||||..|++.+.++ +++.+++.++..+++..|.||+|||... -||||||..|||++ .+|..||+|||.|..+..
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADFGVAGQLTD 181 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhccccchhhh
Confidence 9999999999999866 4578999999999999999999999987 79999999999999 679999999999988876
Q ss_pred cc--cccccCCCccCCCccccC-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcc--cCCCChHH
Q 005916 185 AN--AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL--SKVKDPEV 259 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~--~~~~s~~~ 259 (670)
.. .++++|||.|||||++.+ +|+.++||||||++..||..|++||.+......|+-.-.. .|..+ +...+.++
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~--PPPTF~KPE~WS~~F 259 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK--PPPTFKKPEEWSSEF 259 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC--CCCCCCChHhhhhHH
Confidence 53 578999999999998865 7999999999999999999999999886555444432222 22222 23456789
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+||++||+ +|.+|-||.+|++|||++..
T Consensus 260 ~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 260 NDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 999999997 69999999999999999854
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.73 Aligned_cols=252 Identities=35% Similarity=0.589 Sum_probs=213.9
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ-SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~-s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
|.+.+.||+|++|.||+|.+..+|..||+|.+....... .......+.+|+.++++++||||+++++++.+.. .+++
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~ 81 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE--TLSI 81 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC--eEEE
Confidence 788999999999999999999999999999987543221 1234567889999999999999999999987654 8999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.+++|.+++...+.+++..++.++.|++.||.|||..+ |+||||||+||+++ .++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceeccccc
Confidence 9999999999999998889999999999999999999999998 99999999999998 67899999999987654321
Q ss_pred -----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 187 -----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 187 -----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
.....|++.|+|||++. ..++.++|||||||++|+|++|+.||..........+ +........++...+..++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-HhccCCCCCCCccCCHHHH
Confidence 13456889999999774 4588999999999999999999999977544444443 3333333445667789999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+||.+||. +|.+|||+.++|+||||
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 99999996 79999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=344.40 Aligned_cols=251 Identities=35% Similarity=0.598 Sum_probs=208.1
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|++.+.||+|+||+||+|.+..++..||+|++..... .........+|+.++++++||||+++++++.+.. .+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDDN--YLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--EEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhccccccccccccccccccccc--ccccc
Confidence 7899999999999999999999999999999986542 1222334456999999999999999999988744 79999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh--ccc
Q 005916 108 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQA 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~--~~~ 185 (670)
||++.+++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.++|+|||++... ...
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccccccc
Confidence 999999999999998889999999999999999999999998 99999999999998 7789999999998753 222
Q ss_pred ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCC--CHHHHHHHHhcCCCCCccc--CCCChHH
Q 005916 186 NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGIKPAALS--KVKDPEV 259 (670)
Q Consensus 186 ~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~--~~~~i~~~i~~g~~p~~~~--~~~s~~~ 259 (670)
......||+.|+|||++. ..++.++||||||+++|+|++|..||.... +.............+.... ....+.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 345678899999999876 678999999999999999999999998742 2222222222211111111 1123799
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+++|.+||. +|.+||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999996 89999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.20 Aligned_cols=253 Identities=30% Similarity=0.400 Sum_probs=200.0
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEeCC---
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWIDDQ--- 100 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L---~HpNIVkl~~~~~d~~--- 100 (670)
.|++.+.||+|+||+||+|.++.+|..||+|.++...... .....+.+|+.+++.+ +||||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 3788999999999999999999999999999987543211 1122345677776665 7999999999886532
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 101 NKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
...+++||||+. ++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 79 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg~ 154 (288)
T cd07863 79 ETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGL 154 (288)
T ss_pred CceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccCc
Confidence 346899999997 4898888764 35899999999999999999999998 99999999999998 678999999999
Q ss_pred hhhhcccc-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC-C-----CC--
Q 005916 179 ATIMEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-I-----KP-- 248 (670)
Q Consensus 179 a~~~~~~~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g-~-----~p-- 248 (670)
+....... .....||+.|+|||++ ...++.++|||||||++|+|++|.+||.+......+.+.+... . .+
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 155 ARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 98765432 3456789999999976 5578999999999999999999999997744333322221110 0 00
Q ss_pred ----------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 249 ----------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 249 ----------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
..+....+..++++|.+||. +|.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00112346788999999996 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=374.65 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=219.8
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC-
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN- 101 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~- 101 (670)
..++.|++.+.||+|+||+||+|.+..+|..||+|.+..... +.....++.+|+.++..++|+||++++..+.....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 345789999999999999999999999999999999986543 35567788999999999999999999987754322
Q ss_pred -----CeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEE
Q 005916 102 -----KTVNIITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 172 (670)
Q Consensus 102 -----~~~~lVmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vK 172 (670)
..+++||||+.+|+|.+++..+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-SNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-CCCCEE
Confidence 1478999999999999988653 46899999999999999999999998 99999999999998 568999
Q ss_pred Eeeccchhhhccc----ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC
Q 005916 173 IGDLGLATIMEQA----NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK 247 (670)
Q Consensus 173 L~DFGla~~~~~~----~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~ 247 (670)
|+|||+++.+... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...++..+..+..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRY 262 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCC
Confidence 9999998765432 234578999999999775 4699999999999999999999999987 566666666666544
Q ss_pred CCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 248 PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 248 p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+ .++...+++++++|.+||. +|.+||++.++|+|||++.
T Consensus 263 ~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 D-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred C-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 3 3455678999999999996 8999999999999999864
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.56 Aligned_cols=256 Identities=30% Similarity=0.398 Sum_probs=204.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--- 101 (670)
.+.|++.+.||+|+||+||+|.+..++..||+|.+.... .......++.+|+.+++.++||||++++++|.....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 356899999999999999999999999999999886432 234456778899999999999999999998865331
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 -~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
..+|+||||+.+ +|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~~ 167 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 167 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCcccc
Confidence 357999999965 67766653 5889999999999999999999998 99999999999998 67899999999998
Q ss_pred hhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc--------------
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-------------- 244 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-------------- 244 (670)
...... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+..........+..
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 765432 34568999999999764 56899999999999999999999999764322222111110
Q ss_pred -------C-C------CC-----------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 245 -------G-I------KP-----------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 245 -------g-~------~p-----------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
. . .+ .......+.++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 0 00 00112234678999999996 89999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=352.39 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=192.9
Q ss_pred EEEecccCCeEEEEEEEc--CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 31 KEVIGKGAFKTVYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~--~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
.++||+|+||+||+|.++ .++..||+|.+..... ...+.+|+.+|+.++||||++++++|.......+|++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 468999999999999865 4778999998864321 23467899999999999999999999877677899999
Q ss_pred ecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe---CCCCcEEEeec
Q 005916 109 ELFTSGSLRQYRKKH---------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN---GNQGEVKIGDL 176 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~---~~~g~vKL~DF 176 (670)
||+. ++|.+++... ..+++..++.+++||+.||.|||+++ |+||||||+|||+. ...+.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9995 5888887532 25899999999999999999999998 99999999999995 24578999999
Q ss_pred cchhhhccc-----ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCH---------HHHHH
Q 005916 177 GLATIMEQA-----NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNS---------AQIYK 240 (670)
Q Consensus 177 Gla~~~~~~-----~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~---------~~i~~ 240 (670)
|++...... ......||+.|+|||++. ..|+.++|||||||++|+|++|.+||...... .++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 999776432 134568899999999764 35899999999999999999999999642211 11111
Q ss_pred HHhcCCCC-----------------------------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 241 KVSSGIKP-----------------------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 241 ~i~~g~~p-----------------------------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
.+.....| .......+..+.+||.+||. ||.+||||+|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 11000000 00001234678999999996 8999999999999999
Q ss_pred c
Q 005916 285 L 285 (670)
Q Consensus 285 ~ 285 (670)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=344.12 Aligned_cols=254 Identities=26% Similarity=0.460 Sum_probs=219.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|+++++.++||||+++++++.+.. .+|+
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 78 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS--NLYL 78 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--eEEE
Confidence 58899999999999999999999999999999875432 22445678899999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||+|.|||++ .+|.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC-
Confidence 9999999999999999899999999999999999999999998 99999999999998 6689999999998876544
Q ss_pred cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHH
Q 005916 187 AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~k 265 (670)
.....|++.|+|||.+ ...++.++||||||+++|+|++|..||.. ......++.+..+.. .++...++.++++|.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 231 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEGKV--RFPSFFSPDAKDLIRN 231 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCc--cCCccCCHHHHHHHHH
Confidence 3456789999999966 45688999999999999999999999977 445556666655432 3445568999999999
Q ss_pred cCC-CCCCCC-----CHHHHhcCccccccCC
Q 005916 266 CLV-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 266 cL~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
||. +|.+|+ +++++++||||+...+
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 996 799999 9999999999976544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=397.15 Aligned_cols=281 Identities=22% Similarity=0.343 Sum_probs=242.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|.+.++||+|+||.|.+++++.++..||.|++.+-..+. ...-.-|..|-.+|-.-+.+=||+++-.|.|+. ++|
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~--~LY 151 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQDER--YLY 151 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc--ceE
Confidence 34788999999999999999999999999999998643332 223455788999999999999999999998765 899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||+.||+|-.++.+..+++++.+++|+..|+.||.-||+.| +|||||||+|||++ ..|+|||+|||.+-.+...
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCC
Confidence 99999999999999999999999999999999999999999999 99999999999999 7899999999998888643
Q ss_pred -c--cccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc--CC
Q 005916 186 -N--AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KV 254 (670)
Q Consensus 186 -~--~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~~ 254 (670)
. ....+|||.|++||++. +.|+..||+||+|||+|||++|..||.. ......|.+|+.......+| ..
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~ 307 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETD 307 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccc
Confidence 2 35679999999999882 5699999999999999999999999987 67788899998875444444 34
Q ss_pred CChHHHHHHHHcCCCCCCCCC---HHHHhcCccccccCCCCCCCCCCCCCcCCCcccccccccc
Q 005916 255 KDPEVKSFIEKCLVPASQRLS---AKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLM 315 (670)
Q Consensus 255 ~s~~~k~fI~kcL~dP~~RpS---a~elL~hpf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (670)
.|+++++||+++|.+|..|+. ++++-.||||....|...+. ..++++|.+....+++.+
T Consensus 308 VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~iR~--~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNIRE--SVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred cCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhhhh--cCCCCCCcCCCCCccccc
Confidence 789999999999999999998 99999999999988854443 344577888777776654
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=357.01 Aligned_cols=254 Identities=30% Similarity=0.424 Sum_probs=205.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---- 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~---- 100 (670)
...|++.+.||+|+||+||+|.+..++..||+|++.... .......++.+|+.+++.++||||++++++|....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 356899999999999999999999999999999987432 23445667889999999999999999999875432
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
...+|+||||+.+ +|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~ 174 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 174 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCcc
Confidence 2368999999965 77777653 5889999999999999999999998 99999999999998 67899999999998
Q ss_pred hhcccc-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC------------
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI------------ 246 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~------------ 246 (670)
...... .....||+.|+|||++ ...++.++|||||||++|+|++|..||.+.. ....+..+....
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHhhh
Confidence 765432 3456799999999976 4578999999999999999999999998743 333333222100
Q ss_pred ---------CC-------------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 247 ---------KP-------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 247 ---------~p-------------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.| .......+..+++||.+||. +|.+|||+.++|+||||..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 00111234678999999996 8999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=390.77 Aligned_cols=262 Identities=26% Similarity=0.451 Sum_probs=220.4
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
..-..|++.+.||+|+||+||+|.+..++..||+|.+..... .......+..|+.+|+.|+|||||+++++|.+....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 334569999999999999999999999999999999875432 345567889999999999999999999999887777
Q ss_pred eEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCC-----CCeeeecCccccEEEeC-------
Q 005916 103 TVNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHD-----PPIIHRDLKCDNIFING------- 166 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g-----~~IIHrDLKpeNILl~~------- 166 (670)
.+|||||||.+|+|.+++.. .+.+++..++.|+.||+.||.|||..+ .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 89999999999999998875 357999999999999999999999854 34999999999999962
Q ss_pred ---------CCCcEEEeeccchhhhcccc-cccccCCCccCCCcccc---CCCCccceeeeccchhhhhhhccCCCCCCC
Q 005916 167 ---------NQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECR 233 (670)
Q Consensus 167 ---------~~g~vKL~DFGla~~~~~~~-~~~~~GTp~YmAPEvl~---~~ys~~~DIWSLGvilyeLltG~~Pf~~~~ 233 (670)
..+.+||+|||++..+.... ....+||+.|+|||++. ..|+.++||||||||||+|+||..||....
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 12358999999998764432 35568999999999763 358999999999999999999999998766
Q ss_pred CHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 234 NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 234 ~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...++...+..+.. ......++++.+||.+||. +|.+||++.++|.||||+..
T Consensus 248 ~~~qli~~lk~~p~--lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 248 NFSQLISELKRGPD--LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cHHHHHHHHhcCCC--CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 66677666655432 1223457899999999996 89999999999999999744
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=338.08 Aligned_cols=255 Identities=35% Similarity=0.577 Sum_probs=214.0
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL-QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~-~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
|.+.+.||+|+||.||+|.+..+|..||+|.+...... ........+.+|+.+++.++||||+++++++.+.....+++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 77889999999999999999999999999998754322 22345677899999999999999999999887765568999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
+|||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..+...
T Consensus 84 ~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 84 FMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCcccccccc
Confidence 9999999999999988888999999999999999999999998 99999999999998 6679999999998765331
Q ss_pred ----ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 186 ----NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 186 ----~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
......|+..|+|||.+. ..++.++|||||||++|+|++|..||........+.+..... ....++...++.++
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-TNPQLPSHISEHAR 239 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-CCCCCchhcCHHHH
Confidence 123356899999999764 468899999999999999999999998755555554443333 23344556788999
Q ss_pred HHHHHcCCCCCCCCCHHHHhcCcccc
Q 005916 261 SFIEKCLVPASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 261 ~fI~kcL~dP~~RpSa~elL~hpf~~ 286 (670)
+||..|+.+|.+||+++++++||||+
T Consensus 240 ~li~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 240 DFLGCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHhcCChhhCcCHHHHhcCcccc
Confidence 99955446999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.92 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=204.2
Q ss_pred CCeEEEEEEecccCCeEEEEEEE-----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWID 98 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d-----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d 98 (670)
.+.|++.++||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+|+.+ +|||||+++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 35689999999999999999975 3456789999887432 234566789999999999 89999999998865
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhc-------------------------------------------------------
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKH------------------------------------------------------- 123 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~------------------------------------------------------- 123 (670)
.. ..+++|||||.+|+|.+++...
T Consensus 83 ~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 PN-GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CC-CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 43 4689999999999999998753
Q ss_pred -------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc----cccccC
Q 005916 124 -------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIG 192 (670)
Q Consensus 124 -------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~G 192 (670)
..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....... .....+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCC
Confidence 24778899999999999999999998 99999999999998 56899999999997653321 223456
Q ss_pred CCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-C
Q 005916 193 TPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 269 (670)
Q Consensus 193 Tp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-d 269 (670)
++.|||||++ ...|+.++|||||||++|+|++ |..||.+......+...+..+..+ ..+...++.++++|.+||. +
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQGD 317 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCC
Confidence 7899999966 5679999999999999999997 999998755555555555555432 2345678899999999996 8
Q ss_pred CCCCCCHHHHhc
Q 005916 270 ASQRLSAKELLM 281 (670)
Q Consensus 270 P~~RpSa~elL~ 281 (670)
|.+|||+.++++
T Consensus 318 p~~RPs~~el~~ 329 (338)
T cd05102 318 PKERPTFSALVE 329 (338)
T ss_pred hhhCcCHHHHHH
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=344.88 Aligned_cols=254 Identities=22% Similarity=0.380 Sum_probs=208.7
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|+..++||+|+||+||+|.+..+++.||+|.+...... .......+.+|+.+++.++|+||+.+++.+.+.. .+|+|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--EEEEE
Confidence 67788999999999999999999999999998754332 2334456778999999999999999999886654 79999
Q ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 108 TELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||+.||+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||++......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCC
Confidence 9999999999988654 35899999999999999999999998 99999999999998 5679999999998765432
Q ss_pred c-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHH--HHHHHHhcCCCCCcccCCCChHHHH
Q 005916 186 N-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSA--QIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 186 ~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~--~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
. .....||+.|+|||++ ...++.++|||||||++|+|++|..||....... .....+.... +.......++.+++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-QEEYSEKFSPDARS 234 (285)
T ss_pred ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-hhhcCccCCHHHHH
Confidence 2 2446799999999977 4568999999999999999999999997633211 1122221111 22344557789999
Q ss_pred HHHHcCC-CCCCCCC-----HHHHhcCcccccc
Q 005916 262 FIEKCLV-PASQRLS-----AKELLMDPFLQVN 288 (670)
Q Consensus 262 fI~kcL~-dP~~RpS-----a~elL~hpf~~~~ 288 (670)
||.+||. +|.+||| +.++++||||+..
T Consensus 235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 9999997 8999999 9999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.17 Aligned_cols=255 Identities=28% Similarity=0.422 Sum_probs=210.3
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeEEEeCC----CC
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN-IIRFYNSWIDDQ----NK 102 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN-IVkl~~~~~d~~----~~ 102 (670)
|...+.||+|+||+||+|+++.+|..||+|+++...-. ...-....+|+.+|+.|+|+| ||.+++++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44456799999999999999999999999999975421 112234578999999999999 999999987654 24
Q ss_pred eEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 103 TVNIITELFTSGSLRQYRKKHK----KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~----~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
.+++|+||+.. +|..|+...+ .++...++.+++||+.||.|||+++ |+||||||.|||++ +.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccch
Confidence 79999999954 9999998765 5888999999999999999999999 99999999999999 589999999999
Q ss_pred hhhhccc--ccccccCCCccCCCccc-c-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC--C---
Q 005916 179 ATIMEQA--NAKSVIGTPEFMAPELY-D-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--A--- 249 (670)
Q Consensus 179 a~~~~~~--~~~~~~GTp~YmAPEvl-~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p--~--- 249 (670)
|+.+.-. .....++|.+|.|||++ . ..|+..+||||+|||++||+++.+-|.+.....++.+...--..| .
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 9977632 25677899999999966 3 369999999999999999999999999977777776655421100 0
Q ss_pred ----------ccc------------CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 250 ----------ALS------------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 250 ----------~~~------------~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.++ ...++...+++.+||. +|.+|+||+.+|.||||+..
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 011 1123588999999997 89999999999999999854
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=349.24 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=204.0
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.++.++..||+|.++.... ......+.+|+.+++.++||||+++++++.... .++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK--SLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC--eEE
Confidence 358899999999999999999999999999999875432 122345678999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSV 156 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecCC
Confidence 99999975 888887665 45899999999999999999999998 99999999999998 668999999999876533
Q ss_pred cc--cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC---C-----------
Q 005916 185 AN--AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG---I----------- 246 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g---~----------- 246 (670)
.. .....||+.|+|||++. ..++.++|||||||++|+|++|.+||.+...... ...+... .
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcch
Confidence 22 23457899999999764 3589999999999999999999999977433222 2211110 0
Q ss_pred -------CCC-------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 247 -------KPA-------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 247 -------~p~-------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+. ......++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 000 0112357889999999996 89999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=340.72 Aligned_cols=249 Identities=29% Similarity=0.503 Sum_probs=208.5
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|.+..++..||+|.++... ......+.+|+.+++.++||||+++++++.+.. .+|+
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~--~~~l 83 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD--KLWI 83 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--EEEE
Confidence 5778889999999999999999999999999987542 233456788999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++..+....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeEccCcc
Confidence 9999999999999998899999999999999999999999998 99999999999998 66899999999987654322
Q ss_pred --cccccCCCccCCCccc----cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc--CCCChH
Q 005916 187 --AKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KVKDPE 258 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl----~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~~~s~~ 258 (670)
.....|++.|+|||++ .+.++.++|||||||++|+|++|..||........+.........+..+. ...+..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 2445799999999976 34588999999999999999999999976444444433332222222222 134678
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
+++||.+||. +|.+||++.+++.|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999996 7999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=360.45 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=207.2
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---CeE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---KTV 104 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~---~~~ 104 (670)
|.+.+.||+|+||+||+|.+..+|..||+|.+... ........++.+|+.+|+.++||||+++++++..... ..+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 56788999999999999999999999999988632 2233456678899999999999999999998875431 268
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeeccc
Confidence 99999996 689988888888999999999999999999999998 99999999999998 678999999999976543
Q ss_pred cc---cccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc---------------
Q 005916 185 AN---AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--------------- 244 (670)
Q Consensus 185 ~~---~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~--------------- 244 (670)
.. .....+|+.|+|||++.+ .|+.++|||||||++|+|++|..||.+... ......+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP-IQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHHhhH
Confidence 22 234578999999997743 489999999999999999999999977433 222222211
Q ss_pred --------C-CCCC------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 245 --------G-IKPA------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 245 --------g-~~p~------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
. ..+. ......++++.+||.+||. +|.+|||+.++|.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 1 1111 1223347889999999996 89999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=340.90 Aligned_cols=250 Identities=29% Similarity=0.508 Sum_probs=209.3
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.++||+|+||+||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++.... ..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--RISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--EEEE
Confidence 4778899999999999999999999999999987542 2445567889999999999999999999987754 7899
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.+|+|..+ ..+++..+..++.||+.||.|||+++ |+|+||||+|||++ .++.+||+|||++..+....
T Consensus 77 v~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 77 CTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred EEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceeccccc
Confidence 9999999999765 35789999999999999999999998 99999999999998 67899999999998766555
Q ss_pred cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCC------HHHHHHHHhcCCCCCcccCCCChHH
Q 005916 187 AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN------SAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~------~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.....||+.|+|||++ ...++.++|||||||++|+|++|..||..... .......+.....+.......++++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 5667899999999976 45689999999999999999999999964221 1233333333333322234467899
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++||.+||. +|.+||++++++.||||+..
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999996 89999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=346.20 Aligned_cols=252 Identities=28% Similarity=0.469 Sum_probs=210.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|.+..+|..+|+|.+.... ......++.+|++++++++||||++++++|.+.. .+|+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG--EISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--EEEE
Confidence 4889999999999999999999999999999887432 2455677889999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+|||++ .++.+||+|||++......
T Consensus 77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCccccccc
Confidence 99999999999999988899999999999999999999997 46 99999999999998 5789999999998776554
Q ss_pred ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc--------------------
Q 005916 186 NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-------------------- 244 (670)
Q Consensus 186 ~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-------------------- 244 (670)
......|++.|+|||++. ..++.++|||||||++|+|++|..||... +.......+..
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP-DAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc-chhhHHHhhcCccccccccCCcccccCCCCC
Confidence 456678999999999774 45889999999999999999999999652 22222222211
Q ss_pred ----------------CCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 245 ----------------GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 245 ----------------g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
...|.......+.++++||.+||. +|.+|||+.++++||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 111111112356789999999996 8999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=346.59 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=213.0
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC--C
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD--Q 100 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~--~ 100 (670)
+.+|-.-.++||-|-.|.|..|+++.||+.+|+|++.- + ...++|+++.-.. .|||||.++++|... .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----S----PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----C----HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 33443335799999999999999999999999987752 1 3355788876555 899999999988543 2
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeec
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDL 176 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DF 176 (670)
.+++.+|||.++||+|+..++.++. |+|+++..|++||..|+.|||+++ |.||||||+|+|... .+..+||+||
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccc
Confidence 3578899999999999999998865 999999999999999999999999 999999999999973 3557999999
Q ss_pred cchhhhcc-cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCC---CHHHHHHHHhcCCC--CC
Q 005916 177 GLATIMEQ-ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIK--PA 249 (670)
Q Consensus 177 Gla~~~~~-~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~---~~~~i~~~i~~g~~--p~ 249 (670)
|+|+.... ....+.+-||+|.|||+++ +.|+..+|+||+||++|.|+||.+||.... -......+|..|.. |.
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 99998764 3467788899999999885 579999999999999999999999996532 23345667777763 44
Q ss_pred cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCC
Q 005916 250 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 250 ~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~ 290 (670)
.-+...+..++++|+++|. +|.+|+|+.+++.|||+.....
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 4344568999999999995 8999999999999999975533
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.70 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=202.1
Q ss_pred ecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 005916 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 113 (670)
Q Consensus 34 LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~g 113 (670)
||+|+||+||++.++.+|..||+|.+...... .......+..|+++++.++||||+++++++.+.. .+|+||||+.|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK-KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT--HLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh-cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--eEEEEEecCCC
Confidence 79999999999999999999999999754322 1222344567999999999999999999886543 79999999999
Q ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc-cccc
Q 005916 114 GSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSV 190 (670)
Q Consensus 114 GsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~-~~~~ 190 (670)
|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.++|+|||++....... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeecc
Confidence 99998876543 5899999999999999999999998 99999999999998 67899999999987765432 2345
Q ss_pred cCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCC---HHHHHHHHhcCCCCCcccCCCChHHHHHHHHc
Q 005916 191 IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 266 (670)
Q Consensus 191 ~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~---~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kc 266 (670)
.||+.|+|||++ ...++.++|||||||++|+|++|..||..... ...+.........+. .....+++++++|.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHH
Confidence 789999999976 45689999999999999999999999975322 223333333322221 2234678999999999
Q ss_pred CC-CCCCCCCH----HHHhcCccccccC
Q 005916 267 LV-PASQRLSA----KELLMDPFLQVNG 289 (670)
Q Consensus 267 L~-dP~~RpSa----~elL~hpf~~~~~ 289 (670)
|. +|.+||++ .+++.||||+...
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCC
Confidence 96 89999999 7788999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=354.83 Aligned_cols=254 Identities=29% Similarity=0.426 Sum_probs=204.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---- 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~---- 101 (670)
..|++.+.||+|+||+||+|.+..++..||+|++.... .......++.+|+.+|+.++||||++++++|.....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 46888999999999999999999999999999987432 123345667899999999999999999998764321
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|++|+++ +++|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCcccee
Confidence 3578999998 789988765 457999999999999999999999998 99999999999998 678999999999987
Q ss_pred hcccccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC--CC----------
Q 005916 182 MEQANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IK---------- 247 (670)
Q Consensus 182 ~~~~~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g--~~---------- 247 (670)
.... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ......+... ..
T Consensus 168 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCCC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhcch
Confidence 6442 345679999999997744 589999999999999999999999976332 2222222110 00
Q ss_pred -------------CC----cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 248 -------------PA----ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 248 -------------p~----~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+. ......++.+.+||.+||. +|.+|||+.++|.||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00 0011245678999999996 89999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=343.23 Aligned_cols=242 Identities=22% Similarity=0.307 Sum_probs=206.7
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe--CCCCeEEEEEe
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID--DQNKTVNIITE 109 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d--~~~~~~~lVmE 109 (670)
..||+|+++.||+|.. +|..||+|.++.... ......+.+.+|+.+|++++|||||++++++.+ ....++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 4789999999999976 799999999875432 233446778899999999999999999999877 44457899999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccccc
Q 005916 110 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 188 (670)
Q Consensus 110 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~ 188 (670)
||.+|+|.+++.+.+.+++.....++.|++.||.|||.. + ++||||||+|||++ +++.+||+|||++..+... ..
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~-~~ 178 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSP-PF 178 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhccc-cc
Confidence 999999999999888999999999999999999999985 6 88999999999998 6789999999999876443 23
Q ss_pred cccCCCccCCCcccc---CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHH
Q 005916 189 SVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~---~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~k 265 (670)
...||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+..+++..+.........+...++++++||.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 457899999999875 4789999999999999999999999987 456667777655444444555578999999999
Q ss_pred cCC-CCCCCCCHHHHhc
Q 005916 266 CLV-PASQRLSAKELLM 281 (670)
Q Consensus 266 cL~-dP~~RpSa~elL~ 281 (670)
||. +|.+|||+.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 996 8999999999986
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=331.30 Aligned_cols=250 Identities=30% Similarity=0.568 Sum_probs=211.2
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|++.+.||+|++|.||++.++.++..||+|.+..... .....+.+.+|+.+++.++||||+++++.|... ...+|++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv 78 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIV 78 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEE
Confidence 8899999999999999999999999999999875432 234566788999999999999999999987543 3468999
Q ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 108 TELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||+.+++|.+++... ..+++.+++.++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++..+...
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEeccc
Confidence 9999999999998763 45899999999999999999999998 99999999999998 6789999999998766432
Q ss_pred c--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 N--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
. .....|++.|+|||++ ...++.++|||||||++|+|++|..||.. .+.......+..+..+. .+...++++.+|
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 233 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLPP-MPKDYSPELGEL 233 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCC-CccccCHHHHHH
Confidence 2 3456789999999976 45688999999999999999999999976 34444444455554332 345678999999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
|.+||. +|.+||++.++++||||
T Consensus 234 i~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 234 IATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.28 Aligned_cols=251 Identities=33% Similarity=0.570 Sum_probs=217.5
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.+.+.||.|+||.||+|.+..+|..||+|.+..... .....+++..|+.+++.++||||+++++++....+..++++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 7788999999999999999999999999999875433 35566788999999999999999999998887666789999
Q ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhh-----cCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 108 TELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLH-----SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 108 mEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLH-----s~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
|||+.+++|.+++.. ...+++..++.++.||+.||.||| +.+ ++||||||+||+++ .++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEecccc
Confidence 999999999998875 367899999999999999999999 766 99999999999998 678999999999
Q ss_pred hhhhcccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCC
Q 005916 179 ATIMEQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 179 a~~~~~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
+....... .....|++.|+|||++. ..++.++|+||||+++|+|++|..||.. .+.....+.+..+..+ .++...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 234 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIKEGKFR-RIPYRY 234 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC-cCHHHHHHHHhcCCCC-CCcccc
Confidence 98875543 34567899999999764 5688999999999999999999999987 4466666667666543 345566
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+..+.+++.+||. +|.+||++.++|+|||+
T Consensus 235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 235 SSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 7899999999996 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=338.74 Aligned_cols=252 Identities=30% Similarity=0.518 Sum_probs=210.3
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
+|++.+.||.|+||.||+|.+..++..+++|.+... .....+.+.+|+++++.++||||++++++|.... ..|+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC--EEEE
Confidence 467788999999999999999999999999988643 2456677889999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+.+|+|..++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEcccccccccccc
Confidence 9999999999987754 467999999999999999999999998 99999999999998 6689999999998765432
Q ss_pred --ccccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC-CCcccCCCC
Q 005916 186 --NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKD 256 (670)
Q Consensus 186 --~~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~-p~~~~~~~s 256 (670)
......||+.|+|||++. ..++.++|||||||++|+|++|.+||.... .......+..... ....+...+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWS 235 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccC
Confidence 234567899999999762 347889999999999999999999998743 3333333433322 222344567
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+++||.+||. +|.+||++.++++||||+..
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 899999999996 89999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.96 Aligned_cols=254 Identities=30% Similarity=0.462 Sum_probs=212.6
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
++.|++.+.||+|+||.||+|.+..++..|++|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 84 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--KL 84 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--eE
Confidence 46789999999999999999999999999999998753 3556778899999999999999999999887654 79
Q ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
|+||||+.+++|..++.+ ...+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNV 161 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccceecc
Confidence 999999999999887654 457899999999999999999999998 99999999999998 57899999999886543
Q ss_pred ccc--cccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-CcccCC
Q 005916 184 QAN--AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKV 254 (670)
Q Consensus 184 ~~~--~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~ 254 (670)
... .....|++.|+|||++. ..++.++|||||||++|+|++|.+||... +....+..+.....+ ...+..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQPSK 240 (292)
T ss_pred ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCccCCCCcc
Confidence 321 24567899999999763 34788999999999999999999999764 344444444443332 223345
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+..+.+||.+||. +|.+||++.++++||||...
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 67899999999996 89999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=329.85 Aligned_cols=249 Identities=31% Similarity=0.567 Sum_probs=213.9
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.+.+.||+|+||.||+|.+..+|..|++|.+..... .......+.+|+.+++.++||||+++++++.+.. .+|+|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 77 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDKG--KLNIV 77 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--EEEEE
Confidence 6788999999999999999999999999999875432 2456678899999999999999999999987653 79999
Q ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 108 TELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++..+...
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCc
Confidence 9999999999998774 57899999999999999999999988 99999999999998 5689999999998876543
Q ss_pred c--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 N--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
. .....|++.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+..+..+. .....+..++++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPP-VSQMYSQQLAQL 232 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHH
Confidence 2 23457899999999764 5688999999999999999999999976 44555666666655433 334677899999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
|.+||. +|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999996 79999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=337.80 Aligned_cols=250 Identities=28% Similarity=0.529 Sum_probs=206.6
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC----C
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ----N 101 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~----~ 101 (670)
.|++.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.+++.+ +||||++++++|.... .
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3577789999999999999999999999999987432 2245678899999999 7999999999987643 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 102 KTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
..+|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEEccCCCc
Confidence 4689999999999999998864 46899999999999999999999998 99999999999998 6679999999998
Q ss_pred hhhccc--ccccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcc
Q 005916 180 TIMEQA--NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 251 (670)
Q Consensus 180 ~~~~~~--~~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~ 251 (670)
...... ......|++.|+|||++. ..|+.++|||||||++|+|++|..||.......... .+.....+...
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~ 237 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLK 237 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHhcCCCCCCC
Confidence 765432 234567999999999773 358889999999999999999999997644333333 23332222333
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
....+..+++||.+||. +|.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 34567899999999997 89999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=366.87 Aligned_cols=283 Identities=21% Similarity=0.371 Sum_probs=251.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.+.....||-|+||.|=++........+|+|++++.... ...+.+.+..|-+||..++.|.||++|..|.|.. ++|+
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k--yvYm 497 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV-DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK--YVYM 497 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc-chhHHHHHHhHHHHHHhcCchHHHHHHHHhccch--hhhh
Confidence 355677899999999999977666666999999876554 4677889999999999999999999999997654 8999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
+||-|-||.|+..++.++.|++..++.++..+++|++|||+++ ||+|||||+|.+++ +.|.+||.|||+|+.+..+
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCC
Confidence 9999999999999999999999999999999999999999999 99999999999998 7899999999999999875
Q ss_pred ccccccCCCccCCCc-cccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 186 NAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 186 ~~~~~~GTp~YmAPE-vl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
++.+++|||+|.||| +++++++.++|.||||+++|||++|.+||++ .++-..|..|.+|+....+++.+...+.++|+
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik 653 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIK 653 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHH
Confidence 478999999999999 5688999999999999999999999999998 78889999999999888899999999999999
Q ss_pred HcCC-CCCCCCC-----HHHHhcCccccccCCCCCCCCCCCCCcCCCccccccccccc
Q 005916 265 KCLV-PASQRLS-----AKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMS 316 (670)
Q Consensus 265 kcL~-dP~~RpS-----a~elL~hpf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (670)
++.. .|.+|+. +.++-+|-||....|.-.+...++++.+|.+....+...+.
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd 711 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFD 711 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhcc
Confidence 9775 6999985 89999999999888876655566777777776665554433
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=346.44 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=217.1
Q ss_pred EEE-EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEE
Q 005916 28 IRY-KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 28 yr~-~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~ 105 (670)
|++ .++||+|+|+.|-.|....+|.+||||+|.+.. .-.+.++.+|++++.++ .|+||++++++|.|+. .+|
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FY 152 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFY 152 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC----chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEE
Confidence 444 367999999999999999999999999998542 33477899999999999 7999999999998776 699
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC--CcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ--GEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~--g~vKL~DFGla~~~~ 183 (670)
+|||-+.||.|...|.+++.|+|.++..+++.|+.||.|||.+| |.||||||+|||....+ .-||||||.|..-+.
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 99999999999999999999999999999999999999999999 99999999999986322 348999999876543
Q ss_pred cc---------ccccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCC-------------C-C
Q 005916 184 QA---------NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSEC-------------R-N 234 (670)
Q Consensus 184 ~~---------~~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~-------------~-~ 234 (670)
.. ...+.+|+.+|||||+.. ..|+.++|.||||||+|.||+|.+||.+. . -
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 22 134678999999999652 36999999999999999999999999651 1 1
Q ss_pred HHHHHHHHhcCCC--CCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 235 SAQIYKKVSSGIK--PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 235 ~~~i~~~i~~g~~--p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
...++..|..|.. |..-+..++.+++++|..+|+ ++.+|++|.++|+|||++...
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 3457888999874 554455678999999999996 899999999999999998543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.85 Aligned_cols=252 Identities=32% Similarity=0.497 Sum_probs=209.6
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL--QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~--~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
|++.+.||+|+||+||+|.+ .+|..+|+|.+...... ........+.+|+++++.++||||+++++++.+. ..++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 78 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTIS 78 (265)
T ss_pred ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEE
Confidence 67889999999999999976 47889999998754321 1234456788999999999999999999998765 4899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+|+||||+||+++ .++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhc
Confidence 99999999999999998888999999999999999999999998 99999999999998 6789999999998765321
Q ss_pred --------ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 186 --------NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 186 --------~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
......|++.|+|||++. ..++.++|||||||++|+|++|..||......................+...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS 235 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence 123457899999999775 46889999999999999999999999764444443333222122223455678
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.++++||.+||. +|.+||++.++|.||||
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 899999999996 89999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.26 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=209.5
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|+..+.||+|+||+||+|.+..+|..||+|.+..... ........+.+|+.+|+.++|+||+.+++++.+.. .+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI-KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD--ALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--EEEEE
Confidence 6778899999999999999999999999999875432 22233456788999999999999999999886544 79999
Q ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 108 TELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||+.+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCC
Confidence 9999999999887653 46999999999999999999999998 99999999999998 5679999999998765432
Q ss_pred c-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHH---HHHHHHhcCCCCCcccCCCChHHH
Q 005916 186 N-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSA---QIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 186 ~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~---~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
. .....|++.|+|||++ ...++.++|+|||||++|+|++|..||....... .+...+..+ ........++.+.
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAK 233 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHH
Confidence 2 3456799999999976 4678999999999999999999999998643322 122222222 1223445678999
Q ss_pred HHHHHcCC-CCCCCCC-----HHHHhcCccccccCC
Q 005916 261 SFIEKCLV-PASQRLS-----AKELLMDPFLQVNGT 290 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpS-----a~elL~hpf~~~~~~ 290 (670)
+|+.+||. +|.+||+ +.+++.|+||+...+
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 99999996 8999999 899999999986544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.56 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=200.9
Q ss_pred EecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHH---HhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 005916 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL---KSLKHNNIIRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iL---k~L~HpNIVkl~~~~~d~~~~~~~lVmE 109 (670)
+||+|+||.||+|.+..+|..+|+|.+....... ........+|..++ ...+||||+.+++++...+ .+++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEcccccc-chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEEEEEe
Confidence 4899999999999999999999999987544322 22222334444433 3447999999999887544 7899999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccccccc
Q 005916 110 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 189 (670)
Q Consensus 110 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~~ 189 (670)
|+.+|+|.+++..++.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.++|+|||++..........
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccC
Confidence 9999999999998889999999999999999999999998 99999999999998 66899999999987665444445
Q ss_pred ccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCC--HHHHHHHHhcCCCCCcccCCCChHHHHHHHH
Q 005916 190 VIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRN--SAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265 (670)
Q Consensus 190 ~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~--~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~k 265 (670)
..||+.|+|||.+. ..++.++|||||||++|+|++|..||..... ...+..... ..+..++...++++++||.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--cCCcCCccccCHHHHHHHHH
Confidence 67999999999774 4589999999999999999999999975322 222222111 12333455578899999999
Q ss_pred cCC-CCCCCC-----CHHHHhcCccccccCC
Q 005916 266 CLV-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 266 cL~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
||. +|.+|+ |++++++||||+...+
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 996 899999 6999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.00 Aligned_cols=252 Identities=29% Similarity=0.511 Sum_probs=209.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC----
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD---- 99 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~---- 99 (670)
...|++.+.||.|+||+||+|.+..++..+|+|.+... ......+..|+.+++.+ +||||++++++|...
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 35678889999999999999999999999999988643 23345688899999999 799999999998643
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
....+|++|||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCc
Confidence 235789999999999999998764 45889999999999999999999998 99999999999998 67899999999
Q ss_pred chhhhccc--ccccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC
Q 005916 178 LATIMEQA--NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA 249 (670)
Q Consensus 178 la~~~~~~--~~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~ 249 (670)
++...... ......|++.|+|||++. ..++.++|||||||++|+|++|..||........+.. +.....+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~~~~~~ 245 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRNPPPK 245 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-HhhCCCCC
Confidence 98766432 234567999999999763 3588899999999999999999999977544443332 33332233
Q ss_pred cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 250 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 250 ~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
......+..+.+||.+||. +|.+||++.++|+||||
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 3334567899999999996 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=331.36 Aligned_cols=255 Identities=33% Similarity=0.565 Sum_probs=216.4
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccc-cCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV-LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~-~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
.|++.+.||+|+||.||+|.+..+|..||+|.+..... .........+.+|+.+++.++||||+++++++.+.....++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 48899999999999999999999999999998864321 12345567889999999999999999999998776666789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
++|||+.+++|.+++...+.+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECccccccccccc
Confidence 99999999999999988888999999999999999999999998 99999999999998 5679999999999765431
Q ss_pred -----ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 186 -----NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 186 -----~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
......|++.|+|||++. ..++.++|+|||||++|+|++|..||........+.+.. ....+..++...++++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA-TQPTKPMLPDGVSDAC 238 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-cCCCCCCCCcccCHHH
Confidence 123457899999999764 468899999999999999999999998755455454433 3333344566678899
Q ss_pred HHHHHHcCCCCCCCCCHHHHhcCccc
Q 005916 260 KSFIEKCLVPASQRLSAKELLMDPFL 285 (670)
Q Consensus 260 k~fI~kcL~dP~~RpSa~elL~hpf~ 285 (670)
++||.+||.+|..||++.+++.|||.
T Consensus 239 ~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 239 RDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHhcCcccCccHHHHhcCCCC
Confidence 99999999989999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=335.15 Aligned_cols=253 Identities=28% Similarity=0.512 Sum_probs=214.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||.|+||.||+|.++.++..+|+|.+.... .......+.+|+++++.++||||+++++++... ..+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEE
Confidence 4677889999999999999999999999999887542 235567788999999999999999999998765 47999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
++||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||||+||+++ +++.++|+|||.+.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHH
Confidence 99999999999999876 789999999999999999999999 87 99999999999998 578999999999887755
Q ss_pred cccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCC----CCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 185 ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC----RNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 185 ~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~----~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.......|++.|+|||.+ ...++.++|||||||++|+|++|..||... .......+.+.....+.......++++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 154 SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 443447889999999976 456899999999999999999999999764 233344444444443333333378899
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
++||.+||. +|.+|||+.+++.||||+.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 999999996 8999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=362.79 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=225.8
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
..+.-..|.+.+.||+|.|++|.+|++..+|..||+|.+.+... +...+..+.+|+++|+.|+|||||++|.+.....
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 34455679999999999999999999999999999999886543 3455666999999999999999999999887555
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+||||+.+|.+++|+.++++..+..++.++.|+++|++|||+++ |||||||.+||||+. +..+||+|||++.
T Consensus 129 --~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~-~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 129 --TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDE-NMNIKIADFGFST 203 (596)
T ss_pred --eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccccc-ccceeeeccccce
Confidence 79999999999999999999999999999999999999999999999 999999999999994 4579999999999
Q ss_pred hhcccc-cccccCCCccCCCccccC-CC-CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl~~-~y-s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
.+.... ..+.+|+|.|.|||++.+ .| .+.+|+||+|+++|.|++|.+||.+ .+...+...+..+... .+...+.
T Consensus 204 ~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~r--Ip~~ms~ 280 (596)
T KOG0586|consen 204 FFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYR--IPFYMSC 280 (596)
T ss_pred eecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeec--ccceeec
Confidence 987654 578999999999998864 35 6889999999999999999999987 5666666666666543 3344578
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+++++|+++|+ +|.+|++.+++..|.|+...
T Consensus 281 dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 281 DCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred hhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 99999999997 89999999999999999643
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.78 Aligned_cols=251 Identities=29% Similarity=0.527 Sum_probs=207.6
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC----
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ---- 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~---- 100 (670)
+.|++.+.||+|+||+||+|.++.++..+++|.+.... ...+.+.+|+.+++.+ .||||++++++|.+..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 56888999999999999999999999999999887542 2346788999999999 7999999999987644
Q ss_pred CCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 101 NKTVNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
...+|+||||+.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~-~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEc-cCCeEEECCC
Confidence 4568999999999999998765 357999999999999999999999998 99999999999998 5689999999
Q ss_pred cchhhhcccc--cccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 177 GLATIMEQAN--AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 177 Gla~~~~~~~--~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
|++....... .....|++.|+|||++. ..++.++|||||||++|+|++|.+||........+.+ +..+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~ 236 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK-IPRNPPP 236 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH-hhccCCC
Confidence 9987654322 34567899999999763 2478899999999999999999999976443343333 3333322
Q ss_pred Cc-ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 249 AA-LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 249 ~~-~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.. .....+..+++||.+||. +|.+|||+.+++.|||+
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 21 122356789999999996 89999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.04 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=203.3
Q ss_pred EecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHH---HHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 005916 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSE---VHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~E---i~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmE 109 (670)
+||+|+||.||+|.+..+|+.||+|.+........ ........| +.+++...||||+++++++.+.. .+|+|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEEEe
Confidence 48999999999999999999999999986543221 212223333 34455568999999999887554 7999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccccccc
Q 005916 110 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 189 (670)
Q Consensus 110 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~~ 189 (670)
|+.||+|.+++...+.+++..++.|+.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++..+.......
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccCCcC
Confidence 9999999999988889999999999999999999999998 99999999999998 56899999999987665544556
Q ss_pred ccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCC--CHHHHHHHHhcCCCCCcccCCCChHHHHHHHH
Q 005916 190 VIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265 (670)
Q Consensus 190 ~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~--~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~k 265 (670)
..|++.|+|||++.+ .++.++||||+||++|+|++|..||.... ....+...+.. .+..++...++.+.++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHH
Confidence 789999999998753 58999999999999999999999997642 22222222222 2233455568999999999
Q ss_pred cCC-CCCCCC-----CHHHHhcCccccccCCC
Q 005916 266 CLV-PASQRL-----SAKELLMDPFLQVNGTT 291 (670)
Q Consensus 266 cL~-dP~~Rp-----Sa~elL~hpf~~~~~~~ 291 (670)
||. +|.+|| ++.++++||||+...+.
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 996 799999 99999999999865443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=338.88 Aligned_cols=253 Identities=30% Similarity=0.508 Sum_probs=212.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++.|.+.. .+|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~--~~~ 93 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELW 93 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC--EEE
Confidence 567888999999999999999999999999999876432 23467889999999999999999999987644 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||+.+++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccccchhcccc
Confidence 99999999999999865 46899999999999999999999998 99999999999998 6789999999998765433
Q ss_pred c--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 N--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
. .....|++.|+|||.+. ..++.++|||||||++|+|++|..||........++.....+..+...+...++.+++|
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 2 23457899999999764 45889999999999999999999999874443444443333333333344567889999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
|.+||. +|.+||++.+++.||||...
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999996 89999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.50 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=205.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|++.+.||+|+||.||+|.+..++..||+|.++.... ......+.+|+.+++.|+||||+++++++.+.. .++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~--~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--SLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecCC--eEE
Confidence 458999999999999999999999999999999975432 122345678999999999999999999987554 799
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSI 156 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccCC
Confidence 9999996 5898887764 56899999999999999999999998 99999999999998 668999999999876543
Q ss_pred cc--cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC---C-----------
Q 005916 185 AN--AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG---I----------- 246 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g---~----------- 246 (670)
.. .....+++.|+|||++. ..++.++|||||||++|+|++|.+||..... ......+... .
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhcc
Confidence 22 23456799999999764 3578899999999999999999999987433 2222222110 0
Q ss_pred -------CCC-------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 247 -------KPA-------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 247 -------~p~-------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
.+. ......++.+++||.+||. +|.+|||+.++|+||||+..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 0112357789999999997 899999999999999998554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=340.21 Aligned_cols=259 Identities=22% Similarity=0.376 Sum_probs=213.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|++.+.||+|+||+||+|.+..++..||+|.+...... .......+..|+++++.++||||+++++.+.+. ..+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEE
Confidence 3588999999999999999999999999999999865432 234567789999999999999999999988654 3799
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+||||+.|++|.+++... ..+++..++.++.||+.||.|||+.+ ++||||||+|||++ .++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhccc
Confidence 999999999999998764 56899999999999999999999998 99999999999998 56899999999986543
Q ss_pred ccc-------------------------------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCC
Q 005916 184 QAN-------------------------------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSE 231 (670)
Q Consensus 184 ~~~-------------------------------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~ 231 (670)
... ....+||+.|+|||++ ...++.++|||||||++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 211 1234789999999976 45688999999999999999999999987
Q ss_pred CCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCC----HHHHhcCccccccCCC
Q 005916 232 CRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLS----AKELLMDPFLQVNGTT 291 (670)
Q Consensus 232 ~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpS----a~elL~hpf~~~~~~~ 291 (670)
... ...+..+.............+..+++||.+||. +|.+||| +.++|.||||+...+.
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~ 298 (316)
T cd05574 235 SNR-DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA 298 (316)
T ss_pred Cch-HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChh
Confidence 443 444444443322222222367899999999996 8999999 9999999999875543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=332.06 Aligned_cols=255 Identities=28% Similarity=0.480 Sum_probs=210.9
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ--SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~--s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
|+..+.||+|+||.||+|.+..+|..||+|.+....... .....+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 79 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS--HFN 79 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--eEE
Confidence 677899999999999999999999999999987543211 1234678899999999999999999999986544 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||+.+++|.+++.+.+.+++..+..|+.||+.||.|||+++ ++||||||+||+++.+...+||+|||++..+...
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999998889999999999999999999999998 9999999999999855457999999998776432
Q ss_pred c------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCC--HHHHHHHHhcCCCCCcccCCCC
Q 005916 186 N------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN--SAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 186 ~------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~--~~~i~~~i~~g~~p~~~~~~~s 256 (670)
. .....||..|+|||++. ..++.++||||||+++|+|++|..||..... .......+.........+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 12356889999999764 5689999999999999999999999964322 1222222222223344555677
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
+.+++|+.+||. +|.+||++.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 899999999996 799999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=335.66 Aligned_cols=250 Identities=28% Similarity=0.481 Sum_probs=206.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||.||+|.+..+|..||+|++.... ......+.+|+.+++.++||||+++++++.... .+|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~--~~~ 82 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE--KLW 82 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--EEE
Confidence 45888999999999999999999999999999987542 223456788999999999999999999987654 789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||+.+++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++..+...
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCccceeeccc
Confidence 99999999999999988888999999999999999999999998 99999999999998 6788999999999866432
Q ss_pred c--cccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcc--cCCCCh
Q 005916 186 N--AKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL--SKVKDP 257 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~--~~~~s~ 257 (670)
. .....|++.|+|||.+. ..++.++|||||||++|+|++|..||..................+..+ ....+.
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 2 23457899999999762 347889999999999999999999996543322222211111122211 123568
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
.+.+||.+||. +|.+|||++++|+|+|
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999996 8999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.89 Aligned_cols=250 Identities=25% Similarity=0.426 Sum_probs=201.3
Q ss_pred EEEEeccc--CCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 30 YKEVIGKG--AFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 30 ~~~~LG~G--~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
+.++||+| +|++||++.++.+|..||+|.+..... .....+.+.+|+.+++.++||||++++++|.... .+|+|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--EEEEE
Confidence 45789999 789999999999999999999875432 2345567888999999999999999999997665 79999
Q ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 108 TELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||+.+|+|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++++||+.+......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccc
Confidence 9999999999998764 45899999999999999999999998 99999999999998 6689999999865443211
Q ss_pred c---------cccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC----
Q 005916 186 N---------AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA---- 249 (670)
Q Consensus 186 ~---------~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~---- 249 (670)
. .....++..|+|||++.+ .|+.++|||||||++|+|++|..||............+ .+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh-cCCccccccc
Confidence 0 122356788999998753 58999999999999999999999997644333322222 111110
Q ss_pred ----------------------------------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 250 ----------------------------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 250 ----------------------------------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
......++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0112346789999999996 8999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.51 Aligned_cols=261 Identities=30% Similarity=0.523 Sum_probs=216.6
Q ss_pred CcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 005916 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 97 (670)
Q Consensus 18 ~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~ 97 (670)
+++.......|++.+.||.|+||+||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (296)
T cd06655 11 IVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFL 86 (296)
T ss_pred HHhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEe
Confidence 3444555567999999999999999999999999999999987543 233567889999999999999999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
+.. .+|+|+||+.+++|..++... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||
T Consensus 87 ~~~--~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg 160 (296)
T cd06655 87 VGD--ELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFG 160 (296)
T ss_pred cCc--eEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCc
Confidence 644 799999999999999988654 6899999999999999999999998 99999999999998 67899999999
Q ss_pred chhhhcccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 178 LATIMEQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 178 la~~~~~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
++....... .....|++.|+|||.+. ..++.++|||||||++|+|++|..||..................+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06655 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (296)
T ss_pred cchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCccc
Confidence 987664432 23457899999999764 568899999999999999999999998744434433332233222333455
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.++.+++||.+||. +|.+||++.+++.||||+..
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 67899999999996 89999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=331.48 Aligned_cols=251 Identities=34% Similarity=0.552 Sum_probs=210.8
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC-----HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-----PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s-----~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
|.+...||+|+||.||+|.+..++..||+|.+........ ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD-- 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Confidence 6678899999999999999999999999998875433221 233467889999999999999999999887654
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
+.++||||+.+++|.+++...+.+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCccc
Confidence 78999999999999999999889999999999999999999999998 99999999999998 6789999999998776
Q ss_pred cccc--------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 183 EQAN--------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 183 ~~~~--------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
.... .....|++.|+|||.+. ..++.++|+|||||++|+|++|..||........+ ..+..... ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~~ 234 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENAS-PEIPS 234 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCC-CcCCc
Confidence 5211 12346889999999764 56889999999999999999999999875444433 33333322 23445
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
..+..++++|.+||. +|.+||++.++++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 567899999999997 79999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=337.96 Aligned_cols=252 Identities=32% Similarity=0.535 Sum_probs=212.7
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||.|+||+||+|.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++++.... .+|+
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 79 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN--KLWI 79 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC--eEEE
Confidence 477888999999999999999989999999998754 3456678889999999999999999999987544 7999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+.+++|..++.+. +.+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccchhhccc
Confidence 99999999999998764 57999999999999999999999998 99999999999998 6789999999998765433
Q ss_pred c--cccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-CcccCCCC
Q 005916 186 N--AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKD 256 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~~s 256 (670)
. .....||+.|+|||++. ..++.++|||||||++|+|++|.+||... ........+..+..+ ...+...+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWS 235 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccCC
Confidence 2 24467899999999763 34778999999999999999999999774 444444455544332 22334567
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.++.+||.+||. +|.+||++.++|+||||...
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 899999999996 79999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.96 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=203.1
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|++.+.||.|+||+||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||+++++++.+.. .+|+|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v 77 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQES--RLYLI 77 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--eEEEE
Confidence 7889999999999999999999999999999875432 2223456788999999999999999999987654 79999
Q ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 108 TELFTSGSLRQYRKKH---KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGI 153 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCC
Confidence 99997 6888887653 46899999999999999999999998 99999999999998 678999999999876543
Q ss_pred cc--cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC-------------
Q 005916 185 AN--AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK------------- 247 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~------------- 247 (670)
.. .....+++.|+|||++. ..++.++|||||||++|+|+||.+||.+.......+........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 22 23446789999999764 35789999999999999999999999875444333332211000
Q ss_pred -------------CCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 248 -------------PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 248 -------------p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
........++++++||.+||. +|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 001122357899999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.68 Aligned_cols=250 Identities=30% Similarity=0.509 Sum_probs=209.0
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||.|+||+||+|....++..+|+|++..... ......+.+|+.+++.++||||+++++.+.+.. .+++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD--ELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC--EEEE
Confidence 58899999999999999999999999999998875432 235677899999999999999999999887654 7999
Q ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 107 ITELFTSGSLRQYRKKH---KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
|||++.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +++.++|+|||++..+.
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLG-EDGSVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccchHHHhc
Confidence 99999999999998764 45899999999999999999999998 99999999999998 56899999999998775
Q ss_pred ccc------cccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcc----
Q 005916 184 QAN------AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL---- 251 (670)
Q Consensus 184 ~~~------~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~---- 251 (670)
... .....|++.|+|||++.. .++.++|+|||||++|+|++|..||..... ...+..+.....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQNDPPSLETGAD 232 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhcCCCCCcCCccc
Confidence 432 134578999999997643 588999999999999999999999977433 3334333333221111
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
....++.+++||.+||. +|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 12456889999999996 89999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=339.74 Aligned_cols=251 Identities=29% Similarity=0.447 Sum_probs=202.6
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
+|.+.+.||+|+||.||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||+++++++.+.. .+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSDK--KLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--ceEE
Confidence 37888999999999999999999999999999976432 2223456778999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|+||+. ++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+...
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 77 VFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIP 152 (284)
T ss_pred EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCCC
Confidence 999996 578887765 567999999999999999999999998 99999999999998 5689999999998866432
Q ss_pred c--cccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC---------------
Q 005916 186 N--AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--------------- 246 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~--------------- 246 (670)
. .....+++.|+|||++.+ .++.++|||||||++|+|++|..||....+....++.+....
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 2 234567899999997643 478999999999999999999988654444443333322100
Q ss_pred ----CCC--------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 247 ----KPA--------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 247 ----~p~--------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.+. ......++++++||.+||. +|.+|||+.++|.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000 0112356889999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=328.48 Aligned_cols=250 Identities=30% Similarity=0.527 Sum_probs=210.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|.+.+.||.|+||.||+|.+..++..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+.. .+|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~ 76 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD--KLW 76 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC--EEE
Confidence 35888999999999999999999999999999997543 235678899999999999999999999887654 799
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
++|||+.+++|.+++... ..+++..++.++.|++.||.|||.++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchhhhh
Confidence 999999999999998876 78999999999999999999999998 99999999999998 678999999999887654
Q ss_pred cc--cccccCCCccCCCcccc-C---CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc--ccCCCC
Q 005916 185 AN--AKSVIGTPEFMAPELYD-E---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LSKVKD 256 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~-~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~s 256 (670)
.. .....|++.|+|||++. . .++.++|||||||++|+|++|.+||..................+.. .....+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence 32 34567899999999764 3 6889999999999999999999999875544444433333222211 122346
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
.++++||.+||. +|..|||+.+++.|||
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 789999999996 7999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.31 Aligned_cols=257 Identities=22% Similarity=0.419 Sum_probs=214.5
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
..+.|++.+.||+|+||+||+|.+..+|..||+|++.... .......+.+|+++++.++||||+++++++.+.. .
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 77 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN--N 77 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC--E
Confidence 4466888999999999999999999999999999887542 2445678899999999999999999999987664 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
+++||||+.+|+|.+++.+.+.+++..+..++.|++.||.|||+ ++ ++||||||+||+++ +++.++|+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGEL 154 (284)
T ss_pred EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccch
Confidence 99999999999999999888889999999999999999999997 56 99999999999998 6789999999998766
Q ss_pred cccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCH----------HHHHHHHhcCCCCCcc
Q 005916 183 EQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNS----------AQIYKKVSSGIKPAAL 251 (670)
Q Consensus 183 ~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~----------~~i~~~i~~g~~p~~~ 251 (670)
.........|+..|+|||++ ...++.++|||||||++|+|++|..||...... ......+.....+...
T Consensus 155 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd06620 155 INSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234 (284)
T ss_pred hhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence 44444566899999999965 567889999999999999999999999753321 1222333332222222
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
....+..+.+||.+||. +|.+|||+.++++||||...
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 22356789999999996 89999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=332.64 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=204.4
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHH-HHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHL-LKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~i-Lk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
.|++.+.||+|+||.||+|.+..+|..||+|+++.... .....++..|+.+ ++.++||||+++++++.... .+|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~--~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG--DVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC--cEE
Confidence 48889999999999999999999999999999875421 1223445556665 66779999999999987544 699
Q ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 106 IITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
++|||+. |+|.+++.. ...+++..++.++.||+.||.|||++ + ++||||||+|||++ .++.+||+|||++.
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~ 152 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISG 152 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeeccccc
Confidence 9999996 688777654 24689999999999999999999987 6 99999999999998 56899999999988
Q ss_pred hhccccc-ccccCCCccCCCcccc-----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 181 IMEQANA-KSVIGTPEFMAPELYD-----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 181 ~~~~~~~-~~~~GTp~YmAPEvl~-----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
.+..... ....|++.|+|||++. ..++.++|+|||||++|+|++|..||............+..+..+......
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd06617 153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232 (283)
T ss_pred ccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence 7654332 3357899999999764 357889999999999999999999997544433333444444333322334
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
.+.++++||.+||. +|.+||++.+++.||||+...
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 67899999999996 899999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.05 Aligned_cols=252 Identities=27% Similarity=0.517 Sum_probs=211.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.+..+|..||+|.++... .......+.+|+.++++++||||+++++++... ..+|+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEE
Confidence 4778899999999999999999999999999887431 344567889999999999999999999988764 37999
Q ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 107 ITELFTSGSLRQYRKKH---KKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
||||+.+++|..++... ..+++..+..++.||+.||.|||. ++ |+||||||+||+++ .++.+||+|||++..+
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVN-GNGQVKLCDFGVSGNL 153 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEEC-CCCCEEEeecCCcccc
Confidence 99999999999988763 479999999999999999999996 46 99999999999998 5789999999999876
Q ss_pred cccccccccCCCccCCCccccC-------CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHH---HHhcCCCCCccc
Q 005916 183 EQANAKSVIGTPEFMAPELYDE-------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK---KVSSGIKPAALS 252 (670)
Q Consensus 183 ~~~~~~~~~GTp~YmAPEvl~~-------~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~---~i~~g~~p~~~~ 252 (670)
.........|++.|+|||++.+ .++.++|||||||++|+|++|..||... .....+. .+..+. +...+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~-~~~~~ 231 (286)
T cd06622 154 VASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE-TYANIFAQLSAIVDGD-PPTLP 231 (286)
T ss_pred cCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc-chhhHHHHHHHHhhcC-CCCCC
Confidence 5554556678999999997742 3578999999999999999999999753 2233332 233332 33344
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...++++++||.+||. +|.+||++.+++.||||...
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 4578999999999996 79999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=330.59 Aligned_cols=247 Identities=33% Similarity=0.522 Sum_probs=204.0
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
...||+|+||+||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ..+++|+||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 86 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFMEQ 86 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEec
Confidence 358999999999999999999999999887432 34567789999999999999999999988654 479999999
Q ss_pred CCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc-
Q 005916 111 FTSGSLRQYRKKH-KKV--DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 186 (670)
Q Consensus 111 ~~gGsL~~~i~~~-~~l--se~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~- 186 (670)
+.+++|.+++... ..+ ++..+..++.||+.||.|||+++ |+||||||+||+++...+.++|+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999998764 455 88999999999999999999998 99999999999998657799999999987654322
Q ss_pred -cccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 187 -AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 187 -~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
.....|++.|+|||++.. .++.++||||||+++|+|++|..||............+........++...++++++|
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 234568999999998743 4789999999999999999999999764433332222211112233455677899999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+.+||. +|.+|||+.+++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999996 79999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.40 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=191.4
Q ss_pred EEEecccCCeEEEEEEEcC--CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 31 KEVIGKGAFKTVYKAFDEV--NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~--tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
+.+||+|+||+||+|.++. ++..||+|.+..... ...+.+|+.+|+.++||||+++++++.......+++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 4689999999999998654 668899998864321 23467899999999999999999999876667899999
Q ss_pred ecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe---CCCCcEEEeec
Q 005916 109 ELFTSGSLRQYRKKH---------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN---GNQGEVKIGDL 176 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~---~~~g~vKL~DF 176 (670)
||+. ++|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9986 5888776532 24889999999999999999999998 99999999999994 24578999999
Q ss_pred cchhhhcccc-----cccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCH---------HHHHH
Q 005916 177 GLATIMEQAN-----AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNS---------AQIYK 240 (670)
Q Consensus 177 Gla~~~~~~~-----~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~---------~~i~~ 240 (670)
|++....... .....||+.|+|||++.+ .++.++|||||||++|+|+||.+||...... .++.+
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 9998764321 245678999999997743 5899999999999999999999999642211 11111
Q ss_pred HHhc-CC--------------CC--------------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 241 KVSS-GI--------------KP--------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 241 ~i~~-g~--------------~p--------------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
.+.. +. .+ .......+..++++|.+||. ||.+|||+.|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 1100 00 00 00011234578899999996 8999999999999999
Q ss_pred c
Q 005916 285 L 285 (670)
Q Consensus 285 ~ 285 (670)
|
T Consensus 317 f 317 (317)
T cd07867 317 F 317 (317)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=329.02 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=213.0
Q ss_pred ecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 005916 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 113 (670)
Q Consensus 34 LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~g 113 (670)
||.|+||.||+|.+..++..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.. .+|+||||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--YIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc-hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--ccEEEEecCCC
Confidence 6999999999999999999999999975432 22345678999999999999999999999886554 79999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc-cccccC
Q 005916 114 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIG 192 (670)
Q Consensus 114 GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~-~~~~~G 192 (670)
++|.+++.+...+++..+..++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++....... .....|
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccC
Confidence 999999988888999999999999999999999998 99999999999998 57899999999998775432 344678
Q ss_pred CCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCC-CHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-C
Q 005916 193 TPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR-NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 269 (670)
Q Consensus 193 Tp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-d 269 (670)
++.|+|||.+ ...++.++|+||||+++|+|++|..||.... +....++.+..+......+...++.+++||.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 9999999976 4568999999999999999999999997643 25566666665444444555558899999999996 8
Q ss_pred CCCCCC-----HHHHhcCcccccc
Q 005916 270 ASQRLS-----AKELLMDPFLQVN 288 (670)
Q Consensus 270 P~~RpS-----a~elL~hpf~~~~ 288 (670)
|.+||+ ++|+++||||+..
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCC
Confidence 999999 9999999999854
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=333.54 Aligned_cols=251 Identities=26% Similarity=0.466 Sum_probs=204.7
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC---CC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD---QN 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~---~~ 101 (670)
..|.+.+.||+|+||+||+|.+..+|..+|+|.+.... .....+.+|+.+++.+ +||||+++++++... .+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 34678899999999999999999999999999875321 2235677899999999 799999999987532 33
Q ss_pred CeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 102 KTVNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
..+++||||+.||+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~kl~dfg 169 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFG 169 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEEEccCC
Confidence 579999999999999988653 356899999999999999999999998 99999999999998 56789999999
Q ss_pred chhhhcccc--cccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC-C
Q 005916 178 LATIMEQAN--AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-P 248 (670)
Q Consensus 178 la~~~~~~~--~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~-p 248 (670)
++..+.... .....|++.|+|||++. ..|+.++|||||||++|+|++|..||........+.+ +..... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~~~~~~ 248 (286)
T cd06638 170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRNPPPT 248 (286)
T ss_pred ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-ccccCCCc
Confidence 987664322 34557999999999763 3488999999999999999999999987544343332 222221 2
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
...+...+..+++||.+||. +|.+|||+.++|+|+||
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22334457789999999996 89999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=326.55 Aligned_cols=253 Identities=34% Similarity=0.543 Sum_probs=213.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL-QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~-~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+|+..+.||+|+||+||+|.+..++..|++|.+...... ...+..+.+.+|+.+++.++||||+++++++.+.. .+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED--NLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC--eEE
Confidence 367789999999999999999989999999998764322 23455678899999999999999999999886543 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
++|||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+|+||+|+||+++ .++.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceecccc
Confidence 99999999999999998888999999999999999999999998 99999999999998 5789999999998776543
Q ss_pred c-cccccCCCccCCCcccc-CC-CCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 N-AKSVIGTPEFMAPELYD-EN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 ~-~~~~~GTp~YmAPEvl~-~~-ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
. .....|++.|+|||.+. .. ++.++|+|||||++|+|++|..||........... +.........+...++.+++|
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHhcccCCCcCCCcCHHHHHH
Confidence 3 34567899999999664 34 89999999999999999999999977553333333 332222233445568999999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+.+||. +|.+||++.++|.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999996 89999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=332.64 Aligned_cols=253 Identities=30% Similarity=0.519 Sum_probs=214.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||.|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++++.+.. .+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS--KLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC--eEEE
Confidence 4778899999999999999999999999999987543 2344567889999999999999999999987664 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
|+||+.+++|.+++... ++++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++..+...
T Consensus 77 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeecccc
Confidence 99999999999998765 8999999999999999999999998 99999999999998 5789999999999877543
Q ss_pred -ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 186 -NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 186 -~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
......|++.|+|||++. ..++.++|||||||++|+|++|..||... +.......+..+..+.......++.+.++|
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 234567899999999764 46899999999999999999999999763 344444445444333322222678999999
Q ss_pred HHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 264 EKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 264 ~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
.+||. +|.+|||++++++||||+...
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 99995 899999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=339.96 Aligned_cols=257 Identities=30% Similarity=0.503 Sum_probs=213.2
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
....+.|++.+.||.|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||++++++|....
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 89 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD- 89 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 3344678889999999999999999999999999999875432 23466889999999999999999999987644
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+||||+.+++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.++|+|||++..
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 90 -ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQ 164 (297)
T ss_pred -EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCccceE
Confidence 79999999999999999865 46899999999999999999999998 99999999999998 678999999999876
Q ss_pred hcccc--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 182 MEQAN--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 182 ~~~~~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
..... .....|++.|+|||.+ ...++.++|+|||||++|+|++|..||........++.....+..+...+...++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHH
Confidence 54332 2345789999999976 45688999999999999999999999976444333333222232233344556788
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+++||.+||. +|.+||++.++|+||||+..
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 9999999996 79999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.22 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=206.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC---C
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ---N 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~---~ 101 (670)
..|.+.+.||+|+||.||+|.+..+|..+|+|.+.... .....+.+|+.+++.+ +||||++++++|.... .
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 45788899999999999999999999999999886432 2245677899999999 8999999999987543 2
Q ss_pred CeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 102 KTVNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
..+|+||||+.+|+|.+++.. ...+++..++.++.|++.||.|||.++ ++||||||+||+++ .++.+||+|||
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl~dfg 173 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKLVDFG 173 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEeecc
Confidence 468999999999999998753 457899999999999999999999998 99999999999998 67889999999
Q ss_pred chhhhcccc--cccccCCCccCCCccccC------CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-
Q 005916 178 LATIMEQAN--AKSVIGTPEFMAPELYDE------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP- 248 (670)
Q Consensus 178 la~~~~~~~--~~~~~GTp~YmAPEvl~~------~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p- 248 (670)
++....... .....|++.|+|||++.. .++.++|||||||++|+|++|.+||........+. .+..+..+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~~~ 252 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRNPPPT 252 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-HHhcCCCCC
Confidence 988765432 234578999999997642 36889999999999999999999998744333333 33333222
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
...+......+++||.+||. +|.+||++.++++||||+
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 11223345789999999996 899999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.32 Aligned_cols=250 Identities=30% Similarity=0.501 Sum_probs=214.9
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
+|++.++||.|+||.||.+.+..++..+++|.+..... +.....++.+|+.++++++||||+++++++.+.. .+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN--TLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--eEEE
Confidence 48899999999999999999999999999999876542 2455667889999999999999999999997654 7999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||.+|+|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++.....
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGS 153 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEccc
Confidence 99999999999998775 46899999999999999999999998 99999999999998 568999999999876644
Q ss_pred cc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 185 AN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
.. .....|++.|+|||++. ..++.++||||||+++|+|++|..||.. .+.......+..+..+. .....+..+++
T Consensus 154 ~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08221 154 EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELIS 231 (256)
T ss_pred ccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHH
Confidence 32 34567899999999764 4688999999999999999999999976 45566666666654433 33556789999
Q ss_pred HHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 262 FIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
||.+||. +|.+||++.++|+|||+
T Consensus 232 ~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 232 LVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHcccCcccCCCHHHHhhCcCC
Confidence 9999996 79999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=331.54 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=207.5
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++||||++++++|.... .+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~ 77 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR--KLHL 77 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--EEEE
Confidence 58899999999999999999999999999998875432 1223455788999999999999999999987654 7899
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.++.|..++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCCc
Confidence 9999999999888777778999999999999999999999998 99999999999998 66899999999998765432
Q ss_pred --cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC-----------------
Q 005916 187 --AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG----------------- 245 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g----------------- 245 (670)
.....++..|+|||++. ..++.++|||||||++|+|++|.+||.+..+...++......
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 23456889999999764 458899999999999999999999998755544443322110
Q ss_pred --C-CCCc--------ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 246 --I-KPAA--------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 246 --~-~p~~--------~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
. .+.. .....+..+.+||.+||. +|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 0000 012346789999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=321.23 Aligned_cols=253 Identities=39% Similarity=0.621 Sum_probs=218.4
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|++.+.||+|++|.||+|.+..+|..|++|++..... .....+.+.+|+.++++++||||+++++.+.+.....+++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 7788999999999999999999999999999875442 24567889999999999999999999999876633579999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc-
Q 005916 108 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~- 186 (670)
|||+.+++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++ .++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEcccccEEecccccc
Confidence 999999999999998889999999999999999999999988 99999999999998 57899999999988776543
Q ss_pred ---cccccCCCccCCCccccC-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 187 ---AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 187 ---~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
.....++..|+|||.+.. .++.++||||||+++|+|++|..||....+.......+..+......+...+..+++|
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence 345678999999997754 4899999999999999999999999875544454444444333444555668999999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
|.+||. +|.+||++.+++.||||
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHhCcCChhhCCCHHHHhhCCCC
Confidence 999996 79999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=330.66 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=206.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.+. ..+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeEE
Confidence 37899999999999999999999999999999876442 234456788999999999999999999998764 37999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+ +++|.+++.. .+.+++..++.++.||+.||.|||+++ ++|+||||+||+++ ..+.++|+|||++......
T Consensus 77 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLIS-ADGVLKIADFGLARLFSEE 152 (286)
T ss_pred Eeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEc-CCCcEEEeeeeecccccCC
Confidence 99999 9999998865 457999999999999999999999998 99999999999998 5789999999998876543
Q ss_pred c---cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC------------
Q 005916 186 N---AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP------------ 248 (670)
Q Consensus 186 ~---~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p------------ 248 (670)
. .....|++.|+|||.+. ..++.++|||||||++|+|++|.+||.+..+...+...+..-..+
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 3 34457899999999763 347899999999999999999988887644333322222110000
Q ss_pred --------C-------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 249 --------A-------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 249 --------~-------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
. ......+..+.+||.+||. +|.+|||++++|.||||.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0112345889999999996 899999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=328.40 Aligned_cols=250 Identities=29% Similarity=0.435 Sum_probs=213.1
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|++.+.||.|+||.||+|.+..++..||+|.+..... ......+.+.+|++++++++||||+++++++.+. ..+++|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 78 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE--ENMYLV 78 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--CeEEEE
Confidence 7899999999999999999999999999999985433 2334577899999999999999999999988654 479999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-c
Q 005916 108 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-N 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~-~ 186 (670)
+||+.|++|.+++.....+++..+..|+.||+.||.|||.++ ++|+||+|+|||++ .++.++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCcc
Confidence 999999999999988888999999999999999999999998 99999999999998 6789999999998776543 2
Q ss_pred cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCC--HHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 187 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN--SAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~--~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
.....|+..|+|||++. ..++.++|+||||+++|+|++|..||..... ...+...... .....+...+..+.++|
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAI 233 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHH
Confidence 34567899999999764 5579999999999999999999999987443 3444333332 22234445678999999
Q ss_pred HHcCC-CCCCCCCH--HHHhcCccc
Q 005916 264 EKCLV-PASQRLSA--KELLMDPFL 285 (670)
Q Consensus 264 ~kcL~-dP~~RpSa--~elL~hpf~ 285 (670)
.+||. +|.+||++ ++++.||||
T Consensus 234 ~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 234 NKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHccCChhHcCCccHHHHhcCCCC
Confidence 99996 89999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=351.50 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=199.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEc--CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~--~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
..|++.+.||+|+||.||+|... .++..||+|.+.... ...+|+.+|+.|+|||||+++++|.... .
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~~~--~ 160 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRWKS--T 160 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEeeCC--E
Confidence 46999999999999999999754 456889998876321 2457999999999999999999887554 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||++. ++|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..+.
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLD 236 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCccccccC
Confidence 999999995 689999987888999999999999999999999998 99999999999998 67899999999997664
Q ss_pred ccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCH--HHHHHHHhc------------
Q 005916 184 QAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS--AQIYKKVSS------------ 244 (670)
Q Consensus 184 ~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~--~~i~~~i~~------------ 244 (670)
... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.... ...+..+..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 432 23467999999999775 56899999999999999999999999764321 111111111
Q ss_pred --------------CCCC-Cccc-----CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 245 --------------GIKP-AALS-----KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 245 --------------g~~p-~~~~-----~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...+ ...+ ...+.++++||.+||. +|.+|||+.++|.||||+..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0000 0011 1245688999999996 89999999999999999754
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.84 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=211.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|+..+.||.|++|.||+|.+..++..||+|.+.... ......++.+|+++++.++||||++++++|.+.....+|+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 4788899999999999999999999999999887542 2345677899999999999999999999998776668999
Q ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 107 ITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
||||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeeccccccc
Confidence 9999999999887653 356899999999999999999999998 99999999999998 5679999999998766
Q ss_pred cccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCC----CCHHHHHHHHhcCCCCC---ccc--
Q 005916 183 EQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC----RNSAQIYKKVSSGIKPA---ALS-- 252 (670)
Q Consensus 183 ~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~----~~~~~i~~~i~~g~~p~---~~~-- 252 (670)
.........++..|+|||.+ ...++.++|||||||++|+|++|..||... .........+.....+. ...
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd06621 156 VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235 (287)
T ss_pred cccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence 54444456788999999966 457899999999999999999999999764 22334444444322111 111
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...++.+++||.+||. +|.+|||+.|++.||||+..
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1235789999999996 89999999999999999644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.72 Aligned_cols=258 Identities=21% Similarity=0.348 Sum_probs=214.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||+|+||.||+|.+..++..||+|.+..... ........+.+|+.+++.++||||+++++++... ..+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEEE
Confidence 47889999999999999999999999999998875432 2234566788999999999999999999988654 37999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
||||+.||+|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+|||++ ..|.+||+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCc
Confidence 9999999999999998889999999999999999999999998 99999999999998 6789999999988642100
Q ss_pred ----------------ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 186 ----------------NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 186 ----------------~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
......|++.|+|||.+ ...++.++|||||||++|+|++|..||.+ ....+++..+..+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIE 234 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccC
Confidence 01234678899999965 56789999999999999999999999987 4556666666554322
Q ss_pred Cc-ccCCCChHHHHHHHHcCC-CCCCCCC---HHHHhcCccccccCCC
Q 005916 249 AA-LSKVKDPEVKSFIEKCLV-PASQRLS---AKELLMDPFLQVNGTT 291 (670)
Q Consensus 249 ~~-~~~~~s~~~k~fI~kcL~-dP~~RpS---a~elL~hpf~~~~~~~ 291 (670)
.. .....++++++||.+||. +|.+||+ +.++|.||||....+.
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 235 WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 21 222467889999999996 7999997 8999999999765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.07 Aligned_cols=251 Identities=35% Similarity=0.612 Sum_probs=212.3
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
+|.+.+.||+|+||.||+|.+..++..||+|.++.... .....+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEEE
Confidence 47889999999999999999999999999999886543 245778899999999999999999999987544 47999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|+||+.+++|.+++...+.+++..++.++.|++.||.|||+++ |+||||+|+||+++ .++.+||+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 77 FMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred EEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCCC
Confidence 9999999999999988888999999999999999999999998 99999999999998 57899999999988765432
Q ss_pred c------ccccCCCccCCCccccC-C---CCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccC--C
Q 005916 187 A------KSVIGTPEFMAPELYDE-N---YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK--V 254 (670)
Q Consensus 187 ~------~~~~GTp~YmAPEvl~~-~---ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~--~ 254 (670)
. ....|++.|+|||++.. . ++.++||||||+++|+|++|..||....+.......+..+.. ..++. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHK-PPIPDSLQ 232 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCC-CCCCcccc
Confidence 1 13567899999997753 3 788999999999999999999999775444444444444322 22333 3
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.++.+.+||.+||. +|.+||++.+++.|||+
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 47899999999996 79999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=347.80 Aligned_cols=246 Identities=27% Similarity=0.387 Sum_probs=194.6
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||.||+|.+..++..||+|..... ....|+.+++.++||||+++++++.... ..+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 133 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGA--ITC 133 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCC--eeE
Confidence 4599999999999999999999999999999975422 1346999999999999999999987654 789
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+|||++. |+|.+++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.....
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCcccccccc
Confidence 9999995 588888765 467999999999999999999999998 99999999999998 667999999999875433
Q ss_pred c-ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCC-CCCCC---------HHHHHHHHhc-CCCCCcc
Q 005916 185 A-NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPY-SECRN---------SAQIYKKVSS-GIKPAAL 251 (670)
Q Consensus 185 ~-~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf-~~~~~---------~~~i~~~i~~-g~~p~~~ 251 (670)
. ......||+.|+|||++ ...|+.++|||||||++|+|+++..|+ ..... ...+.+.+.. +..|..+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 2 23456799999999976 457999999999999999999865554 32111 1112221211 1111111
Q ss_pred c------------------------------CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 252 S------------------------------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 252 ~------------------------------~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+ ...+..+.+||.+||. +|.+||||.|+|+||||+.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1 1235677889999996 8999999999999999974
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.79 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=206.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||.||+|.+..+|..||+|.++..... ......+.+|+.++++++||||+++++++.+.....++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4689999999999999999999999999999999764321 12223456799999999999999999998876656799
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++ ..+.+||+|||++.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeeecCC
Confidence 99999964 88887765 367999999999999999999999998 99999999999998 678999999999987654
Q ss_pred c--ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC-CC-----------
Q 005916 185 A--NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-KP----------- 248 (670)
Q Consensus 185 ~--~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~-~p----------- 248 (670)
. ......+++.|+|||++. ..++.++|||||||++|+|++|.+||... +....+..+.... .+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK-SEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 3 223345688999999774 45889999999999999999999999874 4444433332210 00
Q ss_pred -----Ccc-----------cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 -----AAL-----------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 -----~~~-----------~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
... ....++.+++||.+||. +|.+|||+.++|.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 000 01247889999999996 89999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.23 Aligned_cols=251 Identities=28% Similarity=0.502 Sum_probs=212.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+++.++||||+++++.+... ..+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEEE
Confidence 37899999999999999999999999999999975432 334567889999999999999999999988654 37999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
||||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.+++.+||+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999999998764 35899999999999999999999998 999999999999985566789999999987654
Q ss_pred cc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 185 AN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 185 ~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
.. .....|++.|+|||.+. ..++.++||||||+++|+|++|..||... +.......+..+... ..+...++.++++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 232 (256)
T cd08220 155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFA-PISDRYSPDLRQL 232 (256)
T ss_pred CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-chHHHHHHHHhcCCC-CCCCCcCHHHHHH
Confidence 32 23467899999999775 45788999999999999999999999774 444444444444322 2344567899999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
|.+||. +|.+|||+.+++.||||
T Consensus 233 i~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 233 ILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHccCChhhCCCHHHHhhCCCC
Confidence 999996 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=369.62 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=206.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeee-EEEeC---C
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYN-SWIDD---Q 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~-~~~d~---~ 100 (670)
..+++.++|.+|||+.||+|.+...|..||+|++-.. +...++.+.+||.+||.| .|||||.|++ +.... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 3577889999999999999999998899999988654 477889999999999999 5999999999 33222 1
Q ss_pred -CCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 101 -NKTVNIITELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 101 -~~~~~lVmEy~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
...++|+||||.||.|-+++.. +.+|+|.++.+|++|++.||.+||...|||||||||-+||||+ .+|+.||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCccc
Confidence 1357899999999999999884 3569999999999999999999999999999999999999998 67899999999
Q ss_pred chhhhcccc--cc---------cccCCCccCCCccc----cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHH
Q 005916 178 LATIMEQAN--AK---------SVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242 (670)
Q Consensus 178 la~~~~~~~--~~---------~~~GTp~YmAPEvl----~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i 242 (670)
.|+-.-... .. ...-||.|+|||.+ +...++|+|||+|||+||-|+.+..||.+.... .|
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----aI 266 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----AI 266 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----eE
Confidence 986432211 00 12459999999965 346899999999999999999999999773222 25
Q ss_pred hcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 243 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 243 ~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
..+.+..+....++..+++||..||+ +|.+||++.|++.+-+
T Consensus 267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 55555444445677899999999996 8999999999997543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.50 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=213.3
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
.++||.|.||+||-|+++.+|+.||||+|.+-++. ......+++|+.||++++||.||.+--.|...+ .+++|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp--~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e--rvFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP--TKQESQLRNEVAILQNLHHPGIVNLECMFETPE--RVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCC--CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc--eEEEEehh
Confidence 57999999999999999999999999999876654 344578899999999999999999988776554 79999999
Q ss_pred CCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--CCcEEEeeccchhhhcccc
Q 005916 111 FTSGSLRQYRK--KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 111 ~~gGsL~~~i~--~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~g~vKL~DFGla~~~~~~~ 186 (670)
+.| ++.++|. ..+++++...+.++.|||.||.|||-++ |+|+||||+|||+... .-++||||||+|+++.+..
T Consensus 645 l~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 645 LHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 955 6666554 3588999999999999999999999999 9999999999999733 3479999999999997754
Q ss_pred -cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC--CCCCcccCCCChHHHHH
Q 005916 187 -AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAALSKVKDPEVKSF 262 (670)
Q Consensus 187 -~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g--~~p~~~~~~~s~~~k~f 262 (670)
.++++|||.|+|||++ +++|+..-|+||.|||+|.-++|..||.+.. +|-..|... ..|...++.+++++.+|
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE---dIndQIQNAaFMyPp~PW~eis~~Aidl 798 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE---DINDQIQNAAFMYPPNPWSEISPEAIDL 798 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc---chhHHhhccccccCCCchhhcCHHHHHH
Confidence 6789999999999977 5789999999999999999999999997643 444445543 34555556678999999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
|..+|+ +-++|.|..+.|.|||+|...
T Consensus 799 In~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 799 INNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHHhcchHhhccchhhhcch
Confidence 999995 789999999999999998653
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.36 Aligned_cols=250 Identities=25% Similarity=0.491 Sum_probs=212.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||++.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEEE
Confidence 48899999999999999999999999999999875433 234456788999999999999999999988654 47999
Q ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
||||+.+++|.+++.... .+++..+..|+.||+.||.|||+++ ++|+||+|+|||++ .++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNS 153 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecCc
Confidence 999999999999887643 5899999999999999999999998 99999999999998 567999999999876644
Q ss_pred cc--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 185 AN--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
.. .....|++.|+|||++ .+.++.++|+|||||++|+|++|..||.. .+...+...+..+..+. .+...+..+++
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08218 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP-VSSHYSYDLRN 231 (256)
T ss_pred chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCC-CcccCCHHHHH
Confidence 32 2345689999999976 45678899999999999999999999976 45555665665555433 34456789999
Q ss_pred HHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 262 FIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+|.+||. +|.+||++.++|+||||
T Consensus 232 li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 232 LVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHhhCChhhCcCHHHHhhCcCC
Confidence 9999996 79999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=323.48 Aligned_cols=252 Identities=33% Similarity=0.550 Sum_probs=217.4
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|++|.||+|.+..+|..|++|.+..... ......+.+|+.+++.++||||+++++++... ..+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEE
Confidence 37888999999999999999999999999999875432 25567889999999999999999999998765 47999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+.+++|.+++.....+++..++.++.||+.||.|||+ .+ ++||||+|+||+++ .++.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENT 153 (264)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceecccC
Confidence 99999999999999988899999999999999999999999 88 99999999999998 5789999999998876543
Q ss_pred cc--ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCC--CHHHHHHHHhcCCCCCcccCC-CChHH
Q 005916 186 NA--KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGIKPAALSKV-KDPEV 259 (670)
Q Consensus 186 ~~--~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~--~~~~i~~~i~~g~~p~~~~~~-~s~~~ 259 (670)
.. ....|+..|+|||.+. ..++.++|+||||+++|+|++|..||.... ...+..+.+.....+. +... .+..+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 232 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS-LPAEEFSPEF 232 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC-CCcccCCHHH
Confidence 32 2567899999999764 568889999999999999999999997754 5556666666544333 3333 67899
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.++|.+||. +|.+||++.+++.||||+.
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 999999996 7999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=356.77 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=200.3
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
.+..|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|++|+|||||++++++.... .
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~--~ 234 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGG--L 234 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECC--E
Confidence 45679999999999999999999999999999995432 23467999999999999999999887644 7
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 104 VNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.++|||++. ++|..++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceec
Confidence 899999995 6888887764 56999999999999999999999998 99999999999998 5689999999999776
Q ss_pred cccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCC-------CHHHHHHHHhcCCC---
Q 005916 183 EQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR-------NSAQIYKKVSSGIK--- 247 (670)
Q Consensus 183 ~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~-------~~~~i~~~i~~g~~--- 247 (670)
.... .....||+.|||||++ ...++.++|||||||++|||++|..|+.... ...++.+.+.....
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 4322 2245799999999976 4569999999999999999999876653211 12344444433211
Q ss_pred --CC-------------------------ccc--CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 248 --PA-------------------------ALS--KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 248 --p~-------------------------~~~--~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+. .|. ...+..+++||.+||. ||.+|||+.|+|+||||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 011 1235689999999997 8999999999999999973
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=330.82 Aligned_cols=250 Identities=28% Similarity=0.457 Sum_probs=204.0
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|++.+.||.|+||.||+|+++.+|..||+|.+..... .......+.+|++++++++||||+++++++.+.. ..++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~v 77 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYLV 77 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccCC--cEEEE
Confidence 7889999999999999999999999999998875432 2233457889999999999999999999886544 79999
Q ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 108 TELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||+. ++|..++.. ...+++..++.++.||+.||.|||.++ ++||||+|+||+++ .++.+||+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVP 153 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccC
Confidence 99995 689888765 356899999999999999999999998 99999999999998 6789999999998766433
Q ss_pred c--cccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC------------
Q 005916 186 N--AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA------------ 249 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~------------ 249 (670)
. .....+++.|+|||++.+ .++.++|||||||++|+|+||..||..........+.+.....+.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 2 234467899999997643 368899999999999999999999987554444443332111100
Q ss_pred --------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 250 --------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 250 --------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
......+++++++|.+||. +|.+|||++++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112356889999999996 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.48 Aligned_cols=249 Identities=23% Similarity=0.405 Sum_probs=203.8
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHH-HhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL-KSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iL-k~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
+.||.|+||.||+|.+..+|..||+|.+....... ......+..|..++ ..++||||++++++|... ..+|+||||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEec
Confidence 57999999999999999999999999987543221 22333455565554 445999999999998654 379999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccccccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 190 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~~~ 190 (670)
+.+++|.+++...+.+++..+..++.||+.||.|||+++ ++||||+|+|||++ .++.+||+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc--cccC
Confidence 999999999998889999999999999999999999998 99999999999998 578999999998876433 3345
Q ss_pred cCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCCChHHHHHHHHcC
Q 005916 191 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 191 ~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~s~~~k~fI~kcL 267 (670)
.|++.|+|||.+. ..++.++||||||+++|+|++|.+||.. .+....+..+..+.. +.......++.+.+||.+||
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 7899999999764 4578999999999999999999999976 455566655554432 33334456899999999999
Q ss_pred C-CCCCCCC---HHHHhcCccccccC
Q 005916 268 V-PASQRLS---AKELLMDPFLQVNG 289 (670)
Q Consensus 268 ~-dP~~RpS---a~elL~hpf~~~~~ 289 (670)
. +|.+||+ +.|+|.||||+...
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCC
Confidence 6 8999995 47999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=324.35 Aligned_cols=248 Identities=33% Similarity=0.572 Sum_probs=207.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|.+.+.||.|+||.||+|.+..++..|++|.+.... ..+.+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEE
Confidence 45888899999999999999999989999999887432 267789999999999999999999998765 4799
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+++||+.+++|.+++.. ...+++..++.++.||+.||.|||..+ ++||||+|+||+++ .++.+||+|||++.....
T Consensus 75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchhccc
Confidence 99999999999999876 456899999999999999999999998 99999999999998 578999999999987755
Q ss_pred cc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC-CCCcccCCCChHHH
Q 005916 185 AN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-KPAALSKVKDPEVK 260 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~-~p~~~~~~~s~~~k 260 (670)
.. .....|++.|+|||++. ..++.++|||||||++|+|++|..||.......... .+.... .....+...+..+.
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPTLSDPEKWSPEFN 230 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-hhccCCCCCCCchhhcCHHHH
Confidence 43 23456899999999764 568899999999999999999999997643333222 222211 11122334568899
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+||.+||. +|.+|||+.++|.||||
T Consensus 231 ~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 231 DFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999996 89999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.75 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=206.4
Q ss_pred ecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 005916 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 113 (670)
Q Consensus 34 LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~g 113 (670)
||+|+||+||+|.+..+|..||+|.+..... ........+..|+.+|+.++||||+++++++.... .+|+||||+.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL-KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--DLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh-hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--eEEEEEecCCC
Confidence 6999999999999999999999999875432 22334556778999999999999999999886543 79999999999
Q ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-ccccc
Q 005916 114 GSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSV 190 (670)
Q Consensus 114 GsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~-~~~~~ 190 (670)
++|.+++.+.+ .+++..+..++.|++.||.|||.++ ++||||+|+||+++ +++.+||+|||++...... .....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccc
Confidence 99999988765 7999999999999999999999998 99999999999998 6789999999998776532 23445
Q ss_pred cCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCC---HHHHHHHHhcCCCCCcccCCCChHHHHHHHHc
Q 005916 191 IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 266 (670)
Q Consensus 191 ~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~---~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kc 266 (670)
.|+..|+|||.+ .+.++.++|||||||++|+|++|..||..... ...+...+.. .+...+...++.+++||.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 788999999976 45688999999999999999999999976332 2223222222 23344555689999999999
Q ss_pred CC-CCCCCC-----CHHHHhcCccccccCCC
Q 005916 267 LV-PASQRL-----SAKELLMDPFLQVNGTT 291 (670)
Q Consensus 267 L~-dP~~Rp-----Sa~elL~hpf~~~~~~~ 291 (670)
|. +|.+|| ++.+++.||||....+.
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 96 899999 99999999999765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.69 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=204.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--- 101 (670)
.+.|++.+.||+|+||+||+|.+..+|..||+|.+.... .......++.+|+.+++.++||||++++++|.....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 467999999999999999999999999999999886422 234455678899999999999999999998864431
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 -~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
..+|+|||||. ++|.+++... +++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccce
Confidence 35799999995 5888887654 899999999999999999999998 99999999999998 56899999999998
Q ss_pred hhcccc-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC-C----------
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-K---------- 247 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~-~---------- 247 (670)
...... .....||+.|+|||++ ...++.++|||||||++|+|++|..||..... ...+..+.... .
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHhh
Confidence 765432 2445789999999966 55789999999999999999999999976432 22222221100 0
Q ss_pred ----------C----Ccc----------------cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 248 ----------P----AAL----------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 248 ----------p----~~~----------------~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+ ..+ ....+..+++||.+||. +|.+|||+.++|.||||+.-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 0 000 11235678999999996 89999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.15 Aligned_cols=254 Identities=30% Similarity=0.501 Sum_probs=208.6
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccC------CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ------SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~------s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
.|.+.+.||.|+||.||+|.+..+|..||+|.++...... .....+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 4778899999999999999999999999999987532211 122345688899999999999999999987654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++.
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 -EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISK 156 (272)
T ss_pred -CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeeccccc
Confidence 378999999999999999998889999999999999999999999998 99999999999998 67899999999987
Q ss_pred hhcccc----cccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC---CCCc
Q 005916 181 IMEQAN----AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---KPAA 250 (670)
Q Consensus 181 ~~~~~~----~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~---~p~~ 250 (670)
...... .....|+..|+|||++.. .++.++|+||||+++|+|++|..||........+........ .+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence 654321 234568999999997643 378999999999999999999999976444443433222221 2222
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.....+..+++||.+||. +|.+||++.++|+|||+
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 333457899999999996 89999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.59 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=200.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||.||+|.+..+|..||+|.+..... ......+.+|+.+++.++|+||+++++++.+.. ..|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC--eEE
Confidence 568899999999999999999999999999999875432 122335678999999999999999999987543 789
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+. ++|..++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSI 155 (291)
T ss_pred EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEeccccccccCC
Confidence 9999995 677776654 356889999999999999999999998 99999999999998 678999999999876433
Q ss_pred cc--cccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc--CC------------
Q 005916 185 AN--AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GI------------ 246 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~--g~------------ 246 (670)
.. .....+++.|+|||++.+ .++.++|||||||++|+|++|..||............+.. +.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 21 234567999999998743 5788999999999999999999999765443333222211 00
Q ss_pred ---C--------CCc----cc-CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 247 ---K--------PAA----LS-KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 247 ---~--------p~~----~~-~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
. +.. +. ...++.+.+|+.+||. +|.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 000 00 0125688999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=330.59 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=206.8
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ-SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~-s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
|.+.+.||+|+||.||+|.+..+|..||+|.++...... .......+..|+.+++.++||||+++++++.+. ..+++
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l 79 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--SNINL 79 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--CEEEE
Confidence 778899999999999999999999999999998654321 122345677899999999999999999998764 47999
Q ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+ +|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeeccCC
Confidence 99999 999999998776 7999999999999999999999998 99999999999998 6789999999999876543
Q ss_pred c--cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC-CC------------
Q 005916 186 N--AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-KP------------ 248 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~-~p------------ 248 (670)
. .....+++.|+|||.+. ..++.++|||||||++|+|++|.+||........ +..+.... .+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCchhhhhhccccc
Confidence 2 23446788999999763 3578999999999999999999888876443332 22222110 00
Q ss_pred -------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 -------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 -------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.......+..+++||.+||. +|.+|||+.++|.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 00112346789999999996 79999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.39 Aligned_cols=248 Identities=26% Similarity=0.451 Sum_probs=209.1
Q ss_pred ecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 005916 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 113 (670)
Q Consensus 34 LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~g 113 (670)
||+|+||.||+|.+..+|..+++|.+..... ......+.+.+|+.+++.++||||+++++.+... ..+|++|||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC--cEEEEEEecCCC
Confidence 6899999999999999999999999875432 2245677889999999999999999999987654 479999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc--------
Q 005916 114 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-------- 185 (670)
Q Consensus 114 GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~-------- 185 (670)
++|.+++.+.+.+++..+..|+.||+.||.|||.++ ++||||+|+|||++ .++.++|+|||++......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccc
Confidence 999999998889999999999999999999999998 99999999999998 6789999999998765432
Q ss_pred --ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 --NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 --~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
......+++.|+|||.+ ...++.++||||||+++|+|++|..||.. ......+..+..+..+.......+..+.+|
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 22345688999999966 45588899999999999999999999976 456666666665443222222237899999
Q ss_pred HHHcCC-CCCCCCCH---HHHhcCcccccc
Q 005916 263 IEKCLV-PASQRLSA---KELLMDPFLQVN 288 (670)
Q Consensus 263 I~kcL~-dP~~RpSa---~elL~hpf~~~~ 288 (670)
|.+||. +|.+|||+ .++|+||||...
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 999996 79999999 999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=337.21 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=208.2
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCH----------HHHHHHHHHHHHHHhCCCCCeee
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP----------EDLERLYSEVHLLKSLKHNNIIR 91 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~----------~~~e~l~~Ei~iLk~L~HpNIVk 91 (670)
+..+||+.+.+.||.|+||+||+|.+..+|..||+|.++........ .....+.+|+.+++.++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 45677888889999999999999999999999999998754322110 01124778999999999999999
Q ss_pred eeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcE
Q 005916 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 171 (670)
Q Consensus 92 l~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~v 171 (670)
++++|.... .+++||||+. |+|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 85 ~~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~~ 158 (335)
T PTZ00024 85 LVDVYVEGD--FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGIC 158 (335)
T ss_pred eeEEEecCC--cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCCE
Confidence 999987554 7999999996 699999988888999999999999999999999998 99999999999998 67899
Q ss_pred EEeeccchhhhcc----------------cccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCC
Q 005916 172 KIGDLGLATIMEQ----------------ANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECR 233 (670)
Q Consensus 172 KL~DFGla~~~~~----------------~~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~ 233 (670)
||+|||++..... .......+++.|+|||++.+ .++.++|||||||++|+|++|.+||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876541 11123457889999997743 47899999999999999999999998744
Q ss_pred CHHHHHHHHhcCC---CCC--------------------c---ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 234 NSAQIYKKVSSGI---KPA--------------------A---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 234 ~~~~i~~~i~~g~---~p~--------------------~---~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
.... +..+.... .+. . .....+..+.+||.+||. +|.+|||+.++|.||||+
T Consensus 239 ~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 239 EIDQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 3332 22222100 000 0 012236788999999997 899999999999999998
Q ss_pred cc
Q 005916 287 VN 288 (670)
Q Consensus 287 ~~ 288 (670)
..
T Consensus 318 ~~ 319 (335)
T PTZ00024 318 SD 319 (335)
T ss_pred CC
Confidence 55
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=319.02 Aligned_cols=245 Identities=28% Similarity=0.470 Sum_probs=208.7
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.+.+.||.|+||.||++.+..++..||+|.++... .....+.+.+|+.+++.++||||++++++|.+.. .+|+|
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 76 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG--HLYIV 76 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEEE
Confidence 788999999999999999999999999999987543 2445678889999999999999999999987654 79999
Q ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 108 TELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||+++|+|.+++... ..+++..++.|+.||+.||.|||+++ |+|+||||+||+++ .++.++|+|||++..+...
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeeccc
Confidence 9999999999988653 45899999999999999999999998 99999999999998 6789999999998766443
Q ss_pred c--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 N--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
. .....|++.|+|||++. ..++.++|+||||+++|+|++|..||.. .+.......+..+..+ ..+...+..+++|
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 231 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYK-PLPSHYSYELRSL 231 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCC-CCCcccCHHHHHH
Confidence 2 23567899999999775 4688999999999999999999999976 4555555556555433 2345567899999
Q ss_pred HHHcCC-CCCCCCCHHHHhcC
Q 005916 263 IEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~h 282 (670)
|.+||. +|.+||++.+++.-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999996 89999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=330.92 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=196.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcC----------------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEV----------------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~----------------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN 88 (670)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|+.++|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCC
Confidence 3568899999999999999997532 45579999887532 3445677899999999999999
Q ss_pred eeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHhhhhcCC
Q 005916 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-------------------KVDMKAVKGWARQILSGLIYLHSHD 149 (670)
Q Consensus 89 IVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~-------------------~lse~~i~~i~~QIl~aL~yLHs~g 149 (670)
|+++++++.+.. .+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++
T Consensus 81 iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 81 IIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred eeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999987654 6899999999999999986532 3677889999999999999999998
Q ss_pred CCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh
Q 005916 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT 224 (670)
Q Consensus 150 ~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt 224 (670)
|+||||||+|||++ .++.+||+|||++..+.... .....+++.|||||++ .+.++.++|||||||++|+|++
T Consensus 159 --ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 159 --FVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred --ccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 99999999999998 66899999999997654322 2234567899999965 5679999999999999999986
Q ss_pred --ccCCCCCCCCHHHHHHHHhc----CC--CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 225 --FEYPYSECRNSAQIYKKVSS----GI--KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 225 --G~~Pf~~~~~~~~i~~~i~~----g~--~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+..||.... ..+....+.. .. .....+...+..+++||.+||. +|.+|||+.++..
T Consensus 236 ~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 236 LCKEQPYGELT-DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred ccCCCCCCcCC-HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 667887643 3333332221 11 1111233456889999999996 8999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=321.51 Aligned_cols=251 Identities=29% Similarity=0.490 Sum_probs=210.2
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|.+.+.||+|+||.||+|.+..+|..||+|.+..... ........+.+|+.+++.++||||+++++++.+.. .++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN--ELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC--eEE
Confidence 458899999999999999999999999999998875333 23455677889999999999999999999987654 789
Q ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 106 IITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.++|+|||++..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~~ 155 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECcccccee
Confidence 99999999999988753 345899999999999999999999998 99999999999998 568999999999877
Q ss_pred hcccc--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCC-CHHHHHHHHhcCCCCCcccCCCCh
Q 005916 182 MEQAN--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR-NSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 182 ~~~~~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
..... .....|++.|+|||.+ ...++.++|+||||+++|+|++|..||.... +...+...+.....+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08228 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235 (267)
T ss_pred ccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 64422 2346789999999976 4568899999999999999999999986533 334555666555544444445678
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.++++|.+||. +|.+||++.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 89999999996 89999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=329.42 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=205.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|.+.+.||.|+||.||+|.+..++..+|+|.++..... ......+.+|+.+++.++||||+++++++.+.....+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 3588889999999999999999999999999999865432 23344567899999999999999999998877556899
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++..+..
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccC
Confidence 9999997 49998887654 5899999999999999999999998 99999999999998 668999999999887654
Q ss_pred c--ccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC--------------
Q 005916 185 A--NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-------------- 246 (670)
Q Consensus 185 ~--~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~-------------- 246 (670)
. ......+++.|+|||++.+ .++.++|||||||++|+|++|.+||........+.+.+..-.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 2334568899999997743 468899999999999999999999987443332222111000
Q ss_pred --------------CCCcccCC-CChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 247 --------------KPAALSKV-KDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 247 --------------~p~~~~~~-~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
....++.. .++.+++||.+||. +|++|||+.|+|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00112222 47789999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=330.21 Aligned_cols=253 Identities=29% Similarity=0.486 Sum_probs=208.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.+..+|..||+|.+..... ...+....+.+|+.+++.++||||++++++|.+.. ..|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~--~~~ 91 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH--TAW 91 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--eEE
Confidence 448888999999999999999999999999999875432 23455677899999999999999999999988654 689
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.+||+|||++.....
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeecCcceecCC
Confidence 9999996 577776654 457999999999999999999999998 99999999999998 678999999999876543
Q ss_pred cccccccCCCccCCCccc----cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 185 ANAKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 185 ~~~~~~~GTp~YmAPEvl----~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
. ....|++.|+|||++ .+.++.++||||||+++|+|++|..||........++ .+.....+.......+..++
T Consensus 168 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 168 A--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred C--CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhcCCCCCCCchhhCHHHH
Confidence 2 356789999999976 3468899999999999999999999997643333333 33333223322334577899
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++|.+||. +|.+||++.+++.||||+..
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 99999996 89999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=325.81 Aligned_cols=252 Identities=25% Similarity=0.439 Sum_probs=208.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|.+..++..||+|.++.... .....+.+.+|+++++.++||||+++++++.+.. .+++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~i 77 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG--RLYL 77 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEECC--EEEE
Confidence 58899999999999999999999999999998875432 2344577899999999999999999999987643 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.++.|..+..+...+++..+..++.||+.||.|||.++ ++||||+|+||+++ .++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARP 154 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCCCc
Confidence 9999998878777777677999999999999999999999998 99999999999998 57899999999988765432
Q ss_pred ---cccccCCCccCCCccc-cC-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-----------------
Q 005916 187 ---AKSVIGTPEFMAPELY-DE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS----------------- 244 (670)
Q Consensus 187 ---~~~~~GTp~YmAPEvl-~~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~----------------- 244 (670)
.....|++.|+|||++ .. .++.++||||||+++|+|++|.+||.+......++.....
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 3446789999999976 34 6789999999999999999999999875444433322110
Q ss_pred --CC-CC---------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 245 --GI-KP---------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 245 --g~-~p---------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+. .+ ..++...++++++||.+||. +|.+|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 00 01223347889999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=327.52 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=203.0
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCC---C
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN---K 102 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~---~ 102 (670)
.|++.+.||+|+||+||+|.+..+|..||+|.+..... .......+.+|+.+++.+ +||||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 48889999999999999999999999999998875421 122345678899999999 56999999998865442 2
Q ss_pred eEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 103 TVNIITELFTSGSLRQYRKKH-----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~-----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||.++ |+||||||+|||++..++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecc
Confidence 48999999975 888887643 35799999999999999999999998 99999999999999547899999999
Q ss_pred chhhhccc--ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC----
Q 005916 178 LATIMEQA--NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA---- 249 (670)
Q Consensus 178 la~~~~~~--~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~---- 249 (670)
++..+... ......+++.|+|||++. ..++.++|||||||++|+|++|.+||.+........+.+..-..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98765332 123346789999999764 3578999999999999999999999987555444433222100000
Q ss_pred ---------------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 250 ---------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 250 ---------------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
......++++.+||.+||. +|.+||++.++|.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0012357889999999996 899999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=323.58 Aligned_cols=247 Identities=21% Similarity=0.341 Sum_probs=203.6
Q ss_pred CCeEEEEEEecccCCeEEEEEEEc---CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~---~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
...|++.++||+|+||.||+|..+ ..+..||+|.++... +......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-- 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--
Confidence 456999999999999999999765 456789999887532 344556788999999999999999999988654
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 KTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
..+++||||+.+|+|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+|||++ .++.+|++|||.+.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~ 155 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQ 155 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCcccc
Confidence 3799999999999999998774 57899999999999999999999998 99999999999998 67899999999876
Q ss_pred hhcccc---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCC
Q 005916 181 IMEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 181 ~~~~~~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
...... .....+++.|+|||++ ...++.++|||||||++|+|++ |..||.. .....+.+.+..+..+ ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 233 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD-MSGQDVIKAVEDGFRL-PAPRNC 233 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCCCCC-CCCCCC
Confidence 543221 1123456789999976 5678999999999999999764 9999987 4455566666655432 345567
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+..+.+++.+||. +|.+||++.++++
T Consensus 234 ~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 234 PNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 7899999999997 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=347.14 Aligned_cols=273 Identities=25% Similarity=0.386 Sum_probs=225.3
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
+...|+.-++||+|+||.|+-++.+.||+-||+|.+.++.+. ........++|-+||+.++.|.||.+--.|...+ .
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK-kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd--~ 259 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK-KRKGETMALNEKQILEKVSSPFIVSLAYAFETKD--A 259 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH-HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC--c
Confidence 345688889999999999999999999999999988765432 2333445678999999999999999877776554 7
Q ss_pred EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+|+|+.+|+||+|.-+|-+++ .|++..+..|+.+|+.||++||... ||+|||||+|||+| +.|+|+|+|+|||..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEe
Confidence 999999999999998888876 8999999999999999999999998 99999999999999 789999999999999
Q ss_pred hccccc-ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCC---CHHHHHHHHhcCCCCCcccCCCC
Q 005916 182 MEQANA-KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 182 ~~~~~~-~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
+..+.. ...+||.+|||||++ ++.|+..+|+|||||++|+|+.|+.||.... ..+++-+.+.. .+..++...+
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS 414 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFS 414 (591)
T ss_pred cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccC
Confidence 877654 455999999999977 4679999999999999999999999996522 12233344433 3455667788
Q ss_pred hHHHHHHHHcCC-CCCCCC-----CHHHHhcCccccccCCCCCCCCCCCCCcCC
Q 005916 257 PEVKSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGTTKNRPLPLPDIVLP 304 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~~~~~~~~~~~~~~~ 304 (670)
++++++.+.+|. +|++|+ .+.++-+||||+...|.....-.++++..|
T Consensus 415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiP 468 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIP 468 (591)
T ss_pred HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCC
Confidence 999999999996 799998 578999999999876654332223333444
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.23 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=199.7
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~l 106 (670)
|++.+.||+|+||.||+|.+..++..||+|.++.... .... ....+|+.+++++ +||||+++++++.+...+.+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 5788999999999999999999999999998875321 2222 2345799999999 5999999999998775568999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+. |+|.+++... +.+++..++.++.||+.||.|||.++ ++||||||+||+++. +.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence 999996 5888777653 57899999999999999999999998 999999999999984 89999999999876543
Q ss_pred c-cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC----------------
Q 005916 186 N-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---------------- 246 (670)
Q Consensus 186 ~-~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~---------------- 246 (670)
. .....+++.|+|||++. +.++.++|||||||++|+|++|.+||.+. +....+..+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT-NELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC-CHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 23456899999999653 45788999999999999999999999763 3333222221100
Q ss_pred CCCc-----------ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 247 KPAA-----------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 247 ~p~~-----------~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.... +....+..+++||.+||. +|.+||++.++|.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 112346899999999997 79999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=330.08 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=210.3
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
..+.|.+.+.||+|+||+||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~ 90 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVGD--E 90 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC--c
Confidence 3467888999999999999999999999999999986432 233567889999999999999999999987654 6
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|+||+.+++|.+++.+. .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQIT 166 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcceeccc
Confidence 89999999999999998754 5889999999999999999999998 99999999999998 66899999999887654
Q ss_pred ccc--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 184 QAN--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 184 ~~~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
... .....|++.|+|||.+ .+.++.++|+|||||++|+|++|..||........+......+..........+..++
T Consensus 167 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (293)
T cd06647 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246 (293)
T ss_pred ccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence 322 2345789999999976 4568899999999999999999999997644333332222222222222334567899
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+||.+||. +|.+||++.+++.||||+..
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 99999996 79999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=328.24 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=202.7
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~~~ 105 (670)
.|...+.||+|+||+||++.+..+|..||+|.+..... ......+.+|+.++.++. ||||+++++++.... ..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~--~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG--DCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC--cEE
Confidence 35566789999999999999999999999999875432 245667889999999995 999999999887654 688
Q ss_pred EEEecCCCCCHHHHH---H--hcCCCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 106 IITELFTSGSLRQYR---K--KHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 106 lVmEy~~gGsL~~~i---~--~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
++|||+.+ +|.++. . ..+.+++..+..++.|++.||.|||+. + |+||||||+|||++ .++.+||+|||++
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~ 155 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGIS 155 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchh
Confidence 99999864 554432 2 246799999999999999999999974 6 99999999999998 5689999999999
Q ss_pred hhhcccc-cccccCCCccCCCccccC----CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc--
Q 005916 180 TIMEQAN-AKSVIGTPEFMAPELYDE----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS-- 252 (670)
Q Consensus 180 ~~~~~~~-~~~~~GTp~YmAPEvl~~----~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~-- 252 (670)
..+.... .....|++.|+|||++.. .++.++|||||||++|+|++|..||............+..+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235 (288)
T ss_pred HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence 8765432 234578999999998753 589999999999999999999999976543333333333333222111
Q ss_pred -CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 253 -KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 253 -~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...+.++.+||.+||. +|.+|||+.+++.||||+..
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 2367899999999996 79999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=382.64 Aligned_cols=253 Identities=32% Similarity=0.523 Sum_probs=223.0
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
++..+..||.|.||.||-|.+..+|...|+|-++..... ......+.+|..+|..|+|||+|++|++=++.+ .+||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe--kv~I 1311 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE--KVYI 1311 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHH--HHHH
Confidence 355567899999999999999999999999999875543 344566889999999999999999999765544 6999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
.||||.||+|.+.+...+..+|...+.+..|++.||.|||.+| ||||||||.|||++ .+|.+|++|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeEecCch
Confidence 9999999999999988888999999999999999999999999 99999999999999 67899999999998775432
Q ss_pred ------cccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 187 ------AKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 187 ------~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
.....|||-|||||++. .+...+.|||||||++.||+||+.||....+.-+|+-+|..|..|.. +...+
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~-P~~ls 1467 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI-PERLS 1467 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC-chhhh
Confidence 34678999999999884 35677899999999999999999999999999999999999987764 44488
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
++.++||++||. ||++|.++.|||.|.|-+.
T Consensus 1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999999995 9999999999999998753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=344.13 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=203.7
Q ss_pred eEEEEEEecccCCeEEEEEEE-----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d-----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~ 100 (670)
.|++.+.||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+.+|+.+ +|||||+++++|.+..
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 689999999999999999964 4567789999886432 234457788999999999 8999999999986654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC--------------------------------------------------------
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHK-------------------------------------------------------- 124 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~-------------------------------------------------------- 124 (670)
..++|||||.+|+|.+++....
T Consensus 113 --~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 113 --PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred --cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 6899999999999999886432
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 125 -------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 125 -------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCccceeccCc
Confidence 4688899999999999999999998 99999999999998 5678999999999766432
Q ss_pred cc----ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 186 NA----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 186 ~~----~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.. ....+++.|+|||++ ...++.++|||||||++|+|++ |..||........+++.+..+..+. .+...+.++
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 346 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-SPECAPSEM 346 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-CCCCCCHHH
Confidence 21 123456689999976 4579999999999999999998 8999987655666677666654332 344567899
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
++||.+||. +|.+|||+.++++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999996 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=325.69 Aligned_cols=251 Identities=33% Similarity=0.566 Sum_probs=208.4
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeEEEeCCCCe
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK---HNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~---HpNIVkl~~~~~d~~~~~ 103 (670)
.|.+.+.||+|+||.||+|.+..+|..||+|.++... .......+.+|+.+++.++ ||||+++++++.+.. .
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~--~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP--R 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC--E
Confidence 4778889999999999999999999999999887532 2345667889999999996 999999999987644 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+||||+.+++|.+++.. +.+++..+..++.||+.||.|||..+ |+||||+|+||+++ ..+.++|+|||++..+.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecC
Confidence 9999999999999999866 47999999999999999999999998 99999999999998 57899999999988765
Q ss_pred ccc--cccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccC-CCChH
Q 005916 184 QAN--AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK-VKDPE 258 (670)
Q Consensus 184 ~~~--~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~-~~s~~ 258 (670)
... .....|++.|+|||.+.. .++.++|+|||||++|+|++|..||.... .......+... .+..+.. ..+.+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~ 230 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKS-KPPRLEDNGYSKL 230 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccccC-CCCCCCcccCCHH
Confidence 432 234578999999997643 47899999999999999999999997643 33222222222 2222322 36789
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+.+|+.+||. +|.+||++.+++.||||+..
T Consensus 231 ~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 231 LREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 9999999996 79999999999999999754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=325.35 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=200.0
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.++.+|..||+|.+...... .....+.+|+.+++.++||||+++++++.+. ...|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeEE
Confidence 4688999999999999999999999999999998754321 1223466899999999999999999998754 3799
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSV 155 (291)
T ss_pred EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccCC
Confidence 99999975 999988764 46899999999999999999999998 99999999999998 668999999999865432
Q ss_pred c--ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC---CCC---------
Q 005916 185 A--NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG---IKP--------- 248 (670)
Q Consensus 185 ~--~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g---~~p--------- 248 (670)
. ......+++.|+|||++. ..++.++||||||+++|+|++|..||..........+.+... ..+
T Consensus 156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 122345788999999764 458899999999999999999999997654333322222110 000
Q ss_pred -------------Cc---ccCCCC--hHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 249 -------------AA---LSKVKD--PEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 249 -------------~~---~~~~~s--~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.. .....+ ..+.++|.+||. +|.+|||+.++|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 001123 788899999996 79999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.53 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=203.1
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCC-----eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEE
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNG-----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWI 97 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg-----~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~ 97 (670)
..+.|.+.+.||+|+||.||+|.+...| ..||+|.++... .....+.+.+|+.+++.+ +|||||+++++|.
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3446889999999999999999865443 579999987532 244567789999999999 8999999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhc------------------------------------------------------
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKH------------------------------------------------------ 123 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~------------------------------------------------------ 123 (670)
... .+++|||||.+|+|.+++...
T Consensus 113 ~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 113 HGG--PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred CCC--CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 654 699999999999999988643
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccccc
Q 005916 124 ----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 187 (670)
Q Consensus 124 ----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~ 187 (670)
.++++..++.|+.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++..+.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCcc
Confidence 24788899999999999999999998 99999999999998 678999999999876543221
Q ss_pred ----ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 188 ----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 188 ----~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
....+++.|||||++ ...|+.++|||||||++|+|++ |..||........+++.+..+. ....+...++++++
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 346 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-QMSRPDFAPPEIYS 346 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-CccCCCCCCHHHHH
Confidence 223456789999966 5679999999999999999997 9999987554445555554443 22344456799999
Q ss_pred HHHHcCC-CCCCCCCHHHHhc
Q 005916 262 FIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~ 281 (670)
+|.+||. +|.+|||+.++++
T Consensus 347 li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 347 IMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 9999996 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=318.80 Aligned_cols=251 Identities=27% Similarity=0.489 Sum_probs=209.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+++++.++||||+++++.+.+. ..+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEEE
Confidence 37889999999999999999999999999999876432 223456788999999999999999999988654 37999
Q ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|+||+.+++|.+++.... .+++..+..|+.||+.||.|||+++ ++|+||||+||+++.+...+||+|||.+.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999999999987653 4799999999999999999999998 999999999999985544679999999887654
Q ss_pred cc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 185 AN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
.. .....|++.|+|||++. ..++.++|+|||||++|+|++|..||... +.......+..+..+. .....+..+++
T Consensus 155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (257)
T cd08225 155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP-ISPNFSRDLRS 232 (257)
T ss_pred CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCCC-CCCCCCHHHHH
Confidence 32 23456899999999764 56889999999999999999999999763 4444444444443322 23345689999
Q ss_pred HHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 262 FIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+|.+||. +|.+|||+.+++.||||
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhCCCC
Confidence 9999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=347.96 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=209.8
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~ 100 (670)
...|+-|.+.+.||+||.+.||++.... ...||+|.+.... .+...+.-+.+|+.+|.+| .|.+||++|+|=+.+
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d- 432 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD- 432 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC-
Confidence 3467889999999999999999997554 4556777665433 4567788899999999999 799999999986653
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCH-HHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDM-KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse-~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
+++|+||||- ..+|...+++.+...+ -.++.|..|+|.|+.++|.+| |||.||||.|+|+- .|.+||+|||+|
T Consensus 433 -~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA 506 (677)
T KOG0596|consen 433 -GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIA 506 (677)
T ss_pred -ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechh
Confidence 4899999986 4599999988765443 589999999999999999999 99999999999986 589999999999
Q ss_pred hhhcccc----cccccCCCccCCCcccc-C-----------CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHh
Q 005916 180 TIMEQAN----AKSVIGTPEFMAPELYD-E-----------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS 243 (670)
Q Consensus 180 ~~~~~~~----~~~~~GTp~YmAPEvl~-~-----------~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~ 243 (670)
..+.... ..+.+||+.||+||.+. . ..+.++||||||||||+|+.|++||....+....+..|.
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 9887654 24679999999999651 1 256789999999999999999999987665555556665
Q ss_pred cCCCCCcccCCCChH-HHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 244 SGIKPAALSKVKDPE-VKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 244 ~g~~p~~~~~~~s~~-~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
.......++...+.. +.++++.||. ||.+|||+.+||+|||++
T Consensus 587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~ 631 (677)
T KOG0596|consen 587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQ 631 (677)
T ss_pred CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence 544334455554444 9999999996 999999999999999997
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=325.18 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=206.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCC-----eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNG-----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg-----~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
.|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~- 81 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ- 81 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC-
Confidence 4788999999999999999876655 678999876432 3455677899999999999999999999886544
Q ss_pred CeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe
Q 005916 102 KTVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 165 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~ 165 (670)
..|++|||+.+|+|.+++... ..+++..+..++.||+.||.|||.++ ++||||||+|||++
T Consensus 82 -~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 -PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred -ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 689999999999999998765 45788999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHH
Q 005916 166 GNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIY 239 (670)
Q Consensus 166 ~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~ 239 (670)
+++.+||+|||++....... .....+++.|+|||.+ ...++.++|||||||++|+|++ |..||.+ .....+.
T Consensus 159 -~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~ 236 (283)
T cd05048 159 -EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVI 236 (283)
T ss_pred -CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHH
Confidence 66899999999987653322 2344678899999965 5678999999999999999998 9999987 4566777
Q ss_pred HHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 240 KKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 240 ~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..+..+..+. .+...++++.+|+.+||. +|.+||++.+++++
T Consensus 237 ~~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 237 EMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7777665433 345578999999999996 79999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=331.78 Aligned_cols=251 Identities=29% Similarity=0.538 Sum_probs=208.3
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
+|.....||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+.... ..|+
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~~~l 96 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD--ELWV 96 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC--eEEE
Confidence 4444578999999999999999999999999886432 345667889999999999999999999887654 7899
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.+++|.+++.. +.+++..+..++.||+.||.|||+++ |+||||||+||+++ +++.++|+|||++.......
T Consensus 97 v~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 97 VMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhccccc
Confidence 9999999999998754 56899999999999999999999998 99999999999998 56899999999987654322
Q ss_pred --cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC-cccCCCChHHHHH
Q 005916 187 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVKDPEVKSF 262 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~s~~~k~f 262 (670)
.....|++.|+|||++. ..++.++|||||||++|+|++|..||.. ......+..+.....+. ......+..+++|
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCccccccccCHHHHHH
Confidence 24467899999999764 4688999999999999999999999976 34444444444432221 1223457889999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
|.+||. +|.+|||+.++++||||+..
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HHHHccCChhHCcCHHHHhhChhhhcc
Confidence 999996 79999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=326.35 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=204.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||+|++|+||+|.++.+|..||+|.+..... .......+.+|+.+++.++||||+++++++.+.. .+|+
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 78 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--RLYL 78 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--eEEE
Confidence 58899999999999999999999999999998865432 1233456788999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
||||+. ++|.+++..... +++..++.++.||+.||.|||+++ ++||||||+||+++..++.+||+|||++.....
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 999995 588888765443 588999999999999999999998 999999999999985566899999999976543
Q ss_pred c--ccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC------------
Q 005916 185 A--NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP------------ 248 (670)
Q Consensus 185 ~--~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p------------ 248 (670)
. ......|++.|+|||++.+ .++.++|||||||++|+|++|.+||........+.+.+..-..+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 2 1234567899999997643 57899999999999999999999997744444444322110000
Q ss_pred -------C-------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 -------A-------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 -------~-------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
. ......++.+++||.+||. +|.+||++.++|.||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0112356889999999996 79999999999999999754
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=336.27 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=205.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--- 101 (670)
+.+|++.+.||.|+||+||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 5778899999999999999999999999999999876542 345678889999999999999999987755432
Q ss_pred ---------CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEE
Q 005916 102 ---------KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 172 (670)
Q Consensus 102 ---------~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vK 172 (670)
..+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEE
Confidence 25789999996 589888754 57999999999999999999999998 999999999999986667899
Q ss_pred Eeeccchhhhcccc-----cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC
Q 005916 173 IGDLGLATIMEQAN-----AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 245 (670)
Q Consensus 173 L~DFGla~~~~~~~-----~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g 245 (670)
|+|||++..+.... .....|++.|+|||++. ..++.++|||||||++|+|++|..||......... ..+...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHh
Confidence 99999987653321 12346789999999653 45889999999999999999999999764333322 222111
Q ss_pred C-----------------------CC-----CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 246 I-----------------------KP-----AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 246 ~-----------------------~p-----~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
. .+ ..+....+.++++||.+||. +|.+|||+.++|.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 00 00112356889999999997 89999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=333.86 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=203.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---C
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---N 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~---~ 101 (670)
++.|.+.+.||+|+||+||+|.+..+|..||+|++.... ......++.+|+.+++.++||||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 467999999999999999999999999999999986422 2344567888999999999999999999875433 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|+|+||+. ++|..++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~ 155 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARI 155 (336)
T ss_pred ceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECcccceee
Confidence 35899999996 588877744 57999999999999999999999998 99999999999998 678999999999876
Q ss_pred hcccc-----cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHh-----------
Q 005916 182 MEQAN-----AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS----------- 243 (670)
Q Consensus 182 ~~~~~-----~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~----------- 243 (670)
..... .....||+.|+|||++. ..++.++|||||||++|+|++|.+||.+... ......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHHH
Confidence 54321 13457899999999753 4689999999999999999999999976322 11111110
Q ss_pred ----cC---------C--CCCc---ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 244 ----SG---------I--KPAA---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 244 ----~g---------~--~p~~---~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.. . .... .....++++.+||.+||. +|.+|||+.+++.||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00 0 0000 112246789999999996 89999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.71 Aligned_cols=250 Identities=31% Similarity=0.560 Sum_probs=214.9
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+++++.++|||++++++.+.+. ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEE
Confidence 37889999999999999999999999999999875432 245667788999999999999999999998765 47999
Q ss_pred EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 107 ITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
|+||+.+++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVL 153 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceeec
Confidence 99999999999998764 77999999999999999999999998 99999999999998 5689999999998776
Q ss_pred cccc--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 183 EQAN--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 183 ~~~~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.... .....|++.|+|||.+ ...++.++|+||+|+++|+|++|..||.. .....+...+.... ...++...+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQ-YPPIPSQYSSEL 231 (258)
T ss_pred ccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC-CcHHHHHHHHhcCC-CCCCCCCCCHHH
Confidence 5432 3446789999999965 45688999999999999999999999976 44556666555543 333455677899
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+++|.+||. +|.+||++.++|.||||
T Consensus 232 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=330.02 Aligned_cols=255 Identities=30% Similarity=0.453 Sum_probs=201.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcC--CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEV--NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~--tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
.|++.+.||+|+||.||+|.+.. +|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 37888999999999999999988 899999999986331 122334667889999999999999999999988755689
Q ss_pred EEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC---CCCcEEEeec
Q 005916 105 NIITELFTSGSLRQYRKKH-----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING---NQGEVKIGDL 176 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~-----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~---~~g~vKL~DF 176 (670)
++||||+.+ +|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+||
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 999999965 777766432 36899999999999999999999998 999999999999983 1689999999
Q ss_pred cchhhhcccc-----cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHH--------HHHHH
Q 005916 177 GLATIMEQAN-----AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSA--------QIYKK 241 (670)
Q Consensus 177 Gla~~~~~~~-----~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~--------~i~~~ 241 (670)
|++....... .....+|+.|+|||++. ..++.++|||||||++|+|++|.+||....... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 9988764322 23457899999999764 358899999999999999999999997532211 00000
Q ss_pred Hhc------------------------CCCCCccc-----------CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 242 VSS------------------------GIKPAALS-----------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 242 i~~------------------------g~~p~~~~-----------~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+.. ........ ...+..+.++|.+||. +|.+|||+.+++.||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 00000000 1456789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=322.74 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=202.5
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|++.+.||.|++|+||+|.+..+|..||+|.++.... ....+.+.+|+.+++.++||||+++++++.+.. .+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 76 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLMLV 76 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEEE
Confidence 7889999999999999999999999999999986432 223456778999999999999999999997754 68999
Q ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 108 TELFTSGSLRQYRKKH---KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|||+.+ +|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ +++.++|+|||++.....
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGI 152 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcC
Confidence 999975 888887754 35899999999999999999999998 99999999999998 678999999999976543
Q ss_pred cc--cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC------------
Q 005916 185 AN--AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP------------ 248 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p------------ 248 (670)
.. .....+++.|+|||++. ..++.++|||||||++|+|++|.+||.+........+.+.....|
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 21 23456789999999764 357889999999999999999999998754433322221110000
Q ss_pred -------C-------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 249 -------A-------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 249 -------~-------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
. ......++.++++|.+||. +|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0112346789999999996 89999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=335.21 Aligned_cols=257 Identities=26% Similarity=0.363 Sum_probs=207.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--- 101 (670)
++.|++.+.||+|+||+||+|.+..+|..||+|.+.... .......++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 456889999999999999999999999999999987432 123345567889999999999999999998765432
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCccccc
Confidence 35899999995 689999988889999999999999999999999998 99999999999998 568999999999976
Q ss_pred hccc--ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc---C---------
Q 005916 182 MEQA--NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---G--------- 245 (670)
Q Consensus 182 ~~~~--~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~---g--------- 245 (670)
.... ......|+..|+|||.+. ..++.++|||||||++|+|++|.+||.+.. ....+..+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-YVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCChHHhhhc
Confidence 6433 234557899999999764 458999999999999999999999997632 2211111110 0
Q ss_pred ---------------CCC--CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 246 ---------------IKP--AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 246 ---------------~~p--~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+ .......++.+++||.+||. +|.+|||+.++|+||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 01123457889999999997 89999999999999999743
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=310.32 Aligned_cols=248 Identities=34% Similarity=0.605 Sum_probs=208.9
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.+.+.||+|++|.||+|.+..+|..+++|.+..... .....+.+|+.+++.++||||+++++++.... ..+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~l~ 75 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKD--ELWIV 75 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--eEEEE
Confidence 7788999999999999999999999999999875432 45678889999999999999999999887654 78999
Q ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 108 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
+||+.+++|.+++... +.+++..+..++.|++.||.|||.++ ++||||+|+||+++ +++.++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeeccccccccccc
Confidence 9999999999998876 68999999999999999999999988 99999999999998 57899999999988776543
Q ss_pred -cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 187 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 187 -~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
.....|+..|+|||.+. ..++.++|+||||+++|+|++|..||........+.................+..+.+||.
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence 34567899999999764 4578899999999999999999999987544444433332221111122223788999999
Q ss_pred HcCC-CCCCCCCHHHHhcCcc
Q 005916 265 KCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 265 kcL~-dP~~RpSa~elL~hpf 284 (670)
+||. +|.+|||+.++|.|||
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 9996 8999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=325.58 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=204.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++||||++++++|.+. ..+|+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 77 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK--KRLYL 77 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccC--CeEEE
Confidence 48889999999999999999999999999998764332 223456688899999999999999999998654 47999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.++.|..+......+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCc
Confidence 9999999999888777677999999999999999999999998 99999999999998 67899999999987664432
Q ss_pred --cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc------------------
Q 005916 187 --AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS------------------ 244 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~------------------ 244 (670)
.....|++.|+|||++. ..++.++||||||+++|+|++|.+||..........+....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 23456899999999764 35788999999999999999999999764433322221110
Q ss_pred -CC-CCC--------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 245 -GI-KPA--------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 245 -g~-~p~--------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+. .+. ......+..+++|+.+||. +|.+||++.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 000 0012346789999999996 79999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.61 Aligned_cols=259 Identities=34% Similarity=0.589 Sum_probs=215.3
Q ss_pred cccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 19 ~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
++.+-....|.+.+.||.|+||.||+|.+..++..|++|++..... ..+.+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 12 VSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred cCCCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 3334445568888999999999999999998999999999875432 45678899999999999999999999887
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.. .+|+|+||+.+++|.+++..++ .+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||
T Consensus 87 ~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~ 161 (286)
T cd06614 87 GD--ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFG 161 (286)
T ss_pred CC--EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccc
Confidence 64 7999999999999999999877 8999999999999999999999988 99999999999998 67899999999
Q ss_pred chhhhcccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-CCCCCcccC
Q 005916 178 LATIMEQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKPAALSK 253 (670)
Q Consensus 178 la~~~~~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g~~p~~~~~ 253 (670)
++....... .....|++.|+|||++. ..++.++|+|||||++|+|++|..||... +.......+.. +..+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd06614 162 FAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPE 240 (286)
T ss_pred hhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchh
Confidence 987654322 23456889999999764 56899999999999999999999999764 33333333333 222222223
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+..+++||.+||. +|.+||++.++|.||||...
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 367899999999996 79999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=323.63 Aligned_cols=251 Identities=30% Similarity=0.519 Sum_probs=211.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|...+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.+.||||+++++++.+.. .+|+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT--KLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--EEEE
Confidence 4667789999999999999999999999999987543 2455678899999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.||+|.+++.. +.+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceeccCCc
Confidence 9999999999998865 56899999999999999999999998 99999999999998 67899999999987664432
Q ss_pred --cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 187 --AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
.....++..|+|||++ ...++.++|+|||||++|+|++|..||.... .......+..+. +.......+..+.+||
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li 233 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKNN-PPTLTGEFSKPFKEFI 233 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcCC-CCCCchhhhHHHHHHH
Confidence 2345689999999976 4568899999999999999999999998743 333333333332 3334445678899999
Q ss_pred HHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 264 EKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 264 ~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+||. +|.+||++.+++.||||...
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred HHHcccCcccCcCHHHHHhChHhhhc
Confidence 99996 79999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=324.91 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=211.7
Q ss_pred EEEEEEecccCCeEEEEEEEc---CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 28 IRYKEVIGKGAFKTVYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~---~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
|++.+.||.|+||.||+|.+. .+|..||+|.++...........+++.+|+.+++.+ +||||+++++++... ..
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~ 79 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--TK 79 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--Ce
Confidence 788999999999999999875 478999999987544333344567788999999999 699999999988654 37
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+||||+.+++|.+++...+.+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceecc
Confidence 8999999999999999998888999999999999999999999998 99999999999998 57899999999987664
Q ss_pred ccc---cccccCCCccCCCcccc---CCCCccceeeeccchhhhhhhccCCCCCCC---CHHHHHHHHhcCCCCCcccCC
Q 005916 184 QAN---AKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 184 ~~~---~~~~~GTp~YmAPEvl~---~~ys~~~DIWSLGvilyeLltG~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~~ 254 (670)
... .....|++.|+|||.+. ..++.++||||||+++|+|++|..||.... ....+.+.+..... .++..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQE 234 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCcc
Confidence 322 23467899999999774 357889999999999999999999996422 22333333333322 23455
Q ss_pred CChHHHHHHHHcCC-CCCCCC-----CHHHHhcCccccccCC
Q 005916 255 KDPEVKSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
.++.+.+|+.+||. +|.+|| ++.+++.||||+...+
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 78899999999996 799997 8999999999987653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=338.27 Aligned_cols=271 Identities=23% Similarity=0.385 Sum_probs=233.3
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~l 106 (670)
|.+..+||+|+||.|.+|..+.+...||||+++++.+.+ .++++--+.|-++|.-. +-|.+++++.+|...+ .+|+
T Consensus 351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ-dDDvectm~EKrvLAL~~kppFL~qlHScFQTmD--RLyF 427 (683)
T KOG0696|consen 351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD--RLYF 427 (683)
T ss_pred cceEEEeccCccceeeeecccCcchhhhhhhhccceeee-cCcccceehhhhheecCCCCchHHHHHHHhhhhh--heee
Confidence 678899999999999999999999999999998766554 35566666788888777 6678899999887665 6999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh--hcc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI--MEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~--~~~ 184 (670)
||||+.||+|-..+++.+++.|..+..++..|+-||-|||++| ||+||||.+|||++ ..|+|||+|||+++. +..
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEec-cCCceEeeecccccccccCC
Confidence 9999999999999999999999999999999999999999999 99999999999999 679999999999864 344
Q ss_pred cccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 185 ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 185 ~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
..+++++|||.|+|||++ -+.|+.++|+||+||+||||+.|++||.+ .+..++++.|.... ..+++..+.++.+++
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehn--vsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHN--VSYPKSLSKEAVAIC 581 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHcc--CcCcccccHHHHHHH
Confidence 457889999999999965 57899999999999999999999999988 77888999988753 456777889999999
Q ss_pred HHcCC-CCCCCCC-----HHHHhcCccccccCCCCCCCCCCCCCcCCCcc
Q 005916 264 EKCLV-PASQRLS-----AKELLMDPFLQVNGTTKNRPLPLPDIVLPRVG 307 (670)
Q Consensus 264 ~kcL~-dP~~RpS-----a~elL~hpf~~~~~~~~~~~~~~~~~~~~~~~ 307 (670)
...|. .|.+|+. -+++-.||||+...|.+......+++..|+++
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k 631 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIK 631 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccc
Confidence 99996 6999984 46899999999887766544445555556553
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=324.21 Aligned_cols=250 Identities=28% Similarity=0.453 Sum_probs=203.2
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.+.+.||.|++|+||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.+. ...|++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEE
Confidence 5677899999999999999999999999999876432 123345678899999999999999999998755 479999
Q ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 108 TELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||+. ++|.+++.... .+++..+..++.||+.||.|||+++ ++||||+|+|||++ .++.++|+|||++..+...
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVP 152 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCcEEEeecccccccCCC
Confidence 99994 69999988776 7999999999999999999999998 99999999999998 5789999999998765432
Q ss_pred c--cccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-------------
Q 005916 186 N--AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP------------- 248 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p------------- 248 (670)
. .....+++.|+|||++.+ .++.++||||||+++|+|++|.+||.........++.+.....+
T Consensus 153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 2 233467899999997643 47889999999999999999999997744433333322110000
Q ss_pred -------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 249 -------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 249 -------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.......+..+.++|.+||. +|.+|||+++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123356789999999996 79999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.36 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=198.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC-----
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----- 101 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~----- 101 (670)
.|.+.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++.+...
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 48889999999999999999999999999999875432 12223456689999999999999999998765432
Q ss_pred -CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 102 -KTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 102 -~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
...++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCcEEECcCCCc
Confidence 35799999996 5888777654 37899999999999999999999998 99999999999998 6689999999999
Q ss_pred hhhcccc------cccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc--CCCC-
Q 005916 180 TIMEQAN------AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIKP- 248 (670)
Q Consensus 180 ~~~~~~~------~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~--g~~p- 248 (670)
..+.... .....+++.|+|||++.+ .++.++||||||+++|+|++|.+||.... .......+.. +..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~-~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-EQHQLTLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCh
Confidence 7664322 123467889999997643 47889999999999999999999997633 2222111111 1000
Q ss_pred C---------------------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 249 A---------------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 249 ~---------------------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
. ......++.+++||.+||. +|.+|||+.++|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 0112245778899999996 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.22 Aligned_cols=250 Identities=30% Similarity=0.534 Sum_probs=209.5
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.-.+.||+|++|.||+|.+..++..+++|.+.... ....+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~--~~~~v 94 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD--ELWVV 94 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--eEEEE
Confidence 444579999999999999999999999999886432 334566889999999999999999999887644 78999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc-
Q 005916 108 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~- 186 (670)
+||+.|++|.+++.. +.+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchhhccCCc
Confidence 999999999999877 67999999999999999999999998 99999999999998 67899999999887654322
Q ss_pred -cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc-ccCCCChHHHHHH
Q 005916 187 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA-LSKVKDPEVKSFI 263 (670)
Q Consensus 187 -~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~-~~~~~s~~~k~fI 263 (670)
.....|++.|+|||.+. ..++.++|||||||++|+|++|..||.. .+.......+..+..+.. .....+..+.+||
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence 23457899999999764 4689999999999999999999999976 445555555655432221 1223678999999
Q ss_pred HHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 264 EKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 264 ~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+||. +|.+||++.+++.||||+..
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccC
Confidence 99996 79999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=334.38 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=207.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC--CCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--QNK 102 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~--~~~ 102 (670)
++.|.+.+.||+|+||.||+|.++.+|..||+|.+..... .......+.+|+.+|+.++||||++++++|... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 3678999999999999999999999999999999875321 233456778899999999999999999987543 234
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||.++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccceee
Confidence 7899999995 689999888888999999999999999999999998 99999999999998 6789999999998765
Q ss_pred cccc------cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-C--------
Q 005916 183 EQAN------AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-G-------- 245 (670)
Q Consensus 183 ~~~~------~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g-------- 245 (670)
.... .....|+..|+|||++. ..++.++|||||||++|+|++|..||.+.....++...+.. +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 3321 13457899999999764 35899999999999999999999999764332222111100 0
Q ss_pred ----------------CCCCc---ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 246 ----------------IKPAA---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 246 ----------------~~p~~---~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+.. +....++.+++||.+||. +|.+||++.+++.||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00011 112357889999999996 89999999999999999743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.94 Aligned_cols=249 Identities=31% Similarity=0.529 Sum_probs=210.4
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||++++++|.+.. .+|+|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--KLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--eEEEE
Confidence 677889999999999999999999999999876433 2345667889999999999999999999987654 79999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc-
Q 005916 108 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~- 186 (670)
|||+.+++|.+++.. +.+++..+..++.|++.||.|||.++ ++|+||||+||+++ +++.++|+|||++..+....
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccchh
Confidence 999999999998865 46899999999999999999999998 99999999999998 67899999999987654432
Q ss_pred -cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 187 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 187 -~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
.....|+..|+|||.+. ..++.++|+|||||++|+|++|..||.. .+.......+..+. +..+....+.++.++|.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVE 234 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCC-CCCCCcccCHHHHHHHH
Confidence 23457899999999764 4678899999999999999999999976 34444444444432 33345566789999999
Q ss_pred HcCC-CCCCCCCHHHHhcCccccc
Q 005916 265 KCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 265 kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+||. +|.+||++.++++||||..
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 235 ACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred HHccCChhhCcCHHHHHhCHHHhh
Confidence 9996 8999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=314.91 Aligned_cols=250 Identities=31% Similarity=0.527 Sum_probs=209.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|++.+.||+|+||.||+|.+..+|..||+|.++.... ......+++.+|+.++++++|+||+++++++.+.. ..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~--~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN--ELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eEE
Confidence 468999999999999999999999999999999875433 23445678999999999999999999999987654 789
Q ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 106 IITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+||||+.+|+|..++.. ...+++..++.|+.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++..
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~~ 155 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceeee
Confidence 99999999999998864 245899999999999999999999998 99999999999998 578999999999876
Q ss_pred hcccc--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCC-CHHHHHHHHhcCCCCCcccCCCCh
Q 005916 182 MEQAN--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR-NSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 182 ~~~~~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
+.... .....|++.|+|||.+ ...++.++|||||||++|+|++|..||.... +.......+..+..+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08224 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235 (267)
T ss_pred ccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCH
Confidence 54322 2345789999999966 4568999999999999999999999996532 334455555555544333335678
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.++++|.+||. +|.+|||+.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999996 7999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=346.95 Aligned_cols=233 Identities=33% Similarity=0.466 Sum_probs=198.9
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
.+-||.|+.|.||+|+. .++.||||+|+.- -..+|+-|++|+|||||.|.++|. ...++||||||
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVCt--qsPcyCIiMEf 193 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVCT--QSPCYCIIMEF 193 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeeec--CCceeEEeeec
Confidence 35699999999999964 5789999988621 124788999999999999999874 44589999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-cccc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKS 189 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~-~~~~ 189 (670)
|..|-|...++....+.......|..+|+.|++|||.|+ |||||||.-||||.. +..|||+|||-++..... ..-+
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~-~d~VKIsDFGTS~e~~~~STkMS 270 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISY-DDVVKISDFGTSKELSDKSTKMS 270 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeec-cceEEeccccchHhhhhhhhhhh
Confidence 999999999999999999999999999999999999999 999999999999984 458999999999877654 3457
Q ss_pred ccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC
Q 005916 190 VIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268 (670)
Q Consensus 190 ~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~ 268 (670)
++||..|||||+++ +..++++|||||||+|||||||+.||......+.|+. |-........+..++..++-||+.||.
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG-VGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG-VGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-ccCCcccccCcccCchHHHHHHHHHHh
Confidence 89999999999874 6789999999999999999999999987544444442 222333445667778899999999996
Q ss_pred -CCCCCCCHHHHhcC
Q 005916 269 -PASQRLSAKELLMD 282 (670)
Q Consensus 269 -dP~~RpSa~elL~h 282 (670)
+|..|||.+++|.|
T Consensus 350 sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLH 364 (904)
T ss_pred cCCCCCccHHHHHHH
Confidence 89999999999998
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=328.70 Aligned_cols=252 Identities=29% Similarity=0.521 Sum_probs=208.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|.....||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~ 94 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--ELW 94 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeCC--eEE
Confidence 344455689999999999999999999999999875432 23466889999999999999999999887654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||+.+++|..++.. ..+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++..+...
T Consensus 95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhcccc
Confidence 99999999999987754 56899999999999999999999998 99999999999998 6789999999998765433
Q ss_pred c--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-CcccCCCChHHHH
Q 005916 186 N--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVKS 261 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~~s~~~k~ 261 (670)
. .....|++.|+|||++. ..++.++|||||||++|+|++|..||.. .........+.....+ .......+..+.+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 249 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRD 249 (297)
T ss_pred cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCccccCCCCHHHHH
Confidence 2 34567899999999764 5689999999999999999999999976 3444444444433221 1122345788999
Q ss_pred HHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 262 FIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
||.+||. +|.+||++.++++||||...
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 250 FLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 9999996 89999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.40 Aligned_cols=247 Identities=26% Similarity=0.450 Sum_probs=203.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeE----EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLE----VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~----vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
...|++.+.||+|+||+||+|.+..+|.. ||+|.++.. ......+++.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 34589999999999999999988766654 888887632 2345567889999999999999999999988653
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 101 NKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
..++|+||+.+|+|.+++..+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 82 --~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a 156 (316)
T cd05108 82 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLA 156 (316)
T ss_pred --CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEcccccc
Confidence 477999999999999998875 46899999999999999999999998 99999999999998 6679999999999
Q ss_pred hhhccccc----ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 180 TIMEQANA----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 180 ~~~~~~~~----~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
..+..... ....++..|+|||++ ...++.++|||||||++|+|++ |..||.+ ....++...+..+..+ ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 234 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPP 234 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCC-CCCC
Confidence 87653221 223346789999966 5678999999999999999997 9999976 4455555555554332 2344
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..+..+.+++.+||. +|.+||++.+++.+
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 567899999999996 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=336.04 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=204.1
Q ss_pred CCeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWID 98 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d 98 (670)
+++|++.++||+|+||.||+|.+. .+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 457999999999999999999643 346789999886432 234556788999999999 89999999998875
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhc-------------------------------------------------------
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKH------------------------------------------------------- 123 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~------------------------------------------------------- 123 (670)
.. ..++++|||+.+|+|.+++...
T Consensus 83 ~~-~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 PG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred CC-CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 43 4789999999999999988642
Q ss_pred ------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc----cccccCC
Q 005916 124 ------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGT 193 (670)
Q Consensus 124 ------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GT 193 (670)
..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+.... .....++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 26789999999999999999999998 99999999999998 56899999999998764322 2334567
Q ss_pred CccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CC
Q 005916 194 PEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PA 270 (670)
Q Consensus 194 p~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP 270 (670)
+.|+|||++ ...++.++|||||||++|+|++ |..||.+..........+..+..+ ..+...++++.+++.+||. +|
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCCh
Confidence 889999965 5679999999999999999998 999998744444444445444332 3345567899999999996 89
Q ss_pred CCCCCHHHHhcC
Q 005916 271 SQRLSAKELLMD 282 (670)
Q Consensus 271 ~~RpSa~elL~h 282 (670)
.+||++.++++|
T Consensus 318 ~~RPs~~ell~~ 329 (337)
T cd05054 318 EDRPTFSELVEI 329 (337)
T ss_pred hhCcCHHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.33 Aligned_cols=242 Identities=23% Similarity=0.340 Sum_probs=195.0
Q ss_pred eEEEEEE--ecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 27 YIRYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 27 ~yr~~~~--LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
.|.+.+. ||+|+||.||++.++.+|..+|+|.+....... .|+.....+ +||||++++++|.... .
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~~--~ 83 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTLK--G 83 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecCC--e
Confidence 3444444 599999999999999999999999987543211 122222222 7999999999987654 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+||||+.+|+|.+++...+.+++..++.|+.||+.||.|||+.+ ++||||||+||+++.+.+.++|+|||++....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 9999999999999999998889999999999999999999999998 99999999999998443389999999987654
Q ss_pred ccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHH----HHHHHHhcCCCCCcccCCCChH
Q 005916 184 QANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSA----QIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 184 ~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~----~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
.. ....|++.|+|||++. ..++.++|||||||++|+|++|..||....... ...... ..+.......++.
T Consensus 162 ~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 236 (267)
T PHA03390 162 TP--SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKN 236 (267)
T ss_pred CC--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCHH
Confidence 32 3456899999999774 568999999999999999999999997533221 121221 2233344567899
Q ss_pred HHHHHHHcCC-CCCCCCC-HHHHhcCcccc
Q 005916 259 VKSFIEKCLV-PASQRLS-AKELLMDPFLQ 286 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpS-a~elL~hpf~~ 286 (670)
+++||.+||. +|.+||+ ++++|+||||.
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 9999999997 7999996 59999999996
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.10 Aligned_cols=250 Identities=30% Similarity=0.494 Sum_probs=211.6
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~~~ 105 (670)
.|.+.+.||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+++.+. ||||+++++++.+.. .++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--~~~ 78 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE--NLY 78 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc--eEE
Confidence 47889999999999999999999999999998875433 23344577889999999998 999999999886544 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+|||++.+++|.+++.+.+.+++..++.|+.||+.||.|||+++ ++|+||||+||+++ .+|.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCCc
Confidence 99999999999999999889999999999999999999999998 99999999999998 6789999999998766432
Q ss_pred c----------------------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHH
Q 005916 186 N----------------------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242 (670)
Q Consensus 186 ~----------------------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i 242 (670)
. .....|++.|+|||++ ...++.++||||||+++++|++|..||... .....++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS-NEYLTFQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHH
Confidence 2 1235678999999976 456888999999999999999999999874 344445555
Q ss_pred hcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCH----HHHhcCccc
Q 005916 243 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSA----KELLMDPFL 285 (670)
Q Consensus 243 ~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa----~elL~hpf~ 285 (670)
.... ..++...++.+.+||.+||. +|.+||++ .++|+||||
T Consensus 235 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 235 LKLE--YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HhcC--CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 4332 22334457899999999996 79999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=310.62 Aligned_cols=249 Identities=35% Similarity=0.589 Sum_probs=213.4
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.+.+.||+|++|.||+|.+..++..|++|.+..... .....+.+.+|++++++++|||++++++++.+. ..++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 77 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYII 77 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEE
Confidence 7788999999999999999999999999999986542 245677899999999999999999999988764 479999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccccc
Q 005916 108 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 187 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~ 187 (670)
|||+.+++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEC-CCCCEEEeccccceecCCCcc
Confidence 999999999999998889999999999999999999999998 99999999999998 578999999999987755432
Q ss_pred --ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 188 --KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 188 --~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
....|++.|+|||.+. ..++.++||||||+++|+|++|..||.........++.. .... ..++...+..+++||.
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDH-PPLPEGISPELKDFLM 232 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCC-CCCCCCCCHHHHHHHH
Confidence 4567899999999764 457889999999999999999999998744333333333 3222 2345566889999999
Q ss_pred HcCC-CCCCCCCHHHHhcCccc
Q 005916 265 KCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 265 kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+||. +|++||++.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9996 89999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=317.56 Aligned_cols=250 Identities=25% Similarity=0.457 Sum_probs=212.8
Q ss_pred EEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 30 YKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 30 ~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
....||.|+.|+||+++.+.+|...|||+++... +.+...|++..+.++... +.|+||+.|++|+.+. .+++.|
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~IcM 170 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVFICM 170 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHHHHH
Confidence 3457999999999999999999999999998543 577888999999887666 5999999999998766 488999
Q ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccccc
Q 005916 109 ELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 187 (670)
Q Consensus 109 Ey~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~ 187 (670)
|+|. -.+..++++ .++++|..+-.+...++.||.||-.+. +|||||+||+|||++ ..|.|||||||++..+-...+
T Consensus 171 elMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cCCCEEeecccccceeecccc
Confidence 9983 344444443 467999999999999999999997653 399999999999999 679999999999999887765
Q ss_pred cc-ccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc--CCCChHHH
Q 005916 188 KS-VIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS--KVKDPEVK 260 (670)
Q Consensus 188 ~~-~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~~~s~~~k 260 (670)
++ ..|-+.|||||.+. ..|+-.+||||||+.++||.||.+||.+|...-+..-+|..... ..++ ...++.++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPDFQ 326 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHHHH
Confidence 44 57999999999874 36999999999999999999999999999888888877877443 3333 23789999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+|+..||. |+.+||.-.+||+|||+...
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 99999996 79999999999999999754
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.90 Aligned_cols=251 Identities=31% Similarity=0.514 Sum_probs=208.5
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|+..+.||+|+||.||+|.+..+|..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.. .+|+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT--KLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--ceEE
Confidence 3556678999999999999999999999999887442 2345678899999999999999999999987644 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||||+.+++|.+++.. +.+++..++.++.||+.||.|||.++ ++|+||+|+||+++ .++.++|+|||++..+....
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccccCcc
Confidence 9999999999998864 56899999999999999999999998 99999999999998 67899999999987765432
Q ss_pred --cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 187 --AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
.....|+..|+|||++. ..++.++|||||||++|+|++|..||... ........+..+. +..+....+..+.+||
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 233 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPFKEFV 233 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCC-CCCCCcccCHHHHHHH
Confidence 23456899999999774 46889999999999999999999999763 3333333333332 2334445678899999
Q ss_pred HHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 264 EKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 264 ~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+||. +|.+||++.++++||||+..
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 234 EACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHccCCcccCcCHHHHHHhHHHHHH
Confidence 99996 89999999999999999743
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=312.29 Aligned_cols=250 Identities=30% Similarity=0.515 Sum_probs=213.7
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||++.+..+|..+|+|.+..... .......+.+|+.+++.++||||+++++++.+. ..+|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEE
Confidence 37889999999999999999999999999999875432 244566788999999999999999999988765 47999
Q ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 107 ITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
||||+.+++|.+++.+ ...+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++...
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKVL 153 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEe-cCCcEEEeeccchhhh
Confidence 9999999999998766 356899999999999999999999998 99999999999998 5789999999999887
Q ss_pred cccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 183 EQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 183 ~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
.........|++.|+|||.+ ...++.++|+||||+++|+|++|..||.. .+...+...+..+..+. .+...+.++++
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08530 154 KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYPP-IPPIYSQDLQN 231 (256)
T ss_pred ccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCC-CchhhCHHHHH
Confidence 66544556789999999966 45688899999999999999999999977 44555555555554433 33456789999
Q ss_pred HHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 262 FIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+|.+||. +|.+||++.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999996 79999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.12 Aligned_cols=254 Identities=27% Similarity=0.375 Sum_probs=200.4
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--- 101 (670)
-+.|++.+.||.|+||.||+|.+..+|..||+|.+...... ......+.+|+++++.++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 35699999999999999999999999999999998764321 1123356789999999999999999998765442
Q ss_pred ---CeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 102 ---KTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 102 ---~~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
..+++||||+.+ +|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcCc
Confidence 368999999965 67766554 457999999999999999999999998 99999999999998 67899999999
Q ss_pred chhhhcccc-------------cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHH
Q 005916 178 LATIMEQAN-------------AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242 (670)
Q Consensus 178 la~~~~~~~-------------~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i 242 (670)
++....... .....|++.|+|||++. ..++.++|||||||++|+|++|.+||.+...... ...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~ 239 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLI 239 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 997654321 12346789999999764 3588999999999999999999999976443332 2222
Q ss_pred hcC---CCC----------------------Ccc---cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 243 SSG---IKP----------------------AAL---SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 243 ~~g---~~p----------------------~~~---~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
... ..+ ..+ .....+.+.+||.+||. +|.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 110 000 000 01234678899999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=320.94 Aligned_cols=246 Identities=24% Similarity=0.407 Sum_probs=204.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEE-----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d-----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.+.|.+.+.||+|+||+||++.+ ..++..+|+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45689999999999999999975 345677898887642 244567789999999999999999999998754
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHK-------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~-------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~ 166 (670)
. .+++||||+.+|+|.+++..++ .+++..+..++.||+.||.|||.++ ++||||||+|||++
T Consensus 80 ~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~- 154 (288)
T cd05093 80 D--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG- 154 (288)
T ss_pred C--ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-
Confidence 4 7899999999999999987654 4899999999999999999999998 99999999999998
Q ss_pred CCCcEEEeeccchhhhcccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHH
Q 005916 167 NQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYK 240 (670)
Q Consensus 167 ~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~ 240 (670)
.++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |.+||.. .....+..
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~-~~~~~~~~ 233 (288)
T cd05093 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIE 233 (288)
T ss_pred cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHH
Confidence 67899999999987654322 22344678899999765 568999999999999999998 8999977 34555666
Q ss_pred HHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 241 KVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 241 ~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+..+..+ ..+...++++.+|+.+||. +|.+|||+.+++.
T Consensus 234 ~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 234 CITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 67666533 2344567899999999997 7999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=317.60 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=205.0
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.+.+.||.|+||.||+|.+..+|..+|+|.+.... ........+.+|+.+++.++|||++++++++.+.....+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 567889999999999999999999999999998653 223445667889999999999999999999876633589999
Q ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 108 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||+.+ +|..++... ..+++..++.++.||+.||.|||.++ ++|+||||+|||++ +++.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCC
Confidence 999974 898888765 57999999999999999999999998 99999999999998 67899999999998775543
Q ss_pred ---cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC---CCC---------
Q 005916 187 ---AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---KPA--------- 249 (670)
Q Consensus 187 ---~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~---~p~--------- 249 (670)
.....+++.|+|||.+. ..++.++||||||+++|+|++|..||....... ....+.... .+.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccch
Confidence 23456788999999654 357899999999999999999999998744333 222222110 000
Q ss_pred -----------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 250 -----------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 250 -----------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0112237889999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=316.82 Aligned_cols=249 Identities=32% Similarity=0.529 Sum_probs=207.6
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|.+..+|..+|+|.+..... ........+.+|+.+++.++||||++++++|.+.. .+++
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~ 79 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNI 79 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC--eEEE
Confidence 47788999999999999999999999999998875432 23445678889999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 107 ITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
+|||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++..+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhcc
Confidence 9999999999998764 356899999999999999999999998 99999999999998 5689999999998776
Q ss_pred cccc--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCC-HHHHHHHHhcCCCCCcccCCCChH
Q 005916 183 EQAN--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN-SAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 183 ~~~~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~-~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
.... .....|++.|+|||.+ ...++.++|+||||+++|+|++|..||.+... .....+.+.....+.......++.
T Consensus 157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence 5432 2345789999999976 45688999999999999999999999975332 234445555544444344556789
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+++||.+||. +|.+|||+.++++
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999996 8999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=313.79 Aligned_cols=240 Identities=24% Similarity=0.392 Sum_probs=197.9
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 111 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~ 111 (670)
+.||+|+||+||+|.+..+|..||+|.+... ...+....+.+|+.+++.++||||+++++++.+.. .+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--CeEEEEeec
Confidence 4699999999999999999999999987632 23455678899999999999999999999886544 789999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccccc--
Q 005916 112 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK-- 188 (670)
Q Consensus 112 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~-- 188 (670)
.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCccccccccccc
Confidence 999999998765 46899999999999999999999998 99999999999998 6689999999998765432211
Q ss_pred --cccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 189 --SVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 189 --~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
...++..|+|||.+ .+.++.++|||||||++|+|++ |..||.. .........+.... +...+...+..+++|+.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN-LSNQQTREAIEQGV-RLPCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc-cCHHHHHHHHHcCC-CCCCcccCCHHHHHHHH
Confidence 11234579999976 4568999999999999999998 8889876 34445555554433 23345566889999999
Q ss_pred HcCC-CCCCCCCHHHHhc
Q 005916 265 KCLV-PASQRLSAKELLM 281 (670)
Q Consensus 265 kcL~-dP~~RpSa~elL~ 281 (670)
+||. +|.+|||+.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9996 7999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.23 Aligned_cols=247 Identities=23% Similarity=0.385 Sum_probs=205.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.+.|.+.+.||+|+||.||+|.+. .++..||+|.++... ..+..+.+.+|+++|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 345788899999999999999874 346889999886432 234567889999999999999999999998765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHK--------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 165 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~--------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~ 165 (670)
. ..++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+|||++
T Consensus 81 ~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~ 156 (280)
T cd05049 81 D--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG 156 (280)
T ss_pred C--CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc
Confidence 3 7999999999999999987653 4789999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHH
Q 005916 166 GNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIY 239 (670)
Q Consensus 166 ~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~ 239 (670)
.++.+||+|||++....... .....+++.|+|||++ .+.++.++|||||||++|+|++ |..||... +.....
T Consensus 157 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~ 234 (280)
T cd05049 157 -YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVI 234 (280)
T ss_pred -CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHH
Confidence 66899999999987553221 2334567899999976 4578999999999999999998 99999874 455566
Q ss_pred HHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 240 KKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 240 ~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+..+..+. .+...+..+++||.+||. +|.+||++.|++.
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6666655433 334577899999999996 7999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=333.89 Aligned_cols=269 Identities=26% Similarity=0.428 Sum_probs=219.7
Q ss_pred CcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC---HHHHHHHHHHHHHHHhCCCCCeeeeee
Q 005916 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS---PEDLERLYSEVHLLKSLKHNNIIRFYN 94 (670)
Q Consensus 18 ~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s---~~~~e~l~~Ei~iLk~L~HpNIVkl~~ 94 (670)
+-..-....+|.+..+||+|+|+.||+|+|....+.||+|+-...+--.. ........+|..|.+.|+||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 33344446778889999999999999999999999999998765432111 223456789999999999999999999
Q ss_pred EEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEE
Q 005916 95 SWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVK 172 (670)
Q Consensus 95 ~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vK 172 (670)
+|.-+. ..+|-|+|||+|.+|.-|++.++.+++++++.|+.||+.||.||....|||||-||||.|||+-. .-|.||
T Consensus 535 yfslDt-dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 535 YFSLDT-DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeecc-ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 986544 37899999999999999999999999999999999999999999999999999999999999852 247899
Q ss_pred Eeeccchhhhcccc---------cccccCCCccCCCccc--c---CCCCccceeeeccchhhhhhhccCCCCCCCCHHHH
Q 005916 173 IGDLGLATIMEQAN---------AKSVIGTPEFMAPELY--D---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 238 (670)
Q Consensus 173 L~DFGla~~~~~~~---------~~~~~GTp~YmAPEvl--~---~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i 238 (670)
|+||||++++.... +....||.+|++||.+ . ...+.++||||+|||+|.++.|+.||........|
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 99999999996532 2346799999999954 2 24788999999999999999999999764444444
Q ss_pred HH--HHhcCC-CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 239 YK--KVSSGI-KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 239 ~~--~i~~g~-~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.. .|.... ...+...+.++++++||++||+ .-..|....+|..||||..
T Consensus 694 LqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 694 LQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred HhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 32 222221 1223345678999999999998 4689999999999999974
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=311.51 Aligned_cols=241 Identities=25% Similarity=0.410 Sum_probs=205.8
Q ss_pred EEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 32 EVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
+.||+|+||.||+|.+... +..||+|.+..... ....+.+.+|+.+++.++||||+++++++.+ ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence 4799999999999998866 89999999875432 2256788999999999999999999998876 34799999
Q ss_pred ecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 109 ELFTSGSLRQYRKKH---------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
||+.+++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~-~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVG-EDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEEC-CCCcEEEcccccc
Confidence 999999999999875 78999999999999999999999998 99999999999998 5689999999999
Q ss_pred hhhcccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 180 TIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 180 ~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. ....++...+..+.. ...+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG-LSNEEVLEYLRKGYR-LPKPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC-CCCCc
Confidence 8775532 34556789999999764 478999999999999999999 5999987 466667777766543 23445
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..++++.+++.+||. +|.+|||+.+++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 568999999999996 79999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.30 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=208.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
..+|.+.+.||+|+||.||+|.+..+|..+|+|.+.... ........+.+|+.+++++ +||||+++++++.......
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 356888899999999999999999999999999886321 2234456678899999999 9999999999987666667
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+||||+. ++|..++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhccc
Confidence 899999996 5999988765 7899999999999999999999998 99999999999998 67899999999998664
Q ss_pred ccc-------cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC---------
Q 005916 184 QAN-------AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--------- 245 (670)
Q Consensus 184 ~~~-------~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g--------- 245 (670)
... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.+........+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 321 23457899999999763 457899999999999999999999997644433322211110
Q ss_pred -----------------CC--CCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 246 -----------------IK--PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 246 -----------------~~--p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.. ........+.++.+||.+||. +|.+|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00 011112257889999999996 89999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.08 Aligned_cols=255 Identities=30% Similarity=0.422 Sum_probs=210.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---CCe
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---NKT 103 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~---~~~ 103 (670)
+|++.+.||.|+||.||+|++..+|..||+|.+.... ......+.+.+|+.+++.++||||+++++++.+.. ...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 4889999999999999999999999999999887432 22445677899999999999999999999887653 236
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~-~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVN-SNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccCceEeec
Confidence 899999997 589999988889999999999999999999999998 99999999999998 56899999999998765
Q ss_pred ccc-----cccccCCCccCCCcccc-C-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC-CC------
Q 005916 184 QAN-----AKSVIGTPEFMAPELYD-E-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PA------ 249 (670)
Q Consensus 184 ~~~-----~~~~~GTp~YmAPEvl~-~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~-p~------ 249 (670)
... .....+|+.|+|||++. . .++.++||||||+++|+|++|.+||.... ....+..+..... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhhh
Confidence 432 34567899999999774 3 68899999999999999999999998743 3333333332110 00
Q ss_pred -------------------c---ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 250 -------------------A---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 250 -------------------~---~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
. .....++.+.+||.+||. +|.+||++.++|.||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0 012246789999999996 89999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=317.97 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=201.7
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
....|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3456999999999999999999864 346789999875322 23445668899999999999999999998754
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKHK----------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 168 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~~----------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~ 168 (670)
. ...++||||+.+|+|.+++...+ .++...+..++.|++.||.|||+++ ++||||||+|||++ .+
T Consensus 81 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~ 155 (277)
T cd05062 81 G--QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-ED 155 (277)
T ss_pred C--CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CC
Confidence 4 37899999999999999987532 3577889999999999999999998 99999999999998 57
Q ss_pred CcEEEeeccchhhhcccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHH
Q 005916 169 GEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKV 242 (670)
Q Consensus 169 g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i 242 (670)
+.++|+|||++....... .....+++.|||||++. +.++.++|||||||++|+|++ |..||.+ .+.....+.+
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~ 234 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFV 234 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 899999999987654322 12235578899999764 568999999999999999999 7889976 4555555555
Q ss_pred hcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 243 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 243 ~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..+..+ ..+...+..+++||.+||. +|.+|||+.+++.+
T Consensus 235 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 554332 2345567889999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=317.90 Aligned_cols=250 Identities=27% Similarity=0.436 Sum_probs=200.2
Q ss_pred CCCeEEEEEEecccCCeEEEEEE----EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~----d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.+|||++.+.||+|+||+||++. ...++..||+|.++... .......+.+|+++|+.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46888999999999999998864 34578899999887532 234556788999999999999999999988776
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
....+++||||+.+|+|.+++... .+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~ 154 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLA 154 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeecccc
Confidence 666799999999999999998764 5999999999999999999999998 99999999999998 5689999999999
Q ss_pred hhhccccc-----ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHH--------------HHH
Q 005916 180 TIMEQANA-----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSA--------------QIY 239 (670)
Q Consensus 180 ~~~~~~~~-----~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~--------------~i~ 239 (670)
..+..... ....++..|+|||.+ ...++.++|||||||++|+|++|..||....... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 87654221 223456789999976 4568999999999999999999999985422110 011
Q ss_pred HHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 240 KKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 240 ~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+..+.. ...+...+.++++|+.+||. +|++|||+.+++.
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111111 11234457899999999997 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=314.37 Aligned_cols=248 Identities=20% Similarity=0.360 Sum_probs=203.0
Q ss_pred EEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--- 101 (670)
|.+.+.||+|+||.||+|.+..+ +..||+|.++.... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 46788999999999999987653 47899999875432 34556788999999999999999999998765432
Q ss_pred -CeEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 102 -KTVNIITELFTSGSLRQYRKKH------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 102 -~~~~lVmEy~~gGsL~~~i~~~------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
...+++|||+.+|+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEEC
Confidence 3579999999999999987543 36899999999999999999999998 99999999999998 56899999
Q ss_pred eccchhhhcccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 175 DLGLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 175 DFGla~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
|||++....... .....++..|+|||.+. ..++.++|||||||++|+|++ |.+||.+ .....+++.+..+..+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRL 234 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC
Confidence 999987664332 11233567899999764 568999999999999999999 8899977 4455666666665433
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..+...+..+.++|.+||. +|.+|||+.+++++
T Consensus 235 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3445677899999999997 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=322.77 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=206.9
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|...+.||+|+||+||+|.+..+|..|++|.+..... ........+.+|+.+++.++|||++++++++.+.. ..|+|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--TAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--EEEEE
Confidence 5566789999999999999999999999999875432 23445567889999999999999999999987754 78999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 108 TELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||+. |+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecCCCcccCC--
Confidence 99996 577776654 457899999999999999999999998 99999999999998 668999999998864322
Q ss_pred cccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 187 AKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
.....|++.|+|||++. +.++.++|||||||++|+|++|.+||.........+... ....+.......+..+++|
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCCCCccccCHHHHHH
Confidence 34567899999999762 468889999999999999999999998754444444433 3333333344456789999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
|.+||. +|.+||++.+++.||||+.
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCC
Confidence 999996 7999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.26 Aligned_cols=248 Identities=27% Similarity=0.425 Sum_probs=204.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCC-----CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVN-----GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWID 98 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~t-----g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d 98 (670)
...|++.+.||+|+||.||+|..... ...+|+|.+.... ......++.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 34688999999999999999987644 3789999887432 244556788999999999 89999999998865
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccE
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 162 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNI 162 (670)
. ..++++|||+.+|+|..++... +.+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 88 ~--~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Ni 163 (293)
T cd05053 88 E--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNV 163 (293)
T ss_pred C--CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeE
Confidence 4 3699999999999999998642 46899999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHH
Q 005916 163 FINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSA 236 (670)
Q Consensus 163 Ll~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~ 236 (670)
|++ +++.+||+|||++..+.... .....+++.|+|||++ ...++.++|||||||++|+|++ |..||.. ....
T Consensus 164 l~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~ 241 (293)
T cd05053 164 LVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVE 241 (293)
T ss_pred EEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCHH
Confidence 998 67899999999998765432 1122346789999965 5678999999999999999997 9999987 4566
Q ss_pred HHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 237 QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 237 ~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+.++.+..+..+. .+...+..+.+|+.+||. +|.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6777776655332 334567899999999996 79999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=317.33 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=203.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEc----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDE----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
..|++.+.||+|+||+||+|... ..+..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ- 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-
Confidence 35889999999999999999853 456789999887432 3455677889999999999999999999886654
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEE
Q 005916 102 KTVNIITELFTSGSLRQYRKKH-----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI 164 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~-----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl 164 (670)
..|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili 157 (283)
T cd05090 81 -PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI 157 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE
Confidence 689999999999999998643 24788999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeccchhhhcccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHH
Q 005916 165 NGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQI 238 (670)
Q Consensus 165 ~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i 238 (670)
+ .++.+||+|||+++...... .....++..|+|||++. ..++.++|||||||++|+|++ |.+||.+ .....+
T Consensus 158 ~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~ 235 (283)
T cd05090 158 G-EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEV 235 (283)
T ss_pred c-CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 8 66799999999998764322 23445677899999764 568999999999999999998 9999976 445566
Q ss_pred HHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 239 YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 239 ~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
...+.....+ ..+...++.+++++.+||. +|.+||++.+++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6666554433 3455678999999999997 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=318.43 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=204.2
Q ss_pred CeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
..|++.+.||+|+||.||+|.++ ..+..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 46888999999999999999765 235689999876432 2344556889999999999999999999876544
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc
Q 005916 101 NKTVNIITELFTSGSLRQYRKKH----------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 170 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~----------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~ 170 (670)
..|+||||+.+|+|.+++... ...+...+..++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 83 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~~~ 157 (288)
T cd05061 83 --PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HDFT 157 (288)
T ss_pred --CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CCCc
Confidence 689999999999999998753 23466788999999999999999998 99999999999998 5689
Q ss_pred EEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhc
Q 005916 171 VKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS 244 (670)
Q Consensus 171 vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~ 244 (670)
+||+|||++....... .....++..|+|||.+ .+.++.++|||||||++|+|++ |..||.+ .....+.+.+..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMD 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHc
Confidence 9999999987653322 1223457789999976 4578999999999999999998 7889976 455566666655
Q ss_pred CCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc------Ccccccc
Q 005916 245 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM------DPFLQVN 288 (670)
Q Consensus 245 g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~------hpf~~~~ 288 (670)
+..+. .+...++.++++|.+||. +|.+|||+.++++ ||||+..
T Consensus 237 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 237 GGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 54332 334457899999999996 8999999999986 8988743
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=339.62 Aligned_cols=241 Identities=24% Similarity=0.434 Sum_probs=202.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.+++.+.||+|.||.||.|....+ ..||+|.++.... ..+.+.+|+++|++|+|+|||++|+++..+. .+||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyI 278 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYI 278 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEE
Confidence 456678899999999999976533 3799999986532 1355779999999999999999999886544 6999
Q ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
||||+..|+|.+|++. .+.+...+...++.||++|++||++++ +|||||-..||||+ +++.+||+|||||+...+
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccccccccCC
Confidence 9999999999999997 567999999999999999999999999 99999999999998 677999999999996544
Q ss_pred cccccccC---CCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 185 ANAKSVIG---TPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 185 ~~~~~~~G---Tp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.......| ...|.|||.+ .+.++.++|||||||+|+||+| |+.||.+ ....+....+.+|..- ..+..+++++
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRl-p~P~~CP~~v 433 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRL-PRPEGCPDEV 433 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcC-CCCCCCCHHH
Confidence 43333333 3479999976 5679999999999999999998 7888887 5667777788888643 3455688999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHh
Q 005916 260 KSFIEKCLV-PASQRLSAKELL 280 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL 280 (670)
.+++..||. +|++|||.+.+.
T Consensus 434 Y~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 434 YELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHhhCCcccCCCHHHHH
Confidence 999999996 899999998665
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=328.09 Aligned_cols=256 Identities=29% Similarity=0.400 Sum_probs=206.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--- 101 (670)
.+.|.+.+.||+|+||+||+|.+..+|..||+|++.... ........+.+|+.+|+.++||||+++++++.....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 456889999999999999999999999999999886422 233445678899999999999999999998865432
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 -~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
..+++||||+ |++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~~~ 166 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR 166 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeccccc
Confidence 2468999999 7799888764 57999999999999999999999998 99999999999998 67899999999987
Q ss_pred hhcccccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC-----------
Q 005916 181 IMEQANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK----------- 247 (670)
Q Consensus 181 ~~~~~~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~----------- 247 (670)
.... ......+++.|+|||.+.. .++.++|+|||||++|+|++|.+||..........+.+.....
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 167 QTDS-EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred cccc-CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 6543 2334578999999997653 5889999999999999999999999874433222221111000
Q ss_pred --------------C---CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 248 --------------P---AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 248 --------------p---~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+ ..+....++.+.++|.+||. +|.+|||+.+++.||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0 01113456789999999996 89999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.47 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=198.3
Q ss_pred EEeccc--CCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 005916 32 EVIGKG--AFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 32 ~~LG~G--~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmE 109 (670)
..||+| +||+||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||++++++|.... .+++|||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEEEEe
Confidence 456766 999999999999999999999875432 3455678899999999999999999999987654 6899999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc-
Q 005916 110 LFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 186 (670)
Q Consensus 110 y~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~- 186 (670)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++++||+.+.......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCc
Confidence 99999999998765 35899999999999999999999998 99999999999998 66899999998654332211
Q ss_pred -c-------ccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC-C------
Q 005916 187 -A-------KSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-P------ 248 (670)
Q Consensus 187 -~-------~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~-p------ 248 (670)
. ....++..|||||++.+ .|+.++|||||||++|+|++|.+||............+..... +
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 0 11234567999998753 4789999999999999999999999875444433332221100 0
Q ss_pred -------------------------------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 -------------------------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 -------------------------------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.......++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00112245678999999996 89999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=316.60 Aligned_cols=247 Identities=24% Similarity=0.420 Sum_probs=203.8
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCe----EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGL----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~----~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
....|++.++||+|+||+||+|.+..+|. .||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 34578999999999999999999877776 47888886432 345567788999999999999999999988643
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
..++++||+.+|+|.+++..+ +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ +++.+||+|||+
T Consensus 82 ---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~ 155 (279)
T cd05109 82 ---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGL 155 (279)
T ss_pred ---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCc
Confidence 478999999999999998764 56999999999999999999999998 99999999999997 667999999999
Q ss_pred hhhhccccc----ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCccc
Q 005916 179 ATIMEQANA----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALS 252 (670)
Q Consensus 179 a~~~~~~~~----~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 252 (670)
+..+..... ....+++.|+|||.+ ...++.++|||||||++|+|++ |..||.. .....+...+..+..+. .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~ 233 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QP 233 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CC
Confidence 987643221 122346789999966 5679999999999999999998 8999976 44555666665554332 33
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
...+..+.++|.+||. +|.+||++.+++.
T Consensus 234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 234 PICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4567899999999996 8999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=314.34 Aligned_cols=255 Identities=23% Similarity=0.301 Sum_probs=208.3
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC--
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ-- 100 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~-- 100 (670)
-++.+||+.+.||.|||+-||++....++..||+|+|.... .++.+..++|+...++++||||++++++.+...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 35789999999999999999999999999999999998653 577888999999999999999999998765433
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEee
Q 005916 101 -NKTVNIITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 175 (670)
Q Consensus 101 -~~~~~lVmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~D 175 (670)
....|+++.|+..|+|.+++... ..++|.++..|+.+|+.||.+||...||+.||||||.|||+. +.+.++|.|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~~vl~D 172 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGLPVLMD 172 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCceEEEe
Confidence 35799999999999999987653 369999999999999999999999999999999999999998 578999999
Q ss_pred ccchhhhcccc-----c------ccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCH-HHHH
Q 005916 176 LGLATIMEQAN-----A------KSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNS-AQIY 239 (670)
Q Consensus 176 FGla~~~~~~~-----~------~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~-~~i~ 239 (670)
||.++...-.- . ..-..|.-|.|||+++ ...++++|||||||++|.|+.|..||...... ..+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 99987653211 0 1123588899999885 34789999999999999999999999641110 0011
Q ss_pred HHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 240 KKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 240 ~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
-.+..+....+-....+..+.+||+.||+ ||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 12233333233334478999999999995 89999999999874
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=316.52 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=203.8
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcC-----CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~-----tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
.++.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 34668899999999999999999887 78889999876432 23445668899999999999999999998866
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--CC
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKHK-------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QG 169 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~~-------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~g 169 (670)
.. ..++||||+.||+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+|||++.. ..
T Consensus 81 ~~--~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 81 RL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred CC--CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCc
Confidence 54 5789999999999999987653 4899999999999999999999998 9999999999999832 23
Q ss_pred cEEEeeccchhhhccccc----ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHh
Q 005916 170 EVKIGDLGLATIMEQANA----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVS 243 (670)
Q Consensus 170 ~vKL~DFGla~~~~~~~~----~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~ 243 (670)
.+||+|||++..+..... ....+++.|+|||++ ...++.++|||||||++|+|++ |..||.. .....+...+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~-~~~~~~~~~~~ 235 (277)
T cd05036 157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG-RTNQEVMEFVT 235 (277)
T ss_pred ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHH
Confidence 699999999987633221 122335689999976 4679999999999999999997 9999987 44455555555
Q ss_pred cCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 244 SGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 244 ~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.... ...+...+..+.+|+.+||. +|.+|||+.++++|
T Consensus 236 ~~~~-~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 236 GGGR-LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4432 23345567899999999996 79999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.65 Aligned_cols=243 Identities=26% Similarity=0.413 Sum_probs=205.3
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||+|+||.||+|.++.++..||+|.+... ......+.+|+.+++.++||||+++++++.... .+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 79 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYI 79 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCC--CcEE
Confidence 488899999999999999999999999999987643 233567889999999999999999999886544 6899
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
||||+.+++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+|||++ +++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCcccccccc
Confidence 99999999999998764 35899999999999999999999998 99999999999998 678999999999887654
Q ss_pred ccc---ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 185 ANA---KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 185 ~~~---~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
... ....+++.|+|||++ ...++.++|||||||++|+|++ |..||.+ .+....+..+..+..+ ..+...++++
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKV 234 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHH
Confidence 322 122346689999976 4578899999999999999998 9999977 5666677777665433 3455668999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.++|.+||. +|++|||+.++++
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHH
Confidence 999999996 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.44 Aligned_cols=246 Identities=23% Similarity=0.390 Sum_probs=203.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCC-----CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVN-----GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~t-----g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
..|++.+.||+|+||.||+|.++.. +..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG- 81 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-
Confidence 3588999999999999999987644 4889999876432 234456788999999999999999999988655
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHK----------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 170 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~----------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~ 170 (670)
..+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 82 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~~~ 157 (277)
T cd05032 82 -QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-EDLT 157 (277)
T ss_pred -CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CCCC
Confidence 47899999999999999986532 3678899999999999999999998 99999999999998 6789
Q ss_pred EEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhc
Q 005916 171 VKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS 244 (670)
Q Consensus 171 vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~ 244 (670)
+||+|||++....... .....++..|+|||.+ .+.++.++|||||||++|+|++ |..||.+ .+.....+.+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHhc
Confidence 9999999987664432 2334568899999966 4678999999999999999998 9999976 456666666665
Q ss_pred CCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 245 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 245 g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+..+ ..+...+..+.++|.+||. +|.+|||+.+++.
T Consensus 237 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 GGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4332 3344458899999999996 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=314.73 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=201.7
Q ss_pred EEEEEecccCCeEEEEEEEcCCCe--EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----CC
Q 005916 29 RYKEVIGKGAFKTVYKAFDEVNGL--EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----NK 102 (670)
Q Consensus 29 r~~~~LG~G~fG~Vy~a~d~~tg~--~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~----~~ 102 (670)
.++++||+|+||.||+|.+..++. .+|+|.++... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 467899999999999999877765 68988876532 24566788899999999999999999999775432 12
Q ss_pred eEEEEEecCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 103 TVNIITELFTSGSLRQYRKK------HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~------~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
..+++|||+.+|+|.+++.. ...+++..+..++.||+.||.|||.++ |+||||||+|||++ .++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCC
Confidence 57899999999999988743 234899999999999999999999998 99999999999998 6789999999
Q ss_pred cchhhhcccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCc
Q 005916 177 GLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 177 Gla~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 250 (670)
|++..+.... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. .....++..+..+..+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-
Confidence 9998764322 12334677899999764 568999999999999999999 8899976 45667777777664322
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.....+..++++|.+||. +|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 233456789999999996 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.60 Aligned_cols=258 Identities=29% Similarity=0.483 Sum_probs=211.6
Q ss_pred cccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 19 ~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
...+|... |...+.||+|+||+||+|.+..+|..||+|.+..... ...+....+.+|+.+++.++|||++++++++.+
T Consensus 19 ~~~~~~~~-f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 19 FKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred cCCCchhh-hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44455433 7788899999999999999999999999999875432 234556778899999999999999999999876
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.. ..++||||+.| +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.+||+|||
T Consensus 97 ~~--~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~dfg 170 (317)
T cd06635 97 EH--TAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFG 170 (317)
T ss_pred CC--eEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecCC
Confidence 54 68999999975 77776654 466899999999999999999999998 99999999999998 67899999999
Q ss_pred chhhhcccccccccCCCccCCCccc----cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 178 LATIMEQANAKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 178 la~~~~~~~~~~~~GTp~YmAPEvl----~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
++..... .....|++.|+|||++ .+.++.++|||||||++|+|++|.+||........+. .+..+..+.....
T Consensus 171 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 247 (317)
T cd06635 171 SASIASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPTLQSN 247 (317)
T ss_pred CccccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH-HHHhccCCCCCCc
Confidence 9865433 2345789999999975 3468899999999999999999999997744334444 3444333333344
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
..++.+++||.+||. +|.+||++.++++|+|+..
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 567889999999996 7999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.03 Aligned_cols=245 Identities=24% Similarity=0.446 Sum_probs=201.8
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 75 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE--P 75 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC--C
Confidence 3457999999999999999999865 56679999876432 23567889999999999999999999876543 6
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
++++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~ 152 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARV 152 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCcccee
Confidence 89999999999999998763 56899999999999999999999998 99999999999998 678999999999987
Q ss_pred hcccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 182 MEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 182 ~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
..... .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .........+..+... ......+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 230 (261)
T cd05072 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRM-PRMENCP 230 (261)
T ss_pred cCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCC
Confidence 65432 12334567899999764 568899999999999999998 9999977 4455555656555332 2334567
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.++.++|.+||. +|.+||+++++++
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 231 DELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999996 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.87 Aligned_cols=242 Identities=21% Similarity=0.413 Sum_probs=200.0
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|..+ .+..+|+|.+..... ..+.+.+|+.+|+.++||||+++++++.+.. .+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~i 76 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK--PLYI 76 (256)
T ss_pred HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccCC--CEEE
Confidence 4778899999999999999765 456799998764322 2356788999999999999999999886543 6899
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+.+|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCCC
Confidence 99999999999998754 56899999999999999999999998 99999999999998 6689999999998765432
Q ss_pred cc---ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 186 NA---KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 186 ~~---~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
.. ....++..|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...+..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~ 231 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRL-YRPKLASMTVY 231 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHH
Confidence 21 2234566899999764 578999999999999999999 8999976 4556666667665433 23455678999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhc
Q 005916 261 SFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+++.+||. +|.+||++.++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 99999996 7999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.45 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=203.3
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
..+.|.+.+.||+|+||.||+|.+. .++..+++|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc----HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 3456889999999999999999753 355678888775322 3445678899999999999999999998865
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccE
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 162 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNI 162 (670)
.. ..++||||+.+++|.+++..++ .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 79 ~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Ni 154 (291)
T cd05094 79 GD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNC 154 (291)
T ss_pred CC--ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceE
Confidence 43 6899999999999999987653 3889999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHH
Q 005916 163 FINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSA 236 (670)
Q Consensus 163 Ll~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~ 236 (670)
|++ .++.++|+|||++....... .....|++.|+|||++ ...++.++|||||||++|+|+| |..||.. .+..
T Consensus 155 l~~-~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~ 232 (291)
T cd05094 155 LVG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNT 232 (291)
T ss_pred EEc-cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHH
Confidence 998 66899999999987654322 2345578899999966 4678999999999999999998 9999976 4445
Q ss_pred HHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 237 QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 237 ~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.....+..+..+ ......+..+.+++.+||. +|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 233 EVIECITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 555556555433 2345567899999999996 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=329.23 Aligned_cols=256 Identities=30% Similarity=0.434 Sum_probs=208.0
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC--
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN-- 101 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~-- 101 (670)
.++.|.+.+.||+|+||+||+|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 3556899999999999999999999999999999886432 234455678899999999999999999987754432
Q ss_pred --CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 102 --KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 102 --~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
..+++|+||+ +++|.+++.. .++++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~~ 165 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLA 165 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEcccccc
Confidence 3589999999 6799998875 57999999999999999999999998 99999999999998 6789999999999
Q ss_pred hhhcccccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC--CC-------
Q 005916 180 TIMEQANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KP------- 248 (670)
Q Consensus 180 ~~~~~~~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~--~p------- 248 (670)
...... .....+++.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+..+.... .+
T Consensus 166 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 166 RHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhc
Confidence 876443 345678999999997643 578999999999999999999999976433 33333332211 00
Q ss_pred -----------------C---cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 -----------------A---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 -----------------~---~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
. ......++.+.+||.+||. +|.+|||+.+++.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 0 0112347899999999996 79999999999999999854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.74 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=199.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEE--EEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEV--AWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~v--AiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~ 102 (670)
..|.+.+.||+|+||+||+|.++.+|..+ |+|.+. . .........+.+|+.++.++ +||||+++++++.+. .
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~--~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--E-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEec--c-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--C
Confidence 45889999999999999999998888655 555443 2 12345567888999999999 899999999988654 3
Q ss_pred eEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC
Q 005916 103 TVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~ 166 (670)
.+|+||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~- 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG- 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-
Confidence 7999999999999999987543 5789999999999999999999998 99999999999998
Q ss_pred CCCcEEEeeccchhhhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHh
Q 005916 167 NQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVS 243 (670)
Q Consensus 167 ~~g~vKL~DFGla~~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~ 243 (670)
.++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|+| |..||.. .+....++.+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~ 237 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLP 237 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHh
Confidence 56799999999986432211 11223466899999764 458899999999999999998 9999976 44555666665
Q ss_pred cCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 244 SGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 244 ~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.+..+ ..+...++.+.+||.+||. +|.+||++.++|.+
T Consensus 238 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54322 2233457899999999996 79999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.74 Aligned_cols=239 Identities=23% Similarity=0.381 Sum_probs=200.1
Q ss_pred EecccCCeEEEEEEE--cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 33 VIGKGAFKTVYKAFD--EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~d--~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
.||+|+||.||+|.. ..++..+|+|+++... ......+.+.+|+.+++.++||||+++++++.. ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence 689999999999964 5678899999886432 234566788999999999999999999997743 257899999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc----
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 186 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~---- 186 (670)
+.+|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||.|||++ .++.+||+|||++..+....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999998 99999999999998 56799999999997764322
Q ss_pred -cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 187 -AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 187 -~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
.....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. .+...+...+..+..+ ..+...+++++++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 12223467899999764 568889999999999999998 9999976 4556677777766543 34556789999999
Q ss_pred HHcCC-CCCCCCCHHHHhc
Q 005916 264 EKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 264 ~kcL~-dP~~RpSa~elL~ 281 (670)
.+||. +|.+||++.++..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99996 8999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=336.65 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=202.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcC-----CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDD 99 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~-----tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~ 99 (670)
+.|+++++||+|+||+||+|.+.. ++..||+|++.... .....+.+.+|+++|+.|. |||||+++++|.+.
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 457788999999999999998643 34579999886432 2345677899999999995 99999999998654
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc--------------------------------------------------------
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH-------------------------------------------------------- 123 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~-------------------------------------------------------- 123 (670)
. .+|+|||||.+|+|.+++.+.
T Consensus 114 ~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 114 G--PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred C--ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 4 799999999999999987642
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEE
Q 005916 124 ----------------------------------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 163 (670)
Q Consensus 124 ----------------------------------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNIL 163 (670)
..+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nil 269 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEE
Confidence 24778888999999999999999998 999999999999
Q ss_pred EeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHH
Q 005916 164 INGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQ 237 (670)
Q Consensus 164 l~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~ 237 (670)
++ .++.+||+|||++....... .....+++.|+|||++ ...++.++|||||||++|+|++ |..||........
T Consensus 270 l~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 270 LA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred Ee-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 98 56799999999987654322 2334577899999966 5578999999999999999997 9999987555556
Q ss_pred HHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 238 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 238 i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
++..+..+..+ ..+...+..++++|.+||. +|.+||++.++.+
T Consensus 349 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 349 FYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 66666665432 2344567899999999996 8999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=341.02 Aligned_cols=277 Identities=24% Similarity=0.359 Sum_probs=227.4
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
-|..++.||-|+||.|.++....|...||.|.+++.+++. ..++..+..|..||..-+.+=||+||-+|.|.+ .+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--nLYF 706 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYF 706 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ceEE
Confidence 3666789999999999999988899999999999877654 466778899999999999999999999998876 6999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||+|+.||++-.++.+.+.|.|..+++|+..+.+|+++.|..| +|||||||+||||| .+|+|||+||||++-+....
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceecc
Confidence 9999999999999999999999999999999999999999999 99999999999999 78999999999987542110
Q ss_pred --------------------------------------------cccccCCCccCCCccc-cCCCCccceeeeccchhhh
Q 005916 187 --------------------------------------------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLE 221 (670)
Q Consensus 187 --------------------------------------------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilye 221 (670)
++..+||+.|+|||++ ..+|+..||+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1246799999999976 6689999999999999999
Q ss_pred hhhccCCCCCCCCHHHHHHHHhcCC--CCCcccCCCChHHHHHHHHcCCCCCCCC---CHHHHhcCccccccCCCCCCCC
Q 005916 222 MVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVPASQRL---SAKELLMDPFLQVNGTTKNRPL 296 (670)
Q Consensus 222 LltG~~Pf~~~~~~~~i~~~i~~g~--~p~~~~~~~s~~~k~fI~kcL~dP~~Rp---Sa~elL~hpf~~~~~~~~~~~~ 296 (670)
|+.|++||......+..++ |..-. .........++++.++|.++...+..|+ .++++-.||||+...+...+..
T Consensus 864 m~~g~~pf~~~tp~~tq~k-v~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfsslRkq 942 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYK-VINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQ 942 (1034)
T ss_pred HhhCCCCccCCCCCcceee-eeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhhhhc
Confidence 9999999987443333332 22211 1223334578999999999988888888 5788999999997766554433
Q ss_pred CCCCCcCCCccccccc
Q 005916 297 PLPDIVLPRVGAFGDR 312 (670)
Q Consensus 297 ~~~~~~~~~~~~~~~~ 312 (670)
. ...+|++....+.
T Consensus 943 ~--ApYIP~ItHptDT 956 (1034)
T KOG0608|consen 943 R--APYIPRITHPTDT 956 (1034)
T ss_pred c--CCcCccccCCCcc
Confidence 2 2356666544443
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=329.02 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=203.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEE-----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWID 98 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d-----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d 98 (670)
..+|++.+.||+|+||+||+|.+ ..+++.||+|+++... .......+.+|+.+|+++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 45699999999999999999974 3568899999987532 234466788999999999 78999999998865
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhc-------------------------------------------------------
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKH------------------------------------------------------- 123 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~------------------------------------------------------- 123 (670)
.. ..+++|||||.+|+|.+++...
T Consensus 83 ~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 PG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred CC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 44 4689999999999999998643
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc----c
Q 005916 124 ------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----A 187 (670)
Q Consensus 124 ------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~----~ 187 (670)
..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchhhc
Confidence 23678888999999999999999998 99999999999998 56899999999987653321 1
Q ss_pred ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHH
Q 005916 188 KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265 (670)
Q Consensus 188 ~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~k 265 (670)
....+++.|+|||++ ...++.++||||||+++|+|++ |..||........+...+..+..+ ..+...++.+.+++.+
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 317 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLD 317 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHHH
Confidence 233456789999965 5678999999999999999997 999998755555555555555432 2344567899999999
Q ss_pred cCC-CCCCCCCHHHHhcC
Q 005916 266 CLV-PASQRLSAKELLMD 282 (670)
Q Consensus 266 cL~-dP~~RpSa~elL~h 282 (670)
||. +|.+|||+.++++|
T Consensus 318 cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 318 CWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 996 79999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.62 Aligned_cols=242 Identities=23% Similarity=0.348 Sum_probs=190.9
Q ss_pred EEecccCCeEEEEEEEc--CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 005916 32 EVIGKGAFKTVYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~--~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmE 109 (670)
+.||+|+||.||+|... .++..+|+|.++... .......+.+|+.+++.++||||+++++++.+.. .+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEEEEE
Confidence 36899999999999754 456789999876543 2334456888999999999999999999886554 6899999
Q ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 110 LFTSGSLRQYRKKHK-----KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 110 y~~gGsL~~~i~~~~-----~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|+.+|+|.+++.... ..++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccC
Confidence 999999999987532 4567788899999999999999998 99999999999998 568999999999865433
Q ss_pred cc----cccccCCCccCCCccccC--------CCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCC---C
Q 005916 185 AN----AKSVIGTPEFMAPELYDE--------NYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIK---P 248 (670)
Q Consensus 185 ~~----~~~~~GTp~YmAPEvl~~--------~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~---p 248 (670)
.. .....|++.|+|||++.. .++.++|||||||++|+|++ |..||............+..... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence 21 123467889999998743 35789999999999999996 99999775444433333333222 1
Q ss_pred CcccCCCChHHHHHHHHcCCCCCCCCCHHHHhc
Q 005916 249 AALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 281 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~dP~~RpSa~elL~ 281 (670)
.......+..+++++++|+.+|.+|||+.+|+.
T Consensus 233 ~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred CccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 222334567899999999988999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=343.57 Aligned_cols=243 Identities=34% Similarity=0.525 Sum_probs=207.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.+.+.+.||+|.||+||+|+.- | .||||.+..... .++.++.|.+|+.+||+-+|.||+-|.|++..+. +.|
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AI 464 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAI 464 (678)
T ss_pred Hhhccceeccccccceeecccc--c-ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eee
Confidence 4567889999999999999764 3 499999987654 5679999999999999999999999999886543 589
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc-
Q 005916 107 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ- 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~- 184 (670)
|+-+|.|.+|..++.-. ..|...+...|++||+.|+.|||.++ |||||||..|||+. +++.|||+||||++...-
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccceeeeeee
Confidence 99999999999887543 56999999999999999999999999 99999999999998 668999999999876432
Q ss_pred ---cccccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC---cccCC
Q 005916 185 ---ANAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA---ALSKV 254 (670)
Q Consensus 185 ---~~~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~---~~~~~ 254 (670)
.......|...|||||++. ..|++.+||||||+++|||+||..||. ..+.++|.-.+-+|.... .....
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~ 620 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSN 620 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhcc
Confidence 2244566888999999874 369999999999999999999999999 588888877777874322 22334
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
...++++|+..||. ++.+||...+||.
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 55699999999997 7999999999887
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=317.34 Aligned_cols=256 Identities=24% Similarity=0.374 Sum_probs=208.0
Q ss_pred EEEEEEecccCCeEEEEEEEc---CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 28 IRYKEVIGKGAFKTVYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~---~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
|++.+.||+|+||.||+|.+. .++..||+|.++...........+++.+|+.+++++ +||||+++++.+... ..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~~ 79 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--TK 79 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--CE
Confidence 788999999999999999854 467899999987543333334556788999999999 699999999987654 47
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+||||+.+|+|.+++.....+++..++.|+.|++.||.|||..+ ++||||||.||+++ .++.++|+|||++..+.
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECccccccc
Confidence 8999999999999999988888999999999999999999999988 99999999999998 56899999999987654
Q ss_pred ccc---cccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCC---CHHHHHHHHhcCCCCCcccCC
Q 005916 184 QAN---AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 184 ~~~---~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~~ 254 (670)
... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.... ....+.+.+..... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKT 234 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcc
Confidence 322 223568999999997643 36889999999999999999999995422 22333333433322 23445
Q ss_pred CChHHHHHHHHcCC-CCCCCCC---HHHHhcCccccccCC
Q 005916 255 KDPEVKSFIEKCLV-PASQRLS---AKELLMDPFLQVNGT 290 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpS---a~elL~hpf~~~~~~ 290 (670)
.++.+++||.+||. +|++||| +.++|+||||+...+
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 67899999999996 8999998 578899999986544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.54 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=201.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCC----------------eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNG----------------LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI 89 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg----------------~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI 89 (670)
..|++.+.||+|+||.||+|.+...+ ..||+|.+.... .....+.+.+|+.+++.++||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCCE
Confidence 45889999999999999999876544 567888877442 24567788999999999999999
Q ss_pred eeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCc
Q 005916 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-----------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 158 (670)
Q Consensus 90 Vkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~-----------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLK 158 (670)
++++++|.+. ..++++||++.+++|.+++.... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 82 ~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlk 157 (296)
T cd05051 82 ARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLA 157 (296)
T ss_pred eEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccc
Confidence 9999998765 37899999999999999998766 6899999999999999999999998 9999999
Q ss_pred cccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh--ccCCCCC
Q 005916 159 CDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT--FEYPYSE 231 (670)
Q Consensus 159 peNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt--G~~Pf~~ 231 (670)
|+|||++ .++.++|+|||++....... .....+++.|+|||++. +.++.++|||||||++|+|++ +..||..
T Consensus 158 p~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 158 TRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999998 56899999999987654322 23455678999999764 578999999999999999988 7788876
Q ss_pred CCCHHHHHHHHhcC----C--CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 232 CRNSAQIYKKVSSG----I--KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 232 ~~~~~~i~~~i~~g----~--~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
. +...++..+... . .....+...+.++.++|.+||. +|.+|||+.++++
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 L-TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred c-ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 3 344444444332 1 1112233456899999999996 8999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=354.08 Aligned_cols=152 Identities=28% Similarity=0.397 Sum_probs=136.8
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
|.-..|++.+.||+|+||+||+|.+..++..||+|+++.... ........+..|+.+++.++||||++++.++....
T Consensus 1 p~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-- 77 (669)
T cd05610 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN-- 77 (669)
T ss_pred CccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC--
Confidence 345678999999999999999999999999999999986443 33556678899999999999999999998886554
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+||||+.|++|.+++...+.+++..++.|+.||+.||.|||.++ ||||||||+|||++ .++.+||+|||++.
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 79999999999999999998889999999999999999999999998 99999999999998 67899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.06 Aligned_cols=255 Identities=31% Similarity=0.420 Sum_probs=203.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---- 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~---- 100 (670)
.++|.+.+.||+|+||.||+|.+..+|..||+|++.... ......+.+.+|+.++++++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 366889999999999999999999999999999886432 22334567889999999999999999999876432
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
...+|++++++ +++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEecccccc
Confidence 13578899887 7899887764 46999999999999999999999998 99999999999998 67899999999987
Q ss_pred hhcccccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC------------
Q 005916 181 IMEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI------------ 246 (670)
Q Consensus 181 ~~~~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~------------ 246 (670)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||....... ....+....
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc-cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhcc
Confidence 6543 234567899999999764 358899999999999999999999997633322 222211100
Q ss_pred -------------CCC----cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 247 -------------KPA----ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 247 -------------~p~----~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+. ......++.+++||.+||. +|.+||++.++|.||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000 0111347889999999996 89999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=323.70 Aligned_cols=244 Identities=27% Similarity=0.436 Sum_probs=195.9
Q ss_pred CCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHH
Q 005916 38 AFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLR 117 (670)
Q Consensus 38 ~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~ 117 (670)
+++.||.+++..+|..||+|.+.... ......+++.+|+.+++.++||||++++++|.+.. .++++||||.+|+|.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~~e~~~~~~l~ 87 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYVVSPLMAYGSCE 87 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc--cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEEEEeccCCCCHH
Confidence 45666777777899999999998643 23456788999999999999999999999987654 789999999999999
Q ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc---------
Q 005916 118 QYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--------- 186 (670)
Q Consensus 118 ~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~--------- 186 (670)
+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||.+..+....
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccccccccccc
Confidence 998764 46899999999999999999999998 99999999999998 67899999999886543211
Q ss_pred cccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--------C-------
Q 005916 187 AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--------P------- 248 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--------p------- 248 (670)
.....++..|+|||++.. .|+.++|||||||++|+|++|..||........+...+..... +
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 133457889999998753 5889999999999999999999999875544444443322110 0
Q ss_pred ----------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 ----------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 ----------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.......+.++.+||.+||. +|.+|||+.++|.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00111223578899999996 89999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=308.42 Aligned_cols=243 Identities=26% Similarity=0.473 Sum_probs=208.8
Q ss_pred ecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 005916 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 113 (670)
Q Consensus 34 LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~g 113 (670)
||.|+||.||+|.+..++..||+|.+..... ......+.+..|+.+++.++||||+++++.+.+. ..+|+||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE--EKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC--CeeEEEEecCCC
Confidence 6999999999999998999999999876533 2334667889999999999999999999988654 479999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc--cccccc
Q 005916 114 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKSVI 191 (670)
Q Consensus 114 GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~--~~~~~~ 191 (670)
++|.+++...+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ .++.++|+|||++...... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCc
Confidence 999999998888999999999999999999999988 99999999999998 6789999999998776543 234567
Q ss_pred CCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-C
Q 005916 192 GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-P 269 (670)
Q Consensus 192 GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-d 269 (670)
|+..|+|||... ..++.++|+||||+++|+|++|..||.. ......++.+.... ..++...+..+++||.+||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCC
Confidence 899999999764 4578899999999999999999999976 44456666665532 33555567899999999996 8
Q ss_pred CCCCCCH---HHHhcCccc
Q 005916 270 ASQRLSA---KELLMDPFL 285 (670)
Q Consensus 270 P~~RpSa---~elL~hpf~ 285 (670)
|.+||++ .+++.||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.90 Aligned_cols=239 Identities=23% Similarity=0.407 Sum_probs=198.5
Q ss_pred EEecccCCeEEEEEEEcCCC---eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 32 EVIGKGAFKTVYKAFDEVNG---LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg---~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
++||+|+||.||+|+...++ ..+|+|.+..... ....+.+.+|+.+++.++||||+++++++.. ..+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEE
Confidence 47999999999999876555 7899998875432 2456678899999999999999999997753 2589999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccccc-
Q 005916 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA- 187 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~- 187 (670)
||+.+|+|.+++...+.+++..+..|+.|++.||.|||.++ ++||||||+|||++ .++.+||+|||++..+.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCcc
Confidence 99999999999998888999999999999999999999998 99999999999998 678999999999987644321
Q ss_pred ----ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 188 ----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 188 ----~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
....++..|+|||.+ ...++.++|||||||++|+|++ |.+||... +..++...+..+.. ...+...++.+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGER-LPRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCc-CCCCCCCCHHHHH
Confidence 111234679999966 4568999999999999999998 99999774 45566666665542 3344556789999
Q ss_pred HHHHcCC-CCCCCCCHHHHhc
Q 005916 262 FIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~ 281 (670)
+|.+||. +|.+||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999996 8999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.49 Aligned_cols=250 Identities=23% Similarity=0.387 Sum_probs=205.6
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEE-----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEE
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSW 96 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d-----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~ 96 (670)
...+.|.+.+.||+|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 3445799999999999999999975 3456789999876432 234567789999999999 899999999988
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
.... .+|+||||+.+|+|.+++.... .+++.++..++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 109 ~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~ 183 (302)
T cd05055 109 TIGG--PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKIC 183 (302)
T ss_pred ecCC--ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEEC
Confidence 6554 6899999999999999987643 3899999999999999999999998 99999999999998 66799999
Q ss_pred eccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 175 DLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 175 DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
|||++..+.... .....+++.|+|||.+ ...++.++|||||||++|+|++ |..||..........+.+..+..+
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 263 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM 263 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence 999987654322 1233467889999965 5668999999999999999998 999998755555555655555432
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+...++++++|+.+||. +|.+|||+.+++.
T Consensus 264 -~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 -AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3344567899999999996 7999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.03 Aligned_cols=249 Identities=27% Similarity=0.403 Sum_probs=202.0
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~~~l 106 (670)
|.+.+.||+|+||+||+|....++..||+|.+..... . .......+|+..++.++ ||||+++++++.+. ...|+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFREN--DELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEE
Confidence 5788999999999999999999999999998864321 1 22334567999999998 99999999998764 47999
Q ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
||||+ +|+|.+++.... .+++..+..++.||+.+|.|||+++ ++|+||+|+||+++ .++.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccC
Confidence 99999 889999887764 7899999999999999999999998 99999999999998 678999999999987654
Q ss_pred cc-cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-------------
Q 005916 185 AN-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP------------- 248 (670)
Q Consensus 185 ~~-~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p------------- 248 (670)
.. .....|+..|+|||++. ..++.++|+||||+++++|++|.+||.........++.......+
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 32 24467899999999773 457899999999999999999999997755444443322110000
Q ss_pred --------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 249 --------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 249 --------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.......+..+++||.+||. +|.+|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00111225789999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.61 Aligned_cols=255 Identities=27% Similarity=0.466 Sum_probs=205.3
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
...|.+.+.||+|+||+||+|.+..+|..||+|.++.... ......+..|+.++..+ .||||+++++++.+.. .
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS--D 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC--e
Confidence 3558899999999999999999999999999999875432 23345566777777666 5999999999987654 7
Q ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+|+||||+. +.|..++.. .+.+++..+..++.||+.||.|||+ ++ |+||||+|+||+++ +++.+||+|||++..
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchh
Confidence 999999985 577776655 4578999999999999999999997 46 99999999999998 678999999999877
Q ss_pred hcccc-cccccCCCccCCCccccC-----CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC-cccCC
Q 005916 182 MEQAN-AKSVIGTPEFMAPELYDE-----NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKV 254 (670)
Q Consensus 182 ~~~~~-~~~~~GTp~YmAPEvl~~-----~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~ 254 (670)
+.... .....|++.|+|||.+.. .++.++||||||+++|+|++|..||.......+.+..+.....+. .....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 64432 233457889999997753 378899999999999999999999976444444454444443222 12223
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+.++++||.+||. +|.+||++.+++.||||+..
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 57899999999996 89999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.22 Aligned_cols=241 Identities=23% Similarity=0.369 Sum_probs=189.5
Q ss_pred EecccCCeEEEEEEEc--CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 33 VIGKGAFKTVYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~d~--~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
.||+|+||+||+|... .....+|+|.+.... .......+.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--ceEEEEEe
Confidence 6899999999999643 234567777665322 2344567889999999999999999999886544 68999999
Q ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 111 FTSGSLRQYRKKHK-----KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 111 ~~gGsL~~~i~~~~-----~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+.+|+|.+++.... ..++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEec-CCCcEEEeccccccccccc
Confidence 99999999987643 2467888999999999999999998 99999999999998 5789999999998654221
Q ss_pred c----cccccCCCccCCCcccc--------CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCC---C
Q 005916 186 N----AKSVIGTPEFMAPELYD--------ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKP---A 249 (670)
Q Consensus 186 ~----~~~~~GTp~YmAPEvl~--------~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p---~ 249 (670)
. .....+++.|+|||++. ..++.++|||||||++|+|++ |..||....+...+...+..+..+ .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 1 12334677899999763 346889999999999999999 788997754444444444443221 2
Q ss_pred cccCCCChHHHHHHHHcCCCCCCCCCHHHHhc
Q 005916 250 ALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 281 (670)
Q Consensus 250 ~~~~~~s~~~k~fI~kcL~dP~~RpSa~elL~ 281 (670)
.+....++.+++++..|+.+|.+|||+++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 23445678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.72 Aligned_cols=253 Identities=28% Similarity=0.418 Sum_probs=202.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC-----
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----- 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~----- 100 (670)
..|.+.+.||.|+||+||+|.++.+|..||+|.++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4688899999999999999999999999999999764321 223345678999999999999999999886643
Q ss_pred ---CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 101 ---NKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 101 ---~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
+..+++|+||+.+ +|..++... ..+++..++.++.||+.||.|||.++ |+||||||+||+++ +++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCcc
Confidence 2378999999976 777776654 46999999999999999999999998 99999999999998 6789999999
Q ss_pred cchhhhcccc---cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc---CCCC
Q 005916 177 GLATIMEQAN---AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---GIKP 248 (670)
Q Consensus 177 Gla~~~~~~~---~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~---g~~p 248 (670)
|++....... .....+++.|+|||.+. ..++.++|||||||++|+|++|.+||........ ...+.. +..+
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ-LELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCh
Confidence 9998764432 12345688999999764 3478999999999999999999999976333222 222211 1111
Q ss_pred Cc-------------------------ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 249 AA-------------------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 249 ~~-------------------------~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
.. .....++.++++|.+||. +|.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 10 112347899999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.13 Aligned_cols=252 Identities=25% Similarity=0.448 Sum_probs=202.4
Q ss_pred CCCeEEEEEEecccCCeEEEEEEE----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFD----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.++.|++.+.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 357789999999999999999974 4678899999986432 244567789999999999999999999998776
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
....+++||||+.|++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~ 155 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGL 155 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCcc
Confidence 556799999999999999998765 46899999999999999999999998 99999999999998 578999999999
Q ss_pred hhhhcccc-----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCC--------------CHHHH
Q 005916 179 ATIMEQAN-----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR--------------NSAQI 238 (670)
Q Consensus 179 a~~~~~~~-----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~--------------~~~~i 238 (670)
+..+.... .....|+..|+|||++ ...++.++|||||||++|+|+++..|+.... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 98764322 1245577789999965 4568999999999999999999876653211 11112
Q ss_pred HHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 239 YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 239 ~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
...+..+.. .......+..+.+||.+||. +|.+|||+.+++++
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 VRVLEEGKR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHcCcc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 222223322 22234467899999999996 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=363.43 Aligned_cols=249 Identities=34% Similarity=0.585 Sum_probs=208.5
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC--------
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD-------- 99 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~-------- 99 (670)
|...++||+||||.||+++++-+|+.||||+|..+. +.....++.+|+.+|.+|+|||||++|..|+..
T Consensus 481 FEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 481 FEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 445678999999999999999999999999998753 455667899999999999999999999877320
Q ss_pred --------------------------------------------------------------------C-----------
Q 005916 100 --------------------------------------------------------------------Q----------- 100 (670)
Q Consensus 100 --------------------------------------------------------------------~----------- 100 (670)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred ----------------------C--------CeEEEEEecCCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHhhhhcCC
Q 005916 101 ----------------------N--------KTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSGLIYLHSHD 149 (670)
Q Consensus 101 ----------------------~--------~~~~lVmEy~~gGsL~~~i~~~~~l-se~~i~~i~~QIl~aL~yLHs~g 149 (670)
+ .++||-||||..-.|++++..+... ....++++++||++||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 3589999999987777777766544 57889999999999999999999
Q ss_pred CCeeeecCccccEEEeCCCCcEEEeeccchhhhc--------------------ccccccccCCCccCCCccccC----C
Q 005916 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--------------------QANAKSVIGTPEFMAPELYDE----N 205 (670)
Q Consensus 150 ~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~--------------------~~~~~~~~GTp~YmAPEvl~~----~ 205 (670)
||||||||.|||++ .++.|||+|||+|+... ....+..+||.-|+|||++.. .
T Consensus 718 --iIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred --eeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 99999999999999 66799999999998721 012346789999999998842 5
Q ss_pred CCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc---ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 206 YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 206 ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~---~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
|+.|+|+||||||++||+ +||........+...+..+..|.. +... -+.-+.+|+.||. ||++||||.|||+
T Consensus 795 Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~-~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPE-HPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCccccccc-chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999998 578877777788888888887765 2222 3566789999997 8999999999999
Q ss_pred Ccccc
Q 005916 282 DPFLQ 286 (670)
Q Consensus 282 hpf~~ 286 (670)
+.||.
T Consensus 871 s~llp 875 (1351)
T KOG1035|consen 871 SELLP 875 (1351)
T ss_pred ccCCC
Confidence 99997
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.79 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=203.0
Q ss_pred eEEEEEEecccCCeEEEEEEEcCC--CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC--CC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVN--GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD--QN 101 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~t--g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~--~~ 101 (670)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ........+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 478899999999999999999888 9999999886421 2233456778899999999 699999999875432 22
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|++++|+. ++|.+++.....+++..++.++.||+.||.|||.++ |+||||||+|||++ .++.+||+|||++..
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARG 154 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCcee
Confidence 46889999985 699999988889999999999999999999999998 99999999999998 678999999999976
Q ss_pred hcccc------cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc---------
Q 005916 182 MEQAN------AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--------- 244 (670)
Q Consensus 182 ~~~~~------~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~--------- 244 (670)
+.... .....||+.|+|||++. ..++.++|||||||++|+|++|.+||...... .....+..
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 54321 23457899999999764 36899999999999999999999999763322 11111110
Q ss_pred -----------------CCCCC---cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 245 -----------------GIKPA---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 245 -----------------g~~p~---~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..... ......+..+++||.+||. +|.+|||+.+++.||||+.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 00001 1112246889999999996 89999999999999999743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.13 Aligned_cols=247 Identities=25% Similarity=0.428 Sum_probs=203.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
..|++.+.||+|+||+||+|..+.+ ...||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--R 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--C
Confidence 3588999999999999999988654 4578999876432 344566788999999999999999999987654 3
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+++||||+.+|+|.+++..+ +.+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.++|+|||++..
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~ 155 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRR 155 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhc
Confidence 689999999999999998764 47899999999999999999999998 99999999999998 568999999999988
Q ss_pred hcccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCC
Q 005916 182 MEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 182 ~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
+.... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .....+...+..+... ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 233 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKAVEDGYRL-PPPMDC 233 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCC
Confidence 75211 11234467899999764 578999999999999999998 9999976 3455566666655322 234456
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
++.+.+|+.+||. +|.+||++.+++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7899999999996 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.19 Aligned_cols=252 Identities=30% Similarity=0.492 Sum_probs=207.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|...+.||+|+||+||+|++..++..+|+|.+..... .......++.+|+++++.++|||++++++++.... ..+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 91 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAW 91 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--eeE
Confidence 346677899999999999999999999999999875322 23445567889999999999999999999987654 789
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+. |+|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCcccceeecC
Confidence 9999996 578776654 456899999999999999999999998 99999999999998 568999999999876543
Q ss_pred cccccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 185 ANAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 185 ~~~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
.....|++.|+|||++. +.++.++|||||||++|+|++|..||.........+. +..+..+.......+..++
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPALQSGHWSEYFR 244 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH-HhhcCCCCcCcccccHHHH
Confidence 23457899999999752 4688899999999999999999999976443333443 3333334434446778999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+||.+||. +|.+||++.+++.|||+..
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 99999996 7999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.77 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=203.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcC-------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSW 96 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~-------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~ 96 (670)
.+.|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3568999999999999999997643 33579999887432 234566788999999999 899999999988
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccc
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 160 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpe 160 (670)
.... .+|+||||+.+|+|.+++..++ .+++.++..++.||+.||.|||+++ ++||||||+
T Consensus 94 ~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~ 169 (307)
T cd05098 94 TQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 169 (307)
T ss_pred ecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHH
Confidence 6554 7899999999999999997642 4788999999999999999999998 999999999
Q ss_pred cEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCC
Q 005916 161 NIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRN 234 (670)
Q Consensus 161 NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~ 234 (670)
|||++ .++.+||+|||++....... .....+++.|+|||++ ...++.++|||||||++|+|++ |..||.. .+
T Consensus 170 Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~ 247 (307)
T cd05098 170 NVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VP 247 (307)
T ss_pred heEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CC
Confidence 99998 56899999999987664321 1122345789999966 4568999999999999999998 8889876 56
Q ss_pred HHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 235 SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 235 ~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
...+.+.+..+..+ ..+...+.++++||.+||. +|.+|||+.+++.+
T Consensus 248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66777776665432 3445567899999999996 79999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.70 Aligned_cols=248 Identities=30% Similarity=0.530 Sum_probs=204.9
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
..+||+|+||.||++.+..+|..||+|.+.... ......+.+|+.+++.++||||+++++++.... ..++||||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 98 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVMEF 98 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--EEEEEEec
Confidence 357999999999999999999999999876432 344667889999999999999999999987654 79999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc--cc
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AK 188 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~--~~ 188 (670)
+.+++|.+++. .+.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++....... ..
T Consensus 99 ~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 99 LEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceeccccccccc
Confidence 99999998765 456899999999999999999999998 99999999999998 56899999999886554321 23
Q ss_pred cccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC-cccCCCChHHHHHHHHc
Q 005916 189 SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVKDPEVKSFIEKC 266 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~s~~~k~fI~kc 266 (670)
...|++.|+|||.+. ..++.++|+|||||++|+|++|..||.. .........+.....+. ......++.+.+||.+|
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL 253 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHH
Confidence 457899999999764 5688999999999999999999999976 33333334443332211 12234578999999999
Q ss_pred CC-CCCCCCCHHHHhcCccccccC
Q 005916 267 LV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 267 L~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
|. +|.+||++.++|.||||...+
T Consensus 254 l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 254 LVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HhCCcccCcCHHHHhcChHHhccC
Confidence 96 899999999999999998553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=307.86 Aligned_cols=242 Identities=24% Similarity=0.418 Sum_probs=204.3
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
.+.|++.+.||+|+||.||+|... |+.||+|.+.... ...+++.+|+.+++.++||||+++++++.+. ...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 75 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPL 75 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCC--CCe
Confidence 456889999999999999999764 8899999987432 2467889999999999999999999988763 368
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
++||||+.+++|.+++.... .+++..++.++.|++.||.|||.++ ++||||||+|||++ .++.+||+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEccccccccc
Confidence 99999999999999998765 7999999999999999999999998 99999999999998 6789999999999876
Q ss_pred cccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 183 EQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 183 ~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
..... ...++..|+|||.+ .+.++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.+.
T Consensus 153 ~~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (256)
T cd05039 153 SQGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVY 229 (256)
T ss_pred ccccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHH
Confidence 43322 33446679999966 4578899999999999999997 9999976 4566666666554332 33455678999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhc
Q 005916 261 SFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~ 281 (670)
++|.+||. +|.+||++.+++.
T Consensus 230 ~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 230 KVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHhccChhhCcCHHHHHH
Confidence 99999996 8999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.27 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=200.0
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCe--EEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGL--EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~--~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
.|++.++||+|+||.||+|.++.+|. .+++|.++.. ......+.+.+|++++.++ +||||+++++++.+.. .
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~ 77 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG--Y 77 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC--c
Confidence 58899999999999999999887775 4577766521 2344567789999999999 7999999999886544 6
Q ss_pred EEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC
Q 005916 104 VNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 167 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~ 167 (670)
+|+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~ 154 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-E 154 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-C
Confidence 899999999999999987643 4889999999999999999999998 99999999999998 5
Q ss_pred CCcEEEeeccchhhhccccccc-ccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhc
Q 005916 168 QGEVKIGDLGLATIMEQANAKS-VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS 244 (670)
Q Consensus 168 ~g~vKL~DFGla~~~~~~~~~~-~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~ 244 (670)
++.+||+|||++.......... ...+..|+|||++ ...++.++|||||||++|+|++ |..||.. ......+..+..
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~ 233 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQ 233 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhc
Confidence 6799999999986443221111 2234579999976 4568999999999999999997 9999977 455566666665
Q ss_pred CCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 245 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 245 g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+..+ ..+...+..+++||.+||. +|.+||++.++++.
T Consensus 234 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 GYRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5432 2345577899999999996 79999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=356.07 Aligned_cols=251 Identities=28% Similarity=0.407 Sum_probs=200.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
.+|++.++||+|+||+||+|.+..+|+.||+|+++.. ........+++.+|+.+++.++||||+++++++.+.. ..|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~-l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~--~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD--PVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcc-cccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC--EEE
Confidence 4688999999999999999999999999999998743 2233455678999999999999999999999886544 799
Q ss_pred EEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 106 IITELFTSGSLRQYRKKH-----------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~-----------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
+||||+.||+|.+++... ..++...+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKLi 155 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVIL 155 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEEE
Confidence 999999999999987642 23566788999999999999999998 99999999999998 67899999
Q ss_pred eccchhhhccc--------------------ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCC
Q 005916 175 DLGLATIMEQA--------------------NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR 233 (670)
Q Consensus 175 DFGla~~~~~~--------------------~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~ 233 (670)
|||++...... .....+||+.|||||++ ...++.++|||||||++|+|+||..||....
T Consensus 156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 99999765210 01235799999999976 4578999999999999999999999997633
Q ss_pred CHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 234 NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 234 ~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.....+................++.+.+++.+||. +|.+|++..+.|.+
T Consensus 236 ~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 236 GRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32222222211111111123457889999999996 89999876666544
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.48 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=199.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeE----EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLE----VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~----vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
..|++.+.||+|+||+||+|....+|.. +++|.+... ........+..|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---
Confidence 4578889999999999999998877764 555655321 123445678889999999999999999998743
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 KTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
...++++||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~ 157 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVAD 157 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccce
Confidence 2478999999999999998764 57899999999999999999999998 99999999999998 67899999999997
Q ss_pred hhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 181 IMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 181 ~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
...... .....|+..|+|||.+ .+.|+.++|||||||++|+|++ |..||.+ .....+.+.+..+..+ ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~ 235 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG-MRPHEVPDLLEKGERL-AQPQI 235 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcC-CCCCC
Confidence 654321 2234567789999976 4679999999999999999998 9999977 3445555555554433 33445
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+..+.+++.+||. +|.+|||+.++++
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 67789999999996 8999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=310.76 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=208.0
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcC----CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEV----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 97 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~----tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~ 97 (670)
+..++.|++.++||+|+||.||+|.+.. ++..|++|.+... ......+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3567789999999999999999999876 3678888887532 23556778899999999999999999999877
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKH--------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 169 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~--------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g 169 (670)
.. +...+++++|+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++ .++
T Consensus 79 ~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~ 154 (280)
T cd05043 79 ED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EEL 154 (280)
T ss_pred cC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCC
Confidence 54 34688999999999999998764 45899999999999999999999998 99999999999998 568
Q ss_pred cEEEeeccchhhhccccc----ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHh
Q 005916 170 EVKIGDLGLATIMEQANA----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVS 243 (670)
Q Consensus 170 ~vKL~DFGla~~~~~~~~----~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~ 243 (670)
.+||+|||+++.+..... ....++..|+|||++ ...++.++|||||||++|+|++ |..||.. .+...+...+.
T Consensus 155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~ 233 (280)
T cd05043 155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLK 233 (280)
T ss_pred cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHH
Confidence 999999999986643221 233456789999976 4568999999999999999998 9999977 46666776666
Q ss_pred cCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 244 SGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 244 ~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+..+. .....++++.+++.+||. +|++|||+.+++.
T Consensus 234 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 234 DGYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 654322 334467899999999996 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=314.44 Aligned_cols=243 Identities=30% Similarity=0.528 Sum_probs=198.2
Q ss_pred EEEEEecccCCeEEEEEEEc----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 29 RYKEVIGKGAFKTVYKAFDE----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 29 r~~~~LG~G~fG~Vy~a~d~----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
.+.+.||.|+||.||+|... ..+..|++|.++.. ......+.+.+|++++++++||||+++++++.... .+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccccccccccccccccccc--cc
Confidence 46789999999999999887 55788999988532 24556888999999999999999999999998443 58
Q ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
++|||||.+|+|.+++... ..+++..+..|+.||+.||.|||+++ ++||+|++.|||++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLD-SNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEE-TTTEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-cccccccccccccccc
Confidence 9999999999999999987 78999999999999999999999998 99999999999999 5679999999999776
Q ss_pred ccc----ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 183 EQA----NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 183 ~~~----~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
... ......+...|+|||.+. ..++.++||||||+++|||++ |..||... +...+...+..+..+. .+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 231 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCP 231 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchh
Confidence 221 123345677899999874 558999999999999999999 78999874 6677777776654432 445567
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+.++|.+||. +|.+|||+.++++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 899999999996 8999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=321.34 Aligned_cols=255 Identities=30% Similarity=0.453 Sum_probs=204.7
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
.+++|.+.+.||.|+||.||+|.+..+|..||+|.+.... ......+.+.+|+.+++.++||||++++++|.... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF--STPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-ED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-Cc
Confidence 4567999999999999999999999999999999886432 12334567889999999999999999999987543 36
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+||||+ +++|..+++. ..+++..+..++.||+.||.|||+++ |+||||||.|||++ .++.+||+|||++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCccccccccC
Confidence 88999999 6689887764 46889999999999999999999998 99999999999998 67899999999987653
Q ss_pred ccccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc---------------C-
Q 005916 184 QANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---------------G- 245 (670)
Q Consensus 184 ~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~---------------g- 245 (670)
. ......+++.|+|||++. ..++.++|||||||++|+|++|..||.... ....+..+.. .
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 P-QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-HVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred C-CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 3 234457899999999764 368999999999999999999999997632 2211111110 0
Q ss_pred ----------CCCC---cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 246 ----------IKPA---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 246 ----------~~p~---~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+. ......++.++++|.+||. +|.+||++.+++.||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0000 0112356889999999996 89999999999999999744
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.78 Aligned_cols=249 Identities=27% Similarity=0.449 Sum_probs=198.3
Q ss_pred CCeEEEEEEecccCCeEEEEEE----EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~----d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
...|++.+.||+|+||+||+|. +..++..||+|.+... .....+.+.+|+++++.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 4578999999999999999997 4567899999988643 2455678899999999999999999999876665
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 101 NKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||.++ |+||||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~ 155 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLT 155 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCccc
Confidence 56789999999999999998764 46899999999999999999999998 99999999999998 6689999999999
Q ss_pred hhhccccc-----ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCH---------------HHH
Q 005916 180 TIMEQANA-----KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS---------------AQI 238 (670)
Q Consensus 180 ~~~~~~~~-----~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~---------------~~i 238 (670)
..+..... ....++..|+|||++. ..++.++|||||||++|+|++|..|+...... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 87644321 1122345699999764 56899999999999999999987775431110 001
Q ss_pred HHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 239 YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 239 ~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
...+..+. ........+.++.+||.+||. +|.+|||+.+++.
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IELLKNNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHhcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11122221 112234457899999999996 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.95 Aligned_cols=241 Identities=22% Similarity=0.393 Sum_probs=200.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|.+.+.||+|+||.||+|.. .|..||+|.++.. ...+.+.+|+.+++.++||||+++++++.... ..+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceE
Confidence 4688999999999999999965 4788999987632 22456889999999999999999999876543 3689
Q ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS 153 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceecc
Confidence 9999999999999987654 4889999999999999999999998 99999999999998 67899999999987654
Q ss_pred ccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 184 QANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 184 ~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
... ....++..|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+...+..+..+ ......++.+++
T Consensus 154 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (256)
T cd05082 154 STQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYD 230 (256)
T ss_pred ccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHH
Confidence 322 3344567899999764 468899999999999999997 9999976 4566666666665433 344567899999
Q ss_pred HHHHcCC-CCCCCCCHHHHhc
Q 005916 262 FIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~ 281 (670)
+|.+||. +|.+|||+.+++.
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999996 8999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.56 Aligned_cols=244 Identities=23% Similarity=0.428 Sum_probs=200.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|++.+.||+|+||+||+|.... +..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.... .++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 75 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR--PIY 75 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC--CcE
Confidence 458899999999999999997654 45699998874322 1356889999999999999999999886543 689
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.....
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCC
Confidence 999999999999998764 46899999999999999999999998 99999999999998 568999999999876543
Q ss_pred cccc---cccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 185 ANAK---SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 185 ~~~~---~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.... ...++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+...+...+..+..+ ..+...+..+
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER-FNNSETVEKVSQGLRL-YRPHLASEKV 230 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHhcCCCC-CCCCCCCHHH
Confidence 3221 223456799999774 568999999999999999998 9999976 4455566666665433 2344567899
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
++++.+||. +|.+||++.+++.+
T Consensus 231 ~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 231 YAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHh
Confidence 999999996 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=311.50 Aligned_cols=243 Identities=26% Similarity=0.422 Sum_probs=203.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||.|+||+||+|.+.. +..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.. .+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~l 79 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE--PVYI 79 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCC--CeEE
Confidence 47788999999999999999887 8899999987543 334566889999999999999999999886554 6899
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARLIKE 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhhcCC
Confidence 99999999999998763 46899999999999999999999998 99999999999998 678999999999987644
Q ss_pred cc--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 185 AN--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
.. .....+++.|+|||++ .+.++.++||||||+++|+|++ |..||.. .+....+..+..+..+ ..+...++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQEIY 234 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHHHH
Confidence 32 2233457789999976 4578899999999999999998 8999976 4455666666655332 33456788999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhc
Q 005916 261 SFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~ 281 (670)
++|.+||. +|.+|||+.++++
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 235 KIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 99999996 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=307.53 Aligned_cols=244 Identities=25% Similarity=0.431 Sum_probs=200.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
.+.|++.+.||+|+||.||+|.+. .+..||+|.++.... ..+.+.+|+.++++++||||+++++++.... .+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 76 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE--PI 76 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecCC--Ce
Confidence 345899999999999999999875 456899999875432 2355788999999999999999999876544 68
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
|+||||+.+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVI 153 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEc
Confidence 99999999999999987654 6899999999999999999999998 99999999999998 6789999999999876
Q ss_pred cccccccccC---CCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 183 EQANAKSVIG---TPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 183 ~~~~~~~~~G---Tp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
.........| +..|+|||++. ..++.++||||||+++|+|++ |..||.+ .+.......+..... ...+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYR-MPCPPGCPK 231 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC-CCCCCcCCH
Confidence 5433222233 35799999764 568999999999999999999 9999977 445555666655432 223445678
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+.+++.+||. +|.+||++.+++.
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999996 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.76 Aligned_cols=246 Identities=26% Similarity=0.430 Sum_probs=201.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEE-----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d-----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.+.|++.++||+|+||+||+|.. ..++..+|+|.+... .....+.+.+|+++++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 35688999999999999999964 345778888877632 245567899999999999999999999988765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEE
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHK---------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI 164 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~---------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl 164 (670)
. .++++|||+.+|+|.+++..++ .+++..+..++.||+.||.|||+++ ++||||||+|||+
T Consensus 80 ~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~ 155 (280)
T cd05092 80 R--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV 155 (280)
T ss_pred C--ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEE
Confidence 4 6899999999999999987653 4889999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHH
Q 005916 165 NGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQI 238 (670)
Q Consensus 165 ~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i 238 (670)
+ +++.+||+|||++....... .....+++.|+|||.+ ...++.++|||||||++|+|++ |.+||... .....
T Consensus 156 ~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~ 233 (280)
T cd05092 156 G-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEA 233 (280)
T ss_pred c-CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHH
Confidence 8 67899999999987553321 1233457889999965 4678999999999999999998 89999764 44445
Q ss_pred HHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 239 YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 239 ~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
...+..+..+ ..+...++.+.+||.+||. +|.+||++.+++.
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5555555432 2344567899999999996 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.17 Aligned_cols=254 Identities=28% Similarity=0.384 Sum_probs=202.0
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---- 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~---- 101 (670)
..|.+.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 56888999999999999999999999999999887432 122334567899999999999999999998865432
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|+||||+. ++|..++ ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 93 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~~~ 166 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARH 166 (342)
T ss_pred ceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCCcC
Confidence 25789999995 4777664 346899999999999999999999998 99999999999998 678999999999876
Q ss_pred hcccccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC-------------
Q 005916 182 MEQANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI------------- 246 (670)
Q Consensus 182 ~~~~~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~------------- 246 (670)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+..+....
T Consensus 167 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADA-EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC-CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhcc
Confidence 533 2334578999999997643 58899999999999999999999998733222 222222100
Q ss_pred ---------CC----Cc---ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 247 ---------KP----AA---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 247 ---------~p----~~---~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
.+ .. .....++.+++||.+||. +|.+||++.++|.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00 00 012346789999999996 899999999999999998653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.66 Aligned_cols=245 Identities=23% Similarity=0.399 Sum_probs=210.3
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~ 101 (670)
+....|.+...+|.|+|+.|..+.+..+++.+++|++..... ...+|+.++... +||||+++++.+.+..
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~--------~~~~e~~~~~~~~~h~niv~~~~v~~~~~- 389 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD--------DNQDEIPISLLVRDHPNIVKSHDVYEDGK- 389 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc--------ccccccchhhhhcCCCcceeecceecCCc-
Confidence 345567788889999999999999999999999999986522 123467666665 8999999999886554
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..|+|||++.||.|.+.+...+.+. ..+..|++||+.|+.|||.+| ||||||||+|||++++.|+++|+|||.+..
T Consensus 390 -~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 390 -EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred -eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhh
Confidence 7999999999999999888877666 888899999999999999998 999999999999965778999999999988
Q ss_pred hcccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 182 MEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 182 ~~~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
.... ..+.+-|..|.|||++. ..|+++|||||||++||+||+|..||.......+++..+..+.. ....|.+++
T Consensus 466 ~~~~-~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~----s~~vS~~AK 540 (612)
T KOG0603|consen 466 LERS-CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF----SECVSDEAK 540 (612)
T ss_pred Cchh-hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc----ccccCHHHH
Confidence 7665 33445688999999875 57999999999999999999999999876666678877766543 366789999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+||+.||+ +|.+||++.+++.||||
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcch
Confidence 99999996 89999999999999999
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.38 Aligned_cols=244 Identities=23% Similarity=0.409 Sum_probs=200.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||.||+|.++ ++..+|+|.+..... ....+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIF 75 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceE
Confidence 34888999999999999999876 466799998764322 134577899999999999999999987644 3789
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+.+++|.+++..+ +.+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLD 152 (256)
T ss_pred EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceeccc
Confidence 999999999999998764 46899999999999999999999998 99999999999998 678999999999876543
Q ss_pred cccccc---cCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 185 ANAKSV---IGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 185 ~~~~~~---~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
...... .++..|+|||++ ...++.++||||||+++|+|++ |..||.. .....+...+..+.. ...+...++++
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYR-LYRPKLAPTEV 230 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCc-CCCCCCCCHHH
Confidence 322222 234579999976 4678999999999999999999 8999976 445666666665532 23445678999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
++++.+||. +|.+|||+.++++.
T Consensus 231 ~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 231 YTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999996 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.89 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=203.7
Q ss_pred CeEEEEEEecccCCeEEEEEEEcC-----CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~-----tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
..|++.+.||+|+||+||+|.+.. .+..||+|.++... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 347788999999999999998754 35789999987432 2345677889999999999999999999886554
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEE
Q 005916 101 NKTVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI 164 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl 164 (670)
.+++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 82 --~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~ 157 (283)
T cd05091 82 --PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLV 157 (283)
T ss_pred --ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEe
Confidence 689999999999999998532 34788899999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHH
Q 005916 165 NGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQI 238 (670)
Q Consensus 165 ~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i 238 (670)
+ +++.+||+|||++....... .....+++.|+|||.+ .+.++.++|||||||++|+|++ |..||.+ .....+
T Consensus 158 ~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~ 235 (283)
T cd05091 158 F-DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDV 235 (283)
T ss_pred c-CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 8 66789999999987654322 2334567899999966 5678999999999999999998 8888877 455667
Q ss_pred HHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 239 YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 239 ~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
...+..+..+ ..+...+..+.+|+.+||. +|.+||++.+++..
T Consensus 236 ~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 7777665432 2345567889999999996 79999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=345.27 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=190.0
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCC-eEEEEEEEe-------------eccccCCHHHHHHHHHHHHHHHhCCCCCeee
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNG-LEVAWCQVR-------------IDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg-~~vAiK~v~-------------~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVk 91 (670)
..|++.+.||+|+||+||+|..+... ..++.|.+. .+...........+.+|+.+|++|+|||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 46999999999999999998765332 222222111 0111122334567889999999999999999
Q ss_pred eeeEEEeCCCCeEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC
Q 005916 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKH-----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166 (670)
Q Consensus 92 l~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~-----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~ 166 (670)
+++++.+.. ..|+|++++. ++|..++... .......++.|+.||+.||.|||+++ ||||||||+|||++
T Consensus 228 l~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~- 301 (501)
T PHA03210 228 IEEILRSEA--NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN- 301 (501)
T ss_pred EeEEEEECC--eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-
Confidence 999987655 6899999994 5787776532 23456788899999999999999998 99999999999998
Q ss_pred CCCcEEEeeccchhhhcccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCC-CCCCC-C-HHHHH
Q 005916 167 NQGEVKIGDLGLATIMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYP-YSECR-N-SAQIY 239 (670)
Q Consensus 167 ~~g~vKL~DFGla~~~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~P-f~~~~-~-~~~i~ 239 (670)
.+|.+||+|||++..+.... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..| |.... . ..++.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 67899999999998765432 23468999999999764 5699999999999999999998864 43221 2 22333
Q ss_pred HHHhcCC-----CCC-------------------cc-----cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 240 KKVSSGI-----KPA-------------------AL-----SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 240 ~~i~~g~-----~p~-------------------~~-----~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+.+.... .|. .+ ....+..+.++|.+||. ||.+||||.|+|.||||...
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 2222100 000 00 01234567888999996 89999999999999999753
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=316.49 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=202.4
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEc-------CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeE
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDE-------VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNS 95 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~-------~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~ 95 (670)
....|.+.+.||+|+||.||+|.+. ..+..+|+|.++... .......+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3456889999999999999999763 235578999876432 245567788999999999 69999999998
Q ss_pred EEeCCCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCcc
Q 005916 96 WIDDQNKTVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 159 (670)
Q Consensus 96 ~~d~~~~~~~lVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKp 159 (670)
+.+. ..+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 87 ~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 162 (314)
T cd05099 87 CTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA 162 (314)
T ss_pred EccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 8654 3789999999999999998764 24889999999999999999999998 99999999
Q ss_pred ccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCC
Q 005916 160 DNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECR 233 (670)
Q Consensus 160 eNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~ 233 (670)
+|||++ .++.+||+|||+++...... .....+++.|||||++ .+.++.++|||||||++|+|++ |..||.. .
T Consensus 163 ~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~ 240 (314)
T cd05099 163 RNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-I 240 (314)
T ss_pred eeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-C
Confidence 999998 67899999999998664322 1122345689999976 4568999999999999999999 8899976 5
Q ss_pred CHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 234 NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 234 ~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+...++..+..+..+ ..+...+..++++|.+||. +|.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 241 PVEELFKLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 566677776665432 2334556789999999996 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.04 Aligned_cols=240 Identities=26% Similarity=0.429 Sum_probs=198.7
Q ss_pred EEecccCCeEEEEEEEcC-CC--eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 32 EVIGKGAFKTVYKAFDEV-NG--LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~-tg--~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
++||+|++|+||+|.+.. .+ ..||+|.+...... ...+++.+|+.++++++||||+++++++.+ ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 468999999999998765 33 36899988764431 667789999999999999999999999876 4799999
Q ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 109 ELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..+....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEe-cCCEEEeccccccccccccc
Confidence 9999999999987764 6899999999999999999999998 99999999999998 56899999999998764421
Q ss_pred -----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 187 -----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 187 -----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.....++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+..++.+.+.........+...+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG-LSGSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhcCCcCCCCccCCHHH
Confidence 12345778999999764 578999999999999999998 9999976 345555555553222222334567899
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+++.+||. +|.+||++.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999996 7999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=315.68 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=206.4
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEc-------CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeee
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDE-------VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFY 93 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~-------~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~ 93 (670)
......|.+.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 355778999999999999999999752 245679999876331 244567789999999999 899999999
Q ss_pred eEEEeCCCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecC
Q 005916 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 157 (670)
Q Consensus 94 ~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDL 157 (670)
+++.... .+|+||||+.+|+|.+++.+. ..++...+..++.||+.||.|||+++ |+||||
T Consensus 88 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dl 163 (304)
T cd05101 88 GACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDL 163 (304)
T ss_pred EEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence 9887654 789999999999999998764 24778889999999999999999998 999999
Q ss_pred ccccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCC
Q 005916 158 KCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSE 231 (670)
Q Consensus 158 KpeNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~ 231 (670)
||+|||++ .++.+||+|||++..+.... .....+++.|+|||++ ...|+.++||||||+++|+|++ |..||.+
T Consensus 164 kp~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 164 AARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred ccceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99999998 66899999999998764322 2233457789999976 4568999999999999999998 7889876
Q ss_pred CCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 232 CRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 232 ~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.+...+++.+..+... ..+...+..+++||.+||. +|.+|||+.++++.
T Consensus 243 -~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 243 -IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred -CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 4667777777665432 2344567899999999996 79999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=309.65 Aligned_cols=251 Identities=31% Similarity=0.416 Sum_probs=199.0
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEeCCC---
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L---~HpNIVkl~~~~~d~~~--- 101 (670)
|++.+.||+|+||.||+|.++.+|..||+|.++.... .......+.+|+.+++++ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 5788999999999999999998999999999975432 222334566788877766 59999999999876542
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 102 KTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
..++++|||+.+ +|.+++.... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~-~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEc-cCCCEEEeccCcc
Confidence 248999999974 8998887643 5899999999999999999999998 99999999999998 5589999999998
Q ss_pred hhhcccc-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC-C---------
Q 005916 180 TIMEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-K--------- 247 (670)
Q Consensus 180 ~~~~~~~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~-~--------- 247 (670)
..+.... .....+++.|+|||++ ...++.++|||||||++|+|++|.+||...... ..+..+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCCC
Confidence 7764432 2345688999999976 456889999999999999999999999874433 3333332210 0
Q ss_pred --------C----C---cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 248 --------P----A---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 248 --------p----~---~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+ . ......++.+.+||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 0 0011234678899999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.27 Aligned_cols=251 Identities=29% Similarity=0.491 Sum_probs=205.4
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL-QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~-~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+|.+.+.||+|+||+||++.+..++..+++|.++..... ........+..|+.+++.++||||+++++++.+.. ..+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ceE
Confidence 478899999999999999999888777777776542221 12233455778999999999999999999887654 689
Q ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 106 IITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+||||+.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++ ++.+||+|||++..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~--~~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK--NNLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee--cCCEeecccCceee
Confidence 99999999999988753 356899999999999999999999998 99999999999997 35799999999876
Q ss_pred hcccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 182 MEQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 182 ~~~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
..... .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||.. .........+..+..+ .++...+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (260)
T cd08222 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTP-SLPETYSRQ 232 (260)
T ss_pred cCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCC-CCcchhcHH
Confidence 54322 23456899999999664 5688899999999999999999999976 4444555555554433 345567789
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+.++|.+||. +|.+||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999996 79999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.69 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=203.8
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.+.+.||.|++|.||+|.+..+|..+++|.+..... .......+.+|+.+++.++||||+++++++.+.. .+++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG--DLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC--CEEEE
Confidence 4567899999999999999999999999999875432 2244567889999999999999999999887654 79999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 108 TELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||+.+ +|.+++.. ...+++..+..++.||+.||.|||.++ |+|+||||+||+++ .++.+||+|||.+.......
T Consensus 77 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred EeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCc
Confidence 999975 88887766 468999999999999999999999998 99999999999998 56899999999987765432
Q ss_pred --cccccCCCccCCCcccc-C-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CC-----------
Q 005916 187 --AKSVIGTPEFMAPELYD-E-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PA----------- 249 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl~-~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~----------- 249 (670)
.....++..|+|||.+. . .++.++|+||||+++|+|++|..||.......++.+....... +.
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 23456889999999663 3 6889999999999999999999999875544443333221110 00
Q ss_pred --------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 250 --------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 250 --------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
......+.++++||.+||. +|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112346789999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.36 Aligned_cols=248 Identities=21% Similarity=0.343 Sum_probs=203.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCC-----CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVN-----GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~t-----g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
..|++.+.||+|+||+||+|+.+.+ ...|++|.+.... .....+.+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA- 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-
Confidence 4588899999999999999987543 4568888765322 233567899999999999999999999987554
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcE
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHK---------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 171 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~---------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~v 171 (670)
...|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~ 156 (275)
T cd05046 81 -EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQREV 156 (275)
T ss_pred -CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCcE
Confidence 37899999999999999998766 7899999999999999999999998 99999999999998 67899
Q ss_pred EEeeccchhhhcccc---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCC
Q 005916 172 KIGDLGLATIMEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGI 246 (670)
Q Consensus 172 KL~DFGla~~~~~~~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~ 246 (670)
+|+|||++....... .....+++.|+|||.+ ...++.++||||||+++|+|++ |..||.. .........+..+.
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~-~~~~~~~~~~~~~~ 235 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-LSDEEVLNRLQAGK 235 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cchHHHHHHHHcCC
Confidence 999999986543221 2344667889999965 4568899999999999999998 8889976 34455566665554
Q ss_pred CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 247 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 247 ~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.+.......+..+.+++.+||. +|.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 4333445567899999999996 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=308.59 Aligned_cols=242 Identities=23% Similarity=0.400 Sum_probs=198.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
.+|++.+.||+|+||+||+|.+..++ .||+|.++.... ..+++.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~ 76 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 76 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcE
Confidence 45999999999999999999887664 599998874322 23568889999999999999999997643 2578
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+||||+.+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++ +++.+||+|||++..+.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIE 153 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCceeecc
Confidence 999999999999998764 35899999999999999999999998 99999999999998 67899999999997664
Q ss_pred cccc---ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 184 QANA---KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 184 ~~~~---~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
.... ....++..|+|||++ ...++.++|||||||++|+|++ |..||.. .....++..+..+.. .......+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYR-MPCPPECPES 231 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CChHHHHHHHhcCCC-CCCccccCHH
Confidence 4321 233466789999966 4678999999999999999999 8889976 445555665555432 2233456789
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+.++|.+||. +|.+||++.+++.
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999996 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.81 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=199.9
Q ss_pred EEEEEEecccCCeEEEEEEEcC-----CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~-----tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
|++.+.||+|+||+||+|.+.. ....+|+|.+.... .....+++.+|+.+++.++||||+++++.+....
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 76 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG-- 76 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--
Confidence 6788999999999999998753 23568888776332 2445678899999999999999999999886544
Q ss_pred eEEEEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCc
Q 005916 103 TVNIITELFTSGSLRQYRKKH------------------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 158 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~------------------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLK 158 (670)
..+++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence 689999999999999997642 24788999999999999999999998 9999999
Q ss_pred cccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCC
Q 005916 159 CDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSEC 232 (670)
Q Consensus 159 peNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~ 232 (670)
|+|||++ +++.+||+|||++....... .....++..|+|||.+ ...++.++||||||+++|+|++ |..||.+
T Consensus 155 p~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~- 232 (290)
T cd05045 155 ARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG- 232 (290)
T ss_pred hheEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-
Confidence 9999998 67899999999987653321 1233456789999965 5668999999999999999998 9999976
Q ss_pred CCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 233 RNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 233 ~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.....++..+..+..+. .+...+..+++||.+||. +|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 56667777666554332 345567899999999996 7999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=314.42 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=196.6
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCC--------------CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeee
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVN--------------GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~t--------------g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVk 91 (670)
+.|++.+.||+|+||.||+|.+..+ ...||+|.++... .....+.+.+|+++++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 5688999999999999999987543 2358999887432 3455677999999999999999999
Q ss_pred eeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCcc
Q 005916 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 159 (670)
Q Consensus 92 l~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKp 159 (670)
+++++.... .+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||
T Consensus 82 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp 157 (295)
T cd05097 82 LLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLAT 157 (295)
T ss_pred EEEEEcCCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccCh
Confidence 999986544 6899999999999999986532 3688899999999999999999998 99999999
Q ss_pred ccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh--ccCCCCCC
Q 005916 160 DNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT--FEYPYSEC 232 (670)
Q Consensus 160 eNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt--G~~Pf~~~ 232 (670)
+|||++ +++.+||+|||++..+.... .....+++.|+|||++ .+.++.++|||||||++|+|++ +..||...
T Consensus 158 ~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 158 RNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999998 66799999999987654322 1233457789999965 5678999999999999999988 67888763
Q ss_pred CCHHHHHHHHhc-----CC-CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 233 RNSAQIYKKVSS-----GI-KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 233 ~~~~~i~~~i~~-----g~-~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+..++...+.. +. .....+...++.+++||.+||. +|.+|||+.++++
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 -SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred -ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 33333333221 11 1122234467899999999996 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=305.63 Aligned_cols=238 Identities=19% Similarity=0.381 Sum_probs=195.7
Q ss_pred EecccCCeEEEEEEEc--CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 33 VIGKGAFKTVYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~d~--~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
.||+|+||.||+|... ..+..||+|++.... .....+.+.+|+.++++++||||+++++++.. ..+++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEe
Confidence 4899999999999765 456679999886432 34556778999999999999999999998743 358999999
Q ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccccc--
Q 005916 111 FTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-- 187 (670)
Q Consensus 111 ~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~-- 187 (670)
+.+|+|.+++.. ...+++..++.++.||+.||.|||.++ ++||||||+|||++ .++.+||+|||++..+.....
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCccce
Confidence 999999999875 457999999999999999999999998 99999999999998 667999999999876543221
Q ss_pred ---ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 188 ---KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 188 ---~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
....+++.|+|||.+. +.++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+...+++++++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 230 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYAL 230 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 1122357899999764 568999999999999999996 99999874 455566666665433 3555678999999
Q ss_pred HHHcCC-CCCCCCCHHHHhc
Q 005916 263 IEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~ 281 (670)
|.+||. +|.+||++.++++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999997 8999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=302.74 Aligned_cols=243 Identities=26% Similarity=0.460 Sum_probs=204.6
Q ss_pred EEEEEecccCCeEEEEEEEcCCC----eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 29 RYKEVIGKGAFKTVYKAFDEVNG----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 29 r~~~~LG~G~fG~Vy~a~d~~tg----~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
.+.+.||.|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--Cee
Confidence 46789999999999999998766 899999986432 233567889999999999999999999988765 379
Q ss_pred EEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
+++|||+.+++|.+++..... +++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceec
Confidence 999999999999999877554 999999999999999999999998 99999999999998 6679999999998776
Q ss_pred ccccc---ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 183 EQANA---KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 183 ~~~~~---~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
..... ....+++.|+|||.+ ...++.++|||||||++|+|++ |.+||.. .+...++..+..+..+. .+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPP 231 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence 54321 112367899999976 4568999999999999999998 7888876 56666777776665433 3444788
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
++.+++.+||. +|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999996 8999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=306.28 Aligned_cols=248 Identities=25% Similarity=0.450 Sum_probs=201.5
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
....|.+.+.||+|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~- 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN- 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-
Confidence 445688999999999999999987644 4568888776432 245667899999999999999999999988643
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
..|+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+|||++ ..+.+||+|||++
T Consensus 80 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~ 154 (270)
T cd05056 80 --PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLS 154 (270)
T ss_pred --CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCcee
Confidence 4789999999999999997754 5899999999999999999999998 99999999999998 5679999999998
Q ss_pred hhhccccc---ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 180 TIMEQANA---KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 180 ~~~~~~~~---~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
........ ....+++.|+|||.+. ..++.++|||||||++|+|++ |..||..... ......+..+..+ ..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~ 232 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERL-PMPPN 232 (270)
T ss_pred eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcC-CCCCC
Confidence 76644321 1223456899999764 568999999999999999986 9999987443 4444555554433 33455
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.++.++++|.+||. +|.+|||+.+++..
T Consensus 233 ~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 67899999999996 89999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=308.09 Aligned_cols=240 Identities=19% Similarity=0.335 Sum_probs=186.7
Q ss_pred EecccCCeEEEEEEEcCCC--eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 33 VIGKGAFKTVYKAFDEVNG--LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~d~~tg--~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
.||+|+||+||+|.....+ ..+++|.+... ......+.+.+|+.+++.++||||+++++++.+.. .+|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEEEEec
Confidence 6999999999999754332 33455554432 23445678999999999999999999999987654 68999999
Q ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 111 FTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 111 ~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
|.+|+|.+++.+. ...++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcch
Confidence 9999999998764 34677888999999999999999998 99999999999998 6689999999997643211
Q ss_pred ---ccccccCCCccCCCccccC--------CCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCC----CCC
Q 005916 186 ---NAKSVIGTPEFMAPELYDE--------NYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGI----KPA 249 (670)
Q Consensus 186 ---~~~~~~GTp~YmAPEvl~~--------~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~----~p~ 249 (670)
......|++.|+|||++.. .++.++|||||||++|+|++ |..||..... ...+..+..+. ...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQVKLFKP 232 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhcccccCCC
Confidence 1234578899999997632 35788999999999999997 5778876443 34444333322 112
Q ss_pred cccCCCChHHHHHHHHcCCCCCCCCCHHHHhc
Q 005916 250 ALSKVKDPEVKSFIEKCLVPASQRLSAKELLM 281 (670)
Q Consensus 250 ~~~~~~s~~~k~fI~kcL~dP~~RpSa~elL~ 281 (670)
.+....++.+++++.+||.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 QLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 23345678899999999989999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.88 Aligned_cols=247 Identities=27% Similarity=0.447 Sum_probs=205.0
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCe----EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGL----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~----~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
....|++.+.||+|+||+||+|.++.+|. .+|+|...... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 34678999999999999999999877665 57888766432 24566788999999999999999999998875
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
...++||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~ 155 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGL 155 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCcc
Confidence 3689999999999999998774 56899999999999999999999988 99999999999998 667999999999
Q ss_pred hhhhccccc----ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCccc
Q 005916 179 ATIMEQANA----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALS 252 (670)
Q Consensus 179 a~~~~~~~~----~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 252 (670)
+........ ....+++.|+|||.+ ...++.++||||||+++|+|++ |..||.. .....+...+..+.. ...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~ 233 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGER-LPQP 233 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhCCCC-CCCC
Confidence 987653221 112235689999966 4678999999999999999998 9999977 456667777766532 3334
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
...+..+.+++.+||. +|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 234 PICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5567899999999995 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.79 Aligned_cols=243 Identities=23% Similarity=0.395 Sum_probs=198.2
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.+..++ .+|+|.+..... ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 75 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPI 75 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCc
Confidence 345899999999999999999876554 589998764332 23567889999999999999999987742 257
Q ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ +++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLARLI 152 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccceEc
Confidence 8999999999999998764 34789999999999999999999998 99999999999998 6789999999999766
Q ss_pred ccccc---ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 183 EQANA---KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 183 ~~~~~---~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
..... ....++..|+|||+.. ..++.++|||||||++|+|++ |..||.+ .........+..+..+ ..+...+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (260)
T cd05069 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MVNREVLEQVERGYRM-PCPQGCPE 230 (260)
T ss_pred cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCH
Confidence 43221 2234567899999764 568999999999999999999 8999987 3444555555554322 23445678
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+++||.+||. +|.+||+++++++
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 231 SLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999996 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.88 Aligned_cols=246 Identities=25% Similarity=0.427 Sum_probs=201.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCC---eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNG---LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg---~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
..|++.+.||+|+||.||+|.+..++ ..+|+|.++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--K 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 46889999999999999999886544 368888876432 244567889999999999999999999988654 3
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+||||+.+|+|.+++... +.+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.++|+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~~ 155 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRV 155 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCcccc
Confidence 789999999999999998765 46899999999999999999999998 99999999999998 568999999999987
Q ss_pred hccccc-----ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 182 MEQANA-----KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 182 ~~~~~~-----~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
+..... ....+++.|+|||.+. +.++.++|+|||||++|+|++ |..||... ........+..+..+ .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~ 233 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRL-PAPMD 233 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcC-CCCCC
Confidence 644221 1123356899999775 578999999999999999886 99999773 445566666665332 23344
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.++.+++++.+||. +|.+||++.+++.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 234 CPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 67899999999996 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.86 Aligned_cols=243 Identities=24% Similarity=0.425 Sum_probs=199.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.++||+|+||.||+|..+ ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.. ..+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 75 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPI 75 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCc
Confidence 346899999999999999999854 577899998874332 23568889999999999999999997633 358
Q ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
+++|||+.+|+|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLI 152 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceeec
Confidence 9999999999999988754 46899999999999999999999998 99999999999998 6789999999998766
Q ss_pred cccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 183 EQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 183 ~~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
.... .....++..|+|||++. ..++.++||||||+++|+|++ |.+||.+. +.......+..+..+ ..+...+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 230 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCPE 230 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCCH
Confidence 5322 12334567899999774 568899999999999999999 99999874 445555555554322 33445678
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+++++|.+||. +|.+||++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999996 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.85 Aligned_cols=246 Identities=25% Similarity=0.428 Sum_probs=201.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCe---EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~---~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
..|...+.||+|+||.||+|.++.++. .+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK-- 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC--
Confidence 468889999999999999999876654 68888776432 2445677899999999999999999999886554
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+||||+.+++|.+++..+ +.+++..+..++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||++..
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~ 156 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRV 156 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCcccee
Confidence 689999999999999998764 57899999999999999999999998 99999999999998 678999999999876
Q ss_pred hcccccc-----cccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 182 MEQANAK-----SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 182 ~~~~~~~-----~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
....... ....++.|+|||++. +.++.++|||||||++|+|++ |..||.. .+...+.+.+..+.. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~-~~~~~~~~~i~~~~~-~~~~~~ 234 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD-MSNHEVMKAINDGFR-LPAPMD 234 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc-CCHHHHHHHHhcCCC-CCCCCC
Confidence 6432211 122345799999764 568999999999999999997 9999976 345566666665432 223344
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+..+.+|+.+||. +|.+||++.++++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 67899999999996 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.51 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=203.5
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcC-------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeE
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNS 95 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~-------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~ 95 (670)
.+.+|++.+.||+|+||.||+|.+.. .+..||+|.++.. ......+.+.+|+.+++++ +||||++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 34579999999999999999997643 2346899977643 2344567889999999999 89999999998
Q ss_pred EEeCCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCcc
Q 005916 96 WIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 159 (670)
Q Consensus 96 ~~d~~~~~~~lVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKp 159 (670)
+.... .++++|||+.+|+|.+++.+.. .++...+..++.||+.||.|||+++ |+||||||
T Consensus 87 ~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 162 (334)
T cd05100 87 CTQDG--PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAA 162 (334)
T ss_pred EccCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eecccccc
Confidence 86543 6899999999999999987642 3778889999999999999999998 99999999
Q ss_pred ccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCC
Q 005916 160 DNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECR 233 (670)
Q Consensus 160 eNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~ 233 (670)
+|||++ .++.+||+|||+++...... .....+++.|+|||++ ...++.++|||||||++|+|++ |..||.+ .
T Consensus 163 ~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~ 240 (334)
T cd05100 163 RNVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-I 240 (334)
T ss_pred ceEEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-C
Confidence 999998 56899999999987664322 1222345689999976 5578999999999999999998 8899977 4
Q ss_pred CHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCc
Q 005916 234 NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDP 283 (670)
Q Consensus 234 ~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hp 283 (670)
+...+++.+..+..+. .+...+.++.+||.+||. +|.+||++.+++.+-
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 241 PVEELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 5666777676654332 334557899999999996 799999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.75 Aligned_cols=246 Identities=22% Similarity=0.392 Sum_probs=201.0
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCe---EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~---~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
..|++.+.||+|+||.||+|.++.+|. .||+|.+... ........+..|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-- 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR-- 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC--
Confidence 358999999999999999999887665 5999987643 23556678999999999999999999999886543
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+++||||+.+|+|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~ 155 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRF 155 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCccccc
Confidence 689999999999999998764 56899999999999999999999998 99999999999998 567999999999876
Q ss_pred hccccc----c-ccc--CCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCccc
Q 005916 182 MEQANA----K-SVI--GTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALS 252 (670)
Q Consensus 182 ~~~~~~----~-~~~--GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 252 (670)
...... . ... ++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .....+...+.... +...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~-~~~~~ 233 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDY-RLPPP 233 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCC-cCCCc
Confidence 543221 1 111 245799999764 578999999999999999886 9999977 44455555555432 22233
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
...+..+.+++.+||. +|.+||++.+++.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 234 MDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4567899999999996 7999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.27 Aligned_cols=237 Identities=20% Similarity=0.332 Sum_probs=188.2
Q ss_pred EEecccCCeEEEEEEEcCCCeE-------EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLE-------VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~-------vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
+.||+|+||+||+|.+...+.. +|+|.+... .....+.+..|+.+++.++||||+++++++.+.. ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--Cc
Confidence 4699999999999988665443 777766532 2345567889999999999999999999987654 58
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC-------cEEEeec
Q 005916 105 NIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG-------EVKIGDL 176 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g-------~vKL~DF 176 (670)
++||||+.+|+|..++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+.. .++++||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccc
Confidence 89999999999999987654 5899999999999999999999998 999999999999974322 3799999
Q ss_pred cchhhhcccccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhcc-CCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 177 GLATIMEQANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFE-YPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 177 Gla~~~~~~~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~-~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
|++..... .....|++.|+|||++.+ .++.++|||||||++|+|++|. +||.. ............ ...++.
T Consensus 153 g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~---~~~~~~ 226 (258)
T cd05078 153 GISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYED---RHQLPA 226 (258)
T ss_pred ccccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHHc---cccCCC
Confidence 99865543 234578899999998754 5899999999999999999994 66654 333322222221 122333
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..+.++.++|.+||. +|.+|||++++++.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 227 PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 455789999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.36 Aligned_cols=242 Identities=23% Similarity=0.418 Sum_probs=198.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.+. .+..+|+|.+..... . .+.+.+|+.+++.++||||+++++++.. ...|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~ 76 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--S---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIY 76 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--C---HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcE
Confidence 35889999999999999999765 566799998875432 1 3468899999999999999999997642 2578
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ +++.++|+|||++..+.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeeecc
Confidence 999999999999998764 45899999999999999999999998 99999999999998 67899999999997664
Q ss_pred cccc---ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 184 QANA---KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 184 ~~~~---~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
.... ....++..|+|||++ ...++.++||||||+++|+|++ |.+||.+ .+...+...+..+.. ...+...+..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVERGYR-MPCPQDCPIS 231 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC-CCCCCcCCHH
Confidence 4221 223455679999976 4568999999999999999999 8999977 344455555555432 2344566789
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+++|+.+||. +|.+|||+.+++.
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999996 7999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.23 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=195.0
Q ss_pred CeEEEEEEecccCCeEEEEEEEcC----------------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEV----------------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI 89 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~----------------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI 89 (670)
+.|++.+.||+|+||+||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCc
Confidence 458999999999999999985432 34578988886432 34456788999999999999999
Q ss_pred eeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCc
Q 005916 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-----------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 158 (670)
Q Consensus 90 Vkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~-----------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLK 158 (670)
+++++++.+.. .+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ ++|||||
T Consensus 82 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlk 157 (296)
T cd05095 82 IRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLA 157 (296)
T ss_pred ceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCC
Confidence 99999987654 6899999999999999987643 3677899999999999999999998 9999999
Q ss_pred cccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCcc-ccCCCCccceeeeccchhhhhhh--ccCCCCC
Q 005916 159 CDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPEL-YDENYNELADIYSFGMCMLEMVT--FEYPYSE 231 (670)
Q Consensus 159 peNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEv-l~~~ys~~~DIWSLGvilyeLlt--G~~Pf~~ 231 (670)
|+|||++ .++.++|+|||++..+.... .....+++.|+|||+ ..+.++.++|||||||++|+|++ |..||..
T Consensus 158 p~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 158 TRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred hheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999998 57899999999987654322 122344678999995 45679999999999999999998 7789876
Q ss_pred CCCHHHHHHHHhc----C--CCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 232 CRNSAQIYKKVSS----G--IKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 232 ~~~~~~i~~~i~~----g--~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
. +..++...+.. . ......+...++.+++|+.+||. +|.+||++.++++
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 L-SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred c-ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3 33333322211 0 01111223456899999999996 8999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.39 Aligned_cols=240 Identities=26% Similarity=0.388 Sum_probs=193.8
Q ss_pred EEecccCCeEEEEEEEcCCCeE--EEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLE--VAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~--vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
++||+|+||.||+|.++.+|.. +|+|.++.. ......+.+.+|+++++++ +||||+++++++.... .+|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--CceEEE
Confidence 3689999999999999888764 577766522 2345567788999999999 8999999999886543 689999
Q ss_pred ecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEE
Q 005916 109 ELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 172 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vK 172 (670)
||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEE
Confidence 9999999999987643 4789999999999999999999998 99999999999998 668999
Q ss_pred Eeeccchhhhccccc-ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCC
Q 005916 173 IGDLGLATIMEQANA-KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPA 249 (670)
Q Consensus 173 L~DFGla~~~~~~~~-~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 249 (670)
|+|||++........ .....++.|+|||++ ...++.++|||||||++|+|++ |..||.+ .+....++.+..+...
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~- 230 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL- 230 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-
Confidence 999999864322111 122335679999976 4568999999999999999997 9999976 4555566666554322
Q ss_pred cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 250 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 250 ~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+...+.++.+++.+||. +|.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2334567899999999996 7999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=304.19 Aligned_cols=233 Identities=23% Similarity=0.391 Sum_probs=187.8
Q ss_pred EEecccCCeEEEEEEEcCCC----------eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 32 EVIGKGAFKTVYKAFDEVNG----------LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg----------~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~- 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D- 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec-C-
Confidence 47899999999999998777 356777665332 125778899999999999999999998876 3
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC-------cEEE
Q 005916 102 KTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG-------EVKI 173 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g-------~vKL 173 (670)
..++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++ .+||
T Consensus 74 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~-~~~~~~~~~~~~kl 149 (259)
T cd05037 74 -ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVA-RYGLNEGYVPFIKL 149 (259)
T ss_pred -CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEe-cCccccCCceeEEe
Confidence 5789999999999999998776 7999999999999999999999998 99999999999998 444 6999
Q ss_pred eeccchhhhcccccccccCCCccCCCccccC---CCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCC
Q 005916 174 GDLGLATIMEQANAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPA 249 (670)
Q Consensus 174 ~DFGla~~~~~~~~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 249 (670)
+|||++..... .....+++.|+|||++.. .++.++|||||||++|+|++ |..||.... ........... .
T Consensus 150 ~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~---~ 223 (259)
T cd05037 150 SDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ---H 223 (259)
T ss_pred CCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC---C
Confidence 99999887644 234567788999998754 58899999999999999999 578886643 22222222211 1
Q ss_pred cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 250 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 250 ~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+......+.+||.+||. +|.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1222223789999999996 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.25 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=201.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
+.|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 45889999999999999999875 367889999886432 2445567889999999999999999999886544
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCc
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHK----------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 158 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~----------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLK 158 (670)
.+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||.++ ++|||||
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~ 157 (288)
T cd05050 82 --PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLA 157 (288)
T ss_pred --ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccccc
Confidence 6899999999999999987532 3688889999999999999999998 9999999
Q ss_pred cccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCC
Q 005916 159 CDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSEC 232 (670)
Q Consensus 159 peNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~ 232 (670)
|+|||++ .++.++|+|||++....... .....+++.|+|||++ ...++.++|||||||++|+|++ |..||.+
T Consensus 158 p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~- 235 (288)
T cd05050 158 TRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG- 235 (288)
T ss_pred HhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-
Confidence 9999998 67899999999987653321 1223456779999965 4678999999999999999997 8889876
Q ss_pred CCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 233 RNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 233 ~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+...+...+..+..+ ..+...+.++.+||.+||. +|.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 4556666666655432 2334567899999999996 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.96 Aligned_cols=239 Identities=26% Similarity=0.409 Sum_probs=197.6
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 111 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~ 111 (670)
++||.|+||.||+|.+.. +..||+|.+..... ......+.+|+.++++++||||+++++++.+.. ..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEEcC
Confidence 479999999999999887 99999998875432 245678899999999999999999999887654 689999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccccc---
Q 005916 112 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA--- 187 (670)
Q Consensus 112 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~--- 187 (670)
.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||++........
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceec
Confidence 999999998663 56899999999999999999999998 99999999999998 668999999999876543211
Q ss_pred -ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 188 -KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 188 -~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
....++..|+|||++ .+.++.++|||||||++|+|++ |..||.. .........+..+. ....+...+.++.+|+.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG-MSNQQTRERIESGY-RMPAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc-CCHHHHHHHHhcCC-CCCCCccCCHHHHHHHH
Confidence 122345679999976 4578999999999999999999 8889876 34455555555442 22334566789999999
Q ss_pred HcCC-CCCCCCCHHHHhc
Q 005916 265 KCLV-PASQRLSAKELLM 281 (670)
Q Consensus 265 kcL~-dP~~RpSa~elL~ 281 (670)
+||. +|.+|||+.++|+
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9996 7999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.30 Aligned_cols=247 Identities=27% Similarity=0.420 Sum_probs=202.5
Q ss_pred eEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQ 100 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~ 100 (670)
.|.+.+.||+|+||.||+|++. .++..||+|+++... .....+.+.+|+.+|..+. |||||+++++|....
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4677899999999999999853 456789999997532 2344567889999999997 999999999987654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC--------------------------------------------------------
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHK-------------------------------------------------------- 124 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~-------------------------------------------------------- 124 (670)
.+++|||||.+|+|.+++.+.+
T Consensus 115 --~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 115 --PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred --CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 6999999999999999986532
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccE
Q 005916 125 ------------------------------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 162 (670)
Q Consensus 125 ------------------------------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNI 162 (670)
.+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~Ni 270 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNV 270 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceE
Confidence 3567788899999999999999988 99999999999
Q ss_pred EEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHH
Q 005916 163 FINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSA 236 (670)
Q Consensus 163 Ll~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~ 236 (670)
|++ ..+.+||+|||++....... .....|++.|||||++ ...++.++|||||||++|+|++ |..||.......
T Consensus 271 Ll~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 271 LIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 998 56799999999997653221 2234678899999976 4568999999999999999998 899998766666
Q ss_pred HHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 237 QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 237 ~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.....+..+..+ ..+...+.++.+|+.+||. +|.+||++.++++.
T Consensus 350 ~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 666666665433 2344567899999999996 79999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.08 Aligned_cols=250 Identities=31% Similarity=0.457 Sum_probs=202.3
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEE
Confidence 567789999999999999999999999999998643 1233446678899999999999999999988765 479999
Q ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 108 TELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||+. ++|.+++.+. ..+++..+..++.|++.||.|||.++ |+||||+|+||+++ +++.+||+|||++.......
T Consensus 77 ~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 77 FEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred ecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCc
Confidence 99997 5999999887 58999999999999999999999998 99999999999998 57899999999987764432
Q ss_pred --cccccCCCccCCCcccc-C-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc------------------
Q 005916 187 --AKSVIGTPEFMAPELYD-E-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS------------------ 244 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl~-~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~------------------ 244 (670)
.....++..|+|||.+. . .++.++|||||||++|+|++|.+||........+.+....
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 23445688999999763 3 6889999999999999999999999764433322221110
Q ss_pred -CCCCC-------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 245 -GIKPA-------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 245 -g~~p~-------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
...+. ......+..+++||.+||. +|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00000 0011236789999999996 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=328.69 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=206.1
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCe---E-EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGL---E-VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~---~-vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
..+.++||+|+||.||+|..+..+. . ||+|..+... ....+....+.+|.++|++|+|||||+|||+..+.. .
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--P 235 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--P 235 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--c
Confidence 4456899999999999998776432 3 8999887522 234678889999999999999999999999887766 5
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 104 VNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
+|+|||+|.||+|.+|+++.+ .++..+...++.+.+.||+|||+++ +|||||-..|+|++ .++.+||+|||++..-
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeCccccccCC
Confidence 999999999999999999987 4999999999999999999999999 99999999999998 5567899999998765
Q ss_pred ccccc-c-cccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 183 EQANA-K-SVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 183 ~~~~~-~-~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
..... . ...-...|+|||.+. +-|++++|||||||++||+.+ |..||.+ ....++...|.....+...+...+.+
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~ 391 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKE 391 (474)
T ss_pred cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHH
Confidence 42211 1 112346899999774 579999999999999999988 8889998 56667777774444455566677789
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+..++.+|+. +|.+||++.++.+
T Consensus 392 ~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 392 LAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHhccCChhhccCHHHHHH
Confidence 9999999996 8999999998876
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.74 Aligned_cols=244 Identities=24% Similarity=0.423 Sum_probs=200.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
.+.|++.++||+|+||+||+|.+. .+..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 76 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPI 76 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecC--Cce
Confidence 457899999999999999999876 457799998875332 245688999999999999999999987654 368
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
++||||+.+++|.+++.... .+++..+..|+.||+.||.|||.++ ++||||||+||+++ .++.+||+|||++..+
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLARLI 153 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECccccceec
Confidence 99999999999999987653 6899999999999999999999998 99999999999998 6789999999998766
Q ss_pred ccccc---ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 183 EQANA---KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 183 ~~~~~---~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
..... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+ .........+..+.. ...+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG-MTNREVLEQVERGYR-MPRPPNCPE 231 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC-CCCCCCCCH
Confidence 43211 1223467899999764 568899999999999999998 9999977 445555566655432 222334478
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+++++.+||. +|.+||++++++.
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999999996 7999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=301.09 Aligned_cols=242 Identities=22% Similarity=0.359 Sum_probs=194.5
Q ss_pred EEecccCCeEEEEEEEcC---CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 32 EVIGKGAFKTVYKAFDEV---NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~---tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
+.||+|+||+||+|.+.. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++...+ ...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEE
Confidence 468999999999998653 3467899987532 23455678889999999999999999999776443 3678999
Q ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc-
Q 005916 109 ELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN- 186 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~- 186 (670)
||+.+|+|.+++.+. ...++..+..++.||+.||.|||.++ ++||||||+|||++ .++.+||+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcc
Confidence 999999999998764 45678888999999999999999998 99999999999998 67899999999987653211
Q ss_pred -----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhc-cCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 187 -----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 187 -----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG-~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.....+++.|+|||.+ ...++.++|||||||++|+|++| .+||.. .+...+...+..+..+ ..+...+..+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRL-LQPEYCPDPL 231 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCcCCHHH
Confidence 1234567889999976 46789999999999999999995 566655 4555666666655433 2344557889
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.+++.+||. +|.+||++.+++..
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999996 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=298.29 Aligned_cols=239 Identities=24% Similarity=0.394 Sum_probs=195.7
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 111 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~ 111 (670)
++||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++.... .+++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEECC
Confidence 47899999999999864 68889999876432 2444567889999999999999999999886554 689999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccccc---
Q 005916 112 TSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA--- 187 (670)
Q Consensus 112 ~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~--- 187 (670)
.+|+|.+++... ..+++..+..++.|++.||.|||.++ ++||||||+||+++ .++.+||+|||++........
T Consensus 75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccC
Confidence 999999998754 46899999999999999999999998 99999999999998 678999999999875433221
Q ss_pred ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHH
Q 005916 188 KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265 (670)
Q Consensus 188 ~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~k 265 (670)
....+++.|+|||++. +.++.++|||||||++|+|++ |..||... ........+..+... ..+...+..+.+|+.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 1234467799999764 568899999999999999998 99999874 445555555554322 3344567899999999
Q ss_pred cCC-CCCCCCCHHHHhc
Q 005916 266 CLV-PASQRLSAKELLM 281 (670)
Q Consensus 266 cL~-dP~~RpSa~elL~ 281 (670)
||. +|.+||++.++++
T Consensus 230 ~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 230 CWDYKPENRPKFSELQK 246 (250)
T ss_pred HcccCcccCCCHHHHHH
Confidence 996 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.07 Aligned_cols=250 Identities=24% Similarity=0.436 Sum_probs=201.6
Q ss_pred CCeEEEEEEecccCCeEEEEEEEc----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDE----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
.++|++.+.||+|+||.||+|... .++..||+|.+..... ....+.+.+|+.+++.+.||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 467888999999999999999854 3588999999875432 145678899999999999999999999887766
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
+...++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~ 156 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLA 156 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccccc
Confidence 668999999999999999987764 6999999999999999999999998 99999999999998 5689999999999
Q ss_pred hhhccccc-----ccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCH--------------HHHH
Q 005916 180 TIMEQANA-----KSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNS--------------AQIY 239 (670)
Q Consensus 180 ~~~~~~~~-----~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~--------------~~i~ 239 (670)
........ ....++..|+|||.+ ...++.++||||||+++|+|++|..||...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 87753211 123445679999965 467889999999999999999999998653211 1122
Q ss_pred HHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 240 KKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 240 ~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+..+. ....+...+.++.+++.+||. +|.+|||+.+++.
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGE-RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCC-cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222222 122234456889999999996 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=337.13 Aligned_cols=251 Identities=28% Similarity=0.478 Sum_probs=215.0
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC---CCCe
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD---QNKT 103 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~---~~~~ 103 (670)
|.+.++||+|.+|.||+++++.+|+..|+|+..... +..+.+..|+++|+.+ .|||++.+|++|.-. .++.
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 668899999999999999999999999999887543 2345567799999998 899999999998642 2357
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
++||||||.||+.-++++.. .++.|..++.|++.++.||.+||.+. +||||+|-.|||++ ..|.|||+|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEEEeeeeeeee
Confidence 99999999999999998864 57999999999999999999999998 99999999999999 678999999999998
Q ss_pred hccc--ccccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 182 MEQA--NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 182 ~~~~--~~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
+..+ ...+.+|||+|||||++. ..|+..+|+||||++..||.-|.+|+.+......+++..........-++
T Consensus 173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~ 252 (953)
T KOG0587|consen 173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPK 252 (953)
T ss_pred eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchh
Confidence 8765 367899999999999873 24788999999999999999999999886666666665554332222345
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
..+.++.+||..||. +-.+||+..++|+|||+.
T Consensus 253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred hHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 567899999999997 689999999999999997
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=302.26 Aligned_cols=227 Identities=19% Similarity=0.285 Sum_probs=187.5
Q ss_pred cCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCH
Q 005916 37 GAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL 116 (670)
Q Consensus 37 G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL 116 (670)
|.||.||+|.++.+|..||+|.++... ...+|...+....||||+++++++.+.. .+++||||+.||+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSED--SVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCC--eEEEEEecCCCCCH
Confidence 899999999999999999999987532 1223555566668999999999887654 79999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccccccccCCCcc
Q 005916 117 RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF 196 (670)
Q Consensus 117 ~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y 196 (670)
.+++.+...+++..+..|+.|++.||.|||+++ |+||||||+||+++ .++.++++|||++..+... .....+++.|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~-~~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDS-CDGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhccccc-cccCCcCccc
Confidence 999988888999999999999999999999998 99999999999998 5679999999988666543 2344567889
Q ss_pred CCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCC
Q 005916 197 MAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRL 274 (670)
Q Consensus 197 mAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~Rp 274 (670)
+|||.+. +.++.++||||+||++|+|++|..||...... + ........+...++.+++||.+||. +|.+|+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--I-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--c-----ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999775 56899999999999999999999887642211 1 0111122344567899999999996 899999
Q ss_pred CH-----HHHhcCccc
Q 005916 275 SA-----KELLMDPFL 285 (670)
Q Consensus 275 Sa-----~elL~hpf~ 285 (670)
++ +++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=312.03 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=200.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCe----EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGL----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~----~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
+|.....||+|.||.||+|..+.+.. .+|+|+++-.+-. ...-....+|+.+++.|+|||||.+..+|... ..
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~--tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG--TGISMSACREIALLRELKHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC--CCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cc
Confidence 58888899999999999997665543 6899988754221 12223467899999999999999999998864 45
Q ss_pred eEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC---CCcEEEe
Q 005916 103 TVNIITELFTSGSLRQYRKKH-----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN---QGEVKIG 174 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~-----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~---~g~vKL~ 174 (670)
.+++++||.+. +|++.|+-+ +.++...+++++.||+.|+.|||++. |+||||||.|||+.++ .|.|||+
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEee
Confidence 89999999976 899888754 35899999999999999999999999 9999999999999843 4899999
Q ss_pred eccchhhhcccc-----cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCC------C---HHHH
Q 005916 175 DLGLATIMEQAN-----AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECR------N---SAQI 238 (670)
Q Consensus 175 DFGla~~~~~~~-----~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~------~---~~~i 238 (670)
|||+++.+...- ...++-|.+|.|||++- ..|+.++|||++|||+.||+|.++-|.+.. + ..++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999986542 34567799999999763 579999999999999999999988885411 1 1111
Q ss_pred HHHH--hcC-------------------------C-CCC------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCc
Q 005916 239 YKKV--SSG-------------------------I-KPA------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDP 283 (670)
Q Consensus 239 ~~~i--~~g-------------------------~-~p~------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hp 283 (670)
.+.. ... . .+. ...++.++.+.+++.+||. ||-+|+||+++|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1111 000 0 000 0113356678899999996 999999999999999
Q ss_pred ccccc
Q 005916 284 FLQVN 288 (670)
Q Consensus 284 f~~~~ 288 (670)
||..+
T Consensus 339 yF~~d 343 (438)
T KOG0666|consen 339 YFTED 343 (438)
T ss_pred ccccC
Confidence 99865
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=298.12 Aligned_cols=243 Identities=21% Similarity=0.436 Sum_probs=200.4
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+++++.++||||+++++++.+.. .+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~ 76 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS--PICL 76 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC--ceEE
Confidence 5888999999999999999875 467899998864332 1345788999999999999999999876544 6899
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||+.+|+|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeecccC
Confidence 99999999999998764 56899999999999999999999998 99999999999998 6679999999998765432
Q ss_pred cc---ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 186 NA---KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 186 ~~---~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
.. ....++..|+|||++. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...+..+.
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSVY 231 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHHH
Confidence 22 1233467899999764 678899999999999999998 9999976 4555666666655432 23445678999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcC
Q 005916 261 SFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+|+.+||. +|.+|||+.+++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHh
Confidence 99999996 79999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=298.59 Aligned_cols=244 Identities=22% Similarity=0.420 Sum_probs=199.3
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||.||+|.+. .+..+|+|.+... ....+.+.+|+.+++.++|+||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~ 74 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EP 74 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CC
Confidence 4567999999999999999999755 4556898887642 2345678899999999999999999998765 36
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
++++|||+.+|+|.+++.+. ..+++..+..|+.||+.||.|||.++ ++||||||+||+++ ..+.+||+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~ 151 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARV 151 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCcceee
Confidence 89999999999999998764 45788999999999999999999998 99999999999998 678999999999876
Q ss_pred hccccc---ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 182 MEQANA---KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 182 ~~~~~~---~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
+..... ....++..|+|||++. +.++.++|+|||||++|+|++ |..||.. .+...+...+..+.. .......+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 229 (260)
T cd05073 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYR-MPRPENCP 229 (260)
T ss_pred ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCC-CCCcccCC
Confidence 643221 2234567799999774 568889999999999999998 8999987 344455555555432 22334567
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.++.+++.+||. +|.+||++.+++.
T Consensus 230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 230 EELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 899999999996 7999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.05 Aligned_cols=239 Identities=22% Similarity=0.422 Sum_probs=198.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||.||++. .++..||+|.++... ..+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~ 74 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLY 74 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcE
Confidence 458899999999999999985 578889999886432 245688999999999999999999988643 378
Q ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+||||+.+|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGS 151 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceecc
Confidence 9999999999999987653 5899999999999999999999998 99999999999998 56899999999987643
Q ss_pred ccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 184 QANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 184 ~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
.. ......+..|+|||.+. +.++.++|+|||||++|+|++ |.+||.. .........+..+..+. .....++.+++
T Consensus 152 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (254)
T cd05083 152 MG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK-MSLKEVKECVEKGYRME-PPEGCPADVYV 228 (254)
T ss_pred cc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhCCCCCC-CCCcCCHHHHH
Confidence 32 22334467899999764 578999999999999999997 9999977 44555666666654333 34456789999
Q ss_pred HHHHcCC-CCCCCCCHHHHhc
Q 005916 262 FIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~ 281 (670)
|+.+||. +|.+||++.+++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 9999996 7999999999876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=309.32 Aligned_cols=246 Identities=26% Similarity=0.463 Sum_probs=199.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCe----EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGL----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~----~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
..|+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--
Confidence 457888999999999999999887776 46777765322 234445688999999999999999999988643
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
..++++||+.+|+|.+++..++ .+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~ 157 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLAR 157 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEccccccc
Confidence 3679999999999999987754 6899999999999999999999998 99999999999997 56799999999998
Q ss_pred hhcccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 181 IMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 181 ~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
.+.... .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+ .........+..+..+ ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~ 235 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG-IPTREIPDLLEKGERL-PQPPI 235 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCC
Confidence 764322 22334577899999764 568999999999999999997 8999976 3344455545444322 23345
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.+..+.+++.+||. +|.+||++.++++.
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 67899999999996 89999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.33 Aligned_cols=209 Identities=29% Similarity=0.470 Sum_probs=180.0
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC-
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ- 100 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~- 100 (670)
...+.-+...+.||+||||.||+++++.+|+.||||.++... +...+++..+|+++|++|+|||||+++++=.+..
T Consensus 9 ~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 9 SGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 334445667889999999999999999999999999998654 3456788999999999999999999999654444
Q ss_pred ---CCeEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe-CCCCc--E
Q 005916 101 ---NKTVNIITELFTSGSLRQYRKK---HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN-GNQGE--V 171 (670)
Q Consensus 101 ---~~~~~lVmEy~~gGsL~~~i~~---~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~-~~~g~--v 171 (670)
.+...+|||||.||+|+.++.+ +..+++.++..++..+..||.|||.+| |+||||||.||++- +.+|. -
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEE
Confidence 3456799999999999999875 467999999999999999999999999 99999999999975 34343 6
Q ss_pred EEeeccchhhhcccc-cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCH
Q 005916 172 KIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNS 235 (670)
Q Consensus 172 KL~DFGla~~~~~~~-~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~ 235 (670)
||+|||.|+.+.+.. ..+++||+.|.+||++. +.|+.-+|.|||||++|+++||..||-....+
T Consensus 164 KLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 164 KLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred eeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999999999987654 68899999999999987 67999999999999999999999999543333
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=299.79 Aligned_cols=249 Identities=26% Similarity=0.453 Sum_probs=203.0
Q ss_pred EEEEEEecccCCeEEEEEEEcC-CCeEEEEEEEeecccc------CCHHHHHHHHHHHHHHHh-CCCCCeeeeeeEEEeC
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEV-NGLEVAWCQVRIDDVL------QSPEDLERLYSEVHLLKS-LKHNNIIRFYNSWIDD 99 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~-tg~~vAiK~v~~~~~~------~s~~~~e~l~~Ei~iLk~-L~HpNIVkl~~~~~d~ 99 (670)
|.+.+.||+|+||.||+|.+.. ++..+|+|.+...... .......++.+|+.++++ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 6778899999999999999987 7889999998753221 223456678889998876 6999999999988654
Q ss_pred CCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 100 QNKTVNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
...++||||+.|++|.+++.. ...+++..++.++.|++.||.|||. .+ ++||||||+|||++ .++.+||+
T Consensus 82 --~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~ 156 (269)
T cd08528 82 --DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTIT 156 (269)
T ss_pred --CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEe
Confidence 379999999999999988643 3568999999999999999999996 55 99999999999998 67899999
Q ss_pred eccchhhhccc-ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc
Q 005916 175 DLGLATIMEQA-NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS 252 (670)
Q Consensus 175 DFGla~~~~~~-~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 252 (670)
|||++...... ......|+..|+|||.+. +.++.++||||||+++|+|++|.+||.. .+.......+..+..+....
T Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd08528 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPE 235 (269)
T ss_pred cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCc
Confidence 99999776543 234567899999999764 5688999999999999999999999976 44444445555544333333
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
...++.+.+||.+||. +|.+||++.++..+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 3567899999999996 89999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=302.39 Aligned_cols=236 Identities=19% Similarity=0.340 Sum_probs=184.9
Q ss_pred EEecccCCeEEEEEEEcC------------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 32 EVIGKGAFKTVYKAFDEV------------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~------------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
+.||+|+||+||+|+... ....+++|.+... .......+..|+.+++.++||||+++++++.+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 468999999999997432 2335777765532 133455788899999999999999999998765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC-------cE
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG-------EV 171 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g-------~v 171 (670)
. ..++||||+.+|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++ .+
T Consensus 77 ~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~-~~~~~~~~~~~ 151 (262)
T cd05077 77 V--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAR-EGIDGECGPFI 151 (262)
T ss_pred C--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEec-CCccCCCCcee
Confidence 4 578999999999999988754 56999999999999999999999998 999999999999973 33 38
Q ss_pred EEeeccchhhhcccccccccCCCccCCCcccc--CCCCccceeeeccchhhhhh-hccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 172 KIGDLGLATIMEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMV-TFEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 172 KL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLl-tG~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
|++|||++..... .....|+..|+|||++. ..++.++|||||||++|+|+ +|..||... ...... ....+...
T Consensus 152 ~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~~~ 227 (262)
T cd05077 152 KLSDPGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQCM 227 (262)
T ss_pred EeCCCCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcCcc
Confidence 9999999865532 23456889999999774 56899999999999999997 588888653 222222 22222211
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.....+.++++||.+||. +|.+||++.+++++
T Consensus 228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 122235789999999996 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=304.34 Aligned_cols=236 Identities=20% Similarity=0.300 Sum_probs=184.8
Q ss_pred EecccCCeEEEEEEEcCC------------------------CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC
Q 005916 33 VIGKGAFKTVYKAFDEVN------------------------GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~d~~t------------------------g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN 88 (670)
.||+|+||.||+|....+ ...||+|.+... .......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence 589999999999975332 235777776532 1334567888999999999999
Q ss_pred eeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC
Q 005916 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 167 (670)
Q Consensus 89 IVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~ 167 (670)
|+++++++.+.. ..++|||||.+|+|..++.+ .+.+++..+..++.||+.||.|||+++ |+||||||+|||++..
T Consensus 78 iv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 999999987654 68999999999999998865 467899999999999999999999998 9999999999999732
Q ss_pred ------CCcEEEeeccchhhhcccccccccCCCccCCCcccc--CCCCccceeeeccchhhhh-hhccCCCCCCCCHHHH
Q 005916 168 ------QGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEM-VTFEYPYSECRNSAQI 238 (670)
Q Consensus 168 ------~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeL-ltG~~Pf~~~~~~~~i 238 (670)
.+.+|++|||++..... .....+++.|+|||.+. ..++.++|||||||++|+| ++|..||.... ....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~--~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALS--REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEK 230 (274)
T ss_pred CcccCccceeeecCCcccccccc--ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-hHHH
Confidence 22489999998754422 23346788999999774 3589999999999999998 47999997643 3332
Q ss_pred HHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 239 YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 239 ~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
...+... ...+....+.+.++|.+||. +|.+|||+.++|++
T Consensus 231 ~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKK---HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhc---cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2222221 11223345789999999996 79999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=299.54 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=200.1
Q ss_pred EEEEEEecccCCeEEEEEEEc---CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---
Q 005916 28 IRYKEVIGKGAFKTVYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~---~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--- 101 (670)
|++.++||+|+||+||+|..+ .+|..||+|++.... ......+++.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 567889999999999999864 467899999987533 234557788999999999999999999998865432
Q ss_pred -CeEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 102 -KTVNIITELFTSGSLRQYRKKH------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 102 -~~~~lVmEy~~gGsL~~~i~~~------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
...+++++|+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEEC
Confidence 1357899999999999886532 24789999999999999999999998 99999999999998 67899999
Q ss_pred eccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 175 DLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 175 DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
|||++....... .....+++.|++||.+ .+.++.++|||||||++|+|++ |.+||.. .+...++..+..+...
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL 234 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC
Confidence 999988664321 2233456789999976 4568899999999999999999 8899976 4556666666655332
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
......+..+.+++.+||. +|.+|||+.+++..
T Consensus 235 -~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 -KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2233456899999999996 79999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=305.92 Aligned_cols=254 Identities=19% Similarity=0.240 Sum_probs=190.4
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHH-------HHHHHHHHHHHHhCCCCCee
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPED-------LERLYSEVHLLKSLKHNNII 90 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~-------~e~l~~Ei~iLk~L~HpNIV 90 (670)
.+..++.|++.++||+|+||+||+|.+..+ +..+|+|...........+. ......+...++.+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 455678899999999999999999998877 66777775443221110000 01122344556677999999
Q ss_pred eeeeEEEeCCC--CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC
Q 005916 91 RFYNSWIDDQN--KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 168 (670)
Q Consensus 91 kl~~~~~d~~~--~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~ 168 (670)
++++++..... .+.+++++++. .++.+.+......++..++.++.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~-~~ 162 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD-GN 162 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CC
Confidence 99987654432 24578888874 477777776666789999999999999999999998 99999999999998 56
Q ss_pred CcEEEeeccchhhhccc---------ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHH
Q 005916 169 GEVKIGDLGLATIMEQA---------NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 238 (670)
Q Consensus 169 g~vKL~DFGla~~~~~~---------~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i 238 (670)
+.++|+|||+++.+... ......||+.|+|||++. ..|+.++|||||||++|+|++|.+||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 79999999999766321 112357999999999764 56899999999999999999999999875333222
Q ss_pred --------HHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 239 --------YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 239 --------~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+.+..+.. .....++++.+|+..|+. +|.+||+..++++
T Consensus 243 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222322221 122346889999999995 8999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=316.62 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=189.6
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.-..+||+|+||+||+|... +|..||||++...... . ...|.+|+.+|.+++|||+|+++|||.+... ..+||
T Consensus 77 Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LV 150 (361)
T KOG1187|consen 77 FSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLV 150 (361)
T ss_pred CchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEE
Confidence 444578999999999999754 4588999976643221 1 3449999999999999999999999987653 58999
Q ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 108 TELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||+.+|+|.+++.... .+++....+|+.+++.||+|||.. .|+|||||||+.|||+| .+...||+|||+|.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCc
Confidence 99999999999987765 899999999999999999999995 45899999999999999 678999999999966654
Q ss_pred -ccc-ccc-cCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCC--CHH--HH--HHHHhcCC-----CCC
Q 005916 185 -ANA-KSV-IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR--NSA--QI--YKKVSSGI-----KPA 249 (670)
Q Consensus 185 -~~~-~~~-~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~--~~~--~i--~~~i~~g~-----~p~ 249 (670)
... .+. .||.+|+|||++. +..+.++|||||||+++||+||+.|..... ... .. ...+..+. .|.
T Consensus 230 ~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~ 309 (361)
T KOG1187|consen 230 GDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR 309 (361)
T ss_pred cccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence 222 222 8999999999774 679999999999999999999998876422 111 11 12222221 121
Q ss_pred cccCCCC--hHH---HHHHHHcCC-CCCCCCCHHHHhc
Q 005916 250 ALSKVKD--PEV---KSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 250 ~~~~~~s--~~~---k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
......+ .++ ..+..+|+. +|.+||+..|++.
T Consensus 310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1101222 233 355667996 6899999999754
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=300.42 Aligned_cols=240 Identities=25% Similarity=0.450 Sum_probs=194.0
Q ss_pred EEecccCCeEEEEEEEcCCC------eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 32 EVIGKGAFKTVYKAFDEVNG------LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg------~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.||+|+||.||+|.++..+ ..+|+|.+.... .......+.+|+.+++.++||||+++++++.+.. ..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE--PQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--CeE
Confidence 36899999999999876544 789999876432 1344567889999999999999999999887554 689
Q ss_pred EEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC-----cEEE
Q 005916 106 IITELFTSGSLRQYRKKH-------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG-----EVKI 173 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~-------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g-----~vKL 173 (670)
+||||+.+|+|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+|||++ .++ .++|
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVS-EKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEe-cCCCCCCcceEE
Confidence 999999999999998643 34788999999999999999999988 99999999999998 344 7999
Q ss_pred eeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCC
Q 005916 174 GDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIK 247 (670)
Q Consensus 174 ~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~ 247 (670)
+|||++....... .....++..|+|||++ .+.++.++|||||||++|+|++ |..||.. .+.......+..+..
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~ 231 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA-LNNQEVLQHVTAGGR 231 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc-cCHHHHHHHHhcCCc
Confidence 9999987654322 1233457889999976 4578999999999999999998 9999976 344555555554432
Q ss_pred CCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 248 PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 248 p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+ ..+...+..+.+||.+||. +|.+||++.++++
T Consensus 232 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 L-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred c-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2 2334567899999999996 7999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=282.99 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=200.3
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|.-.+.||+|.||+||+|+...+++.||+|.++.++- +...-....+|+-+|+.|+|.|||+++++...+. .+-+|
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsdk--kltlv 79 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLV 79 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc--eeEEe
Confidence 3345689999999999999999999999999998653 1222334678999999999999999999765443 68899
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 108 TELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
+|||. .+|..|... ++.++.+.++.++.|++.||.|||+|+ +.||||||.|.|++ .+|++||+|||+++.+.-..
T Consensus 80 fe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 80 FEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPV 155 (292)
T ss_pred HHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCce
Confidence 99994 588887665 578999999999999999999999999 99999999999999 67999999999999876543
Q ss_pred --cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhc-C-CCCCcccC------
Q 005916 187 --AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS-G-IKPAALSK------ 253 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~-g-~~p~~~~~------ 253 (670)
....+-|.+|.+|.++- .-|+...|+||.|||+.|+.. |.+.|++..-..++.+.... | .....|+.
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 23446699999999774 359999999999999999976 66668775444554443321 1 00111110
Q ss_pred ------------------CCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 254 ------------------VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 254 ------------------~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
..+..-+++++++|. +|.+|++|+.+|+||||..
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 122355899999996 8999999999999999964
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=306.50 Aligned_cols=259 Identities=19% Similarity=0.351 Sum_probs=219.6
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~ 104 (670)
..|++.++||+|+|+.|.+++++.|.+.||+|++++ ...+..++.+-+..|-++..+- +||.+|.++.+|..+. .+
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkk-el~nddedidwvqtek~vfe~asn~pflvglhscfqtes--rl 326 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKK-ELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES--RL 326 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHH-HhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc--eE
Confidence 458999999999999999999999999999999985 4556677788888999998887 8999999999997665 69
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh-c
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM-E 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~-~ 183 (670)
++|.||++||+|--.++++..++++.++.+...|+.||.|||+.| ||+||||.+|+|++ ..|++||+|+|+.+.- .
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlld-aeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEc-cCCceeecccchhhcCCC
Confidence 999999999999988999999999999999999999999999999 99999999999999 6799999999998753 3
Q ss_pred cc-ccccccCCCccCCCccccC-CCCccceeeeccchhhhhhhccCCCC-------CCCCHHHHHHHHhcCCCCCcccCC
Q 005916 184 QA-NAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYS-------ECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 184 ~~-~~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvilyeLltG~~Pf~-------~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
.+ .+.+++|||.|+|||++++ .|...+|+|+|||+++||+.|+.||. +.....-+++.|..... ..+..
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--riprs 481 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPRS 481 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccce
Confidence 33 3578999999999998865 69999999999999999999999994 22334456777766432 23444
Q ss_pred CChHHHHHHHHcCC-CCCCCC------CHHHHhcCccccccCCCC
Q 005916 255 KDPEVKSFIEKCLV-PASQRL------SAKELLMDPFLQVNGTTK 292 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~Rp------Sa~elL~hpf~~~~~~~~ 292 (670)
.+..+..+++..|. ||.+|+ ...++-.||||+...|..
T Consensus 482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 45566677777775 799887 468999999999766643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=330.04 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=178.9
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCC----CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE-
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVN----GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI- 97 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~t----g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~- 97 (670)
.....|.+.+.||+|+||+||+|.+..+ +..||+|++.... ..+....+ .++...+.++..+...|.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 3456799999999999999999999988 9999999875321 11111111 122223333333222221
Q ss_pred ---eCCCCeEEEEEecCCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHhhhhcCCCCeee
Q 005916 98 ---DDQNKTVNIITELFTSGSLRQYRKKHKK--------------------VDMKAVKGWARQILSGLIYLHSHDPPIIH 154 (670)
Q Consensus 98 ---d~~~~~~~lVmEy~~gGsL~~~i~~~~~--------------------lse~~i~~i~~QIl~aL~yLHs~g~~IIH 154 (670)
......+++||||+.+++|.+++..... ..+..+..++.||+.||.|||+++ |+|
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 1334578999999999999998865421 123457789999999999999998 999
Q ss_pred ecCccccEEEeCCCCcEEEeeccchhhhccc---ccccccCCCccCCCcccc-----------------------CCCCc
Q 005916 155 RDLKCDNIFINGNQGEVKIGDLGLATIMEQA---NAKSVIGTPEFMAPELYD-----------------------ENYNE 208 (670)
Q Consensus 155 rDLKpeNILl~~~~g~vKL~DFGla~~~~~~---~~~~~~GTp~YmAPEvl~-----------------------~~ys~ 208 (670)
|||||+|||++...+.+||+|||+++.+... .....+||+.|||||.+. ..++.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 9999999999865689999999999876432 235678999999999542 12455
Q ss_pred cceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC-------------CCc------ccCCCChHHHHHHHHcCC-
Q 005916 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-------------PAA------LSKVKDPEVKSFIEKCLV- 268 (670)
Q Consensus 209 ~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~-------------p~~------~~~~~s~~~k~fI~kcL~- 268 (670)
++|||||||++|+|+++..|+.. ...+....+..... ... .....+...++||.+||.
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 67999999999999997766532 22222222221110 000 001122345689999996
Q ss_pred CCCCCCCHHHHhcCccccccC
Q 005916 269 PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 269 dP~~RpSa~elL~hpf~~~~~ 289 (670)
||.+|||+.++|+||||+...
T Consensus 437 dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred CcccCCCHHHHhCCcCcCCCC
Confidence 899999999999999998643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.40 Aligned_cols=255 Identities=20% Similarity=0.348 Sum_probs=202.1
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC--CC----Ceeeeee
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK--HN----NIIRFYN 94 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~--Hp----NIVkl~~ 94 (670)
.|-...+|.+...||+|.||.|-.+.|..++..||+|+++.- ....+..+-|+++|+++. -| -+|++.+
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 444456677888999999999999999999999999998732 455667778999999993 23 2566666
Q ss_pred EEEeCCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC------
Q 005916 95 SWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING------ 166 (670)
Q Consensus 95 ~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~------ 166 (670)
+| |- .+..|||+|.+ |-+++++++.++ +++...++.+++|++.++.|||+.+ ++|-||||+|||+..
T Consensus 159 wF-dy-rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 159 WF-DY-RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hh-hc-cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEE
Confidence 54 33 45899999999 679999998864 6899999999999999999999999 999999999999841
Q ss_pred -------------CCCcEEEeeccchhhhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCC
Q 005916 167 -------------NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC 232 (670)
Q Consensus 167 -------------~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~ 232 (670)
....|+|+|||.|+.-.+.. .+++.|..|.|||++ +-+++.++||||+||||+||.||...|...
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 12358999999998766544 678899999999965 668999999999999999999999999876
Q ss_pred CCHHHH--HHHHhcCCCC-----------------CcccC----------------------CC---ChHHHHHHHHcCC
Q 005916 233 RNSAQI--YKKVSSGIKP-----------------AALSK----------------------VK---DPEVKSFIEKCLV 268 (670)
Q Consensus 233 ~~~~~i--~~~i~~g~~p-----------------~~~~~----------------------~~---s~~~k~fI~kcL~ 268 (670)
.+.+.+ ++.|... .| ..|+. .. ..++.+||++||.
T Consensus 313 en~EHLaMMerIlGp-~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 313 ENLEHLAMMERILGP-IPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CcHHHHHHHHHhhCC-CcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 655532 3333221 11 00110 01 1356789999996
Q ss_pred -CCCCCCCHHHHhcCccccc
Q 005916 269 -PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 269 -dP~~RpSa~elL~hpf~~~ 287 (670)
||.+|+|+.|+|.||||..
T Consensus 392 fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFAR 411 (415)
T ss_pred cCccccccHHHHhcCHHhhc
Confidence 9999999999999999963
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=299.04 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=207.8
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHH-hCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK-SLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk-~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.+-...||.|+||+|++..++.+|+..|||+++.... .....+++.|..... .=+.||||+||+..+.+. .+++
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWi 140 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWI 140 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceee
Confidence 3345679999999999999999999999999986543 566778888988654 448999999999987655 5999
Q ss_pred EEecCCCCCHHHHH-----HhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 107 ITELFTSGSLRQYR-----KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 107 VmEy~~gGsL~~~i-----~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.||+|. .+|..+. .+...++|..+..|....+.||.||-..- .|||||+||+|||++ ..|.|||||||.+..
T Consensus 141 CMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 141 CMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICGQ 217 (361)
T ss_pred eHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchHh
Confidence 999994 4776543 34568999999999999999999997652 399999999999999 678999999999998
Q ss_pred hccccccc-ccCCCccCCCcccc---CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccC----
Q 005916 182 MEQANAKS-VIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK---- 253 (670)
Q Consensus 182 ~~~~~~~~-~~GTp~YmAPEvl~---~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~---- 253 (670)
+..+.+.+ -.|-.-|||||.+. .+|+-++|+||||++|||+.||..||.+-.+.-+....+..|..|.....
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 87765543 47888999999773 46999999999999999999999999875554444555666665543332
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+..++.||..||. |-+.||...+|+++||++..
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 257889999999996 67899999999999999854
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=330.36 Aligned_cols=244 Identities=25% Similarity=0.383 Sum_probs=205.6
Q ss_pred eEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
..++.+.||+|+||.||+|... .....||||.++... +....+.|.+|+.+|..|+|||||+|+|++...+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~- 562 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREGD- 562 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-
Confidence 4677889999999999999643 345679999987543 3456788999999999999999999999887554
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC
Q 005916 102 KTVNIITELFTSGSLRQYRKKHK--------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 167 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~--------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~ 167 (670)
-+|+|+|||..|+|.+|++.+. +++..+...|+.||+.|+.||-++. +|||||-..|+||. .
T Consensus 563 -P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e 638 (774)
T KOG1026|consen 563 -PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG-E 638 (774)
T ss_pred -eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec-c
Confidence 6999999999999999987542 2788999999999999999999998 99999999999997 5
Q ss_pred CCcEEEeeccchhhhccccccccc----CCCccCCCc-cccCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHH
Q 005916 168 QGEVKIGDLGLATIMEQANAKSVI----GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKK 241 (670)
Q Consensus 168 ~g~vKL~DFGla~~~~~~~~~~~~----GTp~YmAPE-vl~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~ 241 (670)
...|||+||||++..-......+. -...||||| ++.++|+.++||||+||+|||+++ |..||.+. ..++..+.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl-Sn~EVIe~ 717 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL-SNQEVIEC 717 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc-chHHHHHH
Confidence 679999999999876443322222 245899999 778999999999999999999987 88999985 45556667
Q ss_pred HhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHh
Q 005916 242 VSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL 280 (670)
Q Consensus 242 i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL 280 (670)
|..|.. ...+...+.++.+++..||+ .|.+||+++|+-
T Consensus 718 i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 718 IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 888775 55677889999999999997 799999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=279.79 Aligned_cols=240 Identities=35% Similarity=0.602 Sum_probs=205.1
Q ss_pred CCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHH
Q 005916 38 AFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLR 117 (670)
Q Consensus 38 ~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~ 117 (670)
+||.||+|.+..+|..+|+|++...... ...+.+.+|++.++.++|+||+++++++.... ..++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDED--KLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC--EEEEEEeCCCCCCHH
Confidence 5899999999999999999998754321 11678899999999999999999999887653 789999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-ccccccCCCcc
Q 005916 118 QYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVIGTPEF 196 (670)
Q Consensus 118 ~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~-~~~~~~GTp~Y 196 (670)
.++.....++...+..++.+++.+|.|||.++ ++|+||+|.||+++ .++.++|+|||++...... ......|++.|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCCcCC
Confidence 99988777999999999999999999999998 99999999999998 5589999999999877654 34566789999
Q ss_pred CCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCC-CChHHHHHHHHcCC-CCCCC
Q 005916 197 MAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV-KDPEVKSFIEKCLV-PASQR 273 (670)
Q Consensus 197 mAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~-~s~~~k~fI~kcL~-dP~~R 273 (670)
+|||.+. ..++.++||||||+++++|++|..||........+...+..+..+...... .+..+.+|+.+||. +|.+|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999764 678899999999999999999999997756666676666655443322222 66889999999996 89999
Q ss_pred CCHHHHhcCccc
Q 005916 274 LSAKELLMDPFL 285 (670)
Q Consensus 274 pSa~elL~hpf~ 285 (670)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=330.90 Aligned_cols=247 Identities=23% Similarity=0.405 Sum_probs=203.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCC-C----eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVN-G----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~t-g----~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
-....+.+.||+|+||.||.|..... | ..||+|.++.. .+.+....|++|..+|+.++|||||++.+++.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 44577889999999999999976533 3 23777776532 4577888999999999999999999999999874
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEE
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH-------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 172 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~-------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vK 172 (670)
. ..+|++|||.||+|..|+++. ..++...+..++.||+.|+.||++++ +|||||-+.|+||+. ...||
T Consensus 768 ~--~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~-~r~VK 842 (1025)
T KOG1095|consen 768 G--PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDE-RRVVK 842 (1025)
T ss_pred C--CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecc-cCcEE
Confidence 4 688999999999999999875 35899999999999999999999998 999999999999995 47999
Q ss_pred EeeccchhhhcccccccccC----CCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCC
Q 005916 173 IGDLGLATIMEQANAKSVIG----TPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGI 246 (670)
Q Consensus 173 L~DFGla~~~~~~~~~~~~G----Tp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~ 246 (670)
|+|||+|+.+-.......-| ...|||||.+ .+.++.++|||||||++||++| |..||.. .+..++...+..+-
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~-~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS-RSNFEVLLDVLEGG 921 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC-cchHHHHHHHHhCC
Confidence 99999999554332222222 2479999966 5889999999999999999998 7889988 44555555444443
Q ss_pred CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 247 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 247 ~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
....+..++..+.+++..||. +|.+||+...+++
T Consensus 922 -RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 344566778888999999996 8999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=308.03 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=203.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC------CCCeeeeeeEEEeC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK------HNNIIRFYNSWIDD 99 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~------HpNIVkl~~~~~d~ 99 (670)
.+|.+....|+|-|++|.+|.+...|..||||+|+...++. ..=+.|++||++|. --|+++|+..|...
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 34666778999999999999999999999999999765443 33457999999994 23889999988654
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
+ ++|||+|.+ ..+|++.+++.| .+...+++.|+.|++.||..|-.+| |+|.||||+|||++.....+|||||
T Consensus 507 n--HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 507 N--HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred c--eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccC
Confidence 4 899999998 569999999876 4889999999999999999999999 9999999999999987788999999
Q ss_pred cchhhhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHH-----------HHhc
Q 005916 177 GLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK-----------KVSS 244 (670)
Q Consensus 177 Gla~~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~-----------~i~~ 244 (670)
|.|........+.+.-+..|.|||++ +-.|+...|+||+||+||||.||+.-|++..+...+.- .+..
T Consensus 582 GSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 582 GSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 99988876665555567789999965 66899999999999999999999999999666554321 1111
Q ss_pred CC--------------------------------CCC-c----------ccCC---CChHHHHHHHHcCC-CCCCCCCHH
Q 005916 245 GI--------------------------------KPA-A----------LSKV---KDPEVKSFIEKCLV-PASQRLSAK 277 (670)
Q Consensus 245 g~--------------------------------~p~-~----------~~~~---~s~~~k~fI~kcL~-dP~~RpSa~ 277 (670)
|. +|. . ++.. .-.++++|+.+||. ||.+|+|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 11 110 0 0000 01367899999996 999999999
Q ss_pred HHhcCccccc
Q 005916 278 ELLMDPFLQV 287 (670)
Q Consensus 278 elL~hpf~~~ 287 (670)
++|.||||+.
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999973
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=321.32 Aligned_cols=264 Identities=29% Similarity=0.524 Sum_probs=227.5
Q ss_pred CCCCCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeee
Q 005916 14 PDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFY 93 (670)
Q Consensus 14 ~~~~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~ 93 (670)
+.+++...+|..+|+. ..++|.|.||.||+|+++.++...|+|+|+..- .++..-+.+|+-+++.++|||||.+|
T Consensus 4 ~~~disrrnP~ddyel-lqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~ 78 (829)
T KOG0576|consen 4 PKSDISRRNPQDDYEL-LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYF 78 (829)
T ss_pred ccchhhhcCCccchhh-eeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHH
Confidence 3456667788877775 569999999999999999999999999999754 23456678899999999999999999
Q ss_pred eEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEE
Q 005916 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 173 (670)
Q Consensus 94 ~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL 173 (670)
+.|.... .++++||||.||+|.+.-.-.+++++.++..+++..+.||.|||+.+ -+|||||-.|||++ +.|.+|+
T Consensus 79 gsylr~d--klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvkl 153 (829)
T KOG0576|consen 79 GSYLRRD--KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKL 153 (829)
T ss_pred hhhhhhc--CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceee
Confidence 9997655 58999999999999998777789999999999999999999999998 89999999999998 7899999
Q ss_pred eeccchhhhccc--ccccccCCCccCCCccc----cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC
Q 005916 174 GDLGLATIMEQA--NAKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK 247 (670)
Q Consensus 174 ~DFGla~~~~~~--~~~~~~GTp~YmAPEvl----~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~ 247 (670)
+|||.+..+... +.++++|||+|||||+. .+.|+.++|||++|+...|+--.++|.........++-.-.++..
T Consensus 154 aDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~q 233 (829)
T KOG0576|consen 154 ADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQ 233 (829)
T ss_pred cccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCC
Confidence 999999887654 35789999999999965 578999999999999999999999997765555556655566666
Q ss_pred CCccc--CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 248 PAALS--KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 248 p~~~~--~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
|..+. ...++.+-+|++.+|. +|.+||+++.+|.|||+..
T Consensus 234 pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred CCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 65554 2457899999999996 7999999999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.27 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=200.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe------CC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID------DQ 100 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d------~~ 100 (670)
.|.-..+||+|.||.||+|+++.+|+.||+|++-...- ....-....+|+.+|+.|+|+|++.+.+.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 34455689999999999999999999999987754221 11223456789999999999999988776532 12
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 101 NKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
...+|+|+.+|+. +|+-.+... -+++...++.++++++.||.|+|++. |+|||+|+.|+|++ .+|.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt-~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLIT-KDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEc-CCceEEeeccccc
Confidence 3469999999976 888877765 57999999999999999999999999 99999999999999 6789999999999
Q ss_pred hhhcccc------cccccCCCccCCCccc--cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc---CCCC
Q 005916 180 TIMEQAN------AKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---GIKP 248 (670)
Q Consensus 180 ~~~~~~~------~~~~~GTp~YmAPEvl--~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~---g~~p 248 (670)
+.+.... .+..+-|.+|.+||++ .+.|+++.|||..|||+.+|.|+.+-|.+..+..++ ..|.. ...+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql-~~Is~LcGs~tk 250 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL-HLISQLCGSITK 250 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH-HHHHHHhccCCc
Confidence 7765432 2344559999999965 457999999999999999999999999884444333 22211 1111
Q ss_pred Ccc------------------------------cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 AAL------------------------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 ~~~------------------------------~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..| +-+.++++.++++++|. ||.+|+.+.++|+|.||..+
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 111 11245688899999996 99999999999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=305.53 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=185.8
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEc----------------CCCeEEEEEEEeeccccCCHH----------HHHHHHHH
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDE----------------VNGLEVAWCQVRIDDVLQSPE----------DLERLYSE 77 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~----------------~tg~~vAiK~v~~~~~~~s~~----------~~e~l~~E 77 (670)
....|++.++||+|+||+||+|.+. ..++.||+|.+.........+ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4557999999999999999999752 345689999987532110000 11223457
Q ss_pred HHHHHhCCCCCe-----eeeeeEEEeC------CCCeEEEEEecCCCCCHHHHHHhc-----------------------
Q 005916 78 VHLLKSLKHNNI-----IRFYNSWIDD------QNKTVNIITELFTSGSLRQYRKKH----------------------- 123 (670)
Q Consensus 78 i~iLk~L~HpNI-----Vkl~~~~~d~------~~~~~~lVmEy~~gGsL~~~i~~~----------------------- 123 (670)
+.++.+++|.++ ++++++|... .....++||||+.+|+|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788866654 6677766432 123589999999999999987642
Q ss_pred -CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc-cc--cccCCCccCCC
Q 005916 124 -KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AK--SVIGTPEFMAP 199 (670)
Q Consensus 124 -~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~-~~--~~~GTp~YmAP 199 (670)
..+++..++.++.||+.||.|||.++ |+||||||+|||++ .++.+||+|||++..+.... .. ...+||.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12456788999999999999999998 99999999999998 56799999999997654322 12 23458999999
Q ss_pred ccccCC---------------------CC--ccceeeeccchhhhhhhccC-CCCCCCC----------HHHHHHHHhcC
Q 005916 200 ELYDEN---------------------YN--ELADIYSFGMCMLEMVTFEY-PYSECRN----------SAQIYKKVSSG 245 (670)
Q Consensus 200 Evl~~~---------------------ys--~~~DIWSLGvilyeLltG~~-Pf~~~~~----------~~~i~~~i~~g 245 (670)
|++... |+ .++||||+||++|+|++|.. ||..... ....++.+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 976321 22 34799999999999999986 7753211 11122222222
Q ss_pred CCCCcccCCCChHHHHHHHHcCC-CC---CCCCCHHHHhcCcccc
Q 005916 246 IKPAALSKVKDPEVKSFIEKCLV-PA---SQRLSAKELLMDPFLQ 286 (670)
Q Consensus 246 ~~p~~~~~~~s~~~k~fI~kcL~-dP---~~RpSa~elL~hpf~~ 286 (670)
..........++.+++|+.+||. +| .+|+|+.|+|.||||.
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 22223334567899999999995 33 6899999999999995
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.21 Aligned_cols=248 Identities=28% Similarity=0.520 Sum_probs=204.1
Q ss_pred CCCCCeEEEE-------EEecccCCeEEEEEEEc----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCee
Q 005916 22 DPTCRYIRYK-------EVIGKGAFKTVYKAFDE----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90 (670)
Q Consensus 22 dp~gr~yr~~-------~~LG~G~fG~Vy~a~d~----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIV 90 (670)
-|++|.|++. ++||.|.||.||+|... .....||||..+.+. .++..+.|++|.-+|+.++|||||
T Consensus 378 ~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIi 454 (974)
T KOG4257|consen 378 TPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHII 454 (974)
T ss_pred CCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchh
Confidence 4778888774 57999999999999753 234567788776432 466688999999999999999999
Q ss_pred eeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC
Q 005916 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 169 (670)
Q Consensus 91 kl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g 169 (670)
++.|++.+.. .+||||+++-|.|+.|++.++ .++......++.||+.||.|||+.. +|||||-..|||+... -
T Consensus 455 kLIGv~~e~P---~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp-~ 528 (974)
T KOG4257|consen 455 KLIGVCVEQP---MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP-Q 528 (974)
T ss_pred heeeeeeccc---eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-c
Confidence 9999987654 899999999999999998764 6899999999999999999999998 9999999999999854 4
Q ss_pred cEEEeeccchhhhccccc-ccccC--CCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhc
Q 005916 170 EVKIGDLGLATIMEQANA-KSVIG--TPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS 244 (670)
Q Consensus 170 ~vKL~DFGla~~~~~~~~-~~~~G--Tp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~ 244 (670)
.|||+|||+++.+..... +...| ...|||||-++ +.++.++|||.||||+||++. |..||.+..|...|. .+..
T Consensus 529 CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-~iEn 607 (974)
T KOG4257|consen 529 CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-HIEN 607 (974)
T ss_pred eeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-EecC
Confidence 899999999999876532 22222 45799999664 679999999999999999865 899999866655443 3455
Q ss_pred CCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHh
Q 005916 245 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL 280 (670)
Q Consensus 245 g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL 280 (670)
|.. .+.+..++|.+..++.+||. +|.+||...++.
T Consensus 608 GeR-lP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 608 GER-LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CCC-CCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 543 34566788999999999997 899999877664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=278.89 Aligned_cols=251 Identities=22% Similarity=0.373 Sum_probs=208.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~ 103 (670)
...|.+.+.+|+|.|+.||.|++..+...++||+++. -....+.+|+.||+.|. |||||++++...|+..+.
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3457778899999999999999999999999999874 33567899999999995 999999999999988889
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
..+|+||+.+.+.... .+.++...++.++.+++.||.|||+.| |+|||+||.|++++...-.++|+|+|+|.+..
T Consensus 110 paLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999999988665543 456888999999999999999999999 99999999999999766789999999999987
Q ss_pred ccc-cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCC-CCCCCHHHHHHHHhc---------------
Q 005916 184 QAN-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPY-SECRNSAQIYKKVSS--------------- 244 (670)
Q Consensus 184 ~~~-~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf-~~~~~~~~i~~~i~~--------------- 244 (670)
.+. .+-.+.+.+|--||++- +.|+.+-|+|||||++..|+..+-|| .+..+..|+.+...-
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 765 34557788999999773 57999999999999999999998886 455666665432210
Q ss_pred ----------CC-CCCcc--------cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 245 ----------GI-KPAAL--------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 245 ----------g~-~p~~~--------~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
|. ....| ....++++.+|+.++|. |-.+|+||+|++.||||..
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 00 00111 12246899999999997 7899999999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=286.45 Aligned_cols=251 Identities=30% Similarity=0.421 Sum_probs=203.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----C
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----K 102 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~----~ 102 (670)
+|.-...+|.|+- .|-.|.|..+++.||+|.+... ........+.++|..++..+.|+|||+++++|.-... .
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 4555678999998 8888999999999999998755 3334556788999999999999999999998854322 2
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.+|+||||+. ++|.+.+. -.++-..+..+..|++.|+.|||+.+ |+||||||+||+++ .++.+||.|||+|...
T Consensus 95 e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLARTE 168 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchhhccc
Confidence 5899999995 58888776 45788899999999999999999999 99999999999998 6789999999999877
Q ss_pred ccc-ccccccCCCccCCCcc-ccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc----------------
Q 005916 183 EQA-NAKSVIGTPEFMAPEL-YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---------------- 244 (670)
Q Consensus 183 ~~~-~~~~~~GTp~YmAPEv-l~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~---------------- 244 (670)
... ..+..+.|.+|.|||+ ++.+|.+.+||||+|||+.||++|..-|.+.....+..+.+..
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 665 4567889999999995 4667999999999999999999999999874444443332221
Q ss_pred ----------------CCCCCcc-------cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 245 ----------------GIKPAAL-------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 245 ----------------g~~p~~~-------~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
..+|... .+.....+++++.+||+ +|.+|+|++++|+|||++
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0111111 11233578999999996 999999999999999998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=309.91 Aligned_cols=242 Identities=30% Similarity=0.398 Sum_probs=189.7
Q ss_pred EEEEEEecccCCeE-EEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEE
Q 005916 28 IRYKEVIGKGAFKT-VYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 28 yr~~~~LG~G~fG~-Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+...+++|.|+-|+ ||+|. ..|++||||.+-. +..+...+|+.+|+.- .|||||++|+. +.+..+.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-------e~~~~A~rEi~lL~eSD~H~NviRyyc~--E~d~qF~Y 579 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLE-------EFFDFAQREIQLLQESDEHPNVIRYYCS--EQDRQFLY 579 (903)
T ss_pred eccHHHcccCCCCcEEEEEe--eCCceehHHHHhh-------HhHHHHHHHHHHHHhccCCCceEEEEee--ccCCceEE
Confidence 44467899999975 68885 5688999987752 3455678899999999 89999999984 45556999
Q ss_pred EEEecCCCCCHHHHHHhcCC-C---CHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC----CCcEEEeecc
Q 005916 106 IITELFTSGSLRQYRKKHKK-V---DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN----QGEVKIGDLG 177 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~-l---se~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~----~g~vKL~DFG 177 (670)
|+.|+|.. +|.+++...+. + .--..+.++.|+++||++||+.+ ||||||||.||||+.. ...++|+|||
T Consensus 580 IalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfg 656 (903)
T KOG1027|consen 580 IALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFG 656 (903)
T ss_pred EEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccc
Confidence 99999965 99999987521 1 11345788999999999999998 9999999999999852 2468999999
Q ss_pred chhhhcccc-----cccccCCCccCCCccccC-CCCccceeeeccchhhhhhhc-cCCCCCCCCHHHHHHHHhcCCCC-C
Q 005916 178 LATIMEQAN-----AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGIKP-A 249 (670)
Q Consensus 178 la~~~~~~~-----~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvilyeLltG-~~Pf~~~~~~~~i~~~i~~g~~p-~ 249 (670)
+++.+.... .....||-+|+|||++.. .-..++|||||||++|+.++| ..||.. ....-..|..+... .
T Consensus 657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd---~~~R~~NIl~~~~~L~ 733 (903)
T KOG1027|consen 657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD---SLERQANILTGNYTLV 733 (903)
T ss_pred cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc---hHHhhhhhhcCcccee
Confidence 999986543 356789999999998854 456689999999999999987 899965 22222345554422 2
Q ss_pred cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 250 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 250 ~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
.+....+.++++||.+||. +|..||+|.++|.||||-
T Consensus 734 ~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 734 HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 2222222399999999997 799999999999999994
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=294.60 Aligned_cols=245 Identities=26% Similarity=0.412 Sum_probs=199.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
..++++.||+|.||.|.+|.-. .+..||+|.++.... ......|.+|+++|.+|+|||||+++++|+.++ .+++
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~---~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--Picm 612 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT---KNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCM 612 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccc---hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHH
Confidence 4678899999999999999643 368999999986542 334578999999999999999999999998665 5999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
||||++.|+|.+|+.++ ....-....+++.||++|++||.+.+ +|||||.+.|+|++ ..+++||+|||+++-+-.
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~-~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVD-GEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeec-CcccEEecCccccccccc
Confidence 99999999999999988 33455566779999999999999999 99999999999999 457999999999987654
Q ss_pred cccccc----cCCCccCCCc-cccCCCCccceeeeccchhhhh--hhccCCCCCCCCHHHHHHHHh---cCCC---CCcc
Q 005916 185 ANAKSV----IGTPEFMAPE-LYDENYNELADIYSFGMCMLEM--VTFEYPYSECRNSAQIYKKVS---SGIK---PAAL 251 (670)
Q Consensus 185 ~~~~~~----~GTp~YmAPE-vl~~~ys~~~DIWSLGvilyeL--ltG~~Pf~~~~~~~~i~~~i~---~g~~---p~~~ 251 (670)
+....+ +-...||||| ++.++++.++|+|+||+++||+ +|.+.||....+ +++..... .+.- -...
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCcceeccC
Confidence 443333 3357899999 7789999999999999999998 567899988544 44433322 1111 1234
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+..++..+.+++.+|+. +..+|||.+++-.
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 56677889999999996 7899999999854
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=261.54 Aligned_cols=210 Identities=29% Similarity=0.467 Sum_probs=179.6
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEe
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVmE 109 (670)
...||+|++|.|-+.++..+|...|+|.++..- ......++++|+.+..+. .+|.+|.||+.+.++. .+++.||
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--dvwIcME 125 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--DVWICME 125 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--cEEEeHH
Confidence 457999999999999999999999999998543 245667888899886655 8999999999887665 5999999
Q ss_pred cCCCCCHHHH----HHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 110 LFTSGSLRQY----RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 110 y~~gGsL~~~----i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
.+. -+|..+ +++.+.++|..+-+++..|+.||.|||++- .|||||+||+|||++ .+|+||+||||.+-.+.++
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeehhh
Confidence 995 477665 445678999999999999999999999983 399999999999999 6799999999999998877
Q ss_pred cccc-ccCCCccCCCcccc-----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 186 NAKS-VIGTPEFMAPELYD-----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 186 ~~~~-~~GTp~YmAPEvl~-----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
-+.+ -.|-.-|||||.++ ..|+-++||||||+.++||.++++||..-..+-+..+.+.....|
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 6665 57888999999773 369999999999999999999999998777887777777765443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=318.99 Aligned_cols=238 Identities=21% Similarity=0.343 Sum_probs=179.6
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
+....+||+|+||.||+|.+..+|..||+|.+..... ....|++++++++|||||++++++.+.. .+|+|
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv 761 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLI 761 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEE
Confidence 4456789999999999999999999999998863221 1124688999999999999999997654 68999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 108 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||+.+|+|.+++. .+++..+..++.||+.||+|||.+ .++|+||||||+||+++ .++..++. ||.......
T Consensus 762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-ecccccccc--
Confidence 99999999999986 388999999999999999999954 34599999999999998 44566664 665443322
Q ss_pred cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCC-HHHHHHHHh---cC------CCCCc-----
Q 005916 187 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN-SAQIYKKVS---SG------IKPAA----- 250 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~-~~~i~~~i~---~g------~~p~~----- 250 (670)
.....||+.|||||++. ..|+.++|||||||++|||+||+.||..... ...+..... .. ..+..
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence 23347899999999764 5699999999999999999999999853211 111111111 00 00100
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.......++.+++.+||. +|.+|||+.++++.
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000111356788999996 89999999999874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=293.93 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=206.0
Q ss_pred EEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
+++.++||+|+||+|++|..+.. -..||||.++..... ..+..|++|+.+|.+|+|||+|++|++..+. .+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~q---p~ 185 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PA 185 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeeccc---hh
Confidence 55678999999999999976643 357899999866543 2678899999999999999999999988763 48
Q ss_pred EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.+|||++++|+|.+.+.+ ...|....+..|+.||+.|+.||.+++ +|||||-..|+|+-. .-.|||+||||.+-+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllas-prtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLAS-PRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecc-cceeeeecccceecc
Confidence 899999999999998876 356888999999999999999999998 999999999999974 458999999999988
Q ss_pred ccccccccc-----CCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCC
Q 005916 183 EQANAKSVI-----GTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 183 ~~~~~~~~~-----GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
......... -...|+|||-+ .+.++.++|||++||++|||+| |+-||.+ ....+|.+.|..+. ...-++.+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G-~~g~qIL~~iD~~e-rLpRPk~c 340 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG-CRGIQILKNIDAGE-RLPRPKYC 340 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC-CCHHHHHHhccccc-cCCCCCCC
Confidence 654322111 13469999966 4689999999999999999987 7899998 46778888887543 33456778
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
+..+.+++..||. .|.+|||...|...-+++
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 8999999999997 799999999887554443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=280.24 Aligned_cols=137 Identities=26% Similarity=0.391 Sum_probs=117.6
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-----C---CCeeee
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-----H---NNIIRF 92 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-----H---pNIVkl 92 (670)
.-..+.+|.+.++||.|-|+|||+|.|....+.||+|+++.. .-..+....||++|++++ | .+||+|
T Consensus 73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 334558899999999999999999999999999999999843 345667788999999982 3 369999
Q ss_pred eeEEEe--CCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEE
Q 005916 93 YNSWID--DQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI 164 (670)
Q Consensus 93 ~~~~~d--~~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl 164 (670)
++.|.. .++.++|+|+|++ |-+|..+|++. +.++...++.|++|||.||.|||..- +|||-||||+|||+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 999864 3456899999999 77888888764 67999999999999999999999873 49999999999998
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=287.76 Aligned_cols=199 Identities=26% Similarity=0.425 Sum_probs=179.3
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHH----HHHHHHHHHHHhCC---CCCeeeeeeEEEeCC
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDL----ERLYSEVHLLKSLK---HNNIIRFYNSWIDDQ 100 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~----e~l~~Ei~iLk~L~---HpNIVkl~~~~~d~~ 100 (670)
|...+.||.|+||.|++|.++....+|++|.|.+.+.+.+...+ -.+-.|++||..|+ |+||++++++|.+++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 77788999999999999999999999999999987766554333 34668999999996 999999999997765
Q ss_pred CCeEEEEEecCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 101 NKTVNIITELFT-SGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 101 ~~~~~lVmEy~~-gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
++||+||--. |.+|++||..++.++|.+++.|++||+.|+.+||+.| |||||||-+|+.++ .+|-+||+|||.|
T Consensus 643 --~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd-~~g~~klidfgsa 717 (772)
T KOG1152|consen 643 --YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVD-SNGFVKLIDFGSA 717 (772)
T ss_pred --eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEe-cCCeEEEeeccch
Confidence 8999999754 6689999999999999999999999999999999999 99999999999999 5689999999999
Q ss_pred hhhcccccccccCCCccCCCccccC-CC-CccceeeeccchhhhhhhccCCCCC
Q 005916 180 TIMEQANAKSVIGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSE 231 (670)
Q Consensus 180 ~~~~~~~~~~~~GTp~YmAPEvl~~-~y-s~~~DIWSLGvilyeLltG~~Pf~~ 231 (670)
.....+....++||..|.|||++++ .| +..-|||+||++||.++..+.||..
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9998888899999999999999975 34 6789999999999999999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=293.28 Aligned_cols=247 Identities=24% Similarity=0.432 Sum_probs=208.2
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCC---eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNG---LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg---~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
.+..+.++||.|.||.|++|+.+..| ..||||.++..- ...+...|+.|..||-+++||||++|-++. ...+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPNIIrLEGVV--Tks~ 703 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIRLEGVV--TKSK 703 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCcEEEEEEEE--ecCc
Confidence 46888999999999999999998776 568999887543 466778899999999999999999999965 3445
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
-+.||+|||++|+|..|++++ +.|+.-++..+++.|+.|+.||-.++ +|||||-..|||++ .+..+|++||||++.
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVN-snLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRV 780 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeec-cceEEEeccccceee
Confidence 799999999999999998876 77999999999999999999999999 99999999999999 556899999999998
Q ss_pred hcccc---cccccC--CCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 182 MEQAN---AKSVIG--TPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 182 ~~~~~---~~~~~G--Tp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
+++.. ..+.-| ...|.|||.+ .++++.++||||+|++|||.++ |+.||++. ..++..+.|..|.. .+.+-.
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-SNQdVIkaIe~gyR-LPpPmD 858 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVIKAIEQGYR-LPPPMD 858 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc-chHHHHHHHHhccC-CCCCCC
Confidence 86543 122222 3589999955 6889999999999999999765 99999984 55666777888763 223445
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
++..+.+|+..||+ +-..||...|++.+
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 77899999999997 57899999999873
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=283.43 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=213.1
Q ss_pred CCcccCCCCCe-------EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe
Q 005916 17 DVLETDPTCRY-------IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI 89 (670)
Q Consensus 17 ~~~e~dp~gr~-------yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI 89 (670)
.+..+.|+.+. +....+||-|.||.||.|..+.-.-.||||.++.+ .-.++.|+.|..+|+.++|||+
T Consensus 251 tvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNL 325 (1157)
T KOG4278|consen 251 TVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNL 325 (1157)
T ss_pred ceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccH
Confidence 35555666554 44567899999999999999999999999988743 4568899999999999999999
Q ss_pred eeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC
Q 005916 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 167 (670)
Q Consensus 90 Vkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~ 167 (670)
|+++++|..+. .+|||+|||..|+|.+|++... .++.-.+..++.||.+|++||..++ +|||||-..|+|+. .
T Consensus 326 VqLLGVCT~Ep--PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVg-E 400 (1157)
T KOG4278|consen 326 VQLLGVCTHEP--PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-E 400 (1157)
T ss_pred HHHhhhhccCC--CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccc-c
Confidence 99999886544 6999999999999999998754 4777788899999999999999998 99999999999997 4
Q ss_pred CCcEEEeeccchhhhcccccccccC---CCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHH
Q 005916 168 QGEVKIGDLGLATIMEQANAKSVIG---TPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKV 242 (670)
Q Consensus 168 ~g~vKL~DFGla~~~~~~~~~~~~G---Tp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i 242 (670)
+..||++||||++.+.....+...| ...|.|||-+ -..++.++|||+|||+|||+.| |-.||.+ .+..+.|..+
T Consensus 401 nhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LL 479 (1157)
T KOG4278|consen 401 NHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLL 479 (1157)
T ss_pred cceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHH
Confidence 5589999999999997765544444 3479999954 5678999999999999999987 7789988 6788899888
Q ss_pred hcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHh
Q 005916 243 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL 280 (670)
Q Consensus 243 ~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL 280 (670)
..+.. ...+.-+++.+.+|++.||. .|+.||+..++-
T Consensus 480 EkgyR-M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 480 EKGYR-MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred hcccc-ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 88754 33566788999999999997 899999988764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=294.13 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=207.7
Q ss_pred CcccCCCCCeEEEEEEecccCCeEEEEEEEc---C----CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCe
Q 005916 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDE---V----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNI 89 (670)
Q Consensus 18 ~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~---~----tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNI 89 (670)
.++.+..+. .+.+.||.|+||.|++|.-. . ....||+|..+... ...+.+.+..|+++|+.+ .||||
T Consensus 290 ~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 290 KWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred ceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcch
Confidence 666666655 45569999999999999633 1 25678988876432 236778899999999999 79999
Q ss_pred eeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCee
Q 005916 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPII 153 (670)
Q Consensus 90 Vkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~II 153 (670)
+.+.+++.. ...+++|+|||..|+|..|++..+ .++......++.||+.|++||++.. +|
T Consensus 365 v~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~v 440 (609)
T KOG0200|consen 365 VNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CV 440 (609)
T ss_pred hhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--cc
Confidence 999998865 457999999999999999988766 4889999999999999999999997 99
Q ss_pred eecCccccEEEeCCCCcEEEeeccchhhhcccccc---cccC--CCccCCCccc-cCCCCccceeeeccchhhhhhh-cc
Q 005916 154 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK---SVIG--TPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FE 226 (670)
Q Consensus 154 HrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~---~~~G--Tp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~ 226 (670)
||||-..|||+. .+..+||+|||+|+........ ...| ...|||||.+ ...|+.++||||||++|||+++ |.
T Consensus 441 HRDLAaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~ 519 (609)
T KOG0200|consen 441 HRDLAARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG 519 (609)
T ss_pred chhhhhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence 999999999998 4468999999999865443221 1222 2359999966 4679999999999999999988 78
Q ss_pred CCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 227 YPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 227 ~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.||.+......+++.+..|.+.. .+...+.++.++++.||. +|.+||+..++..
T Consensus 520 ~PYp~~~~~~~l~~~l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 520 TPYPGIPPTEELLEFLKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 99988665777788888887543 455668999999999996 8999999998876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=273.11 Aligned_cols=252 Identities=28% Similarity=0.464 Sum_probs=200.3
Q ss_pred EEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC---eEE
Q 005916 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK---TVN 105 (670)
Q Consensus 29 r~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~---~~~ 105 (670)
.-.+.||-|+||+||.+.|..+|+.||.|++. ....+-..-+++.+|+++|..++|.|++..++...-..-. .+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34578999999999999999999999999875 3334455568899999999999999999887754433221 367
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+++|++.+ +|...+..-..++.+.++-+++||+.||.|||+-+ |.||||||.|.|++ .+..+||||||+++..+..
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVN-SNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEec-cCceEEecccccccccchh
Confidence 89999965 88888888889999999999999999999999998 99999999999999 5689999999999887543
Q ss_pred c---cccccCCCccCCCccc--cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHh-----------------
Q 005916 186 N---AKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS----------------- 243 (670)
Q Consensus 186 ~---~~~~~GTp~YmAPEvl--~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~----------------- 243 (670)
. .+..+-|.+|.|||++ .+.|+.++||||.|||+.||+..+..|......+++ ..|.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-QMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-HHHHHHhCCCcHHHHHHHhhh
Confidence 3 3445668999999976 357999999999999999999999888764443333 2111
Q ss_pred ------c-CCCCCccc---CC-----CChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 244 ------S-GIKPAALS---KV-----KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 244 ------~-g~~p~~~~---~~-----~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
. +.++..++ .. ...+...++.++|. +|.+|++..+++.|+++..
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 1 22222222 22 23466777888886 7999999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=276.13 Aligned_cols=250 Identities=30% Similarity=0.494 Sum_probs=190.6
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC--CCCCeeeeeeEEEe
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL--KHNNIIRFYNSWID 98 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L--~HpNIVkl~~~~~d 98 (670)
.-...+.+++.+.||+|.||.||+| ...|..||||++... +...+.+|.+|++.. +|+||+.|.+.=..
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred HHhhhheeEEEEEecCccccceeec--cccCCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 3445678999999999999999999 567999999998743 245678899998886 99999999875322
Q ss_pred CCC--CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhc------CCCCeeeecCccccEEEeCCCCc
Q 005916 99 DQN--KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS------HDPPIIHRDLKCDNIFINGNQGE 170 (670)
Q Consensus 99 ~~~--~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs------~g~~IIHrDLKpeNILl~~~~g~ 170 (670)
..+ -.++||++|-+.|+|+||+.+ ..++.....+++..+++||++||. .+|.|.|||||..||||. ++|.
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~ 354 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGT 354 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCc
Confidence 221 258999999999999999988 579999999999999999999994 257799999999999997 7789
Q ss_pred EEEeeccchhhhcccc------cccccCCCccCCCccccCCCCc-------cceeeeccchhhhhhhc----------cC
Q 005916 171 VKIGDLGLATIMEQAN------AKSVIGTPEFMAPELYDENYNE-------LADIYSFGMCMLEMVTF----------EY 227 (670)
Q Consensus 171 vKL~DFGla~~~~~~~------~~~~~GTp~YmAPEvl~~~ys~-------~~DIWSLGvilyeLltG----------~~ 227 (670)
.-|+|+|||....+.. .+..+||..|||||++....+. .+||||||.++||++.. ++
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 9999999998765432 4678999999999999765443 48999999999999752 57
Q ss_pred CCCCCCC----HHHHHHHHhcCC-CCCccc-CCCChHH---HHHHHHcCC-CCCCCCCHHHHhc
Q 005916 228 PYSECRN----SAQIYKKVSSGI-KPAALS-KVKDPEV---KSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 228 Pf~~~~~----~~~i~~~i~~g~-~p~~~~-~~~s~~~---k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
||.+... .++..+.+--.. .|.... ...++.+ ..+++-||. +|.-|+||-.+-+
T Consensus 435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 8865432 233332221111 222111 1223444 456888995 8999999866543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=276.35 Aligned_cols=244 Identities=28% Similarity=0.417 Sum_probs=188.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC--CCCCeeeeeeEEEeCC--C
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL--KHNNIIRFYNSWIDDQ--N 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L--~HpNIVkl~~~~~d~~--~ 101 (670)
+-..+.++||+|.||.||+|. -+++.||||++.. ...+.+.+|-.|++.. +|+||++|++.=.... .
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 346778899999999999995 4568999999873 4567788898888875 8999999998532111 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhc-------CCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-------HDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-------~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
..++||++|...|+|.+|++.+ .+++....+++..++.||+|||. ++|+|+|||||..||||. +++..-|+
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIa 358 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIA 358 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEee
Confidence 3689999999999999999876 58999999999999999999995 357899999999999997 78999999
Q ss_pred eccchhhhcccc----cccccCCCccCCCccccCCCCc-------cceeeeccchhhhhhhcc------------CCCCC
Q 005916 175 DLGLATIMEQAN----AKSVIGTPEFMAPELYDENYNE-------LADIYSFGMCMLEMVTFE------------YPYSE 231 (670)
Q Consensus 175 DFGla~~~~~~~----~~~~~GTp~YmAPEvl~~~ys~-------~~DIWSLGvilyeLltG~------------~Pf~~ 231 (670)
|||||.++..+. ....+||..|||||++++..+. +.||||+|.++|||++.- .||..
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999998886543 4557999999999999875443 489999999999998742 23421
Q ss_pred ----CCCHHHHHHHHhcCC----CCCcccCCC-ChHHHHHHHHcCC-CCCCCCCHHHHh
Q 005916 232 ----CRNSAQIYKKVSSGI----KPAALSKVK-DPEVKSFIEKCLV-PASQRLSAKELL 280 (670)
Q Consensus 232 ----~~~~~~i~~~i~~g~----~p~~~~~~~-s~~~k~fI~kcL~-dP~~RpSa~elL 280 (670)
....++....+...+ .|..|.+.. -..+++.++.||. ||..|+||.=+-
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 112333333343333 233333322 2467889999995 899999986443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=272.91 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=199.6
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcC---CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEV---NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~---tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~ 100 (670)
...|+...+||.|.|++||+|.+.. ..+.||+|.+.... ...++.+|+++|..+ .+.||+++.+++..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-- 106 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCFRN-- 106 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhhcc--
Confidence 4568899999999999999999887 78999999987543 246799999999999 79999999998754
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
++.+.+|+||++.-+-.++.. .++...++.+++.++.||.++|.+| ||||||||.|+|.+...+.-.|+|||+|.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence 447999999999988887765 4779999999999999999999999 99999999999999878889999999997
Q ss_pred hhcc--------c-------c-------------------------------cccccCCCccCCCccccC--CCCcccee
Q 005916 181 IMEQ--------A-------N-------------------------------AKSVIGTPEFMAPELYDE--NYNELADI 212 (670)
Q Consensus 181 ~~~~--------~-------~-------------------------------~~~~~GTp~YmAPEvl~~--~ys~~~DI 212 (670)
..+. . . .....|||+|.|||++-+ .-+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 3210 0 0 002359999999998743 46789999
Q ss_pred eeccchhhhhhhccCCCCCCCCHHHHHHHHh--------------cCC--------------------------------
Q 005916 213 YSFGMCMLEMVTFEYPYSECRNSAQIYKKVS--------------SGI-------------------------------- 246 (670)
Q Consensus 213 WSLGvilyeLltG~~Pf~~~~~~~~i~~~i~--------------~g~-------------------------------- 246 (670)
||.|||++.++++.+||....+.......+. -|.
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999965443222111110 000
Q ss_pred ---CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 247 ---KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 247 ---~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.+..+....+..+.+|+.+||. +|.+|+||+++|+||||..
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0111223345688999999995 9999999999999999973
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=238.79 Aligned_cols=209 Identities=39% Similarity=0.656 Sum_probs=183.4
Q ss_pred ecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCC
Q 005916 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 113 (670)
Q Consensus 34 LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~g 113 (670)
||.|++|.||++.+..+|..+++|.+...... ...+.+.+|++.++.+.|++|+++++++... ...+++||++.|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence 68999999999999888999999998754321 1456789999999999999999999988754 479999999999
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc--cccc
Q 005916 114 GSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSV 190 (670)
Q Consensus 114 GsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~--~~~~ 190 (670)
++|.+++... ..++...+..++.+++.+|.|||.++ ++|+||+|.||+++...+.++|+|||.+....... ....
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 9999998876 57999999999999999999999998 99999999999998426799999999998776543 4456
Q ss_pred cCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC
Q 005916 191 IGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268 (670)
Q Consensus 191 ~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~ 268 (670)
.+...|++||.+.. .++.+.|+|++|+++++| ..+.+++.+|+.
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhh
Confidence 68899999998755 788999999999999999 678999999996
Q ss_pred -CCCCCCCHHHHhcCc
Q 005916 269 -PASQRLSAKELLMDP 283 (670)
Q Consensus 269 -dP~~RpSa~elL~hp 283 (670)
+|.+||++.++++|+
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 899999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=282.80 Aligned_cols=242 Identities=28% Similarity=0.446 Sum_probs=201.5
Q ss_pred EEEEEecccCCeEEEEEEEcCCCe----EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 29 RYKEVIGKGAFKTVYKAFDEVNGL----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 29 r~~~~LG~G~fG~Vy~a~d~~tg~----~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
+..++||.|+||+||+|..-..|. +||+|++.... +++.-..++.|+-+|.+|+|||++++++++... .+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TL 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hH
Confidence 345789999999999998766654 57888776433 344456788999999999999999999988654 38
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
.||++|+++|.|.+|++.+ ..+-.+....|+.||++|+.|||.+. ++||||-..||||. ...++||.|||+++.+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVk-sP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVK-SPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeec-CCCeEEEEecchhhccC
Confidence 8999999999999998876 57899999999999999999999988 99999999999998 55699999999999886
Q ss_pred cccc--cc--ccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 184 QANA--KS--VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 184 ~~~~--~~--~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
.... .. ..-.+-|||-|.+ ...|+.++|||||||++||++| |..||.+ ....+|-+.+..|.+ ...+.+.+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCti 927 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTI 927 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccH
Confidence 5331 11 1224568888854 5789999999999999999988 7889987 567777777777765 566778889
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+..++.+||. |+..||+++++..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999995 8999999988764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=239.15 Aligned_cols=211 Identities=33% Similarity=0.533 Sum_probs=182.4
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|++.+.||.|++|+||+|.+..++..+|+|.+...... ...+.+.+|+..++.++|+|++++++++.... ..+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPE--PLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCC--ceEEE
Confidence 56788999999999999999988999999998754321 25678899999999999999999999886554 68999
Q ss_pred EecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 108 TELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~~-lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
+|++.+++|.+++..... +++..+..++.|++.+|.|||.++ ++|+||+|.||+++ ..+.++|+|||++......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLG-MDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeCceeeEecCcc
Confidence 999999999999988777 899999999999999999999998 99999999999998 4589999999998877543
Q ss_pred --ccccccCCCccCCCccc-c-CCCCccceeeeccchhhhhhhccCCCCC-CCCHHHHHHHHhcCC
Q 005916 186 --NAKSVIGTPEFMAPELY-D-ENYNELADIYSFGMCMLEMVTFEYPYSE-CRNSAQIYKKVSSGI 246 (670)
Q Consensus 186 --~~~~~~GTp~YmAPEvl-~-~~ys~~~DIWSLGvilyeLltG~~Pf~~-~~~~~~i~~~i~~g~ 246 (670)
......++..|++||.+ . ..++.++|+|+||+++++|++|..||.. ..+...+.+.+..+.
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 23456788899999976 2 4577899999999999999999999976 556667888877765
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-28 Score=285.83 Aligned_cols=199 Identities=21% Similarity=0.237 Sum_probs=146.3
Q ss_pred HhCCC-CCeeeeeeEEEe----C-CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeee
Q 005916 82 KSLKH-NNIIRFYNSWID----D-QNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIH 154 (670)
Q Consensus 82 k~L~H-pNIVkl~~~~~d----~-~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIH 154 (670)
+.++| +||++++++|.. . ....+++++|++ +++|.+++... ..+++..++.+++||+.||.|||+++ |+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 34455 577778777611 1 123577888887 66999999753 56999999999999999999999998 999
Q ss_pred ecCccccEEEeC------------------CCCcEEEeeccchhhhccc------------------ccccccCCCccCC
Q 005916 155 RDLKCDNIFING------------------NQGEVKIGDLGLATIMEQA------------------NAKSVIGTPEFMA 198 (670)
Q Consensus 155 rDLKpeNILl~~------------------~~g~vKL~DFGla~~~~~~------------------~~~~~~GTp~YmA 198 (670)
|||||+||||+. .++.+|++|||+++..... .....+||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999952 2345677777777542110 0012468999999
Q ss_pred Cccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCH
Q 005916 199 PELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSA 276 (670)
Q Consensus 199 PEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa 276 (670)
||++ ...|+.++|||||||+||||++|.+|+... ......+.....+.... ...+.+.+++.+||. +|.+||++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcCh
Confidence 9975 567999999999999999999999887542 12222222222222211 124567899999996 79999999
Q ss_pred HHHhcCccccc
Q 005916 277 KELLMDPFLQV 287 (670)
Q Consensus 277 ~elL~hpf~~~ 287 (670)
.++|+||||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 99999999975
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=237.36 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=194.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~ 104 (670)
+.|.+.+.||.|.||.+.+|.|+.+...+++|.+... ......|.+|.+.--.| .|.||+.-|++-+... +++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~-d~Y 97 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS-DAY 97 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC-ceE
Confidence 4578889999999999999999999999999998743 23467789999987777 6999999988754443 388
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe-CCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN-GNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~-~~~g~vKL~DFGla~~~~ 183 (670)
.+++||++-|+|..-+.. ..+-|...+.++.|+++||.|+|+.+ +||||||.+|||+- .+.-.|||||||+....+
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 899999999999887665 35889999999999999999999999 99999999999975 455689999999987654
Q ss_pred ccccccccCCCccCCCcccc----CC--CCccceeeeccchhhhhhhccCCCCCCCCHHHHH---HHHhcCCCC--Cccc
Q 005916 184 QANAKSVIGTPEFMAPELYD----EN--YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY---KKVSSGIKP--AALS 252 (670)
Q Consensus 184 ~~~~~~~~GTp~YmAPEvl~----~~--ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~---~~i~~g~~p--~~~~ 252 (670)
... ...-.+..|.|||++. +. .++..|||.||+++|.++||.+||.......+-| .+-..+..+ +...
T Consensus 175 ~tV-~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 175 TTV-KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred cee-hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 322 2223466789999663 32 4778999999999999999999997533332222 222333322 1223
Q ss_pred CCCChHHHHHHHHcCC-CCCCC---CCHHHHhcCcccc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQR---LSAKELLMDPFLQ 286 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~R---pSa~elL~hpf~~ 286 (670)
+..++.+..+.++-|. ++.+| .+++.....-|..
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 4457888888899886 57777 5777777777764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=223.40 Aligned_cols=159 Identities=25% Similarity=0.366 Sum_probs=127.8
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccccccccC
Q 005916 114 GSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG 192 (670)
Q Consensus 114 GsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~~~~G 192 (670)
|+|.+++..+ +.+++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeeccc---cCCC
Confidence 7899999874 56999999999999999999999986 99999998 6688998 9998766442 2368
Q ss_pred CCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc-----ccCCCCh--HHHHHHH
Q 005916 193 TPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA-----LSKVKDP--EVKSFIE 264 (670)
Q Consensus 193 Tp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~-----~~~~~s~--~~k~fI~ 264 (670)
|+.|||||++ ...|+.++|||||||++|+|++|..||.........+..+.....+.. .....+. .+++||.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 9999999976 457999999999999999999999999765444455554444332221 1111222 6999999
Q ss_pred HcCC-CCCCCCCHHHHhcCcccc
Q 005916 265 KCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 265 kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
+||. +|.+||++.+++.|+|+.
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHH
Confidence 9996 899999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-24 Score=218.53 Aligned_cols=253 Identities=30% Similarity=0.438 Sum_probs=204.7
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCC-CeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN-NIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~Hp-NIVkl~~~~~d~~~~~~~l 106 (670)
|++.+.||.|+||.||++.+. ..+++|.+....... ......+.+|+.++..+.|+ +|+++++.+.... ..++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--SLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--EEEE
Confidence 778899999999999999887 778889887644322 23577899999999999888 7999999984433 5899
Q ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 107 ITELFTSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+++++.+++|.+++.... .+....+..++.|++.++.|+|..+ ++|||+||+||+++.....++++|||++..+.
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999998877765 7999999999999999999999998 99999999999998443379999999987654
Q ss_pred ccc--------cccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCC---HHHHHHHHhcCCCC
Q 005916 184 QAN--------AKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKVSSGIKP 248 (670)
Q Consensus 184 ~~~--------~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~---~~~i~~~i~~g~~p 248 (670)
... .....||+.|+|||++. ..+....|+||+|++++++++|..||..... .......+.....+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 432 35678999999999775 3688999999999999999999999876543 45666655554433
Q ss_pred -CcccCCC------ChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 -AALSKVK------DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 -~~~~~~~------s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
....... ...+.+++.+|+. +|..|.+..+...++|....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 1111111 1478999999996 79999999999998776543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-25 Score=256.46 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=200.1
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeec--cccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID--DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~--~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
..|.....++|.|++|.|+.+........+++|..+.. ...........+..|+-+-..|.|||++.....+.+..
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-- 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-- 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--
Confidence 34567788999999999998888877777887766532 11122223333777888888999999988776655443
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
..+-+||||++ +|+.++...+.+....+-.+++|++.||.|||.+| |.||||||+|+++. ..|.+||+|||.+..+
T Consensus 395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASVF 470 (601)
T ss_pred cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCcceee
Confidence 23344999999 99999998888999999999999999999999999 99999999999998 6689999999999877
Q ss_pred cccc------cccccCCCccCCCcccc-CCCCc-cceeeeccchhhhhhhccCCCCCCCCHHHHHHHHh-cCC-----CC
Q 005916 183 EQAN------AKSVIGTPEFMAPELYD-ENYNE-LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS-SGI-----KP 248 (670)
Q Consensus 183 ~~~~------~~~~~GTp~YmAPEvl~-~~ys~-~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~-~g~-----~p 248 (670)
.... ...++|+..|+|||++. ..|++ .+||||.|+++..|++|+.||.......+.+.... ... -+
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 5332 34678999999999875 46765 68999999999999999999965443333221111 111 12
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+....+.+.+.+|.+||+ +|.+|+|++++++++||+..
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 22334456788999999996 89999999999999999854
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=227.73 Aligned_cols=182 Identities=17% Similarity=0.214 Sum_probs=137.4
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcC-CCeEEEEEEEeeccc-cCCHHHHHHHHHHHHHHHhCCCCCeee-eeeEEEeC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEV-NGLEVAWCQVRIDDV-LQSPEDLERLYSEVHLLKSLKHNNIIR-FYNSWIDD 99 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~-tg~~vAiK~v~~~~~-~~s~~~~e~l~~Ei~iLk~L~HpNIVk-l~~~~~d~ 99 (670)
+....|.+.++||+|+||+||+|+++. +|..||+|++..... .......+.+.+|+++|+.|+|+||+. ++..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 445679999999999999999998876 788889998753211 112345667899999999999999985 5431
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecC-ccccEEEeCCCCcEEEeeccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL-KCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDL-KpeNILl~~~~g~vKL~DFGl 178 (670)
. ..|+|||||.|++|... .. .. ...|+.|++.||.|||+++ |+|||| ||+|||++ .++.+||+|||+
T Consensus 91 ~--~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGl 158 (365)
T PRK09188 91 G--KDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQL 158 (365)
T ss_pred C--CcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECcc
Confidence 2 47999999999999732 11 11 1568999999999999998 999999 99999997 567999999999
Q ss_pred hhhhcccc----------cccccCCCccCCCccccC-------CCCccceee-eccchhh
Q 005916 179 ATIMEQAN----------AKSVIGTPEFMAPELYDE-------NYNELADIY-SFGMCML 220 (670)
Q Consensus 179 a~~~~~~~----------~~~~~GTp~YmAPEvl~~-------~ys~~~DIW-SLGvily 220 (670)
|..+.... .....|++.|+|||++.. ..+...|-| .-|=+.+
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW~~TGDlg~ 218 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIWLATGKKVY 218 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcEEeCCCEEE
Confidence 98664322 245678999999998842 133446666 4443333
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-24 Score=223.38 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=201.7
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCe-----EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGL-----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~-----~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
.++++..++-+|.||.||+|+...... .|-+|.++.. .++-++..++.|-.++..+.|||+..+.++...+.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 457888889999999999997654432 2334444321 34567788999999999999999999999887654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEE
Q 005916 101 NKTVNIITELFTSGSLRQYRKKH--------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 172 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~--------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vK 172 (670)
...++++.+..-|+|..|+... ..++..++..++.|+..|+.|||+++ |||.||-..|.+++ +.-+||
T Consensus 361 -~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVk 436 (563)
T KOG1024|consen 361 -ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVK 436 (563)
T ss_pred -CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEE
Confidence 4788899999999999998732 24777888999999999999999999 99999999999998 668999
Q ss_pred Eeeccchhhhccccccc----ccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCC
Q 005916 173 IGDLGLATIMEQANAKS----VIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGI 246 (670)
Q Consensus 173 L~DFGla~~~~~~~~~~----~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~ 246 (670)
|+|=.+++.+.+...+. --....||+||.+ +..|+.++|+|||||++|||+| |+.||.+ -++.+.+..+..|.
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGY 515 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhccc
Confidence 99999998876654321 1124579999954 6789999999999999999988 8899987 78888888888886
Q ss_pred CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 247 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 247 ~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+ ...+..++.++..++..||. .|.+||+.+|+..
T Consensus 516 R-laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 R-LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred e-ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 4 34555678899999999996 8999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-25 Score=242.59 Aligned_cols=243 Identities=21% Similarity=0.303 Sum_probs=203.6
Q ss_pred EecccCCeEEEEEE---EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEEEE
Q 005916 33 VIGKGAFKTVYKAF---DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~---d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
++|.|+||.|+++. ....|.-+|.|..++......... +-..|.+++..++ ||.+|+++..|+.+. .+|+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDG--KLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeecccc--chhHhh
Confidence 47999999999863 335577889888876554332222 5567889999995 999999999887665 689999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccccc
Q 005916 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 188 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~ 188 (670)
++..||+|+..+.+...+.+...+.+...++.++.++|..+ |+|||+|++||+++ ..|++++.|||+++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeec-ccCccccCCchhhhHhHhhhhc
Confidence 99999999999999899999999999999999999999999 99999999999999 6799999999999887654433
Q ss_pred cccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC
Q 005916 189 SVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268 (670)
Q Consensus 189 ~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~ 268 (670)
+||..|||||+.+ ++...+|+||||+++++|+||..||.+ ++.+.|.... ...+...++++++++..++.
T Consensus 154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE--LEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHh
Confidence 9999999999988 788899999999999999999999976 4555555432 23455667899999999995
Q ss_pred -CCCCCCC-----HHHHhcCccccccCCCC
Q 005916 269 -PASQRLS-----AKELLMDPFLQVNGTTK 292 (670)
Q Consensus 269 -dP~~RpS-----a~elL~hpf~~~~~~~~ 292 (670)
+|..|+- +.++++|+||+...|..
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~~ 253 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWNE 253 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHhh
Confidence 7888874 57999999999877763
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-21 Score=203.89 Aligned_cols=247 Identities=21% Similarity=0.236 Sum_probs=181.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCC-eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC----CCeeeeeeEEEeCCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNG-LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH----NNIIRFYNSWIDDQN 101 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg-~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H----pNIVkl~~~~~d~~~ 101 (670)
.|++.+.||+|+||.||+|.+..++ ..+|+|.......... ..+..|+.+|+.+.. +++..+++... ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCC
Confidence 7999999999999999999988775 6788888775432211 146778999998863 58888888664 334
Q ss_pred CeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC----CcEEEee
Q 005916 102 KTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ----GEVKIGD 175 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~----g~vKL~D 175 (670)
.+-|+||+++ |.+|.+++... +.++...+..++.|++.+|++||+.| ++||||||+|+++.... -.+.|.|
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 5789999999 88999988655 57999999999999999999999999 99999999999997332 3699999
Q ss_pred ccchhhhc---ccc---------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHH--HH
Q 005916 176 LGLATIME---QAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI--YK 240 (670)
Q Consensus 176 FGla~~~~---~~~---------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i--~~ 240 (670)
||+++... ... .....||..|+++.... ...+.+-|+||++.++.+|+.|..||......... +.
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998322 110 12345999999999764 56889999999999999999999999765433222 22
Q ss_pred HHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 241 KVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 241 ~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
...............+.++..+...+-. +...+|....+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 2211111111222333455555555443 5677787665544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-22 Score=230.77 Aligned_cols=225 Identities=25% Similarity=0.401 Sum_probs=174.0
Q ss_pred cccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 19 ~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
....|....|..+++|..|+||.||+++|+.+.+.+|. .+.+..+. +++ ++.....|.+|
T Consensus 76 s~~~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li--------lRn---ilt~a~npfvv-------- 135 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI--------LRN---ILTFAGNPFVV-------- 135 (1205)
T ss_pred cccCCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchh--------hhc---cccccCCccee--------
Confidence 36778888899999999999999999999999999998 44432211 000 22222333333
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
|+-...++.-++++... +.+++|||+.+ |+|||+||+|.+|+ .-|++|++|||+
T Consensus 136 ---------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgL 189 (1205)
T KOG0606|consen 136 ---------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGL 189 (1205)
T ss_pred ---------------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhh
Confidence 55556666666666443 78999999998 99999999999998 679999999999
Q ss_pred hhhhcc-----------------cccccccCCCccCCCcc-ccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHH
Q 005916 179 ATIMEQ-----------------ANAKSVIGTPEFMAPEL-YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240 (670)
Q Consensus 179 a~~~~~-----------------~~~~~~~GTp~YmAPEv-l~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~ 240 (670)
++..-. -..+.++|||+|+|||+ +.++|...+|+|++|+|+|+.+.|..||.+ ..+++++.
T Consensus 190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg 268 (1205)
T KOG0606|consen 190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFG 268 (1205)
T ss_pred hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHh
Confidence 865311 11245799999999995 477899999999999999999999999988 67788887
Q ss_pred HHhcCC--CCCcccCCCChHHHHHHHHcCC-CCCCCC---CHHHHhcCccccccCCC
Q 005916 241 KVSSGI--KPAALSKVKDPEVKSFIEKCLV-PASQRL---SAKELLMDPFLQVNGTT 291 (670)
Q Consensus 241 ~i~~g~--~p~~~~~~~s~~~k~fI~kcL~-dP~~Rp---Sa~elL~hpf~~~~~~~ 291 (670)
.+.... +|.. .....++++++|.++|+ +|..|. .+-++.+|+||+.-.|.
T Consensus 269 ~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 269 QVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 776533 3333 34467999999999995 788886 68899999999976665
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=200.98 Aligned_cols=211 Identities=22% Similarity=0.329 Sum_probs=174.1
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
|-.|+++++||+|+||+++.|....++..||||.-..+. ..-++..|.+..+.| ..++|...|- +...+.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS------~APQLrdEYr~YKlL~g~~GIP~vYY--FGqeG~~ 98 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS------EAPQLRDEYRTYKLLGGTEGIPQVYY--FGQEGKY 98 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC------CcchHHHHHHHHHHHcCCCCCCceee--eccccch
Confidence 445999999999999999999999999999999654322 234577899999999 6788888774 3445556
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC----CCCcEEEeeccc
Q 005916 104 VNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING----NQGEVKIGDLGL 178 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~----~~g~vKL~DFGl 178 (670)
-.||+|++ |-+|.|+..-. .+|+.+.++-++.|++.-++|+|+++ +|+|||||+|+||.. +...|.|+|||+
T Consensus 99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 67999999 88998887765 46999999999999999999999999 999999999999962 234699999999
Q ss_pred hhhhccccc---------ccccCCCccCCCc-cccCCCCccceeeeccchhhhhhhccCCCCCC--CCHHHHHHHHhcCC
Q 005916 179 ATIMEQANA---------KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSEC--RNSAQIYKKVSSGI 246 (670)
Q Consensus 179 a~~~~~~~~---------~~~~GTp~YmAPE-vl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~--~~~~~i~~~i~~g~ 246 (670)
|+.+....+ ++..||..||+=. -+.+.-+..-|+=|||-+++..|.|.+||.+. .+..+.|++|-..+
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 999865432 4567999999977 45666788899999999999999999999874 45667788876544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=195.99 Aligned_cols=178 Identities=14% Similarity=0.121 Sum_probs=137.7
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHH------HHHHHHHHHhCCCCCeeeeeeE
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLER------LYSEVHLLKSLKHNNIIRFYNS 95 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~------l~~Ei~iLk~L~HpNIVkl~~~ 95 (670)
+.....|+..++||.|+||.||++.+ ++..+|+|+++... ...+....+ +.+|++.+.+|.||+|..+..+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~-~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKV-KRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhc-CchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 34567899999999999999999644 57789999997543 233444444 5789999999999999999998
Q ss_pred EEeCCC------CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC
Q 005916 96 WIDDQN------KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 169 (670)
Q Consensus 96 ~~d~~~------~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g 169 (670)
+.+... ...++||||++|.+|.++. .+++ ..+.+|+.+|..||.+| ++|||+||+||+++ .+|
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~-~~g 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVS-KNG 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEe-CCC
Confidence 775432 2478999999999998873 2333 34669999999999999 99999999999998 566
Q ss_pred cEEEeeccchhhhcccccccccCCCccCCCccccCCCCccceeeeccchhhhhh
Q 005916 170 EVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMV 223 (670)
Q Consensus 170 ~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLl 223 (670)
++|+|||............. | ++.+.|+.++|||+||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~d~-----~----vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKDR-----I----DLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhHHH-----H----HHHhHhcccccccceeEeehHHH
Confidence 99999998866533221110 0 23566888999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=189.89 Aligned_cols=145 Identities=18% Similarity=0.162 Sum_probs=113.1
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHH----------------------HHHHHHHHHHHHHhCCCCC
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPE----------------------DLERLYSEVHLLKSLKHNN 88 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~----------------------~~e~l~~Ei~iLk~L~HpN 88 (670)
...||+|+||.||+|.+. +|..||+|+++......... .......|+++|+.|.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 358999999999999987 89999999998643211000 0122345999999998877
Q ss_pred eeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhh-hcCCCCeeeecCccccEEEeCC
Q 005916 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL-HSHDPPIIHRDLKCDNIFINGN 167 (670)
Q Consensus 89 IVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yL-Hs~g~~IIHrDLKpeNILl~~~ 167 (670)
+...+.... . ..+|||||+.|++|...+...+.+++..++.++.||+.+|.|| |..| |+||||||+|||++
T Consensus 81 v~~p~~~~~--~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-- 152 (190)
T cd05147 81 IPCPEPILL--K--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-- 152 (190)
T ss_pred CCCCcEEEe--c--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE--
Confidence 644333221 1 1379999999988876655567899999999999999999999 6888 99999999999998
Q ss_pred CCcEEEeeccchhhhcc
Q 005916 168 QGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 168 ~g~vKL~DFGla~~~~~ 184 (670)
++.++|+|||+|.....
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 36899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=188.13 Aligned_cols=234 Identities=21% Similarity=0.283 Sum_probs=179.2
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEeCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDDQN 101 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H-pNIVkl~~~~~d~~~ 101 (670)
..+..|++.+.||.|+||.+|+|.....|.+||+|.-+.+.. --.+..|..+.+.|++ ..|..++.+.. ++
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~------hpqL~yEskvY~iL~~g~GiP~i~~y~~--e~ 83 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK------HPQLLYESKVYRILQGGVGIPHIRHYGT--EK 83 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC------CcchhHHHHHHHHhccCCCCchhhhhcc--cc
Confidence 346779999999999999999999999999999997664321 1246778889998854 45555554433 33
Q ss_pred CeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe--CCCCcEEEeeccc
Q 005916 102 KTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGL 178 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~--~~~g~vKL~DFGl 178 (670)
.+-.+||+++ |.+|.++..- .+.++.+++.-++-|++.-++|+|.++ +|||||||+|+|.. .....+.|+|||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccc
Confidence 4677999999 7899887664 357999999999999999999999999 99999999999974 3344799999999
Q ss_pred hhhhcccc---------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCC--CHHHHHHHHhcCC
Q 005916 179 ATIMEQAN---------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSGI 246 (670)
Q Consensus 179 a~~~~~~~---------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~--~~~~i~~~i~~g~ 246 (670)
|+.+.+.. .+...||..|.+-... .-.-+..-|+=|+|.++..+..|..||.+.. +..|.|.+|...+
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 99885533 2356799999876633 3345677899999999999999999998754 3456677776543
Q ss_pred C---CCcccCCCChHHHHHHHHcC
Q 005916 247 K---PAALSKVKDPEVKSFIEKCL 267 (670)
Q Consensus 247 ~---p~~~~~~~s~~~k~fI~kcL 267 (670)
. +..+.+-.+.++--.+.-|-
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R 264 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCR 264 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHh
Confidence 2 23344555667766666665
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=184.54 Aligned_cols=145 Identities=19% Similarity=0.195 Sum_probs=114.8
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc--------------------CCHH--HHHHHHHHHHHHHhCCCCC
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL--------------------QSPE--DLERLYSEVHLLKSLKHNN 88 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~--------------------~s~~--~~e~l~~Ei~iLk~L~HpN 88 (670)
.+.||+|+||.||+|.+. +|..||+|+++..... .... ....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999999865211 0000 1223468999999999998
Q ss_pred eeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCC
Q 005916 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGN 167 (670)
Q Consensus 89 IVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~ 167 (670)
|.....++.. ..++||||+.|+++.........+++..+..++.|++.+|.+||. +| |+||||||+|||++
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-- 152 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-- 152 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence 8554443332 147999999988665543445678899999999999999999999 88 99999999999998
Q ss_pred CCcEEEeeccchhhhcc
Q 005916 168 QGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 168 ~g~vKL~DFGla~~~~~ 184 (670)
++.++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 57999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-20 Score=195.04 Aligned_cols=239 Identities=18% Similarity=0.196 Sum_probs=152.0
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC----------CCeee
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH----------NNIIR 91 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H----------pNIVk 91 (670)
+...+-++.++.||.|+++.||.+.|..||+.+|+|+..... .......+.+.+|......+.+ -.++.
T Consensus 8 ~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~ 86 (288)
T PF14531_consen 8 GQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV 86 (288)
T ss_dssp S--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred CCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence 344556777899999999999999999999999999998766 3444567778777766555422 12222
Q ss_pred eeeEEEe---------CC-CC-----eEEEEEecCCCCCHHHHHH---hcCCC----CHHHHHHHHHHHHHHHhhhhcCC
Q 005916 92 FYNSWID---------DQ-NK-----TVNIITELFTSGSLRQYRK---KHKKV----DMKAVKGWARQILSGLIYLHSHD 149 (670)
Q Consensus 92 l~~~~~d---------~~-~~-----~~~lVmEy~~gGsL~~~i~---~~~~l----se~~i~~i~~QIl~aL~yLHs~g 149 (670)
.++.... .. .. ..+++|+-+ .++|.+.+. ..... .......+..|++..+++||++|
T Consensus 87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G 165 (288)
T PF14531_consen 87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG 165 (288)
T ss_dssp -SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence 2221111 00 01 246778877 458887744 22222 22333455689999999999999
Q ss_pred CCeeeecCccccEEEeCCCCcEEEeeccchhhhcccccccccCCCccCCCccccC---------CCCccceeeeccchhh
Q 005916 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDE---------NYNELADIYSFGMCML 220 (670)
Q Consensus 150 ~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~~---------~ys~~~DIWSLGvily 220 (670)
|+|+||||+|+|++ .+|.++|+||+.....+..... ...+..|.+||+... .++.+.|.|+||+++|
T Consensus 166 --lVHgdi~~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 166 --LVHGDIKPENFLLD-QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp --EEEST-SGGGEEE--TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred --eEecccceeeEEEc-CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999999 6799999999877655443222 344678999996532 3788999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCC
Q 005916 221 EMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQR 273 (670)
Q Consensus 221 eLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~R 273 (670)
.|.||..||........... ........+..++.+|..+|. +|.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~~-------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPEW-------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSGG-------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccccc-------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999999975211110000 111122457889999999996 67776
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=180.95 Aligned_cols=137 Identities=19% Similarity=0.227 Sum_probs=109.0
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-----CCCCeeeeeeEEEeCCC-CeE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-----KHNNIIRFYNSWIDDQN-KTV 104 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-----~HpNIVkl~~~~~d~~~-~~~ 104 (670)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.| .||||+++|+++.+..+ +.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 46899999999995 7777766 6888875432 2346789999999999 57999999999987643 343
Q ss_pred E-EEEec--CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-hhhhcCCCCeeeecCccccEEEeC---CCCcEEEeecc
Q 005916 105 N-IITEL--FTSGSLRQYRKKHKKVDMKAVKGWARQILSGL-IYLHSHDPPIIHRDLKCDNIFING---NQGEVKIGDLG 177 (670)
Q Consensus 105 ~-lVmEy--~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL-~yLHs~g~~IIHrDLKpeNILl~~---~~g~vKL~DFG 177 (670)
+ +|||| +.+|+|.+++++. .+++. +.+++|++.++ .|||+++ |+||||||+|||++. ..+.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 4 78999 5589999999764 56666 46788888888 9999999 999999999999973 23479999954
Q ss_pred ch
Q 005916 178 LA 179 (670)
Q Consensus 178 la 179 (670)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=180.66 Aligned_cols=184 Identities=14% Similarity=0.068 Sum_probs=136.6
Q ss_pred EEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 30 YKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 30 ~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
....|++|+||+||++.. .+..++.+.+.........-....+.+|+++|++| .|++|++++++ . ..+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~--~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D--GRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c--CEEEEE
Confidence 457899999999998744 67777766554322211111123578999999999 55889999884 1 368999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecC-ccccEEEeCCCCcEEEeeccchhhhccccc
Q 005916 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL-KCDNIFINGNQGEVKIGDLGLATIMEQANA 187 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDL-KpeNILl~~~~g~vKL~DFGla~~~~~~~~ 187 (670)
||+.|.+|.+.+.. . ...++.|++.+|.+||.+| |+|||| ||+|||++ .+|.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcch
Confidence 99999999754321 1 2357889999999999999 999999 79999998 568999999999985432210
Q ss_pred ---------------ccccCCCccCCCccc--cCCCC-ccceeeeccchhhhhhhccCCCCC
Q 005916 188 ---------------KSVIGTPEFMAPELY--DENYN-ELADIYSFGMCMLEMVTFEYPYSE 231 (670)
Q Consensus 188 ---------------~~~~GTp~YmAPEvl--~~~ys-~~~DIWSLGvilyeLltG~~Pf~~ 231 (670)
....++|.|++|+.- ....+ ...++++.|+-+|.++|+..|+.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 112368899999832 22333 567888999999999999999865
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.9e-21 Score=218.79 Aligned_cols=243 Identities=21% Similarity=0.265 Sum_probs=181.6
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.+.+.+.||.+.|=.|.+|++. .|. |++|++-+.+-..+-....+...|++ ...++|||++.+.-+-+ ..+..|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~--t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV--TDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH--hhHHHHH
Confidence 4778899999999999999765 454 88898876553333333344445565 66679999999876533 3346889
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh--hcc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI--MEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~--~~~ 184 (670)
|-+|+.. +|.|.+..++.+..-+.+.|+.||+.||.-||..| |+|||||++|||++ .-+.+.|+||..-+. +.+
T Consensus 99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEe-eechhhhhcccccCCccCCC
Confidence 9999966 99999998888999999999999999999999999 99999999999998 456899999975432 222
Q ss_pred cc---ccccc----CCCccCCCccccC-----------C-CCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhc
Q 005916 185 AN---AKSVI----GTPEFMAPELYDE-----------N-YNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSS 244 (670)
Q Consensus 185 ~~---~~~~~----GTp~YmAPEvl~~-----------~-ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~ 244 (670)
.+ ...+. .--+|+|||.+-. . ..++-||||+||+++||++ |.+||. ..|++.--..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~ 250 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSG 250 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhcc
Confidence 11 11122 2348999996521 1 4568899999999999977 688883 3444433222
Q ss_pred CC-C-CCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 245 GI-K-PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 245 g~-~-p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+. . ...+.++.+..++.+|..|++ +|++|+||++.|+.
T Consensus 251 ~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11 1 123456677889999999996 99999999999975
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-21 Score=199.06 Aligned_cols=266 Identities=35% Similarity=0.588 Sum_probs=194.7
Q ss_pred CCCCcccCCCCCeEEEEEEeccc---CCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeee
Q 005916 15 DPDVLETDPTCRYIRYKEVIGKG---AFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91 (670)
Q Consensus 15 ~~~~~e~dp~gr~yr~~~~LG~G---~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVk 91 (670)
..++++..|.+++..-.+..|+- +.-.||++.+...|.+|.|..|+...........+....-...|-++.|.|||+
T Consensus 52 ~~eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvk 131 (458)
T KOG1266|consen 52 ESEILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVK 131 (458)
T ss_pred hhhhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHH
Confidence 35889999999999888888863 345789999999999999988765443333333344444556677778999999
Q ss_pred eeeEEEeCCC---CeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEE
Q 005916 92 FYNSWIDDQN---KTVNIITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI 164 (670)
Q Consensus 92 l~~~~~d~~~---~~~~lVmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl 164 (670)
++.+|-+... ..+.|++||+..|+|.+++++. ..+.....++|+-||+.||.|||+..|+|+|++|.|+.||+
T Consensus 132 fH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi 211 (458)
T KOG1266|consen 132 FHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI 211 (458)
T ss_pred HHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee
Confidence 9999976432 3578999999999999998763 56899999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccchhhhcc------cccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHH
Q 005916 165 NGNQGEVKIGDLGLATIMEQ------ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ 237 (670)
Q Consensus 165 ~~~~g~vKL~DFGla~~~~~------~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~ 237 (670)
. .+|.||++--.....-.. .......|-++|.|||.- -.+.+.++|||+||+|.++|..++..-........
T Consensus 212 q-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~ 290 (458)
T KOG1266|consen 212 Q-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVE 290 (458)
T ss_pred c-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceee
Confidence 8 778888764222111100 011123467899999954 34567789999999999999988755322111111
Q ss_pred HHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 238 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 238 i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
.-..+.... ....+..-+++|.+||. .|..||+|+++|.||.+-
T Consensus 291 ~ee~ia~~i-----~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 291 VEENIANVI-----IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred hhhhhhhhe-----eeccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 111111111 11123445788999997 699999999999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=178.22 Aligned_cols=152 Identities=19% Similarity=0.152 Sum_probs=119.0
Q ss_pred CCCeEEEEEEecccCCeEEEEEE-EcCCCeEEEEEEEeeccccC------------------CHH--HHHHHHHHHHHHH
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAF-DEVNGLEVAWCQVRIDDVLQ------------------SPE--DLERLYSEVHLLK 82 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~-d~~tg~~vAiK~v~~~~~~~------------------s~~--~~e~l~~Ei~iLk 82 (670)
.|+.|++.+.||+|+||.||+|. +..+|..||+|+++...... .+. ....+.+|+++++
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 46678999999999999999998 77899999999998643110 000 1234678999999
Q ss_pred hCCCC--CeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccc
Q 005916 83 SLKHN--NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 160 (670)
Q Consensus 83 ~L~Hp--NIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpe 160 (670)
.|.+. .+.+++.. . ..++||||+.|++|..+......+....+..++.||+.+|.+||.++ .|+||||||+
T Consensus 106 ~L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~ 178 (237)
T smart00090 106 RLYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEY 178 (237)
T ss_pred HHHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChh
Confidence 99653 33444432 1 24799999999888776545556777788999999999999999986 4999999999
Q ss_pred cEEEeCCCCcEEEeeccchhhhcc
Q 005916 161 NIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 161 NILl~~~~g~vKL~DFGla~~~~~ 184 (670)
||+++ .+.++|+|||.+.....
T Consensus 179 NIli~--~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH--DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE--CCCEEEEEChhhhccCC
Confidence 99998 57899999999876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=182.10 Aligned_cols=188 Identities=24% Similarity=0.380 Sum_probs=141.2
Q ss_pred CCCCeeeeeeEEEeC-------------------------CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 005916 85 KHNNIIRFYNSWIDD-------------------------QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQIL 139 (670)
Q Consensus 85 ~HpNIVkl~~~~~d~-------------------------~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl 139 (670)
+|||||++++.|.+. .+..+|+||.-+.. +|++|+-.+ ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 599999999988652 34579999998854 999998654 467778888999999
Q ss_pred HHHhhhhcCCCCeeeecCccccEEEeC-CCC--cEEEeeccchhhhccc--------ccccccCCCccCCCccccCCC--
Q 005916 140 SGLIYLHSHDPPIIHRDLKCDNIFING-NQG--EVKIGDLGLATIMEQA--------NAKSVIGTPEFMAPELYDENY-- 206 (670)
Q Consensus 140 ~aL~yLHs~g~~IIHrDLKpeNILl~~-~~g--~vKL~DFGla~~~~~~--------~~~~~~GTp~YmAPEvl~~~y-- 206 (670)
+|+.|||.|| |.|||||.+|||+.- +++ .+.|+|||++---... ..-..-|....||||+.....
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 999999999999862 233 5799999986433221 112345788999999875321
Q ss_pred -----CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHH
Q 005916 207 -----NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAK 277 (670)
Q Consensus 207 -----s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~ 277 (670)
-.++|.|+.|.+.||+++...||.+......-.+.......| .++...++.++++|..+|. +|++|+++.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP-alp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP-ALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 247999999999999999999997622221112222233333 4666778999999999996 899999854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.4e-19 Score=192.19 Aligned_cols=173 Identities=28% Similarity=0.514 Sum_probs=139.7
Q ss_pred eEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 103 TVNIITELFTSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
++||.|++|.-.+|.+++.... ..+....+.|+.|+..|+.| ++ .+||||||.||++. .+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhhe
Confidence 6899999999999999997654 35677889999999999999 66 99999999999997 6668999999998
Q ss_pred hhhcccc--------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCC
Q 005916 180 TIMEQAN--------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPA 249 (670)
Q Consensus 180 ~~~~~~~--------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 249 (670)
+...... ....+||..||+||.+ .+.|+.++||||||+||+||+. ...+|.. ...+..+..+..|.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIPP 479 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCCh
Confidence 7765432 2456899999999966 4789999999999999999987 4444433 33455567777664
Q ss_pred cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 250 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 250 ~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
.+... .|+-..|+..+|. .|.+||++.+.-.|+|++
T Consensus 480 ~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 480 EFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred HHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 33332 3677799999996 699999998888888864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.5e-19 Score=201.57 Aligned_cols=256 Identities=25% Similarity=0.333 Sum_probs=200.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEc-CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDE-VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~-~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~ 102 (670)
..-|++.+.||+|+|+.|-.+... .....+|.|.+.... .+....++...|..+-+.+. |+|++.+++.+....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-- 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-- 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCc--
Confidence 345788888999999999888653 334455655555432 34455667777888888886 999999999876544
Q ss_pred eEEEEEecCCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHhhhh-cCCCCeeeecCccccEEEeCCCC-cEEEeeccc
Q 005916 103 TVNIITELFTSGSLRQYR-KKHK-KVDMKAVKGWARQILSGLIYLH-SHDPPIIHRDLKCDNIFINGNQG-EVKIGDLGL 178 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i-~~~~-~lse~~i~~i~~QIl~aL~yLH-s~g~~IIHrDLKpeNILl~~~~g-~vKL~DFGl 178 (670)
..+++++|..||+++..+ .... ..+...+..++.|+..+|.|+| ..+ +.|||+||+|.+++ ..+ .+++.|||+
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~-~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLD-ESGSALKIADFGL 171 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhc-cCCCcccCCCchh
Confidence 788999999999999988 5554 6788889999999999999999 777 99999999999998 456 899999999
Q ss_pred hhhhcc-cc----cccccC-CCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--C
Q 005916 179 ATIMEQ-AN----AKSVIG-TPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--P 248 (670)
Q Consensus 179 a~~~~~-~~----~~~~~G-Tp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p 248 (670)
|+.+.. .. ....+| ++.|+|||.+.+ ...+..|+||+|+++..|++|..|+.........+........ .
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT 251 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc
Confidence 998866 22 234678 999999997755 4578899999999999999999998654333333322222211 2
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.......+..+.+++.++|. +|..|.+.+++-.+||+..
T Consensus 252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 33344567889999999995 8999999999999999976
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.9e-17 Score=161.11 Aligned_cols=138 Identities=20% Similarity=0.228 Sum_probs=112.3
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC----HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS----PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s----~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
+.||+|++|.||+|.. .|..+++|+......... .-...++.+|+.++..+.|++|.....++.+.. ..+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence 5799999999999976 778899997654322111 112346788999999999999877666665544 57899
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 108 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
|||+.|++|.+++..... ....++.+++.+|.+||.++ ++|||++|.|||++ .+.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 999999999998876432 78899999999999999998 99999999999998 57899999998865
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-17 Score=196.99 Aligned_cols=194 Identities=21% Similarity=0.257 Sum_probs=156.0
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeEEEe
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK---HNNIIRFYNSWID 98 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~---HpNIVkl~~~~~d 98 (670)
...|..|.+.+.||+|+||+||+|.+.. |+.||+|+=+.... ..++-=.+++.+|+ -+.|+.++..++-
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~-------WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP-------WEFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc-------eeeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3457789999999999999999998876 99999997654321 12233334555554 3455666655554
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC------CCCcEE
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING------NQGEVK 172 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~------~~g~vK 172 (670)
.+ .-++|+||.+.|+|.+++...+.+++..+..+..|+|..|+.||.++ |||+||||+|+||.. +.--++
T Consensus 766 ~~--~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 766 QN--ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CC--cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceE
Confidence 44 46799999999999999998899999999999999999999999999 999999999999961 223489
Q ss_pred Eeeccchhhhc---cc-ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccC
Q 005916 173 IGDLGLATIME---QA-NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEY 227 (670)
Q Consensus 173 L~DFGla~~~~---~~-~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~ 227 (670)
|+|||.+..+. .. ....+++|-.|-.+|.. ++.++..+|.|.|..+++.||.|++
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999987653 22 45677899999999966 5679999999999999999999964
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=157.52 Aligned_cols=135 Identities=21% Similarity=0.235 Sum_probs=106.2
Q ss_pred EecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC----HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEE
Q 005916 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS----PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s----~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVm 108 (670)
.||+|+||+||+|. .+|..+++|+......... .....++.+|+++++.+.|+++....-++.+.. ..++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEE
Confidence 48999999999997 4678899998654322111 122467889999999998887654444444443 468999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
||+.|++|.+++..... .++.|++.+|.+||..+ ++|||++|.||+++ .+.++++|||++...
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcCC
Confidence 99999999988765321 78999999999999998 99999999999998 579999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.6e-16 Score=157.86 Aligned_cols=144 Identities=21% Similarity=0.188 Sum_probs=110.4
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC------------------HHHHHHHHHHHHHHHhCCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS------------------PEDLERLYSEVHLLKSLKH 86 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s------------------~~~~e~l~~Ei~iLk~L~H 86 (670)
+..|.+.+.||+|+||.||+|... +|..||+|+++....... .........|+.++..+.|
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 345788899999999999999864 799999999875331000 0011236779999999987
Q ss_pred CC--eeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEE
Q 005916 87 NN--IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI 164 (670)
Q Consensus 87 pN--IVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl 164 (670)
++ +...+. .. ..++||||+.|++|..... ......++.+|+.++.++|.++ |+||||||+||++
T Consensus 93 ~~i~v~~~~~----~~--~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill 158 (198)
T cd05144 93 EGFPVPKPID----WN--RHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILV 158 (198)
T ss_pred cCCCCCceee----cC--CceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEE
Confidence 74 444443 12 3589999999999976532 1456788999999999999988 9999999999999
Q ss_pred eCCCCcEEEeeccchhhhcc
Q 005916 165 NGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 165 ~~~~g~vKL~DFGla~~~~~ 184 (670)
+ .++.++|+|||++.....
T Consensus 159 ~-~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 D-DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred c-CCCcEEEEECCccccCCC
Confidence 8 578999999999966544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.7e-16 Score=177.71 Aligned_cols=141 Identities=20% Similarity=0.198 Sum_probs=110.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccC----CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ----SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~----s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
..|...+.||+|+||+||+|... +..+++|+...+.... .....+++.+|+++++.++|++|+..+.++.+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~- 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE- 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC-
Confidence 34466789999999999999754 3445555443222111 1123467889999999999999988777666544
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..++||||+.|++|.+++. ....++.||+.+|.|||.++ ++||||||+|||++ ++.++|+|||++..
T Consensus 410 -~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~ 476 (535)
T PRK09605 410 -EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKY 476 (535)
T ss_pred -CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCccccc
Confidence 4679999999999999875 35779999999999999998 99999999999994 56899999999876
Q ss_pred h
Q 005916 182 M 182 (670)
Q Consensus 182 ~ 182 (670)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.9e-16 Score=174.36 Aligned_cols=197 Identities=26% Similarity=0.424 Sum_probs=151.5
Q ss_pred HHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCcc
Q 005916 81 LKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 159 (670)
Q Consensus 81 Lk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKp 159 (670)
|+.+.|.|+.+|++.+++.. ..++|.+||.-|+|.+.+... -.++.--...+++.|+.||.|||..- --.|+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--EMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCC--ceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecc
Confidence 46789999999999998874 789999999999999998873 46788888889999999999999874 239999999
Q ss_pred ccEEEeCCCCcEEEeeccchhhhccc----ccccccCCCccCCCccccCC--------CCccceeeeccchhhhhhhccC
Q 005916 160 DNIFINGNQGEVKIGDLGLATIMEQA----NAKSVIGTPEFMAPELYDEN--------YNELADIYSFGMCMLEMVTFEY 227 (670)
Q Consensus 160 eNILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~YmAPEvl~~~--------ys~~~DIWSLGvilyeLltG~~ 227 (670)
.|.+++ ....+||+|||+....... ......-...|.|||+++.. .+.+.||||||++++|+++...
T Consensus 78 ~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 78 SNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999 5568999999998776431 11111123468999988542 4677999999999999999999
Q ss_pred CCCCCC---CHHHHHHHHhc-CC---CCCcccC-CCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 228 PYSECR---NSAQIYKKVSS-GI---KPAALSK-VKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 228 Pf~~~~---~~~~i~~~i~~-g~---~p~~~~~-~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
||.... .+.++...+.. +. .|..... ...+++..++..||. +|.+||+++++-.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 996522 23445555555 32 1222211 234578999999996 7999999888754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.1e-17 Score=164.03 Aligned_cols=237 Identities=17% Similarity=0.269 Sum_probs=179.6
Q ss_pred EEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 005916 30 YKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 30 ~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmE 109 (670)
+..+|...-.|..|+|+. .|..++.|++...... ...-..|..|.-.|+-+.||||..+++.+..+. .+.++..
T Consensus 194 l~tkl~e~hsgelwrgrw--qgndivakil~vr~~t--~risrdfneefp~lrifshpnilpvlgacnspp--nlv~isq 267 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRW--QGNDIVAKILNVREVT--ARISRDFNEEFPALRIFSHPNILPVLGACNSPP--NLVIISQ 267 (448)
T ss_pred hhhhhccCCCcccccccc--cCcchhhhhhhhhhcc--hhhcchhhhhCcceeeecCCchhhhhhhccCCC--CceEeee
Confidence 445677888999999954 4556677877665432 333456778899999999999999999886654 6889999
Q ss_pred cCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc--EEEeeccchhhhccc
Q 005916 110 LFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE--VKIGDLGLATIMEQA 185 (670)
Q Consensus 110 y~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~--vKL~DFGla~~~~~~ 185 (670)
|++-|+|+..+..... ++..++.+++..|+.|+.|||+..|-|..--|....++++ ++.. +-.+|--++..
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfsfq---- 342 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFSFQ---- 342 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceeeee----
Confidence 9999999998876543 6788999999999999999999985444456888899998 3333 33344222211
Q ss_pred ccccccCCCccCCCccccCC----CCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 186 NAKSVIGTPEFMAPELYDEN----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 186 ~~~~~~GTp~YmAPEvl~~~----ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
.......|.||+||.+++. --.++|+|||.++++||.|.+.||.+..+.+--++.-..|..+. .+.-.++.+..
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~-ippgis~hm~k 420 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH-IPPGISRHMNK 420 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc-CCCCccHHHHH
Confidence 1223447899999977543 23579999999999999999999998777776677777776554 44456788999
Q ss_pred HHHHcCC-CCCCCCCHHHH
Q 005916 262 FIEKCLV-PASQRLSAKEL 279 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~el 279 (670)
++.-|+. ||.+||....+
T Consensus 421 lm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 421 LMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred HHHHHhcCCCCcCCCccee
Confidence 9999996 89999986554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.2e-15 Score=147.41 Aligned_cols=140 Identities=22% Similarity=0.197 Sum_probs=99.8
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHH---------------------HHHHHHHHHHhCCCC--
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLE---------------------RLYSEVHLLKSLKHN-- 87 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e---------------------~l~~Ei~iLk~L~Hp-- 87 (670)
.+.||+|+||+||+|.+. +|..||+|+++...... ..... ....|...+..+.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSF-KKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccch-hhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999876 89999999987543211 11111 113567777777443
Q ss_pred CeeeeeeEEEeCCCCeEEEEEecCCCCCHHHH-HHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEe
Q 005916 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFIN 165 (670)
Q Consensus 88 NIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~-i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~ 165 (670)
.+.+.+.+. ..++||||+.|+.+... +... ... ..++.++.+++.++.++|. ++ |+||||||+||+++
T Consensus 80 ~~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~ 149 (187)
T cd05119 80 PVPKPIDLN------RHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD 149 (187)
T ss_pred CCCceEecC------CCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE
Confidence 344454421 35899999998543221 1111 111 6788999999999999999 87 99999999999998
Q ss_pred CCCCcEEEeeccchhhhcc
Q 005916 166 GNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 166 ~~~g~vKL~DFGla~~~~~ 184 (670)
++.++|+|||.+.....
T Consensus 150 --~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 --DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred --CCcEEEEECcccccccC
Confidence 67999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-14 Score=148.35 Aligned_cols=142 Identities=16% Similarity=0.209 Sum_probs=107.1
Q ss_pred EEEec-ccCCeEEEEEEEcCCCeEEEEEEEeeccc----c-----CCHHHHHHHHHHHHHHHhCCCCCe--eeeeeEEEe
Q 005916 31 KEVIG-KGAFKTVYKAFDEVNGLEVAWCQVRIDDV----L-----QSPEDLERLYSEVHLLKSLKHNNI--IRFYNSWID 98 (670)
Q Consensus 31 ~~~LG-~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~----~-----~s~~~~e~l~~Ei~iLk~L~HpNI--Vkl~~~~~d 98 (670)
..+|| .|+.|+||++... +..+++|.+..... . .......++.+|+.++..|.|++| ++.+.+...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45788 8999999998653 77899998864322 1 112334678899999999988775 666665443
Q ss_pred CCCC--eEEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEee
Q 005916 99 DQNK--TVNIITELFTS-GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 175 (670)
Q Consensus 99 ~~~~--~~~lVmEy~~g-GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~D 175 (670)
.... ..++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||.+| |+||||||.|||++ .++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~-~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLD-PDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEc-CCCCEEEEE
Confidence 3221 23599999997 689888765 3566543 578999999999999 99999999999998 456899999
Q ss_pred ccchhhh
Q 005916 176 LGLATIM 182 (670)
Q Consensus 176 FGla~~~ 182 (670)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.9e-14 Score=129.07 Aligned_cols=134 Identities=18% Similarity=0.103 Sum_probs=108.2
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEeCCCCeEEEEE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH--NNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H--pNIVkl~~~~~d~~~~~~~lVm 108 (670)
.+.||+|.++.||++.... ..+++|.+..... ...+.+|+.+++.|.| +++.+++.++... ...+++|
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLM 72 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEE
Confidence 4689999999999998644 6788898764321 4568889999999966 5888888766443 4689999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCC-CCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD-PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g-~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
||+.|+.+..+ +......++.+++.+|.+||... .+++|+||+|.||+++ ..+.++++|||.+...
T Consensus 73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGYG 139 (155)
T ss_pred EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEecccccCC
Confidence 99999887654 56677788999999999999852 3499999999999998 4679999999988653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-14 Score=161.81 Aligned_cols=252 Identities=25% Similarity=0.288 Sum_probs=193.9
Q ss_pred EEEEEEecc--cCCeEEEEEEE--cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCC
Q 005916 28 IRYKEVIGK--GAFKTVYKAFD--EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 28 yr~~~~LG~--G~fG~Vy~a~d--~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~ 102 (670)
+.+.+.+|. |.+|.||.+.. ..++..+|+|.=+.. ...+....+=++|+...+.+ .|+|.++.+..|....
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p--~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~-- 191 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP--FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG-- 191 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCC--CCCccccccccchhhcccccCccccccccCcccccCC--
Confidence 555678999 99999999998 889999998863321 12222233445677777777 6999999999886544
Q ss_pred eEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 103 TVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILS----GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~-lse~~i~~i~~QIl~----aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
..|+-+|+| +.+|..|...... ++...++....+... ||.++|+.+ ++|-|+||.||+...+....+++|||
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcc
Confidence 789999999 5789888876554 899999999999999 999999998 99999999999998544789999999
Q ss_pred chhhhcccccc-------cccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc
Q 005916 178 LATIMEQANAK-------SVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 178 la~~~~~~~~~-------~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~ 250 (670)
+...+...... ...|...|++||+.++-++...|||++|.++.+..++..++....+. -+..+..+..+..
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS--SWSQLRQGYIPLE 346 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC--CccccccccCchh
Confidence 99888765422 12567789999999999999999999999999998887666442111 1122233334444
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+....+..+...+..|+. ++..|++++.++.|+++...
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 444445566667777775 68899999999999999743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-14 Score=169.44 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=202.3
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.+.+.+-+-+|+++.++.+.-..+|...+.|.......+.. ...+...++-.++-...+|-++..+-.+... ...++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r--sP~~L 881 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSFPCR--SPLPL 881 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCCCCC--CCcch
Confidence 35556688899999999998888887788777665433221 2233444555555556678888776654333 35899
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc---
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--- 183 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~--- 183 (670)
+++|..|++|...+.+.+..++..++.++..++.+++|||... +.|||++|.|+|.. ..|+.+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCcccccccccccc
Confidence 9999999999999988888999999999999999999999987 89999999999997 67899999998432110
Q ss_pred ---------------------------cc---ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCC
Q 005916 184 ---------------------------QA---NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC 232 (670)
Q Consensus 184 ---------------------------~~---~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~ 232 (670)
.. ......||+.|.|||.. .......+|+|++|+++++.++|.+||..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na- 1037 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA- 1037 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-
Confidence 00 01245799999999965 56788899999999999999999999987
Q ss_pred CCHHHHHHHHhcCCCCC-cccCCCChHHHHHHHHcCC-CCCCCCCHH---HHhcCccccccCCCC
Q 005916 233 RNSAQIYKKVSSGIKPA-ALSKVKDPEVKSFIEKCLV-PASQRLSAK---ELLMDPFLQVNGTTK 292 (670)
Q Consensus 233 ~~~~~i~~~i~~g~~p~-~~~~~~s~~~k~fI~kcL~-dP~~RpSa~---elL~hpf~~~~~~~~ 292 (670)
..++++++.+..+..+- ..+...++++++++.+.|. .|.+|..+. ++-.||||+...|..
T Consensus 1038 ~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 77888888887766432 2334567899999999996 799999887 999999999766643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.29 E-value=9.7e-12 Score=138.86 Aligned_cols=145 Identities=19% Similarity=0.154 Sum_probs=97.2
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCH--------------------------H----HH------HHHH
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP--------------------------E----DL------ERLY 75 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~--------------------------~----~~------e~l~ 75 (670)
+.||.|++|.||+|+.+ +|+.||||+.+......-. + .. -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999864 7999999998753210000 0 00 0244
Q ss_pred HHHHHHHhC----CCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHhhhhcCC
Q 005916 76 SEVHLLKSL----KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILS-GLIYLHSHD 149 (670)
Q Consensus 76 ~Ei~iLk~L----~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~-aL~yLHs~g 149 (670)
+|...+..+ .|.+-|.+-..|.+... ..++||||+.|++|.++.... ...+ ...++.+++. .+..+|.+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~-~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTS-ERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcC-CceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 566655555 23333333333332222 368999999999998876432 1222 2345555555 467889888
Q ss_pred CCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 150 ~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
++|+|+||.||+++ .+|.++++|||++..+..
T Consensus 278 --~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 --FFHADLHPGNIFVL-KDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --ceeCCCCcccEEEC-CCCcEEEEeCCCeeECCH
Confidence 99999999999997 668999999999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=1e-11 Score=141.10 Aligned_cols=142 Identities=17% Similarity=0.186 Sum_probs=96.8
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccc--------------------------cCCH----HHHHHH------H
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV--------------------------LQSP----EDLERL------Y 75 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~--------------------------~~s~----~~~e~l------~ 75 (670)
+.||+|++|.||+|+.+.+|+.||||+.+.... .... +..+.+ .
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 589999999999999988899999999985420 0001 112223 3
Q ss_pred HHHHHHHhC----CCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHH--HHhcC----CCCHHHHHHHHHHHHHHHhhh
Q 005916 76 SEVHLLKSL----KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHK----KVDMKAVKGWARQILSGLIYL 145 (670)
Q Consensus 76 ~Ei~iLk~L----~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~--i~~~~----~lse~~i~~i~~QIl~aL~yL 145 (670)
+|+..+.++ .+.+.+.+-.+|.+-.. ..++||||+.|+.|.++ +...+ .+.+..+..++.||+
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st-~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------ 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCS-ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------ 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCC-CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence 444444444 24444444444433222 46799999999999874 33333 355566666777765
Q ss_pred hcCCCCeeeecCccccEEEeCCCC----cEEEeeccchhhhcc
Q 005916 146 HSHDPPIIHRDLKCDNIFINGNQG----EVKIGDLGLATIMEQ 184 (670)
Q Consensus 146 Hs~g~~IIHrDLKpeNILl~~~~g----~vKL~DFGla~~~~~ 184 (670)
.+| ++|+|+||.|||++ .+| .++++|||++..+..
T Consensus 278 -~~G--ffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -RDG--FFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -hCC--eeeCCCChHHeEEe-cCCCCCCeEEEEecceEEECCH
Confidence 366 99999999999998 445 899999999876644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.4e-11 Score=117.92 Aligned_cols=143 Identities=17% Similarity=0.135 Sum_probs=103.0
Q ss_pred EEecccCCeEEEEEEEcC------CCeEEEEEEEeeccc--------c----------CCHHHHHHHH----HHHHHHHh
Q 005916 32 EVIGKGAFKTVYKAFDEV------NGLEVAWCQVRIDDV--------L----------QSPEDLERLY----SEVHLLKS 83 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~------tg~~vAiK~v~~~~~--------~----------~s~~~~e~l~----~Ei~iLk~ 83 (670)
..||.|-=+.||.|.... .+..+|+|+.+.... . ........+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997653 357999999874210 0 0011122333 89999999
Q ss_pred CCC--CCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhh-hcCCCCeeeecCccc
Q 005916 84 LKH--NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL-HSHDPPIIHRDLKCD 160 (670)
Q Consensus 84 L~H--pNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yL-Hs~g~~IIHrDLKpe 160 (670)
|.. -++.+.+.+ . .-+|||||+.++.+..-..+...+++..+..+..|++.+|..| |..+ |||+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~--~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----K--KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----c--CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 933 456666653 1 2569999997755533222333566677788899999999999 8888 999999999
Q ss_pred cEEEeCCCCcEEEeeccchhhhcc
Q 005916 161 NIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 161 NILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|||+. ++.+.|+|||.+.....
T Consensus 155 NIL~~--~~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWH--DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEE--CCcEEEEECCCceeCCC
Confidence 99997 46899999998876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.8e-11 Score=115.13 Aligned_cols=129 Identities=19% Similarity=0.088 Sum_probs=94.2
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCCeEEEEEec
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-Vkl~~~~~d~~~~~~~lVmEy 110 (670)
+.|+.|.++.||++... |..|++|....... ....+..|+.+++.+.+.++ .+++.+ +.. ..++|||+
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~--~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYF--DPE--TGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEE--eCC--CCeEEEEe
Confidence 57899999999999754 77899998653321 11235679999999865554 345543 222 24699999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCC---CeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 111 FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP---PIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 111 ~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~---~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+.|.++... ......++.+++.+|..||..+. .++|+|++|.||+++ ++.++++|||.+..
T Consensus 73 i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~~ 136 (170)
T cd05151 73 IEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAGM 136 (170)
T ss_pred cCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEecccccC
Confidence 999888643 11124567899999999999862 259999999999998 45899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.3e-11 Score=135.85 Aligned_cols=246 Identities=22% Similarity=0.172 Sum_probs=175.9
Q ss_pred EEEEEEecccCCeEEEEEEEc-CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDE-VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~-~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+-....||.|.|+.|+.+.-. .++..|++|-+..... . ......-..|+.+...| .|.+++.++..|.... ..|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~-~-~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r--~~~ 342 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA-T-FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR--QGY 342 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcccc-c-hHhhhcchhhhhHhhHhhcccccCCCCCCccccc--ccc
Confidence 445678999999999987544 5677888887764322 2 22223335677777777 7999999999987554 466
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+=-|||.++++...+.-...+++...+....|++.++.++|+.. ++|+|+||+||++..+++..+++|||+.+.+.-.
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccccccee
Confidence 99999999999887765567899999999999999999999988 9999999999999844478899999998753222
Q ss_pred ccccccCCCccC-CCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 NAKSVIGTPEFM-APELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 ~~~~~~GTp~Ym-APEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
. ....++-.++ .+|++. ..+..+.|++|||.-+.+.+++..--.. ......+..+..+. .+... .++..+
T Consensus 421 ~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----~~~~~~i~~~~~p~-~~~~~-~~~q~~ 493 (524)
T KOG0601|consen 421 S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----GVQSLTIRSGDTPN-LPGLK-LQLQVL 493 (524)
T ss_pred c-ccccccccccccchhhccccccccccccccccccccccccCcccCcc----cccceeeecccccC-CCchH-Hhhhhh
Confidence 1 1222344455 355553 3577899999999999999998643222 11223344444332 22222 566667
Q ss_pred HHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
.+.++. ++..|+.+.++..|.-|-
T Consensus 494 ~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 494 LKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhcCCccccchhhhhhcccchhh
Confidence 777775 678899999998887553
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-10 Score=130.96 Aligned_cols=168 Identities=26% Similarity=0.307 Sum_probs=126.0
Q ss_pred EEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhc
Q 005916 44 KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH 123 (670)
Q Consensus 44 ~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~ 123 (670)
.|..+.++.+|.+...+... ....+...+-++.|+.|+||||++++..+.... .+|+|+|-+. .|..++++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV~--Pl~~~lk~l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERVR--PLETVLKEL 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeeccc--cHHHHHHHh
Confidence 46677889999988876533 244556777889999999999999999987655 7999999985 577777765
Q ss_pred CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccccc--ccccCCCccCCCcc
Q 005916 124 KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA--KSVIGTPEFMAPEL 201 (670)
Q Consensus 124 ~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~--~~~~GTp~YmAPEv 201 (670)
+ ...+..-+.||+.||.|||..+ .++|++|.-+.|||+ ..|+.||++|.++........ ....---.|..|+.
T Consensus 102 ~---~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 G---KEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred H---HHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 4 6677778999999999998543 399999999999999 679999999988765443221 11111223445543
Q ss_pred ccCCCCccceeeeccchhhhhhhc
Q 005916 202 YDENYNELADIYSFGMCMLEMVTF 225 (670)
Q Consensus 202 l~~~ys~~~DIWSLGvilyeLltG 225 (670)
+... .-..|.|-|||++++++.|
T Consensus 177 ~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc-ccchhhhhHHHHHHHHhCc
Confidence 3211 1346999999999999998
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.2e-09 Score=103.81 Aligned_cols=146 Identities=22% Similarity=0.255 Sum_probs=107.8
Q ss_pred EEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHH-----HHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 30 YKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPE-----DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 30 ~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~-----~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...+|-+|+-+.|+++. ..|+.+.||.-..+.. ..+. ...|..+|+++|.++.--.|..-.-+|.|..+ -
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~Y-RHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRY-RHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG--G 85 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccc-cchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC--C
Confidence 45688999999999994 5688878776544333 2332 35677889999999854454433334566654 4
Q ss_pred EEEEecCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc--EEEeeccch
Q 005916 105 NIITELFTS-GSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE--VKIGDLGLA 179 (670)
Q Consensus 105 ~lVmEy~~g-GsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~--vKL~DFGla 179 (670)
.|+|||+.| .++.+|+.... .........++++|-..|.-||.++ |||+||..+||++..+.+. +.++|||++
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecch
Confidence 588999976 47888887653 2333344789999999999999999 9999999999999855554 489999998
Q ss_pred hhh
Q 005916 180 TIM 182 (670)
Q Consensus 180 ~~~ 182 (670)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.7e-09 Score=107.81 Aligned_cols=145 Identities=19% Similarity=0.216 Sum_probs=105.0
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEeCC-CCeEEEEE
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH--NNIIRFYNSWIDDQ-NKTVNIIT 108 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H--pNIVkl~~~~~d~~-~~~~~lVm 108 (670)
+.||.|.++.||++... .|..+++|........ .....+.+|+.+++.+.+ .++.+++.+..... .+..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 57899999999999764 3678999987643321 124467889999999965 34566665443221 12568999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC----------------------------------------
Q 005916 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH---------------------------------------- 148 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~---------------------------------------- 148 (670)
||+.|.+|...+.. ..+++.....++.+++.+|.+||+.
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999888765432 4577777788888888888888842
Q ss_pred --------------CCCeeeecCccccEEEeCC-CCcEEEeeccchhh
Q 005916 149 --------------DPPIIHRDLKCDNIFINGN-QGEVKIGDLGLATI 181 (670)
Q Consensus 149 --------------g~~IIHrDLKpeNILl~~~-~g~vKL~DFGla~~ 181 (670)
...++|+|++|.||+++.+ .+.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1247999999999999843 45689999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.8e-09 Score=102.35 Aligned_cols=135 Identities=24% Similarity=0.282 Sum_probs=98.6
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHH-----HHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED-----LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~-----~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
..+++|+-+.+|++.. -|..+.+|. +..+....++. .++..+|..++..+.--.|..-+-+.+|+.+ ..|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~--~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN--GLI 76 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CEE
Confidence 3578999999999843 455555554 44444444443 3456789999999854444333333355553 569
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
+|||+.|-.|.+++... ...+++.|-.-+.-||..| |+|+||.++||++.+ +.+.++||||+.+-
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~--~~i~~IDfGLg~~s 141 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSG--GRIYFIDFGLGEFS 141 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeC--CcEEEEECCccccc
Confidence 99999999999888765 2567777888888999999 999999999999973 45999999998753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=3e-07 Score=96.46 Aligned_cols=107 Identities=20% Similarity=0.176 Sum_probs=79.7
Q ss_pred HHHHHHHHHHhCC-----CCCeeeeeeEEEeCCCCeEEEEEecCCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHhh
Q 005916 73 RLYSEVHLLKSLK-----HNNIIRFYNSWIDDQNKTVNIITELFTSG-SLRQYRKK--HKKVDMKAVKGWARQILSGLIY 144 (670)
Q Consensus 73 ~l~~Ei~iLk~L~-----HpNIVkl~~~~~d~~~~~~~lVmEy~~gG-sL~~~i~~--~~~lse~~i~~i~~QIl~aL~y 144 (670)
...+|...+..|. -|.+|-+...-.+.....-++|||++.+- +|.+++.. ....+......++.+|+..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 3668888888873 34444443211111123477999999876 79998764 3456677888999999999999
Q ss_pred hhcCCCCeeeecCccccEEEeC------CCCcEEEeeccchhh
Q 005916 145 LHSHDPPIIHRDLKCDNIFING------NQGEVKIGDLGLATI 181 (670)
Q Consensus 145 LHs~g~~IIHrDLKpeNILl~~------~~g~vKL~DFGla~~ 181 (670)
||.+| |+|+||++.|||++. ..+.+.|+||+.+..
T Consensus 154 LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999 999999999999973 246899999997753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.6e-07 Score=103.78 Aligned_cols=214 Identities=17% Similarity=0.269 Sum_probs=149.0
Q ss_pred CCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC--CCeEEEEEecCCC-C
Q 005916 38 AFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ--NKTVNIITELFTS-G 114 (670)
Q Consensus 38 ~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~--~~~~~lVmEy~~g-G 114 (670)
--.+.|+|....+|..|++|++...+. .+. .....-+++++++.|+|||+|.++|.... ..-+++|++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD-QST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc-cCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 446889999999999999999943322 222 11234578999999999999999987332 2358899999874 5
Q ss_pred CHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 115 SLRQYRK---------------KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 115 sL~~~i~---------------~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
+|.++-- .....+|..+|.|+.|+..||.++|+.| +..+-|.|.+||++++. +|+|..-|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~-RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM-RIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-eEEEecccce
Confidence 6766421 1235789999999999999999999999 88899999999999653 7888877766
Q ss_pred hhhcccccccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHH-HHHHhcCCCCCcccCCCChH
Q 005916 180 TIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI-YKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 180 ~~~~~~~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i-~~~i~~g~~p~~~~~~~s~~ 258 (670)
..+..... +.+++ -.+-|.=.||.+++.|.||..--......... ... ....++.+
T Consensus 441 Dvl~~d~~------------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~D 497 (655)
T KOG3741|consen 441 DVLQEDPT------------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYSTD 497 (655)
T ss_pred eeecCCCC------------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhHH
Confidence 55543321 11111 12456777999999999995442221222222 122 22345678
Q ss_pred HHHHHHHcCCC-CCCCCCHHHHhcC
Q 005916 259 VKSFIEKCLVP-ASQRLSAKELLMD 282 (670)
Q Consensus 259 ~k~fI~kcL~d-P~~RpSa~elL~h 282 (670)
++++|.-+..+ +.+ .++.+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 88888877753 544 778888865
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.8e-07 Score=101.22 Aligned_cols=239 Identities=17% Similarity=0.233 Sum_probs=155.5
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeee--------e
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIR--------F 92 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVk--------l 92 (670)
++.|.-+-..+.||+|+-+.+|..- .-+..|| |+...... .... +-+..|-.. .||-+-. +
T Consensus 7 ~~~ge~i~~gr~LgqGgea~ly~l~--e~~d~VA-KIYh~Ppp----a~~a---qk~a~la~~p~~p~~~~rvaWPqa~L 76 (637)
T COG4248 7 DVYGEPIPPGRPLGQGGEADLYTLG--EVRDQVA-KIYHAPPP----AAQA---QKVAELAATPDAPLLNYRVAWPQATL 76 (637)
T ss_pred cccCcccCCCccccCCccceeeecc--hhhchhh-eeecCCCc----hHHH---HHHHHhccCCCCcchhhhhcccHHHh
Confidence 3444445567889999999999762 2333454 66653321 1111 122333333 6664322 2
Q ss_pred eeEEEeCCCCeEEEEEecCCCCC-HHH------HHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe
Q 005916 93 YNSWIDDQNKTVNIITELFTSGS-LRQ------YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 165 (670)
Q Consensus 93 ~~~~~d~~~~~~~lVmEy~~gGs-L~~------~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~ 165 (670)
|+ ......+-++|..+.|.. +.. .++......+.-+.++++.++.+..-||.+| .+-+|+.++|+|+.
T Consensus 77 ~G---~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs 151 (637)
T COG4248 77 HG---GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS 151 (637)
T ss_pred hC---CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee
Confidence 22 122234778999887752 111 2233456888999999999999999999999 88999999999998
Q ss_pred CCCCcEEEeeccchhhhccc-ccccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhc-cCCCCCCC----
Q 005916 166 GNQGEVKIGDLGLATIMEQA-NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTF-EYPYSECR---- 233 (670)
Q Consensus 166 ~~~g~vKL~DFGla~~~~~~-~~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG-~~Pf~~~~---- 233 (670)
+++.|.|.|=..-.+...+ .....+|.++|.+||+-. -.-+...|.|-||+++++|+.| ..||++..
T Consensus 152 -d~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ 230 (637)
T COG4248 152 -DDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD 230 (637)
T ss_pred -cCceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC
Confidence 7889999985433222222 234568999999999653 2356779999999999999887 89997632
Q ss_pred --CHHHHHHHHhc-----------CCCC--Cccc-CCCChHHHHHHHHcCCC---CCCCCCHHH
Q 005916 234 --NSAQIYKKVSS-----------GIKP--AALS-KVKDPEVKSFIEKCLVP---ASQRLSAKE 278 (670)
Q Consensus 234 --~~~~i~~~i~~-----------g~~p--~~~~-~~~s~~~k~fI~kcL~d---P~~RpSa~e 278 (670)
++.+ ..|.. |.+| ..++ ....+.+..+..+|..+ +.-|||++-
T Consensus 231 ap~p~E--~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 231 APNPLE--TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CCCcch--hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 1111 11222 2222 2222 45678999999999964 568998763
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.8e-07 Score=93.10 Aligned_cols=130 Identities=28% Similarity=0.286 Sum_probs=82.6
Q ss_pred EEEEEEEcCCCeEEEEEEEeecccc----------------------CCHHHHHHHHHHHHHHHhCCCC--CeeeeeeEE
Q 005916 41 TVYKAFDEVNGLEVAWCQVRIDDVL----------------------QSPEDLERLYSEVHLLKSLKHN--NIIRFYNSW 96 (670)
Q Consensus 41 ~Vy~a~d~~tg~~vAiK~v~~~~~~----------------------~s~~~~e~l~~Ei~iLk~L~Hp--NIVkl~~~~ 96 (670)
.||.|.. ..|..+|+|..+..... ...-......+|++.|+.+..- ++.+.+.+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 3888875 57889999998752100 0011234567899999999655 56666653
Q ss_pred EeCCCCeEEEEEecCC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhh-hhcCCCCeeeecCccccEEEeCCCCcEEE
Q 005916 97 IDDQNKTVNIITELFT--SGSLRQYRKKHKKVDMKAVKGWARQILSGLIY-LHSHDPPIIHRDLKCDNIFINGNQGEVKI 173 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~--gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~y-LHs~g~~IIHrDLKpeNILl~~~~g~vKL 173 (670)
.. -+|||||+. |..+..+... .++......++.+++..+.. +|..| |+|+||.+.|||++. +.+.|
T Consensus 79 -~~----~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~--~~~~i 147 (188)
T PF01163_consen 79 -NR----NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDD--GKVYI 147 (188)
T ss_dssp -ET----TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEET--TCEEE
T ss_pred -eC----CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeec--ceEEE
Confidence 22 359999998 6555443222 12245567788888886555 57888 999999999999983 48999
Q ss_pred eeccchhhhc
Q 005916 174 GDLGLATIME 183 (670)
Q Consensus 174 ~DFGla~~~~ 183 (670)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.4e-08 Score=109.22 Aligned_cols=150 Identities=18% Similarity=0.299 Sum_probs=107.1
Q ss_pred HHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccccc-----------ccccCCCccCCCccccC-
Q 005916 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-----------KSVIGTPEFMAPELYDE- 204 (670)
Q Consensus 137 QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~-----------~~~~GTp~YmAPEvl~~- 204 (670)
+++.||.|+|.+ +.+||++|.|++|.++ ..|.+||+.|+++........ -...-...|.|||++..
T Consensus 107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS-AKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC-cceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 344999999998 3699999999999999 568999999998766544211 01123568999997654
Q ss_pred CCCccceeeeccchhhhhhhccCC-CCCCCCHHHHHHHHhc--CCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHh
Q 005916 205 NYNELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYKKVSS--GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELL 280 (670)
Q Consensus 205 ~ys~~~DIWSLGvilyeLltG~~P-f~~~~~~~~i~~~i~~--g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL 280 (670)
..+.++|+||+||.+|-+..|..+ +.. ......+..... +..........++++++=+.++|. ++..||++..++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhc-cCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 567899999999999999955444 433 222222222111 111122335567899999999995 788999999999
Q ss_pred cCccccccC
Q 005916 281 MDPFLQVNG 289 (670)
Q Consensus 281 ~hpf~~~~~ 289 (670)
..|||+...
T Consensus 264 ~~~ff~D~~ 272 (700)
T KOG2137|consen 264 SIPFFSDPG 272 (700)
T ss_pred cccccCCch
Confidence 999998543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.6e-06 Score=87.27 Aligned_cols=110 Identities=19% Similarity=0.185 Sum_probs=82.3
Q ss_pred HHHHHHHHHHHHhCCCCC--eeeeeeEEEeCC--CCeEEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHhhh
Q 005916 71 LERLYSEVHLLKSLKHNN--IIRFYNSWIDDQ--NKTVNIITELFTSG-SLRQYRKKHKKVDMKAVKGWARQILSGLIYL 145 (670)
Q Consensus 71 ~e~l~~Ei~iLk~L~HpN--IVkl~~~~~d~~--~~~~~lVmEy~~gG-sL~~~i~~~~~lse~~i~~i~~QIl~aL~yL 145 (670)
..+..+|...+..|..-. +.+.+.+..... ....++|||++++. +|.+++......+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 446778888888773322 223333322221 13468999999874 7999988766678888899999999999999
Q ss_pred hcCCCCeeeecCccccEEEeCCC--CcEEEeeccchhhh
Q 005916 146 HSHDPPIIHRDLKCDNIFINGNQ--GEVKIGDLGLATIM 182 (670)
Q Consensus 146 Hs~g~~IIHrDLKpeNILl~~~~--g~vKL~DFGla~~~ 182 (670)
|.+| |+|+||++.|||++... ..+.++||+-+...
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 99999999999998432 26999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.5e-08 Score=111.16 Aligned_cols=240 Identities=19% Similarity=0.215 Sum_probs=164.6
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN-IIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN-IVkl~~~~~d~~~~~ 103 (670)
.+++..-.-+++|+++.+++.+...+...+ .+.|... ....-++++|.+++||| .+..++.+.. ..+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~~~--E~~ 308 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDYDG--EDY 308 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccCCc--ccc
Confidence 356667778999999999999776665544 5555432 22445889999999999 6666665533 347
Q ss_pred EEEEEecCCCC-CHH-HHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSG-SLR-QYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gG-sL~-~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..++|++|.+| +-. ..-...-.+.+-+....++.-+.+|+|||+.. -+||| ||+.. .+..+.+||+....
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDFAVPPQ 380 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--ccccccccccCCcc
Confidence 88999999887 221 11111122445556677788889999999974 48998 88875 46899999999887
Q ss_pred hccc-ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC-CCCccc--CCCC
Q 005916 182 MEQA-NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-KPAALS--KVKD 256 (670)
Q Consensus 182 ~~~~-~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~-~p~~~~--~~~s 256 (670)
+... ..++..+|+.++|||+. ...|....|+|++|+-..+|.-|.+|-.. .+.... .+-.+. .+.... ....
T Consensus 381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~-~~g~~p~s~~L~~~~aw~~ 457 (829)
T KOG0576|consen 381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLP-MIGNGPNSPMLTDKSAWSP 457 (829)
T ss_pred cCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccC-CCCCCCCccccchhhhcCc
Confidence 7654 35778899999999955 56799999999999988888888877543 111110 011111 000000 0011
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
..-++|...|+. -|..|+.+-.++.|-+|..
T Consensus 458 ~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 458 VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred ccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 122357888996 5889999999999988864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.7e-06 Score=89.74 Aligned_cols=139 Identities=22% Similarity=0.197 Sum_probs=97.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccc-----cC-----------C--HHHHHHHHHHHHHHHhCCCC-
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV-----LQ-----------S--PEDLERLYSEVHLLKSLKHN- 87 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~-----~~-----------s--~~~~e~l~~Ei~iLk~L~Hp- 87 (670)
...++..||-|-=+.||.|.+. .|.++|+|.=+.... .. + --......+|.++|+.|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 4567889999999999999865 788999997664211 00 0 01133456899999999544
Q ss_pred -CeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC
Q 005916 88 -NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166 (670)
Q Consensus 88 -NIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~ 166 (670)
.|.+.+++ + .-.+||||+.|-.|..... +......++..|+.-+.-+-..| |||+|+.+-|||++
T Consensus 171 ~~VP~P~~~----n--RHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~- 236 (304)
T COG0478 171 VKVPKPIAW----N--RHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT- 236 (304)
T ss_pred CCCCCcccc----c--cceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe-
Confidence 66666652 1 4569999999977765431 33444455555665555555566 99999999999998
Q ss_pred CCCcEEEeeccchh
Q 005916 167 NQGEVKIGDLGLAT 180 (670)
Q Consensus 167 ~~g~vKL~DFGla~ 180 (670)
.+|.+.++||--+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 67899999996544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.7e-06 Score=103.28 Aligned_cols=205 Identities=22% Similarity=0.345 Sum_probs=143.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC--eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh
Q 005916 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK--TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146 (670)
Q Consensus 69 ~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~--~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLH 146 (670)
.......-|+..+..+.|+|++.++.+-...... .+.+..++|+.-++...+..-+.++...++.+..++++||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 3444455677788888999999999876544321 23456689999999999999999999999999999999999999
Q ss_pred cCCCCeeeecCccc---cEEEeCCCCcEEEe--eccchhhhcccc-cccccCCCccCCCccccCC-CC--ccceeeeccc
Q 005916 147 SHDPPIIHRDLKCD---NIFINGNQGEVKIG--DLGLATIMEQAN-AKSVIGTPEFMAPELYDEN-YN--ELADIYSFGM 217 (670)
Q Consensus 147 s~g~~IIHrDLKpe---NILl~~~~g~vKL~--DFGla~~~~~~~-~~~~~GTp~YmAPEvl~~~-ys--~~~DIWSLGv 217 (670)
++. ..|.-|... +.-.+ ..+.+.++ ||+.+..+.... .....-+..+.|||....+ +. ...|+|.+|.
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred Hhc--cceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 985 555555444 22222 23456666 888777665432 2333446678888876543 33 3469999999
Q ss_pred hhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 218 CMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 218 ilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+..+..|..+-.....+. ..++.....+..+++.+|+. ++++|+++.+++.|||++..
T Consensus 381 l~~~~~~~~~i~~~~~~~~------------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAVPV------------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HHhhhhhcCcccccccchh------------hhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 9999998875532211111 11111122267888999996 68999999999999999754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.1e-05 Score=79.48 Aligned_cols=141 Identities=13% Similarity=0.144 Sum_probs=97.2
Q ss_pred cccCCeEEEEEEEcCCCeEEEEEEEee--ccccCCHHHHHHHHHHHHHHHhCCCCC--eeeee--eEEEeCCCCeEEEEE
Q 005916 35 GKGAFKTVYKAFDEVNGLEVAWCQVRI--DDVLQSPEDLERLYSEVHLLKSLKHNN--IIRFY--NSWIDDQNKTVNIIT 108 (670)
Q Consensus 35 G~G~fG~Vy~a~d~~tg~~vAiK~v~~--~~~~~s~~~~e~l~~Ei~iLk~L~HpN--IVkl~--~~~~d~~~~~~~lVm 108 (670)
|+||-+-|++... .|..+-+|+-.. ......+-....+.+|+..|+.|..-+ +.+.. +.-.......-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5678888888643 344577776541 111111335678999999999994322 33332 221122223467999
Q ss_pred ecCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc--EEEeeccchh
Q 005916 109 ELFTS-GSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE--VKIGDLGLAT 180 (670)
Q Consensus 109 Ey~~g-GsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~--vKL~DFGla~ 180 (670)
|-+.| -+|.+++... .+.+......++.+|+..|.-||..| +.|+|+-+.|||++. .|. ++++||.-+.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~-~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKT-EGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecC-CCCeeEEEEEhhccc
Confidence 97753 5888887663 35678888899999999999999999 999999999999973 345 9999997544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=9.5e-05 Score=73.66 Aligned_cols=142 Identities=21% Similarity=0.264 Sum_probs=81.0
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCC--CeeeeeeEEEe-CCCCeEEEE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN--NIIRFYNSWID-DQNKTVNII 107 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~Hp--NIVkl~~~~~d-~~~~~~~lV 107 (670)
.+.|+.|..+.||++.... + .+++|.... ......+.+|..+++.|... .+.+++..... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRP------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESS------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCC------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 3689999999999997654 4 788887653 23456778899998888422 34555553322 223457999
Q ss_pred EecCCCCCHHH----------------HHH---hc----CCCCHHH---------HHHH------------HHHHHH-HH
Q 005916 108 TELFTSGSLRQ----------------YRK---KH----KKVDMKA---------VKGW------------ARQILS-GL 142 (670)
Q Consensus 108 mEy~~gGsL~~----------------~i~---~~----~~lse~~---------i~~i------------~~QIl~-aL 142 (670)
|+++.|..+.. .+. .. ..+.... ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999988877 111 11 0001000 0000 011112 23
Q ss_pred hhhhc-----CCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 143 IYLHS-----HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 143 ~yLHs-----~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
..++. ....++|+|+.|.|||++..++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33332 233499999999999998555677899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.6e-05 Score=90.39 Aligned_cols=144 Identities=17% Similarity=0.156 Sum_probs=90.4
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccc--------------------------cCCHH----HHH------HHH
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV--------------------------LQSPE----DLE------RLY 75 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~--------------------------~~s~~----~~e------~l~ 75 (670)
+.|+.++-|.||+|..+. |+.||||+.+..-. ..-.+ ..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578999999999998664 99999999874310 01111 111 234
Q ss_pred HHHHHHHhC-----CCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHHhhhhcC
Q 005916 76 SEVHLLKSL-----KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYLHSH 148 (670)
Q Consensus 76 ~Ei~iLk~L-----~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~--i~~~~~lse~~i~~i~~QIl~aL~yLHs~ 148 (670)
+|...+.++ +.|+| ++=.+|.+-.+ .-.++|||+.|-.+.+. ++. ..++.+.+.....++.-- .+-.+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~-~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~--q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTT-RRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLR--QLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccC-CcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHH--HHHhc
Confidence 455555554 23443 23233332222 35699999999999887 444 445544443333222211 11125
Q ss_pred CCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 149 g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
| ++|.|.+|.||+++ .+|.+.+.|||+...+..
T Consensus 285 g--ffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 G--FFHADPHPGNILVR-SDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred C--ccccCCCccceEEe-cCCcEEEEcCcceecCCH
Confidence 5 99999999999999 568999999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.0001 Score=75.43 Aligned_cols=135 Identities=13% Similarity=0.116 Sum_probs=77.5
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC--eeeeeeEEEeCCCCeEEEEEe
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN--IIRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN--IVkl~~~~~d~~~~~~~lVmE 109 (670)
..||.|..+.||+. .|..+++|...... ....+.+|.++++.+..-. +.+.+.+..+ .....+|||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeee
Confidence 47899999999984 24567777765321 1244678999999885333 3455554333 335778999
Q ss_pred cCCCCC-HH--------------HHHH-----hcC----CCCHHHH-HHHHHH----------HHHH-Hhhh--hcCCCC
Q 005916 110 LFTSGS-LR--------------QYRK-----KHK----KVDMKAV-KGWARQ----------ILSG-LIYL--HSHDPP 151 (670)
Q Consensus 110 y~~gGs-L~--------------~~i~-----~~~----~lse~~i-~~i~~Q----------Il~a-L~yL--Hs~g~~ 151 (670)
++.|.. +. ..+. -|. ....... ..+-.+ +... ..+| +...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 999863 11 1000 010 1111110 111000 0111 1111 223345
Q ss_pred eeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 152 IIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 152 IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
++|+|+.|.||+++ .++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~-~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITS-GKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEc-CCC-cEEEechhcC
Confidence 89999999999998 455 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.0001 Score=75.96 Aligned_cols=144 Identities=19% Similarity=0.179 Sum_probs=96.3
Q ss_pred EEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc------------------CCHHH-H-HHHHHHHHHHHhC--CCC
Q 005916 30 YKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL------------------QSPED-L-ERLYSEVHLLKSL--KHN 87 (670)
Q Consensus 30 ~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~------------------~s~~~-~-e~l~~Ei~iLk~L--~Hp 87 (670)
+...|..|--+.||+|.. ..+..+|+|+.+..... .+... . .-...|+..|+++ .+=
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 344778888899999964 56889999999742110 01111 1 1235688888888 344
Q ss_pred CeeeeeeEEEeCCCCeEEEEEecCCCCCHH-HHHHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEe
Q 005916 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLR-QYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFIN 165 (670)
Q Consensus 88 NIVkl~~~~~d~~~~~~~lVmEy~~gGsL~-~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~ 165 (670)
.+.+-+.+. .-.+||||+....+. -.++.- .+...++..+..+++..+.-|-. .+ +||+||..-|||+.
T Consensus 131 rvP~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~ 201 (268)
T COG1718 131 RVPEPIAFR------NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH 201 (268)
T ss_pred CCCCceeec------CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE
Confidence 455555543 235999999653111 111211 23333678888889988888766 55 99999999999997
Q ss_pred CCCCcEEEeeccchhhhccc
Q 005916 166 GNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 166 ~~~g~vKL~DFGla~~~~~~ 185 (670)
++.+.|+|||-|....+.
T Consensus 202 --~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 202 --DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred --CCeEEEEECccccccCCC
Confidence 579999999998776544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00013 Score=74.64 Aligned_cols=75 Identities=15% Similarity=0.044 Sum_probs=47.9
Q ss_pred EecccCC-eEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEEEEec
Q 005916 33 VIGKGAF-KTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITEL 110 (670)
Q Consensus 33 ~LG~G~f-G~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~lVmEy 110 (670)
.|-.|.. ..||+.... +..+.+|...... ...+.+|+++++.| .+--+.+++.+.... +..++|||+
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~ 73 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSA 73 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEe
Confidence 3444444 889998543 4566667654221 23466799999888 344455667655433 357899999
Q ss_pred CCCCCHHH
Q 005916 111 FTSGSLRQ 118 (670)
Q Consensus 111 ~~gGsL~~ 118 (670)
++|.+|..
T Consensus 74 i~G~~l~~ 81 (244)
T cd05150 74 VPGVPAAA 81 (244)
T ss_pred eCCccHhH
Confidence 99987763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00014 Score=73.95 Aligned_cols=142 Identities=15% Similarity=0.174 Sum_probs=87.2
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC--------HHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS--------PEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s--------~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
...|.+.+++-.....-|.+- ..+|..+.+|..+....... .....++......++...--....+|-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 345677777777666655554 56788899998775332110 01122222333333333333333333222
Q ss_pred EeCC---CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEE
Q 005916 97 IDDQ---NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 173 (670)
Q Consensus 97 ~d~~---~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL 173 (670)
.-.. ....+++|||++|..|.++.. +++ .+...|+.++.-||.+| +.|+|..|.|++++ + +.+++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~-~-~~i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS-N-NGIRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE-C-CcEEE
Confidence 1111 124568999999988876532 333 24466778899999999 99999999999998 3 46999
Q ss_pred eeccchh
Q 005916 174 GDLGLAT 180 (670)
Q Consensus 174 ~DFGla~ 180 (670)
+||+...
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=2.1e-06 Score=104.18 Aligned_cols=214 Identities=16% Similarity=0.034 Sum_probs=147.4
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHhhh
Q 005916 70 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYL 145 (670)
Q Consensus 70 ~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yL 145 (670)
..+.+..|..-++...|+++...+.-..+......|..++||.+|.++..+.+. ..+++.-+.....+.+.+..-+
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 344566777777888999999888765555556788999999999999987654 3445555555555557777777
Q ss_pred hcC---CCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc--ccccccCCCccCCCccccC-CCCccceeeeccchh
Q 005916 146 HSH---DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA--NAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCM 219 (670)
Q Consensus 146 Hs~---g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~--~~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvil 219 (670)
|+. |-..+|++||+-|.++..+ -.+|++++|+.++..+. .....+++|.|++|++.++ .++.+.|+|..|+-+
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 754 2347999999999999854 48999999999955443 2466788999999998875 677789999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcC-CCCCCCCCHHHHhcCcccc
Q 005916 220 LEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 220 yeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL-~dP~~RpSa~elL~hpf~~ 286 (670)
|.+.-|..||-. ....+.+.+.........+...+.++-.....+| .+...||.-...+.-+.+.
T Consensus 1431 y~rs~~n~~fi~--flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIF--FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHhcccHHHHH--HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 999999888743 1111222222222223333443333333333333 3566788877777766653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00024 Score=80.90 Aligned_cols=144 Identities=16% Similarity=0.127 Sum_probs=89.8
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC---------------------------HHHHHHHH------HHH
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS---------------------------PEDLERLY------SEV 78 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s---------------------------~~~~e~l~------~Ei 78 (670)
+.||.-+.|.||+|+.+. |..||||+=+..-.... .+..+.+. +|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999998775 99999997653210000 11122222 333
Q ss_pred HHHH----hCCCCC------eeeeeeEEEeCCCCeEEEEEecCCCCCHHH--HHHhcCCCCHHHHHHHHHHHHHHHhhhh
Q 005916 79 HLLK----SLKHNN------IIRFYNSWIDDQNKTVNIITELFTSGSLRQ--YRKKHKKVDMKAVKGWARQILSGLIYLH 146 (670)
Q Consensus 79 ~iLk----~L~HpN------IVkl~~~~~d~~~~~~~lVmEy~~gGsL~~--~i~~~~~lse~~i~~i~~QIl~aL~yLH 146 (670)
+... .+.|-+ |.++|..+ .. .-.|+||||.|..+.+ ++.+++ ++...+..-+.+...-.-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st-~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~qIf-- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL---ST-KRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQIF-- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc---Cc-ceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHHHH--
Confidence 3222 234555 44555433 22 3579999999987754 466654 4444444333333322222
Q ss_pred cCCCCeeeecCccccEEEeC---CCCcEEEeeccchhhhccc
Q 005916 147 SHDPPIIHRDLKCDNIFING---NQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 147 s~g~~IIHrDLKpeNILl~~---~~g~vKL~DFGla~~~~~~ 185 (670)
.+| ++|+|=.|.||+++. .++.+.+-|||+...+.+.
T Consensus 319 ~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 319 KTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred hcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 245 999999999999983 4678999999998776543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0011 Score=80.38 Aligned_cols=149 Identities=21% Similarity=0.285 Sum_probs=91.1
Q ss_pred EEEecccCCeEEEEEEEcCCC--eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCe--eeeeeEEEeCC-CCeE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNG--LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNI--IRFYNSWIDDQ-NKTV 104 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg--~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNI--Vkl~~~~~d~~-~~~~ 104 (670)
.+.|+.|.+..+|+......+ ..+++|+........ ....+.+|+++|+.|. |++| .+++.++.+.. .+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 467899999999998654332 356666554322211 2345778999999995 6665 66776654431 1357
Q ss_pred EEEEecCCCCCHHH--------------------HHH-hcC------------C---CCHHHHHHHHHHH----------
Q 005916 105 NIITELFTSGSLRQ--------------------YRK-KHK------------K---VDMKAVKGWARQI---------- 138 (670)
Q Consensus 105 ~lVmEy~~gGsL~~--------------------~i~-~~~------------~---lse~~i~~i~~QI---------- 138 (670)
|+||||+.|..+.+ .+. -|. . +-..++..|..|.
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999998864321 011 011 0 1123444443332
Q ss_pred -----HHHHhhhhcCCC---------CeeeecCccccEEEeCCCCc-EEEeeccchhhh
Q 005916 139 -----LSGLIYLHSHDP---------PIIHRDLKCDNIFINGNQGE-VKIGDLGLATIM 182 (670)
Q Consensus 139 -----l~aL~yLHs~g~---------~IIHrDLKpeNILl~~~~g~-vKL~DFGla~~~ 182 (670)
...+.+|..+-| .+||+|+++.|||++..++. +-|.||.++..-
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 233566644322 39999999999999843334 579999988654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0025 Score=64.21 Aligned_cols=133 Identities=19% Similarity=0.235 Sum_probs=92.1
Q ss_pred CCCeEEEEEEecccCC-eEEEEEEEcCCCeEEEEEEEeeccc----------cCC-------HHHHHHHHHHHHHHHhC-
Q 005916 24 TCRYIRYKEVIGKGAF-KTVYKAFDEVNGLEVAWCQVRIDDV----------LQS-------PEDLERLYSEVHLLKSL- 84 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~f-G~Vy~a~d~~tg~~vAiK~v~~~~~----------~~s-------~~~~e~l~~Ei~iLk~L- 84 (670)
.+..+++.+.||.|+- |.||++. -.|..||+|..+.-.. ... ....+-|..|.+..-+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 4478999999999999 9999994 5688999999432110 000 02334577888876666
Q ss_pred --CCCCe--eeeeeEEEeCC----------------CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhh
Q 005916 85 --KHNNI--IRFYNSWIDDQ----------------NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144 (670)
Q Consensus 85 --~HpNI--Vkl~~~~~d~~----------------~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~y 144 (670)
.+.++ |++|++..-.. .....||.||..... .+... =+.+|++-|..
T Consensus 113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHH
Confidence 45566 99999864321 112357888776543 22222 35678888889
Q ss_pred hhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 145 LHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
+|..| |+-+|+++.|.. + -||+|||.+
T Consensus 180 ~~k~g--I~~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG--IVPRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred HHHCC--eeeccCcccccc-C-----CEEEecccC
Confidence 99998 999999999986 2 268999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0021 Score=64.73 Aligned_cols=135 Identities=22% Similarity=0.329 Sum_probs=88.3
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeecccc------------CCHHHHHHHHHHHHHHHhCC------CCCeeeee
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL------------QSPEDLERLYSEVHLLKSLK------HNNIIRFY 93 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~------------~s~~~~e~l~~Ei~iLk~L~------HpNIVkl~ 93 (670)
..||+|+.-.||.- +......||+....... ..........+|+.....+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57899999999864 33444667888765400 00112345566777766665 78899999
Q ss_pred eEEEeCCCCeEEEEEecCCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC
Q 005916 94 NSWIDDQNKTVNIITELFTS------GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 167 (670)
Q Consensus 94 ~~~~d~~~~~~~lVmEy~~g------GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~ 167 (670)
|+..... -.-+|+|.+.. -+|.++++. +.+++ .++. .+-.-..||-.++ |+.+||+|.||++...
T Consensus 84 G~veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~--Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVETNL--GLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHH--IVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEecCC--ceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcC--CeecCCCcccEEEEec
Confidence 9765544 46788887653 368888854 44666 3333 3344455667777 9999999999999732
Q ss_pred -CC--cEEEee-ccc
Q 005916 168 -QG--EVKIGD-LGL 178 (670)
Q Consensus 168 -~g--~vKL~D-FGl 178 (670)
++ .+.|+| ||-
T Consensus 155 ~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGE 169 (199)
T ss_pred CCCceEEEEEeCCCC
Confidence 22 577887 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00069 Score=69.27 Aligned_cols=74 Identities=8% Similarity=0.023 Sum_probs=43.0
Q ss_pred EEecccCCe-EEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCC---CeeeeeeEEEeCCC-CeEEE
Q 005916 32 EVIGKGAFK-TVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN---NIIRFYNSWIDDQN-KTVNI 106 (670)
Q Consensus 32 ~~LG~G~fG-~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~Hp---NIVkl~~~~~d~~~-~~~~l 106 (670)
+.|+.|+.. .||+. +..+++|.... ......+.+|.++|+.|... .+.+++........ ...++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSA------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCc------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 467777766 58876 23466664332 11234688899999888421 23344432222111 24578
Q ss_pred EEecCCCCCH
Q 005916 107 ITELFTSGSL 116 (670)
Q Consensus 107 VmEy~~gGsL 116 (670)
+|+++.|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999998765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00051 Score=68.48 Aligned_cols=100 Identities=22% Similarity=0.136 Sum_probs=78.1
Q ss_pred HHHHHHHhCCC-CCeeeeeeEEEeCCCCeEEEEEecCCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCC-
Q 005916 76 SEVHLLKSLKH-NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ---YRKKHKKVDMKAVKGWARQILSGLIYLHSHDP- 150 (670)
Q Consensus 76 ~Ei~iLk~L~H-pNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~---~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~- 150 (670)
.|.-+|+.+.+ +++.+++|+|- -++|+||...+++.. .+...-..++...++++.+++..+.+|+....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58889999965 69999999881 357899998776642 11222346899999999999999999987421
Q ss_pred CeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 151 ~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.+.-.|++++|+-++ ++|.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVN-DDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEe-CCCcEEEEechhcchh
Confidence 277799999999998 6789999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0011 Score=65.33 Aligned_cols=131 Identities=24% Similarity=0.246 Sum_probs=88.3
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-Vkl~~~~~d~~~~~~~l 106 (670)
.+..+.||+|.+|.||++. ..|.++|+|+-+.+. ....+..|+++|..+.--++ .++|.+- ..++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds------~r~~l~kEakiLeil~g~~~~p~vy~yg------~~~i 89 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDS------PRRNLEKEAKILEILAGEGVTPEVYFYG------EDFI 89 (201)
T ss_pred hhhhhhhhcccccEEEEee--ccCceEEEEEecCCc------chhhHHHHHHHHHHhhhcCCCceEEEec------hhhh
Confidence 4456789999999999994 567799998766433 35668889999999976665 3455432 2346
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCcc--ccEEEeCCCCcEEEeeccchhhhc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC--DNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKp--eNILl~~~~g~vKL~DFGla~~~~ 183 (670)
.|||+.|-.|...-... + +.-+..+++.---|-..| |-|+.|.- .||++. ++.+.|+||..|+...
T Consensus 90 ~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~--~~~~~iIDFd~At~k~ 157 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVN--DRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhc--cchhhhcCCceeEEec--CCcEEEEEccchhhcc
Confidence 69999998886643211 2 222334455544455556 88888763 356664 4589999999988543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0063 Score=67.55 Aligned_cols=80 Identities=23% Similarity=0.256 Sum_probs=55.5
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeecccc--C-CHHHHHHHHHHHHHHHhC-C--CCCeeeeeeEEEeCCCCeEE
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL--Q-SPEDLERLYSEVHLLKSL-K--HNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~--~-s~~~~e~l~~Ei~iLk~L-~--HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.||.|.+..||++.+...++.+++|+-...... . .+-..++...|.+.|+.+ . -.++.++|.+ ++. ..+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~--~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE--LAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC--CCE
Confidence 5799999999999987644468999986422111 1 123467788899999987 2 2457777764 333 467
Q ss_pred EEEecCCCCC
Q 005916 106 IITELFTSGS 115 (670)
Q Consensus 106 lVmEy~~gGs 115 (670)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998754
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0037 Score=66.66 Aligned_cols=81 Identities=15% Similarity=0.146 Sum_probs=53.6
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC---CCeeeeeeEEEeCC-CCe
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH---NNIIRFYNSWIDDQ-NKT 103 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H---pNIVkl~~~~~d~~-~~~ 103 (670)
..-.+.||.|..+.||+.... .| .+.+|..+. . .....+..|...|+.|.. -.+.++++++.+.. .+.
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS-QG-NPMPLMARS-F-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred hheeeecCCccceeEEEEEcC-CC-CEEEEEecc-c-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 334568999999999998432 33 455565432 1 012457789999998842 35777787654421 235
Q ss_pred EEEEEecCCCCCH
Q 005916 104 VNIITELFTSGSL 116 (670)
Q Consensus 104 ~~lVmEy~~gGsL 116 (670)
.++|||++.|+++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 7999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0019 Score=65.51 Aligned_cols=74 Identities=15% Similarity=0.123 Sum_probs=46.0
Q ss_pred EEecccCCeEEEEEEEcC-CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEeCCCCeEEEEEe
Q 005916 32 EVIGKGAFKTVYKAFDEV-NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~-tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H-pNIVkl~~~~~d~~~~~~~lVmE 109 (670)
+.|..|-...+|++.... .+..|++|+...... ..-...+|+.+++.+.. .-..+++..+ .. .+|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-----~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-----LIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-----ceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEE
Confidence 578889999999986433 256788886553211 11123468889998843 3334555432 22 27999
Q ss_pred cCCCCCH
Q 005916 110 LFTSGSL 116 (670)
Q Consensus 110 y~~gGsL 116 (670)
|+.|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.013 Score=64.23 Aligned_cols=84 Identities=17% Similarity=0.166 Sum_probs=55.8
Q ss_pred EecccCCeEEEEEEEcCCCeEEEEEEEeecccc---CCHHHHHHHHHHHHHHHhCC--CC-CeeeeeeEEEeCCCCeEEE
Q 005916 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL---QSPEDLERLYSEVHLLKSLK--HN-NIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~---~s~~~~e~l~~Ei~iLk~L~--Hp-NIVkl~~~~~d~~~~~~~l 106 (670)
.||-|....||++.+...+..++||+-...... ..+-..+|..-|...|+... -| .+.++|. .|+. ...+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e--~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE--MAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc--ccee
Confidence 579999999999987544468999986532221 12445677788999998872 34 4666765 3443 4669
Q ss_pred EEecCCCCC-HHHHH
Q 005916 107 ITELFTSGS-LRQYR 120 (670)
Q Consensus 107 VmEy~~gGs-L~~~i 120 (670)
|||+++... |+..+
T Consensus 78 vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 78 VMEDLSHHKIARKGL 92 (370)
T ss_pred hHhhCccchHHHHHH
Confidence 999996543 44444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0073 Score=62.46 Aligned_cols=135 Identities=15% Similarity=0.152 Sum_probs=73.3
Q ss_pred EecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCCeEEEEEecC
Q 005916 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNKTVNIITELF 111 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-Vkl~~~~~d~~~~~~~lVmEy~ 111 (670)
.+..|-...+|+.. .+|..+++|....... ..--...+|..+++.+..-.+ .+++.. +. -++||||+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~i 70 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEWL 70 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEec
Confidence 35567788889875 4566777775432211 100124678899998853323 233332 22 25899999
Q ss_pred CCCCHHH--------------HHHh-c------CCCCH-HHHHHHHHHH---------HHHHhhhhcC------CCCeee
Q 005916 112 TSGSLRQ--------------YRKK-H------KKVDM-KAVKGWARQI---------LSGLIYLHSH------DPPIIH 154 (670)
Q Consensus 112 ~gGsL~~--------------~i~~-~------~~lse-~~i~~i~~QI---------l~aL~yLHs~------g~~IIH 154 (670)
.|..+.. .+.+ | .+++. ..+..+..++ ...+..+-.. .+.++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 9876531 1111 1 11121 1222222222 1112212111 234899
Q ss_pred ecCccccEEEeCCCCcEEEeeccchhh
Q 005916 155 RDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 155 rDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+|+.|.||++++ ++ +.|+||..+..
T Consensus 151 ~Dl~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 151 MDVHAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred CCCCcCcEEEeC-CC-CEEEeccccCc
Confidence 999999999984 44 78999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.011 Score=62.69 Aligned_cols=75 Identities=21% Similarity=0.185 Sum_probs=45.9
Q ss_pred EEecccCCeEEEEEEEcC------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCCeE
Q 005916 32 EVIGKGAFKTVYKAFDEV------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNKTV 104 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-Vkl~~~~~d~~~~~~ 104 (670)
+.|..|-...||++.... .+..+++|+..... .......+|+.+++.+....+ .+++.++ ..
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC----
Confidence 466777788899886432 25778888755321 112345678888888843223 3455433 22
Q ss_pred EEEEecCCCCCHH
Q 005916 105 NIITELFTSGSLR 117 (670)
Q Consensus 105 ~lVmEy~~gGsL~ 117 (670)
.+|+||++|..+.
T Consensus 73 ~~v~e~i~G~~l~ 85 (302)
T cd05156 73 GRIEEFIPSRTLT 85 (302)
T ss_pred CchhheeCCCcCC
Confidence 2589999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.019 Score=60.47 Aligned_cols=140 Identities=17% Similarity=0.155 Sum_probs=77.9
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCC--CeeeeeeE----EEeCCCCeE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN--NIIRFYNS----WIDDQNKTV 104 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~Hp--NIVkl~~~----~~d~~~~~~ 104 (670)
.+.|..|....+|+... .+..+++|+... .. .+.+..|+.+++.|.+. .+.+++.. +....++..
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 45778888889998743 344688887653 11 24566788888888432 24444332 111112356
Q ss_pred EEEEecCCCCCHHH-----H------HHh-c---CCCC--------HHHHH------------HHHHHHHHHHhhhhc--
Q 005916 105 NIITELFTSGSLRQ-----Y------RKK-H---KKVD--------MKAVK------------GWARQILSGLIYLHS-- 147 (670)
Q Consensus 105 ~lVmEy~~gGsL~~-----~------i~~-~---~~ls--------e~~i~------------~i~~QIl~aL~yLHs-- 147 (670)
++|+++++|..+.. + +.+ | ..+. ..... .....+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999876421 1 000 0 0000 00000 011112233444432
Q ss_pred ---CCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 148 ---HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 148 ---~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~-~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFD-GDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEe-CCceEEEeehhhhc
Confidence 112499999999999998 44556899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.027 Score=61.33 Aligned_cols=148 Identities=18% Similarity=0.181 Sum_probs=96.6
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccc--------------------cCCHH-HHHH-HHHHHHHHHhC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV--------------------LQSPE-DLER-LYSEVHLLKSL 84 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~--------------------~~s~~-~~e~-l~~Ei~iLk~L 84 (670)
.-.+...|..|--+.||.|. ..+|..+|||+++...+ ..++. .+.. ...|++.|++|
T Consensus 145 i~~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl 223 (520)
T KOG2270|consen 145 IVEINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL 223 (520)
T ss_pred eeecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH
Confidence 34456678889999999996 56888999999873211 11111 2222 24588888888
Q ss_pred CCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHH-HHhcCCCCHHHHHHHHHHHHHHHhhhh-cCCCCeeeecCccccE
Q 005916 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLH-SHDPPIIHRDLKCDNI 162 (670)
Q Consensus 85 ~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~-i~~~~~lse~~i~~i~~QIl~aL~yLH-s~g~~IIHrDLKpeNI 162 (670)
....|.----..+ . .-.|||+|+. ++=+-. ..+.-.++...+..+-.|++.-+.-|- .++ +||.||.--|+
T Consensus 224 ~~aGIP~PePIlL-k---~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~ 296 (520)
T KOG2270|consen 224 NNAGIPCPEPILL-K---NHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL 296 (520)
T ss_pred HhcCCCCCCceee-e---cceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence 6544321111111 1 2459999995 332222 122335777788888888888877764 445 99999999999
Q ss_pred EEeCCCCcEEEeeccchhhhcc
Q 005916 163 FINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 163 Ll~~~~g~vKL~DFGla~~~~~ 184 (670)
|+. +|.+.|+|.+-+.....
T Consensus 297 Lyh--dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 297 LYH--DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred eEE--CCEEEEEEccccccCCC
Confidence 995 68999999987765443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.0023 Score=68.36 Aligned_cols=137 Identities=20% Similarity=0.244 Sum_probs=92.3
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc-----C-----------CHHHHHH--HHHHHHHHHhC-CCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL-----Q-----------SPEDLER--LYSEVHLLKSL-KHN 87 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~-----~-----------s~~~~e~--l~~Ei~iLk~L-~Hp 87 (670)
.+.++..||-|--+.||.+-+ ..|.+.++|.-++.... . +--.+-+ ..+|+..|+.| .|-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 456778899999999999865 46788888765543210 0 0011222 35789999998 332
Q ss_pred -CeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC
Q 005916 88 -NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166 (670)
Q Consensus 88 -NIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~ 166 (670)
-|.+.+++ ...++|||++.|-.|.+... ..+ +..+...+..-+--|..+| +||+|..--||++.
T Consensus 172 fpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~---v~d---~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~- 236 (465)
T KOG2268|consen 172 FPVPKPIDH------NRHCVVMELVDGYPLRQVRH---VED---PPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVK- 236 (465)
T ss_pred CCCCCcccc------cceeeHHHhhcccceeeeee---cCC---hHHHHHHHHHHHHHHHHcC--ceecccchheeEEe-
Confidence 34444442 24679999999988865432 122 2334455555666777888 99999999999998
Q ss_pred CCCcEEEeeccch
Q 005916 167 NQGEVKIGDLGLA 179 (670)
Q Consensus 167 ~~g~vKL~DFGla 179 (670)
+++.++++||--.
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 6789999999543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.013 Score=65.92 Aligned_cols=162 Identities=21% Similarity=0.257 Sum_probs=98.5
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCe
Q 005916 73 RLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152 (670)
Q Consensus 73 ~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~I 152 (670)
.+.--.++++.+.|+|...+..+-... .....+|||++ +-+|.++.+.+. +-.... + .++ +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~----------~----~~~--~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHY-TMSLEDILKTGN-LKDESL----------L----AHG--V 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhh-ccchHHHHHhcc-cchhhh----------c----ccc--c
Confidence 355667899999999999988765433 34688999999 569999887654 211111 0 222 3
Q ss_pred eeecCccccEEEeCCCCcEEEeeccchhhhcccccccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCC
Q 005916 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSEC 232 (670)
Q Consensus 153 IHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~ 232 (670)
.| - +.++++| -++.. ..+..| +++||||+|.++.++.-|...+...
T Consensus 89 ~~-----~--------~~~~~td-~~~t~-----~~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 89 LH-----L--------NIIYITD-HFLTK-----YPSPIG---------------PKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred ce-----e--------hhhhccc-ccccc-----CCCCCC---------------cchhhhhHHHHHHHHHHhhHHHHHH
Confidence 22 1 1333344 11100 011111 3999999999999999988777653
Q ss_pred CCHHHHHHHHhcCCCCC---------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 233 RNSAQIYKKVSSGIKPA---------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 233 ~~~~~i~~~i~~g~~p~---------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.+.........-...+. ......+.....+..+|+- .|..||...++.+++-|..
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 33333221111111111 1112245666788889995 7999999999999887753
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.16 Score=54.25 Aligned_cols=29 Identities=28% Similarity=0.324 Sum_probs=23.6
Q ss_pred CeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 151 ~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
++||+|+.|.||+++ .+...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~-~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFE-GDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEE-CCceEEEEeccccc
Confidence 499999999999998 33345799998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.1 Score=58.09 Aligned_cols=77 Identities=16% Similarity=0.072 Sum_probs=52.7
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCH---HHHHHHHHHHHHHHhCC---CCCeeeeeeEEEeCCCCeE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP---EDLERLYSEVHLLKSLK---HNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~---~~~e~l~~Ei~iLk~L~---HpNIVkl~~~~~d~~~~~~ 104 (670)
.+.||-|....||+..+. +..++||+-.......+. -..+|...|...|+.+. -.++.++|.+.. . ..
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d--~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--T--MA 110 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--C--CC
Confidence 568899999999998763 456888876533221111 24666777888888773 247778887543 2 35
Q ss_pred EEEEecCCC
Q 005916 105 NIITELFTS 113 (670)
Q Consensus 105 ~lVmEy~~g 113 (670)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 789999977
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.083 Score=56.22 Aligned_cols=141 Identities=18% Similarity=0.142 Sum_probs=76.6
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCC--CeeeeeeE----EEeCCCCeE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN--NIIRFYNS----WIDDQNKTV 104 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~Hp--NIVkl~~~----~~d~~~~~~ 104 (670)
.+.++.|....+|++.. .+| .+++|+..... . .+.+..|+.++..|... .+.+++.. +.....+..
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~---~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV---K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCC---C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 45678888889998753 344 57778765311 1 23345677777777322 23333321 111123467
Q ss_pred EEEEecCCCCCHH-----HH------HHh-c---CCC--------CHHH-----HH----------HHHHHHHHHHhhhh
Q 005916 105 NIITELFTSGSLR-----QY------RKK-H---KKV--------DMKA-----VK----------GWARQILSGLIYLH 146 (670)
Q Consensus 105 ~lVmEy~~gGsL~-----~~------i~~-~---~~l--------se~~-----i~----------~i~~QIl~aL~yLH 146 (670)
+++++|++|..+. ++ +.+ | ..+ .... .. .....+...+.++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999885431 11 100 1 001 0000 00 00111233444443
Q ss_pred c-----CCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 147 S-----HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 147 s-----~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
. ...++||+|+.+.||+++. ++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDG-DSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEEC-CceEEEeeccccc
Confidence 2 2245999999999999984 4556899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.067 Score=59.32 Aligned_cols=87 Identities=18% Similarity=0.206 Sum_probs=58.7
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc--CCHHHHHHHHHHHHHHHhCC--CC-CeeeeeeEEEeCCCCeEE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL--QSPEDLERLYSEVHLLKSLK--HN-NIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~--~s~~~~e~l~~Ei~iLk~L~--Hp-NIVkl~~~~~d~~~~~~~ 105 (670)
.+.||-|.-.-||++.+...+..|+||+-...-.. ..+-..+|..-|..+|+.+. -| .+.++|. .|+. ...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e--~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV--MNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH--Hhh
Confidence 46889999999999987544567899886532211 12445778888999999872 34 4666775 3443 467
Q ss_pred EEEecCCCCC-HHHHHH
Q 005916 106 IITELFTSGS-LRQYRK 121 (670)
Q Consensus 106 lVmEy~~gGs-L~~~i~ 121 (670)
+|||+++... |+..+.
T Consensus 110 ~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 110 CVMEDLSDHTILRTALI 126 (409)
T ss_pred HHHHhCcccHHHHHHHH
Confidence 9999996533 444443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.066 Score=58.33 Aligned_cols=143 Identities=14% Similarity=0.196 Sum_probs=80.5
Q ss_pred eEEEEEEecccCCeEEEEEEEcC----CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEV----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQN 101 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~----tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-Vkl~~~~~d~~~ 101 (670)
...+. .|-.|-.-.+|++.... .+..|++++..... ....++ .+|..+++.+..-++ .++++.+ ..+
T Consensus 38 ~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~~g 109 (344)
T PLN02236 38 ALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFDR-DDEIRTFECMSRHGQGPRLLGRF--PNG 109 (344)
T ss_pred cEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeech-HHHHHHHHHHHHcCCCCceEEEE--CCc
Confidence 44444 55558889999985322 24678877664321 122233 578999998844333 3455544 222
Q ss_pred CeEEEEEecCCCCCHHHH--------------HHh-cC--------CCCHHHHHHHHHHHHH-----------------H
Q 005916 102 KTVNIITELFTSGSLRQY--------------RKK-HK--------KVDMKAVKGWARQILS-----------------G 141 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~--------------i~~-~~--------~lse~~i~~i~~QIl~-----------------a 141 (670)
.|++|+.|.+|... +.+ |. ......+..|..++.. .
T Consensus 110 ----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~ 185 (344)
T PLN02236 110 ----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDE 185 (344)
T ss_pred ----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHH
Confidence 57899887665311 111 10 1112344444433211 1
Q ss_pred Hhh----hhc--CCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 142 LIY----LHS--HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 142 L~y----LHs--~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+.. +.. ....++|+||++.|||++..++.+.|+||..+..
T Consensus 186 ~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 186 INLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 111 221 1224899999999999985456899999987753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.074 Score=56.18 Aligned_cols=31 Identities=23% Similarity=0.368 Sum_probs=24.8
Q ss_pred CCeeeecCccccEEEeCCCCc-EEEeeccchhh
Q 005916 150 PPIIHRDLKCDNIFINGNQGE-VKIGDLGLATI 181 (670)
Q Consensus 150 ~~IIHrDLKpeNILl~~~~g~-vKL~DFGla~~ 181 (670)
+.++|+|++|.|||++.+ +. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDED-ARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCC-CCEEEEECcHhccc
Confidence 348999999999999843 44 56999997754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.22 Score=53.76 Aligned_cols=147 Identities=16% Similarity=0.180 Sum_probs=82.3
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEeCCCCeEEEEE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH--NNIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H--pNIVkl~~~~~d~~~~~~~lVm 108 (670)
.+....|..-.+|...+. ++.+++. .. .............+|+.+|+.+.- --+-..++.+.+..-+..+.||
T Consensus 30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P--~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT--GQKYVLR-KP--PRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeccCCcccceEEEecC--CceEEEe-cC--CccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 334444444445555433 6667665 21 111223445667788999988833 2233445555444324679999
Q ss_pred ecCCCCCH---------H-HHHH--------h-c-------------CCCCHHHHHHHHHHH--------------HHHH
Q 005916 109 ELFTSGSL---------R-QYRK--------K-H-------------KKVDMKAVKGWARQI--------------LSGL 142 (670)
Q Consensus 109 Ey~~gGsL---------~-~~i~--------~-~-------------~~lse~~i~~i~~QI--------------l~aL 142 (670)
+++.|..+ . ++.. . | ..+...++..|..+. ..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99988322 2 2211 0 0 112233444444433 2223
Q ss_pred hhhhcCC------CCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 143 IYLHSHD------PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 143 ~yLHs~g------~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
.||+.+- +.++|+|+.+.|++++ +.+.+=+.||+++..-.
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~-~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIID-PGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEe-CCCeeEEEeccccccCC
Confidence 4555443 2599999999999998 44568899999886543
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.0089 Score=43.57 Aligned_cols=32 Identities=38% Similarity=0.472 Sum_probs=24.6
Q ss_pred hhhhheeecCCC------ceeeeecccccCCCCcCcch
Q 005916 379 VSLILRIADQSG------RLRNIHFLFYLDSDTAFSVS 410 (670)
Q Consensus 379 I~liLri~D~~g------~i~~ieF~f~~d~Dta~~Ia 410 (670)
|.++||+.|+.. ....|+|.|++.+|++..||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 467899999665 77899999999999998876
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.15 Score=55.28 Aligned_cols=143 Identities=13% Similarity=0.183 Sum_probs=77.3
Q ss_pred eEEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNK 102 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-Vkl~~~~~d~~~~ 102 (670)
.+.+. .|..|=...+|++..... +..|.+++..... ....+ -.+|..+++.+..-++ .+++.++ ..+
T Consensus 16 ~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~~~Id-R~~E~~il~~l~~~gl~P~~l~~~--~~G- 86 (330)
T PLN02421 16 DFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT----DYVID-RERELQAIKYLSAAGFGAKLLGVF--GNG- 86 (330)
T ss_pred ceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCc----CeEec-hHHHHHHHHHHHhcCCCCceeEEe--CCc-
Confidence 34444 455577888888754322 2367777654321 11111 2468888888854444 3455443 222
Q ss_pred eEEEEEecCCCCCHHH-------H-------HHh-cC-C------C-CHHHHHHHHHHH---------------------
Q 005916 103 TVNIITELFTSGSLRQ-------Y-------RKK-HK-K------V-DMKAVKGWARQI--------------------- 138 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~-------~-------i~~-~~-~------l-se~~i~~i~~QI--------------------- 138 (670)
+|.+|+.|..|.. . +++ |. . . -...+..|..++
T Consensus 87 ---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (330)
T PLN02421 87 ---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEE 163 (330)
T ss_pred ---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHH
Confidence 5889987765421 0 111 11 1 1 122333333322
Q ss_pred ----HHHHh-hhhcCC--CCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 139 ----LSGLI-YLHSHD--PPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 139 ----l~aL~-yLHs~g--~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+..+. ++...+ ..++|.||.+.|||++..++.++++||..|..
T Consensus 164 l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 164 LRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111 121112 23789999999999975557899999987753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.11 Score=56.60 Aligned_cols=88 Identities=19% Similarity=0.170 Sum_probs=61.5
Q ss_pred CCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEE
Q 005916 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 163 (670)
Q Consensus 84 L~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNIL 163 (670)
..-++..+.+-+-. ..+.+.|++|++- |+.|.- + +.-..+++..++++.+..+.-+... -+.-||||..+|||
T Consensus 282 ~g~~~~e~~~vv~~-de~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niL 354 (488)
T COG5072 282 CGSVFLETLKVVSL-DETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNIL 354 (488)
T ss_pred ccchhhhcceEEec-CCceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhc-CCccccccccccee
Confidence 33444444443322 3345888999986 555532 1 2234677788888877777766665 35899999999999
Q ss_pred EeCCCCcEEEeeccchh
Q 005916 164 INGNQGEVKIGDLGLAT 180 (670)
Q Consensus 164 l~~~~g~vKL~DFGla~ 180 (670)
++ .|.|.|+||-+++
T Consensus 355 Id--~GnvtLIDfklsR 369 (488)
T COG5072 355 ID--EGNVTLIDFKLSR 369 (488)
T ss_pred ee--cCceEEEEeeeee
Confidence 98 6899999999987
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.36 Score=51.46 Aligned_cols=76 Identities=16% Similarity=0.110 Sum_probs=43.7
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC--C-CCeeeeeeEEEeCCCCeE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK--H-NNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~--H-pNIVkl~~~~~d~~~~~~ 104 (670)
..-.+.|+.|....+|+.. .++..+.+|.-.. . ....+..|..-|+.|. . -.+.+.+.+..... .-
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~--~~ 87 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-S------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD--DA 87 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-G------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS--CC
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh-h------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC--Cc
Confidence 3445688999999999985 6777888887662 1 1245677888888883 3 34556776554433 35
Q ss_pred EEEEecCCCC
Q 005916 105 NIITELFTSG 114 (670)
Q Consensus 105 ~lVmEy~~gG 114 (670)
+|||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 8999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.25 Score=52.70 Aligned_cols=29 Identities=10% Similarity=0.161 Sum_probs=24.9
Q ss_pred CeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 151 ~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
++||+|+.+.|||++ .++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD-ETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEc-CCCCEEEEEhhhcc
Confidence 499999999999998 45688999998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.01 E-value=0.37 Score=49.50 Aligned_cols=86 Identities=21% Similarity=0.318 Sum_probs=60.0
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCC
Q 005916 72 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151 (670)
Q Consensus 72 e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~ 151 (670)
..++.+..++.++. .|+++.. +++..+-++.|.|.-...- -..++..=+.+|.-.|+.++.
T Consensus 103 ~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i~-------------~~N~i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKIN-------------FSNFITAGIKDLMDFHSENQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcccc-------------hhHHHHHhHHHHHHhhccCCC
Confidence 34567888888773 5777774 2444577999999542210 011222225678888977678
Q ss_pred eeeecCccccEEEeCCCCcEEEeecc
Q 005916 152 IIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 152 IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.+|+|-.|+||+-+ ..|.+||.|=+
T Consensus 164 ~lHGD~np~NiM~D-~~G~lKlVDP~ 188 (308)
T PF07387_consen 164 CLHGDCNPDNIMCD-KFGYLKLVDPV 188 (308)
T ss_pred eecCCCChhheeec-CCCCEEecChh
Confidence 99999999999998 67999999965
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.27 E-value=0.8 Score=50.79 Aligned_cols=84 Identities=17% Similarity=0.085 Sum_probs=44.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCC-CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCCeE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVN-GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNKTV 104 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~t-g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-Vkl~~~~~d~~~~~~ 104 (670)
...+. .|..|-...+|++..... +..+.+|.|-........+..-.-.+|+++++.|...++ .++++.+. -
T Consensus 52 ~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~------~ 124 (383)
T PTZ00384 52 FIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG------D 124 (383)
T ss_pred cEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC------C
Confidence 34444 555588899999864322 122222222111110111111112468999999954444 56666552 2
Q ss_pred EEEEecCCCCCHH
Q 005916 105 NIITELFTSGSLR 117 (670)
Q Consensus 105 ~lVmEy~~gGsL~ 117 (670)
++|.||+.|-.|.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 4899999987653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=89.43 E-value=0.077 Score=59.82 Aligned_cols=71 Identities=21% Similarity=0.456 Sum_probs=60.0
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
..+..+..+|+|+||+|+.+..+.++-.+|||.|..+.. .....+..+|+.-+..+.|++|++++..|...
T Consensus 49 ~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~---e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 49 NDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNR---EESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred ccccccccccccCccccCCccccccchhhHHHHhcccch---hhhhhhhhccccchhhhcccchhhheeceecC
Confidence 346778899999999999999998888999999987654 44566788899999999999999998888543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.21 E-value=1 Score=50.17 Aligned_cols=63 Identities=19% Similarity=0.206 Sum_probs=43.9
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh-cCCCCeeeecCccccEEEeCCCC
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH-SHDPPIIHRDLKCDNIFINGNQG 169 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLH-s~g~~IIHrDLKpeNILl~~~~g 169 (670)
..++-+|..|-++..+++.. ..+++..+.++.-.+.||--+- -.+ ++|.||.|.||++....+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNKT 383 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecCC
Confidence 44677788888888887653 4556666667666666654332 234 999999999999974443
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.83 E-value=8.4 Score=48.21 Aligned_cols=31 Identities=26% Similarity=0.440 Sum_probs=24.3
Q ss_pred CeeeecCccccEEEeCCC-CcEE-Eeeccchhh
Q 005916 151 PIIHRDLKCDNIFINGNQ-GEVK-IGDLGLATI 181 (670)
Q Consensus 151 ~IIHrDLKpeNILl~~~~-g~vK-L~DFGla~~ 181 (670)
.+||+|+.+.|||++++. +.+. |+|||-+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 499999999999998432 2555 999997653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.46 E-value=8.9 Score=41.35 Aligned_cols=73 Identities=11% Similarity=0.004 Sum_probs=40.0
Q ss_pred cCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCC--Ceeeee---eEEEeCCCCeEEEEEecC
Q 005916 37 GAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN--NIIRFY---NSWIDDQNKTVNIITELF 111 (670)
Q Consensus 37 G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~Hp--NIVkl~---~~~~d~~~~~~~lVmEy~ 111 (670)
+.-..||+... .+|..+++|+.+.... ....+..|+..+..|... .++... +-....-++..+.+++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~-----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW-----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC-----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 34567888753 4566788887653221 234566788888877221 122211 111111123677899998
Q ss_pred CCCC
Q 005916 112 TSGS 115 (670)
Q Consensus 112 ~gGs 115 (670)
.|..
T Consensus 110 ~G~~ 113 (325)
T PRK11768 110 GGRA 113 (325)
T ss_pred CCCC
Confidence 8763
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.10 E-value=3.1 Score=47.11 Aligned_cols=75 Identities=17% Similarity=0.171 Sum_probs=43.3
Q ss_pred EEEecccCCeEEEEEEEcC--------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCC
Q 005916 31 KEVIGKGAFKTVYKAFDEV--------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQN 101 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~--------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-Vkl~~~~~d~~~ 101 (670)
.+.|..|-.-.+|++.... .+..|.+++.-... +..-.-.+|..+++.+..-+| .++++.+ .+
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t-----e~lIdR~~E~~v~~~ls~~gi~P~l~~~f--~g- 181 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV-----DELYNPISEFEVYKTMSKYRIAPQLLNTF--SG- 181 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc-----cceeCHHHHHHHHHHHHHCCCCCceEEEe--CC-
Confidence 4577778888888886442 14567766554321 111123458888888754444 3455544 22
Q ss_pred CeEEEEEecCCCCCH
Q 005916 102 KTVNIITELFTSGSL 116 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL 116 (670)
..|.||+.|-.|
T Consensus 182 ---g~I~efi~g~~l 193 (442)
T PTZ00296 182 ---GRIEEWLYGDPL 193 (442)
T ss_pred ---CEEEEeeCCccC
Confidence 257899987643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=86.22 E-value=1.3 Score=46.75 Aligned_cols=28 Identities=25% Similarity=0.404 Sum_probs=23.9
Q ss_pred CCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 150 ~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
.+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECccc
Confidence 35999999999999984 57899999854
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 670 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-73 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-28 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-27 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-27 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-25 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-21 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-21 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-21 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-20 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-19 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-19 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-17 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-16 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-16 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-16 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-16 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-16 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-16 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-16 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-16 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-16 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-16 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-16 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-16 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-16 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-16 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 670 | |||
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-157 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-69 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-68 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 8e-68 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-66 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-66 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-65 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-63 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-63 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-61 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-61 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-59 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-59 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-57 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-57 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 6e-57 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-56 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-55 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-54 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-54 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-54 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-52 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-50 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-49 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 7e-49 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-49 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-48 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-48 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 7e-48 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-47 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-47 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-47 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-47 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-47 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-47 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-46 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-46 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-46 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-46 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-08 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-45 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-45 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-45 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 8e-45 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-44 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-43 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-43 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-43 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 6e-43 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-43 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 9e-43 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-42 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-42 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-42 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-42 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 9e-42 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-41 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-41 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-41 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-40 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-40 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-40 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-39 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 5e-39 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 9e-39 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-38 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-38 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-38 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-38 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-38 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-37 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-37 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 7e-37 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-37 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 9e-37 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-36 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-36 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-36 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-36 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 6e-36 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-35 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-35 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-35 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-35 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-35 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-35 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-35 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 6e-35 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-35 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 7e-35 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 7e-35 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-35 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-34 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-34 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-34 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-34 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-34 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-34 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-33 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-33 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-33 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-33 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-33 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 7e-33 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-32 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-32 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-32 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-32 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-32 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-32 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 8e-32 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-31 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-31 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-30 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-30 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-30 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-30 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-30 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-29 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-29 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-29 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-29 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-29 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-29 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-29 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-28 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-28 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-28 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-28 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-28 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-28 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-28 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-28 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-28 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 6e-28 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-28 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 8e-28 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-27 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-27 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-27 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-27 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-27 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-27 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-27 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-27 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 5e-27 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 6e-27 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 7e-27 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-27 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 9e-27 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-26 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-26 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-26 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-26 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-26 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-26 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-26 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-26 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-26 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-26 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-26 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-25 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-25 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-25 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-25 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-25 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-25 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-25 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-25 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-25 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-25 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-25 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-25 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 6e-25 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 6e-25 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 7e-25 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-25 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-24 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-24 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-24 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-24 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-24 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-24 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-24 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-24 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-24 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 6e-24 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-23 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-23 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-23 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-23 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-23 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-23 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-23 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 7e-23 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-22 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-22 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-22 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-22 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-22 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-22 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-22 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-22 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-22 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 6e-22 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-22 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-21 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-21 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-21 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-21 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-21 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 5e-21 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 7e-21 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-20 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 4e-20 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 6e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 8e-20 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-19 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-19 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-19 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-19 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 9e-19 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-18 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-17 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 7e-16 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 9e-16 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-15 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-06 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 7e-14 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-13 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-11 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-11 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-10 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-10 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-09 |
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 454 bits (1169), Expect = e-157
Identities = 141/288 (48%), Positives = 191/288 (66%), Gaps = 5/288 (1%)
Query: 2 ESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI 61
E +E + + R++++ IG+G+FKTVYK D +EVAWC+++
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61
Query: 62 DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID--DQNKTVNIITELFTSGSLRQY 119
+ + +R E +LK L+H NI+RFY+SW K + ++TEL TSG+L+ Y
Sbjct: 62 RK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119
Query: 120 RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179
K+ K + +K ++ W RQIL GL +LH+ PPIIHRDLKCDNIFI G G VKIGDLGLA
Sbjct: 120 LKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 180 TIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY 239
T+ + AK+VIGTPEFMAPE+Y+E Y+E D+Y+FGMCMLEM T EYPYSEC+N+AQIY
Sbjct: 180 TLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239
Query: 240 KKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
++V+SG+KPA+ KV PEVK IE C+ +R S K+LL F Q
Sbjct: 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 6e-69
Identities = 77/266 (28%), Positives = 124/266 (46%), Gaps = 16/266 (6%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
IG G++ K + +G + W ++ + + + L SEV+LL+ LKH NI+R
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM----KAVKGWARQILSGLIYLHS 147
+Y+ ID N T+ I+ E G L K K + V Q+ L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 148 HDPP---IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELY 202
++HRDLK N+F++G VK+GD GLA I+ AK+ +GTP +M+PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 203 -DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
+YNE +DI+S G + E+ P+ + ++ K+ G K + E+
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNE 246
Query: 262 FIEKCLVP-ASQRLSAKELLMDPFLQ 286
I + L R S +E+L +P +
Sbjct: 247 IITRMLNLKDYHRPSVEEILENPLIL 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-68
Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 19/292 (6%)
Query: 2 ESSEDGAAKMEPPDPDVLETDPTCRYI-RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQ 58
S G A P + P + ++ +G G++ V+K + +G A +
Sbjct: 30 RVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR 89
Query: 59 VRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLR 117
+ P+D R +EV + + +H +R +W + + + TE SL+
Sbjct: 90 SMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI--LYLQTE-LCGPSLQ 144
Query: 118 QYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176
Q+ + + V G+ R L L +LHS ++H D+K NIF+ G K+GD
Sbjct: 145 QHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDF 201
Query: 177 GLATIMEQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNS 235
GL + A + G P +MAPEL +Y AD++S G+ +LE+
Sbjct: 202 GLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGW 261
Query: 236 AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
Q+ + A LS E++S + L P R +A+ LL P L+
Sbjct: 262 QQLRQGYLPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 8e-68
Identities = 64/261 (24%), Positives = 125/261 (47%), Gaps = 15/261 (5%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+ IG+G+F +G + ++ I S ++ E EV +L ++KH NI++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQ 87
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM--KAVKGWARQILSGLIYLHSHD 149
+ S+ ++ + + I+ + G L + K V + W QI L ++H
Sbjct: 88 YRESFEENGS--LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELYDEN-Y 206
I+HRD+K NIF+ + G V++GD G+A ++ A++ IGTP +++PE+ + Y
Sbjct: 146 --ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 266
N +DI++ G + E+ T ++ + E + + K+ SG +S +++S + +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQL 260
Query: 267 LVP-ASQRLSAKELLMDPFLQ 286
R S +L F+
Sbjct: 261 FKRNPRDRPSVNSILEKGFIA 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-66
Identities = 84/293 (28%), Positives = 138/293 (47%), Gaps = 16/293 (5%)
Query: 12 EPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDL 71
+ + + + ++ IG+G F VY+A ++G+ VA +V+I D L +
Sbjct: 19 QKALRPDMGYNTLANFRI-EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-LMDAKAR 76
Query: 72 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM--- 128
E+ LLK L H N+I++Y S+I+ + +NI+ EL +G L + K KK
Sbjct: 77 ADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIP 134
Query: 129 -KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QA 185
+ V + Q+ S L ++HS ++HRD+K N+FI G VK+GDLGL
Sbjct: 135 ERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTT 191
Query: 186 NAKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPY-SECRNSAQIYKKVS 243
A S++GTP +M+PE EN YN +DI+S G + EM + P+ + N + KK+
Sbjct: 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 251
Query: 244 SGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRP 295
P S E++ + C+ P +R + T +
Sbjct: 252 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 3e-66
Identities = 94/305 (30%), Positives = 147/305 (48%), Gaps = 30/305 (9%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
M S+E+G + D+LE D + V+GKG + VY D N + +A ++
Sbjct: 2 MRSTEEG-----DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP 56
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ-Y 119
+ + L+ E+ L K LKH NI+++ S+ ++ + I E GSL
Sbjct: 57 ----ERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--FIKIFMEQVPGGSLSALL 110
Query: 120 RKKHKKVDMK--AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177
R K + + + +QIL GL YLH + I+HRD+K DN+ IN G +KI D G
Sbjct: 111 RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFG 168
Query: 178 LATIME--QANAKSVIGTPEFMAPELYDEN---YNELADIYSFGMCMLEMVTFEYPYSEC 232
+ + ++ GT ++MAPE+ D+ Y + ADI+S G ++EM T + P+ E
Sbjct: 169 TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228
Query: 233 RNSAQIYKKVSSGIK----PAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQV 287
KV P ++S E K+FI KC P +R A +LL+D FL+V
Sbjct: 229 GEPQAAMFKVGMFKVHPEIPESMS----AEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284
Query: 288 NGTTK 292
+ K
Sbjct: 285 SSKKK 289
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-65
Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 37/285 (12%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E+IG G F V+KA ++G +V+ ++ E+ EV L L H NI+
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVH 68
Query: 92 FYNSWIDD--------------QNKTVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWA 135
+ W + K + I E G+L Q+ +++ +K+D
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ-ANAKSVIGTP 194
QI G+ Y+HS +I+RDLK NIF+ +VKIGD GL T ++ GT
Sbjct: 129 EQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 195 EFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253
+M+PE ++Y + D+Y+ G+ + E++ E +++ + + GI
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGIISDIFD- 241
Query: 254 VKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLP 297
+ K+ ++K L R + E+L + KN
Sbjct: 242 ---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHT 283
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-63
Identities = 70/293 (23%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 26 RYI-RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK 82
RY+ ++ + +G+G F V++A ++V+ A ++R+ + E++ EV L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALA 58
Query: 83 SLKHNNIIRFYNSWIDDQN----------KTVNIITELFTSGSLRQY---RKKHKKVDMK 129
L+H I+R++N+W++ + I +L +L+ + R ++ +
Sbjct: 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 130 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ----- 184
QI + +LHS ++HRDLK NIF + VK+GD GL T M+Q
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQ 175
Query: 185 ---------ANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRN 234
A +GT +M+PE ++ +Y+ DI+S G+ + E++ YP+S
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQME 232
Query: 235 SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+ V + K L K P ++ L P +R A ++ + +
Sbjct: 233 RVRTLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 3e-63
Identities = 89/290 (30%), Positives = 129/290 (44%), Gaps = 44/290 (15%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
V+G+GAF V KA + ++ A ++R + E L + SEV LL SL H ++R
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 92 FYNSWIDDQNKTVN-----------IITELFTSGSLRQY-RKKHKKVDMKAVKGWARQIL 139
+Y +W++ +N I E +G+L ++ RQIL
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-------------- 185
L Y+HS IIHRDLK NIFI+ + VKIGD GLA + ++
Sbjct: 127 EALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 186 --NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 241
N S IGT ++A E+ D +YNE D+YS G+ EM+ YP+S I KK
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKK 240
Query: 242 VSSGIK--PAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVN 288
+ S P K K I + ++R A+ LL +L V
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-61
Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 30/298 (10%)
Query: 3 SSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID 62
+G E P E ++ ++ +G+G+F V++ D+ G + A +VR++
Sbjct: 35 EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE 94
Query: 63 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK 122
E+ L I+ Y + + VNI EL GSL Q K+
Sbjct: 95 VFRV---------EELVACAGLSSPRIVPLYGAVREGP--WVNIFMELLEGGSLGQLIKQ 143
Query: 123 HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182
+ + Q L GL YLH+ I+H D+K DN+ ++ + + D G A +
Sbjct: 144 MGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCL 201
Query: 183 EQ-------ANAKSVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRN 234
+ + GT MAPE+ + DI+S ML M+ +P+++
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261
Query: 235 SAQIYKKVSSGI----KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQV 287
K S P + + P I++ L R SA EL +
Sbjct: 262 GPLCLKIASEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 6e-61
Identities = 64/294 (21%), Positives = 121/294 (41%), Gaps = 40/294 (13%)
Query: 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEV 78
+++ T + E IG G F +V+K ++G A + + D + EV
Sbjct: 5 MKSRYTTEFHE-LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREV 61
Query: 79 HLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM----KAVKG 133
+ L +H++++R++++W +D + + I E GSL ++ ++ +K
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDH--MLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 134 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN------------------QGEVKIGD 175
Q+ GL Y+HS ++H D+K NIFI+ + KIGD
Sbjct: 120 LLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 176 LGLATIMEQANAKSVIGTPEFMAPELYDEN--YNELADIYSFGMCMLEMVTFEYPYSECR 233
LG T + + + G F+A E+ EN + ADI++ + ++ E
Sbjct: 178 LGHVTRIS--SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN-- 233
Query: 234 NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+ ++ G P + +V E ++ + P +R SA L+ L
Sbjct: 234 --GDQWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-59
Identities = 66/267 (24%), Positives = 111/267 (41%), Gaps = 20/267 (7%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVA---WCQVRIDDVLQSPEDLERLYSEVHLLKSL 84
I Y++ IGKG F V+K + VA + + E + EV ++ +L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLI 143
H NI++ Y ++ E G L K + I G+
Sbjct: 81 NHPNIVKLYGLMH----NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGE----VKIGDLGLATIMEQANAKSVIGTPEFMAP 199
Y+ + +PPI+HRDL+ NIF+ K+ D GL+ + ++G ++MAP
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-SVSGLLGNFQWMAP 195
Query: 200 ELY---DENYNELADIYSFGMCMLEMVTFEYPYSECRNS--AQIYKKVSSGIKPAALSKV 254
E +E+Y E AD YSF M + ++T E P+ E I G++P + +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP-TIPED 254
Query: 255 KDPEVKSFIEKCLVP-ASQRLSAKELL 280
P +++ IE C +R ++
Sbjct: 255 CPPRLRNVIELCWSGDPKKRPHFSYIV 281
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-59
Identities = 78/270 (28%), Positives = 135/270 (50%), Gaps = 16/270 (5%)
Query: 3 SSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID 62
+ + D D ++ + KE IG G+F TV++A E +G +VA +
Sbjct: 16 PTTENLYFQGAMDGDDMDIPW--CDLNIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQ 71
Query: 63 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--- 119
D E + EV ++K L+H NI+ F + N ++I+TE + GSL +
Sbjct: 72 DF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHK 127
Query: 120 RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179
+++D + A + G+ YLH+ +PPI+HR+LK N+ ++ VK+ D GL+
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLS 186
Query: 180 TIMEQ--ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSA 236
+ ++KS GTPE+MAPE+ DE NE +D+YSFG+ + E+ T + P+ +
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246
Query: 237 QIYKKVSSGIKPAALSKVKDPEVKSFIEKC 266
+ + + + +P+V + IE C
Sbjct: 247 VVAAVGFKCKRL-EIPRNLNPQVAAIIEGC 275
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-57
Identities = 74/258 (28%), Positives = 111/258 (43%), Gaps = 17/258 (6%)
Query: 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSE 77
+LE D + +E+IG G F VY+A G EVA R D + +E + E
Sbjct: 1 LLEIDF--AELTLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 78 VHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQ 137
L LKH NII + + N + ++ E G L + K++ + WA Q
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPN--LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQ 113
Query: 138 ILSGLIYLHSHDP-PIIHRDLKCDNIFINGNQGE-------VKIGDLGLATIMEQANAKS 189
I G+ YLH PIIHRDLK NI I +KI D GLA + S
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS 173
Query: 190 VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248
G +MAPE + +++ +D++S+G+ + E++T E P+ A Y + +
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 249 AALSKVKDPEVKSFIEKC 266
S +E C
Sbjct: 234 PIPSTC-PEPFAKLMEDC 250
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-57
Identities = 65/291 (22%), Positives = 119/291 (40%), Gaps = 30/291 (10%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
Y + IG G V++ +E A V +++ + L+ +E+ L L+
Sbjct: 10 IYSI-LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQ 65
Query: 86 HNN--IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
++ IIR Y+ I DQ + ++ E + L + KK K +D K + + +L +
Sbjct: 66 QHSDKIIRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME----QANAKSVIGTPEFMAP 199
+H H I+H DLK N I G +K+ D G+A M+ S +GT +M P
Sbjct: 123 TIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 200 EL------------YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK 247
E + +D++S G + M + P+ + N +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238
Query: 248 PAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLP 297
+ + +++ ++ CL QR+S ELL P++Q+ N+
Sbjct: 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 289
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 6e-57
Identities = 65/309 (21%), Positives = 126/309 (40%), Gaps = 31/309 (10%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQ 58
M ++ ++ ++ + + Y + IG G V++ +E A
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKY 59
Query: 59 VRIDDVLQSPEDLERLYSEVHLLKSLKHNN--IIRFYNSWIDDQNKTVNIITELFTSGSL 116
V +++ + L+ +E+ L L+ ++ IIR Y+ I DQ + ++ E + L
Sbjct: 60 VNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVME-CGNIDL 114
Query: 117 RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176
+ KK K +D K + + +L + +H H I+H DLK N I G +K+ D
Sbjct: 115 NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--VDGMLKLIDF 170
Query: 177 GLATIMEQ----ANAKSVIGTPEFMAPEL------------YDENYNELADIYSFGMCML 220
G+A M+ S +GT +M PE + +D++S G +
Sbjct: 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230
Query: 221 EMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKEL 279
M + P+ + N + + + +++ ++ CL QR+S EL
Sbjct: 231 YMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
Query: 280 LMDPFLQVN 288
L P++Q+
Sbjct: 291 LAHPYVQIQ 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-56
Identities = 69/245 (28%), Positives = 117/245 (47%), Gaps = 20/245 (8%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
I +EV+G+GAF V KA + +VA ++ ++S + + E+ L + H
Sbjct: 10 IEVEEVVGRGAFGVVCKA--KWRAKDVA---IK---QIESESERKAFIVELRQLSRVNHP 61
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQY---RKKHKKVDMKAVKGWARQILSGLIY 144
NI++ Y + + V ++ E GSL + W Q G+ Y
Sbjct: 62 NIVKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 145 LHSHDP-PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYD 203
LHS P +IHRDLK N+ + +KI D G A + Q + + G+ +MAPE+++
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-QTHMTNNKGSAAWMAPEVFE 176
Query: 204 -ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ-IYKKVSSGIKPAALSKVKDPEVKS 261
NY+E D++S+G+ + E++T P+ E A I V +G +P L K ++S
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIES 235
Query: 262 FIEKC 266
+ +C
Sbjct: 236 LMTRC 240
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-55
Identities = 63/285 (22%), Positives = 117/285 (41%), Gaps = 29/285 (10%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN--I 89
+ IG G V++ +E A V +++ + L+ +E+ L L+ ++ I
Sbjct: 62 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
IR Y+ I DQ + ++ E + L + KK K +D K + + +L + +H H
Sbjct: 119 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPEL---- 201
I+H DLK N I G +K+ D G+A M+ S +G +M PE
Sbjct: 176 --IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 202 --------YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253
+ +D++S G + M + P+ + N +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 254 VKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLP 297
+ + +++ ++ CL QR+S ELL P++Q+ N+
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-54
Identities = 44/245 (17%), Positives = 91/245 (37%), Gaps = 15/245 (6%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
+ + + + ++K G ++ +++ D S E L+ H
Sbjct: 12 LNFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHP 67
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYL 145
N++ + +IT GSL + VD +A + G+ +L
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYD-- 203
H+ +P I L ++ I+ + +I + + + P ++APE
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQS---PGRMYAPAWVAPEALQKK 183
Query: 204 --ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
+ AD++SF + + E+VT E P+++ N K G++P + P V
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVSK 242
Query: 262 FIEKC 266
++ C
Sbjct: 243 LMKIC 247
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-54
Identities = 63/258 (24%), Positives = 113/258 (43%), Gaps = 32/258 (12%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLKH 86
+ E+IGKG F VY +G EVA + ID + + L+ EV + +H
Sbjct: 35 LEIGELIGKGRFGQVYHGR--WHG-EVA---IRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYL 145
N++ F + + + + IIT L +L R +D+ + A++I+ G+ YL
Sbjct: 89 ENVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-------KSVIGTPEFMA 198
H+ I+H+DLK N+F + G+V I D GL +I A + G +A
Sbjct: 147 HAK--GILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 199 PEL----------YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248
PE+ +++ +D+++ G E+ E+P+ + I ++ +G+KP
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-PAEAIIWQMGTGMKP 261
Query: 249 AALSKVKDPEVKSFIEKC 266
E+ + C
Sbjct: 262 NLSQIGMGKEISDILLFC 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 6e-54
Identities = 84/278 (30%), Positives = 132/278 (47%), Gaps = 25/278 (8%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
M+ D E I + IG G+F TVYK + +G +VA +
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQ--ITVGQRIGSGSFGTVYKG--KWHG-DVAVKMLN 55
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY- 119
+ +P+ L+ +EV +L+ +H NI+ F Q + I+T+ SL +
Sbjct: 56 VTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHL 110
Query: 120 RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179
K +MK + ARQ G+ YLH+ IIHRDLK +NIF++ + VKIGD GLA
Sbjct: 111 HASETKFEMKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLHED-NTVKIGDFGLA 167
Query: 180 TIMEQ----ANAKSVIGTPEFMAPEL----YDENYNELADIYSFGMCMLEMVTFEYPYSE 231
T + + + G+ +MAPE+ Y+ +D+Y+FG+ + E++T + PYS
Sbjct: 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227
Query: 232 CRNSAQIYKKVSSGIKPAALSKVK---DPEVKSFIEKC 266
N QI + V G LSKV+ +K + +C
Sbjct: 228 INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-50
Identities = 87/280 (31%), Positives = 137/280 (48%), Gaps = 22/280 (7%)
Query: 14 PDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLER 73
P L+ DP + + E IGKG+F V+K D VA ++I D+ ++ +++E
Sbjct: 11 PGMQNLKADPEELFTKL-EKIGKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIED 66
Query: 74 LYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKG 133
+ E+ +L + ++Y S++ D + II E GS + +D +
Sbjct: 67 IQQEITVLSQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALDLL-EPGPLDETQIAT 123
Query: 134 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVI 191
R+IL GL YLHS IHRD+K N+ ++ GEVK+ D G+A + K + +
Sbjct: 124 ILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFV 180
Query: 192 GTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSGIK 247
GTP +MAPE+ ++ Y+ ADI+S G+ +E+ E P+SE + I K
Sbjct: 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-----N 235
Query: 248 PAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
P L +K F+E CL S R +AKELL F+
Sbjct: 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 88/302 (29%), Positives = 143/302 (47%), Gaps = 27/302 (8%)
Query: 13 PPDPDVLETDPTC--RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDD--VLQSP 68
P+VL DP RY+R + +GKG F ++ D A +I +L P
Sbjct: 2 KEIPEVL-VDPRSRRRYVRGR-FLGKGGFAKCFEISDADTKEVFA---GKIVPKSLLLKP 56
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM 128
E++ E+ + +SL H +++ F+ + +D + V ++ EL SL + K+ K +
Sbjct: 57 HQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDF-VFVVLELCRRRSLLELHKRRKALTE 114
Query: 129 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA- 187
+ + RQI+ G YLH + +IHRDLK N+F+N + EVKIGD GLAT +E
Sbjct: 115 PEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGER 171
Query: 188 -KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 245
K + GTP ++APE L + ++ D++S G M ++ P E + Y ++
Sbjct: 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKN 230
Query: 246 I--KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIV 302
P ++ P S I+K L + R + ELL D F LP+ +
Sbjct: 231 EYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR--LPITCLT 284
Query: 303 LP 304
+P
Sbjct: 285 IP 286
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-49
Identities = 53/282 (18%), Positives = 95/282 (33%), Gaps = 33/282 (11%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
++ + + +G+G F V +G A ++ +D E E + +
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC----HEQQDREEAQREADMHRLFN 84
Query: 86 HNNIIRFYNSWIDDQNKT--VNIITELFTSGSLRQY----RKKHKKVDMKAVKGWARQIL 139
H NI+R + ++ ++ F G+L + K + + I
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS---------- 189
GL +H+ HRDLK NI + G+ + DLG S
Sbjct: 145 RGLEAIHA--KGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 190 -VIGTPEFMAPELYDEN----YNELADIYSFGMCML-EMVTFEYPY-SECRNSAQIYKKV 242
T + APEL+ +E D++S G C+L M+ E PY + + V
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAV 260
Query: 243 SSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDP 283
+ + + + + + QR LL
Sbjct: 261 QNQLSIPQSPRH-SSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 94/337 (27%), Positives = 155/337 (45%), Gaps = 28/337 (8%)
Query: 2 ESSEDGAAKMEPPDPDVLET--DPTC--RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWC 57
+ GA PP ++ E DP RY+R + +GKG F ++ D A
Sbjct: 14 GVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGR-FLGKGGFAKCFEISDADTKEVFA-G 71
Query: 58 QVRID-DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL 116
++ + +L P E++ E+ + +SL H +++ F+ + +D + V ++ EL SL
Sbjct: 72 KI-VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDF-VFVVLELCRRRSL 128
Query: 117 RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176
+ K+ K + + + RQI+ G YLH + +IHRDLK N+F+N + EVKIGD
Sbjct: 129 LELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDF 185
Query: 177 GLATIMEQANA--KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECR 233
GLAT +E K + GTP ++APE L + ++ D++S G M ++ P E
Sbjct: 186 GLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETS 244
Query: 234 NSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGT 290
+ Y ++ P ++ P S I+K L + R + ELL D F
Sbjct: 245 CLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300
Query: 291 TKNRPLPLPDIVLPRVGAFGDRCLMSEG--PASVRNK 325
LP+ + +P + L P +V NK
Sbjct: 301 PAR--LPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK 335
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 85/321 (26%), Positives = 148/321 (46%), Gaps = 37/321 (11%)
Query: 3 SSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID 62
+S+ A ++ D L DP + E++G G + VYK G A + +
Sbjct: 3 ASDSPARSLDEIDLSALR-DPAGIFEL-VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 63 DVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVN----IITELFTSGSLR 117
++ E + E+++LK H NI +Y ++I ++ ++ E +GS+
Sbjct: 61 G-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
Query: 118 QYRKKHKKVDMKAVKGW----ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 173
K K +K + W R+IL GL +LH H +IHRD+K N+ + EVK+
Sbjct: 116 DLIKNTKGNTLK--EEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKL 170
Query: 174 GDLGLATIMEQANAK--SVIGTPEFMAPE------LYDENYNELADIYSFGMCMLEMVTF 225
D G++ +++ + + IGTP +MAPE D Y+ +D++S G+ +EM
Sbjct: 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
Query: 226 EYPYSEC---RNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLM 281
P + R I + + +K SK + +SFIE CLV SQR + ++L+
Sbjct: 231 APPLCDMHPMRALFLIPRNPAPRLKSKKWSK----KFQSFIESCLVKNHSQRPATEQLMK 286
Query: 282 DPFLQVNGTTKNRPLPLPDIV 302
PF++ + + L D +
Sbjct: 287 HPFIRDQPNERQVRIQLKDHI 307
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-48
Identities = 74/302 (24%), Positives = 124/302 (41%), Gaps = 36/302 (11%)
Query: 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
M + + Y EVIG GA V A+ +VA ++ ++ +
Sbjct: 1 MSEDSSALPWSINRDDYELQ-EVIGSGATAVVQAAYCAPKKEKVA---IKRINLEKCQTS 56
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA 130
++ L E+ + H NI+ +Y S++ + ++ +L + GS+ K
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHK 114
Query: 131 VKGWA--------RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--- 179
R++L GL YLH + IHRD+K NI + G V+I D G++
Sbjct: 115 SGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFL 171
Query: 180 ----TIMEQANAKSVIGTPEFMAPELYDEN--YNELADIYSFGMCMLEMVTFEYPYSEC- 232
I K+ +GTP +MAPE+ ++ Y+ ADI+SFG+ +E+ T PY +
Sbjct: 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
Query: 233 --RNSAQIYKKVSSGIKPAALSKVKD----PEVKSFIEKCLV--PASQRLSAKELLMDPF 284
+ + ++ K + I CL P +R +A ELL F
Sbjct: 232 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDP-EKRPTAAELLRHKF 290
Query: 285 LQ 286
Q
Sbjct: 291 FQ 292
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-47
Identities = 80/289 (27%), Positives = 134/289 (46%), Gaps = 28/289 (9%)
Query: 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSE 77
+ DP + +G GAF VYKA ++ G A ++ + +S E+LE E
Sbjct: 12 RRDLDPNEVWEIV-GELGDGAFGKVYKAKNKETGALAA---AKVIE-TKSEEELEDYIVE 66
Query: 78 VHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ-YRKKHKKVDMKAVKGWAR 136
+ +L + H I++ ++ D I+ E G++ + + + ++ R
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR 124
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTP 194
Q+L L +LHS IIHRDLK N+ + +G++++ D G++ + K S IGTP
Sbjct: 125 QMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTP 181
Query: 195 EFMAPE------LYDENYNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSG 245
+MAPE + D Y+ ADI+S G+ ++EM E P+ E R +I K
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT 241
Query: 246 IK-PAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTK 292
+ P+ S E + F++ L R SA +LL PF+ + K
Sbjct: 242 LLTPSKWS----VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-47
Identities = 88/290 (30%), Positives = 139/290 (47%), Gaps = 23/290 (7%)
Query: 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
+E V DP +Y R+ E IG+GA TVY A D G EVA +R + LQ
Sbjct: 6 LEKLRSIVSVGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVA---IRQMN-LQQQPK 60
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA 130
E + +E+ +++ K+ NI+ + +S++ + ++ E GSL +D
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVV-TETCMDEGQ 117
Query: 131 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK-- 188
+ R+ L L +LHS+ +IHRD+K DNI + G VK+ D G + +K
Sbjct: 118 IAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRS 174
Query: 189 SVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSS 244
+++GTP +MAPE+ Y DI+S G+ +EM+ E PY R I +
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
Query: 245 GIK-PAALSKVKDPEVKSFIEKCL-VPASQRLSAKELLMDPFLQVNGTTK 292
++ P LS + F+ +CL + +R SAKELL FL++
Sbjct: 235 ELQNPEKLS----AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 77/322 (23%), Positives = 130/322 (40%), Gaps = 55/322 (17%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
+E S+ + P V T + I+ + IGKG + V+ + G +VA V+
Sbjct: 15 IEQSQSSGSGSGLPLL-VQRTIA--KQIQMVKQIGKGRYGEVWMG--KWRGEKVA---VK 66
Query: 61 IDDVLQSPEDLERLY-SEVHLLKSLKHNNIIRFYNSWIDDQNKTVN--IITELFTSGSLR 117
+ + E+ +E++ ++H NI+ F + I +IT+ +GSL
Sbjct: 67 V---FFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY 123
Query: 118 QYRKKHKKVDMKAVKGWARQILSGLIYLHS------HDPPIIHRDLKCDNIFINGNQGEV 171
Y K +D K++ A +SGL +LH+ P I HRDLK NI + N G
Sbjct: 124 DYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTC 181
Query: 172 KIGDLGLATIMEQAN------AKSVIGTPEFMAPELYDEN-------YNELADIYSFGMC 218
I DLGLA + +GT +M PE+ DE+ +AD+YSFG+
Sbjct: 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI 241
Query: 219 MLEMVT----------FEYPYSECRNS----AQIYKKVSSG-----IKPAALSKVKDPEV 259
+ E+ ++ PY + S + + V S ++
Sbjct: 242 LWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM 301
Query: 260 KSFIEKCLVP-ASQRLSAKELL 280
+ +C + RL+A +
Sbjct: 302 GKLMTECWAHNPASRLTALRVK 323
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-47
Identities = 81/290 (27%), Positives = 144/290 (49%), Gaps = 21/290 (7%)
Query: 10 KMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPE 69
+++ D D L P + E +G+G++ +VYKA + G VA ++ V +
Sbjct: 14 QLKKLDEDSLTKQPEEVF-DVLEKLGEGSYGSVYKAIHKETGQIVA---IKQVPVESDLQ 69
Query: 70 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ-YRKKHKKVDM 128
++ + E+ +++ +++++Y S+ +N + I+ E +GS+ R ++K +
Sbjct: 70 EIIK---EISIMQQCDSPHVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIIRLRNKTLTE 124
Query: 129 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK 188
+ + L GL YLH IHRD+K NI +N +G K+ D G+A + AK
Sbjct: 125 DEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAK 181
Query: 189 --SVIGTPEFMAPELYDEN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 245
+VIGTP +MAPE+ E YN +ADI+S G+ +EM + PY++ I+ ++
Sbjct: 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP 241
Query: 246 IKPAALSKVKD--PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTK 292
P K + F+++CLV QR +A +LL PF++
Sbjct: 242 --PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 23/278 (8%)
Query: 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSE 77
+ DP + IG G+F VY A D N VA ++ QS E + + E
Sbjct: 47 FFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKE 104
Query: 78 VHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQ-YRKKHKKVDMKAVKGWAR 136
V L+ L+H N I++ ++ + T ++ E + GS K + +
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREH--TAWLVME-YCLGSASDLLEVHKKPLQEVEIAAVTH 161
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF 196
L GL YLHSH+ +IHRD+K NI ++ G VK+GD G A+IM AN S +GTP +
Sbjct: 162 GALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN--SFVGTPYW 216
Query: 197 MAPE----LYDENYNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSGIKPA 249
MAPE + + Y+ D++S G+ +E+ + P I + S ++
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 276
Query: 250 ALSKVKDPEVKSFIEKCL-VPASQRLSAKELLMDPFLQ 286
S ++F++ CL R +++ LL F+
Sbjct: 277 HWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-47
Identities = 62/265 (23%), Positives = 123/265 (46%), Gaps = 17/265 (6%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNII 90
+G G V+K G +A Q+R + E+ +R+ ++ +LKS I+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDCPYIV 87
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
+ + ++I + + V I EL + + + ++ + + + I+ L YL
Sbjct: 88 QCFGTFITNTD--VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-KH 144
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK-SVIGTPEFMAPE------LYD 203
+IHRD+K NI ++ +G++K+ D G++ + AK G +MAPE
Sbjct: 145 GVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 204 ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK-DPEVKSF 262
+Y+ AD++S G+ ++E+ T ++PY C+ ++ KV P + + +SF
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263
Query: 263 IEKCLV-PASQRLSAKELLMDPFLQ 286
++ CL +R +LL F++
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFIK 288
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 79/283 (27%), Positives = 140/283 (49%), Gaps = 23/283 (8%)
Query: 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSE 77
V + DP Y IG+G+ V A ++ +G +VA V++ D L+ + E L++E
Sbjct: 38 VDQGDPRLLLDSY-VKIGEGSTGIVCLAREKHSGRQVA---VKMMD-LRKQQRRELLFNE 92
Query: 78 VHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQ 137
V +++ +H N++ Y S++ + + ++ E G+L +++ + +
Sbjct: 93 VVIMRDYQHFNVVEMYKSYLVGEE--LWVLMEFLQGGALTDIV-SQVRLNEEQIATVCEA 149
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPE 195
+L L YLH+ +IHRD+K D+I + G VK+ D G + + K S++GTP
Sbjct: 150 VLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPY 206
Query: 196 FMAPEL-YDENYNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSGIK-PAA 250
+MAPE+ Y DI+S G+ ++EMV E PY + ++ +K
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHK 266
Query: 251 LSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTK 292
+S P ++ F+E+ LV +R +A+ELL PFL G +
Sbjct: 267 VS----PVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 51/302 (16%), Positives = 110/302 (36%), Gaps = 50/302 (16%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
+++G+GA V++ + G A +++ + + ++ E +LK L H NI+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM---KAVKGWARQILSGLIYLHS 147
+ + + + +I E GSL ++ R ++ G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 148 HDPPIIHRDLKCDNIFINGNQGE---VKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD 203
+ I+HR++K NI + K+ D G A +E S+ GT E++ P++Y+
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 204 ---------ENYNELADIYSFGMCMLEMVT----FEYPYSECRNSAQIYKKVSSG----- 245
+ Y D++S G+ T F P+ R + ++ K+ +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGA 247
Query: 246 ------------------IKPAALSKVKDPEVKSFIEKCL-VPASQRLSAKELLMDPFLQ 286
+LS+ + + L + + +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
Query: 287 VN 288
++
Sbjct: 308 LH 309
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-46
Identities = 72/295 (24%), Positives = 118/295 (40%), Gaps = 52/295 (17%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLY-SEVHLLKSLKH 86
I E +GKG + V++ G VA V+I S ++ +E++ L+H
Sbjct: 10 ITLLECVGKGRYGEVWRG--SWQGENVA---VKI---FSSRDEKSWFRETELYNTVMLRH 61
Query: 87 NNIIRFYNSWIDDQNKTVN--IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
NI+ F S + ++ + +IT GSL Y + +D + I SGL +
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAH 120
Query: 145 LHS------HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI------MEQANAKSVIG 192
LH P I HRDLK NI + N G+ I DLGLA + +G
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 193 TPEFMAPELYDE-------NYNELADIYSFGMCMLEMVT----------FEYPYSECRNS 235
T +MAPE+ DE + + DI++FG+ + E+ ++ P+ + +
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 236 ----AQIYKKVSSG-----IKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 280
+ K V I S + +++C S RL+A +
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 57/273 (20%), Positives = 107/273 (39%), Gaps = 28/273 (10%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
V A+ + E+ D L SP ++ ++ + N +
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQY---RKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
+ I +L +L+ + R + + QI + +LHS
Sbjct: 127 LQPSSPKVY--LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--------------SVIGTPE 195
++HRDLK NIF + VK+GD GL T M+Q + +GT
Sbjct: 185 --LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 196 FMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV 254
+M+PE ++ NY+ DI+S G+ + E++ Y +S +I V + P ++
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQ- 297
Query: 255 KDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
K P+ ++ L P ++R A +++ + +
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 20/83 (24%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 26 RYIR-YKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK 82
RY+ ++ + +G+G F V++A ++V+ A ++R+ + E++ EV L
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALA 59
Query: 83 SLKHNNIIRFYNSWIDDQNKTVN 105
L+H I+R++N+W++ +
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQ 82
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 76/303 (25%), Positives = 118/303 (38%), Gaps = 54/303 (17%)
Query: 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEV 78
T R I +E IGKG F V++ + G EVA V + E E+
Sbjct: 38 RTIA--RTIVLQESIGKGRFGEVWRG--KWRGEEVA---VKIFSSREERSWFREA---EI 87
Query: 79 HLLKSLKHNNIIRFYNSWIDDQNKTVN--IITELFTSGSLRQYRKKHKKVDMKAVKGWAR 136
+ L+H NI+ F + D ++++ GSL Y ++ V ++ + A
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLAL 146
Query: 137 QILSGLIYLHS------HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA----- 185
SGL +LH P I HRDLK NI + N G I DLGLA + A
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTID 205
Query: 186 -NAKSVIGTPEFMAPELYDEN-------YNELADIYSFGMCMLEMVT----------FEY 227
+GT +MAPE+ D++ + ADIY+ G+ E+ ++
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265
Query: 228 PYSECRNS----AQIYKKVSSG-----IKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAK 277
PY + S ++ K V I S + + +C + RL+A
Sbjct: 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325
Query: 278 ELL 280
+
Sbjct: 326 RIK 328
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 31/266 (11%)
Query: 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLY-SEV 78
P+ + + EV+GKG F K G + + ++++ E+ +R + EV
Sbjct: 6 IFRPSD--LIHGEVLGKGCFGQAIKVTHRETGEVMV-----MKELIRFDEETQRTFLKEV 58
Query: 79 HLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQ 137
+++ L+H N+++F D+ +N ITE G+LR + + +A+
Sbjct: 59 KVMRCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ------------- 184
I SG+ YLHS + IIHRDL N + N V + D GLA +M
Sbjct: 117 IASGMAYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 185 ---ANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
+V+G P +MAPE + +Y+E D++SFG+ + E++ + +
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKC 266
G P +C
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRC 259
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 3e-45
Identities = 59/277 (21%), Positives = 115/277 (41%), Gaps = 27/277 (9%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
+++G+GA V++ + G A +++ + + ++ E +LK L H NI+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM---KAVKGWARQILSGLIYLHS 147
+ + + + +I E GSL ++ R ++ G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 148 HDPPIIHRDLKCDNIFINGNQGE---VKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD 203
+ I+HR++K NI + K+ D G A +E S+ GT E++ P++Y+
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 204 ---------ENYNELADIYSFGMCMLEMVT----FEYPYSECRNSAQIYKKVSSGIKPAA 250
+ Y D++S G+ T F P+ R + ++ K+ +G A
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGA 247
Query: 251 LSKVKDPEVKSFIEKCLVPASQRLSAK-ELLMDPFLQ 286
+S V+ E +P S LS ++L+ P L
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-45
Identities = 68/273 (24%), Positives = 121/273 (44%), Gaps = 20/273 (7%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNII 90
+G+GA+ V K +G +A V+ + ++ +RL ++ ++++ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMA---VKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
FY + + + V I E SL +Q K + + + A I+ L +LH
Sbjct: 70 TFYGALFREGD--VWICME-LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK-SVIGTPEFMAPE----- 200
S +IHRD+K N+ IN G+VK+ D G++ + AK G +MAPE
Sbjct: 127 S-KLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPE 184
Query: 201 LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260
L + Y+ +DI+S G+ M+E+ +PY Q K+V P + E
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV 244
Query: 261 SFIEKCLV-PASQRLSAKELLMDPFLQVNGTTK 292
F +CL + +R + EL+ PF ++ +
Sbjct: 245 DFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 67/298 (22%), Positives = 124/298 (41%), Gaps = 50/298 (16%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+G G V+K + +GL +A + ++ P ++ E+ +L I+
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVG 95
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
FY ++ D ++I E GSL Q KK ++ + + + ++ GL YL
Sbjct: 96 FYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE-KHK 152
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELA 210
I+HRD+K NI +N ++GE+K+ D G++ + + A S +GT +M+PE L +Y+ +
Sbjct: 153 IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 211
Query: 211 DIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD-------------- 256
DI+S G+ ++EM YP AA + +
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271
Query: 257 ---------------------------PEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286
E + F+ KCL+ ++R K+L++ F++
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 63/270 (23%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNII 90
IG+GA+ +V K + +G +A ++R ++ ++L ++ +++S I+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW----ARQILSGLIYLH 146
+FY + + + I EL ++ + Y+ + +D + + L +L
Sbjct: 85 QFYGALFREGD--CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV-IGTPEFMAPE----- 200
+ IIHRD+K NI ++ G +K+ D G++ + + AK+ G +MAPE
Sbjct: 143 E-NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 201 LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD---P 257
+ Y+ +D++S G+ + E+ T +PY + + +V G P + + P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSP 260
Query: 258 EVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286
+F+ CL S+R KELL PF+
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFIL 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-43
Identities = 76/288 (26%), Positives = 136/288 (47%), Gaps = 17/288 (5%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
+ +G GA+ V D+V +E A ++ I S +L EV +LK L H NI+
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERA-IKI-IRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
+ Y+ + D +N ++ E + G L K + +Q+LSG+ YLH H+
Sbjct: 100 KLYDFFEDKRN--YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN- 156
Query: 151 PIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPELYDENYN 207
I+HRDLK +N+ + + +KI D GL+ + E K +GT ++APE+ + Y+
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYD 215
Query: 208 ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIE 264
E D++S G+ + ++ P+ + +I +KV G V K I+
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKDLIK 273
Query: 265 KCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLP--DIVLPRVGAF 309
+ L + +R+SA++ L P+++ + K + LP + + F
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKF 321
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-43
Identities = 69/327 (21%), Positives = 113/327 (34%), Gaps = 70/327 (21%)
Query: 21 TDPTCRYIRYKEVIGKGA--FKTVYKAFDEVNGLEVAWCQVRIDDV-LQSPEDLERLYSE 77
Y VIGKG TV A + G V VR ++ S E + L E
Sbjct: 21 LPEGGCY-ELLTVIGKGFEDLMTVNLARYKPTGEYVT---VRRINLEACSNEMVTFLQGE 76
Query: 78 VHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMK--AVKGWA 135
+H+ K H NI+ + ++I D + ++T GS + H M A+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL 134
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK------- 188
+ +L L Y+H +HR +K +I I+ + G+V + L M +
Sbjct: 135 QGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 189 --SVIGTPEFMAPELYDEN---YNELADIYSFGMCMLEMVTFEYPYSE------------ 231
+ +++PE+ +N Y+ +DIYS G+ E+ P+ +
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
Query: 232 ------------------------CRNSAQIYKKVSSGIKPAALSKVKD-------PEVK 260
NS +S +P+ P
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 261 SFIEKCLVP-ASQRLSAKELLMDPFLQ 286
F+E+CL R SA LL F +
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFFK 338
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-43
Identities = 78/297 (26%), Positives = 120/297 (40%), Gaps = 34/297 (11%)
Query: 10 KMEPPDPDVLETDPTCRYIRY--KEVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQ 66
+E D D + I + K+V+G GA T+ + +VA V RI
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVA---VKRIL---- 57
Query: 67 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHK 124
PE EV LL+ +H N+IR++ + D Q I EL + +L++Y +K
Sbjct: 58 -PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQF--QYIAIEL-CAATLQEYVEQKDF 113
Query: 125 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE----VKIGDLGLAT 180
+Q SGL +LHS + I+HRDLK NI I+ I D GL
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 181 IMEQ-----ANAKSVIGTPEFMAPELYDE----NYNELADIYSFGMCMLEMVTFEY-PYS 230
+ + V GT ++APE+ E N DI+S G +++ P+
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 231 ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+ + + K +D + IEK + +R SAK +L PF
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-43
Identities = 84/287 (29%), Positives = 137/287 (47%), Gaps = 15/287 (5%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
+ V+GKG+F V D++ G E A +V ++ D E L EV LLK L H NI+
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECA-VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
+ Y + D ++ E++T G L K+ RQ+LSG+ Y+H +
Sbjct: 90 KLYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK- 146
Query: 151 PIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPELYDENYN 207
I+HRDLK +N+ + ++ ++I D GL+T E + K IGT ++APE+ Y+
Sbjct: 147 -IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD 205
Query: 208 ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIE 264
E D++S G+ + +++ P++ N I KKV G + KV K I
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKV-SESAKDLIR 263
Query: 265 KCLVP-ASQRLSAKELLMDPFLQVNGTTKNRP-LPLPDIVLPRVGAF 309
K L S R+SA++ L ++Q + +P D + + F
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQF 310
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-43
Identities = 66/311 (21%), Positives = 119/311 (38%), Gaps = 40/311 (12%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
+R + V+ +G F VY+A D +G E A R+ E + EV +K L
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYAL--KRLL--SNEEEKNRAIIQEVCFMKKLS 83
Query: 86 -HNNIIRFYNSWIDDQNKTVN-----IITELFTSGSLRQY---RKKHKKVDMKAVKGWAR 136
H NI++F ++ + ++ ++ G L ++ + + V
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV------ 190
Q + ++H PPIIHRDLK +N+ ++ G +K+ D G AT + S
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 191 --------IGTPEFMAPELYDEN----YNELADIYSFGMCML-EMVTFEYPYSECRNSAQ 237
TP + PE+ D E DI++ G C+L + ++P+ +
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-----G 256
Query: 238 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL 296
++ +G + S I L +RLS E++ N
Sbjct: 257 AKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316
Query: 297 PLPDIVLPRVG 307
P+ +++ G
Sbjct: 317 PITELLEQNGG 327
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 78/279 (27%), Positives = 138/279 (49%), Gaps = 23/279 (8%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDD--VLQSPEDLERLYSEVHLLKS 83
+ ++GKG+F VY+A GLEVA +++ D + ++R+ +EV +
Sbjct: 12 DFKVGN-LLGKGSFAGVYRAESIHTGLEVA---IKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGL 142
LKH +I+ YN + +D N V ++ E+ +G + +Y + + K + + QI++G+
Sbjct: 68 LKHPSILELYN-YFEDSNY-VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA--KSVIGTPEFMAPE 200
+YLHSH I+HRDL N+ + N +KI D GLAT ++ + ++ GTP +++PE
Sbjct: 126 LYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182
Query: 201 -LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDP 257
+ +D++S G ++ P+ + KV P+ LS
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPSFLS----I 237
Query: 258 EVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRP 295
E K I + L + RLS +L PF+ N +TK++
Sbjct: 238 EAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKD 276
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 66/260 (25%), Positives = 124/260 (47%), Gaps = 15/260 (5%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
+GKG F VY A ++ + +A + + ++ +L EV + L+H NI+R
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-GVEHQLRREVEIQSHLRHPNILRL 74
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
Y + D + V +I E G++ + +K K D + + ++ + L Y HS +
Sbjct: 75 YG-YFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--V 130
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELAD 211
IHRD+K +N+ + G+ GE+KI D G + + + GT +++ PE + ++E D
Sbjct: 131 IHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 189
Query: 212 IYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IK-PAALSKVKDPEVKSFIEKCLVP 269
++S G+ E + + P+ E + YK++S P ++ + I + L
Sbjct: 190 LWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVT----EGARDLISRLLKH 244
Query: 270 -ASQRLSAKELLMDPFLQVN 288
SQR +E+L P++ N
Sbjct: 245 NPSQRPMLREVLEHPWITAN 264
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-42
Identities = 80/296 (27%), Positives = 131/296 (44%), Gaps = 23/296 (7%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVA---------WCQVRIDDVLQSPEDLERLYSEVHLL 81
+G GA+ V ++ E A DD + E +Y+E+ LL
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
KSL H NII+ ++ + D + ++TE + G L + K D +QILSG
Sbjct: 101 KSLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158
Query: 142 LIYLHSHDPPIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMA 198
+ YLH H+ I+HRD+K +NI N N +KI D GL++ + + +GT ++A
Sbjct: 159 ICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216
Query: 199 PELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---KPAALSKVK 255
PE+ + YNE D++S G+ M ++ P+ +N I KKV G +
Sbjct: 217 PEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNI- 274
Query: 256 DPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL-PLPDIVLPRVGAF 309
E K I+ L ++R +A+E L +++ N+ L + F
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKF 330
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 9e-42
Identities = 63/275 (22%), Positives = 125/275 (45%), Gaps = 21/275 (7%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
+ IG+G++ V A + + A ++ V ED++R E+ ++KSL H NII
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNII 69
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
R Y ++ D+ + + ++ EL T G L + + + +LS + Y H +
Sbjct: 70 RLYETFEDNTD--IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN- 126
Query: 151 PIIHRDLKCDNIFINGNQGE--VKIGDLGLATIMEQANA-KSVIGTPEFMAPELYDENYN 207
+ HRDLK +N + + +K+ D GLA + ++ +GTP +++P++ + Y
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYG 185
Query: 208 ELADIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSF 262
D +S G M+ ++ YP + +++ K+ G V + +S
Sbjct: 186 PECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVSP-QAESL 241
Query: 263 IEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL 296
I + L QR+++ + L + + ++ R L
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-41
Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 17/288 (5%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
++GKG+F V K D + E A +V I+ +D + EV LLK L H NI+
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYA-VKV-INKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
+ + D + I+ EL+T G L K K+ +Q+ SG+ Y+H H+
Sbjct: 85 KLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 151 PIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPELYDENYN 207
I+HRDLK +NI + + ++KI D GL+T +Q K IGT ++APE+ Y+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYD 200
Query: 208 ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIE 264
E D++S G+ + +++ P+ +N I K+V +G + + K I
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTI-SDDAKDLIR 258
Query: 265 KCLVP-ASQRLSAKELLMDPFLQVNGTTKNR--PLPLPDIVLPRVGAF 309
K L S R++A + L P++Q + LP + + + F
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQF 306
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-41
Identities = 68/268 (25%), Positives = 108/268 (40%), Gaps = 19/268 (7%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
KE +G G F V + + G +VA ++ SP++ ER E+ ++K L H N++
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 91 RFYNSWIDDQNKTVN-----IITELFTSGSLRQYRKKHKKVDM---KAVKGWARQILSGL 142
D K + E G LR+Y + + ++ I S L
Sbjct: 76 SAREV-PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 143 IYLHSHDPPIIHRDLKCDNIFI--NGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAP 199
YLH + IIHRDLK +NI + + KI DLG A ++Q +GT +++AP
Sbjct: 135 RYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 200 ELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258
EL + + Y D +SFG E +T P+ Q + KV +
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 259 VKSFIEKCLVPASQRLSAKELLMDPFLQ 286
F P + ++ +LQ
Sbjct: 253 AVKFSSVLPTP-NHLSGILAGKLERWLQ 279
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-41
Identities = 64/260 (24%), Positives = 126/260 (48%), Gaps = 15/260 (5%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
+GKG F VY A ++ N +A + + + +L E+ + L+H NI+R
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-GVEHQLRREIEIQSHLRHPNILRM 79
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
YN + D+ + + ++ E G L + +KH + D + + ++ L Y H +
Sbjct: 80 YN-YFHDRKR-IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--V 135
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELAD 211
IHRD+K +N+ + G +GE+KI D G + +++ GT +++ PE + + ++E D
Sbjct: 136 IHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVD 194
Query: 212 IYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IK-PAALSKVKDPEVKSFIEKCLVP 269
++ G+ E + P+ + + + ++++ + +K P LS K I K L
Sbjct: 195 LWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFLS----DGSKDLISKLLRY 249
Query: 270 -ASQRLSAKELLMDPFLQVN 288
QRL K ++ P+++ N
Sbjct: 250 HPPQRLPLKGVMEHPWVKAN 269
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 82/271 (30%), Positives = 131/271 (48%), Gaps = 19/271 (7%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
++GKG+F V K D + E A +V I+ +D + EV LLK L H NI+
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYA-VKV-INKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
+ + D + I+ EL+T G L K K+ +Q+ SG+ Y+H H+
Sbjct: 85 KLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 151 PIIHRDLKCDNIFINGNQGE--VKIGDLGLATIMEQANA-KSVIGTPEFMAPELYDENYN 207
I+HRDLK +NI + + + +KI D GL+T +Q K IGT ++APE+ Y+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYD 200
Query: 208 ELADIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSF 262
E D++S G +L ++ P Y + N I K+V +G + D + K
Sbjct: 201 EKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISD-DAKDL 256
Query: 263 IEKCLVP-ASQRLSAKELLMDPFLQVNGTTK 292
I K L S R++A + L P++Q + +
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 64/271 (23%), Positives = 124/271 (45%), Gaps = 29/271 (10%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
K +G GAF V+ + +GLE ++ + +S +E++ +E+ +LKSL H NII
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
+ + + D N + I+ E G L + + K + V +Q+++ L Y H
Sbjct: 84 KIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 147 SHDPPIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPELYD 203
S ++H+DLK +NI F + + +KI D GLA + + + GT +MAPE++
Sbjct: 142 SQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK 199
Query: 204 ENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSGI-----KPAALSKVKD 256
+ DI+S G ++ + + ++ +K + + L+
Sbjct: 200 RDVTFKCDIWSAG-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVECRPLT---- 252
Query: 257 PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
P+ +++ L +R SA ++L + +
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 4e-40
Identities = 46/336 (13%), Positives = 95/336 (28%), Gaps = 57/336 (16%)
Query: 8 AAKMEPPDPDVLETDPTCRYIRYK--EVIGKGAFKTVYKAFDEVNGLEVA---------- 55
+ P +E++ R V+G+ +A D+ G
Sbjct: 53 TSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP 112
Query: 56 --------------WCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101
+R + + R L+K + +IR D
Sbjct: 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 172
Query: 102 KTVNIITELFTS------GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHR 155
+ + S L + HK + A Q++ L LH + ++H
Sbjct: 173 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHT 230
Query: 156 DLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDEN---------- 205
L+ +I ++ G V + + + F PEL
Sbjct: 231 YLRPVDIVLDQR-GGVFLTGFEHL--VRDGARVVSSVSRGFEPPELEARRATISYHRDRR 287
Query: 206 --YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263
D ++ G+ + + + P ++ + + + + V++ +
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCADLPITK-DAALGGSEWIFRS--CKNIP----QPVRALL 340
Query: 264 EKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPL 298
E L RL + + P + T + LPL
Sbjct: 341 EGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPL 376
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-39
Identities = 78/308 (25%), Positives = 131/308 (42%), Gaps = 42/308 (13%)
Query: 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI-------DD 63
+ D V YI K +G GA V AF+ +VA +RI
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKT-LGSGACGEVKLAFERKTCKKVA---IRIISKRKFAIG 176
Query: 64 VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH 123
+ + + +E+ +LK L H II+ N D ++ I+ EL G L +
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAED--YYIVLELMEGGELFDKVVGN 233
Query: 124 KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI--NGNQGEVKIGDLGLATI 181
K++ K + Q+L + YLH + IIHRDLK +N+ + +KI D G + I
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 182 MEQANA-KSVIGTPEFMAPE----LYDENYNELADIYSFGMCMLEMVTFEY-------PY 229
+ + + +++ GTP ++APE + YN D +S G +L + P+
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VIL------FICLSGYPPF 344
Query: 230 SECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFL 285
SE R + +++SG P ++V + ++K LV R + +E L P+L
Sbjct: 345 SEHRTQVSLKDQITSGKYNFIPEVWAEV-SEKALDLVKKLLVVDPKARFTTEEALRHPWL 403
Query: 286 QVNGTTKN 293
Q +
Sbjct: 404 QDEDMKRK 411
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 70/308 (22%), Positives = 115/308 (37%), Gaps = 54/308 (17%)
Query: 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERL 74
+ L ++ EV +G F V+KA ++ VA V+I +
Sbjct: 15 GTENLYFQSMP--LQLLEVKARGRFGCVWKA--QLLNEYVA---VKI---FPIQDKQSWQ 64
Query: 75 Y-SEVHLLKSLKHNNIIRFYNSWIDDQNKTVN--IITELFTSGSLRQYRKKHKKVDMKAV 131
EV+ L +KH NI++F + + V+ +IT GSL + K + V +
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNEL 123
Query: 132 KGWARQILSGLIYLHS--------HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183
A + GL YLH H P I HRD+K N+ + N I D GLA E
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFE 182
Query: 184 QA----NAKSVIGTPEFMAPEL------YDENYNELADIYSFGMCMLEMVT--------- 224
+ +GT +MAPE+ + + D+Y+ G+ + E+ +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 225 --FEYPYSECRNS----AQIYKKVSSG-----IKPAALSKVKDPEVKSFIEKCLVP-ASQ 272
+ P+ E + + V ++ + IE+C A
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 273 RLSAKELL 280
RLSA +
Sbjct: 303 RLSAGCVG 310
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-39
Identities = 74/295 (25%), Positives = 132/295 (44%), Gaps = 42/295 (14%)
Query: 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI-------DDVLQSPEDLERLYS 76
YI + +G GA V AF+ +VA ++I + + + +
Sbjct: 9 RDEYI-MSKTLGSGACGEVKLAFERKTCKKVA---IKIISKRKFAIGSAREADPALNVET 64
Query: 77 EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 136
E+ +LK L H II+ N + D ++ I+ EL G L +K++ K +
Sbjct: 65 EIEILKKLNHPCIIKIKN-FFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE--VKIGDLGLATIMEQANA-KSVIGT 193
Q+L + YLH + IIHRDLK +N+ ++ + + +KI D G + I+ + + +++ GT
Sbjct: 122 QMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 194 PEFMAPE----LYDENYNELADIYSFGMCMLEMVTFEY-------PYSECRNSAQIYKKV 242
P ++APE + YN D +S G +L + P+SE R + ++
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQI 232
Query: 243 SSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKN 293
+SG P ++V + ++K LV R + +E L P+LQ +
Sbjct: 233 TSGKYNFIPEVWAEV-SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 286
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 75/288 (26%), Positives = 132/288 (45%), Gaps = 33/288 (11%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
KE +GKGAF V + + GLE A ++ I+ S D ++L E + + L+H NI+
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFA-AKI-INTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
R ++S ++ ++ +L T G L + + +QIL + Y HS+
Sbjct: 69 RLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG- 125
Query: 151 PIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDENY 206
I+HR+LK +N+ + +G VK+ D GLA + + A GTP +++PE L + Y
Sbjct: 126 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 207 NELADIYSFG------MCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAALSKVK 255
++ DI++ G + YP + E + ++Y ++ +G V
Sbjct: 185 SKPVDIWACGVILYILLV-------GYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVT 235
Query: 256 DPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIV 302
E KS I+ L +R++A + L P++ N + D V
Sbjct: 236 P-EAKSLIDSMLTVNPKKRITADQALKVPWIC-NRERVASAIHRQDTV 281
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 43/313 (13%), Positives = 85/313 (27%), Gaps = 45/313 (14%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
R ++ E + G V+ D + A +V S +LERL+ L
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFA-LKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 86 HNN------------------------IIRFYNSWIDDQNKTVNIITELFTS------GS 115
+ + D ++ + +
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 116 LRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 175
L + A+ Q++ L S ++H DN+FI + G + +GD
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD-GRLMLGD 237
Query: 176 LGLATIMEQANAKSVIGTPEFMAPELYDEN---YNELADIYSFGMCMLEMVTFEYPYSEC 232
+ + + E + + + + + G+ + + P+
Sbjct: 238 VSALWK-VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 233 RNSAQIYKKVSSGIKPAALSKVKD------PEVKSFIEKCLVP-ASQRLSAKELLMDPFL 285
+ K S P S VK+ I + L +RL E + P
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
Query: 286 QVNGTTKNRPLPL 298
+ L
Sbjct: 357 LQLQNEISSSLST 369
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 63/293 (21%), Positives = 123/293 (41%), Gaps = 29/293 (9%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL- 84
Y K+V+G G V + F G + A ++ + D + EV
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCA-LKL-LYDS----PKARQ---EVDHHWQAS 79
Query: 85 KHNNIIRFYNSWIDDQN--KTVNIITELFTSGSL--RQYRKKHKKVDMKAVKGWARQILS 140
+I+ + + + + + + II E G L R + + + R I +
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 141 GLIYLHSHDPPIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANAKSVIGTPEFMA 198
+ +LHSH+ I HRD+K +N+ + + + +K+ D G A Q ++ TP ++A
Sbjct: 140 AIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVA 197
Query: 199 PE-LYDENYNELADIYSFGMCMLEMVTFEYP--YSECRN--SAQIYKKVSSG---IKPAA 250
PE L E Y++ D++S G+ M ++ +P YS S + +++ G
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILLC-GFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 251 LSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIV 302
S+V + + K I L ++RL+ + + P++ + PL ++
Sbjct: 257 WSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVL 308
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 70/315 (22%), Positives = 116/315 (36%), Gaps = 63/315 (20%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQV--RIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
K IG+G++ V A + A ++ + +P+D+ER+ +EV L+K L H N
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRA-IKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWA------------- 135
I R Y + D+Q + ++ EL G L
Sbjct: 90 IARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 136 ---------------------------RQILSGLIYLHSHDPPIIHRDLKCDNI-FINGN 167
RQI S L YLH+ I HRD+K +N F
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNK 205
Query: 168 QGEVKIGDLGLATIMEQANA------KSVIGTPEFMAPEL---YDENYNELADIYSFGMC 218
E+K+ D GL+ + N + GTP F+APE+ +E+Y D +S G+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 219 MLEMVTFEYPYSECRNSAQIYKKVSSG---IKPAALSKVKDPEVKSFIEKCLVP-ASQRL 274
+ ++ P+ N A +V + + + + P + + L +R
Sbjct: 266 LHLLLMGAVPF-PGVNDADTISQVLNKKLCFENPNYNVL-SPLARDLLSNLLNRNVDERF 323
Query: 275 SAKELLMDPFLQVNG 289
A L P++
Sbjct: 324 DAMRALQHPWISQFS 338
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-38
Identities = 77/327 (23%), Positives = 143/327 (43%), Gaps = 35/327 (10%)
Query: 3 SSEDGAAKMEPPDPDVLETDP--TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVR 60
+S G +M ++ + Y KE +GKGAF V + + GLE A ++
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNY-DVKEELGKGAFSVVRRCVHKTTGLEFA-AKI- 61
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
I+ S D ++L E + + L+H NI+R ++S ++ ++ +L T G L +
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF--HYLVFDLVTGGELFEDI 119
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI-FINGNQG-EVKIGDLGL 178
+ +QIL + Y HS+ I+HR+LK +N+ + +G VK+ D GL
Sbjct: 120 VAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 179 ATIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEY-------PY 229
A + + A GTP +++PE L + Y++ DI++ G+ + Y P+
Sbjct: 178 AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL-------YILLVGYPPF 230
Query: 230 SECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFL 285
+ + ++Y ++ +G V E KS I+ L +R++A + L P++
Sbjct: 231 WD-EDQHRLYAQIKAGAYDYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWI 288
Query: 286 QVNGTTKNRPLPLPDIVLPRVGAFGDR 312
+ + + F R
Sbjct: 289 CNRERVASA--IHRQDTVDCLKKFNAR 313
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 72/307 (23%), Positives = 125/307 (40%), Gaps = 25/307 (8%)
Query: 2 ESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI 61
+ ED K P +V + Y E +G GAF V++ ++ G +
Sbjct: 28 KFYEDIWKKYVPQPVEVKQGSVYDYYD-ILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86
Query: 62 DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL--RQY 119
P D + +E+ ++ L H +I ++++ D + +I E + G L R
Sbjct: 87 ----PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIA 140
Query: 120 RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI-FINGNQGEVKIGDLGL 178
+ +K + + + + RQ GL ++H H I+H D+K +NI VKI D GL
Sbjct: 141 AEDYKMSEAEVIN-YMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 179 ATIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP--YSECRN 234
AT + K T EF APE + E D+++ G + ++ E +
Sbjct: 198 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--D 254
Query: 235 SAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGT 290
+ + V A S V E K FI+ L +RL+ + L P+L+ + +
Sbjct: 255 DLETLQNVKRCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313
Query: 291 TKNRPLP 297
+P
Sbjct: 314 NLTSRIP 320
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 7e-37
Identities = 48/327 (14%), Positives = 96/327 (29%), Gaps = 54/327 (16%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL- 84
R + V+G+ +A D+ G V ++++ EV L+ L
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFE-VHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 85 ---------------------KHNNIIRFYNSWIDDQNKTVNIITELFTS---------G 114
K + +D+++ V L+
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 115 SLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174
L + HK + A Q++ L LH + ++H L+ +I ++ G V +
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLT 253
Query: 175 DLGLATIMEQAN---AKSVIGTPEFMAPELY------DENYNELADIYSFGMCMLEMVTF 225
+ PE A + D ++ G+ + +
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 226 EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPF 284
+ P ++ + + + K V++ +E L RL + + P
Sbjct: 314 DLPNTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPE 366
Query: 285 LQVNGTTKNRPLPL--PDIVLPRVGAF 309
+ T + LPL D R G
Sbjct: 367 YEQLRTELSAALPLYQTDGEPTREGGA 393
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 70/262 (26%), Positives = 132/262 (50%), Gaps = 20/262 (7%)
Query: 34 IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ-SPEDLERLYSEVHLLKSLKHNNIIRF 92
IGKG F V A + G EVA ++I D Q +P L++L+ EV ++K L H NI++
Sbjct: 23 IGKGNFAKVKLARHILTGREVA---IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
+ + KT+ +I E + G + Y H ++ K + RQI+S + Y H I
Sbjct: 80 FEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--I 135
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPELY-DENYN-EL 209
+HRDLK +N+ ++ + +KI D G + + G P + APEL+ + Y+
Sbjct: 136 VHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 210 ADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCL 267
D++S G+ + +V+ P+ +N ++ ++V G P +S + ++ +++ L
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFYMS----TDCENLLKRFL 249
Query: 268 VP-ASQRLSAKELLMDPFLQVN 288
V +R + ++++ D ++
Sbjct: 250 VLNPIKRGTLEQIMKDRWINAG 271
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-37
Identities = 66/300 (22%), Positives = 111/300 (37%), Gaps = 53/300 (17%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLL-KS 83
+ ++++G G+ TV G VA V R+ + + E+ LL +S
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVA---VKRML-----IDFCDIALMEIKLLTES 65
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWA-------R 136
H N+IR+Y S D+ + I EL + +L+ + D R
Sbjct: 66 DDHPNVIRYYCSETTDRF--LYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFIN------------GNQGEVKIGDLGLATIME- 183
QI SG+ +LHS IIHRDLK NI ++ + I D GL ++
Sbjct: 123 QIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 184 -----QANAKSVIGTPEFMAPEL--------YDENYNELADIYSFGMCMLEMVTFEYP-- 228
+ N + GT + APEL DI+S G +++
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 229 YSECRNSAQIYKKVSSGIKPAALS-KVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+ + I + + S + L + E I + + +R +A ++L P
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 64/284 (22%), Positives = 113/284 (39%), Gaps = 29/284 (10%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID---DVLQSPEDLERLYSEVHLLKSLKHN 87
EVIGKG F V + + G + A ++ +D E L E + LKH
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFA-VKI-VDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSL--RQYRKKHKKVDM--KAVKGWARQILSGLI 143
+I+ ++ D + ++ E L ++ + RQIL L
Sbjct: 87 HIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 144 YLHSHDPPIIHRDLKCDNI-FIN-GNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAP 199
Y H ++ IIHRD+K + + N VK+G G+A + A +GTP FMAP
Sbjct: 145 YCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 200 E-LYDENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSGIKPAALSKVKD 256
E + E Y + D++ G +L ++ Y ++++ + G K +
Sbjct: 203 EVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKG-KYKMNPRQWS 257
Query: 257 ---PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL 296
K + + L+ ++R++ E L P+L+ +
Sbjct: 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIH 301
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 53/305 (17%), Positives = 109/305 (35%), Gaps = 44/305 (14%)
Query: 33 VIGKGAFKTVY-----------KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
+ +G F + K +++ + +D + + +E+ ++
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGW------- 134
+K+ + + V II E + S+ ++ + +D
Sbjct: 98 TDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 135 -ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGT 193
+ +L+ Y+H+ I HRD+K NI ++ N G VK+ D G + M K GT
Sbjct: 156 IIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSRGT 213
Query: 194 PEFMAPELYDEN---YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG----- 245
EFM PE + DI+S G+C+ M P+S + +++ + +
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP 273
Query: 246 ------------IKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTK 292
K + E F++ L ++R+++++ L +L
Sbjct: 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED 333
Query: 293 NRPLP 297
R
Sbjct: 334 LREFS 338
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 74/296 (25%), Positives = 127/296 (42%), Gaps = 23/296 (7%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWC---QVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
E +G G F V K ++ GLE A + R + E + EV +L+ + H+
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYA-AKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
N+I ++ + + + V +I EL + G L + + + + + + +QIL G+ YLH+
Sbjct: 76 NVITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 148 HDPPIIHRDLKCDNIFI---NGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LY 202
I H DLK +NI + N +K+ D GLA +E K++ GTPEF+APE +
Sbjct: 134 KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 203 DENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAALSKVKDP 257
E AD++S G + ++ + + ++S S +
Sbjct: 192 YEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFSHTSE- 247
Query: 258 EVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDR 312
K FI K LV +RL+ +E L P++ + + L R
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVR 303
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 80/350 (22%), Positives = 146/350 (41%), Gaps = 44/350 (12%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
E +GKGAF V + + G E A + I+ S D ++L E + + LKH NI+
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYA-AMI-INTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
R ++S ++ + +I +L T G L + + +QIL +++ H
Sbjct: 74 RLHDSISEEGH--HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG- 130
Query: 151 PIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIM--EQANAKSVIGTPEFMAPE-LYDEN 205
++HR+LK +N+ + +G VK+ D GLA + EQ GTP +++PE L +
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 206 YNELADIYSFG------MCMLEMVTFEYP--YSECRNSAQIYKKVSSGIKPAALSKVKDP 257
Y + D+++ G + YP + E + ++Y+++ +G A
Sbjct: 190 YGKPVDLWACGVILYILLV-------GYPPFWDE--DQHRLYQQIKAG----AYDFPSPE 236
Query: 258 ------EVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFG 310
E K I K L S+R++A E L P++ T + + + F
Sbjct: 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASC--MHRQETVDCLKKFN 294
Query: 311 DRCLMSEGPASVRNKHPSMDFDSDAELPVITSL---DNSGGGDSYSPSIE 357
R + +V + + V L ++G +SY+ +
Sbjct: 295 ARRKLKGAILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDFESYTKMCD 344
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 28/287 (9%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNI 89
+ +G+G+F K + + A ++ I E+ LK + H NI
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFA-VKI-ISK-----RMEANTQKEITALKLCEGHPNI 68
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
++ + + D + ++ EL G L + KK K R+++S + ++H
Sbjct: 69 VKLHEVFHDQLH--TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 150 PPIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANA--KSVIGTPEFMAPE-LYDE 204
++HRDLK +N+ F + N E+KI D G A + N K+ T + APE L
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 205 NYNELADIYSFGMCMLEMVT----F--EYPYSECRNSAQIYKKVSSG---IKPAALSKVK 255
Y+E D++S G+ + M++ F C ++ +I KK+ G + A V
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 256 DPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDI 301
E K I+ L ++RL L + +LQ + PL PDI
Sbjct: 245 Q-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDI 290
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 65/307 (21%), Positives = 119/307 (38%), Gaps = 36/307 (11%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
YI + +G+G F V + + G E A + + + + + E+ +L+ K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYA-AKF-LKKRRRGQDCRAEILHEIAVLELAK 86
Query: 86 HN-NIIRFYNSWIDDQNKTVNIITELFTSGSL--RQYRKKHKKVDMKAVKGWARQILSGL 142
+I + + + + +I E G + + + V V +QIL G+
Sbjct: 87 SCPRVINLHEVYENTSE--IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 143 IYLHSHDPPIIHRDLKCDNI-FINGNQ-GEVKIGDLGLATIMEQANA-KSVIGTPEFMAP 199
YLH ++ I+H DLK NI + G++KI D G++ + A + ++GTPE++AP
Sbjct: 145 YYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 200 E-LYDENYNELADIYSFG------MCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---K 247
E L + D+++ G + E ++ + Y +S
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLT-------HTSPFVGE--DNQETYLNISQVNVDYS 253
Query: 248 PAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRV 306
S V FI+ LV +R +A+ L +LQ +N P +
Sbjct: 254 EETFSSVSQ-LATDFIQSLLVKNPEKRPTAEICLSHSWLQ-QWDFENLFHPEETSSSSQT 311
Query: 307 GAFGDRC 313
R
Sbjct: 312 QDHSVRS 318
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 69/307 (22%), Positives = 129/307 (42%), Gaps = 43/307 (14%)
Query: 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID-DVLQSPEDLERLYSEVH 79
T+ + + EV+G GAF V+ + G A + I LE E+
Sbjct: 5 TNIRKTF-IFMEVLGSGAFSEVFLVKQRLTGKLFA-LKC-IKKSPAFRDSSLEN---EIA 58
Query: 80 LLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQIL 139
+LK +KH NI+ + + ++ +L + G L + K +Q+L
Sbjct: 59 VLKKIKHENIVTLED-IYESTTH-YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL 116
Query: 140 SGLIYLHSHDPPIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANAKSVIGTPEFM 197
S + YLH + I+HRDLK +N+ ++ + ++ I D GL+ + + + GTP ++
Sbjct: 117 SAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYV 174
Query: 198 APE-LYDENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSG--------- 245
APE L + Y++ D +S G + ++ YP Y E +++++K+ G
Sbjct: 175 APEVLAQKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFW 231
Query: 246 --IKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIV 302
I +A K FI L ++R + ++ L P++ N + V
Sbjct: 232 DDISESA---------KDFICHLLEKDPNERYTCEKALSHPWIDGNTALHR---DIYPSV 279
Query: 303 LPRVGAF 309
++
Sbjct: 280 SLQIQKN 286
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 66/299 (22%), Positives = 119/299 (39%), Gaps = 42/299 (14%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL- 84
Y +V+G G V + F++ + A ++ + D R EV L
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFA-LKM-LQDC----PKARR---EVELHWRAS 112
Query: 85 KHNNIIRFYNSWID--DQNKTVNIITELFTSGSL--RQYRKKHKKVDMKAVKGWARQILS 140
+ +I+R + + + K + I+ E G L R + + + + I
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 141 GLIYLHSHDPPIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANA-KSVIGTPEFM 197
+ YLHS + I HRD+K +N+ + + +K+ D G A N+ + TP ++
Sbjct: 173 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 230
Query: 198 APE-LYDENYNELADIYSFG------MCMLEMVTFEYP--YSECRNSAQ--IYKKVSSGI 246
APE L E Y++ D++S G +C YP YS + + ++ G
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLC-------GYPPFYSNHGLAISPGMKTRIRMGQ 283
Query: 247 ---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDI 301
S+V + EVK I L +QR++ E + P++ + PL +
Sbjct: 284 YEFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 341
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 41/227 (18%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSE--VHLLKSLK 85
++ E+IG+G + VYK ++ VA V++ S + + +E ++ + ++
Sbjct: 15 LKLLELIGRGRYGAVYKG--SLDERPVA---VKVF----SFANRQNFINEKNIYRVPLME 65
Query: 86 HNNIIRFYNSWIDDQNKTVN---IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
H+NI RF ++ E + +GSL +Y H D + A + GL
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGL 124
Query: 143 IYLHS-------HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM----------EQA 185
YLH+ + P I HRDL N+ + + G I D GL+ + E
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 186 NAKSVIGTPEFMAPELYD--------ENYNELADIYSFGMCMLEMVT 224
A S +GT +MAPE+ + E+ + D+Y+ G+ E+
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 68/289 (23%), Positives = 125/289 (43%), Gaps = 33/289 (11%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQV---RIDDVLQSPEDLERLYSEVHLLKS 83
+Y+ ++G G F +VY + L VA V RI D + P + R+ EV LLK
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP-NGTRVPMEVVLLKK 102
Query: 84 LKHN--NIIRFYNSWIDDQNKTVNIITELFT-SGSLRQYRKKHKKVDMKAVKGWARQILS 140
+ +IR + W + + V +I E L + + + + + + Q+L
Sbjct: 103 VSSGFSGVIRLLD-WFERPDSFV-LILERPEPVQDLFDFITERGALQEELARSFFWQVLE 160
Query: 141 GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE 200
+ + H+ ++HRD+K +NI I+ N+GE+K+ D G +++ GT + PE
Sbjct: 161 AVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 218
Query: 201 -LYDENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKD 256
+ Y+ A ++S G+ + +MV + P+ +++ G +S
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQVFFRQRVS---- 267
Query: 257 PEVKSFIEKCLVPA-SQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLP 304
E + I CL S R + +E+ P++Q P +I L
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV----LLPQETAEIHLH 312
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 73/319 (22%), Positives = 125/319 (39%), Gaps = 54/319 (16%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
Y ++V+G+GA V + + E A ++ I+ Q R++ EV +L +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYA-VKI-IEK--QPGHIRSRVFREVEMLYQCQ 68
Query: 86 -HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
H N++ + ++ ++ E GS+ + K + + + + S L +
Sbjct: 69 GHRNVLELIEFFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDF 126
Query: 145 LHSHDPPIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANAKSVI---------GT 193
LH+ I HRDLK +NI + NQ VKI D L + ++ S I G+
Sbjct: 127 LHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 194 PEFMAPE------LYDENYNELADIYSFGMCM--------------LEMVTFEYPYSECR 233
E+MAPE Y++ D++S G+ + ++ +
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 234 NSAQIYKKVSSGIKPAALSKVKDP------EVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+++ + G K I K LV A QRLSA ++L P++Q
Sbjct: 245 CQNMLFESIQEG----KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
Query: 287 VNGTTKNRPLPLPDIVLPR 305
G LP P VL R
Sbjct: 301 --GCAPENTLPTPM-VLQR 316
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 57/298 (19%), Positives = 105/298 (35%), Gaps = 36/298 (12%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNI 89
++G+GAF VY+A + + + P + + LK +
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-----VDMKAVKGWARQILSGLIY 144
++FY S QN +V ++ EL++ G+L +K + V +A ++L +
Sbjct: 130 MKFY-SAHLFQNGSV-LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 145 LHSHDPPIIHRDLKCDNIFING----------NQGEVKIGDLGLA----TIMEQANAKSV 190
+H + IIH D+K DN + + + DLG + + +
Sbjct: 188 VHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 191 IGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA 249
T F E L ++ +N D + + M+ Y + + + +
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP-- 303
Query: 250 ALSKVKDPEVKSFIEKCL-VPASQRLSAKELL---MDPFLQVNGTTKNRPLPLPDIVL 303
F L +P L + +LL + Q + T K R L IVL
Sbjct: 304 -----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVL 356
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 60/289 (20%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVA----------------------WCQVRIDDVLQSP 68
K+ IGKG++ V A++E + A + +Q
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM 128
+E++Y E+ +LK L H N+++ D + ++ EL G + + +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 129 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA- 187
+A + + ++ G+ YLH IIHRD+K N+ + + G +KI D G++ + ++A
Sbjct: 138 QARF-YFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDAL 193
Query: 188 -KSVIGTPEFMAPEL---YDENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242
+ +GTP FMAPE + ++ + D+++ G+ + V + P+ + ++ K+
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKI 252
Query: 243 SSGI----KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
S ++ ++K I + L R+ E+ + P++
Sbjct: 253 KSQALEFPDQPDIA----EDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 72/296 (24%), Positives = 129/296 (43%), Gaps = 35/296 (11%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP--EDLERLYSEVHLLKSL 84
Y+ ++GKG F TV+ + L+VA + + VL D EV LL +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 85 ----KHNNIIRFYNSWIDDQNKTVNIITELFTSGS-LRQYRKKHKKVDMKAVKGWARQIL 139
H +IR + W + Q + ++ E L Y + + + + Q++
Sbjct: 92 GAGGGHPGVIRLLD-WFETQEGFM-LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAP 199
+ + + HS ++HRD+K +NI I+ +G K+ D G ++ GT + P
Sbjct: 150 AAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPP 207
Query: 200 E-LYDENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVK 255
E + Y+ A ++S G+ + +MV + P+ +++ PA +S
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFER-------DQEILEAELHFPAHVS--- 257
Query: 256 DPEVKSFIEKCLVPA-SQRLSAKELLMDPFLQVNGT------TKNRPLPLPDIVLP 304
P+ + I +CL P S R S +E+L+DP++Q +K P PL +LP
Sbjct: 258 -PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLLP 312
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 76/323 (23%), Positives = 136/323 (42%), Gaps = 36/323 (11%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQV---RIDDVLQSPEDLERLYSEVHLLKSLKHN 87
E +G G F V K ++ GL+ A + R + E + EV +LK ++H
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
N+I + + + + V +I EL G L + + + + + + +QIL+G+ YLHS
Sbjct: 75 NVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 148 HDPPIIHRDLKCDNIFI---NGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LY 202
I H DLK +NI + N + +KI D GLA ++ N K++ GTPEF+APE +
Sbjct: 133 LQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190
Query: 203 DENYNELADIYSFG------MCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAAL 251
E AD++S G + + + VS+ +
Sbjct: 191 YEPLGLEADMWSIGVITYILLS-------GASPFLGD--TKQETLANVSAVNYEFEDEYF 241
Query: 252 SKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFG 310
S K FI + LV +R++ ++ L P+++ T + + + + F
Sbjct: 242 SNTSA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFA 300
Query: 311 DRCLMSEGP-ASVRNKHPSMDFD 332
R + G + + + +
Sbjct: 301 ARKKSNNGSGGGLNDIFEAQKIE 323
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 23/296 (7%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQV---RIDDVLQSPEDLERLYSEVHLLKSLKHN 87
E +G G F V K ++ GLE A + R + E + EV +L+ + H
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYA-AKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
NII ++ + + + V +I EL + G L + + + + + + +QIL G+ YLH+
Sbjct: 76 NIITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 148 HDPPIIHRDLKCDNIFI---NGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LY 202
I H DLK +NI + N +K+ D GLA +E K++ GTPEF+APE +
Sbjct: 134 KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 203 DENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAALSKVKDP 257
E AD++S G + ++ + + +++ S+ +
Sbjct: 192 YEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVSYDFDEEFFSQTSE- 247
Query: 258 EVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDR 312
K FI K LV +RL+ +E L P++ T + + L R
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVR 303
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-35
Identities = 72/317 (22%), Positives = 130/317 (41%), Gaps = 22/317 (6%)
Query: 2 ESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI 61
D + P ++ Y E +G GAF V++ + G A V
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVLDHYD-IHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 62 DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL-RQYR 120
D E + E+ + L+H ++ ++++ DD + +I E + G L +
Sbjct: 193 ----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVA 246
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI-FINGNQGEVKIGDLGLA 179
+H K+ + RQ+ GL ++H ++ +H DLK +NI F E+K+ D GL
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 180 TIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYP-YSECRNSA 236
++ + K GT EF APE + D++S G+ +++ P E N
Sbjct: 305 AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDD 362
Query: 237 QIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTK 292
+ + V S +A S + + + K FI K L+ + R++ + L P+L G
Sbjct: 363 ETLRNVKSCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWLT-PGNAP 420
Query: 293 NRPLPLPDIVLPRVGAF 309
R +P ++
Sbjct: 421 GRDSQIPSSRYTKIRDS 437
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 70/317 (22%), Positives = 127/317 (40%), Gaps = 45/317 (14%)
Query: 13 PPDPDVLETDPTCRYIRYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
PD + ++ ++ +G+GA VY+ + A +V L+ D
Sbjct: 38 VPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYA-LKV-----LKKTVD 91
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA 130
+ + +E+ +L L H NII+ + ++++ EL T G L + +
Sbjct: 92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELVTGGELFDRIVEKGYYSERD 149
Query: 131 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANA- 187
+QIL + YLH + I+HRDLK +N+ + +KI D GL+ I+E
Sbjct: 150 AADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207
Query: 188 KSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEY-------PYSECRNSAQIY 239
K+V GTP + APE L Y D++S G+ Y P+ + R ++
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT-------YILLCGFEPFYDERGDQFMF 260
Query: 240 KKVSSGIKPAALSKVKDP------EVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTK 292
+++ + + K + K +V +RL+ + L P++ T K
Sbjct: 261 RRILNC----EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV----TGK 312
Query: 293 NRPLPLPDIVLPRVGAF 309
D ++ F
Sbjct: 313 AANFVHMDTAQKKLQEF 329
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 66/291 (22%), Positives = 116/291 (39%), Gaps = 41/291 (14%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWC------QVRIDDVLQSPEDLERLYSEVHLLKSL 84
KE++G+G V + + E A + E E EV +L+ +
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYA-VKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 85 K-HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
H NII+ +++ + ++ +L G L Y + + K + R +L +
Sbjct: 81 SGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-- 200
LH + I+HRDLK +NI ++ + +K+ D G + ++ + V GTP ++APE
Sbjct: 139 ALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 195
Query: 201 -----LYDENYNELADIYSFGMCMLEMVTFEY-------PYSECRNSAQIYKKVSSGI-- 246
Y + D++S G+ M Y P+ R + + + SG
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIM-------YTLLAGSPPFWH-RKQMLMLRMIMSGNYQ 247
Query: 247 -KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRP 295
D VK + + LV +R +A+E L PF Q + R
Sbjct: 248 FGSPEWDDYSD-TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 62/287 (21%), Positives = 127/287 (44%), Gaps = 27/287 (9%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRI---DDVLQSPEDLERLYSEVHLLKS 83
+Y +++G+G++ V + D A V+I + + P + E+ LL+
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRA---VKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRK-KHKKVDMKAVKGWARQILSGL 142
L+H N+I+ + +++ + + ++ E G K+ + G+ Q++ GL
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI----GTPEFMA 198
YLHS I+H+D+K N+ + G +KI LG+A + A G+P F
Sbjct: 123 EYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 199 PELY--DENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSK 253
PE+ + ++ DI+S G+ + + T YP+ E N ++++ + G P
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPGDCG- 237
Query: 254 VKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLP 299
P + ++ L ++R S +++ + + P+P+P
Sbjct: 238 ---PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIP 281
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 65/269 (24%), Positives = 121/269 (44%), Gaps = 17/269 (6%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
+ + +G+GA+ V A + V VA V+I D+ ++ + E + E+ + K L H
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
N+++FY + + E + G L + + + + Q+++G++YLH
Sbjct: 65 ENVVKFYGHR--REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA----KSVIGTPEFMAPE-L 201
I HRD+K +N+ ++ +KI D GLAT+ N + GT ++APE L
Sbjct: 123 GIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 202 YDENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260
++ E D++S G+ + M+ E P+ + +S Q Y K D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 261 SFIEKCLVP-ASQRLSAKELLMDPFLQVN 288
+ + K LV S R++ ++ D +
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 71/286 (24%), Positives = 120/286 (41%), Gaps = 35/286 (12%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQV---RIDDVLQSPEDLERLYSEVHLLKSLKHN 87
E +G G F V K + G E A + R + E + EV++L+ ++H
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
NII ++ + + + V +I EL + G L + + + + + +QIL G+ YLHS
Sbjct: 69 NIITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 148 HDPPIIHRDLKCDNIFI---NGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LY 202
I H DLK +NI + N +K+ D G+A +E N K++ GTPEF+APE +
Sbjct: 127 KR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184
Query: 203 DENYNELADIYSFG------MCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAAL 251
E AD++S G + E + +S+
Sbjct: 185 YEPLGLEADMWSIGVITYILLS-------GASPFLGE--TKQETLTNISAVNYDFDEEYF 235
Query: 252 SKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL 296
S + K FI + LV +R++ + L +++ R
Sbjct: 236 SNTSE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 72/306 (23%), Positives = 134/306 (43%), Gaps = 40/306 (13%)
Query: 2 ESSEDGAAKMEPPDPDVLE---TDPTCRY-IRYKEVIGKGAFKTVYKAFDEVNGLEVAWC 57
+ D A P D ++ Y + E++G G F V+K + GL++A
Sbjct: 61 ALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK 120
Query: 58 QVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSL- 116
++ + +D E + +E+ ++ L H N+I+ Y+++ + + ++ E G L
Sbjct: 121 IIKT----RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELF 174
Query: 117 -RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI-FINGNQGEVKIG 174
R + + ++ + + +QI G+ ++H I+H DLK +NI +N + ++KI
Sbjct: 175 DRIIDESYNLTELDTIL-FMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKII 231
Query: 175 DLGLATIMEQANA-KSVIGTPEFMAPE-LYDENYNELADIYSFG------MCMLEMVTFE 226
D GLA + K GTPEF+APE + + + D++S G +
Sbjct: 232 DFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-------G 284
Query: 227 YP--YSECRNSAQIYKKVSSGI---KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 280
+ N A+ + + + + + E K FI K L+ S R+SA E L
Sbjct: 285 LSPFLGD--NDAETLNNILACRWDLEDEEFQDISE-EAKEFISKLLIKEKSWRISASEAL 341
Query: 281 MDPFLQ 286
P+L
Sbjct: 342 KHPWLS 347
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 55/290 (18%), Positives = 120/290 (41%), Gaps = 31/290 (10%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
E +G+G F V++ + + + V D + E+ +L +H NI+
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYM-AKF----VKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM--KAVKGWARQILSGLIYLHSH 148
+ S+ + + +I E + + + R ++ + + + Q+ L +LHSH
Sbjct: 65 HLHESFESMEE--LVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 149 DPPIIHRDLKCDNI-FINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYDEN 205
+ I H D++ +NI + +KI + G A ++ + + + PE+ APE +
Sbjct: 122 N--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 206 YNELADIYSFGMCMLEMVTFEYP--YSECRNSAQIYKKVSSGI---KPAALSKVKDPEVK 260
+ D++S G ++ ++ +E + QI + + + A ++ E
Sbjct: 180 VSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISI-EAM 235
Query: 261 SFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAF 309
F+++ LV R++A E L P+L K + + V+ +
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWL------KQKIERVSTKVIRTLKHR 279
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 64/270 (23%), Positives = 125/270 (46%), Gaps = 23/270 (8%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDD--VLQSPEDLERLYSEVHLLKSL 84
Y + +G G F V ++ G +VA V+I + ++S + + ++ E+ LK
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVA---VKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
+H +II+ Y ++ E + G L Y KH +V+ + +QILS + Y
Sbjct: 69 RHPHIIKLYQVI--STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LY 202
H H ++HRDLK +N+ ++ + KI D GL+ +M ++ G+P + APE +
Sbjct: 127 CHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183
Query: 203 DENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEV 259
Y DI+S G+ + ++ P+ + + ++KK+ G+ P L+ V
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLN----RSV 238
Query: 260 KSFIEKCLVP-ASQRLSAKELLMDPFLQVN 288
+ + L +R + K++ + + +
Sbjct: 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 62/228 (27%), Positives = 112/228 (49%), Gaps = 27/228 (11%)
Query: 13 PPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKA----FDEVNGLEVAWCQVRIDDVLQSP 68
+ D + R+++ +G+G F V + G +VA ++ +
Sbjct: 10 ATEVDPTHFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI 67
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVD 127
DL++ E+ +L++L H NI+++ +D + +I E SGSL++Y K+K K++
Sbjct: 68 ADLKK---EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124
Query: 128 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME---- 183
+K +A QI G+ YL S +HRDL N+ + ++ +VKIGD GL +E
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV-ESEHQVKIGDFGLTKAIETDKE 181
Query: 184 ----QANAKSVIGTPEF-MAPE-LYDENYNELADIYSFGMCMLEMVTF 225
+ + S P F APE L + +D++SFG+ + E++T+
Sbjct: 182 YYTVKDDRDS----PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 68/321 (21%), Positives = 136/321 (42%), Gaps = 22/321 (6%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
+ + +G+GA+ V A + V VA V+I D+ ++ + E + E+ + K L H
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
N+++FY + + E + G L + + + + Q+++G++YLH
Sbjct: 65 ENVVKFYGHR--REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA----KSVIGTPEFMAPE-L 201
I HRD+K +N+ ++ +KI D GLAT+ N + GT ++APE L
Sbjct: 123 GIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 202 YDENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIY-KKVSSGIKPAALSKVKDPEV 259
++ E D++S G+ + M+ E P+ + +S Q Y K+ D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSAP 238
Query: 260 KSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSE- 317
+ + K LV S R++ ++ D + + + + + + + S
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNL 298
Query: 318 --GPASVRNKHPSMDFDSDAE 336
P + ++ P + +
Sbjct: 299 DFSPVNSASRTPGSGWSKEHH 319
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 28/284 (9%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNI 89
KE IG G++ + + +E A V+I + +S D E+ LL+ +H NI
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFA---VKI--IDKSKRDPTE---EIEILLRYGQHPNI 78
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
I + + D + V ++TEL G L + K + I + YLH+
Sbjct: 79 ITLKDVYDDGKY--VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 150 PPIIHRDLKCDNI-FIN--GNQGEVKIGDLGLATIMEQANA--KSVIGTPEFMAPE-LYD 203
++HRDLK NI +++ GN ++I D G A + N + T F+APE L
Sbjct: 137 --VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 204 ENYNELADIYSFGMCMLEMVTFEYP--YSECRNSAQ-IYKKVSSG---IKPAALSKVKDP 257
+ Y+ DI+S G+ + M+T Y + ++ + I ++ SG + + V D
Sbjct: 195 QGYDAACDIWSLGVLLYTMLT-GYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD- 252
Query: 258 EVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
K + K L QRL+A +L P++ L D
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD 296
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 58/233 (24%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 26 RYIRYKEVIGKGAFKTVYKA----FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
R+++Y +GKG F +V + G VA Q++ D +R E+ +L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQR---EIQIL 78
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILS 140
K+L + I+++ +++ ++ E SG LR + ++H+ ++D + ++ QI
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 141 GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEF 196
G+ YL S +HRDL NI + ++ VKI D GLA ++ + +P F
Sbjct: 139 GMEYLGSRR--CVHRDLAARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 197 -MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSGI 246
APE L D ++ +D++SFG+ + E+ T+ + S ++
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 71/274 (25%), Positives = 122/274 (44%), Gaps = 34/274 (12%)
Query: 7 GAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKA----FDEVNGLEVAWCQVRID 62
GA D D + + R++++ + +GKG F +V + G VA +++
Sbjct: 24 GAMGSAFEDRDPTQFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS 81
Query: 63 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK 122
+ E L E+ +LKSL+H+NI+++ + + +I E GSLR Y +K
Sbjct: 82 ----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK 137
Query: 123 HK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181
HK ++D + + QI G+ YL + IHRDL NI + N+ VKIGD GL +
Sbjct: 138 HKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKV 194
Query: 182 ME--------QANAKSVIGTPEF-MAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSE 231
+ + +S P F APE L + ++ +D++SFG+ + E+ T Y E
Sbjct: 195 LPQDKEYYKVKEPGES----PIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIE 246
Query: 232 CRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265
S G ++ + ++
Sbjct: 247 KSKSPPAEFMRMIGNDKQG--QMIVFHLIELLKN 278
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 64/235 (27%), Positives = 109/235 (46%), Gaps = 28/235 (11%)
Query: 6 DGAAKMEPPDP-DVLETDPTCRYIRYKEVIGKGAFKTVYKA----FDEVNGLEVAWCQVR 60
GA ++ P D RY++ +G+G F V ++ G VA ++
Sbjct: 12 HGALEVLFQGPGDPTVFHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK 69
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
D Q ++ E+ +L++L H +II++ D ++ ++ E GSLR Y
Sbjct: 70 ADAGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL 126
Query: 121 KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
+H + + + +A+QI G+ YLH+ IHRDL N+ + N VKIGD GLA
Sbjct: 127 PRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLAK 182
Query: 181 IME--------QANAKSVIGTPEF-MAPE-LYDENYNELADIYSFGMCMLEMVTF 225
+ + + S P F APE L + + +D++SFG+ + E++T
Sbjct: 183 AVPEGHEYYRVREDGDS----PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 38/294 (12%)
Query: 12 EPPDPDVLETDPTCR--YI-RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRI----- 61
EPP LE C Y +Y +G GAF V+ A D+ EV V+
Sbjct: 5 EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVV---VKFIKKEK 61
Query: 62 --DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGS-LRQ 118
+D L ++ E+ +L ++H NII+ + ++Q ++ E SG L
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD-IFENQGFFQ-LVMEKHGSGLDLFA 119
Query: 119 YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178
+ +H ++D RQ++S + YL D IIHRD+K +NI I + +K+ D G
Sbjct: 120 FIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGS 176
Query: 179 ATIMEQANA-KSVIGTPEFMAPELY-DENYN-ELADIYSFGMCMLEMVTFEYPYSECRNS 235
A +E+ + GT E+ APE+ Y +++S G+ + +V E P+ E
Sbjct: 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE---- 232
Query: 236 AQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
++ P +S E+ S + L P +R + ++L+ DP++
Sbjct: 233 ---LEETVEAAIHPPYLVS----KELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 68/314 (21%), Positives = 128/314 (40%), Gaps = 46/314 (14%)
Query: 2 ESSEDGAAKMEPPDPDVLETDPTCRYIRY--KEVIGKGAFKTVYKAFDEVNGLEVA---- 55
+ M P D Y +Y K+VIG+G V + G E A
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 56 ---WCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNIITELF 111
++ + + + E R E H+L+ + H +II +S+ + ++ +L
Sbjct: 128 EVTAERLSPEQLEEVREATRR---ETHILRQVAGHPHIITLIDSYESSSF--MFLVFDLM 182
Query: 112 TSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 171
G L Y + + K + R +L + +LH+++ I+HRDLK +NI ++ N ++
Sbjct: 183 RKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN-MQI 239
Query: 172 KIGDLGLATIMEQANA-KSVIGTPEFMAPE-------LYDENYNELADIYSFGMCMLEMV 223
++ D G + +E + + GTP ++APE Y + D+++ G+ +
Sbjct: 240 RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL---- 295
Query: 224 TFEY-------PYSECRNSAQIYKKVSSGIKPAALSKVKD---PEVKSFIEKCLVP-ASQ 272
+ P+ R + + + G + S D VK I + L
Sbjct: 296 ---FTLLAGSPPFWH-RRQILMLRMIMEG-QYQFSSPEWDDRSSTVKDLISRLLQVDPEA 350
Query: 273 RLSAKELLMDPFLQ 286
RL+A++ L PF +
Sbjct: 351 RLTAEQALQHPFFE 364
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 67/255 (26%), Positives = 116/255 (45%), Gaps = 32/255 (12%)
Query: 26 RYIRYKEVIGKGAFKTVYKA----FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
R++++ + +GKG F +V + G VA +++ + E L E+ +L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEIL 65
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILS 140
KSL+H+NI+++ + + +I E GSLR Y +KHK ++D + + QI
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 141 GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--------QANAKSVIG 192
G+ YL + IHRDL NI + N+ VKIGD GL ++ + +S
Sbjct: 126 GMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGES--- 179
Query: 193 TPEF-MAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250
P F APE L + ++ +D++SFG+ + E+ T Y E S G
Sbjct: 180 -PIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQG 234
Query: 251 LSKVKDPEVKSFIEK 265
++ + ++
Sbjct: 235 --QMIVFHLIELLKN 247
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 78/282 (27%), Positives = 136/282 (48%), Gaps = 24/282 (8%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDD--VLQSPEDLERLYSEVHLLKSL 84
Y E +G+G+F V A +VA ++ +L+ + R+ E+ LK L
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYLKLL 66
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
+H +II+ Y+ + ++ E + G L Y + K++ + + +QI+ + Y
Sbjct: 67 RHPHIIKLYDVI--TTPTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPE-LY 202
H H I+HRDLK +N+ ++ N VKI D GL+ IM N K+ G+P + APE +
Sbjct: 124 CHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180
Query: 203 DENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEV 259
+ Y D++S G+ + M+ P+ + ++KKV+S + P LS P
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLS----PGA 235
Query: 260 KSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
+S I + +V QR++ +E+ DP+ VN RP+
Sbjct: 236 QSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQ 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 21/229 (9%)
Query: 28 IRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS 83
+ +V+G GAF TVYK E + VA ++ SP+ + + E +++ S
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMAS 73
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGL 142
+ + ++ R + V +IT+L G L Y ++HK + + + W QI G+
Sbjct: 74 VDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF----MA 198
YL ++HRDL N+ + Q VKI D GLA ++ + + MA
Sbjct: 131 NYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 199 PE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
E + Y +D++S+G+ + E++TF PY S +I + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKG 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 69/268 (25%), Positives = 124/268 (46%), Gaps = 24/268 (8%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRI--DDVLQSPEDLERLYSEVHLLKSL 84
RYK + +G G TVY A D + ++VA ++ + E L+R EVH L
Sbjct: 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
H NI+ + +D+++ ++ E +L +Y + H + + + QIL G+ +
Sbjct: 69 SHQNIVSMID--VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA---NAKSVIGTPEFMAPEL 201
H I+HRD+K NI I + +KI D G+A + + V+GT ++ +PE
Sbjct: 127 AHDMR--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 202 -YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI-YKKVSSGIKPAALSKVKD--- 256
E +E DIYS G+ + EM+ E P++ + I K + + P + V+
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSV-PNVTTDVRKDIP 241
Query: 257 PEVKSFIEKCLV--PASQRLSAKELLMD 282
+ + I + A++ + +E+ D
Sbjct: 242 QSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 91/360 (25%), Positives = 142/360 (39%), Gaps = 84/360 (23%)
Query: 1 MESSEDGAAKMEPPDPD-----VLETD---PTCRYIRYK--EVIGKGAFKTVYKAFDEVN 50
M ++ K+ P D VL +D R I Y +VIG G+F V++A +
Sbjct: 5 MSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVES 64
Query: 51 GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR----FYNSWIDDQNKTVNI 106
EVA I VLQ R E+ +++ +KH N++ FY++ +N+
Sbjct: 65 D-EVA-----IKKVLQDKRFKNR---ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115
Query: 107 ITELFTS---GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 163
+ E + R Y K + + M +K + Q+L L Y+HS I HRD+K N+
Sbjct: 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLL 173
Query: 164 INGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM---------APELY--DENYNELADI 212
++ G +K+ D G AK +I + APEL NY DI
Sbjct: 174 LDPPSGVLKLIDFGS--------AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDI 225
Query: 213 YSFGMCMLEMVTFE--YPYSECRN------------SAQIYKKVSSG--------IKPAA 250
+S G M E++ + +P + S + K ++ I+P
Sbjct: 226 WSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHP 285
Query: 251 LSKV----KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLP 304
SKV P+ I + L P S RL+A E L PF L + +P
Sbjct: 286 FSKVFRPRTPPDAIDLISRLLEYTP-SARLTAIEALCHPFFD--------ELRTGEARMP 336
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-30
Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 22/212 (10%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDE-VNGLEVAWCQVRIDDVLQS---PEDLERLYSEVHLL 81
+Y K I G +Y A D VNG V ++ L E +E L
Sbjct: 81 QY-EVKGCIAHGGLGWIYLALDRNVNGRPVV---LK---GLVHSGDAEAQAMAMAERQFL 133
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVN---IITELFTSGSLRQYRKKHKKVDMKAVKGWARQI 138
+ H +I++ +N I+ E SL++ + + + + + +I
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEI 191
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMA 198
L L YLHS +++ DLK +NI + Q +K+ DLG + + + GTP F A
Sbjct: 192 LPALSYLHSI--GLVYNDLKPENIMLTEEQ--LKLIDLGAVSRINSFGY--LYGTPGFQA 245
Query: 199 PELYDENYNELADIYSFGMCMLEMVTFEYPYS 230
PE+ DIY+ G + + +
Sbjct: 246 PEIVRTGPTVATDIYTVGRTLAALTLDLPTRN 277
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 57/249 (22%), Positives = 93/249 (37%), Gaps = 18/249 (7%)
Query: 4 SEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDD 63
+ G D + + E IG+G F V+ + VA R
Sbjct: 94 KKSGVVLHRAVPKDKWVLNHED--LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET- 150
Query: 64 VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKK 122
P+ + E +LK H NI+R + Q + + I+ EL G + R +
Sbjct: 151 --LPPDLKAKFLQEARILKQYSHPNIVRLIG--VCTQKQPIYIVMELVQGGDFLTFLRTE 206
Query: 123 HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182
++ +K + +G+ YL S IHRDL N + +KI D G++
Sbjct: 207 GARLRVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLVTEK-NVLKISDFGMSREE 263
Query: 183 EQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSA 236
+ G + APE L Y+ +D++SFG+ + E + PY N
Sbjct: 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-Q 322
Query: 237 QIYKKVSSG 245
Q + V G
Sbjct: 323 QTREFVEKG 331
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 70/302 (23%), Positives = 123/302 (40%), Gaps = 31/302 (10%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRI--DDVLQSPEDLERLYSEVHLLKSL 84
RY+ E++G G V+ A D + +VA V++ D+ + P R E +L
Sbjct: 13 RYELGEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 85 KHNNIIRFYNSWIDD--QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
H I+ Y++ + I+ E +LR + K L
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK-----SVIGTPEFM 197
+ H + IIHRD+K NI I VK+ D G+A + + +VIGT +++
Sbjct: 130 NFSHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 198 APEL-YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI-YKKVSSGIKPAALSKVK 255
+PE ++ + +D+YS G + E++T E P++ + + Y+ V P S
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVRE--DPIPPSARH 243
Query: 256 D---PEVKSFIEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRPLPLPD----IVLPRV 306
+ ++ + + K L P ++ +A E+ D NG P L D +L
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSA 303
Query: 307 GA 308
Sbjct: 304 AG 305
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-30
Identities = 69/270 (25%), Positives = 130/270 (48%), Gaps = 23/270 (8%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDD--VLQSPEDLERLYSEVHLLKSL 84
Y + +G G F V E+ G +VA V+I + ++S + + ++ E+ LK
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVA---VKILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
+H +II+ Y + ++ E + G L Y K+ ++D K + +QILSG+ Y
Sbjct: 74 RHPHIIKLYQVI--STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPE-LY 202
H H ++HRDLK +N+ ++ + KI D GL+ +M ++ G+P + APE +
Sbjct: 132 CHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 188
Query: 203 DENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEV 259
Y DI+S G+ + ++ P+ + + ++KK+ GI P L+ P V
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLN----PSV 243
Query: 260 KSFIEKCLVP-ASQRLSAKELLMDPFLQVN 288
S ++ L +R + K++ + + +
Sbjct: 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQD 273
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 73/327 (22%), Positives = 126/327 (38%), Gaps = 77/327 (23%)
Query: 28 IRYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
+ Y +VIG G+F VY+A +G VA I VLQ D E+ +++ L
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVA-----IKKVLQ---DKRFKNRELQIMRKLD 105
Query: 86 HNNIIR----FYNSWIDDQNKTVNIITELFTS---GSLRQYRKKHKKVDMKAVKGWARQI 138
H NI+R FY+S +N++ + R Y + + + + VK + Q+
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM- 197
L Y+HS I HRD+K N+ ++ + +K+ D G A + + E
Sbjct: 166 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---------GEPNV 214
Query: 198 ---------APELY--DENYNELADIYSFGMCMLEMVTFE--YPYSECRN---------- 234
APEL +Y D++S G + E++ + +P +
Sbjct: 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274
Query: 235 --SAQIYKKVSSG--------IKPAALSKV----KDPEVKSFIEKCLV--PASQRLSAKE 278
+ + ++++ IK +KV PE + + L P + RL+ E
Sbjct: 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP-TARLTPLE 333
Query: 279 LLMDPFLQVNGTTKNRPLPLPDIVLPR 305
F L P++ LP
Sbjct: 334 ACAHSFFD--------ELRDPNVKLPN 352
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 50/237 (21%), Positives = 108/237 (45%), Gaps = 23/237 (9%)
Query: 20 ETDPTCRYIRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLY 75
T +R +V+G G F TV+K E + V +++ + + + +
Sbjct: 9 IFKETE--LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVC---IKVIEDKSGRQSFQAVT 63
Query: 76 SEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGW 134
+ + SL H +I+R + ++T+ GSL + ++H+ + + + W
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP 194
QI G+ YL H ++HR+L N+ + +V++ D G+A ++ + + +
Sbjct: 121 GVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEA 177
Query: 195 EF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
+ MA E ++ Y +D++S+G+ + E++TF PY+ R + ++ + G
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVPDLLEKG 233
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 81/325 (24%), Positives = 137/325 (42%), Gaps = 33/325 (10%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY + IG G F D++ VA V+ + + E + E+ +SL+H
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVA---VKYIE--RGAAIDENVQREIINHRSLRH 75
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
NI+RF + II E + G L + + + + +Q+LSG+ Y H
Sbjct: 76 PNIVRFKEVI--LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 147 SHDPPIIHRDLKCDNIFINGNQ-GEVKIGDLGLATIMEQANA-KSVIGTPEFMAPE-LYD 203
S I HRDLK +N ++G+ +KI D G + + KS +GTP ++APE L
Sbjct: 134 SMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 191
Query: 204 ENYN-ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD----PE 258
+ Y+ ++AD++S G+ + M+ YP+ E + Y+K I S D PE
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250
Query: 259 VKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSE 317
I + V + R+S E+ + N LP ++ E
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFLKN---------LPADLMNESNTGSQ---FQE 298
Query: 318 GPASVRNKHPSMDFDSDAELPVITS 342
+++ M S+A +P + +
Sbjct: 299 PEQPMQSLDTIMQIISEATIPAVRN 323
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 70/249 (28%), Positives = 108/249 (43%), Gaps = 25/249 (10%)
Query: 7 GAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAF---DEVNGLEVAWCQVRI-- 61
G+A P +R E +G G+F V + + VA V+
Sbjct: 1 GSAGEGPLQSLTCLIGEKD--LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCLK 55
Query: 62 DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRK 121
DVL PE ++ EV+ + SL H N+IR Y + + ++TEL GSL +
Sbjct: 56 PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLR 112
Query: 122 KHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
KH+ + + +A Q+ G+ YL S IHRDL N+ + VKIGD GL
Sbjct: 113 KHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMR 169
Query: 181 IMEQA----NAKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECR 233
+ Q + P + APE L ++ +D + FG+ + EM T+ + P+
Sbjct: 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229
Query: 234 NSAQIYKKV 242
S QI K+
Sbjct: 230 GS-QILHKI 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 66/302 (21%), Positives = 114/302 (37%), Gaps = 50/302 (16%)
Query: 28 IRYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
R++ + G+G F TV ++ G+ VA I V+Q P R + L L
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVA-----IKKVIQDPRFRNRELQIMQDLAVLH 77
Query: 86 HNNIIR----FYNSWIDDQNKT-VNIITELFTS---GSLRQYRKKHKKVDMKAVKGWARQ 137
H NI++ FY D+ +N++ E R Y ++ +K + Q
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK-SVIGTPEF 196
++ + LH + HRD+K N+ +N G +K+ D G A + + + I + +
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 197 MAPELY--DENYNELADIYSFGMCMLEMVTFE--YPYSECRN------------SAQIYK 240
APEL +++Y DI+S G EM+ E + S ++ +
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257
Query: 241 KVSSG--------IKPAALSKV-------KDPEVKSFIEKCLV--PASQRLSAKELLMDP 283
K++ K S V E + L P +R+ E L P
Sbjct: 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP-EERMKPYEALCHP 316
Query: 284 FL 285
+
Sbjct: 317 YF 318
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 14/240 (5%)
Query: 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERL 74
+ P+ + + EVIG+G F VY N + C V+ + + ++ +
Sbjct: 14 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 73
Query: 75 YSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKG 133
+E ++K H N++ + + + ++ G LR + R + +K + G
Sbjct: 74 LTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 132
Query: 134 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGT 193
+ Q+ G+ YL S +HRDL N ++ VK+ D GLA M SV
Sbjct: 133 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNK 189
Query: 194 PEF------MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
MA E L + + +D++SFG+ + E++T PY + I + G
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 248
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 21/229 (9%)
Query: 28 IRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS 83
+ +V+G GAF TVYK E + VA ++ SP+ + + E +++ S
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMAS 73
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGL 142
+ + ++ R + V +IT+L G L Y ++HK + + + W QI G+
Sbjct: 74 VDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF----MA 198
YL ++HRDL N+ + Q VKI D GLA ++ + + MA
Sbjct: 131 NYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 199 PE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
E + Y +D++S+G+ + E++TF PY S +I + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKG 235
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 59/291 (20%), Positives = 109/291 (37%), Gaps = 47/291 (16%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL- 84
Y +V+G G V + F++ + A ++ + D R EV L
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFA-LKM-LQDC----PKARR---EVELHWRAS 68
Query: 85 KHNNIIRFYNSWID--DQNKTVNIITELFTSGSL--RQYRKKHKKVDMKAVKGWARQILS 140
+ +I+R + + + K + I+ E G L R + + + + I
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 141 GLIYLHSHDPPIIHRDLKCDNI-FINGNQG-EVKIGDLGLATIMEQANAKSVIGTPEFMA 198
+ YLHS + I HRD+K +N+ + + +K+ D G A
Sbjct: 129 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------A 167
Query: 199 PELYDENYNELADIYSFGMCMLEMVT----FEYPYSECRNSAQIYKKVSSGI---KPAAL 251
E E Y++ D++S G+ M ++ F Y S + ++ G
Sbjct: 168 KETTGEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 252 SKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDI 301
S+V + EVK I L +QR++ E + P++ + PL +
Sbjct: 227 SEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 276
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 63/248 (25%), Positives = 120/248 (48%), Gaps = 15/248 (6%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
++G+G+F TV A + E A + +++ + + E ++ L H ++
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPFFVKL 95
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
Y ++ DD+ + +G L +Y +K D + + +I+S L YLH I
Sbjct: 96 YFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--I 151
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLA----TIMEQANAKSVIGTPEFMAPE-LYDENYN 207
IHRDLK +NI +N ++I D G A +QA A S +GT ++++PE L +++
Sbjct: 152 IHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 210
Query: 208 ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267
+ +D+++ G + ++V P+ N I++K+ + P+ + +EK L
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKLL 267
Query: 268 VP-ASQRL 274
V A++RL
Sbjct: 268 VLDATKRL 275
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 64/240 (26%), Positives = 111/240 (46%), Gaps = 22/240 (9%)
Query: 14 PDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLER 73
P+ D E + T I K +G G + VY+ + L VA ++ D + ++E
Sbjct: 3 PNYDKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEE 55
Query: 74 LYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVK- 132
E ++K +KH N+++ + + IITE T G+L Y ++ + ++ AV
Sbjct: 56 FLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 133 -GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVI 191
A QI S + YL + IHRDL N + N VK+ D GL+ +M +
Sbjct: 114 LYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHA 170
Query: 192 GTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
G +F APE L ++ +D+++FG+ + E+ T+ PY +Q+Y+ +
Sbjct: 171 GA-KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 60/267 (22%), Positives = 124/267 (46%), Gaps = 25/267 (9%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
IGKG+F V A + ++ ++ ++ E+ +++ L+H ++
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEHPFLVNL 80
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
+ S+ D+++ + ++ +L G LR + +++ + VK + +++ L YL + I
Sbjct: 81 WYSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--I 136
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYDEN----YN 207
IHRD+K DNI ++ G V I D +A ++ + ++ GT +MAPE++ Y+
Sbjct: 137 IHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYS 195
Query: 208 ELADIYSFGMCMLEMVT----FEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVKS 261
D +S G+ E++ + S +S +I + + P+A S E+ S
Sbjct: 196 FAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFETTVVTYPSAWS----QEMVS 249
Query: 262 FIEKCLVP-ASQRL-SAKELLMDPFLQ 286
++K L P QR ++ P++
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 55/247 (22%), Positives = 110/247 (44%), Gaps = 25/247 (10%)
Query: 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAF--DEVNGLEVAWCQVRIDDVLQSP 68
+E P + D + KE +G G F TV K + + VA ++ + P
Sbjct: 3 LEEIRPKEVYLDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DP 59
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM 128
+ L +E ++++ L + I+R + ++ ++ E+ G L +Y ++++ V
Sbjct: 60 ALKDELLAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKD 116
Query: 129 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME----- 183
K + Q+ G+ YL + +HRDL N+ + Q KI D GL+ +
Sbjct: 117 KNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENY 173
Query: 184 ---QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQI 238
Q + K + ++ APE + ++ +D++SFG+ M E ++ + PY + S ++
Sbjct: 174 YKAQTHGKWPV---KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EV 229
Query: 239 YKKVSSG 245
+ G
Sbjct: 230 TAMLEKG 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 59/243 (24%), Positives = 107/243 (44%), Gaps = 21/243 (8%)
Query: 12 EPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAF---DEVNGLEVAWCQVRIDDVLQSP 68
P E I IG+G F V++ E + VA ++ S
Sbjct: 378 TMPSTRDYEIQRER--IELGRCIGEGQFGDVHQGIYMSPENPAMAVA---IKTCKNCTSD 432
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVD 127
E+ E ++ H +I++ ++ V II EL T G LR + + K +D
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKFSLD 489
Query: 128 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA 187
+ ++ +A Q+ + L YL S +HRD+ N+ + + VK+GD GL+ ME +
Sbjct: 490 LASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTY 546
Query: 188 KSVIGT--P-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKV 242
P ++MAPE + + +D++ FG+CM E++ P+ +N+ + ++
Sbjct: 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRI 605
Query: 243 SSG 245
+G
Sbjct: 606 ENG 608
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 53/238 (22%), Positives = 103/238 (43%), Gaps = 21/238 (8%)
Query: 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAF---DEVNGLEVAWCQVRIDDVLQSPEDLER 73
+ ++G+G F VY+ + + VA + D L + E
Sbjct: 5 PQYGIARED--VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 62
Query: 74 LYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVK 132
E ++K+L H +I++ + + II EL+ G L Y + + + +
Sbjct: 63 ---EAVIMKNLDHPHIVKLIGII---EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLV 116
Query: 133 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG 192
++ QI + YL S + +HRD+ NI + + VK+GD GL+ +E +
Sbjct: 117 LYSLQICKAMAYLESIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASV 173
Query: 193 T--P-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
T P ++M+PE + + +D++ F +CM E+++F + P+ N + + G
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGVLEKG 230
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 61/302 (20%), Positives = 120/302 (39%), Gaps = 58/302 (19%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK- 85
Y+ V +G+G + V++A + N +V ++ P +++ E+ +L++L+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRG 89
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL 145
NII + D ++T ++ E + +Q + D ++ + +IL L Y
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYC 146
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV-IGTPEFMAPE--LY 202
HS I+HRD+K N+ I+ ++++ D GLA +V + + F PE +
Sbjct: 147 HSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 203 DENYNELADIYSFGMCML-EMVT---------------------------FEYPYSECRN 234
+ Y+ D++S G CML M+ ++Y
Sbjct: 205 YQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263
Query: 235 SAQIY--------KKVSSGIKPAALSKVKDPEVKSFIEKCLV--PASQRLSAKELLMDPF 284
+ +K + + PE F++K L RL+A+E + P+
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ-SRLTAREAMEHPY 322
Query: 285 LQ 286
Sbjct: 323 FY 324
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 60/245 (24%), Positives = 106/245 (43%), Gaps = 27/245 (11%)
Query: 13 PPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKA---FDEVNGLEVAWCQVRIDDVLQSPE 69
E I IG+G F V++ E L VA + S
Sbjct: 4 GSSTRDYEIQRER--IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDS 58
Query: 70 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDM 128
E+ E ++ H +I++ ++ V II EL T G LR + + K +D+
Sbjct: 59 VREKFLQEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDL 115
Query: 129 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME----- 183
++ +A Q+ + L YL S +HRD+ N+ + + VK+GD GL+ ME
Sbjct: 116 ASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYY 172
Query: 184 -QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYK 240
+ K I ++MAPE + + +D++ FG+CM E++ P+ +N+ +
Sbjct: 173 KASKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIG 228
Query: 241 KVSSG 245
++ +G
Sbjct: 229 RIENG 233
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 63/242 (26%), Positives = 111/242 (45%), Gaps = 20/242 (8%)
Query: 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
P+ D E + T I K +G G + VY+ + L VA + + + +
Sbjct: 207 GVSPNYDKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTME 259
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA 130
+E E ++K +KH N+++ + + IITE T G+L Y ++ + ++ A
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 317
Query: 131 VK--GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QAN 186
V A QI S + YL + IHR+L N + N VK+ D GL+ +M
Sbjct: 318 VVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTYT 374
Query: 187 AKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVS 243
A + P ++ APE L ++ +D+++FG+ + E+ T+ PY S Q+Y+ +
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLE 433
Query: 244 SG 245
Sbjct: 434 KD 435
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 66/245 (26%), Positives = 109/245 (44%), Gaps = 44/245 (17%)
Query: 1 MESSEDGAAKMEPPDPDVLETDPTCRYI-RYK--EVIGKGAFKTVYKAFDEVNGLEVAWC 57
+E+ G M P+ I RY+ +G+G + VYKA D V VA
Sbjct: 12 LEAQTQGPGSMSVSAA------PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65
Query: 58 QVRIDDVLQSPEDLERLYS----EVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTS 113
++R++ + E + EV LLK L+H NII + + N +++I E +
Sbjct: 66 RIRLE------HEEEGVPGTAIREVSLLKELQHRNIIELKS--VIHHNHRLHLIFE-YAE 116
Query: 114 GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN----GNQG 169
L++Y K+ V M+ +K + Q+++G+ + HS +HRDLK N+ ++
Sbjct: 117 NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETP 174
Query: 170 EVKIGDLGLATIMEQANAKSVIG---TPEFM-----APELY--DENYNELADIYSFGMCM 219
+KIGD GL A A + T E + PE+ +Y+ DI+S
Sbjct: 175 VLKIGDFGL------ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIW 228
Query: 220 LEMVT 224
EM+
Sbjct: 229 AEMLM 233
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 50/251 (19%), Positives = 102/251 (40%), Gaps = 32/251 (12%)
Query: 5 EDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV 64
A + + ++ + IGKG F V + G +VA V+
Sbjct: 2 GGSVAAQDEFYRSGWALNMKE--LKLLQTIGKGEFGDVMLG--DYRGNKVA---VK---C 51
Query: 65 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK 124
+++ + +E ++ L+H+N+++ I ++ + I+TE GSL Y +
Sbjct: 52 IKNDATAQAFLAEASVMTQLRHSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRG 110
Query: 125 KVDMKAVK--GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--T 180
+ + ++ + + YL ++ +HRDL N+ ++ + K+ D GL
Sbjct: 111 RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEA 167
Query: 181 IMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRN 234
Q K APE L ++ ++ +D++SFG+ + E+ +F PY
Sbjct: 168 SSTQDTGK-------LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220
Query: 235 SAQIYKKVSSG 245
+ +V G
Sbjct: 221 -KDVVPRVEKG 230
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 56/234 (23%), Positives = 100/234 (42%), Gaps = 24/234 (10%)
Query: 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNG-LEVAWCQVRIDDVLQSPEDLERLYSEV 78
DP+ + + + IG G F V+ +VA +R + S ED E
Sbjct: 4 VIDPSE--LTFVQEIGSGQFGLVHLG--YWLNKDKVAIKTIREGAM--SEEDF---IEEA 54
Query: 79 HLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQ 137
++ L H +++ Y + + + ++TE G L Y R + + + G
Sbjct: 55 EVMMKLSHPKLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF- 196
+ G+ YL +IHRDL N + G +K+ D G+ + S GT +F
Sbjct: 113 VCEGMAYLEEAC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGT-KFP 168
Query: 197 ---MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
+PE Y+ +D++SFG+ M E+ + + PY NS ++ + +S+G
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTG 221
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 44/237 (18%), Positives = 97/237 (40%), Gaps = 31/237 (13%)
Query: 28 IRYKEVIGKGAFKTVYKA-------FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHL 80
+ + E +G+G F ++K + +++ EV + E + +
Sbjct: 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYSESFFEAASM 65
Query: 81 LKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQIL 139
+ L H +++ Y + ++ E GSL Y KK+K +++ A+Q+
Sbjct: 66 MSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFIN-------GNQGEVKIGDLGLA-TIMEQANAKSVI 191
+ + +L + +IH ++ NI + GN +K+ D G++ T++ + + I
Sbjct: 124 AAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 192 GTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
++ PE +N N D +SFG + E+ + + P S + + +
Sbjct: 182 ---PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYEDR 234
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 24/234 (10%)
Query: 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNG-LEVAWCQVRIDDVLQSPEDLERLYSEV 78
E I + +G G F V + G +VA ++ S ++ + E
Sbjct: 4 ELKREE--ITLLKELGSGQFGVVKLG--KWKGQYDVAVKMIKEG--SMSEDEF---FQEA 54
Query: 79 HLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQ 137
+ L H +++FY + + + I+TE ++G L Y R K ++ +
Sbjct: 55 QTMMKLSHPKLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF- 196
+ G+ +L SH IHRDL N ++ + VK+ D G+ + S +GT +F
Sbjct: 113 VCEGMAFLESHQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYVSSVGT-KFP 168
Query: 197 ---MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
APE + Y+ +D+++FG+ M E+ + + PY NS ++ KVS G
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-EVVLKVSQG 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 45/228 (19%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 31 KEVIGKGAFKTVYKAF--DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
+G G F +V + ++VA ++ E++ R E ++ L +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPY 71
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLHS 147
I+R Q + + ++ E+ G L ++ K +++ + V Q+ G+ YL
Sbjct: 72 IVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--------QANAKSVIGTPEFMAP 199
+ +HRDL N+ + N+ KI D GL+ + ++ K + ++ AP
Sbjct: 129 KN--FVHRDLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAP 182
Query: 200 E-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
E + ++ +D++S+G+ M E +++ + PY + + ++ + G
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQG 229
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 55/249 (22%), Positives = 103/249 (41%), Gaps = 29/249 (11%)
Query: 10 KMEPPD-----PDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNG-LEVAWCQVRIDD 63
P E DP + + + +G G F V + G +VA ++
Sbjct: 5 SKNAPSTAGLGYGSWEIDPKD--LTFLKELGTGQFGVVKYG--KWRGQYDVAIKMIKEGS 60
Query: 64 VLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKK 122
+ E ++ +L H +++ Y + + + + IITE +G L Y R+
Sbjct: 61 -----MSEDEFIEEAKVMMNLSHEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREM 113
Query: 123 HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182
+ + + + + + YL S +HRDL N +N G VK+ D GL+ +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYV 170
Query: 183 EQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSA 236
S +G+ +F PE L ++ +DI++FG+ M E+ + + PY NS
Sbjct: 171 LDDEYTSSVGS-KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS- 228
Query: 237 QIYKKVSSG 245
+ + ++ G
Sbjct: 229 ETAEHIAQG 237
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 35/218 (16%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLK 82
+Y+ E IG+G + TV+KA + VA +VR+DD D E + S E+ LLK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD------DDEGVPSSALREICLLK 56
Query: 83 SLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSG 141
LKH NI+R ++ + +K + ++ E F L++Y D + VK + Q+L G
Sbjct: 57 ELKHKNIVRLHD--VLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG---TPEFM- 197
L + HS + ++HRDLK N+ IN GE+K+ + GLA A + + E +
Sbjct: 114 LGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLA------RAFGIPVRCYSAEVVT 164
Query: 198 ----APELY--DENYNELADIYSFGMCMLEMVTFEYPY 229
P++ + Y+ D++S G E+ P
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 49/237 (20%), Positives = 98/237 (41%), Gaps = 25/237 (10%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI---DDVLQSPEDLERLYSEVHLLKSL 84
++GKG F +V +A ++ + ++ +V + + + D+E E +K
Sbjct: 25 FTLGRMLGKGEFGSVREA--QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 85 KHNNIIRFYNSWIDDQNKTVN----IITELFTSGSLRQYRKKHKKVD------MKAVKGW 134
H ++ + + + K +I G L + + + ++ + +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTP 194
I G+ YL S + IHRDL N + + V + D GL+ + +
Sbjct: 143 MVDIACGMEYLSSRN--FIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 195 EF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
+ +A E L D Y +D+++FG+ M E++T + PY+ N A+IY + G
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYNYLIGG 255
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 54/241 (22%), Positives = 100/241 (41%), Gaps = 14/241 (5%)
Query: 14 PDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLER 73
+ P+ + + EVIG+G F VY N + C V+ + + ++ +
Sbjct: 77 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136
Query: 74 LYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVK 132
+E ++K H N++ + + + ++ G LR + R + +K +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLI 195
Query: 133 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG 192
G+ Q+ G+ +L S +HRDL N ++ VK+ D GLA M SV
Sbjct: 196 GFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHN 252
Query: 193 TPE------FMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSS 244
+MA E L + + +D++SFG+ + E++T PY + I +
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQ 311
Query: 245 G 245
G
Sbjct: 312 G 312
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 74/316 (23%), Positives = 126/316 (39%), Gaps = 75/316 (23%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY + +G G V+ A D VA ++ VL P+ ++ E+ +++ L H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----VLTDPQSVKHALREIKIIRRLDH 67
Query: 87 NNIIRFYN------------SWIDDQNKTVNIITEL--------FTSGSLRQYRKKHKKV 126
+NI++ + + +V I+ E G L ++H ++
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL---EEHARL 124
Query: 127 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186
M Q+L GL Y+HS + ++HRDLK N+FIN +KIGD GLA IM+
Sbjct: 125 FM-------YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 187 AKSVIGTPE-----FMAPE--LYDENYNELADIYSFGMCMLEMVT----F---------- 225
+ + + +P L NY + D+++ G EM+T F
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235
Query: 226 ----------EYPYSECRNSAQIYKKVSSGIKPAALSKV---KDPEVKSFIEKCLV--PA 270
E E + +Y + L+++ E F+E+ L P
Sbjct: 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP- 294
Query: 271 SQRLSAKELLMDPFLQ 286
RL+A+E L P++
Sbjct: 295 MDRLTAEEALSHPYMS 310
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 74/329 (22%), Positives = 131/329 (39%), Gaps = 75/329 (22%)
Query: 13 PPDPDVLETDPTCRYI-RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPE 69
D+ + + + +Y+ ++G+G++ V K ++ G VA + +
Sbjct: 9 SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES------D 62
Query: 70 DLE-------RLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK 122
D + R E+ LLK L+H N++ + + K ++ E F ++ +
Sbjct: 63 DDKMVKKIAMR---EIKLLKQLRHENLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLEL 116
Query: 123 HKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181
+D + V+ + QI++G+ + HSH+ IIHRD+K +NI ++ G VK+ D G A
Sbjct: 117 FPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFART 173
Query: 182 MEQANAKSVIGTPEFM-----APELY--DENYNELADIYSFGMCMLEMVTFEYPY----S 230
+ A + E APEL D Y + D+++ G + EM E P S
Sbjct: 174 L---AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PLFPGDS 229
Query: 231 ECRNSAQIYK--------------KVSS--GIKPAALSKVK------------DPEVKSF 262
+ Q+Y + L ++K V
Sbjct: 230 D---IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDL 286
Query: 263 IEKCLV--PASQRLSAKELLMDPFLQVNG 289
+KCL P +R ELL F Q++G
Sbjct: 287 AKKCLHIDPD-KRPFCAELLHHDFFQMDG 314
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 49/251 (19%), Positives = 99/251 (39%), Gaps = 26/251 (10%)
Query: 13 PPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI---DDVLQSPE 69
+ + D + +++G+G F +V + + + +V + S
Sbjct: 23 QNKLEDVVIDRNL--LILGKILGEGEFGSVMEG--NLKQEDGTSLKVAVKTMKLDNSSQR 78
Query: 70 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN---IITELFTSGSLRQYRKKHK-- 124
++E SE +K H N+IR I+ ++ + +I G L Y +
Sbjct: 79 EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138
Query: 125 ----KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180
+ ++ + + I G+ YL + + +HRDL N + + V + D GL+
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD-MTVCVADFGLSK 195
Query: 181 IMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRN 234
+ + + +A E L D Y +D+++FG+ M E+ T PY +N
Sbjct: 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255
Query: 235 SAQIYKKVSSG 245
++Y + G
Sbjct: 256 -HEMYDYLLHG 265
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 22/241 (9%)
Query: 12 EPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDL 71
+ D E +R + +G+G F V+ +V I +
Sbjct: 172 QGLAKDAWEIPRES--LRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPGTMSP 223
Query: 72 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMK 129
E E ++K L+H +++ Y ++ + I+TE + GSL + K K + +
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLP 280
Query: 130 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QANA 187
+ A QI SG+ Y+ + +HRDL+ NI + N K+ D GLA ++E + A
Sbjct: 281 QLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTA 337
Query: 188 KSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSS 244
+ P ++ APE + +D++SFG+ + E+ T PY N ++ +V
Sbjct: 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVER 396
Query: 245 G 245
G
Sbjct: 397 G 397
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 28/248 (11%)
Query: 12 EPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKA---FDEVNGLEVAWCQVRIDDVLQSP 68
+ E D T I +V+G G F V + VA +++ +
Sbjct: 33 QTVHEFAKELDATN--ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TE 87
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVD 127
+ E ++ H NIIR + ++K V I+TE +GSL + +KH +
Sbjct: 88 KQRRDFLGEASIMGQFDHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 128 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME---- 183
+ + G R I SG+ YL +HRDL NI IN N K+ D GL ++E
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPE 202
Query: 184 ----QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQ 237
K I + +PE + + +D++S+G+ + E++++ E PY E N
Sbjct: 203 AAYTTRGGKIPI---RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QD 258
Query: 238 IYKKVSSG 245
+ K V G
Sbjct: 259 VIKAVDEG 266
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 64/249 (25%), Positives = 114/249 (45%), Gaps = 29/249 (11%)
Query: 12 EPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQS 67
+ E P+C + ++VIG G F VYK + VA ++ +
Sbjct: 32 QAVLKFTTEIHPSC--VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---T 86
Query: 68 PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KV 126
+ E ++ H+NIIR + + K + IITE +G+L ++ ++ +
Sbjct: 87 EKQRVDFLGEAGIMGQFSHHNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKDGEF 144
Query: 127 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--- 183
+ + G R I +G+ YL + + +HRDL NI +N N K+ D GL+ ++E
Sbjct: 145 SVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP 201
Query: 184 -----QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSA 236
+ K I + APE + + +D++SFG+ M E++T+ E PY E N
Sbjct: 202 EATYTTSGGKIPI---RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH- 257
Query: 237 QIYKKVSSG 245
++ K ++ G
Sbjct: 258 EVMKAINDG 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 55/248 (22%), Positives = 99/248 (39%), Gaps = 28/248 (11%)
Query: 12 EPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKA---FDEVNGLEVAWCQVRIDDVLQSP 68
E + + I +++IG G V + VA ++ +
Sbjct: 37 RAGRSFTREIEASR--IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TE 91
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVD 127
SE ++ H NIIR + + + I+TE +GSL + + H +
Sbjct: 92 RQRRDFLSEASIMGQFDHPNIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT 149
Query: 128 MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME---- 183
+ + G R + +G+ YL +HRDL N+ ++ N K+ D GL+ ++E
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDPD 206
Query: 184 ----QANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQ 237
K I + APE + ++ +D++SFG+ M E++ + E PY N
Sbjct: 207 AAYTTTGGKIPI---RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-D 262
Query: 238 IYKKVSSG 245
+ V G
Sbjct: 263 VISSVEEG 270
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 59/256 (23%), Positives = 104/256 (40%), Gaps = 34/256 (13%)
Query: 12 EPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGL--EVAWCQVRI----DDVL 65
+ PD E I +G+G+F VY+ G+ + +V I +
Sbjct: 13 DVYVPDEWEVAREK--ITMSRELGQGSFGMVYEG--VAKGVVKDEPETRVAIKTVNEAA- 67
Query: 66 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY------ 119
S + +E ++K ++++R + Q + +I EL T G L+ Y
Sbjct: 68 -SMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRP 124
Query: 120 ----RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 175
+ + A +I G+ YL+++ +HRDL N + + VKIGD
Sbjct: 125 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDF-TVKIGD 181
Query: 176 LGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPY 229
G+ + + + G M+PE L D + +D++SFG+ + E+ T E PY
Sbjct: 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 230 SECRNSAQIYKKVSSG 245
N Q+ + V G
Sbjct: 242 QGLSN-EQVLRFVMEG 256
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 56/245 (22%), Positives = 113/245 (46%), Gaps = 24/245 (9%)
Query: 9 AKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP 68
+P + D E ++ ++ +G G F V+ A + +V + +
Sbjct: 173 KPQKPWEKDAWEIPRES--LKLEKKLGAGQFGEVWMATYNKHT------KVAVKTMKPGS 224
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDM 128
+E +E +++K+L+H+ +++ + + + IITE GSL + K +
Sbjct: 225 MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQ 281
Query: 129 KAVK--GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186
K ++ QI G+ ++ + IHRDL+ NI ++ + KI D GLA ++E
Sbjct: 282 PLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNE 338
Query: 187 AKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYK 240
+ G +F APE + ++ +D++SFG+ ++E+VT+ PY N ++ +
Sbjct: 339 YTAREGA-KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIR 396
Query: 241 KVSSG 245
+ G
Sbjct: 397 ALERG 401
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 49/227 (21%), Positives = 87/227 (38%), Gaps = 14/227 (6%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
VIGKG F VY C ++ + + +E E L++ L H
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLH 146
N++ + + ++ G L Q+ R + +K + + Q+ G+ YL
Sbjct: 83 NVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE------FMAPE 200
+HRDL N ++ + VK+ D GLA + SV + A E
Sbjct: 142 EQK--FVHRDLAARNCMLDES-FTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 201 -LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
L + +D++SFG+ + E++T PY + ++ G
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQG 244
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 26 RYIRYKEVIGKGAFKTVYKA--FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS 83
+ +G+G + VYKA D + + A Q+ + S E+ LL+
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRE 74
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITE--------LFTSGSLRQYRKKHKKVDMKAVKGWA 135
LKH N+I ++ ++ V ++ + + + KK ++ VK
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFING---NQGEVKIGDLGLATIMEQANAKSVIG 192
QIL G+ YLH++ ++HRDLK NI + G +G VKI D+G A +
Sbjct: 135 YQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 193 TPEFM-----APELY--DENYNELADIYSFGMCMLEMVT 224
P + APEL +Y + DI++ G E++T
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 63/267 (23%), Positives = 103/267 (38%), Gaps = 36/267 (13%)
Query: 2 ESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLE-------V 54
+ A D+ E I +G GAF VY+ +V+G+ V
Sbjct: 8 HNPNYCFAGKTSSISDLKEVPRKN--ITLIRGLGHGAFGEVYEG--QVSGMPNDPSPLQV 63
Query: 55 AWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG 114
A V+ + S +D E ++ H NI+R + Q+ I+ EL G
Sbjct: 64 A---VKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILMELMAGG 118
Query: 115 SLRQYRKKH-------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 167
L+ + ++ + M + AR I G YL + IHRD+ N +
Sbjct: 119 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLT-C 175
Query: 168 QGE---VKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCM 219
G KIGD G+A + +A+ G M PE + + D +SFG+ +
Sbjct: 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
Query: 220 LEMVTF-EYPYSECRNSAQIYKKVSSG 245
E+ + PY N ++ + V+SG
Sbjct: 236 WEIFSLGYMPYPSKSN-QEVLEFVTSG 261
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 50/249 (20%), Positives = 107/249 (42%), Gaps = 24/249 (9%)
Query: 3 SSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID 62
E A + + ++ + IGKG F V + G +VA V+
Sbjct: 172 VMEGTVAAQDEFYRSGWALNMKE--LKLLQTIGKGEFGDVMLG--DYRGNKVA---VK-- 222
Query: 63 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK 122
+++ + +E ++ L+H+N+++ ++++ + I+TE GSL Y +
Sbjct: 223 -CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVTEYMAKGSLVDYLRS 280
Query: 123 H--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA- 179
+ + ++ + + YL ++ +HRDL N+ ++ + K+ D GL
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTK 337
Query: 180 -TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSA 236
Q K + ++ APE L ++ ++ +D++SFG+ + E+ +F PY
Sbjct: 338 EASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK- 393
Query: 237 QIYKKVSSG 245
+ +V G
Sbjct: 394 DVVPRVEKG 402
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 63/309 (20%), Positives = 116/309 (37%), Gaps = 74/309 (23%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLE-------RLYSEVH 79
+Y+ IG+G++ V+K + G VA + ED R E+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES------EDDPVIKKIALR---EIR 54
Query: 80 LLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQI 138
+LK LKH N++ + + + ++++ E + ++ ++++ V VK Q
Sbjct: 55 MLKQLKHPNLVNLLE--VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM- 197
L + + H H+ IHRD+K +NI I +K+ D G A ++ S E
Sbjct: 112 LQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLL---TGPSDYYDDEVAT 165
Query: 198 ----APELY--DENYNELADIYSFGMCMLEMVTFEYPY----SECRNSAQIYK------- 240
+PEL D Y D+++ G E+++ P S+ Q+Y
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV-PLWPGKSD---VDQLYLIRKTLGD 221
Query: 241 ------------------KVSSGIKPAALSKVK---DPEVKSFIEKCLV--PASQRLSAK 277
K+ L ++ CL P +RL+ +
Sbjct: 222 LIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPT-ERLTCE 280
Query: 278 ELLMDPFLQ 286
+LL P+ +
Sbjct: 281 QLLHHPYFE 289
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 58/242 (23%), Positives = 104/242 (42%), Gaps = 22/242 (9%)
Query: 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
+ D E +R + +G+G F V+ +V I +
Sbjct: 254 TQGLAKDAWEIPRES--LRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPGTMS 305
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDM 128
E E ++K L+H +++ Y ++ + I+TE + GSL + K K + +
Sbjct: 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRL 362
Query: 129 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--QAN 186
+ A QI SG+ Y+ + +HRDL+ NI + N K+ D GLA ++E +
Sbjct: 363 PQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT 419
Query: 187 AKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVS 243
A+ P ++ APE + +D++SFG+ + E+ T PY N ++ +V
Sbjct: 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVE 478
Query: 244 SG 245
G
Sbjct: 479 RG 480
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 24/242 (9%)
Query: 12 EPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDL 71
+P D E ++ E +G G F V+ + +VA ++ +
Sbjct: 1 KPWWEDEWEVPRET--LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SP 52
Query: 72 ERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMK 129
+ +E +L+K L+H ++R Y + + IITE +GSL + K K+ +
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 130 AVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 189
+ A QI G+ ++ + IHRDL+ NI ++ KI D GLA ++E +
Sbjct: 110 KLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEYTA 166
Query: 190 VIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVS 243
G +F APE + + +D++SFG+ + E+VT PY N ++ + +
Sbjct: 167 REGA-KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLE 224
Query: 244 SG 245
G
Sbjct: 225 RG 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 79/314 (25%), Positives = 123/314 (39%), Gaps = 71/314 (22%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
++ ++G+GA+ V A + G VA ++ P R E+ +LK KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKH 68
Query: 87 NNIIRFYNSWIDDQNKTVN---IITELFTSGSLRQYRKK------HKKVDMKAVKGWARQ 137
NII +N D + N II EL + L + H + + Q
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI-------YQ 120
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPE 195
L + LH + +IHRDLK N+ IN N ++K+ D GLA A+ G
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 196 FM----------APE--LYDENYNELADIYSFGMCMLEMVT-----------------FE 226
M APE L Y+ D++S G + E+ F
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 227 Y---PYSE------CRNSAQIYKKVSSGIKPAALSKV---KDPEVKSFIEKCLV--PASQ 272
P+S+ A+ Y K A L K+ +P+ +++ LV P ++
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP-AK 296
Query: 273 RLSAKELLMDPFLQ 286
R++AKE L P+LQ
Sbjct: 297 RITAKEALEHPYLQ 310
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 67/226 (29%), Positives = 94/226 (41%), Gaps = 42/226 (18%)
Query: 25 CRYI-RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----E 77
RY+ IG GA+ TVYKA D +G VA VR+ L E
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVRE 61
Query: 78 VHLLKSLK---HNNIIRFYN---SWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA- 130
V LL+ L+ H N++R + + D+ V ++ E LR Y K + A
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAE 120
Query: 131 -VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS 189
+K RQ L GL +LH++ I+HRDLK +NI + + G VK+ D GLA
Sbjct: 121 TIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLA---------R 168
Query: 190 VIGTPEFM----------APE-LYDENYNELADIYSFGMCMLEMVT 224
+ + APE L Y D++S G EM
Sbjct: 169 IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 60/261 (22%), Positives = 97/261 (37%), Gaps = 26/261 (9%)
Query: 3 SSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYK--AFDEVNGLEVAWCQVR 60
+ A D+ E I +G GAF VY+ N V+
Sbjct: 50 NPNYCFAGKTSSISDLKEVPRKN--ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 107
Query: 61 IDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYR 120
+ S +D E ++ H NI+R + Q+ I+ EL G L+ +
Sbjct: 108 TLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFL 165
Query: 121 KKHK-------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE--- 170
++ + + M + AR I G YL + IHRD+ N + G
Sbjct: 166 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLT-CPGPGRV 222
Query: 171 VKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF 225
KIGD G+A + +A G M PE + + D +SFG+ + E+ +
Sbjct: 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 282
Query: 226 -EYPYSECRNSAQIYKKVSSG 245
PY N ++ + V+SG
Sbjct: 283 GYMPYPSKSN-QEVLEFVTSG 302
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 60/246 (24%), Positives = 121/246 (49%), Gaps = 16/246 (6%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
+G G+F V + +G A + V++ + +E +E +L+++ +++
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
S+ D+ N + ++ E G + + ++ + + +A QI+ YLHS D +
Sbjct: 107 EFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--L 162
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELAD 211
I+RDLK +N+ I+ QG +++ D G A ++ ++ GTPE +APE + + YN+ D
Sbjct: 163 IYRDLKPENLLID-QQGYIQVTDFGFAKRVKG-RTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 212 IYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IK-PAALSKVKDPEVKSFIEKCLVP 269
++ G+ + EM P+ QIY+K+ SG ++ P+ S ++K + L
Sbjct: 221 WWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHFS----SDLKDLLRNLLQV 275
Query: 270 -ASQRL 274
++R
Sbjct: 276 DLTKRF 281
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 73/302 (24%), Positives = 125/302 (41%), Gaps = 60/302 (19%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLK 85
Y +G GA+ +V A D+ +G +VA + ++ QS +R Y E+ LLK ++
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVA---IKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 86 HNNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRKK-----HKKVDMKAVKGWAR 136
H N+I + + + ++ + L++ + +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLV-------Y 133
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF 196
Q+L GL Y+HS ++HRDLK N+ +N + E+KI D GLA + V+ T +
Sbjct: 134 QMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLARHADAEMTGYVV-TRWY 189
Query: 197 MAPE--LYDENYNELADIYSFGMCMLEMVT----F---------------------EYPY 229
APE L +YN+ DI+S G M EM+T F E+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 230 SECRNSAQIYKKVSSGIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPF 284
+A+ Y + +++ P+ +EK L +RL+A + L PF
Sbjct: 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV-DKRLTAAQALTHPF 308
Query: 285 LQ 286
+
Sbjct: 309 FE 310
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 52/269 (19%), Positives = 103/269 (38%), Gaps = 25/269 (9%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI--DDVLQSPEDLERLYSEVHLLKS 83
Y R + ++G+G VY+A D V VA +++ + + P R+ E
Sbjct: 35 PY-RLRRLVGRGGMGDVYEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTAGR 90
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
L+ +++ ++ D + + L L ++ + RQI S L
Sbjct: 91 LQEPHVVPIHDFGEIDG--QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALD 148
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---AKSVIGTPEFMAPE 200
H+ HRD+K +NI ++ + + D G+A+ + +GT +MAPE
Sbjct: 149 AAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 201 -LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI-YKKVSSGIKPAALSKVKD-- 256
+ + ADIY+ + E +T PY + + ++ S V+
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQ--GDQLSVMGAHINQ--AIPRPSTVRPGI 261
Query: 257 -PEVKSFIEKCLV--PASQRLSAKELLMD 282
+ I + + P + ++ +L
Sbjct: 262 PVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 39/216 (18%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED------LERLYSEVH 79
YI+ + +G+G + TVYK ++ VA ++R++ E+ + R EV
Sbjct: 3 TYIK-LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-----EEGAPCTAI-R---EVS 52
Query: 80 LLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQI 138
LLK LKH NI+ ++ I K++ ++ E + L+QY + +M VK + Q+
Sbjct: 53 LLKDLKHANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG---TPE 195
L GL Y H ++HRDLK N+ IN +GE+K+ D GL A AKS+ E
Sbjct: 110 LRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGL------ARAKSIPTKTYDNE 160
Query: 196 FM-----APELY--DENYNELADIYSFGMCMLEMVT 224
+ P++ +Y+ D++ G EM T
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 46/241 (19%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLK 85
RY+ +IG G++ V +A+D++ VA + +I V + D +R+ E+ +L L
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVA---IKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 86 HNNIIRFYN---SWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
H+++++ + ++ + ++ E+ S ++ + + +K +L G+
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-------------------TIME 183
Y+HS I+HRDLK N +N + VK+ D GLA M
Sbjct: 170 KYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 184 QANAKSVIGTPEFM----------APE--LYDENYNELADIYSFGMCML-EMVTFEYPYS 230
+ APE L ENY E D++S G C+ E++
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKENV 285
Query: 231 E 231
Sbjct: 286 A 286
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 36/213 (16%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLK 82
+Y E IG+G + VYKA + A ++R++ + E + S E+ +LK
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEK------EDEGIPSTTIREISILK 55
Query: 83 SLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSG 141
LKH+NI++ Y+ + K + ++ E L++ + + K + Q+L+G
Sbjct: 56 ELKHSNIVKLYD--VIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG---TPEFM- 197
+ Y H ++HRDLK N+ IN +GE+KI D GL A A + T E +
Sbjct: 113 IAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGL------ARAFGIPVRKYTHEIVT 163
Query: 198 ----APELY--DENYNELADIYSFGMCMLEMVT 224
AP++ + Y+ DI+S G EMV
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 43/215 (20%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED------LERLYSEVHLLKSLK 85
E +G G + TVYK ++ G+ VA +V++D E+ + R E+ L+K LK
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-----EEGTPSTAI-R---EISLMKELK 61
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA------VKGWARQIL 139
H NI+R Y+ + + ++ E F L++Y + VK + Q+L
Sbjct: 62 HENIVRLYD--VIHTENKLTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG---TPEF 196
GL + H + I+HRDLK N+ IN +G++K+GD GL A A + + E
Sbjct: 119 QGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGL------ARAFGIPVNTFSSEV 169
Query: 197 M-----APELY--DENYNELADIYSFGMCMLEMVT 224
+ AP++ Y+ DI+S G + EM+T
Sbjct: 170 VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 62/260 (23%), Positives = 110/260 (42%), Gaps = 41/260 (15%)
Query: 14 PDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGL--EVAWCQVRI----DDVLQS 67
V I K +G+GAF V+ A E L V + D L +
Sbjct: 5 SGIHVQHIKRRD--IVLKRELGEGAFGKVFLA--ECYNLSPTKDKMLVAVKALKDPTLAA 60
Query: 68 PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH---- 123
+D +R E LL +L+H +I++FY + + ++ E G L ++ + H
Sbjct: 61 RKDFQR---EAELLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDA 115
Query: 124 ------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 171
++ + + A QI SG++YL S +HRDL N + N V
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LV 172
Query: 172 KIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF- 225
KIGD G++ + + V G M PE + + +D++SFG+ + E+ T+
Sbjct: 173 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232
Query: 226 EYPYSECRNSAQIYKKVSSG 245
+ P+ + N ++ + ++ G
Sbjct: 233 KQPWFQLSN-TEVIECITQG 251
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 54/262 (20%), Positives = 102/262 (38%), Gaps = 39/262 (14%)
Query: 13 PPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI------DDVLQ 66
P D E ++ + +G+GAF V +A + G++ + +
Sbjct: 16 PYDASKWEFPRDR--LKLGKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGA-- 69
Query: 67 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 125
+ + L SE+ +L + H N++ + + +I E G+L Y + +
Sbjct: 70 THSEHRALMSELKILIHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRN 128
Query: 126 VDMKAVKG----------------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 169
+ ++ Q+ G+ +L S IHRDL NI ++
Sbjct: 129 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-N 185
Query: 170 EVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVT 224
VKI D GLA + + G MAPE ++D Y +D++SFG+ + E+ +
Sbjct: 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
Query: 225 F-EYPYSECRNSAQIYKKVSSG 245
PY + + +++ G
Sbjct: 246 LGASPYPGVKIDEEFCRRLKEG 267
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 74/326 (22%), Positives = 128/326 (39%), Gaps = 73/326 (22%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLE----RLYSEVHLL 81
RY + + +G+G F TVYKA D+ VA ++++ ++ + + R E+ LL
Sbjct: 11 RYEK-LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLL 66
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILS 140
+ L H NII + ++++ + F L K + V +K + L
Sbjct: 67 QELSHPNIIGLLD--AFGHKSNISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 141 GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG---TPEFM 197
GL YLH H I+HRDLK +N+ ++ G +K+ D GLA + T + +
Sbjct: 124 GLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAK------SFGSPNRAYTHQVV 174
Query: 198 -----APELY--DENYNELADIYSFGMCMLEMVTFEYPY----SECRNSAQIYK------ 240
APEL Y D+++ G + E++ P+ S+ Q+ +
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSD---LDQLTRIFETLG 230
Query: 241 --------KVSS--------GIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKEL 279
+ S L + ++ I+ + P R++A +
Sbjct: 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC-ARITATQA 289
Query: 280 LMDPFLQVNGTTKNRPLPLPDIVLPR 305
L + NRP P P LPR
Sbjct: 290 LKMKYF------SNRPGPTPGCQLPR 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 60/339 (17%), Positives = 113/339 (33%), Gaps = 101/339 (29%)
Query: 28 IRYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
+Y + +G G+F V + FD +G A + VLQ D E+ ++K L
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFA-----LKKVLQ---DPRYKNRELDIMKVLD 58
Query: 86 HNNIIR----FYNSWIDDQNKT--------------------------------VNIITE 109
H NII+ FY + ++ +N+I E
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 110 LFTS---GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166
L+ + + + + M + + Q+ + ++HS I HRD+K N+ +N
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNS 176
Query: 167 NQGEVKIGDLGLATIMEQANAKSVIGTPEFM----------APELY--DENYNELADIYS 214
+K+ D G A + + E APEL Y D++S
Sbjct: 177 KDNTLKLCDFGSAKKLIPS---------EPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227
Query: 215 FGMCMLEMVTFE--YPYSECRN------------SAQIYKKVSSG--------IKPAALS 252
G E++ + + + + + +++ +K
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287
Query: 253 KV----KDPEVKSFIEKCLV--PASQRLSAKELLMDPFL 285
K+ +E+ L P R++ E + PF
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEP-DLRINPYEAMAHPFF 325
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 57/259 (22%), Positives = 105/259 (40%), Gaps = 40/259 (15%)
Query: 14 PDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGL--EVAWCQVRI----DDVLQS 67
D V I K +G+GAF V+ A E + L E V + + S
Sbjct: 31 SDACVHHIKRRD--IVLKWELGEGAFGKVFLA--ECHNLLPEQDKMLVAVKALKEA---S 83
Query: 68 PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH---- 123
+ E LL L+H +I+RF+ + + + + ++ E G L ++ + H
Sbjct: 84 ESARQDFQREAELLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 141
Query: 124 -----------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 172
+ + + A Q+ +G++YL +HRDL N + VK
Sbjct: 142 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVK 198
Query: 173 IGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-E 226
IGD G++ + + V G M PE + + +D++SFG+ + E+ T+ +
Sbjct: 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 227 YPYSECRNSAQIYKKVSSG 245
P+ + N + ++ G
Sbjct: 259 QPWYQLSN-TEAIDCITQG 276
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 36/213 (16%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS----EVHLLK 82
+Y+ E +G+G + VYKA D G VA ++R+D + E + S E+ LLK
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLD------AEDEGIPSTAIREISLLK 74
Query: 83 SLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV-DMKAVKGWARQILSG 141
L H NI+ + + + + ++ E F L++ ++K +K + Q+L G
Sbjct: 75 ELHHPNIVSLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG---TPEFM- 197
+ + H H I+HRDLK N+ IN + G +K+ D GL A A + T E +
Sbjct: 132 VAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGL------ARAFGIPVRSYTHEVVT 182
Query: 198 ----APELY--DENYNELADIYSFGMCMLEMVT 224
AP++ + Y+ DI+S G EM+T
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 43/228 (18%), Positives = 99/228 (43%), Gaps = 26/228 (11%)
Query: 31 KEVIGKGAFKTVYKAF--DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
+G G F +V + ++VA ++ E++ R E ++ L +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPY 397
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHS 147
I+R Q + + ++ E+ G L ++ + ++ + V Q+ G+ YL
Sbjct: 398 IVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME--------QANAKSVIGTPEFMAP 199
+ +HR+L N+ + N+ KI D GL+ + ++ K + ++ AP
Sbjct: 455 KN--FVHRNLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAP 508
Query: 200 E-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
E + ++ +D++S+G+ M E +++ + PY + + ++ + G
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQG 555
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 79/309 (25%), Positives = 132/309 (42%), Gaps = 60/309 (19%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLK 85
RY+ + IG GA V A+D + VA + ++ Q+ +R Y E+ L+K +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVA---IKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 86 HNNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
H NII N + ++ + V I+ EL + +L Q + ++D + + Q+L G
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG 139
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-TIMEQANAKSVIGTPEFMAPE 200
+ +LHS IIHRDLK NI + + +KI D GLA T + T + APE
Sbjct: 140 IKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 201 -LYDENYNELADIYSFGMCMLEMVTFE--YPYSECRN------------SAQIYKKVSSG 245
+ Y E DI+S G M EM+ +P ++ + + KK+
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 246 IK-------------------------PAALSKVKDPEVKSFIEKCLV--PASQRLSAKE 278
++ + +K+K + + + K LV S+R+S E
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA-SKRISVDE 315
Query: 279 LLMDPFLQV 287
L P++ V
Sbjct: 316 ALQHPYINV 324
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 67/244 (27%), Positives = 120/244 (49%), Gaps = 12/244 (4%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
+G G+F V+ NG A ++ + V++ + +E E +L + H IIR
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHPFIIRM 71
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
+ ++ D Q + +I + G L +K ++ K +A ++ L YLHS D I
Sbjct: 72 WGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--I 127
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELAD 211
I+RDLK +NI ++ G +KI D G A + ++ GTP+++APE + + YN+ D
Sbjct: 128 IYRDLKPENILLD-KNGHIKITDFGFAKYVPD-VTYTLCGTPDYIAPEVVSTKPYNKSID 185
Query: 212 IYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-A 270
+SFG+ + EM+ P+ N+ + Y+K+ + + +VK + + +
Sbjct: 186 WWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDL 242
Query: 271 SQRL 274
SQRL
Sbjct: 243 SQRL 246
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 41/229 (17%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLK 85
Y +IG+G++ VY A+D+ VA + +++ + + D +R+ E+ +L LK
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVA---IKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 86 HNNIIRFYNSWIDDQNKTVN---IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
+ IIR Y+ I D + I+ E+ S L++ K + + +K +L G
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--------------TIMEQANAK 188
++H IIHRDLK N +N + VK+ D GLA +
Sbjct: 143 NFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 189 SVIGTPEFM----------APE--LYDENYNELADIYSFGMCML-EMVT 224
+ + APE L ENY + DI+S G C+ E++
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLN 247
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 84/339 (24%), Positives = 133/339 (39%), Gaps = 82/339 (24%)
Query: 19 LETDPTCRYI-RYK--EVIGKGAFKTVYKAFDE-VNGLEVAWCQVRIDDVLQSPEDLERL 74
+E D CR +Y+ IG+GA+ V+KA D G VA +VR+ + E +
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-----GE-EGM 54
Query: 75 YS----EVHLLKSLK---HNNIIRFYN---SWIDDQNKTVNIITELFTSGSLRQYRKKHK 124
EV +L+ L+ H N++R ++ D+ + ++ E L Y K
Sbjct: 55 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVP 113
Query: 125 KV--DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182
+ + +K Q+L GL +LHSH ++HRDLK NI + + G++K+ D GLA
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLA--- 167
Query: 183 EQANAKSVIGTPEFM----------APE-LYDENYNELADIYSFGMCMLEMVTFEYPY-- 229
+ + APE L +Y D++S G EM + P
Sbjct: 168 ------RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PLFR 220
Query: 230 --SECRNSAQIYK--------------KVSS-------GIKPAALSKVK---DPEVKSFI 263
S+ Q+ K + + + K D K +
Sbjct: 221 GSSD---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 277
Query: 264 EKCLV--PASQRLSAKELLMDP-FLQVNGTTKNRPLPLP 299
KCL PA +R+SA L P F + +N LP
Sbjct: 278 LKCLTFNPA-KRISAYSALSHPYFQDLERCKENLDSHLP 315
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 79/297 (26%), Positives = 129/297 (43%), Gaps = 49/297 (16%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLK 85
Y+ + +G GA+ V A D G +VA + ++ QS +R Y E+ LLK ++
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVA---IKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 86 HNNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
H N+I + + D+ ++ + L + KH+K+ ++ Q+L G
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKL-MKHEKLGEDRIQFLVYQMLKG 140
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE- 200
L Y+H+ IIHRDLK N+ +N + E+KI D GLA + V+ T + APE
Sbjct: 141 LRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQADSEMTGYVV-TRWYRAPEV 196
Query: 201 -LYDENYNELADIYSFGMCMLEMVT----F---------------------EYPYSECRN 234
L Y + DI+S G M EM+T F E+ +
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 235 SAQIYKKVSSGIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 286
A+ Y K ++ + + P + +EK LV QR++A E L P+ +
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA-EQRVTAGEALAHPYFE 312
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 47/296 (15%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ +G GA+ +V AFD GL VA ++ QS +R Y E+ LLK +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVA--VKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 87 NNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
N+I + + ++ V ++T L + L K +K+ V+ QIL GL
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNI-VKCQKLTDDHVQFLIYQILRGL 145
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-- 200
Y+HS D IIHRDLK N+ +N + E+KI D GLA V T + APE
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARHTADEMTGYVA-TRWYRAPEIM 201
Query: 201 LYDENYNELADIYSFGMCMLEMVT----F---------------------EYPYSECRNS 235
L +YN+ DI+S G M E++T F E S
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 236 AQIYKKVSSGIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 286
A+ Y + + + + V +P +EK LV +R++A + L +
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS-DKRITAAQALAHAYFA 316
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 55/234 (23%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLK 85
+Y+ + +GKGA+ V+K+ D G VA V +I D Q+ D +R + E+ +L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVA---VKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 86 -HNNIIRFYNSWIDDQNKTVNIITEL--------FTSGSLRQYRKKHKKVDMKAVKGWAR 136
H NI+ N D ++ V ++ + + L HK+ +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL---EPVHKQYVV-------Y 116
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-------------TIME 183
Q++ + YLHS ++HRD+K NI +N VK+ D GL+ +
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 184 QANAKSVIGTPEFM----------APE--LYDENYNELADIYSFGMCML-EMVT 224
N ++ + APE L Y + D++S G C+L E++
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILC 226
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 82/369 (22%), Positives = 133/369 (36%), Gaps = 87/369 (23%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK- 85
RY +G G F TV+ A D VN VA VR E E+ LL+ +
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVND 74
Query: 86 ----------HNNIIRFYNS--WIDDQNKTVNIITELFTSGSLRQYRKK--HKKVDMKAV 131
N+I++ + V ++ E+ +L KK H+ + + V
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRGIPLIYV 133
Query: 132 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI-----NGNQGEVKIGDLGLATIMEQAN 186
K ++Q+L GL Y+H IIH D+K +N+ + N ++KI DLG A ++ +
Sbjct: 134 KQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-H 191
Query: 187 AKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT----F--EYPYSECRNSAQI- 238
+ I T E+ +PE L + ADI+S + E++T F + +S ++ I
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 239 ------------------------------YKKVSSGIKP--------AALSKVKDPEVK 260
P SK + E+
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 261 SFIEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGAFGDRCLMSEG 318
F+ L P +R A L+ P+L+ T + +PD L G+ G
Sbjct: 312 DFLSPMLQLDP-RKRADAGGLVNHPWLK--DTLGMEEIRVPDRELYGSGSD------IPG 362
Query: 319 PASVRNKHP 327
H
Sbjct: 363 WFEEVRDHK 371
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 50/246 (20%), Positives = 97/246 (39%), Gaps = 38/246 (15%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI------DDVLQSPEDLERLYSEVHLL 81
+R+ E +G+ F VYK + G + D E E L
Sbjct: 11 VRFMEELGEDRFGKVYKG--HLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLR 66
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH----------------KK 125
L+H N++ + +++ +++I + G L ++
Sbjct: 67 ARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 126 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185
++ QI +G+ YL SH ++H+DL N+ + VKI DLGL + A
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK-LNVKISDLGLFREVYAA 181
Query: 186 NAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIY 239
+ ++G MAPE + ++ +DI+S+G+ + E+ ++ PY N +
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVV 240
Query: 240 KKVSSG 245
+ + +
Sbjct: 241 EMIRNR 246
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 64/313 (20%), Positives = 106/313 (33%), Gaps = 69/313 (22%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNG------LEVAWCQVRIDDVLQSPEDLERLYSEVHL 80
Y I G++ V D + R ++L +R+ E+ L
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 81 LKSLKHNNIIRFYN---SWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWAR 136
L H NI+ + + + + ++TEL + L Q + + + ++ +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF 196
IL GL LH ++HRDL NI + N ++ I D LA
Sbjct: 142 HILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNLA---------REDTADAN 189
Query: 197 M----------APE--LYDENYNELADIYSFGMCMLEMVT----F--------------- 225
APE + + + +L D++S G M EM F
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249
Query: 226 ------EYPYSECRNSAQIYKKVSSGIKP----AALSKVKDPEVKSFIEKCLV--PASQR 273
E SA+ Y + S P A+ DP I K L P +R
Sbjct: 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP-QRR 308
Query: 274 LSAKELLMDPFLQ 286
+S ++ L P+ +
Sbjct: 309 ISTEQALRHPYFE 321
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 68/300 (22%), Positives = 122/300 (40%), Gaps = 51/300 (17%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY IG+GA+ V A+D +N + VA ++ + +R E+ +L +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 87 NNIIRFYNSWIDDQNKTVN---IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
NII + + + I+ +L + L + K + + + QIL GL
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDH-ICYFLYQILRGLK 142
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPE-----FMA 198
Y+HS + ++HRDLK N+ +N ++KI D GLA + + + + T + A
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 199 PE--LYDENYNELADIYSFGMCMLEMVT----F---------------------EYPYSE 231
PE L + Y + DI+S G + EM++ F E
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 232 CRNSAQIYKKVSSGIKPAALSKV---KDPEVKSFIEKCLV--PASQRLSAKELLMDPFLQ 286
A+ Y +++ D + ++K L P +R+ ++ L P+L+
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP-HKRIEVEQALAHPYLE 318
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 67/268 (25%), Positives = 107/268 (39%), Gaps = 39/268 (14%)
Query: 7 GAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKA--FDEVNGLEVAWCQVRI--- 61
G ++ E P+ E + + +G+GAF V A V +
Sbjct: 18 GVSEYELPEDPKWEFPRDK--LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75
Query: 62 -DDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY 119
DD + +DL L SE+ ++K + KH NII Q+ + +I E + G+LR+Y
Sbjct: 76 KDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREY 131
Query: 120 RKKHKKVDMKAVKG----------------WARQILSGLIYLHSHDPPIIHRDLKCDNIF 163
+ + M+ Q+ G+ YL S IHRDL N+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 189
Query: 164 INGNQGEVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMC 218
+ +KI D GLA + + MAPE L+D Y +D++SFG+
Sbjct: 190 V-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 219 MLEMVTF-EYPYSECRNSAQIYKKVSSG 245
M E+ T PY +++K + G
Sbjct: 249 MWEIFTLGGSPYPGIPV-EELFKLLKEG 275
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 77/336 (22%), Positives = 129/336 (38%), Gaps = 72/336 (21%)
Query: 23 PTCRYI-RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEV 78
P C + +Y+ IG+G F V+KA G +VA +V +++ + P R E+
Sbjct: 11 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EI 67
Query: 79 HLLKSLKHNNIIRFY------NSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAV 131
+L+ LKH N++ S + ++ ++ + F L K + +
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLSEI 126
Query: 132 KGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM-EQANAKSV 190
K + +L+GL Y+H + I+HRD+K N+ I G +K+ D GLA N++
Sbjct: 127 KRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPN 183
Query: 191 IGTPE-----FMAPELY--DENYNELADIYSFGMCMLEMVT------------------- 224
T + PEL + +Y D++ G M EM T
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 225 -------------FEYP-YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-- 268
Y Y + +KV +K V+DP I+K LV
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY----VRDPYALDLIDKLLVLD 299
Query: 269 PASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLP 304
PA QR+ + + L F + P+P +
Sbjct: 300 PA-QRIDSDDALNHDFF------WSDPMPSDLKGML 328
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 57/267 (21%), Positives = 103/267 (38%), Gaps = 46/267 (17%)
Query: 12 EPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI------DDVL 65
+ P E + + + +G GAF V +A GL + + +
Sbjct: 11 QLPYDHKWEFPRNR--LSFGKTLGAGAFGKVVEA--TAYGLIKSDAAMTVAVKMLKPSA- 65
Query: 66 QSPEDLERLYSEVHLLKSL-KHNNIIRFYN--SWIDDQNKTVNIITELFTSGSLRQYRKK 122
+ E L SE+ +L L H NI+ + +ITE G L + ++
Sbjct: 66 -HLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVITEYCCYGDLLNFLRR 120
Query: 123 HKKVDMKAVKG------------------WARQILSGLIYLHSHDPPIIHRDLKCDNIFI 164
+ + + ++ Q+ G+ +L S + IHRDL NI +
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL 178
Query: 165 NGNQGEVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCM 219
+ KI D GLA ++ + V G MAPE +++ Y +D++S+G+ +
Sbjct: 179 -THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
Query: 220 LEMVTF-EYPYSECRNSAQIYKKVSSG 245
E+ + PY ++ YK + G
Sbjct: 238 WELFSLGSSPYPGMPVDSKFYKMIKEG 264
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 23/253 (9%)
Query: 33 VIGKGAFKTVY---KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI 89
V+GKG + V+ K G A ++ ++++ +D +E ++L+ +KH I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 90 IRFYNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 148
+ ++ Q + +I E + G L ++ + +I L +LH
Sbjct: 84 VDLIYAF---QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYDEN 205
II+RDLK +NI +N +QG VK+ D GL +I + + GT E+MAPE L
Sbjct: 141 G--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 206 YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAALSKVKDPEVKSFI 263
+N D +S G M +M+T P+ N + K+ P L+ E + +
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYLT----QEARDLL 252
Query: 264 EKCLV--PASQRL 274
+K L + RL
Sbjct: 253 KKLLKRNA-ASRL 264
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 79/310 (25%), Positives = 126/310 (40%), Gaps = 62/310 (20%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLK 85
RY+ + IG GA V A+D V VA + ++ Q+ +R Y E+ L+K +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVA---IKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 86 HNNIIRFYNSWIDDQN----KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
H NII N + + + V ++ EL + +L Q + ++D + + Q+L G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG 176
Query: 142 LIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA-TIMEQANAKSVIGTPEFMAPE 200
+ +LHS IIHRDLK NI + + +KI D GLA T + T + APE
Sbjct: 177 IKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 201 -LYDENYNELADIYSFGMCMLEMVT----F------------------------------ 225
+ Y E DI+S G M EMV F
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293
Query: 226 ------EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV--PASQRLSAK 277
P +++ + +K+K + + + K LV PA +R+S
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLLSKMLVIDPA-KRISVD 351
Query: 278 ELLMDPFLQV 287
+ L P++ V
Sbjct: 352 DALQHPYINV 361
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 67/269 (24%), Positives = 112/269 (41%), Gaps = 26/269 (9%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
V+G+G F V+ + G A C+ L+ + + E +L + I+
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYA-CKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 93 YNSWIDDQNKT-VNIITELFTSGSL----RQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
++ + KT + ++ + G + + + + QI+SGL +LH
Sbjct: 251 AYAF---ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYDE 204
+ II+RDLK +N+ ++ + G V+I DLGLA Q K GTP FMAPE L E
Sbjct: 308 RN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 205 NYNELADIYSFGMCMLEMVTFEYPY---SECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
Y+ D ++ G+ + EM+ P+ E + ++ ++V P K
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSPASKD 422
Query: 262 FIEKCLVP-ASQRL-----SAKELLMDPF 284
F E L +RL S L P
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 56/273 (20%), Positives = 102/273 (37%), Gaps = 52/273 (19%)
Query: 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGL--EVAWCQVRI----DDV 64
+ P LE I Y IG+GAF V++A GL + V + ++
Sbjct: 34 LLNPKLLSLEYPRNN--IEYVRDIGEGAFGRVFQA--RAPGLLPYEPFTMVAVKMLKEEA 89
Query: 65 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK 124
S + E L+ + NI++ + + ++ E G L ++ +
Sbjct: 90 --SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMS 145
Query: 125 KVDMKAVKGW------------------------ARQILSGLIYLHSHDPPIIHRDLKCD 160
+ ++ ARQ+ +G+ YL +HRDL
Sbjct: 146 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATR 203
Query: 161 NIFINGNQGEVKIGDLGLA-TIMEQ----ANAKSVIGTP-EFMAPE-LYDENYNELADIY 213
N + N VKI D GL+ I A+ I P +M PE ++ Y +D++
Sbjct: 204 NCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAI--PIRWMPPESIFYNRYTTESDVW 260
Query: 214 SFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
++G+ + E+ ++ PY + ++ V G
Sbjct: 261 AYGVVLWEIFSYGLQPYYGMAH-EEVIYYVRDG 292
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 66/268 (24%), Positives = 106/268 (39%), Gaps = 39/268 (14%)
Query: 7 GAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKA--FDEVNGLEVAWCQVRI--- 61
G ++ E P+ E + + +G+G F V A V +
Sbjct: 64 GVSEYELPEDPKWEFPRDK--LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML 121
Query: 62 -DDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY 119
DD + +DL L SE+ ++K + KH NII + D + +I E + G+LR+Y
Sbjct: 122 KDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREY 177
Query: 120 RKKHKKVDMKAVKG----------------WARQILSGLIYLHSHDPPIIHRDLKCDNIF 163
+ + M+ Q+ G+ YL S IHRDL N+
Sbjct: 178 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 235
Query: 164 INGNQGEVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMC 218
+ +KI D GLA + + MAPE L+D Y +D++SFG+
Sbjct: 236 V-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 294
Query: 219 MLEMVTF-EYPYSECRNSAQIYKKVSSG 245
M E+ T PY +++K + G
Sbjct: 295 MWEIFTLGGSPYPGIPV-EELFKLLKEG 321
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 54/257 (21%), Positives = 109/257 (42%), Gaps = 24/257 (9%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
VIG+GAF V + A + ++L+ + E +L + I
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR-AETACFREERDVLVNGDSKWITTL 139
Query: 93 YNSWIDDQNKTVNIITELFTSGSL-RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+ ++ DD N + ++ + + G L K ++ + + + +++ + +H
Sbjct: 140 HYAFQDDNN--LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH-- 195
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIM---EQANAKSVIGTPEFMAPEL------Y 202
+HRD+K DNI ++ G +++ D G + + +GTP++++PE+
Sbjct: 196 YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 203 DENYNELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIK----PAALSKVKDP 257
Y D +S G+CM EM+ E P Y+E + + Y K+ + + P ++ V
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPTQVTDV-SE 311
Query: 258 EVKSFIEKCLVPASQRL 274
K I + + RL
Sbjct: 312 NAKDLIRRLICSREHRL 328
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 55/253 (21%), Positives = 107/253 (42%), Gaps = 20/253 (7%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
VIG+GAF V + A + ++++ D + E ++ +++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-SDSAFFWEERDIMAFANSPWVVQL 134
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
+ ++ DD+ + ++ E G L + V K + + +++ L +HS
Sbjct: 135 FYAFQDDRY--LYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMG--F 189
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---AKSVIGTPEFMAPEL-----YDE 204
IHRD+K DN+ ++ G +K+ D G M + + +GTP++++PE+ D
Sbjct: 190 IHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248
Query: 205 NYNELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYKKVSSGIKPAALSKVKD--PEVKS 261
Y D +S G+ + EM+ + P Y++ + Y K+ + D E K+
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306
Query: 262 FIEKCLVPASQRL 274
I L RL
Sbjct: 307 LICAFLTDREVRL 319
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 65/274 (23%), Positives = 110/274 (40%), Gaps = 43/274 (15%)
Query: 3 SSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYK--AFDEVNGLEVAWCQVR 60
G ++ E P+ E + + +G+GAF V A +V
Sbjct: 48 GMLAGVSEYELPEDPRWELPRDR--LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVA 105
Query: 61 I----DDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYN--SWIDDQNKTVNIITELFTS 113
+ D + +DL L SE+ ++K + KH NII + Q+ + +I E +
Sbjct: 106 VKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT----QDGPLYVIVEYASK 159
Query: 114 GSLRQYRKKHKKVDMKAVKG----------------WARQILSGLIYLHSHDPPIIHRDL 157
G+LR+Y + + ++ A Q+ G+ YL S IHRDL
Sbjct: 160 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDL 217
Query: 158 KCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADI 212
N+ + + +KI D GLA + + MAPE L+D Y +D+
Sbjct: 218 AARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 276
Query: 213 YSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
+SFG+ + E+ T PY +++K + G
Sbjct: 277 WSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKEG 309
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 62/270 (22%), Positives = 111/270 (41%), Gaps = 48/270 (17%)
Query: 12 EPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGL--EVAWCQVRI----DDVL 65
+ + E + + +G+G F V KA L + V + ++
Sbjct: 11 KILEDPKWEFPRKN--LVLGKTLGEGEFGKVVKA--TAFHLKGRAGYTTVAVKMLKENA- 65
Query: 66 QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 125
SP +L L SE ++LK + H ++I+ Y + D + +I E GSLR + ++ +K
Sbjct: 66 -SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG--PLLLIVEYAKYGSLRGFLRESRK 122
Query: 126 VDMKAVKG------------------------WARQILSGLIYLHSHDPPIIHRDLKCDN 161
V + +A QI G+ YL ++HRDL N
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARN 180
Query: 162 IFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFG 216
I + ++KI D GL+ + + ++ MA E L+D Y +D++SFG
Sbjct: 181 ILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 217 MCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
+ + E+VT PY +++ + +G
Sbjct: 240 VLLWEIVTLGGNPYPGIPP-ERLFNLLKTG 268
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 69/269 (25%), Positives = 128/269 (47%), Gaps = 34/269 (12%)
Query: 33 VIGKGAFKTV----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
++GKG F V KA +++ +R + ++ +++ +E +L++ +H
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKI----LRKEVIIAK-DEVAHTVTESRVLQNTRHPF 66
Query: 89 IIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
+ ++ Q + + E G L + + + + + + +I+S L YLHS
Sbjct: 67 LTALKYAF---QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYDE 204
D +++RD+K +N+ ++ G +KI D GL I + A K+ GTPE++APE L D
Sbjct: 124 RD--VVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 205 NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IK-PAALSKVKDPEVKSF 262
+Y D + G+ M EM+ P+ ++ ++++ + I+ P LS PE KS
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLS----PEAKSL 235
Query: 263 IEKCLV--PASQRL-----SAKELLMDPF 284
+ L P QRL AKE++ F
Sbjct: 236 LAGLLKKDPK-QRLGGGPSDAKEVMEHRF 263
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 49/188 (26%), Positives = 90/188 (47%), Gaps = 15/188 (7%)
Query: 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166
I +L G L + +H ++ +A +I+ GL ++H+ +++RDLK NI ++
Sbjct: 270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD- 326
Query: 167 NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVT 224
G V+I DLGLA + + +GT +MAPE Y+ AD +S G + +++
Sbjct: 327 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386
Query: 225 FEYPY--SECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRL-----SA 276
P+ + ++ +I + + L PE++S +E L ++RL A
Sbjct: 387 GHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 444
Query: 277 KELLMDPF 284
+E+ PF
Sbjct: 445 QEVKESPF 452
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 5e-22
Identities = 66/266 (24%), Positives = 116/266 (43%), Gaps = 23/266 (8%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
V+GKG F V G A C+ ++ + +E +L+ + ++
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYA-CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 93 YNSWIDDQNKT-VNIITELFTSGSLRQ--YRKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
++ + K + ++ L G L+ Y +A +I GL LH
Sbjct: 250 AYAY---ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT-IMEQANAKSVIGTPEFMAPE-LYDENYN 207
I++RDLK +NI ++ + G ++I DLGLA + E K +GT +MAPE + +E Y
Sbjct: 307 --IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 208 ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVKDPEVKSFIEK 265
D ++ G + EM+ + P+ + R ++V + P S+ P+ +S +
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422
Query: 266 CLV--PASQRL-----SAKELLMDPF 284
L PA +RL SA+E+ P
Sbjct: 423 LLCKDPA-ERLGCRGGSAREVKEHPL 447
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 63/261 (24%), Positives = 111/261 (42%), Gaps = 38/261 (14%)
Query: 12 EPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI----DDVLQS 67
+ P + E +++ + +G GAF V +A G E A +V +
Sbjct: 34 QLPYNEKWEFPRNN--LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--H 89
Query: 68 PEDLERLYSEVHLLKSL-KHNNIIRFYN--SWIDDQNKTVNIITELFTSGSLRQY-RKKH 123
++ E L SE+ ++ L +H NI+ + V +ITE G L + R+K
Sbjct: 90 ADEKEALMSELKIMSHLGQHENIVNLLGACT----HGGPVLVITEYCCYGDLLNFLRRKS 145
Query: 124 KKVDMKAVKG-------------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 170
+ ++ ++ Q+ G+ +L S + IHRD+ N+ + N
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHV 202
Query: 171 VKIGDLGLATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF 225
KIGD GLA + + V G MAPE ++D Y +D++S+G+ + E+ +
Sbjct: 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262
Query: 226 -EYPYSECRNSAQIYKKVSSG 245
PY +++ YK V G
Sbjct: 263 GLNPYPGILVNSKFYKLVKDG 283
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 65/259 (25%), Positives = 106/259 (40%), Gaps = 38/259 (14%)
Query: 12 EPPDPDVL-ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI----DDVLQ 66
PDP + D I++++VIG+G F V KA + +GL + I +
Sbjct: 12 NNPDPTIYPVLDWND--IKFQDVIGEGNFGQVLKARIKKDGLRM---DAAIKRMKEYA-- 64
Query: 67 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 125
S +D E+ +L L H NII + + + E G+L + +K +
Sbjct: 65 SKDDHRDFAGELEVLCKLGHHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRV 122
Query: 126 VDMKAVKGW----------------ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 169
++ A + G+ YL IHRDL NI + N
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY- 179
Query: 170 EVKIGDLGLATIMEQANAKSVIGTP-EFMAPE-LYDENYNELADIYSFGMCMLEMVTF-E 226
KI D GL+ E K++ P +MA E L Y +D++S+G+ + E+V+
Sbjct: 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 239
Query: 227 YPYSECRNSAQIYKKVSSG 245
PY A++Y+K+ G
Sbjct: 240 TPYCGMTC-AELYEKLPQG 257
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 12/149 (8%)
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIG 192
A +I S L YLHS + I++RDLK +NI ++ +QG + + D GL I + + G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 193 TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 251
TPE++APE L+ + Y+ D + G + EM+ P+ RN+A++Y + + KP L
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILN--KPLQL 258
Query: 252 SKVKDPEVKSFIEKCLV--PASQRLSAKE 278
+ +E L +RL AK+
Sbjct: 259 KPNITNSARHLLEGLLQKDRT-KRLGAKD 286
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 66/278 (23%), Positives = 107/278 (38%), Gaps = 75/278 (26%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
V+G+G+F V+ V+ S D +LY+ +K LK +
Sbjct: 31 VLGQGSFGKVF--------------LVK----KISGSDARQLYA----MKVLKKATLK-- 66
Query: 93 YNSWIDDQNKTVNIITE--------------LFTS----------------GSLRQYRKK 122
V E L + G L K
Sbjct: 67 -------VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 123 HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--T 180
+ VK + ++ L +LHS II+RDLK +NI ++ +G +K+ D GL+ +
Sbjct: 120 EVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKES 176
Query: 181 IMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY 239
I + A S GT E+MAPE + + + AD +SFG+ M EM+T P+ + ++ +
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETM 235
Query: 240 KKVSSG--IKPAALSKVKDPEVKSFIEKCLVP-ASQRL 274
+ P LS PE +S + + RL
Sbjct: 236 TMILKAKLGMPQFLS----PEAQSLLRMLFKRNPANRL 269
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 56/271 (20%), Positives = 117/271 (43%), Gaps = 27/271 (9%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
VIG+GAF V + G A + D+L+ ++ E +L + I +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-GEVSCFREERDVLVNGDRRWITQL 126
Query: 93 YNSWIDDQNKTVNIITELFTSGSL-RQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+ ++ D+ + ++ E + G L K +++ + + + +I+ + +H
Sbjct: 127 HFAFQDENY--LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG-- 182
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIM---EQANAKSVIGTPEFMAPEL------- 201
+HRD+K DNI ++ G +++ D G + + +GTP++++PE+
Sbjct: 183 YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 202 -YDENYNELADIYSFGMCMLEMVTFEYP-YSECRNSAQIYKKVSSG---IKPAALSKVKD 256
+Y D ++ G+ EM + P Y++ ++A+ Y K+ + + +
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STAETYGKIVHYKEHLSLPLVDEGVP 299
Query: 257 PEVKSFIEKCLVPASQRL---SAKELLMDPF 284
E + FI++ L P RL A + PF
Sbjct: 300 EEARDFIQRLLCPPETRLGRGGAGDFRTHPF 330
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 59/260 (22%), Positives = 120/260 (46%), Gaps = 29/260 (11%)
Query: 33 VIGKGAFKTVY---KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN- 88
V+G GA+ V+ K G A ++ ++Q + E +E +L+ ++ +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 89 IIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS 147
++ + ++ Q +T +++I + G L + + ++ V+ + +I+ L +LH
Sbjct: 121 LVTLHYAF---QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 177
Query: 148 HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA---TIMEQANAKSVIGTPEFMAPELYDE 204
II+RD+K +NI ++ + G V + D GL+ E A GT E+MAP++
Sbjct: 178 LG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 205 N---YNELADIYSFGMCMLEMVT----FEYPYSECRNSAQIYKKVSSG-IK-PAALSKVK 255
+++ D +S G+ M E++T F E + A+I +++ P +S
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKSEPPYPQEMS--- 290
Query: 256 DPEVKSFIEKCLVP-ASQRL 274
K I++ L+ +RL
Sbjct: 291 -ALAKDLIQRLLMKDPKKRL 309
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 68/265 (25%), Positives = 124/265 (46%), Gaps = 25/265 (9%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
++GKG F V ++ G A ++ + ++ +++ +E +L++ +H +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTLTENRVLQNSRHPFLTAL 213
Query: 93 YNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
S+ Q + + E G L + + + + + +I+S L YLHS
Sbjct: 214 KYSF---QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN- 269
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYDENYNE 208
+++RDLK +N+ ++ G +KI D GL I + A K+ GTPE++APE L D +Y
Sbjct: 270 VVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 328
Query: 209 LADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK-VSSGIK-PAALSKVKDPEVKSFIEKC 266
D + G+ M EM+ P+ ++ ++++ + I+ P L PE KS +
Sbjct: 329 AVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLG----PEAKSLLSGL 383
Query: 267 LV--PASQRL-----SAKELLMDPF 284
L P QRL AKE++ F
Sbjct: 384 LKKDPK-QRLGGGSEDAKEIMQHRF 407
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 68/266 (25%), Positives = 124/266 (46%), Gaps = 31/266 (11%)
Query: 33 VIGKGAFKTV----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHN 87
++GKG+F V +K ++ ++ ++ D VL +D+E E L + +H
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKA----LKKDVVLMD-DDVECTMVEKRVLSLAWEHP 78
Query: 88 NIIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
+ + ++ Q K + + E G L + + K D+ +A +I+ GL +LH
Sbjct: 79 FLTHMFCTF---QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYD 203
S I++RDLK DNI ++ G +KI D G+ ++ A + GTP+++APE L
Sbjct: 136 SKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 192
Query: 204 ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAALSKVKDPEVKS 261
+ YN D +SFG+ + EM+ + P+ ++ +++ + P L E K
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLE----KEAKD 247
Query: 262 FIEKCLV--PASQRLSAKELLMD-PF 284
+ K V P +RL + + P
Sbjct: 248 LLVKLFVREPE-KRLGVRGDIRQHPL 272
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 55/254 (21%), Positives = 97/254 (38%), Gaps = 45/254 (17%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI------DDVLQSPEDLERLYSEVHLL 81
+ + +V+G GAF V A G+ +++ + + E L SE+ ++
Sbjct: 47 LEFGKVLGSGAFGKVMNA--TAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMM 102
Query: 82 KSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKG------- 133
L H NI+ + + +I E G L Y + ++ +
Sbjct: 103 TQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 134 ----------------WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177
+A Q+ G+ +L +HRDL N+ + VKI D G
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG-KVVKICDFG 217
Query: 178 LATIMEQANAKSVIGTPEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSE 231
LA + + V G MAPE L++ Y +D++S+G+ + E+ + PY
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277
Query: 232 CRNSAQIYKKVSSG 245
A YK + +G
Sbjct: 278 IPVDANFYKLIQNG 291
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 72/327 (22%), Positives = 120/327 (36%), Gaps = 80/327 (24%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ +VIGKG+F V KA+D VA +++ V + E+ +L+ L+
Sbjct: 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVA---LKM--VRNEKRFHRQAAEEIRILEHLRK 152
Query: 87 ------NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQI 138
N+I +N + EL S +L + KK+K + V+ +A I
Sbjct: 153 QDKDNTMNVIHMLE-NFTFRNHIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNI-FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM 197
L L LH + IIH DLK +NI + +K+ D G + Q + I + +
Sbjct: 210 LQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-RVYTYIQSRFYR 266
Query: 198 APE-LYDENYNELADIYSFGMCMLEMVT-------------------------------- 224
APE + Y D++S G + E++T
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326
Query: 225 ------FE---YPYSECRNSAQIYKKVSSGIKP---------------AALSKVKDPEVK 260
YP + V +G + AL DP
Sbjct: 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 261 SFIEKCLVP-ASQRLSAKELLMDPFLQ 286
F+++CL + R++ + L P+L+
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 61/259 (23%), Positives = 119/259 (45%), Gaps = 30/259 (11%)
Query: 33 VIGKGAFKTVY----KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHN 87
V+GKG+F V K ++ ++V ++ D +LQ +D+E +E L + H
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKV----LKKDVILQD-DDVECTMTEKRILSLARNHP 84
Query: 88 NIIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
+ + + + Q + + E G L + +K ++ D + +A +I+S L++LH
Sbjct: 85 FLTQLFCCF---QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYD 203
II+RDLK DN+ ++ +G K+ D G+ I + GTP+++APE L +
Sbjct: 142 DKG--IIYRDLKLDNVLLDH-EGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE 198
Query: 204 ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK-VSSGIK-PAALSKVKDPEVKS 261
Y D ++ G+ + EM+ P+ E N +++ ++ + P L +
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLH----EDATG 253
Query: 262 FIEKCLV--PASQRLSAKE 278
++ + P RL +
Sbjct: 254 ILKSFMTKNPT-MRLGSLT 271
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 62/263 (23%), Positives = 120/263 (45%), Gaps = 37/263 (14%)
Query: 33 VIGKGAFKTVY----KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHN 87
VIG+G++ V K D + ++V V+ + V ED++ + +E H ++ H
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKV----VKKELVNDD-EDIDWVQTEKHVFEQASNHP 70
Query: 88 NIIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
++ ++ + Q ++ + + E G L + ++ +K+ + + ++ +I L YLH
Sbjct: 71 FLVGLHSCF---QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYD 203
II+RDLK DN+ ++ +G +K+ D G+ + + GTP ++APE L
Sbjct: 128 ERG--IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 184
Query: 204 ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY----KKVSSGIK------PAALSK 253
E+Y D ++ G+ M EM+ P+ +S + I P +LS
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS- 243
Query: 254 VKDPEVKSFIEKCLV--PASQRL 274
+ S ++ L P +RL
Sbjct: 244 ---VKAASVLKSFLNKDPK-ERL 262
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 42/311 (13%), Positives = 88/311 (28%), Gaps = 48/311 (15%)
Query: 9 AKMEPPDPDVLETDPTCRYI--RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV 64
+ PD ++ P R RY+ G ++A D +VA V V
Sbjct: 10 DRESSAPPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV 69
Query: 65 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK 124
L + L+ S L + + R + + ++ E GSL++
Sbjct: 70 L-PDDVLQETLSRTLRLSRIDKPGVARVLD--VVHTRAGGLVVAEWIRGGSLQEVADTS- 125
Query: 125 KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184
+ + + H + + ++ + G+V + M
Sbjct: 126 -PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAYPA---TMPD 178
Query: 185 ANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI---YKK 241
AN + DI G + ++ +P E + + +
Sbjct: 179 ANPQD---------------------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD 217
Query: 242 VSSGIKPAALSKVKD---PEVKSFIEKCLV--PASQRLSAKELLMDPFLQVNGTTKNRP- 295
+ +P + + ++ + + + + S LM V T+
Sbjct: 218 TAG--QPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
Query: 296 -LPLPDIVLPR 305
P PR
Sbjct: 276 IDEAPVSAAPR 286
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
+G+G F VYK + VN VA ++ + + E ++ E+ ++ +H N++
Sbjct: 38 KMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQY---RKKHKKVD----MKAVKGWARQILSGLIYL 145
D + ++ +GSL + K +G A G+ +L
Sbjct: 96 LGFSSDGDDLC--LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFL 149
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS-----VIGTPEFMAPE 200
H + IHRD+K NI ++ KI D GLA E+ A++ ++GT +MAPE
Sbjct: 150 H--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEK-FAQTVMTSRIVGTTAYMAPE 205
Query: 201 LYDENYNELADIYSFGMCMLEMVT 224
+DIYSFG+ +LE++T
Sbjct: 206 ALRGEITPKSDIYSFGVVLLEIIT 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 62/263 (23%), Positives = 119/263 (45%), Gaps = 37/263 (14%)
Query: 33 VIGKGAFKTVY----KAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHN 87
VIG+G++ V K D + + V V+ + V ED++ + +E H ++ H
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRV----VKKELVNDD-EDIDWVQTEKHVFEQASNHP 113
Query: 88 NIIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
++ ++ + Q ++ + + E G L + ++ +K+ + + ++ +I L YLH
Sbjct: 114 FLVGLHSCF---QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYD 203
II+RDLK DN+ ++ +G +K+ D G+ + + GTP ++APE L
Sbjct: 171 ERG--IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 204 ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY----KKVSSGIK------PAALSK 253
E+Y D ++ G+ M EM+ P+ +S + I P +LS
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS- 286
Query: 254 VKDPEVKSFIEKCLV--PASQRL 274
+ S ++ L P +RL
Sbjct: 287 ---VKAASVLKSFLNKDP-KERL 305
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 3e-19
Identities = 63/270 (23%), Positives = 125/270 (46%), Gaps = 35/270 (12%)
Query: 33 VIGKGAFKTV----YKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHN 87
V+GKG+F V K DE+ +++ ++ D V+Q +D+E E L K
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI----LKKDVVIQD-DDVECTMVEKRVLALPGKPP 402
Query: 88 NIIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
+ + ++ + Q + + E G L + ++ + +A +I GL +L
Sbjct: 403 FLTQLHSCF---QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTPEFMAPE-LYD 203
S II+RDLK DN+ ++ +G +KI D G+ I + K+ GTP+++APE +
Sbjct: 460 SKG--IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 516
Query: 204 ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAALSKVKDPEVKS 261
+ Y + D ++FG+ + EM+ + P+ E + ++++ + P ++S E +
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMS----KEAVA 571
Query: 262 FIEKCLV--PASQRL-----SAKELLMDPF 284
+ + P +RL +++ F
Sbjct: 572 ICKGLMTKHPG-KRLGCGPEGERDIKEHAF 600
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 40/159 (25%), Positives = 80/159 (50%), Gaps = 19/159 (11%)
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA--TIMEQANAKSVIGTP 194
+I GL +L S II+RDLK DN+ ++ ++G +KI D G+ I + K+ GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 195 EFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--IKPAAL 251
+++APE + + Y + D ++FG+ + EM+ + P+ E + ++++ + P ++
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244
Query: 252 SKVKDPEVKSFIEKCLVP-ASQRL-----SAKELLMDPF 284
S E + + + +RL +++ F
Sbjct: 245 S----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 9e-19
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ +IGKG+F V KA+D V VA ++I + L + EV LL+ +
Sbjct: 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVA---IKI--IKNKKAFLNQAQIEVRLLELMNK 109
Query: 87 ------NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQI 138
I+ +N ++ E+ S +L + V + + +A+Q+
Sbjct: 110 HDTEMKYYIVHLKR-HFMFRNHLC-LVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNI-FINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM 197
+ L++L + + IIH DLK +NI N + +KI D G + + Q I + +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-RIYQYIQSRFYR 225
Query: 198 APE-LYDENYNELADIYSFGMCMLEMVT 224
+PE L Y+ D++S G ++EM T
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQV-RIDDVLQSPEDLERLYSEVHLLKSLKHN 87
K ++G+G F VYK +G VA V R+ + +L+ +EV ++ H
Sbjct: 33 SNKNILGRGGFGKVYKGRLA-DGTLVA---VKRLKEERTQGGELQFQ-TEVEMISMAVHR 87
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQ----YRKKHKKVD----MKAVKGWARQIL 139
N++R + + ++ +GS+ + +D + G AR
Sbjct: 88 NLLRLRGFCMTPTERL--LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR--- 142
Query: 140 SGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK---SVIGTPE 195
GL YLH H DP IIHRD+K NI ++ E +GD GLA +M+ + +V GT
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 196 FMAPELYDENY------NELADIYSFGMCMLEMVT 224
+APE Y +E D++ +G+ +LE++T
Sbjct: 201 HIAPE-----YLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 51/243 (20%), Positives = 93/243 (38%), Gaps = 39/243 (16%)
Query: 7 GAAKMEPPDPDVLETDPTCRYIRYKE------------VIGKGAFKTVYKAFDEVNGLEV 54
+ + + +IG G F VYK +G +V
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKV 66
Query: 55 AWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG 114
A + + E +E+ L +H +++ + +I + +G
Sbjct: 67 ALKRRTPESSQGIEEFE----TEIETLSFCRHPHLVSLIGFCDERNEMI--LIYKYMENG 120
Query: 115 SLRQ--YRKKHKKVD------MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166
+L++ Y + ++ G AR GL YLH+ IIHRD+K NI ++
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAAR----GLHYLHT--RAIIHRDVKSINILLDE 174
Query: 167 NQGEVKIGDLGLATIMEQANAK----SVIGTPEFMAPELYDENY-NELADIYSFGMCMLE 221
N KI D G++ + + V GT ++ PE + + E +D+YSFG+ + E
Sbjct: 175 NF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 222 MVT 224
++
Sbjct: 234 VLC 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 63/337 (18%), Positives = 112/337 (33%), Gaps = 91/337 (27%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
+ +G G F V N A V++ V + E +LK +++
Sbjct: 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYA---VKV--VRNIKKYTRSAKIEADILKKIQN 90
Query: 87 -----NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV--DMKAVKGWARQIL 139
NNI++++ + +I E SL + ++ ++ +K + +IL
Sbjct: 91 DDINNNNIVKYHG-KFMYYDHMC-LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 140 SGLIYLHSHDPPIIHRDLKCDNIFINGNQG------------------------EVKIGD 175
L YL + H DLK +NI ++ +K+ D
Sbjct: 148 KALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 176 LGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT----F----- 225
G AT + S+I T ++ APE + + ++ +D++SFG + E+ T F
Sbjct: 206 FGCAT-FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264
Query: 226 ----------------------------------EYPYSECRNSAQI-YKKVSSGIKPAA 250
E + N++ I K P
Sbjct: 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324
Query: 251 LSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+K F+ L + R S ELL FL+
Sbjct: 325 K-IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 41/224 (18%), Positives = 79/224 (35%), Gaps = 39/224 (17%)
Query: 3 SSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRID 62
+E+ + P + D + IG G F +Y AF + A V+++
Sbjct: 14 GTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE 73
Query: 63 DVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG-------- 114
++ L+SE+ + + + I WI+ + I + SG
Sbjct: 74 -----YQENGPLFSELKFYQRVAKKDCI---KKWIERKQLDYLGIPLFYGSGLTEFKGRS 125
Query: 115 -----------SLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 163
L++ ++ V ++L L Y+H ++ +H D+K N+
Sbjct: 126 YRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLL 183
Query: 164 IN-GNQGEVKIGDLGLATI---------MEQANAKSVIGTPEFM 197
+ N +V + D GL+ ++ K GT EF
Sbjct: 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 64/329 (19%), Positives = 120/329 (36%), Gaps = 83/329 (25%)
Query: 29 RYK--EVIGKGAFKTVYKAFD-EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
RY+ + +G+GAF V + D + G VA V+I V E SE+ +L+ L
Sbjct: 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVA---VKI--VKNVDRYCEAARSEIQVLEHLN 69
Query: 86 H------NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV--DMKAVKGWARQ 137
++ W + I+ EL S + K++ + + ++ A Q
Sbjct: 70 TTDPNSTFRCVQMLE-WFEHHGHIC-IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG------------------EVKIGDLGLA 179
I + +LHS+ + H DLK +NI + ++K+ D G A
Sbjct: 127 ICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 180 TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT-------------- 224
T + + +++ T + APE + +++ D++S G ++E
Sbjct: 185 T-YDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 225 -----------------------FEYPYSECRNSAQIYKKVSSGIKP----AALSKVKDP 257
F + + + + VS KP V+
Sbjct: 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303
Query: 258 EVKSFIEKCLVP-ASQRLSAKELLMDPFL 285
+ I+K L ++R++ +E L PF
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 9/118 (7%)
Query: 134 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGT 193
++ Q+ G+ +L S IHRDL NI ++ VKI D GLA + + G
Sbjct: 198 YSFQVAKGMEFLASR--KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD 254
Query: 194 PEF----MAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQIYKKVSSG 245
MAPE ++D Y +D++SFG+ + E+ + PY + + +++ G
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 40/222 (18%), Positives = 75/222 (33%), Gaps = 35/222 (15%)
Query: 13 PPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI------DDVLQ 66
P D E ++ + +G+GAF V +A + G++ + +
Sbjct: 11 PYDASKWEFPRDR--LKLGKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGA-- 64
Query: 67 SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK 125
+ + L SE+ +L + H N++ + +I E G+L Y + +
Sbjct: 65 THSEHRALMSELKILIHIGHHLNVVNLL-GACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 123
Query: 126 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185
+ K + G Y+ + I DLK I +Q +
Sbjct: 124 -EFVPYKTKGARFRQGKDYVGA-----IPVDLKRRLDSITSSQS---------SASSGFV 168
Query: 186 NAKSVIGTPEFMAPELYDENYNELADIYSF------GMCMLE 221
KS+ E APE +++ L + + GM L
Sbjct: 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 56/330 (16%), Positives = 116/330 (35%), Gaps = 83/330 (25%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLE-VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
RY+ +G+G F V + D G VA ++I + + E E+++LK +K
Sbjct: 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVA---LKI--IRNVGKYREAARLEINVLKKIK 74
Query: 86 H------NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV--DMKAVKGWARQ 137
+ + W + I EL + ++ K++ + V+ A Q
Sbjct: 75 EKDKENKFLCVLMSD-WFNFHGHMC-IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG------------------EVKIGDLGLA 179
+ L +LH + + H DLK +NI ++ +++ D G A
Sbjct: 132 LCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 180 TIMEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVT----F--------- 225
T + + +++ T + PE + + + + D++S G + E F
Sbjct: 190 T-FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 226 ---------------------------EYPYSECRNSAQIYKKVSSGIKPAALSK-VKDP 257
+ E + + K+ +K L ++
Sbjct: 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 308
Query: 258 EVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
++ + + L +QR++ E L+ PF
Sbjct: 309 QLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 46/184 (25%), Positives = 70/184 (38%), Gaps = 26/184 (14%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ IG G+F +Y D G EVA + L+ E + K ++
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ------LHIESKIYKMMQG 63
Query: 87 -NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIY 144
I W + ++ EL SL +K +K V A Q++S + Y
Sbjct: 64 GVGIPTIR--WCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 145 LHSHDPPIIHRDLKCDNIFI--NGNQGEVKIGDLGLA---------TIMEQANAKSVIGT 193
+HS + IHRD+K DN + V I D GLA + K++ GT
Sbjct: 121 IHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 194 PEFM 197
+
Sbjct: 179 ARYA 182
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 37/186 (19%), Positives = 69/186 (37%), Gaps = 28/186 (15%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
YK IG+G+F +++ + +N +VA L E K L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ------LRDEYRTYKLLAG 64
Query: 87 -NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIY 144
I Y + + ++ +L SL +K +K V A+Q+L+ +
Sbjct: 65 CTGIPNVY--YFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGE----VKIGDLGLATI---------MEQANAKSVI 191
+H +++RD+K DN I + + + D G+ + K++
Sbjct: 122 IHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179
Query: 192 GTPEFM 197
GT +M
Sbjct: 180 GTARYM 185
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 38/184 (20%), Positives = 69/184 (37%), Gaps = 26/184 (14%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK- 85
+++ IG G+F +Y + EVA + L E + + L+
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ------LLYESKIYRILQG 61
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIY 144
I W + ++ +L SL +K+ +K V A Q+++ + +
Sbjct: 62 GTGIPNVR--WFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 145 LHSHDPPIIHRDLKCDNIFI--NGNQGEVKIGDLGLATI---------MEQANAKSVIGT 193
+HS +HRD+K DN + +V I D GLA + K++ GT
Sbjct: 119 VHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 194 PEFM 197
+
Sbjct: 177 ARYA 180
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 44/229 (19%), Positives = 79/229 (34%), Gaps = 43/229 (18%)
Query: 3 SSEDGAAKMEPPDP----DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQ 58
+ +AK + +++ TD + IG+G F +Y A + +
Sbjct: 9 AGRQSSAKRHLAEQFAVGEII-TDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAP 67
Query: 59 VRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG---- 114
+ P D L++E+ + I WI + + + + SG
Sbjct: 68 CVVK---VEPSDNGPLFTELKFYQRAAKPEQI---QKWIRTRKLKYLGVPKYWGSGLHDK 121
Query: 115 ---------------SLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 158
L++ + K+ K V + +IL L Y+H H+ +H D+K
Sbjct: 122 NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIK 179
Query: 159 CDNIFIN-GNQGEVKIGDLGLATI---------MEQANAKSVIGTPEFM 197
N+ +N N +V + D GLA + GT EF
Sbjct: 180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 42/186 (22%), Positives = 72/186 (38%), Gaps = 28/186 (15%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
++ + IG G F + + VA ++++ + L E K L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRAPQLHL---EYRFYKQLGS 63
Query: 87 -NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIY 144
+ I + Y + K ++ EL SL + +K V A Q++S + Y
Sbjct: 64 GDGIPQVY--YFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 145 LHSHDPPIIHRDLKCDNIFI----NGNQGEVKIGDLGLATI---------MEQANAKSVI 191
+HS + +I+RD+K +N I N Q + I D LA + KS+
Sbjct: 121 VHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 192 GTPEFM 197
GT +M
Sbjct: 179 GTARYM 184
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 1e-10
Identities = 84/624 (13%), Positives = 184/624 (29%), Gaps = 177/624 (28%)
Query: 19 LETDPTCRYIRYKEVIG--KGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYS 76
++ + +YK+++ + AF + D + + + ID ++ S + +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66
Query: 77 EVHLLKSLKHNNIIRF--------YNSWIDDQNKTVNI----ITELFTSGSLRQYR---- 120
L S + + +F Y ++ KT +T ++ R Y
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVLRINYK-FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125
Query: 121 -KKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIH---------------RDLK-----C 159
K+ ++ ++ L+ L +I K
Sbjct: 126 FAKYNVSRLQPYL----KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD 181
Query: 160 DNIF-IN-GNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE----------------- 200
IF +N N + T++E P + +
Sbjct: 182 FKIFWLNLKNCNSPE-------TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 201 ---LYDENYNE----LADIYS------FGM-CMLEMVTFEYPYSECRN-------SAQIY 239
L + Y L ++ + F + C + + T R SA
Sbjct: 235 RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT--------RFKQVTDFLSAATT 286
Query: 240 KKVSSGIKPAALSKVKDPEVKSFIEKCLVPASQRLSAKELLMDPF--------LQVNGTT 291
+S L+ EVKS + K L Q L + L +P ++
Sbjct: 287 THISLDHHSMTLTP---DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG--- 340
Query: 292 KNRPLPLPDIVLPRVGAFGDRCLMSEGPASVRNKHPSMD-FDSDAELP--VITSL-DNSG 347
+ ++ + L PA R + F A +P +++ + +
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV- 399
Query: 348 GGDSYSPSIEVRRSKRGNFFLLKGESNDE-YSV-SLILRIADQSGRLRNIH--------F 397
+ V +K + L++ + + S+ S+ L + + +H
Sbjct: 400 --IKSDVMVVV--NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNI 455
Query: 398 LFYLDSDTAFSVSSEM---------VEQLELADQNVTFIAELIDLLLLNLIPGWKPCVRI 448
DSD + ++ +E ++ L ++ L+ +
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPER-----MTLFRMVFLDF--RF------ 502
Query: 449 DHLIPQKSRRQSPEDHEKDALS--LERVDNSSGLSHRSYEADNHSRSSDGQDSTSLKEGI 506
+ QK R S + ++ L+++ ++ Y DN + E +
Sbjct: 503 ---LEQKIRHDSTAWNASGSILNTLQQLKF-----YKPYICDNDPK----------YERL 544
Query: 507 QTTVLGPDF-MKPDEKRSHNDFSC 529
+L DF K +E + ++
Sbjct: 545 VNAIL--DFLPKIEENLICSKYTD 566
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 76/367 (20%), Positives = 132/367 (35%), Gaps = 119/367 (32%)
Query: 29 RYKEV--IGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY + +G G F TV+ ++D VA +++ V + E E+ LLKS+++
Sbjct: 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVA---MKV--VKSAEHYTETALDEIRLLKSVRN 92
Query: 87 NN--------IIRFYNS-WIDDQNKT-VNIITELFTSGSLRQYRKK--HKKVDMKAVKGW 134
++ +++ + I N T + ++ E+ L ++ K ++ + + VK
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEV-LGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 135 ARQILSGLIYLHSHDPPIIHRDLKCDNIFI------------------------------ 164
+Q+L GL YLH+ IIH D+K +NI +
Sbjct: 152 IQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 165 ------------------NGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDEN 205
N + +VKI DLG A + + I T ++ + E L
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-EDIQTRQYRSLEVLIGSG 269
Query: 206 YNELADIYSFGMCMLEMVTFEYPY------------------------------SECRNS 235
YN ADI+S E+ T +Y + + S
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 236 AQIYK-----KVSSGIKPAALSKV-------KDPEVK---SFIEKCLV--PASQRLSAKE 278
+ + K + +KP L +V E F+ L P +R +A E
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIP-EKRATAAE 388
Query: 279 LLMDPFL 285
L P+L
Sbjct: 389 CLRHPWL 395
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 29/203 (14%), Positives = 64/203 (31%), Gaps = 44/203 (21%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGL--------EVA----------WCQVRIDDVLQSP 68
++K + +Y+A + + + + P
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSG-SLRQYRKK--HKK 125
+ + L S I + ++ L G SL+
Sbjct: 103 LQVNKWKK----LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL---GRSLQSALDVSPKHV 155
Query: 126 VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN-GNQGEVKIGDLGLAT---- 180
+ ++V A ++L L +LH ++ +H ++ +NIF++ +Q +V + G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 181 ------IMEQANAKSVIGTPEFM 197
+E + G EF+
Sbjct: 214 SGKHVAYVEGSR-SPHEGDLEFI 235
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 1e-09
Identities = 49/324 (15%), Positives = 89/324 (27%), Gaps = 75/324 (23%)
Query: 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDD----VLQSPEDLERLYSEVHLLK 82
++ E IG+G F V++ + VA + I+ + E + E+ + K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 83 SL---------KHNNIIRFYNSWI----------------DDQNKTVNIITELFTS---- 113
L + I + + + N + F
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 114 -------GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166
G + + + K + K Q+ + L HRDL N+ +
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLLKK 197
Query: 167 NQG-------------------EVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYN 207
+V I D L+ + V+ M +L+ + +
Sbjct: 198 TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI---VVFCDVSMDEDLFTGDGD 254
Query: 208 ELADIYSFGMCMLEMVTFEY-PYSECR-----NSAQIYKKVSSGIKPAALSKVKDPEVKS 261
DIY EY PYS + + K +++
Sbjct: 255 YQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQE 314
Query: 262 FIEKCLVPASQRLSAKELLMDPFL 285
F L + SA +LL L
Sbjct: 315 FHRTMLNFS----SATDLLCQHSL 334
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 670 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 98.6 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.94 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.7 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.27 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 98.19 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.93 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.72 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.27 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.25 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.96 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.3 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.22 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.18 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.11 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.11 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 94.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.28 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 90.6 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 89.76 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.94 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 84.53 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 83.6 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-63 Score=520.53 Aligned_cols=271 Identities=51% Similarity=0.951 Sum_probs=246.2
Q ss_pred CCCCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeee
Q 005916 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYN 94 (670)
Q Consensus 15 ~~~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~ 94 (670)
....+...+.||||++.+.||+|+||+||+|.++.+|..||+|++..... .....+++.+|+.+|++|+|||||++|+
T Consensus 15 ~~~~~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~ 92 (290)
T 3fpq_A 15 ETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYD 92 (290)
T ss_dssp --CEEEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhcCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 34455667889999999999999999999999999999999999985442 4566788999999999999999999999
Q ss_pred EEEeC--CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEE
Q 005916 95 SWIDD--QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 172 (670)
Q Consensus 95 ~~~d~--~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vK 172 (670)
+|.+. ....+|||||||.||+|.+++.+.+.+++..++.|++||+.||.|||+++++||||||||+|||+++.+|.+|
T Consensus 93 ~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vK 172 (290)
T 3fpq_A 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEE
T ss_pred EEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEE
Confidence 98763 3357899999999999999999999999999999999999999999999888999999999999986678999
Q ss_pred EeeccchhhhcccccccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCccc
Q 005916 173 IGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS 252 (670)
Q Consensus 173 L~DFGla~~~~~~~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 252 (670)
|+|||+|+........+.+|||.|||||++.+.|+.++|||||||++|+|+||.+||.+..+...+++.+..+..|..++
T Consensus 173 l~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 173 IGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp ECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred EEeCcCCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC
Confidence 99999998776666778899999999999999999999999999999999999999998788899999999988888888
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
...++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 8889999999999996 8999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-59 Score=493.76 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=227.6
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.++||+|+||+||+|+++.+|+.||+|++.+.... .....+++.+|+++|+.|+|||||++|++|.+.. .+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~y 108 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KLY 108 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEE
Confidence 3599999999999999999999999999999999864332 1234678999999999999999999999998654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||||.||+|.+++++.+.+++..++.|++||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCCC
Confidence 99999999999999999999999999999999999999999999 99999999999998 6789999999999887432
Q ss_pred ----ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 186 ----NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 186 ----~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
...+.+|||.|||||++. +.|+.++|||||||++|+|+||.+||.+ .+..+++..|..+.. .++...+++++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~ 262 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKAR 262 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHH
Confidence 246789999999999874 5799999999999999999999999987 677888888887653 34566789999
Q ss_pred HHHHHcCC-CCCCCCCHHH------HhcCccccccCCC
Q 005916 261 SFIEKCLV-PASQRLSAKE------LLMDPFLQVNGTT 291 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~e------lL~hpf~~~~~~~ 291 (670)
+||.+||. ||.+|||++| +++||||+...|.
T Consensus 263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 99999996 8999999987 5899999876554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-58 Score=491.40 Aligned_cols=252 Identities=29% Similarity=0.517 Sum_probs=222.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
.+|++.+.||+|+||+||+|+++.+|+.||+|++..... ...+.+.+|+.+|+.|+|||||++|++|.+.. .+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~ 147 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELW 147 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEE
Confidence 458999999999999999999999999999999986542 22456889999999999999999999998765 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||||.||+|.+++.+ +.+++..++.|++||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEC-CCCCEEEecCcCceecCCC
Confidence 99999999999999876 57999999999999999999999999 99999999999998 6789999999999887543
Q ss_pred --ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-CcccCCCChHHHH
Q 005916 186 --NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVKS 261 (670)
Q Consensus 186 --~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~~s~~~k~ 261 (670)
...+.+|||.|||||++. ..|+.++|||||||++|||++|.+||.+ .+...++..+.....+ .......++++++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 356789999999999875 5799999999999999999999999987 5667777777765432 2233457899999
Q ss_pred HHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 262 FIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
||.+||. ||.+|||+.|+|+||||+..
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 9999996 89999999999999999854
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-58 Score=477.92 Aligned_cols=252 Identities=27% Similarity=0.510 Sum_probs=208.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|+++.+|+.||+|++..... ......+++.+|+.+|+.|+|||||+++++|.+.. .+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL-AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD--EII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc-CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEE
Confidence 358999999999999999999999999999999986433 23445678999999999999999999999997654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||| +|+|.+++.+++.+++..++.|++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTCCEEECCSSCC------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEEC-CCCCEEEeecCCCeecCCC
Confidence 999999 7899999999999999999999999999999999999 99999999999998 6789999999999877654
Q ss_pred c-cccccCCCccCCCccccC-CC-CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 N-AKSVIGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 ~-~~~~~GTp~YmAPEvl~~-~y-s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
. ..+.+|||.|||||++.+ .| +.++|||||||++|+|+||.+||.+ .+...+++.+..+.. .++...++++++|
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~l 242 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVY--TLPKFLSPGAAGL 242 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHH
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 3 467899999999998754 44 6899999999999999999999987 677888888887753 3456678999999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
|.+||. +|.+|||+.|+|+||||+.
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHccCChhHCcCHHHHHcCccccc
Confidence 999996 8999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=490.85 Aligned_cols=254 Identities=24% Similarity=0.458 Sum_probs=219.7
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
.+|++.+.||+|+||+||+|+++.+|+.||+|++..... .....+++.+|+.+|++|+|||||++|++|.+.. .+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~--~~y 99 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEENG--SLY 99 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC--EEE
Confidence 369999999999999999999999999999999986543 4566788999999999999999999999998754 799
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
||||||.||+|.+++..+ ..+++..++.|+.||+.||.|||+++ ||||||||+||||+ .+|.+||+|||+|+.+.
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCCEEEcccccceeec
Confidence 999999999999999765 35799999999999999999999999 99999999999998 67899999999998876
Q ss_pred ccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 184 QAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 184 ~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
... ..+.+|||.|||||++. ..|+.++|||||||++|+|+||.+||.+ .+..+++..+..+..+. .+...+++++
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s~~~~ 254 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYSYDLR 254 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHHHH
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCCHHHH
Confidence 532 45678999999999875 5799999999999999999999999987 56777777777776543 4455789999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+||.+||. ||.+|||+.|+|+||||+..
T Consensus 255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 99999996 89999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=494.17 Aligned_cols=252 Identities=29% Similarity=0.517 Sum_probs=222.0
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
.+|++.+.||+|+||+||+|+++.+|+.||+|++..... ...+.+.+|+.+|+.|+|||||++|++|.+.. .+|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~ 224 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELW 224 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--EEE
Confidence 468999999999999999999999999999999986542 23456889999999999999999999998765 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
||||||.||+|.++++. +.+++..++.|++||+.||.|||+++ ||||||||+||||+ .+|.+||+|||+|+.+...
T Consensus 225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~-~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEEC-TTCCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEecCccceECCCC
Confidence 99999999999999865 56999999999999999999999999 99999999999998 6789999999999877543
Q ss_pred --ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-CcccCCCChHHHH
Q 005916 186 --NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVKDPEVKS 261 (670)
Q Consensus 186 --~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~~s~~~k~ 261 (670)
...+.+|||+|||||++. ..|+.++|||||||++|+|++|.+||.+ .+...++..+.....+ .......++++++
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence 356789999999999875 5799999999999999999999999987 5666777777765432 2233457899999
Q ss_pred HHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 262 FIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
||.+||. ||.+||||.|+|+||||+..
T Consensus 380 li~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 9999996 89999999999999999854
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=480.74 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=216.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEc---CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~---~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
..|++.+.||+|+||+||+|++. .+++.||+|+++..... .....++.+|+.+|++|+|||||++|++|.+..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-- 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK--VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-- 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE--EEECC------CCCCCCCCTTEECEEEEEEETT--
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC--hHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--
Confidence 36999999999999999999874 47899999999754321 112345788999999999999999999998765
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.+|||||||.||+|.+++.+.+.+++..++.|++||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+..
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTSCEEEESSEEEEC-
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEc-CCCCEEecccccceec
Confidence 79999999999999999999999999999999999999999999999 99999999999998 6789999999999876
Q ss_pred cc--cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 183 EQ--ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 183 ~~--~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.. ....+.+|||.|||||++. +.|+.++|||||||++|+|+||.+||.+ .+..+++..+..+.. .++...++++
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 253 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL--GMPQFLSPEA 253 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCcCCHHH
Confidence 43 2356789999999999774 6799999999999999999999999987 677778888877653 3456678999
Q ss_pred HHHHHHcCC-CCCCCCC-----HHHHhcCccccccCC
Q 005916 260 KSFIEKCLV-PASQRLS-----AKELLMDPFLQVNGT 290 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpS-----a~elL~hpf~~~~~~ 290 (670)
++||.+||. ||.+||| ++|+++||||+...|
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 999999996 8999998 589999999986554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=472.40 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=213.5
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
.-.+|++.++||+|+||+||+|+++.+|+.||+|+++..... .+|+.+|+.|+|||||++|++|.+.. .
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~---------~~E~~il~~l~HpnIV~l~~~~~~~~--~ 124 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR---------VEELVACAGLSSPRIVPLYGAVREGP--W 124 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---------THHHHTTTTCCCTTBCCEEEEEEETT--E
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH---------HHHHHHHHhCCCCCCCcEEEEEEECC--E
Confidence 346799999999999999999999999999999999865431 36999999999999999999998754 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|||||||.||+|.+++++.+.+++..++.|+.||+.||.|||+++ ||||||||+||||+.+..++||+|||+|+.+.
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 9999999999999999999999999999999999999999999998 99999999999998433379999999998765
Q ss_pred ccc-------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-CcccCC
Q 005916 184 QAN-------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKV 254 (670)
Q Consensus 184 ~~~-------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~ 254 (670)
... ...++|||.|||||++. +.|+.++|||||||++|+|+||.+||.+. +...++..+..+..+ ..++..
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 281 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY-FRGPLCLKIASEPPPIREIPPS 281 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT-CCSCCHHHHHHSCCGGGGSCTT
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHcCCCCchhcCcc
Confidence 421 23468999999999774 57999999999999999999999999874 344445555554433 345567
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHH-------------hcCccccc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKEL-------------LMDPFLQV 287 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~el-------------L~hpf~~~ 287 (670)
.++++++||.+||. +|.+|||+.|+ |+|||++.
T Consensus 282 ~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 78999999999996 89999999998 57888864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-54 Score=470.03 Aligned_cols=257 Identities=28% Similarity=0.393 Sum_probs=215.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC----C
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD----Q 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~----~ 100 (670)
+..|++.+.||+|+||+||+|+++.+|+.||||+++... ......+++.+|+++|+.|+|||||++++++... .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 457999999999999999999999999999999996432 3456678899999999999999999999987643 2
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
...+|||||||. |+|.+++.+.+.+++..++.|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC-CCCCEEEeecceee
Confidence 357999999995 689999999999999999999999999999999999 99999999999998 67899999999998
Q ss_pred hhccc------ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc--CCCC--
Q 005916 181 IMEQA------NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIKP-- 248 (670)
Q Consensus 181 ~~~~~------~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~--g~~p-- 248 (670)
.+... ...+.+||+.|||||++. ..|+.++||||+|||+|+|++|.+||.+. +....+..|.. +..+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-NYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-SHHHHHHHHHHHHCCCCGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhcCCCChH
Confidence 76332 245789999999999764 35799999999999999999999999884 44444443332 1111
Q ss_pred ----------------------Cc---ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 ----------------------AA---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 ----------------------~~---~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.. .....++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 00 112357899999999997 89999999999999999854
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=456.77 Aligned_cols=251 Identities=25% Similarity=0.454 Sum_probs=203.8
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC------
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN------ 101 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~------ 101 (670)
|++.+.||+|+||+||+|+++.+|+.||+|+++... .....+++.+|+.+|++|+|||||++|++|.+.+.
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 899999999999999999999999999999998643 35566789999999999999999999999986543
Q ss_pred ----CeEEEEEecCCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 102 ----KTVNIITELFTSGSLRQYRKKHKKV---DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 102 ----~~~~lVmEy~~gGsL~~~i~~~~~l---se~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
.++|+|||||.||+|.+++..++.+ ++..++.|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CCCcEEEc
Confidence 2579999999999999999887654 45678999999999999999998 99999999999998 67899999
Q ss_pred eccchhhhcccc--------------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHH
Q 005916 175 DLGLATIMEQAN--------------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY 239 (670)
Q Consensus 175 DFGla~~~~~~~--------------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~ 239 (670)
|||+|+.+.... ..+.+|||.|||||++. ..|+.++|||||||++|||++ ||....+.....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 999998775421 23468999999999775 579999999999999999996 886533334455
Q ss_pred HHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 240 KKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 240 ~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+.....|..+. ..++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 238 ~~~~~~~~p~~~~-~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 238 TDVRNLKFPPLFT-QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHTTCCCHHHH-HHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHhcCCCCCCCc-ccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 5566655554333 235788999999996 89999999999999999753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-53 Score=483.51 Aligned_cols=264 Identities=23% Similarity=0.353 Sum_probs=226.4
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL--QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~--~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.++-..|++.++||+|+||+||+|+++.+|..||+|++.+.... ...........++.+++.++|||||++|++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 34456799999999999999999999999999999999864432 1122233334456777888999999999999876
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
. .+|||||||.||+|++++.+.+.+++..++.|++||+.||.|||++| ||||||||+||||+ .+|+|||+|||+|
T Consensus 265 ~--~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld-~~G~vKL~DFGlA 339 (689)
T 3v5w_A 265 D--KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLA 339 (689)
T ss_dssp S--EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTSCEEECCCTTC
T ss_pred C--EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe-CCCCEEeccccee
Confidence 5 79999999999999999999999999999999999999999999999 99999999999998 6789999999999
Q ss_pred hhhcccccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCC--CCHHHHHHHHhcCCCCCcccCCC
Q 005916 180 TIMEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSEC--RNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 180 ~~~~~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~--~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
+.+......+.+|||.|||||++. ..|+.++|||||||++|+|++|.+||.+. .+...+++.+.... ..++...
T Consensus 340 ~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~~~p~~~ 417 (689)
T 3v5w_A 340 CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSF 417 (689)
T ss_dssp EECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--CCCCTTS
T ss_pred eecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--CCCCccC
Confidence 988777778899999999999874 36999999999999999999999999753 34456666666643 3345667
Q ss_pred ChHHHHHHHHcCC-CCCCCCC-----HHHHhcCccccccCCCC
Q 005916 256 DPEVKSFIEKCLV-PASQRLS-----AKELLMDPFLQVNGTTK 292 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpS-----a~elL~hpf~~~~~~~~ 292 (670)
++++++||.+||. ||.+|++ |.|+++||||+...|..
T Consensus 418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 8999999999996 8999998 89999999999776643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=450.30 Aligned_cols=250 Identities=21% Similarity=0.354 Sum_probs=204.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEc---CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~---~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~ 100 (670)
.+.|++.+.||+|+||+||+|+++ .+++.||+|.+.... ...++.+|+++|+.+ +|||||+++++|.+.+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 456999999999999999999875 468899999886432 235678999999999 7999999999998754
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
++|+|||||.||+|.++++ .+++..++.|++||+.||.|||++| ||||||||+|||++.+.+.+||+|||+|+
T Consensus 94 --~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 94 --HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp --EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred --EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 7999999999999999883 5999999999999999999999999 99999999999999666899999999997
Q ss_pred hhccc------------------------------ccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCC
Q 005916 181 IMEQA------------------------------NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYP 228 (670)
Q Consensus 181 ~~~~~------------------------------~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~P 228 (670)
..... ...+.+|||.|||||++.+ .|+.++||||+||++|+|+||.+|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 54321 1234689999999997743 589999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhc--C--------------------------------------CC------------CCcccCCCC
Q 005916 229 YSECRNSAQIYKKVSS--G--------------------------------------IK------------PAALSKVKD 256 (670)
Q Consensus 229 f~~~~~~~~i~~~i~~--g--------------------------------------~~------------p~~~~~~~s 256 (670)
|....+.......|.. | .. ........+
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 9765554433322211 0 00 001123467
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+++++||.+||+ ||.+||||+|+|+||||+.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 899999999997 8999999999999999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=440.14 Aligned_cols=249 Identities=23% Similarity=0.397 Sum_probs=213.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
..|.+.+.||+|+||+||+|.+. .+|..||||+++.. +....+.+.+|+++|++|+|||||++|++|.+..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 35889999999999999999865 46889999998642 3566788999999999999999999999987654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHK-------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 167 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~-------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~ 167 (670)
.+|||||||.+|+|.+++.+++ .+++..+..|+.||+.||.|||+++ ||||||||+|||++ .
T Consensus 89 --~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~-~ 163 (299)
T 4asz_A 89 --PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-E 163 (299)
T ss_dssp --SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-G
T ss_pred --EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEEC-C
Confidence 6999999999999999998653 6999999999999999999999998 99999999999998 5
Q ss_pred CCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHH
Q 005916 168 QGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKK 241 (670)
Q Consensus 168 ~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~ 241 (670)
++.+||+|||+|+...... .....||+.|||||++ .+.|+.++|||||||++|||+| |+.||.+ .+..++...
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~ 242 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIEC 242 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 6899999999998775432 2345799999999976 5789999999999999999998 8999987 567778888
Q ss_pred HhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 242 VSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 242 i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+..+..+. .+...++++++||.+||. +|.+|||+.++ ++||+.
T Consensus 243 i~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 243 ITQGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred HHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 88876543 456678999999999996 89999999999 457763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=439.26 Aligned_cols=253 Identities=31% Similarity=0.470 Sum_probs=210.8
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
..|++++. .+++.+.||+|+||+||+|+.. ..||||+++... .+.+..+.+.+|+.+|++|+|||||++++++
T Consensus 29 ~~Wei~~~--~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 29 YYWEIEAS--EVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp CCCBCCTT--SCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCcEEcHH--HeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45666553 5678899999999999999754 359999987433 3567788999999999999999999999976
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEee
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 175 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~D 175 (670)
.+ . .+|||||||.||+|.+++... +.+++..+..|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|
T Consensus 102 ~~-~--~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~-~~~~~Ki~D 175 (307)
T 3omv_A 102 TK-D--NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGD 175 (307)
T ss_dssp CS-S--SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEE-TTEEEEECC
T ss_pred EC-C--eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEEC-CCCcEEEee
Confidence 43 2 489999999999999999765 57999999999999999999999998 99999999999998 678999999
Q ss_pred ccchhhhccc----ccccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC
Q 005916 176 LGLATIMEQA----NAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK 247 (670)
Q Consensus 176 FGla~~~~~~----~~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~ 247 (670)
||+|+..... .....+||+.|||||++. +.|+.++|||||||++|||+||..||.+..+...+...+..+..
T Consensus 176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~ 255 (307)
T 3omv_A 176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA 255 (307)
T ss_dssp CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC
T ss_pred ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence 9999876432 235678999999999873 35999999999999999999999999987777778777777654
Q ss_pred CC---cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 248 PA---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 248 p~---~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+. ..+...++++++||.+||. +|.+|||+.|++.+
T Consensus 256 ~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 256 SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 33 2345578899999999996 89999999987654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=467.62 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=224.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
.+|++.+.||+|+||+||+|+++.+|+.||+|++.... ....+.+.+|+.+|+.|+|||||+++++|.+.. .+|
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 230 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--EMV 230 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS--EEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEE
Confidence 46999999999999999999999999999999997543 455678899999999999999999999997654 799
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC-CCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN-QGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~-~g~vKL~DFGla~~~~ 183 (670)
||||||.||+|++++.. ++.+++..++.|++||+.||.|||+++ |+||||||+|||++.+ .|.+||+|||+|+.+.
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999999999864 468999999999999999999999999 9999999999999843 4799999999999876
Q ss_pred ccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCCChHH
Q 005916 184 QAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEV 259 (670)
Q Consensus 184 ~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~s~~~ 259 (670)
... ..+.+||+.|||||++. ..|+.++|||||||++|+|++|.+||.+ .+..+++..|..+.. +.......++++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 543 46779999999999774 5799999999999999999999999987 566777777777643 334445678999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
++||.+||. ||.+|||+.|+|+||||+...
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 999999996 899999999999999998643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=435.71 Aligned_cols=246 Identities=24% Similarity=0.408 Sum_probs=206.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
..+.+.+.||+|+||+||+|... .++..||||+++.. +....++|.+|+.+|++|+|||||++|++|.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 46889999999999999999864 46899999998642 3566788999999999999999999999987654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe
Q 005916 101 NKTVNIITELFTSGSLRQYRKKH---------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 165 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~ 165 (670)
.+|||||||.+|+|.+++.++ +++++.++..|+.||+.||.|||+++ ||||||||+||||+
T Consensus 117 --~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 117 --PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG 192 (329)
T ss_dssp --SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE
T ss_pred --EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC
Confidence 699999999999999998764 35899999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHH
Q 005916 166 GNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIY 239 (670)
Q Consensus 166 ~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~ 239 (670)
.++.+||+|||+|+.+.... ....+||+.|||||++ .+.|+.++|||||||++|||+| |+.||.+ .+..+++
T Consensus 193 -~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~ 270 (329)
T 4aoj_A 193 -QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAI 270 (329)
T ss_dssp -TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHH
T ss_pred -CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHH
Confidence 67899999999998764432 2456899999999976 4679999999999999999999 8999987 5567777
Q ss_pred HHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 240 KKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 240 ~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..+..+..+ ..+...++++++||.+||. +|.+|||+.|++.+
T Consensus 271 ~~i~~g~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 271 DCITQGREL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHTCCC-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHcCCCC-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 778777543 3556678999999999996 89999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=431.42 Aligned_cols=247 Identities=22% Similarity=0.317 Sum_probs=210.5
Q ss_pred CeEEEEEEecccCCeEEEEEEE-----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d-----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
..+++.+.||+|+||+||+|.. ..+++.||||+++... .....+.|.+|+.+|++|+|||||++++++.+..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 3588999999999999999985 3578899999986432 2334577999999999999999999999987654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEE
Q 005916 101 NKTVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI 164 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl 164 (670)
.+|||||||.+|+|.+++..+ ..+++..+..|+.||+.||.|||+++ ||||||||+||||
T Consensus 103 --~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl 178 (308)
T 4gt4_A 103 --PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV 178 (308)
T ss_dssp --SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred --EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE
Confidence 689999999999999999753 35899999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHH
Q 005916 165 NGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQI 238 (670)
Q Consensus 165 ~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i 238 (670)
+ +++.+||+|||+|+.+.... ....+||+.|||||++ .+.|+.++|||||||++|||+| |..||.+ .+..++
T Consensus 179 ~-~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~~~ 256 (308)
T 4gt4_A 179 Y-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDV 256 (308)
T ss_dssp C-GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHHHH
T ss_pred C-CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHHHH
Confidence 8 66899999999998765432 3456899999999976 5789999999999999999998 8999988 567778
Q ss_pred HHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 239 YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 239 ~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
...+..+..+. .+...++++.+|+.+||. +|.+|||+.+++.+
T Consensus 257 ~~~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88888776543 455678999999999996 89999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=457.50 Aligned_cols=364 Identities=25% Similarity=0.380 Sum_probs=275.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.++.+|..||+|++...... ......+.+|+.+|+.|+|||||+++++|.+.. .+|+
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~l 113 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR--NYYL 113 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEEE
Confidence 799999999999999999999999999999999864432 223567889999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DFGla~~~~~ 184 (670)
|||||.||+|.+++...+.+++..++.|++||+.||.|||+++ |+||||||+|||++. ..+.+||+|||++.....
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999999998899999999999999999999999998 999999999999973 245699999999987755
Q ss_pred cc-cccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC--cccCCCChHHHH
Q 005916 185 AN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALSKVKDPEVKS 261 (670)
Q Consensus 185 ~~-~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~--~~~~~~s~~~k~ 261 (670)
.. ....+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+...+...+..+.... ......++.+++
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred CccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 33 456789999999999988999999999999999999999999987 56677777777765432 233457899999
Q ss_pred HHHHcCC-CCCCCCCHHHHhcCccccccCCCC--CCCCCCCCCcCCCccccccccc--------------ccCCCCcccC
Q 005916 262 FIEKCLV-PASQRLSAKELLMDPFLQVNGTTK--NRPLPLPDIVLPRVGAFGDRCL--------------MSEGPASVRN 324 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~hpf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--------------~~e~~~~~~~ 324 (670)
||.+||. +|.+|||+.++|+||||+...... ....+.....+.++..+..... ..+....+..
T Consensus 271 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~ 350 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTD 350 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHHHH
T ss_pred HHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHHHH
Confidence 9999996 899999999999999997542211 1111111222222333322110 0011111222
Q ss_pred CCCCCCCCCCCCCccccccCCCCCCCCCCCchhhhhcccCccccccC--------CCCCccchhhhheeec--CCCceee
Q 005916 325 KHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFLLKG--------ESNDEYSVSLILRIAD--QSGRLRN 394 (670)
Q Consensus 325 ~~~~~d~d~d~~~~~~~~~~~~~~~~~~~~~i~~~~l~~~~~~~~~g--------~~~~~~~I~liLri~D--~~g~i~~ 394 (670)
.|..+|.+.+| .++.+++.... ...| ....+..+..+++..| .+|.|.+
T Consensus 351 ~F~~~D~d~dG-------------------~I~~~El~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~ 409 (494)
T 3lij_A 351 IFRHIDKNGDG-------------------QLDRQELIDGY--SKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDY 409 (494)
T ss_dssp HHHHHCTTCSS-------------------EECHHHHHHTT--HHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEH
T ss_pred HHHHhCcCCCC-------------------eEcHHHHHHHH--HHhcccccccccccccHHHHHHHHHHhCCCCCCcCcH
Confidence 23334444333 46667766542 2222 1234678889999988 4679999
Q ss_pred eecc-------------------cccCCCCcCcchHHHHhccc
Q 005916 395 IHFL-------------------FYLDSDTAFSVSSEMVEQLE 418 (670)
Q Consensus 395 ieF~-------------------f~~d~Dta~~Ia~EmV~~l~ 418 (670)
-||. ..+|+|..|.|+.+++..+.
T Consensus 410 ~EF~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l 452 (494)
T 3lij_A 410 SEFVTVAMDRKSLLSKDKLESAFQKFDQDGNGKISVDELASVF 452 (494)
T ss_dssp HHHHHHHSCHHHHTCHHHHHHHHHHHCTTCSSEECHHHHHHHC
T ss_pred HHHHHHHHhhhccccHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 9998 46799999999999999853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=459.35 Aligned_cols=369 Identities=27% Similarity=0.402 Sum_probs=280.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
..+|++.++||+|+||+||+|.++.+|..||+|++...... .....+.+.+|+.+|++|+|||||+++++|.+.. .+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~ 101 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG--YF 101 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EE
Confidence 46799999999999999999999999999999999754332 2334677899999999999999999999987644 89
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe--CCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~--~~~g~vKL~DFGla~~~ 182 (670)
|+|||||.||+|.+++...+.+++..++.|++||+.||.|||+++ |+||||||+|||++ ..++.+||+|||++..+
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999999999999999999999999999999999998 99999999999995 25678999999999877
Q ss_pred cccc-cccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc--ccCCCChHH
Q 005916 183 EQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LSKVKDPEV 259 (670)
Q Consensus 183 ~~~~-~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~s~~~ 259 (670)
.... ....+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+...+...+..+..... .....++++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 6543 356689999999999988999999999999999999999999987 566777777777654332 334578999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCccccccCCCCCC-CCCCCCCcCCCccccccccc--------------ccCCCCccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTKNR-PLPLPDIVLPRVGAFGDRCL--------------MSEGPASVR 323 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--------------~~e~~~~~~ 323 (670)
++||.+||. +|.+|||+.++|+||||+........ ..+.....+.++..|..... ..+....+.
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~ 338 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELT 338 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHH
Confidence 999999997 89999999999999999864332111 11111111111222211100 011111223
Q ss_pred CCCCCCCCCCCCCCccccccCCCCCCCCCCCchhhhhcccCcc--ccccCCCCC-------ccchhhhheeecC--CCce
Q 005916 324 NKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNF--FLLKGESND-------EYSVSLILRIADQ--SGRL 392 (670)
Q Consensus 324 ~~~~~~d~d~d~~~~~~~~~~~~~~~~~~~~~i~~~~l~~~~~--~~~~g~~~~-------~~~I~liLri~D~--~g~i 392 (670)
..|..+|.+.++ .++.+++..+.. +...|.... +..+..+++..|. +|.|
T Consensus 339 ~~F~~~D~d~dG-------------------~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i 399 (484)
T 3nyv_A 339 AIFHKMDKNGDG-------------------QLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYI 399 (484)
T ss_dssp HHHHHHCTTCSS-------------------EEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEE
T ss_pred HHHHHhCcCCCc-------------------eEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeE
Confidence 334444555444 366666643211 122233333 6778889999884 6799
Q ss_pred eeeecc-------------------cccCCCCcCcchHHHHhccc
Q 005916 393 RNIHFL-------------------FYLDSDTAFSVSSEMVEQLE 418 (670)
Q Consensus 393 ~~ieF~-------------------f~~d~Dta~~Ia~EmV~~l~ 418 (670)
++-||. ..+|+|..|.|+.+++..+.
T Consensus 400 ~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~El~~~l 444 (484)
T 3nyv_A 400 EYSEFVTVAMDRKTLLSRERLERAFRMFDSDNSGKISSTELATIF 444 (484)
T ss_dssp EHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHH
T ss_pred eHHHHHHHHHhccccCcHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 999997 45799999999999998843
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=408.51 Aligned_cols=275 Identities=51% Similarity=0.942 Sum_probs=244.1
Q ss_pred CCCCCCCCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCee
Q 005916 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90 (670)
Q Consensus 11 ~~~~~~~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIV 90 (670)
++.-..........+++|++.+.||+|+||+||+|.+..++..||+|.+..... .....+.+.+|+.+|+.++||||+
T Consensus 11 ~~~l~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv 88 (290)
T 1t4h_A 11 IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIV 88 (290)
T ss_dssp -------CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred HHHHhhhhhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCee
Confidence 344455666778889999999999999999999999999999999999985432 456678899999999999999999
Q ss_pred eeeeEEEeC--CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC
Q 005916 91 RFYNSWIDD--QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 168 (670)
Q Consensus 91 kl~~~~~d~--~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~ 168 (670)
+++++|.+. ....+++||||+.+|+|.+++...+.+++..++.|+.||+.||.|||+++++|+||||||+|||++..+
T Consensus 89 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~ 168 (290)
T 1t4h_A 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT 168 (290)
T ss_dssp CEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTT
T ss_pred eeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCC
Confidence 999998653 345789999999999999999998999999999999999999999999987799999999999998667
Q ss_pred CcEEEeeccchhhhcccccccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 169 GEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 169 g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
+.+||+|||++............||+.|+|||++.+.++.++|||||||++|+|++|..||....+...++..+..+..+
T Consensus 169 ~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (290)
T 1t4h_A 169 GSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248 (290)
T ss_dssp SCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred CCEEEeeCCCcccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc
Confidence 89999999999877666566778999999999998889999999999999999999999999888888999999888888
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
..+....++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 77888888999999999996 8999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=461.84 Aligned_cols=371 Identities=26% Similarity=0.368 Sum_probs=278.3
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC---------HHHHHHHHHHHHHHHhCCCCCeeeee
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS---------PEDLERLYSEVHLLKSLKHNNIIRFY 93 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s---------~~~~e~l~~Ei~iLk~L~HpNIVkl~ 93 (670)
..+..|++.+.||+|+||+||+|.++.++..||+|++........ ....+.+.+|+.+|+.|+|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 345679999999999999999999999999999999986432210 12356789999999999999999999
Q ss_pred eEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC--CcE
Q 005916 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ--GEV 171 (670)
Q Consensus 94 ~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~--g~v 171 (670)
++|.+.. .+|+|||||.||+|.+++...+.+++..++.|++||+.||.|||+++ |+||||||+|||++.+. ..+
T Consensus 113 ~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 113 DVFEDKK--YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEECSS--EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSE
T ss_pred EEEEcCC--EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccE
Confidence 9987644 79999999999999999998899999999999999999999999998 99999999999998432 269
Q ss_pred EEeeccchhhhccc-ccccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc
Q 005916 172 KIGDLGLATIMEQA-NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 172 KL~DFGla~~~~~~-~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~ 250 (670)
||+|||++...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+...+...+..+.....
T Consensus 189 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp EECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCC
T ss_pred EEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCC
Confidence 99999999877553 3456789999999999988999999999999999999999999987 567777777877764332
Q ss_pred --ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCCCCCCCC-CCCCCcCCCcccccccc-------------
Q 005916 251 --LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTKNRPL-PLPDIVLPRVGAFGDRC------------- 313 (670)
Q Consensus 251 --~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------------- 313 (670)
.....++++++||.+||. +|.+|||+.|+|+||||+.......... ......+.+++.|....
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~ 347 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSK 347 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 224578999999999996 8999999999999999986432211000 00000111222222111
Q ss_pred c-ccCCCCcccCCCCCCCCCCCCCCccccccCCCCCCCCCCCchhhhhcccCcccc------ccCCCCCccchhhhheee
Q 005916 314 L-MSEGPASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNFFL------LKGESNDEYSVSLILRIA 386 (670)
Q Consensus 314 ~-~~e~~~~~~~~~~~~d~d~d~~~~~~~~~~~~~~~~~~~~~i~~~~l~~~~~~~------~~g~~~~~~~I~liLri~ 386 (670)
+ ..+....+...|..+|.+.+| .++.+++....... ..|....+..+..+++..
T Consensus 348 ~~~~~~~~~l~~~F~~~D~d~dG-------------------~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (504)
T 3q5i_A 348 LTTLEERKELTDIFKKLDKNGDG-------------------QLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEV 408 (504)
T ss_dssp TSCHHHHHHHHHHHHHHCTTCSS-------------------EECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHH
T ss_pred CCcHHHHHHHHHHHHeeCCCCCC-------------------eEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHh
Confidence 0 001111122233344444443 35666655431110 113345677899999999
Q ss_pred cC--CCceeeeecc-------------------cccCCCCcCcchHHHHhcc
Q 005916 387 DQ--SGRLRNIHFL-------------------FYLDSDTAFSVSSEMVEQL 417 (670)
Q Consensus 387 D~--~g~i~~ieF~-------------------f~~d~Dta~~Ia~EmV~~l 417 (670)
|. +|.|.+-||. ..+|+|..|.|+.+++..+
T Consensus 409 D~d~dG~I~~~EF~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~ 460 (504)
T 3q5i_A 409 DFDKNGYIEYSEFISVCMDKQILFSEERLRRAFNLFDTDKSGKITKEELANL 460 (504)
T ss_dssp CTTCSSSEEHHHHHHHHSCHHHHTCHHHHHHHHHHHCTTCCSEECHHHHHHH
T ss_pred CCCCCCcEeHHHHHHHHHhhhcccCHHHHHHHHHHhcCCCCCcCcHHHHHHH
Confidence 84 6799999997 4579999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=432.72 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=215.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCC-----CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEeC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVN-----GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDD 99 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~t-----g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H-pNIVkl~~~~~d~ 99 (670)
..|++.+.||+|+||+||+|.+..+ ++.||+|.+.... .....+.+.+|+.+|++|+| ||||+++++|..+
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 4699999999999999999987654 4689999886432 35567789999999999955 9999999988654
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEE
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 163 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNIL 163 (670)
. ..+|||||||.+|+|.+++++. ..+++..+..|+.||+.||.|||+++ ||||||||+|||
T Consensus 141 ~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NIL 217 (353)
T 4ase_A 141 G-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNIL 217 (353)
T ss_dssp T-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred C-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCcccee
Confidence 3 3689999999999999999763 34899999999999999999999998 999999999999
Q ss_pred EeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHH
Q 005916 164 INGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQ 237 (670)
Q Consensus 164 l~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~ 237 (670)
++ .++.+||+|||+|+.+.... ....+||+.|||||++ .+.|+.++|||||||++|||+| |..||.+......
T Consensus 218 l~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 218 LS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp EC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 98 66899999999998764322 3456899999999976 5789999999999999999998 8999998777777
Q ss_pred HHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC--cccc
Q 005916 238 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD--PFLQ 286 (670)
Q Consensus 238 i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h--pf~~ 286 (670)
+.+.+..+..+. .+...++++++||.+||. +|.+|||+.++++| .+++
T Consensus 297 ~~~~i~~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 FCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 888888876543 456678999999999996 89999999999997 4444
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=460.11 Aligned_cols=371 Identities=26% Similarity=0.416 Sum_probs=276.0
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
......+|++.++||+|+||+||+|.+..+|..||+|++...... ......+.+|+.+|+.|+|||||++++++.+..
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence 333456799999999999999999999999999999999754321 123567889999999999999999999987644
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeeccc
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGL 178 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DFGl 178 (670)
.+|+|||||.||+|.+++...+.+++..++.|++||+.||.|||+++ |+||||||+|||++. .++.+||+|||+
T Consensus 95 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 95 --SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred --EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 79999999999999999998899999999999999999999999998 999999999999962 456899999999
Q ss_pred hhhhcccc-cccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc--ccCCC
Q 005916 179 ATIMEQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LSKVK 255 (670)
Q Consensus 179 a~~~~~~~-~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~ 255 (670)
+..+.... ....+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+...+...+..+..+.. .....
T Consensus 171 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (486)
T 3mwu_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTI 249 (486)
T ss_dssp TTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGS
T ss_pred CeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCC
Confidence 98775433 456789999999999998999999999999999999999999987 566777777777654433 23456
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCCCCCCCCCCC--CCcCCCcccccccc-------------c-ccCC
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTTKNRPLPLP--DIVLPRVGAFGDRC-------------L-MSEG 318 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-------------~-~~e~ 318 (670)
++++++||.+||. +|.+|||+.++|+||||+............+ ...+.++..|.... + ..+.
T Consensus 250 s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~ 329 (486)
T 3mwu_A 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDE 329 (486)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHH
Confidence 8999999999996 8999999999999999986432211000000 00111122221110 0 0011
Q ss_pred CCcccCCCCCCCCCCCCCCccccccCCCCCCCCCCCchhhhhcccCcc--ccccCCC----------CCccchhhhheee
Q 005916 319 PASVRNKHPSMDFDSDAELPVITSLDNSGGGDSYSPSIEVRRSKRGNF--FLLKGES----------NDEYSVSLILRIA 386 (670)
Q Consensus 319 ~~~~~~~~~~~d~d~d~~~~~~~~~~~~~~~~~~~~~i~~~~l~~~~~--~~~~g~~----------~~~~~I~liLri~ 386 (670)
...+...|..+|.+.+| .++.+++..+.. +...|.. ..+..+..+|+..
T Consensus 330 ~~~l~~~F~~~D~d~dG-------------------~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (486)
T 3mwu_A 330 TKQLTEIFRKLDTNNDG-------------------MLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLL 390 (486)
T ss_dssp HHHHHHHHHHHCTTCSS-------------------SBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCc-------------------eeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHh
Confidence 11222333444555444 355555533211 1112222 2267788999998
Q ss_pred c--CCCceeeeecc-------------------cccCCCCcCcchHHHHhcc
Q 005916 387 D--QSGRLRNIHFL-------------------FYLDSDTAFSVSSEMVEQL 417 (670)
Q Consensus 387 D--~~g~i~~ieF~-------------------f~~d~Dta~~Ia~EmV~~l 417 (670)
| .+|.|++-||+ ..+|+|..|.|+.+++..+
T Consensus 391 D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~ 442 (486)
T 3mwu_A 391 DMDGSGSIEYSEFIASAIDRTILLSRERMERAFKMFDKDGSGKISTKELFKL 442 (486)
T ss_dssp CTTCCSSBCHHHHHHHHSCTTTTCCHHHHHHHHHHHCSSCSSSBCSSCC---
T ss_pred cCCCCCcCcHHHHHHHHHhhhccchHHHHHHHHHHhCCCCCCcCCHHHHHHH
Confidence 8 46799999996 3578999999999988874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=406.61 Aligned_cols=258 Identities=26% Similarity=0.491 Sum_probs=226.2
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
..+.-..|++.+.||+|+||+||+|.+..+|..||+|++.... ......+++.+|+.+|+.++||||+++++++.+..
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ--LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 3444556999999999999999999999999999999997543 24567788999999999999999999999987544
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+|||||.||+|.+++..++.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 88 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 88 --TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD-ADMNIKIADFGFSN 162 (328)
T ss_dssp --EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCG
T ss_pred --EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEc-CCCCEEEeeccCce
Confidence 79999999999999999999999999999999999999999999998 99999999999998 67899999999998
Q ss_pred hhccc-ccccccCCCccCCCcccc-CCC-CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 181 IMEQA-NAKSVIGTPEFMAPELYD-ENY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 181 ~~~~~-~~~~~~GTp~YmAPEvl~-~~y-s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
..... .....+||+.|+|||++. ..| +.++|||||||++|+|++|.+||.+ .+...+...+..+..+ .+...++
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~ 239 (328)
T 3fe3_A 163 EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMST 239 (328)
T ss_dssp GGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCH
T ss_pred ecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCH
Confidence 76543 346678999999999774 444 4799999999999999999999987 6677777777776543 3445789
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 240 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 99999999996 89999999999999999854
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=410.75 Aligned_cols=257 Identities=24% Similarity=0.430 Sum_probs=223.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.++||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.+|+.++||||++++++|.+.. .+|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~~ 81 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLC 81 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC--EEE
Confidence 4699999999999999999999999999999999854321 1234567889999999999999999999997654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc-
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ- 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~- 184 (670)
+|||||.||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++....
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEEC-CCCCEEEeeccchhhcccC
Confidence 99999999999999999899999999999999999999999998 99999999999998 678999999999976432
Q ss_pred -cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 185 -ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 185 -~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...++..+..+.. .++...++++++|
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~l 235 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 2346778999999999774 5699999999999999999999999987 566777777766542 3455678999999
Q ss_pred HHHcCC-CCCCCC-----CHHHHhcCccccccCCC
Q 005916 263 IEKCLV-PASQRL-----SAKELLMDPFLQVNGTT 291 (670)
Q Consensus 263 I~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~~ 291 (670)
|.+||. +|.+|| ++.++++||||+...|.
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 999996 899999 99999999999876553
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=417.04 Aligned_cols=258 Identities=22% Similarity=0.404 Sum_probs=220.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
-..|++.++||+|+||+||+|+++.+|..||+|+++..... .....+.+.+|+.+|+.+ +||||++++++|.+.. .
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~--~ 98 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD--R 98 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--E
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC--E
Confidence 35699999999999999999999999999999999854321 233456788999999998 7999999999987654 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||.||+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEEC-CCCCEEEccccceeecc
Confidence 9999999999999999999999999999999999999999999998 99999999999998 67899999999997643
Q ss_pred c--cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 184 Q--ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 184 ~--~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
. ....+.+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+ .+...++..+..+.. .++...++.++
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~ 252 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLHEDAT 252 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 2 2345678999999999774 5699999999999999999999999987 667778888877643 34455789999
Q ss_pred HHHHHcCC-CCCCCCCH------HHHhcCccccccCCC
Q 005916 261 SFIEKCLV-PASQRLSA------KELLMDPFLQVNGTT 291 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa------~elL~hpf~~~~~~~ 291 (670)
+||.+||. +|.+||++ .++++||||+...|.
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 99999996 89999998 999999999876554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=409.53 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=193.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC--C
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--K 102 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--~ 102 (670)
.+.|.+.+.||+|+||+||+|.+ +|+.||||++.... ........|+..+..|+|||||++++++.+... .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 46799999999999999999976 69999999986432 122223456677778999999999999987643 3
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC------CCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH------DPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~------g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
.+|||||||++|+|.+++..+ .+++..+..++.|++.||.|||++ .++||||||||+|||++ .++.+||+||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DF 152 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADL 152 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCC
T ss_pred EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeC
Confidence 689999999999999999764 689999999999999999999987 33599999999999998 6789999999
Q ss_pred cchhhhcccc------cccccCCCccCCCccccC-------CCCccceeeeccchhhhhhhccCCCCCC-----------
Q 005916 177 GLATIMEQAN------AKSVIGTPEFMAPELYDE-------NYNELADIYSFGMCMLEMVTFEYPYSEC----------- 232 (670)
Q Consensus 177 Gla~~~~~~~------~~~~~GTp~YmAPEvl~~-------~ys~~~DIWSLGvilyeLltG~~Pf~~~----------- 232 (670)
|+|+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||.+||...
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 9998765432 234689999999998754 3678999999999999999997765321
Q ss_pred ---CCHHHHHHHHhcCCCCCcccCC-----CChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 233 ---RNSAQIYKKVSSGIKPAALSKV-----KDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 233 ---~~~~~i~~~i~~g~~p~~~~~~-----~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.....+.+.+........++.. ....+.+|+.+||. +|.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1234455555444332222221 12467899999996 89999999999863
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=412.08 Aligned_cols=261 Identities=27% Similarity=0.415 Sum_probs=225.1
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s--~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
....+|++.+.||+|+||+||+|.++.+|..||+|.+........ ....+.+.+|+.+|+.|+||||++++++|.+..
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 345679999999999999999999999999999999986543221 113567889999999999999999999987654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC---cEEEeecc
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG---EVKIGDLG 177 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g---~vKL~DFG 177 (670)
.+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+ .+||+|||
T Consensus 89 --~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 89 --DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp --EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred --EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 79999999999999999998889999999999999999999999998 999999999999984332 79999999
Q ss_pred chhhhccc-ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC--CcccC
Q 005916 178 LATIMEQA-NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSK 253 (670)
Q Consensus 178 la~~~~~~-~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~ 253 (670)
++...... .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+ .+...++..+..+... .....
T Consensus 165 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp SCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchhcc
Confidence 99877553 245678999999999775 5799999999999999999999999987 5667777777776532 23345
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 678999999999996 89999999999999999743
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=399.93 Aligned_cols=255 Identities=30% Similarity=0.501 Sum_probs=219.7
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
..+.|++.+.||+|+||+||+|.+..+|..||+|++..... ...+.+.+|+.+++.++||||++++++|.+.. .
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~ 91 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD--E 91 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC--E
Confidence 34568899999999999999999999999999999986542 22466889999999999999999999998755 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||.||+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred EEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEC-CCCCEEEeeCCCceecC
Confidence 99999999999999998765 6999999999999999999999998 99999999999998 66899999999987765
Q ss_pred ccc--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 184 QAN--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 184 ~~~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
... ....+||+.|+|||++ ...|+.++|||||||++|+|++|..||.........+.....+......+...++.++
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 432 3567899999999976 5679999999999999999999999998755445555544444444445566789999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+||.+||. +|.+|||+.++|+||||+..
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 99999996 89999999999999999853
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=416.32 Aligned_cols=261 Identities=21% Similarity=0.365 Sum_probs=221.8
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~ 101 (670)
..-..|++.++||+|+||+||+|+++.+|..||+|+++.... ......+.+.+|..+|+++ +|||||+++++|.+..
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~-~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~- 126 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES- 126 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT-C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS-
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC-
Confidence 344579999999999999999999999999999999986433 3344556788999999887 8999999999987654
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+|||||.||+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++.
T Consensus 127 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 127 -RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKE 202 (396)
T ss_dssp -EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBC
T ss_pred -EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC-CCCCEEEeecceeee
Confidence 79999999999999999999899999999999999999999999998 99999999999998 678999999999986
Q ss_pred hcc--cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCC--------CCHHHHHHHHhcCCCCCc
Q 005916 182 MEQ--ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC--------RNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 182 ~~~--~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~--------~~~~~i~~~i~~g~~p~~ 250 (670)
... ....+.+||+.|+|||++. ..|+.++|||||||++|+|++|.+||... .....+++.+.... ..
T Consensus 203 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~ 280 (396)
T 4dc2_A 203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IR 280 (396)
T ss_dssp CCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CC
T ss_pred cccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cC
Confidence 322 2356789999999999764 57999999999999999999999999632 23344666666653 23
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCH------HHHhcCccccccCCC
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSA------KELLMDPFLQVNGTT 291 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa------~elL~hpf~~~~~~~ 291 (670)
++...++++++||.+||. +|.+||++ .++++||||+...|.
T Consensus 281 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 281 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 455678999999999996 89999985 899999999876554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=420.23 Aligned_cols=277 Identities=20% Similarity=0.326 Sum_probs=226.9
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.++||+|+||+||+|.++.+|..||+|++....... ....+.+.+|+.+|+.++|||||+++++|.+.. .
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~ 143 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR--Y 143 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--E
Confidence 4457999999999999999999999999999999997532111 112234778999999999999999999997654 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||.||+|.+++.. ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeEC-CCCCEEEeccceeEeec
Confidence 9999999999999999876 46999999999999999999999998 99999999999998 67899999999998765
Q ss_pred ccc---cccccCCCccCCCccccC-C----CCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccC
Q 005916 184 QAN---AKSVIGTPEFMAPELYDE-N----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSK 253 (670)
Q Consensus 184 ~~~---~~~~~GTp~YmAPEvl~~-~----ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~ 253 (670)
... ..+.+||+.|+|||++.+ . |+.++|||||||++|+|++|.+||.+ .+...++..+..+.. ......
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTC
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcc
Confidence 432 357789999999997743 2 78999999999999999999999987 567777777766431 222233
Q ss_pred CCChHHHHHHHHcCC-CCCC--CCCHHHHhcCccccccCCCCCCCCCCCCCcCCCccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQ--RLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGA 308 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~--RpSa~elL~hpf~~~~~~~~~~~~~~~~~~~~~~~~ 308 (670)
..++++++||.+||. +|.+ |+++.++++||||+...|.........++.+|.+..
T Consensus 299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~ 356 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSS 356 (410)
T ss_dssp CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSS
T ss_pred cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCC
Confidence 578999999999997 4667 999999999999998766443322333445565543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=407.12 Aligned_cols=258 Identities=22% Similarity=0.380 Sum_probs=226.0
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
.-..|++.+.||+|+||+||+|.++.+|..||+|++...... .....+.+.+|+.+|+.++||||++++++|.+.. .
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~ 115 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--N 115 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--E
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC--E
Confidence 345799999999999999999999999999999999754321 1233567889999999999999999999987654 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECS
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEEC-CCCCEEEcccccceecc
Confidence 9999999999999999999899999999999999999999999998 99999999999998 67899999999998764
Q ss_pred ccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 184 QANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 184 ~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
.. ....+||+.|+|||++ ...|+.++|||||||++|+|++|.+||.. .+...++..+..+.. .++...++++++|
T Consensus 193 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 268 (350)
T 1rdq_E 193 GR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDL 268 (350)
T ss_dssp SC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHH
T ss_pred CC-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 43 4567899999999976 55789999999999999999999999987 567778888877643 3455678999999
Q ss_pred HHHcCC-CCCCCCC-----HHHHhcCccccccCCC
Q 005916 263 IEKCLV-PASQRLS-----AKELLMDPFLQVNGTT 291 (670)
Q Consensus 263 I~kcL~-dP~~RpS-----a~elL~hpf~~~~~~~ 291 (670)
|.+||. +|.+||+ +.++++||||+...|.
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 999996 8999998 9999999999876553
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=401.07 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=222.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.+++.++||||++++++|.+.. .+|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~ 82 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ--QIF 82 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS--EEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC--EEE
Confidence 4699999999999999999999999999999999854321 1123567889999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSS-
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEc-CCCCEEEeecCcceecCC-
Confidence 99999999999999999999999999999999999999999998 99999999999998 678999999999987643
Q ss_pred ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 186 NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 186 ~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
...+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+....+..+..+.. .++...++++++||.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLS 235 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHH
Confidence 345678999999999764 5799999999999999999999999987 566667777766542 344567899999999
Q ss_pred HcCC-CCCCCC-----CHHHHhcCccccccCC
Q 005916 265 KCLV-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 265 kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
+||. +|.+|| +++++++||||+...|
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 9996 899999 9999999999986554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=401.73 Aligned_cols=258 Identities=21% Similarity=0.369 Sum_probs=222.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
-..|++.+.||+|+||+||+|+++.+|+.||+|++.... .......+.+.+|+.+++.+ +|||||+++++|.+.. .
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--~ 84 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--R 84 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGG-SCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--E
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHH-hcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC--E
Confidence 346999999999999999999999999999999998643 34456778899999999998 8999999999987654 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEEecccccccc
Confidence 9999999999999999998889999999999999999999999998 99999999999998 67899999999998643
Q ss_pred c--cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCC--------CCHHHHHHHHhcCCCCCccc
Q 005916 184 Q--ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC--------RNSAQIYKKVSSGIKPAALS 252 (670)
Q Consensus 184 ~--~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~--------~~~~~i~~~i~~g~~p~~~~ 252 (670)
. ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....+++.+..... .++
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIP 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCC
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCC
Confidence 2 2346678999999999764 57999999999999999999999999642 234456666666532 345
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCH------HHHhcCccccccCC
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSA------KELLMDPFLQVNGT 290 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa------~elL~hpf~~~~~~ 290 (670)
...++++++||.+||. +|.+||++ .++++||||+...|
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 5678999999999996 89999995 89999999986554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=406.85 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=223.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.++.+|..||+|++..... .....+.+.+|+.+|+.|+|||||+++++|.+.. .+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~ 103 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FH 103 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EE
Confidence 3469999999999999999999999999999999986443 4566788999999999999999999999987654 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--CCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~g~vKL~DFGla~~~ 182 (670)
|+|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||++...
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999999999999998889999999999999999999999998 9999999999999732 356999999999877
Q ss_pred cccc-cccccCCCccCCCccccC-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC--CcccCCCChH
Q 005916 183 EQAN-AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPE 258 (670)
Q Consensus 183 ~~~~-~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~s~~ 258 (670)
.... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+ .+...++..+..+... .......+++
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 260 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPE 260 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 5433 356789999999997754 799999999999999999999999987 5666777777776532 2233456899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+++||.+||. +|.+|||+.++|+||||+.
T Consensus 261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 261 AKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999996 8999999999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=416.97 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=222.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|++.+.||+|+||+||+|.++.+|..||+|++..... .....+.+.+|+.+|+.|+|||||+++++|.+.. .+|
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~ 86 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEEG--HHY 86 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS--EEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC--EEE
Confidence 469999999999999999999999999999999986543 3455678899999999999999999999987554 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DFGla~~~~ 183 (670)
+|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++....
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999999999999999999999999999999999998 999999999999984 35789999999998765
Q ss_pred ccc--cccccCCCccCCCccccC-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC--CcccCCCChH
Q 005916 184 QAN--AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPE 258 (670)
Q Consensus 184 ~~~--~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~s~~ 258 (670)
... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+ .+...++..+..+... .......+++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 432 346789999999998754 699999999999999999999999987 5677777777776543 2233456899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999996 89999999999999999743
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=408.97 Aligned_cols=260 Identities=24% Similarity=0.426 Sum_probs=224.1
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~ 101 (670)
..-..|++.++||+|+||+||+|+++.+|+.||+|+++...... ....+.+..|..+|+.+ +||||++++++|.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~- 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE- 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-
Confidence 34567999999999999999999999999999999998643211 12356678899999887 9999999999987654
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++.
T Consensus 92 -~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 92 -NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKE 167 (345)
T ss_dssp -EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBC
T ss_pred -EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC-CCCCEEEeEChhhhh
Confidence 79999999999999999999889999999999999999999999998 99999999999998 678999999999976
Q ss_pred hcc--cccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 182 MEQ--ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 182 ~~~--~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
... ......+||+.|+|||++ ...|+.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...+++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~ 244 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKE 244 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHH
Confidence 432 235678899999999976 45799999999999999999999999987 567777777776542 345567899
Q ss_pred HHHHHHHcCC-CCCCCCCHH-HHhcCccccccCCC
Q 005916 259 VKSFIEKCLV-PASQRLSAK-ELLMDPFLQVNGTT 291 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~-elL~hpf~~~~~~~ 291 (670)
+++||.+||. +|.+||++. ++++||||+...|.
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 9999999996 899999998 99999999876553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=391.72 Aligned_cols=256 Identities=23% Similarity=0.438 Sum_probs=213.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC----------------------HHHHHHHHHHHHHHHh
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS----------------------PEDLERLYSEVHLLKS 83 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s----------------------~~~~e~l~~Ei~iLk~ 83 (670)
..|++.+.||+|+||+||+|.+..+|..||+|++........ ....+.+.+|+.+|+.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 469999999999999999999999999999999976542211 1234678899999999
Q ss_pred CCCCCeeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEE
Q 005916 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 163 (670)
Q Consensus 84 L~HpNIVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNIL 163 (670)
|+||||+++++++.+.....+|+||||+.+|+|.+++ ..+.+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil 169 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLL 169 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEE
Confidence 9999999999999876667899999999999998764 3457999999999999999999999998 999999999999
Q ss_pred EeCCCCcEEEeeccchhhhcccc--cccccCCCccCCCccccCC----CCccceeeeccchhhhhhhccCCCCCCCCHHH
Q 005916 164 INGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELYDEN----YNELADIYSFGMCMLEMVTFEYPYSECRNSAQ 237 (670)
Q Consensus 164 l~~~~g~vKL~DFGla~~~~~~~--~~~~~GTp~YmAPEvl~~~----ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~ 237 (670)
++ .++.+||+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|++|..||.. .....
T Consensus 170 ~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~ 247 (298)
T 2zv2_A 170 VG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMC 247 (298)
T ss_dssp EC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHH
T ss_pred EC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHH
Confidence 98 66899999999998765432 3456899999999987543 37889999999999999999999987 45556
Q ss_pred HHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 238 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 238 i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
+...+.....+.......++.+++||.+||. +|.+|||+.++|+||||+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 6666666544433344578999999999996 899999999999999995
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=399.95 Aligned_cols=254 Identities=20% Similarity=0.335 Sum_probs=220.1
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.+..+|..||+|.+... ....+.+.+|+.+|+.++||||++++++|.+.. .+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~ 76 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESME--EL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC--EE
Confidence 35699999999999999999999999999999998743 344567889999999999999999999997654 79
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC-CCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN-QGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~-~g~vKL~DFGla~~~ 182 (670)
|+|||||.||+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+||+|||++..+
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999999999999765 47999999999999999999999998 9999999999999842 689999999999877
Q ss_pred cccc-cccccCCCccCCCccccC-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC--cccCCCChH
Q 005916 183 EQAN-AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALSKVKDPE 258 (670)
Q Consensus 183 ~~~~-~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~--~~~~~~s~~ 258 (670)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+ .+...+...+..+.... ......+++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 5433 355789999999998755 479999999999999999999999987 55666777776655332 223456899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999996 89999999999999999854
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=404.90 Aligned_cols=261 Identities=24% Similarity=0.383 Sum_probs=216.4
Q ss_pred CCCCCeEEEEEEeccc--CCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 22 DPTCRYIRYKEVIGKG--AFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G--~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
-+.+..|++.++||+| +||+||+|.++.+|..||+|++.... ......+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 3567889999999999 99999999999999999999998653 2456678899999999999999999999999875
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
. .+|+|||||.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 99 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~dfg 173 (389)
T 3gni_B 99 N--ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLR 173 (389)
T ss_dssp T--EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCGG
T ss_pred C--EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccc
Confidence 5 799999999999999999876 77999999999999999999999998 99999999999998 67899999999
Q ss_pred chhhhccc---------ccccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC
Q 005916 178 LATIMEQA---------NAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 245 (670)
Q Consensus 178 la~~~~~~---------~~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g 245 (670)
++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+...+...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 88654321 1234579999999997754 68999999999999999999999998755444443322111
Q ss_pred C-------------------------------------------CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 246 I-------------------------------------------KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 246 ~-------------------------------------------~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
. ....+....++.+++||.+||. +|.+|||+.|+|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 0011334567899999999996 8999999999999
Q ss_pred CccccccC
Q 005916 282 DPFLQVNG 289 (670)
Q Consensus 282 hpf~~~~~ 289 (670)
||||+...
T Consensus 334 hp~f~~~~ 341 (389)
T 3gni_B 334 HSFFKQIK 341 (389)
T ss_dssp SGGGGGC-
T ss_pred CHHHHHHh
Confidence 99998643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=386.53 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=210.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|++.+.||+|+||+||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.+.. .++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC--EEE
Confidence 359999999999999999999999999999999986542 3445677889999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+|||||.++.+..+....+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCSC
T ss_pred EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecCCc
Confidence 99999976444444444678999999999999999999999998 99999999999998 6689999999999876533
Q ss_pred --ccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC---CCC---------
Q 005916 186 --NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---KPA--------- 249 (670)
Q Consensus 186 --~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~---~p~--------- 249 (670)
......||+.|+|||++.+ .|+.++|||||||++|+|++|..||....+.......+.... ...
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 2355689999999997643 389999999999999999999888655566655555443210 000
Q ss_pred ---------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 250 ---------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 250 ---------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
......++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 1112357899999999996 8999999999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=408.77 Aligned_cols=263 Identities=22% Similarity=0.408 Sum_probs=225.4
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
.+..-..|++.++||+|+||+||+|.+..+|..||+|++....... ......+.+|+.+|+.++|||||+++++|.+..
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3445578999999999999999999999999999999997543211 233567889999999999999999999997654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+|||||.||+|..++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.
T Consensus 89 --~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 89 --DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAA 163 (384)
T ss_dssp --EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred --EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEC-CCCCEEEeccceee
Confidence 79999999999999999999889999999999999999999999998 99999999999998 67899999999998
Q ss_pred hhccc-ccccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCC--CCHHHHHHHHhcCCCCCcccC
Q 005916 181 IMEQA-NAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSEC--RNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 181 ~~~~~-~~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~--~~~~~i~~~i~~g~~p~~~~~ 253 (670)
.+... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....++..+.... ..++.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~ 241 (384)
T 4fr4_A 164 MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPS 241 (384)
T ss_dssp ECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCT
T ss_pred eccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCC
Confidence 76543 356788999999999874 35899999999999999999999999642 34455666555543 23445
Q ss_pred CCChHHHHHHHHcCC-CCCCCCC-HHHHhcCccccccCCC
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLS-AKELLMDPFLQVNGTT 291 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpS-a~elL~hpf~~~~~~~ 291 (670)
..++.+++||.+||. +|.+||+ +.++++||||+...|.
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 678999999999996 8999998 9999999999876553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=415.71 Aligned_cols=258 Identities=24% Similarity=0.418 Sum_probs=214.2
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.++||+|+||+||+|.+..+|..||+|++..... .......++.+|+.+|+.++||||++++++|.+.. .
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~ 222 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--R 222 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEETT--E
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC--E
Confidence 34569999999999999999999999999999999985432 23445667889999999999999999999997655 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEEC-CCCCEEEccCCCceec
Confidence 99999999999999999998999999999999999999999998 87 99999999999998 6689999999999864
Q ss_pred ccc--ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 183 EQA--NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 183 ~~~--~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
... .....+||+.|+|||++ ...|+.++|||||||++|+|++|..||.+ .+...++..+..... .++...++++
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~ 376 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLGPEA 376 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHH
Confidence 332 34567899999999977 56799999999999999999999999987 566667766665543 3455678999
Q ss_pred HHHHHHcCC-CCCCCC-----CHHHHhcCccccccCC
Q 005916 260 KSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 260 k~fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
++||.+||. +|.+|| ++.++|+||||+...+
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 999999996 899999 9999999999986654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=414.18 Aligned_cols=277 Identities=20% Similarity=0.316 Sum_probs=225.2
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
.....|++.++||+|+||+||+|+++.+|+.||+|+++..... .....+.+.+|+.+|+.++||||++++++|.+..
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-- 134 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN-- 134 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS--
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--
Confidence 3456799999999999999999999999999999999753221 1223445788999999999999999999997654
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+|||||.||+|.+++.+.+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|++||+|||+++.
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld-~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLK 211 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeec-CCCCEEEeechhhee
Confidence 7999999999999999998764 7999999999999999999999998 99999999999998 678999999999987
Q ss_pred hcccc---cccccCCCccCCCcccc--------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC---C
Q 005916 182 MEQAN---AKSVIGTPEFMAPELYD--------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---K 247 (670)
Q Consensus 182 ~~~~~---~~~~~GTp~YmAPEvl~--------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~---~ 247 (670)
..... ....+||+.|+|||++. +.|+.++|||||||++|+|++|..||.+ .+...++..+.... .
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcC
Confidence 65432 24568999999999874 4689999999999999999999999987 56667776666432 1
Q ss_pred CCcccCCCChHHHHHHHHcCCCCCCC---CCHHHHhcCccccccCCCCCCCCCCCCCcCCCccc
Q 005916 248 PAALSKVKDPEVKSFIEKCLVPASQR---LSAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVGA 308 (670)
Q Consensus 248 p~~~~~~~s~~~k~fI~kcL~dP~~R---pSa~elL~hpf~~~~~~~~~~~~~~~~~~~~~~~~ 308 (670)
........++++++||.+||.+|.+| ++++++++||||+...|..... ..++..|.+..
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~--~~~p~~p~~~~ 352 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRD--SVPPFTPDFEG 352 (412)
T ss_dssp CC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTSTT--SCCSCCCC---
T ss_pred CCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHHhh--cCCCCCCcCCC
Confidence 11223457899999999999988777 5999999999999776654432 22334455443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=396.38 Aligned_cols=261 Identities=27% Similarity=0.428 Sum_probs=222.0
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s--~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.....+|++.+.||+|+||+||+|.++.+|..||+|.+........ ....+.+.+|+.+|+.|+||||++++++|.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3445679999999999999999999999999999999986543221 11356788999999999999999999998764
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC----cEEEee
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG----EVKIGD 175 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g----~vKL~D 175 (670)
. .+++|||||.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|
T Consensus 87 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~-~~~~~~~~~kl~D 161 (326)
T 2y0a_A 87 T--DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKIID 161 (326)
T ss_dssp S--EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES-CSSSSSCCEEECC
T ss_pred C--EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEe-cCCCCCCCEEEEE
Confidence 4 79999999999999999998889999999999999999999999998 99999999999998 344 799999
Q ss_pred ccchhhhccc-ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcc
Q 005916 176 LGLATIMEQA-NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAAL 251 (670)
Q Consensus 176 FGla~~~~~~-~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~ 251 (670)
||++...... ......||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .........+..... +...
T Consensus 162 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~ 240 (326)
T 2y0a_A 162 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEY 240 (326)
T ss_dssp CTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHTCCCCCHHH
T ss_pred CCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHhcCCCcCccc
Confidence 9999877543 345678999999999775 5799999999999999999999999987 455555555555432 2233
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
....++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 35568899999999996 89999999999999999743
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=404.38 Aligned_cols=258 Identities=22% Similarity=0.353 Sum_probs=223.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
-..|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|..+|+.+ +||||++++++|.+.. .
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--~ 95 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--R 95 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS--E
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC--E
Confidence 356999999999999999999999999999999998643211 23356788999999998 8999999999987654 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc-CCCcEEEEeCCcccccc
Confidence 9999999999999999998889999999999999999999999998 99999999999998 67899999999998643
Q ss_pred c--cccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 184 Q--ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 184 ~--~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
. ......+||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+ .+...++..+..+.. .++...+++++
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~ 249 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAV 249 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHH
Confidence 2 235677899999999976 46799999999999999999999999987 567778887777543 34556789999
Q ss_pred HHHHHcCC-CCCCCC-----CHHHHhcCccccccCCC
Q 005916 261 SFIEKCLV-PASQRL-----SAKELLMDPFLQVNGTT 291 (670)
Q Consensus 261 ~fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~~ 291 (670)
+||.+||. +|.+|| ++.++++||||+...|.
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 99999996 899999 47999999999866553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=395.54 Aligned_cols=259 Identities=25% Similarity=0.349 Sum_probs=211.3
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEc---CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~---~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
....|++.+.||+|+||+||+|++. .+|..||+|+++.............+.+|+.+|+.++||||++++++|.+..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 4467999999999999999999985 6899999999986544333445667889999999999999999999987654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 95 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 95 --KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCK 169 (327)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTSCEEECCCSCC-
T ss_pred --EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEEC-CCCcEEEEeCCccc
Confidence 69999999999999999999889999999999999999999999998 99999999999998 67899999999997
Q ss_pred hhccc--ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 181 IMEQA--NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 181 ~~~~~--~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
..... .....+||+.|+|||++ ...|+.++|||||||++|+|++|..||.+ .+....+..+..+.. .++...++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~ 246 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPYLTQ 246 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTTSCH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCH
Confidence 65332 24567899999999976 45789999999999999999999999987 456666666666532 34456789
Q ss_pred HHHHHHHHcCC-CCCCCC-----CHHHHhcCccccccCC
Q 005916 258 EVKSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
++++||.+||. +|.+|| ++.++++||||+...+
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 99999999996 899999 8999999999986544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=395.53 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=216.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
-..|++.+.||+|+||+||+|.+..+|..||+|++..... ....+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSS--EE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--eE
Confidence 3569999999999999999999999999999999975432 233466889999999999999999999987544 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|+|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRY 157 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEe-CCCCEEEEEeeccceecc
Confidence 999999999999999988888999999999999999999999998 99999999999998 668999999999987643
Q ss_pred cc----cccccCCCccCCCccccC-C-CCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 185 AN----AKSVIGTPEFMAPELYDE-N-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 185 ~~----~~~~~GTp~YmAPEvl~~-~-ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
.. ....+||+.|+|||++.+ . ++.++|||||||++|+|++|..||.........+................++.
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHH
Confidence 22 346789999999998743 4 47789999999999999999999987665555555555544333334556899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 238 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 9999999996 89999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=416.72 Aligned_cols=263 Identities=19% Similarity=0.328 Sum_probs=220.3
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
.....|++.++||+|+||+||+|+++.+|..||+|++....... ......+.+|+.+++.++||||++++++|.+..
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-- 147 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDDN-- 147 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS--
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--
Confidence 34467999999999999999999999999999999997532211 112234788999999999999999999987654
Q ss_pred eEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+|||||.||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||++..
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~-~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLK 224 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEc-CCCCEEEcchhhhhh
Confidence 79999999999999999987 578999999999999999999999998 99999999999998 678999999999976
Q ss_pred hcccc---cccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC----CC
Q 005916 182 MEQAN---AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI----KP 248 (670)
Q Consensus 182 ~~~~~---~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~----~p 248 (670)
..... ....+||+.|||||++. +.|+.++|||||||++|+|++|.+||.+ .+..+.+..+.... .|
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCC
Confidence 64432 34578999999999774 4689999999999999999999999987 56667777665432 22
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCC--CCCHHHHhcCccccccCCCCC
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQ--RLSAKELLMDPFLQVNGTTKN 293 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~--RpSa~elL~hpf~~~~~~~~~ 293 (670)
. .....++++++||.+||. +|.+ |++++++++||||+...|...
T Consensus 304 ~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 304 T-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp S-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred c-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 2 223468999999999996 4555 899999999999997766544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=403.90 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=204.6
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~~ 104 (670)
+.|++.+.||+|+||+||+|.+..+|..||+|++... ........++.+|+.+|+.+. ||||++++++|.......+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4699999999999999999999999999999998632 344667788999999999996 9999999999987766689
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|+|||||. |+|..++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEc-CCCCEEecCCcccccccc
Confidence 99999997 589998876 57999999999999999999999998 99999999999998 678999999999976532
Q ss_pred -----------------------cccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHH
Q 005916 185 -----------------------ANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY 239 (670)
Q Consensus 185 -----------------------~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~ 239 (670)
......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1124468999999999774 469999999999999999999999998854444433
Q ss_pred HHHhcCCCCCc--------------------------------------------ccCCCChHHHHHHHHcCC-CCCCCC
Q 005916 240 KKVSSGIKPAA--------------------------------------------LSKVKDPEVKSFIEKCLV-PASQRL 274 (670)
Q Consensus 240 ~~i~~g~~p~~--------------------------------------------~~~~~s~~~k~fI~kcL~-dP~~Rp 274 (670)
..+.....|.. .....++++++||.+||. +|.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 32211111100 011457899999999997 899999
Q ss_pred CHHHHhcCcccccc
Q 005916 275 SAKELLMDPFLQVN 288 (670)
Q Consensus 275 Sa~elL~hpf~~~~ 288 (670)
|+.|+|+||||+..
T Consensus 322 t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 322 SANDALKHPFVSIF 335 (388)
T ss_dssp CHHHHTTSTTTTTT
T ss_pred CHHHHhCCHHHHHh
Confidence 99999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=381.79 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=212.6
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
..+.|++.+.||+|+||+||+|.+..+|..||+|.+..... ....+.+.+|+.+|+.++||||+++++++.+.. .
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~ 94 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH--N 94 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--E
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHheecCC--e
Confidence 34679999999999999999999999999999999986542 223567889999999999999999999987544 7
Q ss_pred EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeecc
Q 005916 104 VNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLG 177 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DFG 177 (670)
+++|||||.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 9999999999999998754 367999999999999999999999998 999999999999953 35789999999
Q ss_pred chhhhcccc-cccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC-cccCCC
Q 005916 178 LATIMEQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVK 255 (670)
Q Consensus 178 la~~~~~~~-~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~ 255 (670)
++..+.... .....||+.|+|||++.+.++.++|||||||++|+|++|..||.+ .....+...+....... ......
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~ 251 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKEPNYAVECRPL 251 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCC--CCC
T ss_pred cceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhccCCcccccccCcC
Confidence 998765433 456789999999999988999999999999999999999999987 44555555444433222 222346
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 7899999999996 8999999999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=396.45 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=207.3
Q ss_pred ccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 20 e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.......+|++.+.||+|+||+||+|++..+|..||+|++..... ..+.+.+|+.+++.|+||||++++++|.+.
T Consensus 14 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp CCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 344456789999999999999999999999999999999975432 125578999999999999999999998765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC-CCcEEEeeccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN-QGEVKIGDLGL 178 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~-~g~vKL~DFGl 178 (670)
. .+|+|||||.||+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||+
T Consensus 89 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 89 T--HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp S--EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred C--EEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 4 79999999999999999998889999999999999999999999998 9999999999999833 23599999999
Q ss_pred hhhhccc-ccccccCCCccCCCccc-cCCCCcc-ceeeeccchhhhhhhccCCCCCCCC---HHHHHHHHhcCCCCCccc
Q 005916 179 ATIMEQA-NAKSVIGTPEFMAPELY-DENYNEL-ADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKVSSGIKPAALS 252 (670)
Q Consensus 179 a~~~~~~-~~~~~~GTp~YmAPEvl-~~~ys~~-~DIWSLGvilyeLltG~~Pf~~~~~---~~~i~~~i~~g~~p~~~~ 252 (670)
+...... .....+||+.|+|||++ ...++.+ +|||||||++|+|++|.+||.+... ...+...+..........
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 165 SKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244 (361)
T ss_dssp C---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred cccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence 9754332 34567899999999976 4556555 8999999999999999999976432 234445555544333333
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...++++++||.+||. +|.+|||+.++|+||||...
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 4568999999999996 89999999999999999743
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=402.63 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=216.1
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHH-HHhCCCCCeeeeeeEEEeCCCC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHL-LKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~i-Lk~L~HpNIVkl~~~~~d~~~~ 102 (670)
.-..|++.++||+|+||+||+|+++.++..||+|++...... .......+.+|..+ ++.++|||||+++++|.+..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~-- 112 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-- 112 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSS--
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC--
Confidence 445799999999999999999999999999999999865443 23445567778777 57789999999999997654
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.+|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++..
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGG
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEeeCcccccc
Confidence 79999999999999999999899999999999999999999999998 99999999999998 6789999999999865
Q ss_pred cc--cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 183 EQ--ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 183 ~~--~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.. ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+...++..+.... ..++...++.+
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~ 266 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSA 266 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSC--CCCCSSSCHHH
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcc--cCCCCCCCHHH
Confidence 33 2356788999999999764 5699999999999999999999999987 56777787777653 23455678999
Q ss_pred HHHHHHcCC-CCCCCCCH----HHHhcCccccccCCC
Q 005916 260 KSFIEKCLV-PASQRLSA----KELLMDPFLQVNGTT 291 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa----~elL~hpf~~~~~~~ 291 (670)
++||.+||. +|.+||++ .++++||||+...|.
T Consensus 267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 999999996 89999986 699999999876554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=379.71 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=221.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
.++|++.+.||+|+||+||+|.+..++..||+|.+..... ...+++.+|+.+++.++||||+++++++.+.. .+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 81 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT--DI 81 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--eE
Confidence 4679999999999999999999999999999999975432 23567889999999999999999999987544 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe--CCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~--~~~g~vKL~DFGla~~~ 182 (670)
++|||||.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+. ..++.+||+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999999999998899999999999999999999999998 99999999999992 25679999999999876
Q ss_pred cccc-cccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc--ccCCCChHH
Q 005916 183 EQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LSKVKDPEV 259 (670)
Q Consensus 183 ~~~~-~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~s~~~ 259 (670)
.... .....||+.|+|||++.+.++.++||||||+++|+|++|..||.. .........+..+..... .....++.+
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 160 KPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp CTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred cCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence 5433 456789999999999988899999999999999999999999987 455666666666543322 223568999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++||.+||. +|.+|||+.++|+||||+..
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 999999996 89999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=396.74 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=216.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
...|++.+.||+|+||+||+|.++.+|..||+|++..... ...+|+++|.++ +||||++++++|.+.. .
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~ 90 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDGK--Y 90 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECSS--E
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC--E
Confidence 3569999999999999999999999999999999975432 134688888888 8999999999987644 8
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC---CcEEEeeccchh
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ---GEVKIGDLGLAT 180 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~---g~vKL~DFGla~ 180 (670)
+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+...+ +.+||+|||++.
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999999999999999999999999999999999999998 99999999999986333 359999999998
Q ss_pred hhccc--ccccccCCCccCCCccccC-CCCccceeeeccchhhhhhhccCCCCCC--CCHHHHHHHHhcCCCCC--cccC
Q 005916 181 IMEQA--NAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSEC--RNSAQIYKKVSSGIKPA--ALSK 253 (670)
Q Consensus 181 ~~~~~--~~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvilyeLltG~~Pf~~~--~~~~~i~~~i~~g~~p~--~~~~ 253 (670)
..... ...+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||... .....++..+..+..+. ....
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 76543 2456789999999998754 5899999999999999999999999753 45677888887766432 2334
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..++++++||.+||. +|.+|||+.++|+||||...
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 578999999999996 89999999999999999643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=402.73 Aligned_cols=253 Identities=28% Similarity=0.481 Sum_probs=213.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.+..+|..||+|++...... ......++.+|+.+|+.++||||+++++++.+.. .++
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~ 85 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT--DIV 85 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEE
Confidence 4589999999999999999999999999999999753211 1122357889999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||+ +|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEEC-TTCCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEc-CCCCEEEEEeccceeccCC
Confidence 999999 7899999998899999999999999999999999998 99999999999998 6789999999999877554
Q ss_pred c-cccccCCCccCCCccccCC-C-CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 N-AKSVIGTPEFMAPELYDEN-Y-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 ~-~~~~~GTp~YmAPEvl~~~-y-s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
. ....+||+.|+|||++.+. | +.++|||||||++|+|++|..||.+.. ...+++.+..+. ...+...++.+++|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-~~~~~~~i~~~~--~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVNSCV--YVMPDFLSPGAQSL 238 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS-STTCBCCCCSSC--CCCCTTSCHHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHcCC--CCCcccCCHHHHHH
Confidence 3 4667899999999987653 4 789999999999999999999997632 222222222222 23455678999999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
|.+||. +|.+|||+.|+++||||+..
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999996 89999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=392.15 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=218.2
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEeC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH--NNIIRFYNSWIDD 99 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H--pNIVkl~~~~~d~ 99 (670)
...++.|++.+.||+|+||+||+|.+ .++..||+|++.... ......+.+.+|+.+|+.|+| |||+++++++.+.
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 45688999999999999999999987 468899999998653 345667889999999999976 9999999998765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
. .+|+||| +.+|+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++
T Consensus 82 ~--~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~a 154 (343)
T 3dbq_A 82 Q--YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIA 154 (343)
T ss_dssp S--EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSS
T ss_pred C--EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CCcEEEeecccc
Confidence 4 8999999 568899999999999999999999999999999999998 99999999999997 478999999999
Q ss_pred hhhcccc----cccccCCCccCCCcccc------------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHh
Q 005916 180 TIMEQAN----AKSVIGTPEFMAPELYD------------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS 243 (670)
Q Consensus 180 ~~~~~~~----~~~~~GTp~YmAPEvl~------------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~ 243 (670)
..+.... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||....+.......+.
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 8765432 24568999999999773 5689999999999999999999999987666656666666
Q ss_pred cCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 244 SGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 244 ~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.......++...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 6555556677778899999999996 89999999999999999853
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=396.89 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=216.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s-~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
...|++.+.||+|+||+||+|.++.+|..||+|++........ ....+.+.+|+.+++.|+||||++++++|.+.. .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG--M 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--E
Confidence 3579999999999999999999999999999999975432211 113567889999999999999999999987654 7
Q ss_pred EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--CCcEEEeecc
Q 005916 104 VNIITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLG 177 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~g~vKL~DFG 177 (670)
+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999998877643 35899999999999999999999998 9999999999999732 3459999999
Q ss_pred chhhhcccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc--cc
Q 005916 178 LATIMEQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA--LS 252 (670)
Q Consensus 178 la~~~~~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~ 252 (670)
++....... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ ....++..+..+..... ..
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHH
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCcccc
Confidence 998775433 34578999999999774 5689999999999999999999999986 34566666666543222 22
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 4568999999999996 89999999999999999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=391.80 Aligned_cols=262 Identities=27% Similarity=0.385 Sum_probs=207.1
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
...-..|++.+.||+|+||+||+|.+..+|..||+|+++.... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH- 106 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETT-
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-
Confidence 3445579999999999999999999999999999999975432 2344566789999999999999999999987654
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC----CCCcEEEeecc
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING----NQGEVKIGDLG 177 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~----~~g~vKL~DFG 177 (670)
.+|+|||||. |+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||
T Consensus 107 -~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 107 -RLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp -EEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred -EEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 7999999997 599999999999999999999999999999999998 999999999999962 34569999999
Q ss_pred chhhhccc--ccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC--c-
Q 005916 178 LATIMEQA--NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--A- 250 (670)
Q Consensus 178 la~~~~~~--~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~--~- 250 (670)
++..+... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+......+.+.+.....+. .
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 99877543 2355678999999997743 589999999999999999999999988554444444332211110 0
Q ss_pred ------------------------ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCC
Q 005916 251 ------------------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 251 ------------------------~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~ 290 (670)
+....++++++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 111257899999999996 8999999999999999986543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=400.09 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=219.6
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEeCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK--HNNIIRFYNSWIDDQ 100 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~--HpNIVkl~~~~~d~~ 100 (670)
..++.|++.+.||+|+||+||+|.+.. |..||+|++..... .....+.+.+|+.+|+.|. |||||++++++....
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 356789999999999999999998765 99999999986542 4567788999999999996 599999999887654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+||| |.+++|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.
T Consensus 130 --~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~--~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 130 --YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIAN 202 (390)
T ss_dssp --EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES--SSCEEECCCSSSC
T ss_pred --EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE--CCeEEEEecCccc
Confidence 7999999 568899999999999999999999999999999999998 99999999999996 4799999999998
Q ss_pred hhcccc----cccccCCCccCCCccccC------------CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc
Q 005916 181 IMEQAN----AKSVIGTPEFMAPELYDE------------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS 244 (670)
Q Consensus 181 ~~~~~~----~~~~~GTp~YmAPEvl~~------------~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~ 244 (670)
.+.... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....+.......+..
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 765432 345789999999998743 6899999999999999999999999876666666666666
Q ss_pred CCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 245 GIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 245 g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+.....++...+..+++||.+||. +|.+|||+.++|+||||+..
T Consensus 283 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 555555666678899999999996 89999999999999999853
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=399.31 Aligned_cols=263 Identities=27% Similarity=0.365 Sum_probs=209.7
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC-
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN- 101 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~- 101 (670)
-..+.|++.+.||+|+||+||+|.+..+|..||+|++... .......+++.+|+.+|+.|+||||+++++++.....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 3456799999999999999999999999999999999742 3456677889999999999999999999999876532
Q ss_pred --CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 102 --KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 102 --~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
..+|+||||+. |+|.+++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kL~DFGla 176 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLA 176 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred cCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEEC-CCCCEEEccCCCc
Confidence 46999999995 599999998888999999999999999999999998 99999999999998 6789999999999
Q ss_pred hhhccc------------------------ccccccCCCccCCCccc--cCCCCccceeeeccchhhhhhhc--------
Q 005916 180 TIMEQA------------------------NAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVTF-------- 225 (670)
Q Consensus 180 ~~~~~~------------------------~~~~~~GTp~YmAPEvl--~~~ys~~~DIWSLGvilyeLltG-------- 225 (670)
...... .....+||+.|+|||++ ...|+.++|||||||++|+|++|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 876432 12567899999999964 45699999999999999999984
Q ss_pred ---cCCCCCCCC-----------------HHHHH-----------------------HHHhcCC--CCCc---ccCCCCh
Q 005916 226 ---EYPYSECRN-----------------SAQIY-----------------------KKVSSGI--KPAA---LSKVKDP 257 (670)
Q Consensus 226 ---~~Pf~~~~~-----------------~~~i~-----------------------~~i~~g~--~p~~---~~~~~s~ 257 (670)
.++|.+... ..++. +.+.... .+.. .....++
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 344433210 11111 1111110 0100 1134689
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhcCccccccCCC
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGTT 291 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~~ 291 (670)
++++||.+||. +|.+|||+.|+|+||||+...+.
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 99999999997 89999999999999999865443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=374.03 Aligned_cols=258 Identities=26% Similarity=0.460 Sum_probs=222.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.. ..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 80 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FH 80 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC--EE
Confidence 4569999999999999999999999999999999986543 4566788999999999999999999999986544 78
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--CCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~g~vKL~DFGla~~~ 182 (670)
++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||++...
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999999999998899999999999999999999999998 9999999999999732 345999999999776
Q ss_pred cccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCCChH
Q 005916 183 EQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPE 258 (670)
Q Consensus 183 ~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~s~~ 258 (670)
.... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+.......+..+.. +.......+++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 3kk8_A 159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPE 237 (284)
T ss_dssp CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccCHH
Confidence 5433 34578999999999764 5689999999999999999999999987 556666666666543 22233456899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
+++||.+||. +|.+|||+.++|+||||+...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999996 899999999999999997543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=387.13 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=208.7
Q ss_pred ccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 20 e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
..+.....|++.+.||+|+||+||+|.+. +|..||+|++..... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 44455678999999999999999999985 589999999975432 233457788999999999999999999998654
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
. .+++|||||.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 92 ~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~ 165 (311)
T 3niz_A 92 R--CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGL 165 (311)
T ss_dssp S--CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTT
T ss_pred C--EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEEC-CCCCEEEccCcC
Confidence 4 79999999975 788877665 45999999999999999999999998 99999999999998 668999999999
Q ss_pred hhhhccc--ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHh--cCCCCCcc-
Q 005916 179 ATIMEQA--NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS--SGIKPAAL- 251 (670)
Q Consensus 179 a~~~~~~--~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~--~g~~p~~~- 251 (670)
+...... ......||+.|+|||++. ..|+.++|||||||++|+|++|..||.+......+..... ....+..+
T Consensus 166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 9876533 234568999999999764 4689999999999999999999999987555444333222 11111111
Q ss_pred ------------------------cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 252 ------------------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 252 ------------------------~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
....++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 12346789999999997 8999999999999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=397.73 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=220.3
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
....++|++.+.||+|+||+||+|.++.+|..||+|.+.... ......+.+|+.+|+.|+||||++++++|.+..
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 121 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY- 121 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-
Confidence 334567999999999999999999999999999999987532 445667899999999999999999999987644
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC-CCCcEEEeeccch
Q 005916 102 KTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-NQGEVKIGDLGLA 179 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~-~~g~vKL~DFGla 179 (670)
.+++|||||.||+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||++
T Consensus 122 -~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 122 -EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp -EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred -EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccc
Confidence 7999999999999999987654 7999999999999999999999998 999999999999973 3578999999999
Q ss_pred hhhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCC
Q 005916 180 TIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVK 255 (670)
Q Consensus 180 ~~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~ 255 (670)
....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+.......+..... +.......
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 277 (387)
T 1kob_A 199 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSV 277 (387)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTS
T ss_pred eecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCccccccC
Confidence 8775433 34568999999999775 5689999999999999999999999987 455555566655432 22233456
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 278 s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 8999999999996 89999999999999999854
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=382.66 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=210.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~ 104 (670)
+.|++.++||+|+||+||+|.+..+|..||+|++.... .......+...|+..+..+ +||||++++++|.+.. .+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~--~~ 132 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG--IL 132 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC--CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc--cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC--EE
Confidence 57999999999999999999999999999999876432 2344555566666666655 9999999999987654 79
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
|+||||| +|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEECC
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeeecc
Confidence 9999999 77998887765 46999999999999999999999998 99999999999998 56899999999987765
Q ss_pred ccc-cccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 184 QAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 184 ~~~-~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
... .....||+.|+|||++.+.|+.++|||||||++|+|++|..||.. ...+..+..+..+..+....++++++|
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 209 TAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp ------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred cCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHHH
Confidence 433 345679999999999988999999999999999999999777654 233455666666666667788999999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
|.+||. +|.+|||+.++|+||||+.
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHcCCChhhCcCHHHHHhCccccC
Confidence 999996 8999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=407.88 Aligned_cols=260 Identities=22% Similarity=0.356 Sum_probs=198.3
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---C
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---N 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~---~ 101 (670)
...|++.++||+|+||+||+|+++.+|..||+|++... .......+++.+|+.+|+.|+|||||+++++|.... .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 36799999999999999999999999999999998642 334667788999999999999999999999986543 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|+||||+ +|+|.+++...+.+++..++.|+.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++.
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLART 205 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBC
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC-CCCCEeecccccchh
Confidence 4699999998 5799999998889999999999999999999999998 99999999999998 678999999999987
Q ss_pred hccc-----------------------------ccccccCCCccCCCccc--cCCCCccceeeeccchhhhhhh------
Q 005916 182 MEQA-----------------------------NAKSVIGTPEFMAPELY--DENYNELADIYSFGMCMLEMVT------ 224 (670)
Q Consensus 182 ~~~~-----------------------------~~~~~~GTp~YmAPEvl--~~~ys~~~DIWSLGvilyeLlt------ 224 (670)
.... .....+||+.|+|||++ ...|+.++||||||||+|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6421 12456889999999964 4569999999999999999999
Q ss_pred -----ccCCCCCCCC--------------------HHHHHHHH--hc--------------------C---CC---CCcc
Q 005916 225 -----FEYPYSECRN--------------------SAQIYKKV--SS--------------------G---IK---PAAL 251 (670)
Q Consensus 225 -----G~~Pf~~~~~--------------------~~~i~~~i--~~--------------------g---~~---p~~~ 251 (670)
|.++|.+... ..++...+ .. . .. ....
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 6777765321 11111100 00 0 00 0111
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCC
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~ 290 (670)
....++++++||.+||. ||.+|||+.|+|+||||+...+
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 22347899999999997 8999999999999999986543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=379.92 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=205.2
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.+ .+|..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--eEE
Confidence 3589999999999999999998 6799999999975432 1223456789999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+||||+.+ +|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGI 152 (288)
T ss_dssp EEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC
T ss_pred EEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEeECccccccCc
Confidence 99999975 999988764 67999999999999999999999998 99999999999998 678999999999987753
Q ss_pred c--ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-CC-CCC---------
Q 005916 185 A--NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI-KPA--------- 249 (670)
Q Consensus 185 ~--~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g~-~p~--------- 249 (670)
. ......||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+......+...+.. +. ...
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 2 234567899999999774 35899999999999999999999999875444433332221 00 000
Q ss_pred ---------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 250 ---------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 250 ---------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
......++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 1113467899999999996 8999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=391.25 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=206.8
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
...++|++.+.||+|+||+||+|.+..+++.||+|++.... ..+.+.+|+.+|+.|+||||++++++|.+..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 121 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-- 121 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSS--
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCC--
Confidence 34567999999999999999999999999999999987432 2456788999999999999999999987654
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeeccchh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLAT 180 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DFGla~ 180 (670)
.+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++.
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 79999999999999999998889999999999999999999999998 999999999999973 36899999999998
Q ss_pred hhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC--CcccCCCC
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKD 256 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~s 256 (670)
...... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||........++..+..+... ..+....+
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 765433 35678999999999775 469999999999999999999999998867777677777765432 23334568
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.++++||.+||. +|.+|||+.++|+||||+..
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 899999999996 89999999999999999743
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=389.37 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=199.5
Q ss_pred CeEEEE---EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCC
Q 005916 26 RYIRYK---EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQN 101 (670)
Q Consensus 26 r~yr~~---~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~ 101 (670)
..|.+. +.||+|+||+||+|.++.+|..||+|++... ....+.+|+.+++.+. ||||++++++|.+..
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~- 79 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL- 79 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Confidence 346664 7899999999999999999999999998742 2456778999999996 999999999987654
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC--CcEEEeeccch
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ--GEVKIGDLGLA 179 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~--g~vKL~DFGla 179 (670)
.+|+|||||.||+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++..+ ..+||+|||++
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 80 -HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp -EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred -EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 79999999999999999999999999999999999999999999998 99999999999998322 27999999999
Q ss_pred hhhcccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCC------CCHHHHHHHHhcCCCCCc
Q 005916 180 TIMEQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC------RNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 180 ~~~~~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~------~~~~~i~~~i~~g~~p~~ 250 (670)
....... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....+...+..+..+..
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 157 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp EECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred eecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 8664432 35678999999999774 56999999999999999999999999753 234566777777654322
Q ss_pred --ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 251 --LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 251 --~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
.....++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 223568999999999996 899999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=383.38 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=221.2
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s--~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
..++|++.+.||+|+||+||+|.++.+|..||+|.+........ ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 88 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT- 88 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 45679999999999999999999999999999999986543221 113567889999999999999999999987654
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC----cEEEeecc
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG----EVKIGDLG 177 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g----~vKL~DFG 177 (670)
.+++|||||.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|||
T Consensus 89 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~-~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 89 -DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLL-DKNIPIPHIKLIDFG 164 (321)
T ss_dssp -EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CTTSSSCCEEECCCT
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEe-cCCCCcCCEEEccCc
Confidence 79999999999999999998889999999999999999999999998 99999999999998 444 79999999
Q ss_pred chhhhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccC
Q 005916 178 LATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSK 253 (670)
Q Consensus 178 la~~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~ 253 (670)
++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .........+..... +.....
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHT
T ss_pred cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChhhhc
Confidence 998765432 35668999999999774 5789999999999999999999999987 455666666665543 222335
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
..++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 578899999999996 8999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=381.02 Aligned_cols=259 Identities=28% Similarity=0.384 Sum_probs=207.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccC-CHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEeCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ-SPEDLERLYSEVHLLKSL---KHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~-s~~~~e~l~~Ei~iLk~L---~HpNIVkl~~~~~d~~ 100 (670)
..+|++.+.||+|+||+||+|.+..+|..||+|++....... .......+.+|+.+++.+ +||||++++++|.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 467999999999999999999999999999999998643211 111123455677777766 5999999999987754
Q ss_pred CC---eEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEee
Q 005916 101 NK---TVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 175 (670)
Q Consensus 101 ~~---~~~lVmEy~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~D 175 (670)
.. .+++||||+. |+|.+++..... +++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEEC-TTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEEee
Confidence 32 5899999996 599999988754 999999999999999999999999 99999999999998 668999999
Q ss_pred ccchhhhcccc-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc--CCC-CCc
Q 005916 176 LGLATIMEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIK-PAA 250 (670)
Q Consensus 176 FGla~~~~~~~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~--g~~-p~~ 250 (670)
||++....... .....||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+.. .......+.. +.. ...
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-EADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-HHHHHHHHHHHHCCCCTTT
T ss_pred CccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhh
Confidence 99998775433 4567899999999976 5679999999999999999999999998744 4433333322 111 011
Q ss_pred ----------------------ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 251 ----------------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 251 ----------------------~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.....++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 112457899999999996 89999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=376.05 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=217.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
-..|++.+.||+|+||+||+|.+..++..||+|++..... ........+.+|+.+++.++||||++++++|.+.. .+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 84 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT--RV 84 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC--EE
Confidence 3569999999999999999999999999999999875321 11223466889999999999999999999987654 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEEC-TTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEc-CCCCEEEEeccccccCCc
Confidence 999999999999999998889999999999999999999999998 99999999999998 678999999999877665
Q ss_pred cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 185 ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 185 ~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
.......||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+....+..+..... .++...++.+++||
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 238 (279)
T 3fdn_A 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLI 238 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHH
T ss_pred ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHHH
Confidence 5556678999999999764 5688999999999999999999999987 566666666665432 34455789999999
Q ss_pred HHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 264 EKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 264 ~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
.+||. +|.+|||+.++|+||||+...
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHhccChhhCCCHHHHhhCccccCCc
Confidence 99996 899999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=381.86 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=208.0
Q ss_pred CeEEE-EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 26 RYIRY-KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 26 r~yr~-~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
..|++ .++||+|+||+||+|.+..+|..||+|++.... ....+++.+|+.+|+++ +||||+++++++.+.. .
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~--~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED--R 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--E
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--E
Confidence 34666 578999999999999999999999999997542 22356788999999995 8999999999987654 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC--CcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ--GEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~--g~vKL~DFGla~~ 181 (670)
+|+|||||.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+. +.+||+|||++..
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999999999999889999999999999999999999998 99999999999998332 2399999999876
Q ss_pred hccc---------ccccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCC------------
Q 005916 182 MEQA---------NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRN------------ 234 (670)
Q Consensus 182 ~~~~---------~~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~------------ 234 (670)
.... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 5321 123456999999999875 4589999999999999999999999976432
Q ss_pred --HHHHHHHHhcCCCCCc--ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 235 --SAQIYKKVSSGIKPAA--LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 235 --~~~i~~~i~~g~~p~~--~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...++..+..+..... .....++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2345666666543222 223467899999999996 89999999999999999854
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=378.34 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=219.5
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||+||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 80 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTT--H 80 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCC--E
Confidence 3467999999999999999999999999999999998543 223456889999999999999999999987644 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe--CCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~--~~~g~vKL~DFGla~~ 181 (670)
+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+. ..++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 9999999999999999998889999999999999999999999998 99999999999993 2567999999999987
Q ss_pred hcccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC--CcccCCCChH
Q 005916 182 MEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPE 258 (670)
Q Consensus 182 ~~~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~s~~ 258 (670)
..........||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .....+...+..+..+ .......++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 159 EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp CCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred cCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 6554455667999999999775 5689999999999999999999999987 5566677777766532 2334556899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+++||.+||. +|.+|||+.++|+||||+..
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999996 89999999999999999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=388.97 Aligned_cols=258 Identities=26% Similarity=0.467 Sum_probs=218.4
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
......|++.+.||+|+||+||+|.+..+|..||+|++.... .....+.+.+|+.+|+.++||||++++++|.+..
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 104 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG- 104 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-
Confidence 344667999999999999999999999999999999997542 4566788999999999999999999999987654
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||+. + |+||||||+|||++ .++.+||+|||++.
T Consensus 105 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 105 -EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSG 180 (360)
T ss_dssp -EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCH
T ss_pred -EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEEC-CCCCEEEEECCCCc
Confidence 7999999999999999999988999999999999999999999985 7 99999999999998 56899999999998
Q ss_pred hhcccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHH---------------------
Q 005916 181 IMEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI--------------------- 238 (670)
Q Consensus 181 ~~~~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i--------------------- 238 (670)
...........||+.|+|||++. ..|+.++|||||||++|+|++|..||... +...+
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC-CHHHHHHHHC----------------
T ss_pred ccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccCCCCCCCccc
Confidence 77665566778999999999764 56899999999999999999999999763 33222
Q ss_pred ---------------------HHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 239 ---------------------YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 239 ---------------------~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...+.....+.......+.++++||.+||. +|.+|||+.++|+||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 122222333333334567899999999996 89999999999999999854
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=385.55 Aligned_cols=253 Identities=28% Similarity=0.487 Sum_probs=197.2
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.++.+|..||+|.++.... ....+.+.+|+.+|+.|+||||+++++++.+. ..+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHTE--NKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--CeEE
Confidence 468899999999999999999999999999999986542 22345678899999999999999999998654 3799
Q ss_pred EEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 106 IITELFTSGSLRQYRKKH------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
+|||||. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLA 155 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCSSC
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEc-CCCCEEECcCccc
Confidence 9999997 5999988754 35999999999999999999999998 99999999999998 6689999999999
Q ss_pred hhhccc--ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc--CCCC-----
Q 005916 180 TIMEQA--NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIKP----- 248 (670)
Q Consensus 180 ~~~~~~--~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~--g~~p----- 248 (670)
...... ......||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.. .......+.. +..+
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-DEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCSCCTTTCG
T ss_pred eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhHhh
Confidence 876532 234568999999999774 368999999999999999999999998744 3333333321 1000
Q ss_pred -------------------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 -------------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 -------------------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 00112457899999999996 89999999999999999854
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=374.00 Aligned_cols=257 Identities=23% Similarity=0.404 Sum_probs=221.4
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
.-..|++.+.||+|+||+||+|.+..++..||+|++...... .....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 88 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK--R 88 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--E
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC--E
Confidence 345699999999999999999999999999999999753221 1122467889999999999999999999987644 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMG-YKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEc-CCCCEEEecccccccCc
Confidence 9999999999999999998889999999999999999999999998 99999999999998 66899999999987766
Q ss_pred ccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 184 QANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 184 ~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
........||+.|+|||++. ..++.++||||||+++|+|++|..||.. .........+..... .++...+..+++|
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 242 (284)
T 2vgo_A 166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDL--KFPPFLSDGSKDL 242 (284)
T ss_dssp SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHH
T ss_pred ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhcccc--CCCCcCCHHHHHH
Confidence 55556778999999999765 5689999999999999999999999987 455555666655432 2445578999999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
|.+||. +|.+|||+.++|+||||+...
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 999996 899999999999999998653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=377.55 Aligned_cols=257 Identities=21% Similarity=0.359 Sum_probs=209.2
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.+..+|..||+|++.... ......+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR--RLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecCC--eEE
Confidence 45899999999999999999999999999999986543 34555677889999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+|||||.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC--
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccCc
Confidence 99999999999999988889999999999999999999999998 99999999999998 6789999999999876532
Q ss_pred c--cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHh--cCC-------------
Q 005916 186 N--AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS--SGI------------- 246 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~--~g~------------- 246 (670)
. .....||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+............ ...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2 34568999999999774 4689999999999999999999999987544433332211 000
Q ss_pred -----CCC--c------ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 247 -----KPA--A------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 247 -----~p~--~------~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
.+. . .....++.+.+||.+||. +|.+|||+.++|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 000 0 012357789999999996 899999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=382.78 Aligned_cols=251 Identities=25% Similarity=0.449 Sum_probs=208.6
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC-----
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN----- 101 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~----- 101 (670)
.|++.+.||+|+||+||+|.++.+|..||+|+++... .....+.+.+|+.+|+.|+|||||+++++|.+...
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 5899999999999999999999999999999998543 24456789999999999999999999999876532
Q ss_pred --------------------------------------------------CeEEEEEecCCCCCHHHHHHhcCC---CCH
Q 005916 102 --------------------------------------------------KTVNIITELFTSGSLRQYRKKHKK---VDM 128 (670)
Q Consensus 102 --------------------------------------------------~~~~lVmEy~~gGsL~~~i~~~~~---lse 128 (670)
.++++|||||.||+|.+++..... .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 248999999999999999987654 566
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc--------------cccccCCC
Q 005916 129 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--------------AKSVIGTP 194 (670)
Q Consensus 129 ~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~--------------~~~~~GTp 194 (670)
..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....... .....||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 678999999999999999998 99999999999998 66899999999998765431 23457999
Q ss_pred ccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCC
Q 005916 195 EFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQ 272 (670)
Q Consensus 195 ~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~ 272 (670)
.|+|||++. ..|+.++|||||||++|+|++|..|+.. .......+.....+..+. ..++.+++||.+||. +|.+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFT-QKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHH-HHCHHHHHHHHHHHCSSGGG
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccc-cCChhHHHHHHHHccCCCCc
Confidence 999999764 5799999999999999999998777632 344455555554443322 345788999999996 8999
Q ss_pred CCCHHHHhcCccccc
Q 005916 273 RLSAKELLMDPFLQV 287 (670)
Q Consensus 273 RpSa~elL~hpf~~~ 287 (670)
|||+.++|+||||+.
T Consensus 317 Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 317 RPEATDIIENAIFEN 331 (332)
T ss_dssp SCCHHHHHHSTTCCC
T ss_pred CCCHHHHhhchhhhc
Confidence 999999999999973
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=387.47 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=211.1
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL-QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~-~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
.+.|++.+.||+|+||+||+|.+..++..||+|++...... ......+++.+|+.+|+.++||||++++++|.+.. .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ--Y 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC--e
Confidence 35699999999999999999999999999999999764321 13456778999999999999999999999987644 7
Q ss_pred EEEEEecCCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHh
Q 005916 104 VNIITELFTSGSLRQYRKK----------------------------------------HKKVDMKAVKGWARQILSGLI 143 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~----------------------------------------~~~lse~~i~~i~~QIl~aL~ 143 (670)
+++|||||.||+|.+++.. ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999998742 112468889999999999999
Q ss_pred hhhcCCCCeeeecCccccEEEeCC-CCcEEEeeccchhhhcccc------cccccCCCccCCCcccc---CCCCccceee
Q 005916 144 YLHSHDPPIIHRDLKCDNIFINGN-QGEVKIGDLGLATIMEQAN------AKSVIGTPEFMAPELYD---ENYNELADIY 213 (670)
Q Consensus 144 yLHs~g~~IIHrDLKpeNILl~~~-~g~vKL~DFGla~~~~~~~------~~~~~GTp~YmAPEvl~---~~ys~~~DIW 213 (670)
|||+++ |+||||||+|||++.+ .+.+||+|||++..+.... .....||+.|+|||++. ..|+.++|||
T Consensus 183 ~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 183 YLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 999998 9999999999999732 2389999999998664321 34567999999999774 5689999999
Q ss_pred eccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC--CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 214 SFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 214 SLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
||||++|+|++|..||.+.. .......+...... .......++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 261 slG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVN-DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 99999999999999998844 44444444444322 22233468999999999996 89999999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=409.39 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=222.3
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||+||+|.+..+|..||+|++...... .....+++.+|+.+|+.++||||+++++++.+.. .
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~ 90 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS--D 90 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--E
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--E
Confidence 345699999999999999999999999999999999754321 1223567899999999999999999999987654 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~-~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEe-cCCCeEEEeccchhhcc
Confidence 9999999999999999998889999999999999999999999998 99999999999998 66899999999998765
Q ss_pred ccc-cccccCCCccCCCccccCC-C-CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 184 QAN-AKSVIGTPEFMAPELYDEN-Y-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 184 ~~~-~~~~~GTp~YmAPEvl~~~-y-s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
... ..+.+||+.|+|||++.+. | +.++|||||||++|+|++|..||.+ .+...++..+..+... .+...+++++
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 244 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLNPSVI 244 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCCHHHH
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCCHHHH
Confidence 433 4567899999999987543 3 7899999999999999999999987 4556677777776532 3455789999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+||.+||. +|.+|||+.++++||||+..
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 99999996 89999999999999999753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=405.76 Aligned_cols=254 Identities=29% Similarity=0.410 Sum_probs=202.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----C
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----N 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~----~ 101 (670)
++|++.+.||+|+||+||+|++..+|+.||+|++... .......+++.+|+.+|+.++|||||+++++|.... .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG--GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc--ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 5688999999999999999999999999999999753 234566788999999999999999999999986543 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|+|||||.+ +|.+.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEeeee
Confidence 468999999976 5666654 35999999999999999999999998 99999999999998 678999999999987
Q ss_pred hcccc-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-----------
Q 005916 182 MEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP----------- 248 (670)
Q Consensus 182 ~~~~~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p----------- 248 (670)
..... ....+||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+.....++.+.+.....|
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 76543 4567899999999976 5579999999999999999999999998844443333322210000
Q ss_pred -------------Ccc----cC-----------CCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 249 -------------AAL----SK-----------VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 249 -------------~~~----~~-----------~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
..+ +. ..++++++||.+||. ||.+|||+.|+|+||||+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 000 00 014679999999997 8999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=402.99 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=210.7
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccC----CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ----SPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~----s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
..|++.+.||+|+||+||+|.+..+|..||+|++....... .......+.+|+.+|++|+|||||+++++|...
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-- 212 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 212 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS--
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 46899999999999999999999999999999998654321 122234578999999999999999999987432
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeeccch
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLA 179 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DFGla 179 (670)
.+|+|||||.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++
T Consensus 213 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 -DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccc
Confidence 58999999999999999988889999999999999999999999998 999999999999973 2346999999999
Q ss_pred hhhcccc-cccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC--ccc
Q 005916 180 TIMEQAN-AKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALS 252 (670)
Q Consensus 180 ~~~~~~~-~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~--~~~ 252 (670)
....... ....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||........+...+..+..+. ...
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 8875543 45678999999999873 5688999999999999999999999987555555666666655332 222
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 4568899999999996 89999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=391.86 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=207.3
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC---
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--- 99 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~--- 99 (670)
...+.|++.+.||+|+||+||+|.+..+|..||+|++...... ..+|+.+|+.|+|||||+++++|...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 3456799999999999999999999999999999998754322 23699999999999999999998653
Q ss_pred ---------------------------------CCCeEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHH
Q 005916 100 ---------------------------------QNKTVNIITELFTSGSLRQYRK----KHKKVDMKAVKGWARQILSGL 142 (670)
Q Consensus 100 ---------------------------------~~~~~~lVmEy~~gGsL~~~i~----~~~~lse~~i~~i~~QIl~aL 142 (670)
...++++|||||.+ +|.+.+. ..+.+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 23468999999974 7666544 457899999999999999999
Q ss_pred hhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-ccccccCCCccCCCccccC--CCCccceeeeccchh
Q 005916 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA-NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCM 219 (670)
Q Consensus 143 ~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~-~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvil 219 (670)
.|||+++ |+||||||+|||++..++.+||+|||++..+... ......||+.|+|||++.+ .|+.++|||||||++
T Consensus 155 ~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 155 GFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999998 9999999999999866789999999999876543 3456789999999997643 589999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHhcCCCC--------------------------CcccCCCChHHHHHHHHcCC-CCCC
Q 005916 220 LEMVTFEYPYSECRNSAQIYKKVSSGIKP--------------------------AALSKVKDPEVKSFIEKCLV-PASQ 272 (670)
Q Consensus 220 yeLltG~~Pf~~~~~~~~i~~~i~~g~~p--------------------------~~~~~~~s~~~k~fI~kcL~-dP~~ 272 (670)
|+|++|.+||.+.....++...+.....| ..++...++++++||.+||. +|.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999998855555544443211000 01233467889999999997 8999
Q ss_pred CCCHHHHhcCccccc
Q 005916 273 RLSAKELLMDPFLQV 287 (670)
Q Consensus 273 RpSa~elL~hpf~~~ 287 (670)
|||+.|+|+||||+.
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=386.95 Aligned_cols=252 Identities=30% Similarity=0.506 Sum_probs=216.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+.+|+.+|+.++||||++++++|.+.. .++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--eEE
Confidence 458999999999999999999999999999999975432 23455678999999999999999999999998754 799
Q ss_pred EEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+|||||. |+|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEeeccCceecCC
Confidence 9999997 57877765 4567999999999999999999999998 99999999999998 678999999999977643
Q ss_pred cccccccCCCccCCCccc----cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 185 ANAKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 185 ~~~~~~~GTp~YmAPEvl----~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
.....||+.|+|||++ .+.|+.++|||||||++|+|++|.+||........++ .+..+..+.......++.++
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~ 283 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFR 283 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCCCCCTTSCHHHH
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCCCCCCHHHH
Confidence 3457899999999976 4578999999999999999999999998754444444 44444445445556789999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+||.+||. +|.+|||+.++|+||||..
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 99999996 8999999999999999974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=369.95 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=218.2
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.+..+|..||+|++..... ....+.+.+|+.+++.++||||+++++++.+.. .+|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC--EEE
Confidence 469999999999999999999999999999999975442 345677899999999999999999999987654 789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||||+.+|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..+...
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEc-cCCCEEEeeCCCccccCCC
Confidence 99999999999999988888999999999999999999999998 99999999999998 6689999999999766432
Q ss_pred c----cccccCCCccCCCccccC-C-CCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 186 N----AKSVIGTPEFMAPELYDE-N-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 186 ~----~~~~~GTp~YmAPEvl~~-~-ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
. .....||+.|+|||++.+ . ++.++|||||||++|+|++|..||.........+..+.............++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHH
Confidence 2 345689999999998754 4 477899999999999999999999876555455555554433333334568999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++||.+||. +|.+|||+.++++||||+..
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 999999996 89999999999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=384.92 Aligned_cols=258 Identities=23% Similarity=0.300 Sum_probs=212.7
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-----CCCeee
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-----HNNIIR 91 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-----HpNIVk 91 (670)
.+.+.....+.|++.+.||+|+||+||+|.+..+|..||+|+++. .......+..|+.+++.+. |||||+
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 334444556789999999999999999999999999999999863 2455667788999999996 999999
Q ss_pred eeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC---
Q 005916 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--- 166 (670)
Q Consensus 92 l~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--- 166 (670)
++++|.... .+++||||| +++|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~--~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYD--HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETT--EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTC
T ss_pred ccceeeECC--eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccc
Confidence 999998754 799999999 999999998764 5999999999999999999999998 999999999999973
Q ss_pred ---------------------CCCcEEEeeccchhhhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh
Q 005916 167 ---------------------NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT 224 (670)
Q Consensus 167 ---------------------~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt 224 (670)
..+.+||+|||++..... ......||+.|+|||++ ...|+.++|||||||++|+|++
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 367899999999976543 23567899999999976 5579999999999999999999
Q ss_pred ccCCCCCCCCHHHHHHHHhcCCC--CC------------------------------------------cccCCCChHHH
Q 005916 225 FEYPYSECRNSAQIYKKVSSGIK--PA------------------------------------------ALSKVKDPEVK 260 (670)
Q Consensus 225 G~~Pf~~~~~~~~i~~~i~~g~~--p~------------------------------------------~~~~~~s~~~k 260 (670)
|..||... +.......+..... |. .+....++.+.
T Consensus 255 g~~pf~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 255 GSLLFRTH-EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp SSCSCCCS-SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred CCCCCCCC-cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 99999874 33333333322111 10 00112246788
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
+||.+||. +|.+|||+.|+|+||||+
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 99999996 899999999999999995
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=380.53 Aligned_cols=251 Identities=29% Similarity=0.523 Sum_probs=215.7
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|...+.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|.... .+++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE--ELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEE
Confidence 4788889999999999999999999999999997543 223567889999999999999999999998754 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
||||+.||+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 120 v~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp EECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSS
T ss_pred EEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCcEEEeeeeeeeecccCc
Confidence 9999999999998764 57999999999999999999999998 99999999999998 6689999999998776543
Q ss_pred -ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC-cccCCCChHHHHH
Q 005916 186 -NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVKDPEVKSF 262 (670)
Q Consensus 186 -~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~s~~~k~f 262 (670)
......||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+.......+.....+. ......++.+++|
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 274 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDF 274 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHHHHHH
T ss_pred cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHHHHHH
Confidence 235678999999999774 5689999999999999999999999987 45556666666554332 2234567899999
Q ss_pred HHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 263 IEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
|.+||. +|.+|||+.++|+||||+..
T Consensus 275 i~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 275 LERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHHccCChhhCcCHHHHhcChhhccC
Confidence 999996 89999999999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=370.55 Aligned_cols=263 Identities=29% Similarity=0.443 Sum_probs=226.4
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
+++......+.|++.+.||+|+||+||+|.+..++..||+|.+..... ......+.+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp SEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 444444567889999999999999999999999999999999975432 3456778899999999999999999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
.+.. .+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 85 ~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~df 159 (294)
T 2rku_A 85 EDND--FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDF 159 (294)
T ss_dssp ECSS--EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCC
T ss_pred ccCC--EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEc-CCCCEEEEec
Confidence 7544 79999999999999999998889999999999999999999999998 99999999999998 6789999999
Q ss_pred cchhhhccc--ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 177 GLATIMEQA--NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 177 Gla~~~~~~--~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
|++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.. ......+..+..... .++.
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~ 236 (294)
T 2rku_A 160 GLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPK 236 (294)
T ss_dssp TTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCT
T ss_pred cCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhccC--CCcc
Confidence 999876432 234567999999999764 4689999999999999999999999987 455556666655432 3445
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..++.++++|.+||. +|.+|||+.++|+||||+..
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 678999999999996 89999999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=389.80 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=207.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--- 101 (670)
.+.|++.+.||+|+||+||+|.+..+|..||+|++... .......+++.+|+.+|+.++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc--ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 45799999999999999999999999999999998643 2345667889999999999999999999999875432
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 -~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR 176 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc-CCCCEEEEeeeccc
Confidence 3579999999 8899999876 57999999999999999999999998 99999999999998 67899999999998
Q ss_pred hhcccccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-CCCC---------
Q 005916 181 IMEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKP--------- 248 (670)
Q Consensus 181 ~~~~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g~~p--------- 248 (670)
.... .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....++...+.. +..+
T Consensus 177 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 177 QADS-EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp ECCS-SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cccc-ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 7643 245678999999999764 47999999999999999999999999874443333322211 1100
Q ss_pred ---------------C---cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 ---------------A---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 ---------------~---~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
. .+....++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0 1123457899999999996 89999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=386.55 Aligned_cols=255 Identities=24% Similarity=0.462 Sum_probs=219.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCH----HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP----EDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~----~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~ 100 (670)
..|++.+.||+|+||+||+|.+..+|..||+|+++........ ...+.+.+|+.+++.+ +||||++++++|....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 4599999999999999999999999999999999865422222 2356788999999999 8999999999987644
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+||||+.||+|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.
T Consensus 174 --~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 174 --FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSC 248 (365)
T ss_dssp --EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCE
T ss_pred --EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEecCccc
Confidence 79999999999999999998889999999999999999999999998 99999999999998 67899999999998
Q ss_pred hhccc-ccccccCCCccCCCcccc-------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc--
Q 005916 181 IMEQA-NAKSVIGTPEFMAPELYD-------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA-- 250 (670)
Q Consensus 181 ~~~~~-~~~~~~GTp~YmAPEvl~-------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~-- 250 (670)
.+... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+.......+..+.....
T Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCHH
T ss_pred ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCc
Confidence 76543 345678999999999774 2588999999999999999999999987 455666666666554322
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
.....++.+++||.+||. +|.+|||+.++|+||||+
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 224567899999999996 899999999999999996
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=379.45 Aligned_cols=261 Identities=30% Similarity=0.441 Sum_probs=225.3
Q ss_pred cccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 19 ~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
.......+.|++.+.||+|+||+||+|.+..++..||+|++.... .......+.+.+|+.+++.++||||+++++++.+
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 112 (335)
T 2owb_A 34 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL-LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 112 (335)
T ss_dssp EEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhh-hcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 333445778999999999999999999999999999999998543 3345677889999999999999999999999876
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
.. .+|+|||||.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 113 ~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~ 187 (335)
T 2owb_A 113 ND--FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGL 187 (335)
T ss_dssp SS--EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTT
T ss_pred CC--eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEc-CCCCEEEeeccC
Confidence 44 79999999999999999998889999999999999999999999998 99999999999998 668999999999
Q ss_pred hhhhccc--ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCC
Q 005916 179 ATIMEQA--NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 179 a~~~~~~--~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
+...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.. ......+..+..... .++...
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~ 264 (335)
T 2owb_A 188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHI 264 (335)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTS
T ss_pred ceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCCC--CCCccC
Confidence 9876432 234567999999999774 5689999999999999999999999977 455555655655432 244567
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 265 ~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 265 NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 8999999999996 89999999999999999754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=414.34 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=223.1
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
.....|++.++||+|+||+||+|.++.+|..||+|++....... ......+.+|+.+|+.++|||||+++++|.+..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-- 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC--
Confidence 34567999999999999999999999999999999997643211 223456889999999999999999999987654
Q ss_pred eEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+|||||.||+|.+++...+. +++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld-~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEe-CCCCeEEEecccce
Confidence 79999999999999999987654 999999999999999999999998 99999999999998 67899999999998
Q ss_pred hhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCC---CHHHHHHHHhcCCCCCcccCCC
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
...... ....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.... ....++..+... +..++...
T Consensus 335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~ 412 (576)
T 2acx_A 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERF 412 (576)
T ss_dssp ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTS
T ss_pred ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccC
Confidence 775433 35678999999999775 469999999999999999999999997643 345666666654 33455667
Q ss_pred ChHHHHHHHHcCC-CCCCCC-----CHHHHhcCccccccCC
Q 005916 256 DPEVKSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
++++++||.+||. +|.+|| ++.++++||||+...|
T Consensus 413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 8999999999996 899999 8999999999987554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=377.80 Aligned_cols=262 Identities=27% Similarity=0.495 Sum_probs=213.7
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeE
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNS 95 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~ 95 (670)
.+.+.......|++.+.||+|+||+||+|.+..+|..||+|++.... ...+.+.+|+.+++.+ +||||++++++
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 33344445667899999999999999999999999999999987542 2245688999999999 89999999999
Q ss_pred EEeCC----CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC
Q 005916 96 WIDDQ----NKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG 169 (670)
Q Consensus 96 ~~d~~----~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g 169 (670)
|.... ...+|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~ 166 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENA 166 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTC
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc-CCC
Confidence 98743 45799999999999999999875 57999999999999999999999998 99999999999998 678
Q ss_pred cEEEeeccchhhhccc--ccccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHH
Q 005916 170 EVKIGDLGLATIMEQA--NAKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKK 241 (670)
Q Consensus 170 ~vKL~DFGla~~~~~~--~~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~ 241 (670)
.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.... .......
T Consensus 167 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~ 245 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFL 245 (326)
T ss_dssp CEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHH
T ss_pred CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHH
Confidence 9999999999876543 234568999999999773 468999999999999999999999998744 4444444
Q ss_pred HhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 242 VSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 242 i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+.....+.......++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 246 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 444444444455678999999999996 8999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=368.57 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=220.2
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccC-C----HHHHHHHHHHHHHHHhCC-CCCeeeeeeEE
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ-S----PEDLERLYSEVHLLKSLK-HNNIIRFYNSW 96 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~-s----~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~ 96 (670)
.....|++.+.||+|+||+||+|.++.+|..||+|++....... . ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34567999999999999999999999999999999997643211 1 234567889999999995 99999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
.+. ..+++||||+.+|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 94 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~df 168 (298)
T 1phk_A 94 ETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDF 168 (298)
T ss_dssp ECS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCC
T ss_pred ccC--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc-CCCcEEEecc
Confidence 654 479999999999999999998889999999999999999999999998 99999999999998 6789999999
Q ss_pred cchhhhccc-ccccccCCCccCCCcccc-------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 177 GLATIMEQA-NAKSVIGTPEFMAPELYD-------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 177 Gla~~~~~~-~~~~~~GTp~YmAPEvl~-------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
|++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+..+...
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC
T ss_pred cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCcc
Confidence 999876543 245668999999999763 4588999999999999999999999987 4555666666665432
Q ss_pred Cc--ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 AA--LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 ~~--~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.. .....+..+++||.+||. +|.+|||+.++|+||||+..
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 22 223467899999999996 89999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=393.93 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=202.1
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHh-CCCCCeeeeeeEEEe--CCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS-LKHNNIIRFYNSWID--DQN 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~-L~HpNIVkl~~~~~d--~~~ 101 (670)
++|+...++||+|+||+||+|.++.+|..||+|++... ..+.+|+.++.+ ++||||++++++|.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 44555558999999999999999999999999998632 346678888744 599999999998864 234
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--CCcEEEeecc
Q 005916 102 KTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLG 177 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~g~vKL~DFG 177 (670)
.++|+|||||.||+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.. ++.+||+|||
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecc
Confidence 47999999999999999998754 5999999999999999999999998 9999999999999842 6789999999
Q ss_pred chhhhccc-ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCH---HHHHHHHhcCCC--CCc
Q 005916 178 LATIMEQA-NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNS---AQIYKKVSSGIK--PAA 250 (670)
Q Consensus 178 la~~~~~~-~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~---~~i~~~i~~g~~--p~~ 250 (670)
++...... .....+||+.|+|||++ ...|+.++|||||||++|+|++|..||...... ......+..+.. +..
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 99876543 24567899999999987 457999999999999999999999999763321 123444544443 222
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.....++++++||.+||. +|.+|||+.++|+||||...
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 234568999999999996 89999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=370.69 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=202.7
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
.....|++.+.||+|+||+||+|.+..+|..||+|+++... ......+.+..+...++.++||||+++++++.+..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-- 79 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-- 79 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC--
Confidence 34567999999999999999999999999999999987542 22333444555556688889999999999987654
Q ss_pred eEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 103 TVNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.+++||||+. |+|.+++.. .+.+++..++.|+.||+.||.|||++ + |+||||||+|||++ .++.+||+|||
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg 155 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFG 155 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC-
T ss_pred CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecC
Confidence 6899999997 488776543 56899999999999999999999998 8 99999999999998 56899999999
Q ss_pred chhhhcccc-cccccCCCccCCCccc-----cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcc
Q 005916 178 LATIMEQAN-AKSVIGTPEFMAPELY-----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 251 (670)
Q Consensus 178 la~~~~~~~-~~~~~GTp~YmAPEvl-----~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~ 251 (670)
++....... .....||+.|+|||++ ...++.++|||||||++|+|++|..||..................+...
T Consensus 156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 235 (290)
T 3fme_A 156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP 235 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC
T ss_pred CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc
Confidence 998775543 3445799999999985 3468999999999999999999999998755665555555554444444
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
....++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 45678999999999997 89999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=420.17 Aligned_cols=273 Identities=21% Similarity=0.341 Sum_probs=231.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~ 104 (670)
..|++.++||+|+||+||+|.++.+|+.||+|+++..... .....+.+..|..+|..+ +||||++++.+|.+.. .+
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~--~~ 417 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RL 417 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS--EE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC--EE
Confidence 4589999999999999999999999999999999854321 123456788899999998 8999999999886544 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
||||||+.||+|.+++...+.+++..++.|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+++....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEEC-SSSCEEECCCTTCEECCC
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEc-CCCcEEEeecceeecccc
Confidence 999999999999999999899999999999999999999999998 99999999999998 678999999999986432
Q ss_pred --cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 185 --ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 185 --~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
....+.+||+.|||||++. ..|+.++|||||||++|||++|.+||.+ .+...++..|..+.. .++...++++++
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~ 571 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVA 571 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHHH
T ss_pred CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHH
Confidence 2356789999999999764 6799999999999999999999999987 677788888887643 345667899999
Q ss_pred HHHHcCC-CCCCCCCH-----HHHhcCccccccCCCCCCCCCCCCCcCCCcc
Q 005916 262 FIEKCLV-PASQRLSA-----KELLMDPFLQVNGTTKNRPLPLPDIVLPRVG 307 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa-----~elL~hpf~~~~~~~~~~~~~~~~~~~~~~~ 307 (670)
||.+||. +|.+||++ +++++||||+...|.........++..|...
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~ 623 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS 623 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC
T ss_pred HHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC
Confidence 9999996 89999997 9999999999766543322233344555544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=381.89 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=212.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc----CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL----QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~----~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
..|++.+.||+|+||+||+|.+..+|..||+|++...... ........+.+|+.+|+.|+||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 5699999999999999999999999999999999754321 1122345688999999999999999999988643
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--CCcEEEeeccch
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLA 179 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~g~vKL~DFGla 179 (670)
.+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||++
T Consensus 88 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp -SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred -ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 38999999999999999988889999999999999999999999998 9999999999999833 235999999999
Q ss_pred hhhcccc-cccccCCCccCCCccc----cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC--ccc
Q 005916 180 TIMEQAN-AKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA--ALS 252 (670)
Q Consensus 180 ~~~~~~~-~~~~~GTp~YmAPEvl----~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~--~~~ 252 (670)
....... .....||+.|+|||++ ...|+.++|||||||++|+|++|..||........+...+..+.... ...
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 8765432 3456799999999976 35689999999999999999999999987555445555555554322 223
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 4567899999999996 89999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=379.70 Aligned_cols=251 Identities=21% Similarity=0.350 Sum_probs=209.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~ 103 (670)
...|++.+.||+|+||+||+|.+..+|..||+|++.... .+.+.+|+.+|+.|+ ||||+++++++.+.....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 457999999999999999999999999999999986322 356889999999996 999999999998866678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+++||||+.+++|.+++. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+||+|||++....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999999998874 4899999999999999999999998 99999999999998554589999999998765
Q ss_pred cc-ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHh-------------cCCC
Q 005916 184 QA-NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS-------------SGIK 247 (670)
Q Consensus 184 ~~-~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~-------------~g~~ 247 (670)
.. ......||+.|+|||++. ..|+.++|||||||++|+|++|..||............+. ....
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 43 345678999999999764 4689999999999999999999999965444333222111 1100
Q ss_pred ----------------------CCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 248 ----------------------PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 248 ----------------------p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+.......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 011122268899999999996 8999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=389.36 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=211.6
Q ss_pred CCCeEEE--EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 24 TCRYIRY--KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 24 ~gr~yr~--~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
.+.+|++ .++||+|+||+||+|.+..+|..||+|+++... ....+.+.+|+.+|+.|+||||++++++|.+..
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 159 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKN- 159 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-
Confidence 3455666 578999999999999999999999999998543 355678999999999999999999999987654
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe-CCCCcEEEeeccch
Q 005916 102 KTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN-GNQGEVKIGDLGLA 179 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~-~~~g~vKL~DFGla 179 (670)
.+++|||||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+|||++
T Consensus 160 -~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 160 -DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp -EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred -EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 799999999999999988664 46999999999999999999999998 99999999999985 35578999999999
Q ss_pred hhhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCC
Q 005916 180 TIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVK 255 (670)
Q Consensus 180 ~~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~ 255 (670)
..+.... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+.......+..... +.......
T Consensus 237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 315 (373)
T 2x4f_A 237 RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG-DNDAETLNNILACRWDLEDEEFQDI 315 (373)
T ss_dssp EECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCSCSGGGTTS
T ss_pred eecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCChhhhccC
Confidence 8775433 34567999999999775 5689999999999999999999999987 445555555555432 22233456
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 8999999999996 89999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=389.64 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=215.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEc---CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~---~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~ 101 (670)
..|++.+.||+|+||+||+|.+. .+|..||+|+++...........+.+.+|+.+|+.+ +||||+++++++.+..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 132 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET- 132 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc-
Confidence 57999999999999999999984 589999999987543222222345567899999999 7999999999987654
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+|||||.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 133 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 -KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKE 208 (355)
T ss_dssp -EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEE
T ss_pred -eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCcEEEeeCCCCee
Confidence 79999999999999999998889999999999999999999999998 99999999999998 678999999999976
Q ss_pred hccc---ccccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCC---CCHHHHHHHHhcCCCCCccc
Q 005916 182 MEQA---NAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSEC---RNSAQIYKKVSSGIKPAALS 252 (670)
Q Consensus 182 ~~~~---~~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~---~~~~~i~~~i~~g~~p~~~~ 252 (670)
+... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+.+.+..... .++
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~ 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYP 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CCC
Confidence 5332 2345689999999998753 4789999999999999999999999642 234455555554432 344
Q ss_pred CCCChHHHHHHHHcCC-CCCCCC-----CHHHHhcCccccccCC
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
...++.+++||.+||. +|.+|| ++.++++||||+...+
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 5567899999999996 899999 9999999999986554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=380.34 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=215.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC--
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK-- 102 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~-- 102 (670)
.+.|++.+.||+|+||+||+|.+..+|..||+|++... .........++.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTT-TTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcc-ccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 45699999999999999999999999999999999753 334466778899999999999999999999998765432
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTSCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEc-CCCCEEEeeccCcccc
Confidence 56999999999999999998899999999999999999999999998 99999999999998 5689999999999876
Q ss_pred cccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC-cccCCC
Q 005916 183 EQAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA-ALSKVK 255 (670)
Q Consensus 183 ~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~ 255 (670)
.... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.......+..+.....+. ......
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 4422 23467999999999764 5789999999999999999999999988544444455554443322 233457
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++++++||.+||. +|.+||++.++|.|+|++..
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 8999999999996 89999999999999999854
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=372.30 Aligned_cols=254 Identities=29% Similarity=0.470 Sum_probs=210.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
.+.|++.+.||+|+||+||+|.+..+|..||+|++.... ....+++.+|+.+++.++||||+++++++.+.. .+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 91 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG--KL 91 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC--eE
Confidence 466899999999999999999999999999999987542 334677889999999999999999999987654 69
Q ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
++|||||.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTSCEEECCCHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEC-CCCCEEEEECCCCcccc
Confidence 999999999999998776 467999999999999999999999998 99999999999998 66899999999986543
Q ss_pred cc--ccccccCCCccCCCccc------cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-CcccCC
Q 005916 184 QA--NAKSVIGTPEFMAPELY------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKV 254 (670)
Q Consensus 184 ~~--~~~~~~GTp~YmAPEvl------~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~ 254 (670)
.. ......||+.|+|||++ ...++.++|||||||++|+|++|..||... +.......+..+..+ ...+..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLLTPSK 247 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSSGGG
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHhccCCcccCCccc
Confidence 32 23456899999999976 456899999999999999999999999874 444444444444333 233455
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+..+++||.+||. +|.+|||+.++++||||+..
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 68899999999996 89999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=368.24 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=220.5
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 4569999999999999999999999999999999986432 45667889999999999999999999999887666789
Q ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhcCC---CCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 105 NIITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHD---PPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g---~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~dfg 161 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFG 161 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCCC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecCc
Confidence 9999999999999998764 34999999999999999999999986 3499999999999998 66899999999
Q ss_pred chhhhcccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 178 LATIMEQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 178 la~~~~~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
++....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+...+...+..+..+ .++..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~ 239 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYR 239 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-CCCTT
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhcccc-cCCcc
Confidence 998765432 23467999999999764 5689999999999999999999999987 4566677777776543 34456
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.++++++||.+||. +|.+|||+.++|+|+|+...
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 78999999999996 89999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=378.04 Aligned_cols=256 Identities=20% Similarity=0.338 Sum_probs=211.9
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
..+++|++.++||+|+||+||+|.+..+|..||+|++...... ...+.+.+|+.+|+.++||||+++++++.+....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 4567899999999999999999999999999999999754432 2356678999999999999999999999877766
Q ss_pred eEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEE----eCCCCcEEEee
Q 005916 103 TVNIITELFTSGSLRQYRKKHKK---VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI----NGNQGEVKIGD 175 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~---lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl----~~~~g~vKL~D 175 (670)
.+++|||||.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||+ + ..+.+||+|
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~D 159 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTD 159 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTT-SCEEEEECC
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCC-CCceEEEcc
Confidence 89999999999999999987543 999999999999999999999998 9999999999998 4 456799999
Q ss_pred ccchhhhcccc-cccccCCCccCCCcccc---------CCCCccceeeeccchhhhhhhccCCCCCCCC---HHHHHHHH
Q 005916 176 LGLATIMEQAN-AKSVIGTPEFMAPELYD---------ENYNELADIYSFGMCMLEMVTFEYPYSECRN---SAQIYKKV 242 (670)
Q Consensus 176 FGla~~~~~~~-~~~~~GTp~YmAPEvl~---------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~---~~~i~~~i 242 (670)
||++....... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ...+...+
T Consensus 160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 99998765433 35678999999999763 5789999999999999999999999964332 23333344
Q ss_pred hcCCCCC-----------------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 243 SSGIKPA-----------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 243 ~~g~~p~-----------------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
..+..+. .+....++.+.+||.+||. ||.+|||+.|+|+||-
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 3332111 1112234578999999996 8999999999999984
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=367.94 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=216.3
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s--~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
+.|++.+.||+|+||+||+|.+..+|..||+|.+........ ....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT--D 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC--e
Confidence 569999999999999999999999999999999986543221 113567889999999999999999999987644 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCC----cEEEeeccch
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQG----EVKIGDLGLA 179 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g----~vKL~DFGla 179 (670)
+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|||++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLL-DKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES-CSSSSSCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEe-cCCCCCCceEEEecccc
Confidence 9999999999999999998889999999999999999999999998 99999999999998 334 7999999999
Q ss_pred hhhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCC
Q 005916 180 TIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVK 255 (670)
Q Consensus 180 ~~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~ 255 (670)
....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.. .........+..... +.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhcccC
Confidence 8765432 34567999999999775 5789999999999999999999999987 455566666655443 22233456
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 7899999999996 89999999999999999854
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=407.68 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=222.5
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
.....|++.++||+|+||+||+|+++.+|+.||+|++...... .....+.+.+|+.+|+.++||||++++++|.+..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-- 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT-- 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC--
Confidence 3456799999999999999999999999999999999754321 1223567889999999999999999999987654
Q ss_pred eEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 103 TVNIITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
.+|+|||||.||+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~-~~g~vkL~DFGl 335 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGL 335 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTT
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe-CCCCEEEeecce
Confidence 799999999999999998764 36999999999999999999999998 99999999999998 678999999999
Q ss_pred hhhhcccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCC---CHHHHHHHHhcCCCCCccc
Q 005916 179 ATIMEQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIKPAALS 252 (670)
Q Consensus 179 a~~~~~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~---~~~~i~~~i~~g~~p~~~~ 252 (670)
+..+.... ....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.... ....+++.+..... .++
T Consensus 336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p 413 (543)
T 3c4z_A 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYP 413 (543)
T ss_dssp CEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCC
T ss_pred eeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCC
Confidence 98765433 34568999999999764 579999999999999999999999997642 45667777766532 344
Q ss_pred CCCChHHHHHHHHcCC-CCCCCCC-----HHHHhcCccccccCCC
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRLS-----AKELLMDPFLQVNGTT 291 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~RpS-----a~elL~hpf~~~~~~~ 291 (670)
...++.+++||.+||. +|.+||+ +.++++||||+...|.
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 5678999999999996 8999995 5899999999876553
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.94 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=209.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~ 104 (670)
..|++.+.||+|+||+||+|.+..+|..||+|.+..... .......+.+|+.++..+ +||||++++++|.+.. .+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~--~~ 86 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD--HM 86 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT--EE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eE
Confidence 469999999999999999999999999999999885432 234567788999999999 9999999999987654 79
Q ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--------------
Q 005916 105 NIITELFTSGSLRQYRKKH----KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-------------- 166 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~-------------- 166 (670)
++|||||.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC---------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999999998765 67999999999999999999999998 999999999999972
Q ss_pred ----CCCcEEEeeccchhhhcccccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHH
Q 005916 167 ----NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240 (670)
Q Consensus 167 ----~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~ 240 (670)
..+.+||+|||++...... ....||+.|+|||++.+ .++.++|||||||++|+|++|.+|+... ..+.
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~ 238 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWH 238 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHH
T ss_pred cccCCceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHH
Confidence 2347999999999876543 34569999999998755 4567999999999999999999887542 2344
Q ss_pred HHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 241 KVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 241 ~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+..+..+ .++...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 239 EIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHTTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHcCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 45555443 3455678999999999996 89999999999999999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=382.10 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=201.3
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+|+.+|+.++||||+++++++.+.. .+++
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 77 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--SLTL 77 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS--CEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC--EEEE
Confidence 58999999999999999999999999999999875331 112224557999999999999999999987654 6999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||||. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIP 153 (324)
T ss_dssp EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEEC-TTCCEEECSSSEEECC---
T ss_pred Eecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEEC-CCCCEEEccCcccccccCC
Confidence 999997 5899888775 45999999999999999999999998 99999999999998 6689999999999765432
Q ss_pred --ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc---CCCCCcc-------
Q 005916 186 --NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---GIKPAAL------- 251 (670)
Q Consensus 186 --~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~---g~~p~~~------- 251 (670)
......||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.. .......+.. ...+..+
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-VEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHhchhhhcch
Confidence 234568899999999764 468999999999999999999999998744 3333333322 1111111
Q ss_pred ------------------cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCC
Q 005916 252 ------------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 252 ------------------~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~ 290 (670)
....++++++||.+||. +|.+|||+.|+|+||||.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 12357889999999997 8999999999999999986543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=367.68 Aligned_cols=256 Identities=23% Similarity=0.429 Sum_probs=211.8
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||+||+|.+..+|..||+|.+...... .....+++.+|+.+++.++||||+++++++.+.. .
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 85 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT--D 85 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--E
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--e
Confidence 345699999999999999999999999999999999753211 1223567889999999999999999999987644 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEEC-TTSCEEECCCCGGGCCC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEEC-CCCCEEEeecccccccC
Confidence 9999999999999999998889999999999999999999999998 99999999999998 66899999999998765
Q ss_pred ccc-cccccCCCccCCCccccCC-C-CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 184 QAN-AKSVIGTPEFMAPELYDEN-Y-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 184 ~~~-~~~~~GTp~YmAPEvl~~~-y-s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
... .....||+.|+|||++.+. + +.++||||||+++|+|++|..||.. .....++..+..+..+ ++...+..++
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~ 239 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVA 239 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHH
Confidence 432 3456799999999987653 3 6899999999999999999999977 5566677777665432 3455678999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++|.+||. +|.+|||+.++++||||+..
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 99999996 89999999999999999743
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=380.89 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=211.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
-..|++.+.||+|+||+||+|.+..+|..||+|++.... ......+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 99 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK--RW 99 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC--EE
Confidence 346999999999999999999999999999999987543 34555677889999999999999999999987654 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|+||||+.+++|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+..
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCTTC-----
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEc-CCCcEEEEeCCCceeecC
Confidence 999999999999998888888999999999999999999999998 99999999999998 668999999999987654
Q ss_pred c--ccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-C--------------
Q 005916 185 A--NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-G-------------- 245 (670)
Q Consensus 185 ~--~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g-------------- 245 (670)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+...+.. +
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 3 2345689999999997754 6899999999999999999999999885544444433221 0
Q ss_pred ----C-CCC--------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 246 ----I-KPA--------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 246 ----~-~p~--------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
. .+. ......++.+++||.+||. +|.+|||+.|+|+||||+..+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 0 000 0112357899999999996 899999999999999998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=391.67 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=207.1
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC---
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--- 99 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~--- 99 (670)
+....|++.++||+|+||+||+|++..+|..||+|++...... ..+|+++|+.|+|||||+++++|...
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~E~~il~~l~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh--------HHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence 3445799999999999999999999999999999998754321 23699999999999999999988653
Q ss_pred -CCCeEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 100 -QNKTVNIITELFTSGSLRQYRK----KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 100 -~~~~~~lVmEy~~gGsL~~~i~----~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
...++++||||+.+ +|.+.+. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.+.+.+||+
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEEC
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEec
Confidence 22357899999976 5655443 3578999999999999999999999998 99999999999999666789999
Q ss_pred eccchhhhccc-ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC-----
Q 005916 175 DLGLATIMEQA-NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI----- 246 (670)
Q Consensus 175 DFGla~~~~~~-~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~----- 246 (670)
|||+++.+... .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....++.+.+....
T Consensus 200 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 200 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp CCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99999876443 245678999999999764 3699999999999999999999999988554554444332100
Q ss_pred -------------CCC--------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 247 -------------KPA--------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 247 -------------~p~--------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+. .+....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 000 0123457899999999996 89999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=373.33 Aligned_cols=257 Identities=21% Similarity=0.430 Sum_probs=217.2
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|++.+.||+|+||.||+|.+..+|..||+|++............+.+.+|+.+++.++||||+++++++.+.....+|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 46889999999999999999999999999999998654332234567899999999999999999999998766666899
Q ss_pred EEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|||||.+| |.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-CCCcEEeeccccccccC
Confidence 999999876 7777765 357999999999999999999999998 99999999999998 66899999999997764
Q ss_pred cc----ccccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 184 QA----NAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 184 ~~----~~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+.. .++...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~~ 237 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDCG 237 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSSC
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCccC
Confidence 32 2345679999999998754 247899999999999999999999987 566677777766543 3445678
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
+.+.+||.+||. +|.+|||+.++++||||+...
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 999999999996 899999999999999998653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=369.96 Aligned_cols=257 Identities=30% Similarity=0.490 Sum_probs=222.4
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
.+.|++.+.||+|+||+||+|.+..+|..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 96 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSS--SF 96 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC--eE
Confidence 45799999999999999999999999999999999754322 234567889999999999999999999987644 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--CCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~g~vKL~DFGla~~~ 182 (670)
++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.. .+.+||+|||++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 999999999999999988889999999999999999999999998 9999999999999733 347999999999876
Q ss_pred cccc-cccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcc--cCCCChHH
Q 005916 183 EQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL--SKVKDPEV 259 (670)
Q Consensus 183 ~~~~-~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~--~~~~s~~~ 259 (670)
.... .....||+.|+|||++.+.++.++||||||+++|+|++|..||.. .+...+...+..+..+... ....++++
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 175 QQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred cCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 5432 345578999999999888899999999999999999999999987 5566677777776543332 24568999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++||.+||. +|.+|||+.++|+||||+..
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999996 89999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=381.06 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=208.2
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC-----
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----- 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~----- 100 (670)
..|++.+.||+|+||+||+|.+..+|..||+|++...... ......+.+|+.+|+.++||||+++++++.+..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 5699999999999999999999999999999998754322 223456778999999999999999999987653
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 101 -NKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 101 -~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
...+|+|||||.+ +|.+.+... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCCEEEccchh
Confidence 3478999999975 777766554 67999999999999999999999998 99999999999998 668999999999
Q ss_pred hhhhccc------ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc---CCC
Q 005916 179 ATIMEQA------NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---GIK 247 (670)
Q Consensus 179 a~~~~~~------~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~---g~~ 247 (670)
+..+... ......||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+. ........+.. ...
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSIT 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCC
Confidence 9876421 234567899999999774 45899999999999999999999999874 44433333322 111
Q ss_pred CCcccCC---------------------------CChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 248 PAALSKV---------------------------KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 248 p~~~~~~---------------------------~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+..++.. .++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 2211111 26789999999997 89999999999999999753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=380.34 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=212.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---C
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---N 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~---~ 101 (670)
+..|++.+.||+|+||+||+|.+..+|..||+|++... ......+++.+|+.+|+.++||||+++++++.... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 56799999999999999999999999999999998743 24566688999999999999999999999886543 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|+||||+. |+|.+++.. +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARV 177 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred ceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcceEe
Confidence 46899999996 599998876 46999999999999999999999998 99999999999998 678999999999987
Q ss_pred hcccc-----cccccCCCccCCCccc-c-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC------
Q 005916 182 MEQAN-----AKSVIGTPEFMAPELY-D-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP------ 248 (670)
Q Consensus 182 ~~~~~-----~~~~~GTp~YmAPEvl-~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p------ 248 (670)
..... ....+||+.|+|||++ . ..|+.++|||||||++|+|++|.+||.+......+...+.....+
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 65432 2456899999999975 3 458999999999999999999999998754443333222110000
Q ss_pred ----------------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 ----------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 ----------------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 01113457899999999996 89999999999999999854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=368.05 Aligned_cols=250 Identities=33% Similarity=0.534 Sum_probs=207.5
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEecC
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELF 111 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmEy~ 111 (670)
.+||+|+||+||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||++++++|.+.. .+++||||+
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 101 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--FIKIFMEQV 101 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEECC
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC--cEEEEEEeC
Confidence 38999999999999999999999999987543 344577889999999999999999999987654 799999999
Q ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc--
Q 005916 112 TSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-- 186 (670)
Q Consensus 112 ~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~-- 186 (670)
.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 9999999988752 4679999999999999999999998 99999999999998657899999999998765422
Q ss_pred cccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHH
Q 005916 187 AKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI 263 (670)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.....................++...++++++||
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 345689999999998743 38999999999999999999999997755544433322222223345566789999999
Q ss_pred HHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 264 EKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 264 ~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
.+||. +|.+|||+.++|+||||+...
T Consensus 260 ~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99996 899999999999999998553
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.95 Aligned_cols=258 Identities=32% Similarity=0.519 Sum_probs=210.5
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
.+.....|++.+.||+|+||+||+|.+ +|..||+|++.... ......+.+.+|+.+|++++||||+++++++.+..
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD--FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC--CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 344466799999999999999999976 68899999987543 24566788999999999999999999999986554
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKK---VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~---lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.+++|||||.+|+|.+++...+. +++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||+|||
T Consensus 108 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg 184 (309)
T 3p86_A 108 --NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFG 184 (309)
T ss_dssp --CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC
T ss_pred --ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCC
Confidence 68999999999999999987654 9999999999999999999999987899999999999998 66899999999
Q ss_pred chhhhcccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 178 LATIMEQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 178 la~~~~~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+.........+..
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRN 263 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTT
T ss_pred CCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCcc
Confidence 998654432 34578999999999764 5689999999999999999999999987 4556666656544445556677
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhc--Ccccc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLM--DPFLQ 286 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~--hpf~~ 286 (670)
.++++++||.+||. +|.+|||+.++++ +++++
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 88999999999996 8999999999998 46654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=368.03 Aligned_cols=255 Identities=28% Similarity=0.484 Sum_probs=193.2
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
-..|++.+.||+|+||+||+|.+..+|..||+|.+...... .....+++.+|+.+++.++||||+++++++.+.. .+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN--YV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS--EE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC--eE
Confidence 35699999999999999999999999999999999753221 1123467889999999999999999999987644 79
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
++||||+.+++|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEEeecceeecc
Confidence 9999999999999999876 67999999999999999999999998 99999999999998 66899999999998764
Q ss_pred cc--ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 184 QA--NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 184 ~~--~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|..||....... ....+... ....+...+++++
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~ 240 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-TLNKVVLA--DYEMPSFLSIEAK 240 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS--CCCCCTTSCHHHH
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-HHHHHhhc--ccCCccccCHHHH
Confidence 32 234567999999999774 568899999999999999999999997643322 22222221 1234455789999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+||.+||. +|.+|||+.++|+||||+..
T Consensus 241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 99999996 89999999999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=386.93 Aligned_cols=255 Identities=31% Similarity=0.426 Sum_probs=193.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----C
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----N 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~----~ 101 (670)
.+|++.+.||+|+||+||+|.+..+|..||+|++... ........++.+|+.+|+.|+||||++++++|.... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc--ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 5689999999999999999999999999999998643 234566788999999999999999999999986532 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|+|||++ +++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEeecccccc
Confidence 4689999999 7899988865 67999999999999999999999998 99999999999998 678999999999987
Q ss_pred hcccccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-CCC-----------
Q 005916 182 MEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIK----------- 247 (670)
Q Consensus 182 ~~~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g~~----------- 247 (670)
.... ....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....++...+.. +..
T Consensus 182 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 182 TADE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cccc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 6543 34578999999999764 47899999999999999999999999884443333222211 100
Q ss_pred -------------CCc---ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 248 -------------PAA---LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 248 -------------p~~---~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+.. .....++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 000 112357889999999997 89999999999999999854
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=382.40 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=210.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC----HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS----PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s----~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
+.|++.+.||+|+||+||+|.+..+|..||+|.+........ ....+++.+|+.+|+.++||||++++++|.+..
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~- 102 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG- 102 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC-
Confidence 469999999999999999999999999999999986543221 113345778999999999999999999987544
Q ss_pred CeEEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 KTVNIITELFTSG-SLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 ~~~~lVmEy~~gG-sL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 103 -~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 -FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIA-EDFTIKLIDFGSAA 178 (335)
T ss_dssp -EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred -EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEc-CCCcEEEeecccce
Confidence 799999999776 99999999999999999999999999999999998 99999999999998 56899999999998
Q ss_pred hhcccc-cccccCCCccCCCccccC-CC-CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELYDE-NY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl~~-~y-s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
...... ....+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... ... .....+...++
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~--~~~~~~~~~~~ 249 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVE--AAIHPPYLVSK 249 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTT--TCCCCSSCCCH
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHh--hccCCCcccCH
Confidence 775543 456789999999997743 44 7899999999999999999999976211 111 11223445689
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
++++||.+||. +|.+|||+.++|+||||+.
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 99999999996 8999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=376.26 Aligned_cols=258 Identities=22% Similarity=0.378 Sum_probs=212.1
Q ss_pred CeEEEE-EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 26 RYIRYK-EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 26 r~yr~~-~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
.+|.+. +.||+|+||+||+|.+..+|..||+|++..... .......+.+|+.+++.+ .||||++++++|.+.. .
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~--~ 103 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS--E 103 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--E
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC--e
Confidence 345555 899999999999999999999999999975432 233456788999999999 6799999999987544 7
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeeccch
Q 005916 104 VNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLA 179 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DFGla 179 (670)
+|+|||||.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||++
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 99999999999999988553 67999999999999999999999998 999999999999984 2579999999999
Q ss_pred hhhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC--CCCcccCCC
Q 005916 180 TIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--KPAALSKVK 255 (670)
Q Consensus 180 ~~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~--~p~~~~~~~ 255 (670)
....... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+....+..+.... .+.......
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 260 (327)
T 3lm5_A 182 RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG-EDNQETYLNISQVNVDYSEETFSSV 260 (327)
T ss_dssp EEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred cccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHhcccccCchhhccc
Confidence 8775432 35678999999999774 5789999999999999999999999987 44555555554433 233334456
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCC
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~ 290 (670)
++.+++||.+||. +|.+|||+.++|+||||+...+
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 8999999999996 8999999999999999986543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=379.86 Aligned_cols=260 Identities=22% Similarity=0.346 Sum_probs=204.0
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s-~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
....+.|++.+.||+|+||+||+|.+..+|..||+|++........ ......+.+|+.+++.++||||++++++|.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 3445679999999999999999999999999999999975432111 112346789999999999999999999986544
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 101 NKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
.+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 86 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 --NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLA 159 (346)
T ss_dssp --CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGG
T ss_pred --ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEc-CCCCEEEEecccc
Confidence 68999999976 888887765 46899999999999999999999998 99999999999998 6789999999999
Q ss_pred hhhcccc--cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc--CC-CCCcc-
Q 005916 180 TIMEQAN--AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GI-KPAAL- 251 (670)
Q Consensus 180 ~~~~~~~--~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~--g~-~p~~~- 251 (670)
..+.... ....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+... ...+..+.. +. .+..+
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSS
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcCCCChhhhh
Confidence 8775432 35578999999999774 3589999999999999999999999987443 333333322 11 11111
Q ss_pred ----------------------cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 252 ----------------------SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 252 ----------------------~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13346889999999996 89999999999999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=367.23 Aligned_cols=254 Identities=29% Similarity=0.526 Sum_probs=209.7
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||+||+|.+..+|..||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 98 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT--D 98 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT--E
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--E
Confidence 4567999999999999999999999999999999997532 2356889999999999999999999987654 7
Q ss_pred EEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 104 VNIITELFTSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
+|+||||+.+|+|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEEC-CCCCEEEeecccchhh
Confidence 999999999999999987 4568999999999999999999999998 99999999999998 5689999999999776
Q ss_pred cccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 183 EQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 183 ~~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.... .....||+.|+|||++. ..++.++|||||||++|+|++|..||........+.............+...+..+
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF 255 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHH
Confidence 5432 34568999999999764 56899999999999999999999999874444433333333222223345568899
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++||.+||. +|.+|||+.++|+||||+..
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 999999996 89999999999999999854
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=364.33 Aligned_cols=251 Identities=35% Similarity=0.519 Sum_probs=207.6
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC-----
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----- 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~----- 100 (670)
..|++.+.||+|+||+||+|.+..+|..||+|.+... ....+.+.+|+.+++.++||||++++++|.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 4589999999999999999999999999999999642 455678999999999999999999999987642
Q ss_pred ------CCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEE
Q 005916 101 ------NKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 173 (670)
Q Consensus 101 ------~~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL 173 (670)
...+|+|||||.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~kl 157 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKI 157 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEEE
Confidence 357899999999999999998654 5889999999999999999999998 99999999999998 6789999
Q ss_pred eeccchhhhccc----------------ccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCH
Q 005916 174 GDLGLATIMEQA----------------NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNS 235 (670)
Q Consensus 174 ~DFGla~~~~~~----------------~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~ 235 (670)
+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 999998765421 1245679999999998753 68999999999999999998 66543444
Q ss_pred HHHHHHHhcCC--CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 236 AQIYKKVSSGI--KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 236 ~~i~~~i~~g~--~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
..+...+.... .|..+....++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 55555555533 3444555667889999999996 8999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=367.99 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=206.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC-----
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD----- 99 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~----- 99 (670)
+..|++.+.||+|+||+||+|.+..+|+.||+|++... .....+++.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 56799999999999999999999999999999998753 356678899999999999999999999987432
Q ss_pred -------CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEE
Q 005916 100 -------QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 172 (670)
Q Consensus 100 -------~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vK 172 (670)
....+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+|
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEE
Confidence 2357899999997 699998864 67999999999999999999999998 999999999999986677999
Q ss_pred Eeeccchhhhccc-----ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC
Q 005916 173 IGDLGLATIMEQA-----NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 245 (670)
Q Consensus 173 L~DFGla~~~~~~-----~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g 245 (670)
|+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.. .......+...
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~~~~~~ 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-ELEQMQLILES 240 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHh
Confidence 9999999876432 234457899999999763 578999999999999999999999998744 33333333221
Q ss_pred CC------------------------C----CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 246 IK------------------------P----AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 246 ~~------------------------p----~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.. + .......++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 10 0 01123467899999999996 89999999999999999854
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=387.93 Aligned_cols=257 Identities=27% Similarity=0.386 Sum_probs=208.9
Q ss_pred ccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC------CCCCeeeee
Q 005916 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL------KHNNIIRFY 93 (670)
Q Consensus 20 e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L------~HpNIVkl~ 93 (670)
..+....+|++.++||+|+||+||+|.+..+|..||+|+++.. ......+.+|+.+++.+ .||||++++
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 3445567799999999999999999999999999999998742 34456778888888887 577999999
Q ss_pred eEEEeCCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc-
Q 005916 94 NSWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE- 170 (670)
Q Consensus 94 ~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~- 170 (670)
++|.... .+++||||+. |+|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 166 ~~~~~~~--~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~-~~~~~ 239 (429)
T 3kvw_A 166 ENFTFRN--HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLK-QQGRS 239 (429)
T ss_dssp EEEEETT--EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEES-STTSC
T ss_pred eecccCC--eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-cCCCc
Confidence 9987654 7999999995 69999988764 4999999999999999999999998 99999999999998 4455
Q ss_pred -EEEeeccchhhhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-CCC
Q 005916 171 -VKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIK 247 (670)
Q Consensus 171 -vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g~~ 247 (670)
+||+|||++..... .....+||+.|+|||++ ...|+.++|||||||++|+|++|.+||.+......+...+.. +..
T Consensus 240 ~vkL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQ-RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp CEEECCCTTCEETTC-CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceEEeecccceecCC-cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999999976543 34567899999999976 557999999999999999999999999875443333322211 000
Q ss_pred CC-------------------------------------------------------cccCCCChHHHHHHHHcCC-CCC
Q 005916 248 PA-------------------------------------------------------ALSKVKDPEVKSFIEKCLV-PAS 271 (670)
Q Consensus 248 p~-------------------------------------------------------~~~~~~s~~~k~fI~kcL~-dP~ 271 (670)
+. .+....++.+++||.+||. +|.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~ 398 (429)
T 3kvw_A 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398 (429)
T ss_dssp CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence 00 0112236889999999997 899
Q ss_pred CCCCHHHHhcCcccccc
Q 005916 272 QRLSAKELLMDPFLQVN 288 (670)
Q Consensus 272 ~RpSa~elL~hpf~~~~ 288 (670)
+|||+.|+|+||||+..
T Consensus 399 ~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 399 VRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TSCCHHHHHTSTTTC--
T ss_pred hCCCHHHHhCChhhccC
Confidence 99999999999999853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=383.68 Aligned_cols=255 Identities=26% Similarity=0.344 Sum_probs=205.1
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---- 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~---- 100 (670)
...|++.++||+|+||+||+|.+..++. ||+|++....... .+|+.+|+.|+||||++++++|....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~--------~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK--------NRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSC--------CHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchH--------HHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 4469999999999999999999887766 8888886543222 26999999999999999999986543
Q ss_pred CCeEEEEEecCCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 101 NKTVNIITELFTSGSLRQY---RKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~---i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
..++|+|||||.++.+... ......+++..++.|+.||+.||.|||+++ |+||||||+|||++..++.+||+|||
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 2358899999987544332 334578999999999999999999999998 99999999999998667899999999
Q ss_pred chhhhccc-ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC---------
Q 005916 178 LATIMEQA-NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--------- 245 (670)
Q Consensus 178 la~~~~~~-~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g--------- 245 (670)
+++.+... .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.....++...+...
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99876443 345678999999999764 359999999999999999999999998855444444333210
Q ss_pred ---------CCC--------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccCC
Q 005916 246 ---------IKP--------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNGT 290 (670)
Q Consensus 246 ---------~~p--------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~~ 290 (670)
..+ ..+....++++++||.+||. +|.+|||+.++|+||||+...+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 000 01223467899999999997 8999999999999999986443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=366.33 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=211.7
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
.+.+|++.+.||+|+||+||+|.+..+|..||+|.+.... .......+++.+|+.+++.++||||+++++++.+. ..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~ 85 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP-REKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED--DC 85 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS-SCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS--SE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc-cccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC--Ce
Confidence 3567999999999999999999999999999999997543 23466778899999999999999999999988654 47
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||.||+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILID-SNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCSSSTTC-
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEEeCCCccccc
Confidence 9999999999999999999999999999999999999999999998 99999999999998 66899999999998765
Q ss_pred ccc---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC--CcccCCCCh
Q 005916 184 QAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDP 257 (670)
Q Consensus 184 ~~~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~s~ 257 (670)
... .....||+.|+|||++ ...++.++|||||||++|+|++|..||.+........+.+.....+ .......++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 432 3456799999999976 4568999999999999999999999998854444444444433221 123455789
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
.+.++|.+||. +|.+||+..+.+.+.|..
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999999996 899999666666666654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=380.75 Aligned_cols=254 Identities=30% Similarity=0.431 Sum_probs=200.1
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--- 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--- 101 (670)
.+.|++.+.||+|+||+||+|.+..+|..||+|++.... ......+++.+|+.+++.++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 356999999999999999999999999999999997532 345667788999999999999999999999865432
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 -~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
..+|+|||||.+ +|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 175 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC--
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeeccc
Confidence 378999999965 7888875 46999999999999999999999998 99999999999998 67899999999998
Q ss_pred hhcccc-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC-CC--------
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PA-------- 249 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~-p~-------- 249 (670)
...... ....+||+.|+|||++ ...|+.++|||||||++|+|++|..||.+. +....+..+..... +.
T Consensus 176 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT-DHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 765432 3557899999999976 457999999999999999999999999874 44444444433211 00
Q ss_pred -----------c--------------cc------CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 250 -----------A--------------LS------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 250 -----------~--------------~~------~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
. ++ ...++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0 00 0014678999999996 8999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=367.13 Aligned_cols=262 Identities=24% Similarity=0.415 Sum_probs=218.1
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC--CCCeeeeee
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK--HNNIIRFYN 94 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~--HpNIVkl~~ 94 (670)
.+-.....++.|++.+.||+|+||+||+|.+. +|..||+|++.... ......+.+.+|+.+++.|. ||||+++++
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc--ccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 34445556888999999999999999999875 58899999997644 24567788999999999996 599999999
Q ss_pred EEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 95 SWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 95 ~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
++.+.. .+|+||| +.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+
T Consensus 96 ~~~~~~--~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~--~~~~kL~ 168 (313)
T 3cek_A 96 YEITDQ--YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLI 168 (313)
T ss_dssp EEECSS--EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEEC
T ss_pred EeecCC--EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE--CCeEEEe
Confidence 887654 7999999 568899999999999999999999999999999999998 99999999999997 3799999
Q ss_pred eccchhhhcccc----cccccCCCccCCCccccC------------CCCccceeeeccchhhhhhhccCCCCCCCCHHHH
Q 005916 175 DLGLATIMEQAN----AKSVIGTPEFMAPELYDE------------NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 238 (670)
Q Consensus 175 DFGla~~~~~~~----~~~~~GTp~YmAPEvl~~------------~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i 238 (670)
|||++..+.... .....||+.|+|||++.. .++.++|||||||++|+|++|..||.........
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence 999998765432 235679999999998753 6889999999999999999999999876666555
Q ss_pred HHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 239 YKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 239 ~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...+........++...+..+++||.+||. +|.+|||+.++|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 555655544445566678899999999996 89999999999999999743
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=370.00 Aligned_cols=261 Identities=27% Similarity=0.474 Sum_probs=193.2
Q ss_pred ccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 20 e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
........|++.+.||+|+||+||+|.+..+|..||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESS
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 344556779999999999999999999999999999998865432 33456788999999999999999999998765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcE
Q 005916 100 QNKTVNIITELFTSGSLRQYRKK--------HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 171 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~--------~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~v 171 (670)
. .+++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 86 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~ 160 (303)
T 2vwi_A 86 D--ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSV 160 (303)
T ss_dssp S--CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCE
T ss_pred C--CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEc-CCCCE
Confidence 5 68999999999999999874 456999999999999999999999998 99999999999998 66899
Q ss_pred EEeeccchhhhcccc-------cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHH
Q 005916 172 KIGDLGLATIMEQAN-------AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242 (670)
Q Consensus 172 KL~DFGla~~~~~~~-------~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i 242 (670)
||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||............+
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 240 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh
Confidence 999999998764321 23467999999999875 468999999999999999999999998755444444333
Q ss_pred hcCCCC-------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 243 SSGIKP-------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 243 ~~g~~p-------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...... .......++.+++||.+||. +|.+|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 322111 11224467899999999996 89999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=392.26 Aligned_cols=251 Identities=16% Similarity=0.175 Sum_probs=200.5
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHH---HHHHhCCCCCeeeee------
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEV---HLLKSLKHNNIIRFY------ 93 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei---~iLk~L~HpNIVkl~------ 93 (670)
...+.|++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+.+|+ ++|+.++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 345789999999999999999999999999999999986433 2345677899999 555556899999998
Q ss_pred -eEEEeCCC----------C-----eEEEEEecCCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHhhhhcCCC
Q 005916 94 -NSWIDDQN----------K-----TVNIITELFTSGSLRQYRKKHKKVDM-------KAVKGWARQILSGLIYLHSHDP 150 (670)
Q Consensus 94 -~~~~d~~~----------~-----~~~lVmEy~~gGsL~~~i~~~~~lse-------~~i~~i~~QIl~aL~yLHs~g~ 150 (670)
+++.+... . ..|+||||| +|+|.+++...+.+++ ..++.|+.||+.||.|||+++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 55543321 0 378999999 6899999987666666 888889999999999999998
Q ss_pred CeeeecCccccEEEeCCCCcEEEeeccchhhhcccccccccCCCccCCCccccC------------CCCccceeeeccch
Q 005916 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDE------------NYNELADIYSFGMC 218 (670)
Q Consensus 151 ~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~~------------~ys~~~DIWSLGvi 218 (670)
|+||||||+|||++ .+|.+||+|||++..... .....+| +.|+|||++.+ .|+.++|||||||+
T Consensus 227 -ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 -LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp -EECSCCCGGGEEEC-TTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred -eecCCCCHHHEEEc-CCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 99999999999998 668999999999986443 3456678 99999997743 59999999999999
Q ss_pred hhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 219 MLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 219 lyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+|+|++|..||.+.. .......+.. .....++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 303 l~elltg~~Pf~~~~-~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 303 IYWIWCADLPITKDA-ALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHSSCCC-------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHCCCCCcccc-cccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999999997632 1111111111 123467899999999996 8999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=369.98 Aligned_cols=258 Identities=27% Similarity=0.396 Sum_probs=210.0
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ--- 100 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~--- 100 (670)
....|++.+.||+|+||+||+|.+..+|..||+|++... .......++.+|+.+++.++||||+++++++....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 456799999999999999999999999999999998643 24566778889999999999999999999876432
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
...+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLAR 160 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-CCCcEEEEeccccc
Confidence 247899999996 599998876 57999999999999999999999998 99999999999998 66899999999997
Q ss_pred hhcccc------------cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-C
Q 005916 181 IMEQAN------------AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-G 245 (670)
Q Consensus 181 ~~~~~~------------~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g 245 (670)
...... ....+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+......+...... +
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 664321 22457899999999763 56899999999999999999999999874433332221110 0
Q ss_pred CC------------------------C----CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 246 IK------------------------P----AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 246 ~~------------------------p----~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
.. + .......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00 0 00113467899999999996 899999999999999998543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=376.74 Aligned_cols=259 Identities=21% Similarity=0.359 Sum_probs=219.2
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC-------------HHHHHHHHHHHHHHHhCCCCCe
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-------------PEDLERLYSEVHLLKSLKHNNI 89 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s-------------~~~~e~l~~Ei~iLk~L~HpNI 89 (670)
.....|++.+.||+|+||+||+|.+ +|..||+|.+........ ....+.+.+|+.+++.|+||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3346799999999999999999998 899999999985432211 0122778999999999999999
Q ss_pred eeeeeEEEeCCCCeEEEEEecCCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccc
Q 005916 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQY------RKK--HKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCD 160 (670)
Q Consensus 90 Vkl~~~~~d~~~~~~~lVmEy~~gGsL~~~------i~~--~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpe 160 (670)
+++++++.+.. .+|+||||+.+|+|.++ +.. ...+++..++.++.||+.||.|||+ ++ |+||||||+
T Consensus 106 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~ 181 (348)
T 2pml_X 106 LTCEGIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPS 181 (348)
T ss_dssp CCCSEEEESSS--EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGG
T ss_pred ceEEEEEeeCC--eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChH
Confidence 99999987654 79999999999999998 665 5789999999999999999999999 88 999999999
Q ss_pred cEEEeCCCCcEEEeeccchhhhcccccccccCCCccCCCccccC--CCCc-cceeeeccchhhhhhhccCCCCCCCCHHH
Q 005916 161 NIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDE--NYNE-LADIYSFGMCMLEMVTFEYPYSECRNSAQ 237 (670)
Q Consensus 161 NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~~--~ys~-~~DIWSLGvilyeLltG~~Pf~~~~~~~~ 237 (670)
|||++ .++.+||+|||++............||+.|+|||++.+ .++. ++|||||||++|+|++|..||........
T Consensus 182 Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 182 NILMD-KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp GEEEC-TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred hEEEc-CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 99998 66899999999998776555567789999999998754 4555 99999999999999999999988666577
Q ss_pred HHHHHhcCCCCCccc-----------------CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 238 IYKKVSSGIKPAALS-----------------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 238 i~~~i~~g~~p~~~~-----------------~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+...+..+..+.... ...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 777777664322211 4568999999999996 89999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=362.83 Aligned_cols=253 Identities=31% Similarity=0.510 Sum_probs=217.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.+..+|..||+|++..... ....+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--KL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--eE
Confidence 3558899999999999999999999999999999976542 234677899999999999999999999988654 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
++||||+.+++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECBT
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEEC-CCCCEEEeecccceecCc
Confidence 999999999999999865 57999999999999999999999998 99999999999998 668999999999977654
Q ss_pred cc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 185 AN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 185 ~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
.. .....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .........+..+.. ..+....+..+++
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 249 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKNNP-PTLEGNYSKPLKE 249 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCC-CCCCSSCCHHHHH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcCCC-CCCccccCHHHHH
Confidence 32 34568999999999764 5689999999999999999999999987 445555555555433 3355567899999
Q ss_pred HHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 262 FIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
||.+||. +|.+|||+.++|+||||...
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 9999996 89999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=384.60 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=190.9
Q ss_pred CeEEE-EEEecccCCeEEEEEEEc--CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRY-KEVIGKGAFKTVYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~-~~~LG~G~fG~Vy~a~d~--~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
..|.+ +++||+|+||+||+|.++ .++..||+|++..... ...+.+|+.+|+.|+|||||+++++|.+....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 44666 568999999999999966 5789999999874322 23577899999999999999999999887777
Q ss_pred eEEEEEecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe---CCCCc
Q 005916 103 TVNIITELFTSGSLRQYRKKH---------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN---GNQGE 170 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~---~~~g~ 170 (670)
.+|+||||+. |+|.+++..+ ..+++..++.|+.||+.||.|||+++ |+||||||+|||+. ...+.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTC
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCc
Confidence 8999999996 5888877532 24999999999999999999999998 99999999999994 25679
Q ss_pred EEEeeccchhhhccc-----ccccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCC---------
Q 005916 171 VKIGDLGLATIMEQA-----NAKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRN--------- 234 (670)
Q Consensus 171 vKL~DFGla~~~~~~-----~~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~--------- 234 (670)
+||+|||++..+... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999999876542 2345789999999997753 589999999999999999999999975322
Q ss_pred HHHHHHHHhc-CCC-CCccc---------------------------------CCCChHHHHHHHHcCC-CCCCCCCHHH
Q 005916 235 SAQIYKKVSS-GIK-PAALS---------------------------------KVKDPEVKSFIEKCLV-PASQRLSAKE 278 (670)
Q Consensus 235 ~~~i~~~i~~-g~~-p~~~~---------------------------------~~~s~~~k~fI~kcL~-dP~~RpSa~e 278 (670)
..++...+.. +.. ...+. ...++.+++||.+||. +|.+|||+.|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1222222211 110 01110 1126789999999997 8999999999
Q ss_pred HhcCcccccc
Q 005916 279 LLMDPFLQVN 288 (670)
Q Consensus 279 lL~hpf~~~~ 288 (670)
+|+||||+..
T Consensus 331 ~L~hp~f~~~ 340 (405)
T 3rgf_A 331 AMQDPYFLED 340 (405)
T ss_dssp HHTSGGGTSS
T ss_pred HhcChhhccC
Confidence 9999999854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=375.12 Aligned_cols=253 Identities=27% Similarity=0.386 Sum_probs=204.7
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC---
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK--- 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~--- 102 (670)
+.|++.+.||+|+||+||+|.+..+|..||+|++.... .......++.+|+.+++.++||||++++++|......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 56889999999999999999999999999999987432 3456678899999999999999999999998765431
Q ss_pred -eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 -TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 -~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+||||+. |+|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSTTCC--
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEecCcccc
Confidence 2489999997 68887763 45999999999999999999999998 99999999999998 678999999999986
Q ss_pred hcccccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-----------
Q 005916 182 MEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP----------- 248 (670)
Q Consensus 182 ~~~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p----------- 248 (670)
.... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+......+...+.....+
T Consensus 194 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 194 ADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred cccC-cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 6543 35578999999999764 478999999999999999999999998744333333222211000
Q ss_pred -----------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 249 -----------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 249 -----------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.......++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 01123457899999999997 8999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=371.62 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=194.4
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC----
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---- 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~---- 100 (670)
-..|++.+.||+|+||+||+|.+..+|..||+|++...... ..+..++++.++.++||||++++++|....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 34699999999999999999999999999999998654322 234567888899999999999999987533
Q ss_pred -CCeEEEEEecCCCCCHHHH----HHhcCCCCHHHHHHHHHHHHHHHhhhh--cCCCCeeeecCccccEEEeCCCCcEEE
Q 005916 101 -NKTVNIITELFTSGSLRQY----RKKHKKVDMKAVKGWARQILSGLIYLH--SHDPPIIHRDLKCDNIFINGNQGEVKI 173 (670)
Q Consensus 101 -~~~~~lVmEy~~gGsL~~~----i~~~~~lse~~i~~i~~QIl~aL~yLH--s~g~~IIHrDLKpeNILl~~~~g~vKL 173 (670)
..++++|||||.++ |... ......+++..++.++.||+.||.||| +++ |+||||||+|||++..++.+||
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEE
Confidence 22488999999874 4433 335678999999999999999999999 666 9999999999999955789999
Q ss_pred eeccchhhhcccc-cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC-
Q 005916 174 GDLGLATIMEQAN-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA- 249 (670)
Q Consensus 174 ~DFGla~~~~~~~-~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~- 249 (670)
+|||++..+.... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+......+...+.....+.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 9999998775543 34668999999999763 3489999999999999999999999988443333333222100000
Q ss_pred ----------------------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 250 ----------------------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 250 ----------------------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
......++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0011135789999999997 899999999999999998643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=374.37 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=214.5
Q ss_pred CCCCeEEEEEEecccCCeEEEEEE-----EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEE
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAF-----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSW 96 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~-----d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~ 96 (670)
...+.|++.+.||+|+||+||+|. +..+++.||+|+++.. ......+.+.+|+.+|+.| +|||||+++++|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 345779999999999999999998 5667899999999743 2355677899999999999 899999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcCC---------------------------------------------------
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHKK--------------------------------------------------- 125 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~~--------------------------------------------------- 125 (670)
.+.. ..+++|||||.+|+|.+++.....
T Consensus 96 ~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 96 TKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp CSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred ecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 7644 368999999999999999987543
Q ss_pred ---------------CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc----
Q 005916 126 ---------------VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---- 186 (670)
Q Consensus 126 ---------------lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~---- 186 (670)
+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+....
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCcEEEEeccceeeecccccchh
Confidence 899999999999999999999998 99999999999998 56899999999998664322
Q ss_pred cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 187 AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
.....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.+......+...+..+.. ...+...++++.++|.
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTML 330 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-CCCCCCCCHHHHHHHH
Confidence 3456789999999976 5679999999999999999998 99999886666666666666543 3345567899999999
Q ss_pred HcCC-CCCCCCCHHHHhcC
Q 005916 265 KCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 265 kcL~-dP~~RpSa~elL~h 282 (670)
+||. +|.+|||+.++++|
T Consensus 331 ~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHH
Confidence 9996 89999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=355.73 Aligned_cols=252 Identities=29% Similarity=0.437 Sum_probs=197.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.+. |..||+|+++...........+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 81 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP--NL 81 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----C
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC--ce
Confidence 457999999999999999999874 88999999876543333344677899999999999999999999986544 68
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCC-CeeeecCccccEEEeC-------CCCcEEEeec
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP-PIIHRDLKCDNIFING-------NQGEVKIGDL 176 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~-~IIHrDLKpeNILl~~-------~~g~vKL~DF 176 (670)
++||||+.+|+|.+++. .+.+++..++.++.||+.||.|||+++. +|+||||||+|||++. ..+.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999875 4679999999999999999999999873 3889999999999974 2678999999
Q ss_pred cchhhhcccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCC
Q 005916 177 GLATIMEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 177 Gla~~~~~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
|++............||+.|+|||++. ..++.++||||||+++|+|++|..||.+. +.......+.........+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCTTC
T ss_pred CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCccc
Confidence 999877665555678999999999764 56899999999999999999999999874 4444444444444445556677
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
++.+++||.+||. +|.+|||+.+++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 8999999999996 89999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=376.33 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=202.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC--------CCCeeeeeeEE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK--------HNNIIRFYNSW 96 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~--------HpNIVkl~~~~ 96 (670)
...|++.+.||+|+||+||+|++..+|+.||+|++... ....+.+.+|+.+|+.++ ||||++++++|
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 46799999999999999999999999999999998632 455678899999999995 78899999998
Q ss_pred EeC--CCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEEeCCC---
Q 005916 97 IDD--QNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQ--- 168 (670)
Q Consensus 97 ~d~--~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl~~~~--- 168 (670)
... ....+|+||||+ +|+|.+++... +.+++..++.|+.||+.||.|||++ + |+||||||+|||++.+.
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhh
Confidence 732 345799999999 66777766654 5699999999999999999999998 8 99999999999998332
Q ss_pred ---------------------------------------------CcEEEeeccchhhhcccccccccCCCccCCCccc-
Q 005916 169 ---------------------------------------------GEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY- 202 (670)
Q Consensus 169 ---------------------------------------------g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl- 202 (670)
..+||+|||++...... ....+||+.|+|||++
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhc
Confidence 27999999999876543 4556899999999976
Q ss_pred cCCCCccceeeeccchhhhhhhccCCCCCCCC-----HHHHHHHHhc--CCCCC--------------------------
Q 005916 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRN-----SAQIYKKVSS--GIKPA-------------------------- 249 (670)
Q Consensus 203 ~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~-----~~~i~~~i~~--g~~p~-------------------------- 249 (670)
...|+.++|||||||++|+|++|..||..... .......+.. +..|.
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 45699999999999999999999999975332 1111111111 11110
Q ss_pred ------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 250 ------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 250 ------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
.+....++.+++||.+||. +|.+|||+.|+|+||||+
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0111123578899999996 899999999999999996
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=356.44 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=210.2
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHH---HHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDL---ERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~---e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.....|++.+.||+|+||+||+|.+..++..||+|.+............ +++.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4457799999999999999999999999999999999765433332222 6789999999999999999999988543
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc-----EEE
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE-----VKI 173 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~-----vKL 173 (670)
. ++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++++|+||||||+|||++ .++. +||
T Consensus 96 ~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~-~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 P----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ-SLDENAPVCAKV 170 (287)
T ss_dssp T----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES-CCCTTCSCCEEE
T ss_pred C----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe-ccCCCCceeEEe
Confidence 2 6999999999999887655 479999999999999999999999987799999999999997 3444 999
Q ss_pred eeccchhhhcccccccccCCCccCCCcccc---CCCCccceeeeccchhhhhhhccCCCCCCCCHHH-HHHHHhcCCCCC
Q 005916 174 GDLGLATIMEQANAKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ-IYKKVSSGIKPA 249 (670)
Q Consensus 174 ~DFGla~~~~~~~~~~~~GTp~YmAPEvl~---~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~-i~~~i~~g~~p~ 249 (670)
+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||........ ....+.....+.
T Consensus 171 ~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 171 ADFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CCCTTCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCCCccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 99999975443 234578999999999873 3578999999999999999999999977544333 344444444445
Q ss_pred cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 250 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 250 ~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+...++.+++||.+||. +|.+|||+.++++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 5666778999999999996 8999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=367.98 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=206.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.++||+|+||+||+|.+..+|..||+|.+.. ......+.+.+|+.+|+.|+||||+++++++.+.. .+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~ 82 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--RL 82 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC--ee
Confidence 4569999999999999999999999999999998853 24667788999999999999999999999988654 79
Q ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
++|||||.+|+|.+++.. .+.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEEC-CCCCEEEeecccceecc
Confidence 999999999999999987 567999999999999999999999998 99999999999998 67899999999997664
Q ss_pred cccc----------------ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHH----HHHHH
Q 005916 184 QANA----------------KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ----IYKKV 242 (670)
Q Consensus 184 ~~~~----------------~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~----i~~~i 242 (670)
.... ...+||+.|+|||++. ..|+.++|||||||++|+|++|..||........ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 3221 1568999999999764 5689999999999999999999999865322110 01111
Q ss_pred hcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 243 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 243 ~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
.. ...+...++.+.++|.+||. +|.+|||+.++++ |++
T Consensus 240 ~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~ 278 (310)
T 3s95_A 240 LD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE 278 (310)
T ss_dssp HH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred cc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence 11 11234467889999999996 8999999999987 554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=371.28 Aligned_cols=262 Identities=21% Similarity=0.322 Sum_probs=185.0
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
........++|..+.++||+|+||+||+|.++.+|+.||+|++... .... ......++.+.||||++++++|
T Consensus 20 ~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~---~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKAR---QEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHH---HHHHHHHHHTTSTTBCCEEEEE
T ss_pred CCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHH---HHHHHHHHhcCCCChHHHHHHH
Confidence 3333333445444467899999999999999999999999998642 2222 2233446777999999999998
Q ss_pred EeC--CCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCc
Q 005916 97 IDD--QNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGE 170 (670)
Q Consensus 97 ~d~--~~~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~ 170 (670)
... .+..+++|||||.||+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++. ..+.
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCC
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCce
Confidence 652 2346899999999999999998764 6999999999999999999999998 999999999999973 2456
Q ss_pred EEEeeccchhhhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHH---HHHHHhcCC
Q 005916 171 VKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ---IYKKVSSGI 246 (670)
Q Consensus 171 vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~---i~~~i~~g~ 246 (670)
+||+|||++............||+.|+|||++ ...|+.++|||||||++|+|++|..||........ ....+..+.
T Consensus 170 ~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 170 LKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp EEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred EEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 99999999987766556677899999999977 45689999999999999999999999976332211 112222222
Q ss_pred --CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 247 --KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 247 --~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+.......++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 2222334568999999999996 89999999999999999854
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=372.24 Aligned_cols=259 Identities=23% Similarity=0.335 Sum_probs=201.9
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccc-------cCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV-------LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~-------~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
....|++.+.||+|+||+||+|.+.. |..||+|++..... .......+++.+|+.+|+.++||||++++++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34568999999999999999998765 99999999965332 12344567899999999999999999999998
Q ss_pred EeC---CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEE
Q 005916 97 IDD---QNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 172 (670)
Q Consensus 97 ~d~---~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vK 172 (670)
... ....+|+|||||. |+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~k 174 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA-DNNDIT 174 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEE
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc-CCCCEE
Confidence 653 3347899999997 5888877654 47999999999999999999999998 99999999999998 668999
Q ss_pred Eeeccchhhhcccc-cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-CCCC
Q 005916 173 IGDLGLATIMEQAN-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GIKP 248 (670)
Q Consensus 173 L~DFGla~~~~~~~-~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g~~p 248 (670)
|+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.. .......+.. ...+
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST-FYNQLNKIVEVVGTP 253 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCC
Confidence 99999997654432 34568999999999764 568999999999999999999999998744 3333332221 0000
Q ss_pred -----------------------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 -----------------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 -----------------------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.......++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 01123357889999999996 89999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=362.95 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=205.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEE-cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC------eeeeeeEEE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFD-EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN------IIRFYNSWI 97 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d-~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN------IVkl~~~~~ 97 (670)
...|++.+.||+|+||+||+|.+ ..+|..||+|+++.. ....+.+.+|+.+++.++|++ |++++++|.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 46799999999999999999998 568999999998632 455677889999999997654 999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--------
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN-------- 167 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~-------- 167 (670)
+.. .+++||||| +++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++..
T Consensus 88 ~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 88 HHG--HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp ETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC-
T ss_pred cCC--cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCC
Confidence 654 799999999 889999998775 6899999999999999999999998 9999999999999742
Q ss_pred ----------CCcEEEeeccchhhhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHH
Q 005916 168 ----------QGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSA 236 (670)
Q Consensus 168 ----------~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~ 236 (670)
++.+||+|||++..... ......||+.|+|||++ ...|+.++|||||||++|+|++|..||.... ..
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~ 240 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD-SK 240 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC-HH
T ss_pred ccccccccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-hH
Confidence 56799999999976543 23567899999999976 4579999999999999999999999998743 33
Q ss_pred HHHHHHhc--CCCCCc----------------------------------------ccCCCChHHHHHHHHcCC-CCCCC
Q 005916 237 QIYKKVSS--GIKPAA----------------------------------------LSKVKDPEVKSFIEKCLV-PASQR 273 (670)
Q Consensus 237 ~i~~~i~~--g~~p~~----------------------------------------~~~~~s~~~k~fI~kcL~-dP~~R 273 (670)
.....+.. +..|.. .....++.+++||.+||. +|.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 32222211 111100 011124678899999996 89999
Q ss_pred CCHHHHhcCcccccc
Q 005916 274 LSAKELLMDPFLQVN 288 (670)
Q Consensus 274 pSa~elL~hpf~~~~ 288 (670)
||+.|+|+||||+..
T Consensus 321 pt~~ell~hp~f~~~ 335 (339)
T 1z57_A 321 ITLREALKHPFFDLL 335 (339)
T ss_dssp CCHHHHTTSGGGGGG
T ss_pred cCHHHHhcCHHHHHH
Confidence 999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=379.12 Aligned_cols=258 Identities=15% Similarity=0.147 Sum_probs=192.2
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC--CCCCeeeee-------eE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL--KHNNIIRFY-------NS 95 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L--~HpNIVkl~-------~~ 95 (670)
.+.|++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+.+|+.+++.| +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 3459999999999999999999999999999999986532 2345667788886555555 699988765 44
Q ss_pred EEeCCC---------------CeEEEEEecCCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHhhhhcCCCCee
Q 005916 96 WIDDQN---------------KTVNIITELFTSGSLRQYRKKH-KKVDMKAV------KGWARQILSGLIYLHSHDPPII 153 (670)
Q Consensus 96 ~~d~~~---------------~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i------~~i~~QIl~aL~yLHs~g~~II 153 (670)
+..... ..+|+|||||. |+|.+++... ..+.+... ..++.||+.||.|||+++ |+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--iv 216 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LV 216 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Cc
Confidence 433221 35899999998 8999998874 33455555 577799999999999998 99
Q ss_pred eecCccccEEEeCCCCcEEEeeccchhhhcccccccccCCCccCCCcccc---CCCCccceeeeccchhhhhhhccCCCC
Q 005916 154 HRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYS 230 (670)
Q Consensus 154 HrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~---~~ys~~~DIWSLGvilyeLltG~~Pf~ 230 (670)
||||||+|||++ .+|.+||+|||++....... ....||+.|+|||++. ..|+.++|||||||++|+|++|..||.
T Consensus 217 HrDikp~NIll~-~~~~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 217 HGHFTPDNLFIM-PDGRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp ETTCSGGGEEEC-TTSCEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCcCCHHHEEEC-CCCCEEEEecceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999998 67899999999998765432 2456779999999875 469999999999999999999999997
Q ss_pred CCCCHH-HHHHH---HhcCC--CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 231 ECRNSA-QIYKK---VSSGI--KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 231 ~~~~~~-~i~~~---i~~g~--~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+..... ..+.. ..... .........++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 742211 00000 00111 1111223568999999999996 89999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=367.98 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=204.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---- 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~---- 101 (670)
+.|++.+.||+|+||+||+|.+..+|..||+|++.... .......++.+|+.+++.++||||+++++++.+...
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 56899999999999999999999999999999987432 345567789999999999999999999999876542
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|+||||+. |+|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTCCEEECSTTCTTC
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC-CCCcEEEeecccccC
Confidence 13589999997 58887764 35999999999999999999999998 99999999999998 678999999999987
Q ss_pred hcccccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc--CCC----------
Q 005916 182 MEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIK---------- 247 (670)
Q Consensus 182 ~~~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~--g~~---------- 247 (670)
.... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+...... ...+.. +..
T Consensus 176 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 176 ADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHTTCSC
T ss_pred CCCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHHhh
Confidence 5432 34568999999999764 4689999999999999999999999987443333 222211 000
Q ss_pred --------------C---CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 248 --------------P---AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 248 --------------p---~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
. .......++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 11223457899999999996 89999999999999999743
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=372.59 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=205.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CC-----CeeeeeeEEEe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HN-----NIIRFYNSWID 98 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-Hp-----NIVkl~~~~~d 98 (670)
...|++.+.||+|+||+||+|.+..+|..||+|+++.. ......+..|+.+++.+. |+ +|++++++|..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 45799999999999999999999999999999998742 345667788999999884 55 49999999876
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC-CCCcEEEee
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-NQGEVKIGD 175 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~-~~g~vKL~D 175 (670)
.. .+|+||||+. |+|.+++... +.+++..++.++.||+.||.|||++..+|+||||||+|||++. ..+.+||+|
T Consensus 128 ~~--~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 RN--HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TT--EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CC--ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 54 7999999995 5999998876 4699999999999999999999975445999999999999962 467899999
Q ss_pred ccchhhhcccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc--CCCCCcc-
Q 005916 176 LGLATIMEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--GIKPAAL- 251 (670)
Q Consensus 176 FGla~~~~~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~--g~~p~~~- 251 (670)
||++...... ....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.. .......+.. +..+..+
T Consensus 205 FG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 205 FGSSCQLGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN-EVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CTTCEETTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCCHHHH
T ss_pred ccCceecccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHH
Confidence 9999876542 45678999999999764 579999999999999999999999998744 3333333322 1110000
Q ss_pred --------------------------------cCC---------------------------CChHHHHHHHHcCC-CCC
Q 005916 252 --------------------------------SKV---------------------------KDPEVKSFIEKCLV-PAS 271 (670)
Q Consensus 252 --------------------------------~~~---------------------------~s~~~k~fI~kcL~-dP~ 271 (670)
+.. ..+++++||.+||. ||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 000 01378999999996 899
Q ss_pred CCCCHHHHhcCcccccc
Q 005916 272 QRLSAKELLMDPFLQVN 288 (670)
Q Consensus 272 ~RpSa~elL~hpf~~~~ 288 (670)
+|||+.|+|+||||+..
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=372.72 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=211.8
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEc-------CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeE
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDE-------VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNS 95 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~-------~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~ 95 (670)
..+.|++.+.||+|+||+||+|.+. .++..||+|+++.. ......+++.+|+.+|+.+ +||||++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT---CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC---cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3467999999999999999999874 45678999998743 2356678899999999999 89999999998
Q ss_pred EEeCCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCcc
Q 005916 96 WIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 159 (670)
Q Consensus 96 ~~d~~~~~~~lVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKp 159 (670)
|.+.. .+|+|||||.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 156 ~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 156 CTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp ECSSS--SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred EccCC--CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 86544 6899999999999999998754 4799999999999999999999998 99999999
Q ss_pred ccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCC
Q 005916 160 DNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECR 233 (670)
Q Consensus 160 eNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~ 233 (670)
+|||++ .+|.+||+|||++....... .....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.+ .
T Consensus 232 ~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~ 309 (370)
T 2psq_A 232 RNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-I 309 (370)
T ss_dssp GGEEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-C
T ss_pred hhEEEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-C
Confidence 999998 67899999999998665422 2345678999999966 5679999999999999999999 9999987 4
Q ss_pred CHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 234 NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 234 ~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
....++..+..+..+ ..+...++++++||.+||. +|.+|||+.+++++
T Consensus 310 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566677777766543 3445678899999999996 89999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=360.13 Aligned_cols=258 Identities=29% Similarity=0.402 Sum_probs=207.3
Q ss_pred CCeEEEEEEecccCCeEEEEEEEc-CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEe--
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDE-VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWID-- 98 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~-~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L---~HpNIVkl~~~~~d-- 98 (670)
.+.|++.+.||+|+||+||+|.+. .+|..||+|++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc--ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 467999999999999999999995 78999999999864321 11122355677776666 89999999998863
Q ss_pred -CCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEee
Q 005916 99 -DQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 175 (670)
Q Consensus 99 -~~~~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~D 175 (670)
.....+++||||+. |+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~-~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc-CCCCEEEec
Confidence 23357899999997 69999988754 4999999999999999999999998 99999999999998 678999999
Q ss_pred ccchhhhccc-ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC-CCC----
Q 005916 176 LGLATIMEQA-NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IKP---- 248 (670)
Q Consensus 176 FGla~~~~~~-~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g-~~p---- 248 (670)
||++...... ......||+.|+|||++ ...++.++|||||||++|+|++|.+||.+..... ....+... ..+
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGG
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCccc
Confidence 9999876543 24567899999999976 4578999999999999999999999998744433 33333210 000
Q ss_pred --------------------CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 249 --------------------AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 249 --------------------~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
..+....++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 11223467899999999996 899999999999999997543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=350.88 Aligned_cols=248 Identities=18% Similarity=0.293 Sum_probs=209.4
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
-..|++.+.||+|+||+||+|.+. |..||+|++.... ......+.+.+|+.+++.++||||+++++++.+.....+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 456899999999999999999874 8899999997643 345667789999999999999999999999987655688
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
++||||+.+|+|.+++...+ .+++..++.|+.||+.||.|||+++++|+||||||+|||++ .++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSF 163 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCTT
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccceeee
Confidence 99999999999999998765 48999999999999999999999988899999999999998 6789999998886543
Q ss_pred cccccccccCCCccCCCccccC-C---CCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 183 EQANAKSVIGTPEFMAPELYDE-N---YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 183 ~~~~~~~~~GTp~YmAPEvl~~-~---ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
. .....||+.|+|||++.+ . ++.++|||||||++|+|++|..||.... .......+.........+...++.
T Consensus 164 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 164 Q---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp S---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred c---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2 245678999999998753 2 3447999999999999999999998744 444444444433344456677899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+.++|.+||. +|.+|||+.++++
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999996 8999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=373.49 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=214.2
Q ss_pred CCCeEEEEEEecccCCeEEEEEE-----EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAF-----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~-----d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
..+.|++.+.||+|+||+||+|. +..++..||+|.+... .......++.+|+.+++.++|||||++++++.+
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 35679999999999999999999 5567889999998632 235566778999999999999999999999865
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCC
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKHK-------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQG 169 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~~-------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g 169 (670)
.. ..|+|||||.||+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++. ...
T Consensus 146 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 146 SL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp SS--SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTC
T ss_pred CC--CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCc
Confidence 44 5799999999999999998753 5899999999999999999999998 999999999999982 233
Q ss_pred cEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHh
Q 005916 170 EVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVS 243 (670)
Q Consensus 170 ~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~ 243 (670)
.+||+|||++..+.... .....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.. .....+...+.
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~i~ 300 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVT 300 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHH
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 59999999998764322 3456789999999976 5679999999999999999998 9999987 56677777777
Q ss_pred cCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 244 SGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 244 ~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.+..+. .+...++.+.+||.+||. +|.+|||+.+++++.++..
T Consensus 301 ~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCC-CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 765433 345567899999999996 8999999999999987753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=359.61 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=213.6
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEE-----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d-----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
+...+.|++.+.||+|+||+||+|.+ ..++..||+|.+... ......+.+.+|+.+|+.|+||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 44567899999999999999999988 356689999998743 2466778899999999999999999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHhhhhcCCCCe
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHKK------------------------VDMKAVKGWARQILSGLIYLHSHDPPI 152 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~~------------------------lse~~i~~i~~QIl~aL~yLHs~g~~I 152 (670)
.+.. .+++|||||.+|+|.+++...+. +++..++.++.||+.||.|||+++ |
T Consensus 96 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i 171 (314)
T 2ivs_A 96 SQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--L 171 (314)
T ss_dssp CSSS--SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred ecCC--ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--C
Confidence 6544 68999999999999999987643 899999999999999999999998 9
Q ss_pred eeecCccccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-cc
Q 005916 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FE 226 (670)
Q Consensus 153 IHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~ 226 (670)
+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++ |.
T Consensus 172 vH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 172 VHRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp ECCCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cccccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999998 67899999999997664322 2345678999999976 4568999999999999999999 99
Q ss_pred CCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 227 YPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 227 ~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.||.+ .....++..+..+..+ ..+...++.++++|.+||. +|.+|||+.+++++
T Consensus 251 ~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 251 NPYPG-IPPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCC-CCHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99987 4556666666665433 3445678999999999996 89999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=364.53 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=210.0
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCe---EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~---~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
......|++.+.||+|+||+||+|.+..+|. .||+|.++.. ......+.+.+|+.+|+.|+||||++++++|.+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG---YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3445689999999999999999999986554 5999998743 245667789999999999999999999999865
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.. .+|+|||||.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 122 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg 196 (325)
T 3kul_A 122 GR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVD-SNLVCKVSDFG 196 (325)
T ss_dssp GG--CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCS
T ss_pred CC--ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEC-CCCCEEECCCC
Confidence 44 689999999999999999765 67999999999999999999999998 99999999999998 67899999999
Q ss_pred chhhhcccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCc
Q 005916 178 LATIMEQAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 178 la~~~~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 250 (670)
++....... .....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.. .....+...+..+..+ .
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~ 274 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRL-P 274 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-C
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCC-C
Confidence 998765432 22345688999999775 678999999999999999999 9999987 5566666767666432 3
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+...++.+.+||.+||. +|.+|||+.++++
T Consensus 275 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 445678999999999996 8999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=363.20 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=195.6
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCe---EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~---~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
....+.|++.+.||+|+||+||+|.+..++. .||+|.++.... .....+++.+|+.+++.++||||+++++++.+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3445679999999999999999999887775 899999875432 24557889999999999999999999999876
Q ss_pred CCCC----eEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC
Q 005916 99 DQNK----TVNIITELFTSGSLRQYRKKHK------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 168 (670)
Q Consensus 99 ~~~~----~~~lVmEy~~gGsL~~~i~~~~------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~ 168 (670)
.... .+++|||||.+|+|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~-~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA-ED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc-CC
Confidence 5431 2489999999999999986543 5999999999999999999999998 99999999999998 66
Q ss_pred CcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHH
Q 005916 169 GEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKV 242 (670)
Q Consensus 169 g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i 242 (670)
+.+||+|||++....... .....||+.|+|||++ ...|+.++|||||||++|+|++ |.+||.+ .....++..+
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~ 252 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG-IENAEIYNYL 252 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc-cChHHHHHHH
Confidence 899999999998764432 2344578899999976 4568999999999999999999 8999987 4455566666
Q ss_pred hcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCC-------HHHHhcCcccccc
Q 005916 243 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLS-------AKELLMDPFLQVN 288 (670)
Q Consensus 243 ~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpS-------a~elL~hpf~~~~ 288 (670)
..+..+ ..+...++++++||.+||. +|.+||| +++++.|||+...
T Consensus 253 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 253 IGGNRL-KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp HTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred hcCCCC-CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 655432 3345567899999999996 8999999 7788899999754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=368.23 Aligned_cols=259 Identities=27% Similarity=0.365 Sum_probs=206.1
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-----------CCCe
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-----------HNNI 89 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-----------HpNI 89 (670)
.......|++.+.||+|+||+||+|.+..+|..||+|++... ....+.+.+|+.+++.+. ||||
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 334567899999999999999999999999999999998742 345667889999999886 8999
Q ss_pred eeeeeEEEeCC--CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEE
Q 005916 90 IRFYNSWIDDQ--NKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFI 164 (670)
Q Consensus 90 Vkl~~~~~d~~--~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl 164 (670)
+++++++.... ...+++||||+ +++|.+++... +.+++..++.++.||+.||.|||++ + |+||||||+|||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll 165 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLM 165 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEE
Confidence 99999987643 23789999999 89999998874 4599999999999999999999998 8 9999999999999
Q ss_pred eC-----CCCcEEEeeccchhhhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCC----
Q 005916 165 NG-----NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN---- 234 (670)
Q Consensus 165 ~~-----~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~---- 234 (670)
+. ..+.+||+|||++...... .....||+.|+|||++ ...|+.++|||||||++|+|++|..||.....
T Consensus 166 ~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 166 EIVDSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred eccCCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 62 3347999999999876543 3456899999999976 45689999999999999999999999975321
Q ss_pred -HHHHHHHHhc--CCCCC--------------------------------------cccCCCChHHHHHHHHcCC-CCCC
Q 005916 235 -SAQIYKKVSS--GIKPA--------------------------------------ALSKVKDPEVKSFIEKCLV-PASQ 272 (670)
Q Consensus 235 -~~~i~~~i~~--g~~p~--------------------------------------~~~~~~s~~~k~fI~kcL~-dP~~ 272 (670)
.......+.. +..|. .++...++++++||.+||. +|.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 1111111111 11110 0112234688999999996 8999
Q ss_pred CCCHHHHhcCcccccc
Q 005916 273 RLSAKELLMDPFLQVN 288 (670)
Q Consensus 273 RpSa~elL~hpf~~~~ 288 (670)
|||+.|+|+||||+..
T Consensus 325 Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDT 340 (373)
T ss_dssp CBCHHHHHTCGGGTTC
T ss_pred cCCHHHHhhChhhhcc
Confidence 9999999999999854
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=365.68 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=214.0
Q ss_pred CcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC--HHHHHHHHHHHHHHHhCC--CCCeeeee
Q 005916 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLK--HNNIIRFY 93 (670)
Q Consensus 18 ~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s--~~~~e~l~~Ei~iLk~L~--HpNIVkl~ 93 (670)
..+.++....|++.+.||+|+||+||+|.+..+|..||+|.+........ ....+++.+|+.+++.+. ||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 34455667789999999999999999999999999999999986543210 012245678999999995 59999999
Q ss_pred eEEEeCCCCeEEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEE
Q 005916 94 NSWIDDQNKTVNIITELFTS-GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 172 (670)
Q Consensus 94 ~~~~d~~~~~~~lVmEy~~g-GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vK 172 (670)
+++.+.. .+++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+++.+|
T Consensus 115 ~~~~~~~--~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 115 DWFERPD--SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EEEECSS--EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEE
T ss_pred EEEecCC--cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEE
Confidence 9987654 79999999986 899999999899999999999999999999999998 999999999999986678999
Q ss_pred EeeccchhhhcccccccccCCCccCCCcccc-CC-CCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc
Q 005916 173 IGDLGLATIMEQANAKSVIGTPEFMAPELYD-EN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 173 L~DFGla~~~~~~~~~~~~GTp~YmAPEvl~-~~-ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~ 250 (670)
|+|||++............||+.|+|||++. .. ++.++|||||||++|+|++|..||... .. +..+. ..
T Consensus 191 L~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---~~----~~~~~--~~ 261 (320)
T 3a99_A 191 LIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---EE----IIRGQ--VF 261 (320)
T ss_dssp ECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHHCC--CC
T ss_pred EeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh---hh----hhccc--cc
Confidence 9999999887766566778999999999774 33 478899999999999999999999652 21 22222 22
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+....++++++||.+||. +|.+|||+.++++||||+..
T Consensus 262 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 345578999999999996 89999999999999999743
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=356.99 Aligned_cols=256 Identities=24% Similarity=0.415 Sum_probs=196.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
-..|++.+.||+|+||+||+|.+..+|..||+|++..... .....+.+..+..+++.++||||+++++++.+.. .+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--~~ 99 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT--DV 99 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--cE
Confidence 3468889999999999999999999999999999975431 2233344455556788889999999999987654 79
Q ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
++||||+ ++.+..+... .+.+++..++.++.||+.||.|||+. + |+||||||+|||++ .++.+||+|||++...
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGQIKLCDFGISGRL 175 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEEC-TTSCEEECCCTTC---
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEEC-CCCCEEEEECCCchhc
Confidence 9999999 5566665544 57899999999999999999999994 8 99999999999998 6689999999999776
Q ss_pred cccc-cccccCCCccCCCcccc------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc-ccCC
Q 005916 183 EQAN-AKSVIGTPEFMAPELYD------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA-LSKV 254 (670)
Q Consensus 183 ~~~~-~~~~~GTp~YmAPEvl~------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~-~~~~ 254 (670)
.... .....||+.|+|||++. ..++.++|||||||++|+|++|..||............+..+..+.. ....
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 5432 34567999999999873 46889999999999999999999999886677677666666543322 2234
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 68999999999996 89999999999999999743
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=357.53 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=205.9
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEE----EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~----d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
.....+.|++.+.||+|+||+||+|. +..+|..||+|++... .....+.+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34557889999999999999999998 6778999999998743 356678899999999999999999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEee
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 175 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~D 175 (670)
.......+++|||||.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~D 157 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGD 157 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEc-CCCeEEEcc
Confidence 7655556899999999999999998764 4999999999999999999999998 99999999999998 568999999
Q ss_pred ccchhhhcccc-----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCH--------------
Q 005916 176 LGLATIMEQAN-----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNS-------------- 235 (670)
Q Consensus 176 FGla~~~~~~~-----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~-------------- 235 (670)
||++....... .....||+.|+|||++ ...|+.++|||||||++|+|++|..||......
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 99998765432 2344578889999976 467999999999999999999999998641100
Q ss_pred -HHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 236 -AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 236 -~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+...+..+. ....+...++++.+||.+||. +|.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 238 VFHLIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01222233332 223455678999999999996 8999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=364.25 Aligned_cols=249 Identities=26% Similarity=0.302 Sum_probs=201.2
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC-
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ- 100 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~- 100 (670)
-.....|++.++||+|+||+||+|.+. |..||+|++... ........+|+.+|+.++|||||++++++.+..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 344578999999999999999999765 899999998643 233445667999999999999999999998754
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC----------CCCeeeecCccccEEEeCCCC
Q 005916 101 -NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH----------DPPIIHRDLKCDNIFINGNQG 169 (670)
Q Consensus 101 -~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~----------g~~IIHrDLKpeNILl~~~~g 169 (670)
...+++|||||.+|+|.+++... .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~~ 168 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK-NNL 168 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC-TTC
T ss_pred CCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC-CCC
Confidence 33589999999999999999764 599999999999999999999998 7 99999999999998 678
Q ss_pred cEEEeeccchhhhcccc----cccccCCCccCCCccccC------CCCccceeeeccchhhhhhhccCCCCCCC------
Q 005916 170 EVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELYDE------NYNELADIYSFGMCMLEMVTFEYPYSECR------ 233 (670)
Q Consensus 170 ~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl~~------~ys~~~DIWSLGvilyeLltG~~Pf~~~~------ 233 (670)
.+||+|||++..+.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 99999999997764432 334689999999998754 46678999999999999999999996532
Q ss_pred ---------CHHHHHHHHhcCCCCCcccCC-----CChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 234 ---------NSAQIYKKVSSGIKPAALSKV-----KDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 234 ---------~~~~i~~~i~~g~~p~~~~~~-----~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
....+...+........+... .++++.+||.+||. +|.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 223333444333322222211 12459999999996 8999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=362.81 Aligned_cols=258 Identities=24% Similarity=0.427 Sum_probs=190.5
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEeCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~-iLk~L~HpNIVkl~~~~~d~~ 100 (670)
+.....|++.+.||+|+||+||+|.+..+|..||+|++.... ......++..|+. +++.++||||+++++++.+..
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 445577999999999999999999999999999999997542 2444556666666 677779999999999987654
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHhhhhcC-CCCeeeecCccccEEEeCCCCcEEEe
Q 005916 101 NKTVNIITELFTSGSLRQYRKK-----HKKVDMKAVKGWARQILSGLIYLHSH-DPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~-----~~~lse~~i~~i~~QIl~aL~yLHs~-g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
.+++||||+.+ +|.+++.. ...+++..++.++.|++.||.|||++ + |+||||||+|||++ .++.+||+
T Consensus 95 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~-~~~~~kl~ 168 (327)
T 3aln_A 95 --DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLC 168 (327)
T ss_dssp --EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEE-TTTEEEEC
T ss_pred --ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEc-CCCCEEEc
Confidence 79999999975 88877663 57799999999999999999999998 8 99999999999998 67899999
Q ss_pred eccchhhhcccc-cccccCCCccCCCccc-----cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 175 DLGLATIMEQAN-AKSVIGTPEFMAPELY-----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 175 DFGla~~~~~~~-~~~~~GTp~YmAPEvl-----~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++|..||............+..+..+
T Consensus 169 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3aln_A 169 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248 (327)
T ss_dssp CCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred cCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence 999998765433 3345799999999987 3468999999999999999999999997643333333223333222
Q ss_pred C---cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 A---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 ~---~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
. ......++.+++||.+||. +|.+|||+.++++||||...
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 1 1223568899999999996 89999999999999999753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=365.02 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=205.6
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCH--HHHHHHHHHHHHHHhC----CCCCeeeeee
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP--EDLERLYSEVHLLKSL----KHNNIIRFYN 94 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~--~~~e~l~~Ei~iLk~L----~HpNIVkl~~ 94 (670)
.......|++.+.||+|+||+||+|.+..+|..||+|++......... .....+.+|+.+++.+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344456799999999999999999999999999999999754432111 2234466799999999 8999999999
Q ss_pred EEEeCCCCeEEEEEec-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEE
Q 005916 95 SWIDDQNKTVNIITEL-FTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 173 (670)
Q Consensus 95 ~~~d~~~~~~~lVmEy-~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL 173 (670)
++.+.. .+++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||
T Consensus 106 ~~~~~~--~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 106 WFETQE--GFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCC--eEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEE
Confidence 886654 68899999 789999999999889999999999999999999999998 9999999999999866789999
Q ss_pred eeccchhhhcccccccccCCCccCCCcccc-CCC-CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcc
Q 005916 174 GDLGLATIMEQANAKSVIGTPEFMAPELYD-ENY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 251 (670)
Q Consensus 174 ~DFGla~~~~~~~~~~~~GTp~YmAPEvl~-~~y-s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~ 251 (670)
+|||++............||+.|+|||++. ..+ +.++|||||||++|+|++|..||... ..+ .... ..+
T Consensus 182 ~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~----~~~~--~~~ 252 (312)
T 2iwi_A 182 IDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---QEI----LEAE--LHF 252 (312)
T ss_dssp CCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHH----HHTC--CCC
T ss_pred EEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---HHH----hhhc--cCC
Confidence 999999887766666778999999999774 344 45899999999999999999999652 222 2221 223
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 45568999999999996 89999999999999999854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=350.20 Aligned_cols=245 Identities=20% Similarity=0.424 Sum_probs=209.3
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 80 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PI 80 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--ce
Confidence 356999999999999999999886 577899999875432 2356889999999999999999999986544 68
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECCTTGGGGBC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEc-CCCCEEecccccccccc
Confidence 9999999999999999764 56899999999999999999999998 99999999999998 56799999999998764
Q ss_pred ccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 184 QAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 184 ~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .....+...+..+..+ ..+...++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTH 235 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHH
Confidence 432 34456788999999774 679999999999999999999 9999987 5666777777766433 344556899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+++||.+||. +|.+|||+.++++|
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999996 89999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.32 Aligned_cols=248 Identities=21% Similarity=0.400 Sum_probs=208.0
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
....+.|++.+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 92 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR- 92 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC-
Confidence 345668999999999999999999776 678899999975432 1356889999999999999999999886544
Q ss_pred CeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 KTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 93 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 93 -PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSR 168 (283)
T ss_dssp -SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTSCEEECSTTGGG
T ss_pred -CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEc-CCCCEEEccccccc
Confidence 68999999999999999987 567999999999999999999999998 99999999999998 67899999999998
Q ss_pred hhcccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCC
Q 005916 181 IMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 181 ~~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
...... .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+.......+..+..+ ..+...
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 246 (283)
T 3gen_A 169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLA 246 (283)
T ss_dssp GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTC
T ss_pred cccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCCCcC
Confidence 764432 23455788999999764 679999999999999999998 9999987 4566666667665432 344556
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
++.+.+||.+||. +|.+|||+.++++|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 8999999999996 89999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=362.61 Aligned_cols=251 Identities=21% Similarity=0.297 Sum_probs=213.5
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
......|++.+.||+|+||+||+|.+. .++..||+|.++... .....+.+.+|+.+++.++||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 445577999999999999999999987 456899999987432 356677899999999999999999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCe
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKH------------------------KKVDMKAVKGWARQILSGLIYLHSHDPPI 152 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~------------------------~~lse~~i~~i~~QIl~aL~yLHs~g~~I 152 (670)
.+.. .+|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |
T Consensus 120 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--i 195 (343)
T 1luf_A 120 AVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--F 195 (343)
T ss_dssp CSSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred ccCC--ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 6544 689999999999999999874 57999999999999999999999998 9
Q ss_pred eeecCccccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-cc
Q 005916 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FE 226 (670)
Q Consensus 153 IHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~ 226 (670)
+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++ ...|+.++|||||||++|+|++ |.
T Consensus 196 vH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 196 VHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ecCCCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 9999999999998 56899999999998764432 2345789999999976 4679999999999999999999 99
Q ss_pred CCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 227 YPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 227 ~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.||.+ .+...+...+..+..+ ..+...++.+.+||.+||. +|.+|||+.+++++
T Consensus 275 ~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 275 QPYYG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCC-CChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 99987 5566677777666543 3455678999999999996 89999999999873
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=361.41 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=211.0
Q ss_pred CCCeEEEEEEecccCCeEEEEEEE-----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEE
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWI 97 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d-----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~ 97 (670)
..+.|++.+.||+|+||+||+|.+ ..++..||+|.+.... .....+.+.+|+.+|+.| +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 456799999999999999999997 3467889999997432 234567889999999999 9999999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeee
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKHK-----------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIH 154 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~~-----------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIH 154 (670)
+.. .+++|||||.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+|
T Consensus 120 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH 195 (344)
T 1rjb_A 120 LSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 195 (344)
T ss_dssp SSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred eCC--ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 644 6899999999999999998653 3799999999999999999999998 999
Q ss_pred ecCccccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCC
Q 005916 155 RDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYP 228 (670)
Q Consensus 155 rDLKpeNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~P 228 (670)
|||||+|||++ .++.+||+|||++....... .....||+.|+|||++ .+.|+.++|||||||++|+|+| |..|
T Consensus 196 ~Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 196 RDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999998 67899999999998765432 2345678899999976 5679999999999999999998 9999
Q ss_pred CCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 229 YSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 229 f~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
|.+..........+..+.. ...+...++.+.+||.+||. +|.+|||+.++++|-.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp STTCCCSHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccCCcHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 9886666666666666543 33455678999999999996 8999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.92 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=208.9
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEE----EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeee
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~----d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl 92 (670)
.+.......++|++.+.||+|+||+||+|. +..+|..||+|.+.... .....+++.+|+.+|+.++||||+++
T Consensus 12 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (302)
T 4e5w_A 12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKY 88 (302)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeee
Confidence 333344556789999999999999999998 67799999999997543 23345778899999999999999999
Q ss_pred eeEEEeCCCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcE
Q 005916 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 171 (670)
Q Consensus 93 ~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~v 171 (670)
++++.+.....+++||||+.+|+|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 89 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~ 165 (302)
T 4e5w_A 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQV 165 (302)
T ss_dssp EEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEE
T ss_pred eeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEc-CCCCE
Confidence 999988765679999999999999999854 467999999999999999999999998 99999999999998 56899
Q ss_pred EEeeccchhhhcccc-----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCC--------------
Q 005916 172 KIGDLGLATIMEQAN-----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSE-------------- 231 (670)
Q Consensus 172 KL~DFGla~~~~~~~-----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~-------------- 231 (670)
||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++|..|+..
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc
Confidence 999999998765432 3456789999999976 45688999999999999999999887632
Q ss_pred CCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 232 CRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 232 ~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
......+...+..+. ....+...++.+.+||.+||. +|.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGHHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCHHHHHHHHhccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 112223334444443 233455678999999999996 8999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=360.80 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=202.6
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEE----EEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEV----AWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 97 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~v----AiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~ 97 (670)
......|++.++||+|+||+||+|.+..+|..+ |+|.++.. ......+++.+|+.+++.++||||+++++++.
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 345677999999999999999999998888765 55555432 12344577899999999999999999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
+. ..++|+||+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 88 ~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Df 161 (327)
T 3poz_A 88 TS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDF 161 (327)
T ss_dssp SS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCT
T ss_pred cC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEEC-CCCCEEEccC
Confidence 64 378999999999999998874 67999999999999999999999998 99999999999998 5689999999
Q ss_pred cchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCc
Q 005916 177 GLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 177 Gla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 250 (670)
|++..+.... .....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.+ .+...+...+..+... .
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~ 239 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-P 239 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-C
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcCCCC-C
Confidence 9998875432 2344678899999966 5679999999999999999999 9999987 4555566666655432 3
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.+...+..+.++|.+||. +|.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 445567899999999996 89999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=357.85 Aligned_cols=253 Identities=20% Similarity=0.335 Sum_probs=203.9
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCC-eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC------eeeeeeEE
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNG-LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN------IIRFYNSW 96 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg-~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN------IVkl~~~~ 96 (670)
..+.|++.+.||+|+||+||+|.+..++ ..||+|+++. .....+.+.+|+.+++.|+|++ ++.+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 3567999999999999999999998877 7999999863 2455677889999999997765 89999988
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--------
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-------- 166 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~-------- 166 (670)
.... .+++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 92 ~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 92 NFHG--HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred eeCC--eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccc
Confidence 7654 799999999 677877776653 6999999999999999999999998 999999999999931
Q ss_pred ----------CCCcEEEeeccchhhhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCH
Q 005916 167 ----------NQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNS 235 (670)
Q Consensus 167 ----------~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~ 235 (670)
..+.+||+|||++..... ......||+.|+|||++ ...|+.++|||||||++|+|++|..||......
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccccCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 467899999999976543 23567899999999976 567999999999999999999999999874433
Q ss_pred HHHHHHHhc--CCCCCcc----------------------------------------cCCCChHHHHHHHHcCC-CCCC
Q 005916 236 AQIYKKVSS--GIKPAAL----------------------------------------SKVKDPEVKSFIEKCLV-PASQ 272 (670)
Q Consensus 236 ~~i~~~i~~--g~~p~~~----------------------------------------~~~~s~~~k~fI~kcL~-dP~~ 272 (670)
.. ...+.. +..|..+ ....++++++||.+||. +|.+
T Consensus 246 ~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 246 EH-LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HH-HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HH-HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 32 222211 1111100 01113478899999996 8999
Q ss_pred CCCHHHHhcCcccccc
Q 005916 273 RLSAKELLMDPFLQVN 288 (670)
Q Consensus 273 RpSa~elL~hpf~~~~ 288 (670)
|||+.++|+||||+..
T Consensus 325 Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 325 RITLAEALLHPFFAGL 340 (355)
T ss_dssp SCCHHHHTTSGGGGGC
T ss_pred CcCHHHHhcChhhcCC
Confidence 9999999999999853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=353.67 Aligned_cols=255 Identities=31% Similarity=0.463 Sum_probs=203.4
Q ss_pred CCCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeE
Q 005916 16 PDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNS 95 (670)
Q Consensus 16 ~~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~ 95 (670)
+.....+..+..|++.+.||+|+||+||+|.+. ..||+|+++... ......+.+.+|+.+|+.++||||++++++
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence 344444556778999999999999999999754 359999987543 346677889999999999999999999996
Q ss_pred EEeCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 96 WIDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 96 ~~d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
+. . ..+++|||||.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 89 ~~-~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~ 162 (289)
T 3og7_A 89 ST-A--PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLH-EDNTVKIG 162 (289)
T ss_dssp EC-S--SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEEC
T ss_pred cc-C--CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEEc
Confidence 53 2 2588999999999999998644 56999999999999999999999998 99999999999998 56899999
Q ss_pred eccchhhhccc----ccccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC
Q 005916 175 DLGLATIMEQA----NAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI 246 (670)
Q Consensus 175 DFGla~~~~~~----~~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~ 246 (670)
|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||........+...+..+.
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 242 (289)
T 3og7_A 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS 242 (289)
T ss_dssp CCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS
T ss_pred cceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc
Confidence 99999765432 234567999999999763 4688899999999999999999999998788888887777765
Q ss_pred CCCcc---cCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 247 KPAAL---SKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 247 ~p~~~---~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+..+ ....++.+++||.+||. +|.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44333 34567899999999996 8999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=358.64 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=214.9
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEE-----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeE
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNS 95 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d-----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~ 95 (670)
....+.|++.+.||+|+||+||+|.+ ..++..||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34567899999999999999999985 4678999999987432 355667899999999999 79999999998
Q ss_pred EEeCCCCeEEEEEecCCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCcc
Q 005916 96 WIDDQNKTVNIITELFTSGSLRQYRKKHKK----------------VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKC 159 (670)
Q Consensus 96 ~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~----------------lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKp 159 (670)
+.... ..+++|||||.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||
T Consensus 100 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp 176 (316)
T 2xir_A 100 CTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176 (316)
T ss_dssp ECCTT-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EecCC-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 86543 468999999999999999987654 899999999999999999999998 99999999
Q ss_pred ccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCC
Q 005916 160 DNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECR 233 (670)
Q Consensus 160 eNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~ 233 (670)
+|||++ .++.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++ |..||.+..
T Consensus 177 ~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 177 RNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999998 56899999999998764322 2345688999999976 5679999999999999999998 999998866
Q ss_pred CHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 234 NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 234 ~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
........+..+..+ ..+...++.++++|.+||. +|.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 IDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666666666665432 3445578999999999996 89999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=357.76 Aligned_cols=251 Identities=20% Similarity=0.246 Sum_probs=204.4
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC--CC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD--QN 101 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~--~~ 101 (670)
.++.|++.+.||+|+||+||+|.+..+|..||+|++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 467899999999999999999999999999999998753 356678899999999999999999999998743 23
Q ss_pred CeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 102 KTVNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
..+++|||||.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEEecC
Confidence 478999999999999999876 467999999999999999999999998 99999999999998 66899999999
Q ss_pred chhhhcccc-----------cccccCCCccCCCccccC----CCCccceeeeccchhhhhhhccCCCCCCCC-HHHHHHH
Q 005916 178 LATIMEQAN-----------AKSVIGTPEFMAPELYDE----NYNELADIYSFGMCMLEMVTFEYPYSECRN-SAQIYKK 241 (670)
Q Consensus 178 la~~~~~~~-----------~~~~~GTp~YmAPEvl~~----~ys~~~DIWSLGvilyeLltG~~Pf~~~~~-~~~i~~~ 241 (670)
++....... .....||+.|+|||++.. .++.++|||||||++|+|++|..||..... ...+...
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 876543211 123568999999998753 268999999999999999999999953110 0112222
Q ss_pred HhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 242 VSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 242 i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+... .........++.+++||.+||. +|.+|||+.+++++
T Consensus 260 ~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQNQ-LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcc-CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2222 2222334567899999999996 89999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=353.15 Aligned_cols=245 Identities=20% Similarity=0.339 Sum_probs=203.2
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCC-------eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNG-------LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg-------~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
....|++.+.||+|+||+||+|.+..++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 4567999999999999999999998877 579999886432 34467789999999999999999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc-----
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE----- 170 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~~-lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~----- 170 (670)
.+.. ..++|||||.+|+|.+++...+. +++..++.++.||+.||.|||+++ |+||||||+|||++. ++.
T Consensus 82 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~-~~~~~~~~ 156 (289)
T 4fvq_A 82 VCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIR-EEDRKTGN 156 (289)
T ss_dssp CCTT--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEE-CCBGGGTB
T ss_pred EeCC--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEec-CCcccccc
Confidence 7654 67899999999999999987755 999999999999999999999998 999999999999983 444
Q ss_pred ---EEEeeccchhhhcccccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC
Q 005916 171 ---VKIGDLGLATIMEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 245 (670)
Q Consensus 171 ---vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g 245 (670)
+||+|||++...... ....||+.|+|||++. ..++.++|||||||++|+|++|..|+................
T Consensus 157 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234 (289)
T ss_dssp CCEEEECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred cceeeeccCcccccccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc
Confidence 999999998765432 3456899999999775 568999999999999999999655544435555544444332
Q ss_pred CCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 246 IKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 246 ~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
...+...++++++||.+||. +|.+|||+.++++|
T Consensus 235 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 ---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22333456789999999996 89999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=374.80 Aligned_cols=255 Identities=20% Similarity=0.342 Sum_probs=209.5
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
...+++|++.++||+|+||+||+|.+..+|..||+|++...... ...+.+.+|+.+|+.++||||+++++++.+...
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 34578899999999999999999999999999999999754332 235667899999999999999999999987776
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEE----eCCCCcEEEe
Q 005916 102 KTVNIITELFTSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI----NGNQGEVKIG 174 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl----~~~~g~vKL~ 174 (670)
..+++|||||.+|+|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+|||+ + ..+.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~ 158 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLT 158 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTT-SCEEEEEC
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCC-CceeEEEe
Confidence 68999999999999999987653 3999999999999999999999998 9999999999998 4 45679999
Q ss_pred eccchhhhcccc-cccccCCCccCCCcccc---------CCCCccceeeeccchhhhhhhccCCCCCCC---CHHHHHHH
Q 005916 175 DLGLATIMEQAN-AKSVIGTPEFMAPELYD---------ENYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKK 241 (670)
Q Consensus 175 DFGla~~~~~~~-~~~~~GTp~YmAPEvl~---------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~---~~~~i~~~ 241 (670)
|||++....... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||.... ....+...
T Consensus 159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred cCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 999998765433 45678999999999774 467889999999999999999999996422 23344444
Q ss_pred HhcCCCCCc-----------------------ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 242 VSSGIKPAA-----------------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 242 i~~g~~p~~-----------------------~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+..+..+.. +....++.+.+||.+||. ||.+|||+.+++.+
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 444432211 112234578899999996 89999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.28 Aligned_cols=247 Identities=21% Similarity=0.388 Sum_probs=207.9
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
.....|++.+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 76 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY-- 76 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence 34567999999999999999999776 677899999975432 2356889999999999999999999886543
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+++||||+.+|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD-RDLCVKVSDFGMTRY 153 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEEC-TTCCEEECCTTCEEE
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEEC-CCCCEEEccCcccee
Confidence 6899999999999999988764 5999999999999999999999998 99999999999998 678999999999987
Q ss_pred hcccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 182 MEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 182 ~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
..... .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .........+..+.. ...+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 231 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNSEVVLKVSQGHR-LYRPHLAS 231 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCC-CCCCTTSC
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-cChHHHHHHHHcCCC-CCCCCcCh
Confidence 65433 23345677899999775 468999999999999999999 9999987 455555555655543 23345568
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+.+.+||.+||. +|.+|||+.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999996 79999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.21 Aligned_cols=249 Identities=26% Similarity=0.429 Sum_probs=198.9
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.....|++.+.||+|+||+||+|.+..+ +..||+|.+... ......+++.+|+.+++.++||||+++++++.+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-
Confidence 4457899999999999999999998654 567888877532 245667889999999999999999999998743
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
..+|+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 88 --NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGL 162 (281)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC---
T ss_pred --CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEEC-CCCCEEECcccc
Confidence 35889999999999999998764 6999999999999999999999998 99999999999998 568999999999
Q ss_pred hhhhcccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 179 ATIMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 179 a~~~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
+....... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+. ....+...+..+..+ ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-~~~~~~~~i~~~~~~-~~~~ 240 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMPP 240 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCT
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-CHHHHHHHHHcCCCC-CCCC
Confidence 98775432 23446788999999774 678999999999999999996 99999874 444555566655432 3455
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..++.+.+||.+||. +|.+|||+.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 678999999999996 89999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=364.41 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=214.0
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcC-------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeee
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYN 94 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~-------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~ 94 (670)
...+.|++.+.||+|+||+||+|.+.. .+..||+|+++.. .......++.+|+.+++.+ +|||||++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 345689999999999999999998753 3468999998743 2456678899999999999 9999999999
Q ss_pred EEEeCCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCc
Q 005916 95 SWIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 158 (670)
Q Consensus 95 ~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLK 158 (670)
++.+.. .+++|||||.+|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+|||||
T Consensus 143 ~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 218 (382)
T 3tt0_A 143 ACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 218 (382)
T ss_dssp EECSSS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred eeccCC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence 986544 6899999999999999998764 4999999999999999999999998 9999999
Q ss_pred cccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCC
Q 005916 159 CDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSEC 232 (670)
Q Consensus 159 peNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~ 232 (670)
|+|||++ .++.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++ |..||.+
T Consensus 219 p~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~- 296 (382)
T 3tt0_A 219 ARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG- 296 (382)
T ss_dssp GGGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred cceEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-
Confidence 9999998 66899999999998765422 3345678999999976 5578999999999999999999 9999987
Q ss_pred CCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 233 RNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 233 ~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.+...+...+..+..+. .+...++++++||.+||. +|.+|||+.+++++
T Consensus 297 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 297 VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56777777777765433 345678999999999996 79999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.55 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=214.1
Q ss_pred cccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 19 ~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
-.-....+.|++.+.||+|+||+||+|.+..++..||+|.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 34445677899999999999999999999999999999998743 3356778999999999999999999998865
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
.. .+++||||+.||+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 81 ~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Df 155 (288)
T 3kfa_A 81 EP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADF 155 (288)
T ss_dssp SS--SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEEC-GGGCEEECCC
T ss_pred CC--CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEc-CCCCEEEccC
Confidence 44 689999999999999999874 45999999999999999999999998 99999999999998 5679999999
Q ss_pred cchhhhcccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcc
Q 005916 177 GLATIMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAAL 251 (670)
Q Consensus 177 Gla~~~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~ 251 (670)
|++....... .....||+.|+|||++. ..++.++||||||+++|+|++ |.+||.. .+...+...+.....+ ..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~ 233 (288)
T 3kfa_A 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ER 233 (288)
T ss_dssp CGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CC
T ss_pred ccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CC
Confidence 9998775433 23455788999999764 679999999999999999999 9999977 4555666666655433 34
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+...++.+++||.+||. +|.+|||+.++++
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 45678999999999996 8999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=352.57 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=213.2
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEE-----cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEE
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSW 96 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d-----~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~ 96 (670)
.....|++.+.||+|+||+||+|.+ ..++..||+|.+.... .....+.+.+|+.+++.| +||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3456799999999999999999985 4678899999987432 345678899999999999 999999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCc
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHK------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 158 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLK 158 (670)
.+.. .+++|||||.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 97 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk 172 (313)
T 1t46_A 97 TIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (313)
T ss_dssp CSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred ecCC--CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCc
Confidence 6654 6899999999999999998764 4899999999999999999999998 9999999
Q ss_pred cccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCC
Q 005916 159 CDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSEC 232 (670)
Q Consensus 159 peNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~ 232 (670)
|+|||++ .++.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++ |..||.+.
T Consensus 173 p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 173 ARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cceEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999998 67899999999998765432 2345678899999966 5679999999999999999999 99999886
Q ss_pred CCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 233 RNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 233 ~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.........+..+..+ ..+...++.++++|.+||. +|.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 252 PVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 6666666666655433 2345568899999999996 89999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=353.69 Aligned_cols=261 Identities=21% Similarity=0.354 Sum_probs=206.8
Q ss_pred CCCCcccCCCCCeEEEEEEecccCCeEEEEEEEcC---CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeee
Q 005916 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEV---NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91 (670)
Q Consensus 15 ~~~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~---tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVk 91 (670)
...+.......+.|++.+.||+|+||+||+|.+.. ++..||+|.+.... ......+.+.+|+.+++.++||||++
T Consensus 23 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 23 QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN--SSQREIEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp -CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C--CCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc--cchhHHHHHHHHHHHHhcCCCCCeee
Confidence 34555555667889999999999999999998765 56789999987543 24566788999999999999999999
Q ss_pred eeeEEEeCCCC---eEEEEEecCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccE
Q 005916 92 FYNSWIDDQNK---TVNIITELFTSGSLRQYRKK------HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 162 (670)
Q Consensus 92 l~~~~~d~~~~---~~~lVmEy~~gGsL~~~i~~------~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNI 162 (670)
+++++.+.... .+++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NI 178 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNC 178 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGE
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceE
Confidence 99998765432 46999999999999999853 356999999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHH
Q 005916 163 FINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSA 236 (670)
Q Consensus 163 Ll~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~ 236 (670)
|++ .++.+||+|||++....... .....|++.|+|||++ ...|+.++|||||||++|+|++ |.+||.. ....
T Consensus 179 li~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~ 256 (313)
T 3brb_A 179 MLR-DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG-VQNH 256 (313)
T ss_dssp EEC-TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGG
T ss_pred EEc-CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc-CCHH
Confidence 998 66899999999998764432 2345678899999976 4568999999999999999999 8899977 4555
Q ss_pred HHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 237 QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 237 ~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.++..+..+..+ ..+...++.+.+||.+||. +|.+|||+.+++.+
T Consensus 257 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 257 EMYDYLLHGHRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp GHHHHHHTTCCC-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCC-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566666665433 3445577899999999996 89999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.96 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=192.6
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEe-
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWID- 98 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d- 98 (670)
.+..+..|++.++||+|+||+||+|.+..+|..||+|++... .....+.+.+|+.+++.+. ||||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 344567899999999999999999999999999999998654 3556778899999999995 9999999998853
Q ss_pred -----CCCCeEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc
Q 005916 99 -----DQNKTVNIITELFTSGSLRQYRKK---HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 170 (670)
Q Consensus 99 -----~~~~~~~lVmEy~~gGsL~~~i~~---~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~ 170 (670)
.....+++|||||. |+|.+++.. .+.+++..++.|+.||+.||.|||+++++|+||||||+|||++ .++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~ 176 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGT 176 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSC
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCC
Confidence 33446899999995 699988765 5679999999999999999999999987899999999999998 6689
Q ss_pred EEEeeccchhhhcccc--------------cccccCCCccCCCccc----cCCCCccceeeeccchhhhhhhccCCCCCC
Q 005916 171 VKIGDLGLATIMEQAN--------------AKSVIGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSEC 232 (670)
Q Consensus 171 vKL~DFGla~~~~~~~--------------~~~~~GTp~YmAPEvl----~~~ys~~~DIWSLGvilyeLltG~~Pf~~~ 232 (670)
+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998764321 1145699999999986 346889999999999999999999999763
Q ss_pred CCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 233 RNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 233 ~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
.. ..+ ..+..........++.+++||.+||. +|.+|||+.++++|-+
T Consensus 257 ~~-~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 257 AK-LRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp --------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hH-HHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22 222 22222223344556789999999996 8999999999999854
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=349.12 Aligned_cols=253 Identities=32% Similarity=0.526 Sum_probs=203.6
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||+||+|.+..+|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--E 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--E
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--c
Confidence 34579999999999999999999999999999999975433 34567788999999999999999999999988654 7
Q ss_pred EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 104 VNIITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEeccce
Confidence 9999999999999998864 466999999999999999999999998 99999999999998 6789999999999
Q ss_pred hhhcccc--cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCC-CHHHHHHHHhcCCCCCcccCCC
Q 005916 180 TIMEQAN--AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECR-NSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 180 ~~~~~~~--~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
....... .....||+.|+|||++ ...++.++|||||||++|+|++|..||.+.. +...+...+..+..+.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 184 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred eeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence 8765432 3456799999999976 4568999999999999999999999997543 4445666666665555444567
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
++++++||.+||. +|.+|||+.+++++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8999999999996 89999999999973
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.12 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=211.7
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 97 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~ 97 (670)
...+.|++.+.||+|+||+||+|.+. .++..||+|.+... .......++.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34578999999999999999999877 46889999988743 23456677899999999999999999999886
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKH----------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN 167 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~----------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~ 167 (670)
+.. .+++|||||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 99 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~-~ 173 (322)
T 1p4o_A 99 QGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-E 173 (322)
T ss_dssp SSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-T
T ss_pred cCC--ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc-C
Confidence 544 689999999999999998753 45799999999999999999999998 99999999999998 6
Q ss_pred CCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHH
Q 005916 168 QGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKK 241 (670)
Q Consensus 168 ~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~ 241 (670)
++.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++ |..||.. .....+...
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~ 252 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRF 252 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHH
Confidence 6899999999998764432 2345678999999977 4679999999999999999999 8999977 566667776
Q ss_pred HhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 242 VSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 242 i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+..+..+. .+...++.+++||.+||. +|.+|||+.+++++
T Consensus 253 ~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 253 VMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 66654332 345567899999999996 89999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.24 Aligned_cols=245 Identities=29% Similarity=0.486 Sum_probs=208.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe------
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID------ 98 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d------ 98 (670)
+..|++.+.||+|+||+||+|.+..+|..||+|.+.... +.+.+|+++++.++||||++++++|..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 356999999999999999999999999999999997542 246689999999999999999998864
Q ss_pred --------CCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC
Q 005916 99 --------DQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 168 (670)
Q Consensus 99 --------~~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~ 168 (670)
.....+++|||||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~ 158 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DT 158 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ET
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEc-CC
Confidence 1234689999999999999999765 67999999999999999999999998 99999999999998 56
Q ss_pred CcEEEeeccchhhhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC
Q 005916 169 GEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI 246 (670)
Q Consensus 169 g~vKL~DFGla~~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~ 246 (670)
+.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.. ....+..+..+.
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~ 235 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGI 235 (284)
T ss_dssp TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTC
T ss_pred CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhccc
Confidence 899999999998765432 34567999999999764 5689999999999999999999998854 234445555443
Q ss_pred CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 247 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 247 ~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
++...++.+++||.+||. +|.+|||+.++++|.|.-.
T Consensus 236 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 ----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 334567899999999996 8999999999999988753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=353.18 Aligned_cols=251 Identities=20% Similarity=0.260 Sum_probs=202.7
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
.-+.|++.+.||+|+||+||+|.+..+|..||+|++.... .......+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~ 108 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL-SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG--Q 108 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG-GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--E
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc-ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC--e
Confidence 3456999999999999999999999999999999987533 234556688999999999999999999999987654 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+||||+.|++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVS-ADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSCCC-----
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEc-CCCCEEEecCccCcccc
Confidence 9999999999999999999889999999999999999999999998 99999999999998 56899999999998765
Q ss_pred ccc---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC-CCcccCCCChH
Q 005916 184 QAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKDPE 258 (670)
Q Consensus 184 ~~~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~-p~~~~~~~s~~ 258 (670)
... .....||+.|+|||++ ...++.++||||||+++|+|++|..||.. .+...+...+..... +.......++.
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS-CHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC-chHHHHHHHhccCCCCccccCCCCCHH
Confidence 432 2456799999999977 45689999999999999999999999987 334444444444332 33445567889
Q ss_pred HHHHHHHcCC-CCCCCC-CHHHHhc
Q 005916 259 VKSFIEKCLV-PASQRL-SAKELLM 281 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~Rp-Sa~elL~ 281 (670)
++++|.+||. +|.+|| +++++++
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999996 899999 8888876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.83 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=213.5
Q ss_pred ccCCCCCeEEEEEEecccCCeEEEEEE----EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeE
Q 005916 20 ETDPTCRYIRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNS 95 (670)
Q Consensus 20 e~dp~gr~yr~~~~LG~G~fG~Vy~a~----d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~ 95 (670)
.+-...+.|++.+.||+|+||+||+|. +..+|..||+|++... .....+.+.+|+.+++.|+||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 92 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGV 92 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEE
Confidence 344556889999999999999999998 5778999999998743 35667789999999999999999999999
Q ss_pred EEeCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 96 WIDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 96 ~~d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
+.......+|+|||||.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~-~~~~~kl~ 169 (327)
T 3lxl_A 93 SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIA 169 (327)
T ss_dssp EECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEEC
T ss_pred EecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEEC-CCCCEEEc
Confidence 9877777899999999999999998874 56999999999999999999999998 99999999999998 56899999
Q ss_pred eccchhhhcccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCC--------------
Q 005916 175 DLGLATIMEQAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN-------------- 234 (670)
Q Consensus 175 DFGla~~~~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~-------------- 234 (670)
|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.....
T Consensus 170 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3lxl_A 170 DFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249 (327)
T ss_dssp CGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCH
T ss_pred ccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccccc
Confidence 999998764322 23456889999999764 5689999999999999999999999854211
Q ss_pred HHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 235 SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 235 ~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
...+...+..+. ....+...++.+++||.+||. +|.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 250 LSRLLELLEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 122333343433 233455678999999999996 89999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=356.68 Aligned_cols=244 Identities=20% Similarity=0.244 Sum_probs=202.6
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
+..|++.+.||+|+||+||+|.+..+|..||+|.+..... .+.+.+|+.+++.| +||||+++++++.+.. .
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~ 79 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK--Y 79 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT--E
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC--c
Confidence 5679999999999999999999999999999999875432 23477899999999 9999999999987754 7
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc-----EEEeecc
Q 005916 104 VNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE-----VKIGDLG 177 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~-----vKL~DFG 177 (670)
+++||||+ +|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++. +||+|||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~-~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIG-RPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-CGGGTCTTSEEECCCT
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-cCCCCCCceEEEEEcc
Confidence 99999999 99999999874 68999999999999999999999998 99999999999998 4455 9999999
Q ss_pred chhhhcccc---------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCC--CHHHHHHHHhcC
Q 005916 178 LATIMEQAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSG 245 (670)
Q Consensus 178 la~~~~~~~---------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~--~~~~i~~~i~~g 245 (670)
++..+.... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.. .....+..+...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 998764432 24678999999999764 568999999999999999999999997642 334445555433
Q ss_pred CCCC---cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 246 IKPA---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 246 ~~p~---~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+. .+.... +++++||.+||. +|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 236 KRATPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHSCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccCCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2111 112223 499999999995 8999999998876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.92 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=209.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.+..+|..||+|.++.. ......+.+.+|+.+|+.++|||||++++++.+.. .+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS--SC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC--Cc
Confidence 46799999999999999999999999999999988643 23556677899999999999999999999986544 68
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
|+|||||.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVT-EKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECT
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEc-CCCcEEECcCCCceecC
Confidence 99999999999999988654 6999999999999999999999998 99999999999998 66899999999997654
Q ss_pred cccc----ccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 184 QANA----KSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 184 ~~~~----~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
.... ....+++.|+|||++. +.|+.++|||||||++|+|++ |..||.+ ....+....+..+.. ...+...++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 342 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQTREFVEKGGR-LPCPELCPD 342 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT-SCHHHHHHHHHTTCC-CCCCTTCCH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC-CCCCCCCCH
Confidence 3221 2234577899999774 678999999999999999998 9999987 455666666666543 234556788
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+.+||.+||. +|.+|||+.++++
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999996 8999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=347.31 Aligned_cols=248 Identities=20% Similarity=0.347 Sum_probs=207.4
Q ss_pred CCCeEEEEE-EecccCCeEEEEEE--EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 24 TCRYIRYKE-VIGKGAFKTVYKAF--DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 24 ~gr~yr~~~-~LG~G~fG~Vy~a~--d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
..+.|++.+ .||+|+||+||+|. +..++..||+|++.... ......+++.+|+.+++.++||||+++++++. .
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICE-A- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S-
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-C-
Confidence 345678877 99999999999995 46678999999987542 23455778999999999999999999999883 2
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 90 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 90 -ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSK 165 (291)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCE
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe-CCCcEEEccCCcce
Confidence 358899999999999999999889999999999999999999999998 99999999999998 56899999999997
Q ss_pred hhcccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 181 IMEQAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 181 ~~~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
...... .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 243 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPA 243 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCT
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCC
Confidence 764322 12345678999999774 568899999999999999999 9999987 5666677777766543 3455
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..++.+.++|.+||. +|.+|||+.++++
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 678999999999996 8999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=345.53 Aligned_cols=247 Identities=17% Similarity=0.210 Sum_probs=204.9
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~ 102 (670)
.++.|++.+.||+|+||+||+|.+..+|..||+|++..... .+.+.+|+.+++.+ +||||+++++++.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-- 79 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-- 79 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc--
Confidence 46679999999999999999999999999999999875432 23477899999999 8999999999886544
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc-----EEEeec
Q 005916 103 TVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE-----VKIGDL 176 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~-----vKL~DF 176 (670)
.+++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +||+||
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIG-RPNSKNANMIYVVDF 155 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-CSSSTTTTCEEECCC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-cCCCCCCCeEEEEEC
Confidence 799999999 999999998764 5999999999999999999999998 99999999999997 3344 999999
Q ss_pred cchhhhcccc---------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCC--CHHHHHHHHhc
Q 005916 177 GLATIMEQAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSS 244 (670)
Q Consensus 177 Gla~~~~~~~---------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~--~~~~i~~~i~~ 244 (670)
|++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.... .....+..+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 9998765432 24567999999999764 568999999999999999999999997643 34444444433
Q ss_pred CCC---CCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 245 GIK---PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 245 g~~---p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
... ........++++++||.+||. +|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 221 122234567899999999995 89999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=355.10 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=211.2
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEc-------CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeee
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDE-------VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYN 94 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~-------~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~ 94 (670)
...+.|++.+.||+|+||+||+|.+. .++..||+|++.... .....+++.+|+.+++.+ +||||+++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 34578999999999999999999876 467889999987432 456678899999999999 9999999999
Q ss_pred EEEeCCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCc
Q 005916 95 SWIDDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLK 158 (670)
Q Consensus 95 ~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLK 158 (670)
++.+.. .+|+|||||.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 109 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 184 (334)
T 2pvf_A 109 ACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA 184 (334)
T ss_dssp EECSSS--CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EEccCC--ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence 886544 6899999999999999998754 3899999999999999999999998 9999999
Q ss_pred cccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCC
Q 005916 159 CDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSEC 232 (670)
Q Consensus 159 peNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~ 232 (670)
|+|||++ .++.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++ |..||.+
T Consensus 185 p~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~- 262 (334)
T 2pvf_A 185 ARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG- 262 (334)
T ss_dssp GGGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred cceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc-
Confidence 9999998 67899999999997665422 2345678999999976 4568999999999999999999 9999987
Q ss_pred CCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 233 RNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 233 ~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.....+...+..+..+ ..+...++.+++||.+||. +|.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 263 IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CCHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5667777777666533 3445678999999999996 89999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=346.40 Aligned_cols=249 Identities=18% Similarity=0.341 Sum_probs=209.2
Q ss_pred CCeEEEEEEecccCCeEEEEEEEc--CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~--~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
++++.+.+.||+|+||+||+|.+. .++..||+|+++.. ......+++.+|+.+++.|+||||+++++++.. .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---E 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---S
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---C
Confidence 455555669999999999999854 57889999998754 245677889999999999999999999998843 2
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEc-CCCCEEECcccceee
Confidence 589999999999999998654 56999999999999999999999998 99999999999998 568999999999987
Q ss_pred hcccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 182 MEQAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 182 ~~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
..... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~ 237 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPE 237 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC-CCCTT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHhcCCcC-CCCCC
Confidence 64322 23345789999999774 678999999999999999998 99999874 455566666665433 34556
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
.++.++++|.+||. +|.+||++.+++++.+
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 78999999999996 8999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=355.75 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=211.3
Q ss_pred CCCCeEEEEEEecccCCeEEEEEE-----EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAF-----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 97 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~-----d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~ 97 (670)
...+.|++.+.||+|+||+||+|. +..++..||+|.+... .......++.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 345679999999999999999998 6678899999998632 24556678899999999999999999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CC
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKHK-------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQ 168 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~~-------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~ 168 (670)
+.. .+|+|||||.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++. ..
T Consensus 104 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 104 QSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp SSS--SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTT
T ss_pred CCC--CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCc
Confidence 654 5899999999999999998763 4899999999999999999999998 999999999999982 34
Q ss_pred CcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHH
Q 005916 169 GEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKV 242 (670)
Q Consensus 169 g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i 242 (670)
+.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++ |..||.. .....+...+
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~ 258 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 258 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHHHH
Confidence 469999999998764322 2345789999999976 5679999999999999999998 9999977 5666677777
Q ss_pred hcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 243 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 243 ~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
..+..+. .+...++.+++||.+||. +|.+|||+.++++|.|+..
T Consensus 259 ~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 259 TSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCC-CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 6665432 345578999999999996 8999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.36 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=204.5
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeE----EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLE----VAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 97 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~----vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~ 97 (670)
-.....|++.+.||+|+||+||+|.+..+|.. ||+|.+.... ......++.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT---SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc---cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 34556799999999999999999999888876 6666654322 1222345678999999999999999999875
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
+ ..+++||||+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 86 ~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Df 159 (325)
T 3kex_A 86 G---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADF 159 (325)
T ss_dssp B---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEES-SSSCEEECSC
T ss_pred C---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEEC-CCCeEEECCC
Confidence 3 3589999999999999998875 57999999999999999999999998 99999999999998 6789999999
Q ss_pred cchhhhcccc----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCc
Q 005916 177 GLATIMEQAN----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 177 Gla~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 250 (670)
|++....... .....||+.|+|||++. +.|+.++|||||||++|+|++ |..||.+ .....+...+..+.. ..
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~-~~ 237 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG-LRLAEVPDLLEKGER-LA 237 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCTTHHHHHHHTTCB-CC
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc-cCHHHHHHHHHcCCC-CC
Confidence 9998875432 24456888999999774 679999999999999999999 9999987 444555555655532 23
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.+...++.+.++|.+||. +|.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 344567889999999996 89999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=352.96 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=212.0
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCe-----EEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeE
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGL-----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNS 95 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~-----~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~ 95 (670)
......|++.+.||+|+||+||+|.+..+|. .||+|.+.... .....+.+.+|+.+|+.| +||||++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3445679999999999999999999877664 79999886432 355678899999999999 89999999999
Q ss_pred EEeCCCCeEEEEEecCCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCcccc
Q 005916 96 WIDDQNKTVNIITELFTSGSLRQYRKKH--------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 161 (670)
Q Consensus 96 ~~d~~~~~~~lVmEy~~gGsL~~~i~~~--------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeN 161 (670)
+.+.. .+++|||||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 119 ~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~N 194 (333)
T 2i1m_A 119 CTHGG--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARN 194 (333)
T ss_dssp ECSSS--SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred EecCC--ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccce
Confidence 86544 689999999999999998753 35899999999999999999999998 9999999999
Q ss_pred EEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCH
Q 005916 162 IFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNS 235 (670)
Q Consensus 162 ILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~ 235 (670)
||++ .++.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++ |..||.+....
T Consensus 195 Il~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 195 VLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp CEEE-GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred EEEC-CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 9998 56899999999998764432 2345678899999966 5679999999999999999998 99999886666
Q ss_pred HHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 236 AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 236 ~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
......+..+.. ...+...++.+.++|.+||. +|.+|||+.+++++
T Consensus 274 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 274 SKFYKLVKDGYQ-MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 666665555533 33445568999999999996 89999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=340.88 Aligned_cols=245 Identities=21% Similarity=0.430 Sum_probs=209.3
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 78 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PI 78 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--Ce
Confidence 457999999999999999999886 678899999875432 2356889999999999999999999986644 68
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-GGGCEEECCTTGGGGBC
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEC-CCCCEEEcccccccccc
Confidence 9999999999999999875 56899999999999999999999998 99999999999998 56899999999998764
Q ss_pred ccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 184 QAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 184 ~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
... .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~ 233 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTH 233 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHH
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHH
Confidence 322 23456788999999775 678999999999999999999 8999987 5666677777766432 334556899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
++++|.+||. +|.+|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999996 89999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=347.32 Aligned_cols=255 Identities=23% Similarity=0.379 Sum_probs=208.4
Q ss_pred CcccCCCCCeEEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeee
Q 005916 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYN 94 (670)
Q Consensus 18 ~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~ 94 (670)
...+++....|++.++||+|+||+||+|.+..+ +..||+|.+.. .......+++.+|+.++++++||||+++++
T Consensus 17 ~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 93 (298)
T 3f66_A 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLG 93 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT---CCSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred heecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc---CCCHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence 445778888999999999999999999986543 34688887763 234567788999999999999999999999
Q ss_pred EEEeCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEE
Q 005916 95 SWIDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKI 173 (670)
Q Consensus 95 ~~~d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL 173 (670)
++.... ...++||||+.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 94 ~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl 169 (298)
T 3f66_A 94 ICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKV 169 (298)
T ss_dssp EECCSS-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEE
T ss_pred EEEcCC-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEC-CCCCEEE
Confidence 876543 4688999999999999999764 56899999999999999999999998 99999999999998 6789999
Q ss_pred eeccchhhhcccc------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcC
Q 005916 174 GDLGLATIMEQAN------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSG 245 (670)
Q Consensus 174 ~DFGla~~~~~~~------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g 245 (670)
+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++ |.+||.. .+...+...+..+
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~ 248 (298)
T 3f66_A 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQG 248 (298)
T ss_dssp CSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTT
T ss_pred CcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcC
Confidence 9999998664322 2345678999999976 4678999999999999999999 5566655 4444455555555
Q ss_pred CCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 246 IKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 246 ~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+ ..+...++.+.++|.+||. +|.+|||+.++++
T Consensus 249 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 RRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 432 3345567899999999996 8999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=345.96 Aligned_cols=249 Identities=22% Similarity=0.417 Sum_probs=205.1
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcC---CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEV---NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~---tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.....|++.+.||+|+||+||+|.+.. ++..||+|.+.... .....+++.+|+.+++.|+||||+++++++.+.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 345679999999999999999998653 45569999887432 356678899999999999999999999987543
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
..|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 86 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 86 ---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVA-SPECVKLGDFGL 159 (281)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-ETTEEEECCCCG
T ss_pred ---CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEC-CCCcEEeCccCC
Confidence 468999999999999998765 45999999999999999999999998 99999999999998 568999999999
Q ss_pred hhhhcccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccC
Q 005916 179 ATIMEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSK 253 (670)
Q Consensus 179 a~~~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 253 (670)
+....... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||... ........+..+..+ ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 237 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEKGDRL-PKPD 237 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CGGGHHHHHHHTCCC-CCCT
T ss_pred CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC-ChHHHHHHHhcCCCC-CCCC
Confidence 98765432 23456788999999774 678999999999999999998 99999763 334445555554332 2345
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..++.+.++|.+||. +|.+|||+.+++++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 578999999999996 89999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=355.08 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=206.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEE--EEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEV--AWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~v--AiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~ 101 (670)
-..|++.+.||+|+||+||+|.+..+|..+ |+|.+... ......+++.+|+.+++.+ +||||+++++++.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~- 99 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG- 99 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc---cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC-
Confidence 356899999999999999999999999866 88887642 2344566789999999999 9999999999987654
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe
Q 005916 102 KTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN 165 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~ 165 (670)
.+|+|||||.+|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 100 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 -YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 176 (327)
T ss_dssp -EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred -ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEc
Confidence 7999999999999999998764 7999999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeeccchhhhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHH
Q 005916 166 GNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKV 242 (670)
Q Consensus 166 ~~~g~vKL~DFGla~~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i 242 (670)
.++.+||+|||++....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .+...++..+
T Consensus 177 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~ 254 (327)
T 1fvr_A 177 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKL 254 (327)
T ss_dssp -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHG
T ss_pred -CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHHHHh
Confidence 56799999999987544322 23456789999999774 568999999999999999998 9999987 5667777777
Q ss_pred hcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 243 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 243 ~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..+..+ ..+...++.+++||.+||. +|.+|||+.+++++
T Consensus 255 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 255 PQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 666433 2344567999999999996 89999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=356.21 Aligned_cols=249 Identities=26% Similarity=0.448 Sum_probs=201.9
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEE----EEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEV----AWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~v----AiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
.....|++.++||+|+||+||+|.+..+|..+ |+|.+.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 45677999999999999999999998888766 555443221 23346778899999999999999999999876
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.. .++|++|+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 89 ~~---~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kL~DfG 162 (327)
T 3lzb_A 89 ST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFG 162 (327)
T ss_dssp SS---EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTT
T ss_pred CC---ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEc-CCCCEEEccCc
Confidence 43 88999999999999998874 57999999999999999999999998 99999999999998 56899999999
Q ss_pred chhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcc
Q 005916 178 LATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAAL 251 (670)
Q Consensus 178 la~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~ 251 (670)
++....... .....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.+ .....+...+..+..+ ..
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~ 240 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQ 240 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CC
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CC
Confidence 998764432 2344578899999966 5679999999999999999999 9999987 4555566666655432 34
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+...++++.+||.+||. +|.+|||+.++++.
T Consensus 241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 241 PPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 45578899999999996 89999999999973
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.09 Aligned_cols=252 Identities=19% Similarity=0.304 Sum_probs=208.9
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCe---EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~---~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
...-.|++.++||+|+||+||+|.+..++. .||+|.+.. .......+.+.+|+.+++.++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR---ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT---CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc---cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 334457788999999999999998765544 789998863 23456778899999999999999999999998765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
.. ..++||||+.+|+|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 95 ~~-~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~ 170 (298)
T 3pls_A 95 EG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD-ESFTVKVADFGL 170 (298)
T ss_dssp SS-CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECCTTS
T ss_pred CC-CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEeCcCCC
Confidence 43 45899999999999999987 467899999999999999999999998 99999999999998 678999999999
Q ss_pred hhhhccc------ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcc
Q 005916 179 ATIMEQA------NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 251 (670)
Q Consensus 179 a~~~~~~------~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~ 251 (670)
+...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....+...+...+..+.. ...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~ 249 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-LPQ 249 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-CCC
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-CCC
Confidence 9765432 234467899999999775 46899999999999999999966665555666666666666543 234
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+...++.+.+||.+||. +|.+|||+.++++.
T Consensus 250 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 250 PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 45568899999999996 89999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=347.61 Aligned_cols=245 Identities=28% Similarity=0.438 Sum_probs=194.7
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHh--CCCCCeeeeeeEEEeCC-
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS--LKHNNIIRFYNSWIDDQ- 100 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~--L~HpNIVkl~~~~~d~~- 100 (670)
..+.|++.+.||+|+||+||+|.+ +|..||+|++... ....+..|.+++.. ++||||+++++++.+..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 456799999999999999999976 6999999998643 23455667777777 79999999999876532
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh--------cCCCCeeeecCccccEEEeCCCCcE
Q 005916 101 -NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH--------SHDPPIIHRDLKCDNIFINGNQGEV 171 (670)
Q Consensus 101 -~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLH--------s~g~~IIHrDLKpeNILl~~~~g~v 171 (670)
...+++|||||.+|+|.++++. ..+++..++.++.||+.||.||| +++ |+||||||+|||++ .++.+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~-~~~~~ 152 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK-KNGQC 152 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC-TTSCE
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc-CCCCE
Confidence 3468999999999999999954 57999999999999999999999 777 99999999999998 66899
Q ss_pred EEeeccchhhhcccc------cccccCCCccCCCccccCC-------CCccceeeeccchhhhhhhc----------cCC
Q 005916 172 KIGDLGLATIMEQAN------AKSVIGTPEFMAPELYDEN-------YNELADIYSFGMCMLEMVTF----------EYP 228 (670)
Q Consensus 172 KL~DFGla~~~~~~~------~~~~~GTp~YmAPEvl~~~-------ys~~~DIWSLGvilyeLltG----------~~P 228 (670)
||+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|++| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999997654322 2345899999999987543 44789999999999999999 888
Q ss_pred CCCCC----CHHHHHHHHhcCCCCCccc-----CCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 229 YSECR----NSAQIYKKVSSGIKPAALS-----KVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 229 f~~~~----~~~~i~~~i~~g~~p~~~~-----~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
|.... ....+...+.........+ ...++.+.+||.+||. +|.+|||+.++++
T Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 86532 2233333332222221121 2234679999999996 8999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.25 Aligned_cols=261 Identities=17% Similarity=0.194 Sum_probs=201.4
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcC---CCeEEEEEEEeeccccCCH--H-----HHHHHHHHHHHHHhCCC
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEV---NGLEVAWCQVRIDDVLQSP--E-----DLERLYSEVHLLKSLKH 86 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~---tg~~vAiK~v~~~~~~~s~--~-----~~e~l~~Ei~iLk~L~H 86 (670)
+..-.+..+..|++.+.||+|+||+||+|.+.. ++..||+|.+......... . ....+.+|+.+++.++|
T Consensus 28 g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h 107 (345)
T 2v62_A 28 GKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY 107 (345)
T ss_dssp TCEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSC
T ss_pred CCeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccc
Confidence 444466778899999999999999999999987 8889999998754311000 0 11235678899999999
Q ss_pred CCeeeeeeEEEeC--CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEE
Q 005916 87 NNIIRFYNSWIDD--QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFI 164 (670)
Q Consensus 87 pNIVkl~~~~~d~--~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl 164 (670)
|||+++++++.+. ....+|+||||| +++|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||+
T Consensus 108 ~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll 184 (345)
T 2v62_A 108 LGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLL 184 (345)
T ss_dssp CCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred cCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEE
Confidence 9999999998873 245899999999 9999999988889999999999999999999999998 9999999999999
Q ss_pred eCCCC--cEEEeeccchhhhcccc---------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCC
Q 005916 165 NGNQG--EVKIGDLGLATIMEQAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSEC 232 (670)
Q Consensus 165 ~~~~g--~vKL~DFGla~~~~~~~---------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~ 232 (670)
+. ++ .+||+|||++..+.... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||...
T Consensus 185 ~~-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 185 GY-KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp ES-SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred cc-CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 83 44 99999999997664321 14568999999999775 45899999999999999999999999653
Q ss_pred CC-HHHHHHHHh--cCCCCCcc-----cCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 233 RN-SAQIYKKVS--SGIKPAAL-----SKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 233 ~~-~~~i~~~i~--~g~~p~~~-----~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.. ......... ....+..+ ....++++++||.+||. +|.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 264 LKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp TTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 32 222221111 11112111 11567899999999996 8999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=357.58 Aligned_cols=253 Identities=17% Similarity=0.245 Sum_probs=205.1
Q ss_pred CCCCcccCCCCCeEEEEEEecccCCeEEEEEEEcCC--------CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC
Q 005916 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVN--------GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86 (670)
Q Consensus 15 ~~~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~t--------g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H 86 (670)
.++..-.++.++.|++.+.||+|+||+||+|.+..+ +..||+|.+... +.+.+|+.+++.++|
T Consensus 31 ~~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h 101 (352)
T 2jii_A 31 PTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAK 101 (352)
T ss_dssp CTTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCC
T ss_pred CCCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcc
Confidence 334455677789999999999999999999999874 889999998743 347789999999999
Q ss_pred CCeee---------------eeeEEEeCCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCC
Q 005916 87 NNIIR---------------FYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHD 149 (670)
Q Consensus 87 pNIVk---------------l~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g 149 (670)
|||++ +++++... ...+|+||||| +|+|.+++... +.+++..++.++.||+.||.|||+++
T Consensus 102 ~niv~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 179 (352)
T 2jii_A 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE 179 (352)
T ss_dssp HHHHHHHHHHTTCTTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cchhhhhhhhccCCccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99988 56666543 35899999999 99999999986 78999999999999999999999998
Q ss_pred CCeeeecCccccEEEeCCCC--cEEEeeccchhhhcccc---------cccccCCCccCCCcccc-CCCCccceeeeccc
Q 005916 150 PPIIHRDLKCDNIFINGNQG--EVKIGDLGLATIMEQAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGM 217 (670)
Q Consensus 150 ~~IIHrDLKpeNILl~~~~g--~vKL~DFGla~~~~~~~---------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGv 217 (670)
|+||||||+|||++ .++ .+||+|||++..+.... .....||+.|+|||++. ..|+.++|||||||
T Consensus 180 --ivH~Dikp~NIl~~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 256 (352)
T 2jii_A 180 --YVHGNVTAENIFVD-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGY 256 (352)
T ss_dssp --CBCSCCCGGGEEEE-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred --ccCCCCCHHHEEEc-CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHH
Confidence 99999999999998 455 89999999997764322 13458999999999775 47999999999999
Q ss_pred hhhhhhhccCCCCCCC-CHHHHHHHHh---cCCCCCc----ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 218 CMLEMVTFEYPYSECR-NSAQIYKKVS---SGIKPAA----LSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 218 ilyeLltG~~Pf~~~~-~~~~i~~~i~---~g~~p~~----~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
++|+|++|..||.... ....+..... ....+.. .....++++++||.+||. +|.+|||+.++++
T Consensus 257 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 257 CMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 9999999999998754 4444443332 1111110 112357999999999996 8999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=352.81 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=206.9
Q ss_pred CCCeEEEEEEecccCCeEEEEEE----EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~----d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.++||++.+.||+|+||+||+|. +..+|..||+|++... ......+.+.+|+.+|+.|+||||+++++++.+.
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 46889999999999999998774 4568999999998753 2456678899999999999999999999999887
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
....+++|||||.+|+|.+++... .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGLA 181 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGC
T ss_pred CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEc-CCCCEEECCcccc
Confidence 667899999999999999998765 4999999999999999999999998 99999999999998 6689999999999
Q ss_pred hhhcccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCH--------------HHHH
Q 005916 180 TIMEQAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS--------------AQIY 239 (670)
Q Consensus 180 ~~~~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~--------------~~i~ 239 (670)
....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||...... ..+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 8765432 23456889999999774 56889999999999999999999999652111 1122
Q ss_pred HHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 240 KKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 240 ~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+..+. ....+...++.+.+||.+||. +|.+|||+.++++
T Consensus 262 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2333332 333455678999999999996 8999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=360.83 Aligned_cols=261 Identities=19% Similarity=0.237 Sum_probs=201.2
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcCC-----CeEEEEEEEeeccccCCHHH--------HHHHHHHHHHHHh
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVN-----GLEVAWCQVRIDDVLQSPED--------LERLYSEVHLLKS 83 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~t-----g~~vAiK~v~~~~~~~s~~~--------~e~l~~Ei~iLk~ 83 (670)
+..-.+.....|++.+.||+|+||+||+|.+..+ +..||+|++...... .... ...+..|+..++.
T Consensus 26 g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~ 104 (364)
T 3op5_A 26 GEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRK 104 (364)
T ss_dssp TCEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CcEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhh
Confidence 3344456677899999999999999999998765 588999998754210 0000 1123345667777
Q ss_pred CCCCCeeeeeeEEEeCCC--CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccc
Q 005916 84 LKHNNIIRFYNSWIDDQN--KTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCD 160 (670)
Q Consensus 84 L~HpNIVkl~~~~~d~~~--~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpe 160 (670)
++||||+++++++..... .++|+||||| ||+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+
T Consensus 105 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~ 181 (364)
T 3op5_A 105 LKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKAS 181 (364)
T ss_dssp CSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred ccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHH
Confidence 889999999999876533 4689999999 99999999876 67999999999999999999999998 999999999
Q ss_pred cEEEe-CCCCcEEEeeccchhhhcccc---------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCC
Q 005916 161 NIFIN-GNQGEVKIGDLGLATIMEQAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPY 229 (670)
Q Consensus 161 NILl~-~~~g~vKL~DFGla~~~~~~~---------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf 229 (670)
|||++ ..++.+||+|||++..+.... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||
T Consensus 182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99998 245799999999997764322 13456999999999775 46999999999999999999999999
Q ss_pred CCCCCHHHHHHHHhcCC---CCC-----cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 230 SECRNSAQIYKKVSSGI---KPA-----ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 230 ~~~~~~~~i~~~i~~g~---~p~-----~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+............... .+. ......++++.+||.+||. +|.+||++.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 262 EDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp GGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 86433333222111110 000 0113457899999999996 8999999999886
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=340.92 Aligned_cols=247 Identities=23% Similarity=0.267 Sum_probs=201.6
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
++.|++.+.||+|+||+||+|.+..+|..||+|++..... .+.+.+|+.+++.++|++++..+..+... ...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~ 80 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYN 80 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCC-CCce
Confidence 5679999999999999999999999999999999875432 13578899999999998877777665443 3478
Q ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe--CCCCcEEEeeccchhh
Q 005916 105 NIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATI 181 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~--~~~g~vKL~DFGla~~ 181 (670)
++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..++.+||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 9999999 9999999874 467999999999999999999999998 99999999999995 3567999999999987
Q ss_pred hcccc---------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCC--HHHHHHHHhcCC---
Q 005916 182 MEQAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN--SAQIYKKVSSGI--- 246 (670)
Q Consensus 182 ~~~~~---------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~--~~~i~~~i~~g~--- 246 (670)
..... .....||+.|+|||++. ..++.++|||||||++|+|++|..||..... ....+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 65432 24568999999999764 5689999999999999999999999976322 112222222211
Q ss_pred CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 247 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 247 ~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
....+....++.+.+||.+||. +|.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1112334567899999999996 8999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.97 Aligned_cols=249 Identities=26% Similarity=0.350 Sum_probs=192.2
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~ 101 (670)
..+++|...++||+|+||+||.+ ...+|+.||+|++.... .+.+.+|+.+|+.+ +|||||++++++.+.
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-- 81 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSETTD-- 81 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS--
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecC--
Confidence 34677888999999999999875 56789999999987432 34578899999986 899999999988654
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--------
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVD-------MKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-------- 166 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~ls-------e~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~-------- 166 (670)
..+|+|||||. |+|.+++...+... +..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccc
Confidence 47999999995 69999998765432 3345789999999999999998 999999999999973
Q ss_pred ----CCCcEEEeeccchhhhcccc------cccccCCCccCCCcccc--------CCCCccceeeeccchhhhhhh-ccC
Q 005916 167 ----NQGEVKIGDLGLATIMEQAN------AKSVIGTPEFMAPELYD--------ENYNELADIYSFGMCMLEMVT-FEY 227 (670)
Q Consensus 167 ----~~g~vKL~DFGla~~~~~~~------~~~~~GTp~YmAPEvl~--------~~ys~~~DIWSLGvilyeLlt-G~~ 227 (670)
..+.+||+|||++..+.... .....||+.|+|||++. ..++.++|||||||++|+|++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 23589999999998765432 23468999999999774 468999999999999999999 999
Q ss_pred CCCCCCCHHHHHHHHhcCCCC-CcccC----CCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 228 PYSECRNSAQIYKKVSSGIKP-AALSK----VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 228 Pf~~~~~~~~i~~~i~~g~~p-~~~~~----~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
||....... ..+..+... ..... ..++++++||.+||. +|.+|||+.++|+||||..
T Consensus 239 Pf~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 239 PFGDKYSRE---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTCSTTTHH---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCchhhH---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 997643332 223333211 11111 124789999999996 8999999999999999964
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.56 Aligned_cols=251 Identities=24% Similarity=0.407 Sum_probs=204.8
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCC----eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNG----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 97 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg----~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~ 97 (670)
......|++.+.||+|+||+||+|.+..++ ..||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 445677999999999999999999877553 469999987432 3556678999999999999999999999886
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
+. ..+++|||||.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 117 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Df 191 (333)
T 1mqb_A 117 KY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDF 191 (333)
T ss_dssp SS--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC
T ss_pred cC--CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC-CCCcEEECCC
Confidence 54 3799999999999999998875 67999999999999999999999998 99999999999998 6789999999
Q ss_pred cchhhhcccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCC
Q 005916 177 GLATIMEQAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPA 249 (670)
Q Consensus 177 Gla~~~~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 249 (670)
|++....... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .....+...+..+..+.
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~~ 270 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRLP 270 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHCCCcCC
Confidence 9998765432 12335688999999774 679999999999999999998 9999987 45666777777664332
Q ss_pred cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 250 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 250 ~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.+...++.++++|.+||. +|.+||++.+++++
T Consensus 271 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 -TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 344567899999999996 89999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=342.83 Aligned_cols=244 Identities=21% Similarity=0.395 Sum_probs=199.2
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
...+.|++.+.||+|+||+||+|.+ +|..||+|.++... ..+++.+|+.+++.++||||+++++++.+.. .
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 88 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-G 88 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC---
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-C
Confidence 4467899999999999999999976 48899999886432 3567889999999999999999999876543 3
Q ss_pred eEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+||||+.+|+|.+++...+. +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTK 165 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC--
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEe-CCCcEEEeeccccc
Confidence 68999999999999999887643 899999999999999999999998 99999999999998 66899999999987
Q ss_pred hhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 181 IMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 181 ~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
..... .....+|+.|+|||++ ...++.++||||||+++|+|++ |..||.. .+...+...+..+.. ...+...++.
T Consensus 166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 242 (278)
T 1byg_A 166 EASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYK-MDAPDGCPPA 242 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCC-CCCCTTCCHH
T ss_pred ccccc-ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCC-CCCcccCCHH
Confidence 66443 2345678999999977 4678999999999999999998 9999987 445556666666543 3345567899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
++++|.+||. +|.+|||+.++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 243 VYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCCCHHHHHH
Confidence 9999999996 8999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=344.57 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=201.2
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcC-CC--eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEV-NG--LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~-tg--~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
....+.|++.+.||+|+||+||+|.+.. ++ ..||+|+++.... ......+++.+|+.+++.++||||+++++++.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 3456789999999999999999998643 33 3689998875432 234567889999999999999999999998865
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.. .++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 93 ~~---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg 166 (291)
T 1u46_A 93 PP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFG 166 (291)
T ss_dssp SS---CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCT
T ss_pred CC---ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEc-CCCCEEEcccc
Confidence 43 78999999999999998764 67999999999999999999999998 99999999999998 56899999999
Q ss_pred chhhhcccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCc
Q 005916 178 LATIMEQAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAA 250 (670)
Q Consensus 178 la~~~~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 250 (670)
++....... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+...+........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLP 245 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCC
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCCCC
Confidence 998764432 23456788999999774 568999999999999999999 9999987 456666666665544444
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+...++.++++|.+||. +|.+|||+.++++
T Consensus 246 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 556678999999999996 8999999999997
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=366.33 Aligned_cols=243 Identities=21% Similarity=0.400 Sum_probs=204.8
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||+||+|.+. |..||+|.++... ..+.+.+|+.+|++|+|||||++++++.+.. ..
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 261 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GG 261 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-Cc
Confidence 3457999999999999999999764 7899999987432 2467889999999999999999999887654 36
Q ss_pred EEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKKHKK--VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+|+|||||.+|+|.+++...+. +++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEC-CCCCEEEeeCCCccc
Confidence 8999999999999999987654 799999999999999999999998 99999999999998 668999999999975
Q ss_pred hcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 182 MEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 182 ~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.... .....+|+.|+|||++ ...|+.++|||||||++|+|++ |..||.+. +..++...+..+..+ ..+...++.+
T Consensus 339 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l 415 (450)
T 1k9a_A 339 ASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAV 415 (450)
T ss_dssp CC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-CTTTHHHHHHTTCCC-CCCTTCCHHH
T ss_pred cccc-ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHH
Confidence 5332 2334678999999976 5679999999999999999998 99999874 444556667666533 3455678999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+||.+||. +|.+|||+.+++.
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 999999996 8999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=348.51 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=192.0
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHH--HHhCCCCCeeeeeeEEEe-
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHL--LKSLKHNNIIRFYNSWID- 98 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~i--Lk~L~HpNIVkl~~~~~d- 98 (670)
...-..|++.+.||+|+||+||+|.+ +|..||+|++.... ...+..|..+ ++.++||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 34456799999999999999999965 78999999987432 2333344444 555899999999976532
Q ss_pred --CCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC---------CCCeeeecCccccEEEeCC
Q 005916 99 --DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH---------DPPIIHRDLKCDNIFINGN 167 (670)
Q Consensus 99 --~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~---------g~~IIHrDLKpeNILl~~~ 167 (670)
.....+++|||||.+|+|.+++...+ .++..++.++.||+.||.|||++ + |+||||||+|||++ .
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~-~ 155 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK-N 155 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC-T
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc-C
Confidence 23346889999999999999997654 58999999999999999999998 7 99999999999998 6
Q ss_pred CCcEEEeeccchhhhccc----------ccccccCCCccCCCccccC--------CCCccceeeeccchhhhhhhccCCC
Q 005916 168 QGEVKIGDLGLATIMEQA----------NAKSVIGTPEFMAPELYDE--------NYNELADIYSFGMCMLEMVTFEYPY 229 (670)
Q Consensus 168 ~g~vKL~DFGla~~~~~~----------~~~~~~GTp~YmAPEvl~~--------~ys~~~DIWSLGvilyeLltG~~Pf 229 (670)
++.+||+|||++..+... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 689999999999766432 1235579999999998754 4667899999999999999997766
Q ss_pred CCCCC-----------------HHHHHHHHhcCCCCCcccCC------CChHHHHHHHHcCC-CCCCCCCHHHHh-----
Q 005916 230 SECRN-----------------SAQIYKKVSSGIKPAALSKV------KDPEVKSFIEKCLV-PASQRLSAKELL----- 280 (670)
Q Consensus 230 ~~~~~-----------------~~~i~~~i~~g~~p~~~~~~------~s~~~k~fI~kcL~-dP~~RpSa~elL----- 280 (670)
..... ...+...+........++.. .++.+++||.+||. +|.+|||+.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 33211 11222222222222222222 23479999999996 899999999995
Q ss_pred -cCccccccC
Q 005916 281 -MDPFLQVNG 289 (670)
Q Consensus 281 -~hpf~~~~~ 289 (670)
.++|-+..+
T Consensus 316 ll~~~~~~~~ 325 (336)
T 3g2f_A 316 LMMIWERNKS 325 (336)
T ss_dssp HHHCCCC---
T ss_pred HHHHHHhccc
Confidence 567776543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=342.08 Aligned_cols=239 Identities=21% Similarity=0.314 Sum_probs=190.5
Q ss_pred ccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHH-HhCCCCCeeeeeeEEEe
Q 005916 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL-KSLKHNNIIRFYNSWID 98 (670)
Q Consensus 20 e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iL-k~L~HpNIVkl~~~~~d 98 (670)
.....++|+.+.++||+|+||+||+|.+..+|..||+|++... ..+.+|+.++ +.++||||++++++|.+
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3344456666668999999999999999999999999998632 3466788888 55699999999999865
Q ss_pred --CCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--CCcEE
Q 005916 99 --DQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--QGEVK 172 (670)
Q Consensus 99 --~~~~~~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~g~vK 172 (670)
.....+++|||||.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEE
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEE
Confidence 23457999999999999999998864 6999999999999999999999998 9999999999999842 67899
Q ss_pred EeeccchhhhcccccccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc----CCC-
Q 005916 173 IGDLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS----GIK- 247 (670)
Q Consensus 173 L~DFGla~~~~~~~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~----g~~- 247 (670)
|+|||++.... ...|+.++|||||||++|+|++|..||..... ......+.. +..
T Consensus 161 l~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 161 LTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKTRIRMGQYE 220 (299)
T ss_dssp ECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCS
T ss_pred Eeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc-hhhhHHHHHHHhhcccc
Confidence 99999875432 24578899999999999999999999976322 211111111 111
Q ss_pred -CCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 248 -PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 248 -p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
+.......++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 111114468899999999996 899999999999999998653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=372.82 Aligned_cols=249 Identities=28% Similarity=0.322 Sum_probs=192.4
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
...|++.++||+|+||+||. ....+|+.||+|++..... ..+.+|+.+|+.+ +|||||++++++.+.. .
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--~ 92 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDRQ--F 92 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEETT--E
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecCC--E
Confidence 45699999999999999764 4567899999999864322 2245799999999 8999999999887654 7
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCC--C--CcEEEeeccc
Q 005916 104 VNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGN--Q--GEVKIGDLGL 178 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~--~--g~vKL~DFGl 178 (670)
+|+|||||. |+|.+++.... .+.+..++.|+.||+.||.|||+++ |+||||||+|||++.. + ..+||+|||+
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999999996 59999988664 4566677899999999999999998 9999999999999521 2 3588999999
Q ss_pred hhhhccc-----ccccccCCCccCCCcccc----CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 179 ATIMEQA-----NAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 179 a~~~~~~-----~~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
+..+... .....+||+.|+|||++. ..++.++|||||||++|+|++ |..||... ...+....+.....+
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~-~~~~~~~~~~~~~~~ 248 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS-LQRQANILLGACSLD 248 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST-TTHHHHHHTTCCCCT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh-hHHHHHHHhccCCcc
Confidence 9876532 234578999999999875 457889999999999999999 99999663 333322222211111
Q ss_pred -CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 249 -AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 249 -~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.......++.+++||.+||. +|.+|||+.++|+||||..
T Consensus 249 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 11112234668999999996 8999999999999999974
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=345.77 Aligned_cols=243 Identities=29% Similarity=0.482 Sum_probs=195.2
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
..+.|++.+.||+|+||+||+|.+. +..||+|++.. ....+.+.+|+.+|++++||||+++++++.+ .
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~ 73 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACLN----P 73 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT----T
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----C
Confidence 3467999999999999999999764 78999998753 2346778999999999999999999998752 3
Q ss_pred EEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhc---CCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 104 VNIITELFTSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHS---HDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs---~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.++||||+.+|+|.+++.... .+++..+..|+.||+.||.|||+ ++ |+||||||+|||++.+...+||+|||
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg 151 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFG 151 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccc
Confidence 789999999999999998765 47899999999999999999999 56 99999999999998443348999999
Q ss_pred chhhhcccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCC-HHHHHHHHhcCCCCCcccCCC
Q 005916 178 LATIMEQANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRN-SAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 178 la~~~~~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~-~~~i~~~i~~g~~p~~~~~~~ 255 (670)
++...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||..... ...+...+..+..+ ......
T Consensus 152 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (307)
T 2eva_A 152 TACDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNL 229 (307)
T ss_dssp C-------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTC
T ss_pred cccccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-Cccccc
Confidence 99766432 23457999999999775 4789999999999999999999999976433 33344445554433 344557
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
++.++++|.+||. +|.+|||+.+++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 8999999999996 89999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=339.14 Aligned_cols=247 Identities=23% Similarity=0.267 Sum_probs=197.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
+..|++.+.||+|+||+||+|.+..+|..||+|++..... ...+.+|+.+++.++|++++..+..+.... ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~~ 80 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEG-DYN 80 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET-TEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCCC-Cce
Confidence 4679999999999999999999999999999998765432 234778999999999988887777665443 478
Q ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe--CCCCcEEEeeccchhh
Q 005916 105 NIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATI 181 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~--~~~g~vKL~DFGla~~ 181 (670)
++||||+ +|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..++.+||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999999 9999999885 467999999999999999999999998 99999999999993 2567999999999987
Q ss_pred hcccc---------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCH--HHHHHHHhcCC---
Q 005916 182 MEQAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNS--AQIYKKVSSGI--- 246 (670)
Q Consensus 182 ~~~~~---------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~--~~i~~~i~~g~--- 246 (670)
..... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.... ...+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 65432 23568999999999764 57899999999999999999999999764321 12222222211
Q ss_pred CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 247 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 247 ~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.........++.+++||.+||. +|.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1112224467899999999996 8999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=337.78 Aligned_cols=244 Identities=24% Similarity=0.435 Sum_probs=206.3
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||+||+|.+. .+..||+|.+..... ..+.+.+|+.+|+.++||||+++++++.+. .
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 81 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---P 81 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCCCcCcceEEEEEcCC---C
Confidence 3467999999999999999999875 677899999874321 246788999999999999999999987532 4
Q ss_pred EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARL 158 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEE
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEc-CCCCEEECCCccccc
Confidence 889999999999999987543 6999999999999999999999998 99999999999998 678999999999987
Q ss_pred hcccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 182 MEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 182 ~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
..... .....||+.|+|||++. +.++.++|||||||++|+|++ |..||.+ .....+...+..+..+ ..+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 236 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRPDNCP 236 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCC
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCccccc
Confidence 65432 23456788999999775 568999999999999999999 9999987 4566666777665433 3345678
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+.+.++|.+||. +|.+|||+.++++
T Consensus 237 ~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 237 EELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999996 8999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.54 Aligned_cols=249 Identities=23% Similarity=0.400 Sum_probs=198.7
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEc---CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDE---VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~---~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
.....|.+.+.||+|+||+||+|.+. .++..||+|.++... .....+.+.+|+.+|++|+||||+++++++.+.
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 34567899999999999999999877 567789999987432 456677899999999999999999999998654
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
. .+++|||||.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 119 ~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~ 193 (373)
T 2qol_A 119 K--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGL 193 (373)
T ss_dssp S--SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC--
T ss_pred C--ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEc-CCCCEEECcCcc
Confidence 3 6899999999999999998764 6999999999999999999999998 99999999999998 668999999999
Q ss_pred hhhhcccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcc
Q 005916 179 ATIMEQAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAAL 251 (670)
Q Consensus 179 a~~~~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~ 251 (670)
+....... .....+|+.|+|||++. +.|+.++|||||||++|+|++ |..||.. .....+...+..+... ..
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~~~~-~~ 271 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEGYRL-PP 271 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTTEEC-CC
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CC
Confidence 98765432 12234578899999764 679999999999999999997 9999987 4566666667665422 22
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+...+..+.++|.+||. +|.+||++.++++
T Consensus 272 ~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 34567899999999996 8999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=369.66 Aligned_cols=245 Identities=24% Similarity=0.386 Sum_probs=209.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...|++.+.||+|+||+||+|.++.++..||+|.++... ...+.+.+|+.+|++|+|||||++++++.+.. .+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~ 291 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PF 291 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC--cE
Confidence 456999999999999999999999999999999987532 22567899999999999999999999986544 68
Q ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
|+|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG-ENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEECC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEC-CCCcEEEeecccceec
Confidence 9999999999999999874 45899999999999999999999998 99999999999998 5689999999999876
Q ss_pred cccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 183 EQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 183 ~~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
.... .....+|+.|+|||++. +.|+.++|||||||++|+|++ |..||.+ .+..+++..+..+... ..+...++
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 446 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPE 446 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCH
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCH
Confidence 4432 23345678999999774 679999999999999999999 9999987 4555666667665432 34456789
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+++||.+||. +|.+|||+.++++
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHH
Confidence 99999999996 8999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=363.53 Aligned_cols=244 Identities=22% Similarity=0.420 Sum_probs=207.0
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||+||+|.+. .+..||+|.++... ...+.+.+|+.+|+.|+|||||++++++.. ..
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~ 256 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EP 256 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEECS---SS
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC---Cc
Confidence 3467999999999999999999875 57889999987533 235678999999999999999999998742 35
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+|+|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARV 333 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTCCEEECSTTGGGG
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEC-CCCcEEEeeCCCceE
Confidence 89999999999999998754 36899999999999999999999998 99999999999998 678999999999987
Q ss_pred hcccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 182 MEQAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 182 ~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
..... .....+|+.|+|||++. +.|+.++|||||||++|+|++ |..||.+ .+..++...+..+.... .+...+
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~ 411 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRMP-RPENCP 411 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCCCC-CCTTSC
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCC
Confidence 64422 23445678999999774 679999999999999999999 9999987 45666666676664332 345578
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+++.+||.+||. +|.+|||+.+++.
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 999999999996 8999999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=344.52 Aligned_cols=247 Identities=27% Similarity=0.429 Sum_probs=193.1
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC--CCCCeeeeeeEEEeCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL--KHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L--~HpNIVkl~~~~~d~~ 100 (670)
...+.|++.+.||+|+||+||+|.+. |..||+|++.... ......|.+++..+ +||||+++++++.+..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 34467999999999999999999875 8999999986432 23445566666555 9999999999988764
Q ss_pred C--CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC--------CCCeeeecCccccEEEeCCCCc
Q 005916 101 N--KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH--------DPPIIHRDLKCDNIFINGNQGE 170 (670)
Q Consensus 101 ~--~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~--------g~~IIHrDLKpeNILl~~~~g~ 170 (670)
. ..+|+|||||.+|+|.++++.. .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK-KNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC-TTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC-CCCC
Confidence 3 4799999999999999999765 699999999999999999999998 6 99999999999998 6689
Q ss_pred EEEeeccchhhhcccc------cccccCCCccCCCccccCC-CCcc------ceeeeccchhhhhhhc----------cC
Q 005916 171 VKIGDLGLATIMEQAN------AKSVIGTPEFMAPELYDEN-YNEL------ADIYSFGMCMLEMVTF----------EY 227 (670)
Q Consensus 171 vKL~DFGla~~~~~~~------~~~~~GTp~YmAPEvl~~~-ys~~------~DIWSLGvilyeLltG----------~~ 227 (670)
+||+|||++..+.... .....||+.|+|||++.+. +... +|||||||++|+|++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997664322 2356899999999987543 4443 8999999999999999 77
Q ss_pred CCCCCC----CHHHHHHHHhcCCCCCcccC-----CCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 228 PYSECR----NSAQIYKKVSSGIKPAALSK-----VKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 228 Pf~~~~----~~~~i~~~i~~g~~p~~~~~-----~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
||.... ........+........++. ..++++.+||.+||. +|.+|||+.++++|
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 775432 22233333322222222221 234678999999996 89999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=357.01 Aligned_cols=255 Identities=22% Similarity=0.372 Sum_probs=200.6
Q ss_pred cccCCCCCeEEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeE
Q 005916 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNS 95 (670)
Q Consensus 19 ~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~ 95 (670)
+.+.+....|++.++||+|+||+||+|.+..+ +..||+|.++.. ......+++.+|+.+|+.++||||++++++
T Consensus 82 ~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~ 158 (373)
T 3c1x_A 82 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158 (373)
T ss_dssp TBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEE
T ss_pred cccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34556677899999999999999999987543 346788877532 345667889999999999999999999998
Q ss_pred EEeCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 96 WIDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 96 ~~d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
+.... ...++|||||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 159 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~ 234 (373)
T 3c1x_A 159 CLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVA 234 (373)
T ss_dssp ECCCS-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEEC
T ss_pred EEcCC-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC-CCCCEEEe
Confidence 76543 3678999999999999999865 45899999999999999999999998 99999999999998 67899999
Q ss_pred eccchhhhcccc------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCC
Q 005916 175 DLGLATIMEQAN------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGI 246 (670)
Q Consensus 175 DFGla~~~~~~~------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~ 246 (670)
|||++..+.... .....||+.|+|||++ ...|+.++|||||||++|+|++ |.+||... +...+...+..+.
T Consensus 235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-~~~~~~~~~~~~~ 313 (373)
T 3c1x_A 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 313 (373)
T ss_dssp CC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CSSCHHHHHHTTC
T ss_pred eccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-CHHHHHHHHHcCC
Confidence 999998664322 2334678899999976 4679999999999999999999 67788763 3344445555554
Q ss_pred CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 247 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 247 ~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.+ ..+...++.+.++|.+||. +|.+|||+.+++++
T Consensus 314 ~~-~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 314 RL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32 3345578899999999996 89999999999974
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=347.25 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=206.3
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEE----EcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAF----DEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~----d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
.....+.|++.+.||+|+||+||+|. +..+|..||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 44557789999999999999999998 4678999999998743 345677899999999999999999999998
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEee
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 175 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~D 175 (670)
.......+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kL~D 188 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGD 188 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECC
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEc-CCCcEEEec
Confidence 776555789999999999999999876 46999999999999999999999998 99999999999998 568999999
Q ss_pred ccchhhhcccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCC-----------C----
Q 005916 176 LGLATIMEQAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR-----------N---- 234 (670)
Q Consensus 176 FGla~~~~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~-----------~---- 234 (670)
||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.... .
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 99998765432 23346788899999764 568999999999999999999999985411 0
Q ss_pred HHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 235 SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 235 ~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
...+...+..+.. ...+...++++.+||.+||. +|.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 269 VFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0012223333322 23345678999999999996 8999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.47 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=201.0
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lV 107 (670)
|...+.||+|+||+||+|.+ ++..||+|++............+.+.+|+.+++.++||||+++++++.+.. .+++|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD--DLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC--ceEEE
Confidence 33457999999999999975 688999999975443344566788999999999999999999999886544 68999
Q ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 108 TELFTSGSLRQYRKK---HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 108 mEy~~gGsL~~~i~~---~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD-EAFTAKISDFGLARASEK 185 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc-CCCcEEEeeccccccccc
Confidence 999999999999874 356999999999999999999999998 99999999999998 678999999999876643
Q ss_pred cc----cccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHH---HHHHHHhcCCC---------C
Q 005916 185 AN----AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSA---QIYKKVSSGIK---------P 248 (670)
Q Consensus 185 ~~----~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~---~i~~~i~~g~~---------p 248 (670)
.. .....||+.|+|||++.+.++.++|||||||++|+|++|.+||....... .+...+..... .
T Consensus 186 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 186 FAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp CSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred ccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 22 23467999999999988889999999999999999999999997643322 22222222111 0
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.......+..+.++|.+||. +|.+|||+.+++++
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11112234678899999996 89999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=353.35 Aligned_cols=258 Identities=22% Similarity=0.356 Sum_probs=201.5
Q ss_pred CcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 005916 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 97 (670)
Q Consensus 18 ~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~ 97 (670)
..+.......|++.+.||+|+||+||+|.+ .+|..||+|++...... ....++.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 334445667789999999999999999974 46899999998754321 12235889999999999999999999987
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHhhhhcC---CCCeeeecCccccEEEeCCCCc
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKHK----KVDMKAVKGWARQILSGLIYLHSH---DPPIIHRDLKCDNIFINGNQGE 170 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~~----~lse~~i~~i~~QIl~aL~yLHs~---g~~IIHrDLKpeNILl~~~~g~ 170 (670)
+.. ..++|||||.+|+|.+++.... .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.
T Consensus 98 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~-~~~~ 172 (326)
T 3uim_A 98 TPT--ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFE 172 (326)
T ss_dssp CSS--CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEEC-TTCC
T ss_pred cCC--ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEEC-CCCC
Confidence 654 5789999999999999998653 499999999999999999999998 7 99999999999998 6689
Q ss_pred EEEeeccchhhhcccc---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCC----CCHHHHHHHH
Q 005916 171 VKIGDLGLATIMEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSEC----RNSAQIYKKV 242 (670)
Q Consensus 171 vKL~DFGla~~~~~~~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~----~~~~~i~~~i 242 (670)
+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++|..||... .........+
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 9999999998764322 3445699999999977 567899999999999999999999999521 1111111112
Q ss_pred hcCCCCCc------------ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 243 SSGIKPAA------------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 243 ~~g~~p~~------------~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
........ .....+..+.+++.+||. +|.+|||+.++++|-.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 11111111 111112678999999996 8999999999999754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.58 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=204.6
Q ss_pred CCcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Q 005916 17 DVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSW 96 (670)
Q Consensus 17 ~~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~ 96 (670)
.+.+.......|++.+.||+|+||+||+|.+. +|..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34445555677899999999999999999864 68999999876432 34567889999999999999999999988
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEE
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHK----KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVK 172 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~----~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vK 172 (670)
.+.. .+++|||||.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 105 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~k 179 (321)
T 2qkw_B 105 DERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD-ENFVPK 179 (321)
T ss_dssp CCTT--CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC-TTCCEE
T ss_pred cCCC--eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC-CCCCEE
Confidence 6543 6899999999999999886543 5899999999999999999999998 99999999999998 678999
Q ss_pred Eeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHH-----HH-HHH
Q 005916 173 IGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSA-----QI-YKK 241 (670)
Q Consensus 173 L~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~-----~i-~~~ 241 (670)
|+|||++....... .....||+.|+|||++ .+.++.++|||||||++|+|++|..||....... .. ...
T Consensus 180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 259 (321)
T 2qkw_B 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259 (321)
T ss_dssp ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence 99999997654321 2345689999999976 5679999999999999999999999997532211 10 111
Q ss_pred HhcCCCCC--------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcc
Q 005916 242 VSSGIKPA--------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPF 284 (670)
Q Consensus 242 i~~g~~p~--------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf 284 (670)
...+.... ......+..+.+++.+||. +|.+|||+.+++++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111111 1111224578899999996 8999999999998743
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=373.74 Aligned_cols=244 Identities=20% Similarity=0.352 Sum_probs=204.7
Q ss_pred EEE-EEEecccCCeEEEEEEE--cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 28 IRY-KEVIGKGAFKTVYKAFD--EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 28 yr~-~~~LG~G~fG~Vy~a~d--~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
+.+ .+.||+|+||+||+|.+ +.++..||+|+++... ......+.+.+|+.+|+.|+|||||++++++.+. .+
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~ 444 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SW 444 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CE
Confidence 444 45899999999999954 4677899999987532 2345567899999999999999999999988533 48
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
++|||||.+|+|.+++...+.+++..++.|+.||+.||.|||+++ ||||||||+|||++ .++.+||+|||++..+..
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEe-CCCCEEEEEcCCcccccc
Confidence 899999999999999999999999999999999999999999998 99999999999998 568999999999987754
Q ss_pred cc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 185 AN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 185 ~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
.. .....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.+ .+...+...+..+..+ ..+...++
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~ 599 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPR 599 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCH
Confidence 32 22345788999999774 579999999999999999998 9999987 5666777777776543 34556789
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
++.+||.+||. +|.+|||+.++++
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999996 8999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=352.49 Aligned_cols=245 Identities=21% Similarity=0.289 Sum_probs=192.3
Q ss_pred ccCCCCCeEEEEEEecccCCeEEEEE-----EEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC---CCCeee
Q 005916 20 ETDPTCRYIRYKEVIGKGAFKTVYKA-----FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK---HNNIIR 91 (670)
Q Consensus 20 e~dp~gr~yr~~~~LG~G~fG~Vy~a-----~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~---HpNIVk 91 (670)
+....++.|++.+.||+|+||+||+| .+..++..||+|++.... ...+..|+++++.|+ |+||++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 33455788999999999999999999 477889999999986432 345778888888886 999999
Q ss_pred eeeEEEeCCCCeEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC
Q 005916 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKK-----HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166 (670)
Q Consensus 92 l~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~-----~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~ 166 (670)
+++++.... ..|+|||||.+|+|.+++.. .+.+++..++.|+.||+.||.|||+++ ||||||||+|||++.
T Consensus 132 ~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 132 FYSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGN 207 (365)
T ss_dssp EEEEEECSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECG
T ss_pred hheeeecCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecc
Confidence 999987655 68999999999999999874 467999999999999999999999998 999999999999973
Q ss_pred C----------CCcEEEeeccchhhhcc----cccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCC
Q 005916 167 N----------QGEVKIGDLGLATIMEQ----ANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSE 231 (670)
Q Consensus 167 ~----------~g~vKL~DFGla~~~~~----~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~ 231 (670)
. .+.+||+|||++..+.. ......+||+.|||||++. ..|+.++|||||||++|+|+||..||..
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 1 68999999999976542 2245678999999999774 4689999999999999999999999965
Q ss_pred CCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 232 CRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 232 ~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..... +. .....+ ....+..+.+++.+||. +|.+|++..+.|.+
T Consensus 288 ~~~~~--~~--~~~~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 288 NEGGE--CK--PEGLFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp EETTE--EE--ECSCCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred CCCCc--ee--echhcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 22110 00 000111 11235678999999996 78877654444443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=357.75 Aligned_cols=251 Identities=19% Similarity=0.206 Sum_probs=195.4
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc----CCHHHHHHHHHHHHHHHhCC---------CCCe
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL----QSPEDLERLYSEVHLLKSLK---------HNNI 89 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~----~s~~~~e~l~~Ei~iLk~L~---------HpNI 89 (670)
.....|++.+.||+|+||+||+|++ +|..||+|++...... ......+.+.+|+.+|+.|+ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3446788899999999999999987 7899999999875421 12233567889999999886 7777
Q ss_pred eeeeeEEEeC----------------------------CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 005916 90 IRFYNSWIDD----------------------------QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141 (670)
Q Consensus 90 Vkl~~~~~d~----------------------------~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~a 141 (670)
|++++.+... ....+|+|||||.+|++.+.+.+ +.+++..++.|++||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 7776654321 14579999999999977666643 678999999999999999
Q ss_pred Hhhhh-cCCCCeeeecCccccEEEeCCCC--------------------cEEEeeccchhhhcccccccccCCCccCCCc
Q 005916 142 LIYLH-SHDPPIIHRDLKCDNIFINGNQG--------------------EVKIGDLGLATIMEQANAKSVIGTPEFMAPE 200 (670)
Q Consensus 142 L~yLH-s~g~~IIHrDLKpeNILl~~~~g--------------------~vKL~DFGla~~~~~~~~~~~~GTp~YmAPE 200 (670)
|.||| +++ |+||||||+|||++. +| .+||+|||+|+.... ...+||+.|||||
T Consensus 174 L~~lH~~~~--ivHrDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---~~~~gt~~y~aPE 247 (336)
T 2vuw_A 174 LAVAEASLR--FEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHC--CBCSCCCGGGEEEEE-CSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---TEEECCCCTTCSG
T ss_pred HHHHHHhCC--EeECCCCHHHEEEec-cCCcceeeeccCccccccCCCceEEEeeccccEecCC---CcEEEeecccChh
Confidence 99999 898 999999999999984 44 899999999987654 3458999999999
Q ss_pred cccCCCCccceeeeccch-hhhhhhccCCCCCCCCHHHHHHHHhcCC-C----CCcccCCCChHHHHHHHHcCCCCCCCC
Q 005916 201 LYDENYNELADIYSFGMC-MLEMVTFEYPYSECRNSAQIYKKVSSGI-K----PAALSKVKDPEVKSFIEKCLVPASQRL 274 (670)
Q Consensus 201 vl~~~ys~~~DIWSLGvi-lyeLltG~~Pf~~~~~~~~i~~~i~~g~-~----p~~~~~~~s~~~k~fI~kcL~dP~~Rp 274 (670)
++.+..+.++||||||++ .+++++|..||........+...+.... . +.......++++++||.+||..+
T Consensus 248 ~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 248 LFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 998777999999998776 8889999999964211122333333221 1 11122335789999999999633
Q ss_pred CHHHHh-cCcccc
Q 005916 275 SAKELL-MDPFLQ 286 (670)
Q Consensus 275 Sa~elL-~hpf~~ 286 (670)
||.|+| +||||+
T Consensus 324 sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHCGGGC
T ss_pred CHHHHHhcCCCcC
Confidence 999999 999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=341.12 Aligned_cols=245 Identities=28% Similarity=0.429 Sum_probs=199.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHh--CCCCCeeeeeeEEEeCCC-
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS--LKHNNIIRFYNSWIDDQN- 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~--L~HpNIVkl~~~~~d~~~- 101 (670)
.+.|++.+.||+|+||+||+|.+ +|..||+|++... ....+.+|+++++. ++||||+++++++.....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 46799999999999999999987 5999999998632 24567789999988 699999999999876543
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh--------cCCCCeeeecCccccEEEeCCCCcEE
Q 005916 102 -KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH--------SHDPPIIHRDLKCDNIFINGNQGEVK 172 (670)
Q Consensus 102 -~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLH--------s~g~~IIHrDLKpeNILl~~~~g~vK 172 (670)
..+|+||||+.+|+|.+++.+. .+++..++.++.||+.||.||| +++ |+||||||+|||++ .++.+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~~k 187 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCC 187 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC-TTSCEE
T ss_pred cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC-CCCCEE
Confidence 2689999999999999999764 6999999999999999999999 777 99999999999998 668999
Q ss_pred Eeeccchhhhcccc------cccccCCCccCCCccccCC-------CCccceeeeccchhhhhhhc----------cCCC
Q 005916 173 IGDLGLATIMEQAN------AKSVIGTPEFMAPELYDEN-------YNELADIYSFGMCMLEMVTF----------EYPY 229 (670)
Q Consensus 173 L~DFGla~~~~~~~------~~~~~GTp~YmAPEvl~~~-------ys~~~DIWSLGvilyeLltG----------~~Pf 229 (670)
|+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999997765432 2456899999999987653 33689999999999999999 7888
Q ss_pred CCCC----CHHHHHHHHhcCCCCCcccC-----CCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 230 SECR----NSAQIYKKVSSGIKPAALSK-----VKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 230 ~~~~----~~~~i~~~i~~g~~p~~~~~-----~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.... ....+...+........++. .....+.++|.+||. +|.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 6532 33455555544333222221 123578899999996 89999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=358.61 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=201.7
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||+||+|.+.. +..||+|.++.... ..+.+.+|+.+|+.|+||||+++++++.+ ..
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~ 252 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EP 252 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC---Cc
Confidence 34679999999999999999998875 46799999875331 24578899999999999999999998754 35
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+|+|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARL 329 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC-
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEC-CCCCEEECCCcccee
Confidence 89999999999999998753 56999999999999999999999998 99999999999998 568999999999987
Q ss_pred hcccc---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 182 MEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 182 ~~~~~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
..... .....+|+.|+|||++ .+.|+.++|||||||++|+|++ |..||.+ ....++...+..+..+ ..+...+
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~ 407 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPECP 407 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTSC
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCC
Confidence 65432 2334578899999976 4679999999999999999999 9999987 4566677777766433 2345678
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+.+.+||.+||. +|.+|||+.+++.
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 899999999996 8999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=370.33 Aligned_cols=249 Identities=18% Similarity=0.353 Sum_probs=203.3
Q ss_pred eEEEEEEecccCCeEEEEEEEc--CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~--~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
++.....||+|+||+||+|.++ .++..||+|+++... .....+.+.+|+.+|+.|+|||||++++++.+. .+
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~ 410 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---AL 410 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---SE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---Ce
Confidence 3444448999999999999876 456789999987542 233467889999999999999999999998653 48
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
|+|||||.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+.
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLV-NRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEc-CCCcEEEeeccCccccc
Confidence 9999999999999998754 46999999999999999999999998 99999999999998 56899999999998764
Q ss_pred ccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 184 QAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 184 ~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
... .....+|+.|+|||++. +.|+.++|||||||++|+|++ |..||.+. +..++...+..+..+ ..+...+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~ 565 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPECP 565 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CSHHHHHHHHTTCCC-CCCTTCC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCC
Confidence 322 12234578999999774 679999999999999999998 99999884 455667777776543 3455678
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHh---cCcccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELL---MDPFLQ 286 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL---~hpf~~ 286 (670)
+++.+||.+||. +|.+||++.+++ ++.|+.
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 999999999996 899999999985 445544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.24 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=206.2
Q ss_pred cccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 19 ~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
.+.......|++.+.||+|+||+||+|.+.. .||+|++..... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 3334455679999999999999999998764 499999875432 12233457789999999999999999999876
Q ss_pred CCCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 99 DQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 99 ~~~~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.. .+++||||+.|++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||
T Consensus 101 ~~--~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~~~~~l~Dfg 174 (319)
T 2y4i_B 101 PP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFG 174 (319)
T ss_dssp SS--CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCS
T ss_pred CC--ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--CCCEEEeecC
Confidence 54 6999999999999999988765 6999999999999999999999998 99999999999997 4799999999
Q ss_pred chhhhccc-------ccccccCCCccCCCcccc----------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHH
Q 005916 178 LATIMEQA-------NAKSVIGTPEFMAPELYD----------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240 (670)
Q Consensus 178 la~~~~~~-------~~~~~~GTp~YmAPEvl~----------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~ 240 (670)
++...... ......||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .....+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~ 253 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIW 253 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHH
Confidence 98765321 123456899999999774 2478999999999999999999999987 55666667
Q ss_pred HHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 241 KVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 241 ~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+..+..+.......+.++.++|.+||. +|.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 254 QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 7777766555555678899999999996 8999999999997
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=361.66 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=206.7
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
....|++.+.||+|+||+||+|.+.. +..||+|+++.... ..+.+.+|+.+|+.|+|||||++++++.+ ..
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~ 335 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EP 335 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee---cc
Confidence 35679999999999999999998865 46799999875431 24578899999999999999999998754 35
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 104 VNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+|+|||||.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARL 412 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCTTSTTT
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEc-CCCcEEEccccccee
Confidence 89999999999999998753 56999999999999999999999998 99999999999998 567999999999987
Q ss_pred hcccc---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 182 MEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 182 ~~~~~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
..... .....+++.|+|||++ .+.|+.++|||||||++|+|++ |..||.+ ....++...+..+... ..+...+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~ 490 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPECP 490 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCC
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCC
Confidence 65322 2344578899999966 5679999999999999999999 9999987 4566677777766432 2345678
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+.+||.+||. +|.+|||+.+|+.
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 899999999996 8999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=380.61 Aligned_cols=258 Identities=29% Similarity=0.401 Sum_probs=205.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe----CC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID----DQ 100 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d----~~ 100 (670)
...|++.+.||+|+||+||+|.+..+|..||+|+++.. ......+++.+|+.+|+.++||||+++++++.+ ..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 35689999999999999999999999999999988643 246677889999999999999999999998654 12
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC--CcEEEee
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHK---KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ--GEVKIGD 175 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~--g~vKL~D 175 (670)
+...|+|||||.||+|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+. ..+||+|
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcc
Confidence 457899999999999999998754 6999999999999999999999998 99999999999998432 2499999
Q ss_pred ccchhhhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHh----------
Q 005916 176 LGLATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS---------- 243 (670)
Q Consensus 176 FGla~~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~---------- 243 (670)
||++....... .....||+.|+|||++. ..|+.++|||||||++|+|++|..||............+.
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 99998775543 35678999999999775 6799999999999999999999999976432222111000
Q ss_pred ---cCC--------CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 244 ---SGI--------KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 244 ---~g~--------~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.+. .+..+....++.+.+||.+||. +|.+|||+.++|+||||+.
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000 1112223346789999999996 8999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=365.21 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=206.1
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
....|++.+.||+|+||+||+|.+..+ +..||+|.+... ......+++.+|+.+|+.++||||+++++++.+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 462 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-- 462 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 346799999999999999999998653 567888877532 345667889999999999999999999998743
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
..+|+|||||.+|+|.+++...+ .+++..+..|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~~~vkL~DFG~a 538 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLS 538 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCCC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEe-CCCCEEEEecCCC
Confidence 25889999999999999998664 6999999999999999999999998 99999999999998 5689999999999
Q ss_pred hhhcccc---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 180 TIMEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 180 ~~~~~~~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
....... .....||+.|+|||++ ...|+.++|||||||++|+|++ |..||.+ .....+...+..+..+ ..+..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~ 616 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPN 616 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCC-CCCTT
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCC-CCCcc
Confidence 8765432 2345678899999976 4679999999999999999997 9999987 4556666666665433 34556
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.++.+.+||.+||. +|.+|||+.+++..
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 78999999999996 89999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=354.51 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=198.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN-IIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN-IVkl~~~~~d~~~~~ 103 (670)
+..|++.++||+|+||+||+|.+..+|..||+|++...... ..+.+|+.+++.|.|++ |..++.++.+ ...
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~ 77 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVE--GDY 77 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEee--CCE
Confidence 56799999999999999999999999999999988754432 23778999999997754 4444444433 347
Q ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEe--CCCCcEEEeeccchh
Q 005916 104 VNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLAT 180 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~--~~~g~vKL~DFGla~ 180 (670)
.++||||| +++|.+++.. .+.+++..++.|+.||+.||.|||+++ ||||||||+||||+ ...+.+||+|||++.
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 89999999 9999999986 567999999999999999999999998 99999999999994 256899999999998
Q ss_pred hhcccc---------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCC--HHHHHHHHhcCC--
Q 005916 181 IMEQAN---------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRN--SAQIYKKVSSGI-- 246 (670)
Q Consensus 181 ~~~~~~---------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~--~~~i~~~i~~g~-- 246 (670)
.+.... .....||+.|+|||++ ...|+.++|||||||++|+|++|..||.+... ..+.+..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 765432 1267899999999976 45799999999999999999999999987433 334444333221
Q ss_pred -CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 247 -KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 247 -~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
....+....+.++.+||.+||. +|.+||++.+|++
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1112334567899999999996 8999999998875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=352.92 Aligned_cols=251 Identities=17% Similarity=0.192 Sum_probs=191.3
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-CCeee----------
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIR---------- 91 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H-pNIVk---------- 91 (670)
...+.|++.++||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+++.|.| +|+..
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 345668899999999999999999999999999998874332 222346778999999999977 32211
Q ss_pred -----------eeeEEEeCC---CCeEEEEEecCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHhhhhcCCC
Q 005916 92 -----------FYNSWIDDQ---NKTVNIITELFTSGSLRQYRKK-------HKKVDMKAVKGWARQILSGLIYLHSHDP 150 (670)
Q Consensus 92 -----------l~~~~~d~~---~~~~~lVmEy~~gGsL~~~i~~-------~~~lse~~i~~i~~QIl~aL~yLHs~g~ 150 (670)
++.++.... ...++++|+++ +++|.+++.. .+.+++..+..++.||+.||.|||+++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 231 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 111111111 12467888876 6799988752 234788899999999999999999998
Q ss_pred CeeeecCccccEEEeCCCCcEEEeeccchhhhcccccccccCCCccCCCccc----------c-CCCCccceeeeccchh
Q 005916 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY----------D-ENYNELADIYSFGMCM 219 (670)
Q Consensus 151 ~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl----------~-~~ys~~~DIWSLGvil 219 (670)
|+||||||+|||++ .+|.+||+|||++...... ....+| +.|+|||++ . ..|+.++|||||||++
T Consensus 232 -iiHrDiKp~NILl~-~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp -EECSCCCGGGEEEC-TTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred -cccCCcccceEEEe-cCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999998 6689999999998776544 456678 999999976 2 2478899999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 220 LEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 220 yeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
|+|++|..||.... .......+.. .....++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 308 ~elltg~~Pf~~~~-~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 308 YWIWCADLPNTDDA-ALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHSSCCCCTTG-GGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHCCCCCCCcc-hhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999999997632 2222221211 112457899999999997 8999999999999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=326.77 Aligned_cols=234 Identities=14% Similarity=0.123 Sum_probs=188.4
Q ss_pred CCCcccC-CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeee
Q 005916 16 PDVLETD-PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYN 94 (670)
Q Consensus 16 ~~~~e~d-p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~ 94 (670)
+.+...+ ..+.+|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+++.+|+.+++.++||||+++++
T Consensus 20 ~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~ 98 (286)
T 3uqc_A 20 VQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG-VLPDDVLQETLSRTLRLSRIDKPGVARVLD 98 (286)
T ss_dssp CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC-CSCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccc-ccCHHHHHHHHHHHHHHhcCCCCCcceeeE
Confidence 3444444 45577999999999999999999999999999999997543 334566788999999999999999999999
Q ss_pred EEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 95 SWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 95 ~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
++.+.. .+|+|||||.|++|.++++. + .....+..|+.||+.||.|||++| |+||||||+|||++ .+|.+||+
T Consensus 99 ~~~~~~--~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~-~~g~~kl~ 171 (286)
T 3uqc_A 99 VVHTRA--GGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVS-IDGDVVLA 171 (286)
T ss_dssp EEEETT--EEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-TTSCEEEC
T ss_pred EEEECC--cEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEc-CCCCEEEE
Confidence 987654 79999999999999999854 3 466678999999999999999998 99999999999998 67899987
Q ss_pred eccchhhhcccccccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHH---HHHHhcCC-CCCc
Q 005916 175 DLGLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI---YKKVSSGI-KPAA 250 (670)
Q Consensus 175 DFGla~~~~~~~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i---~~~i~~g~-~p~~ 250 (670)
++ .|++| ++.++|||||||++|+|++|..||.+......+ ++.+.... .+..
T Consensus 172 ~~------------------~~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T 3uqc_A 172 YP------------------ATMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPAD 227 (286)
T ss_dssp SC------------------CCCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHH
T ss_pred ec------------------cccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhh
Confidence 43 44554 789999999999999999999999874332211 01111111 1112
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.....++++++||.+||. +|.+| |+.++++.
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 334567899999999996 89999 99999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=370.57 Aligned_cols=244 Identities=21% Similarity=0.287 Sum_probs=201.3
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcC-CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC-
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEV-NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN- 101 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~-tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~- 101 (670)
....|++.+.||+|+||+||+|.+.. +|+.||+|++... ......+.+.+|+.+|+.|+|||||+++++|.....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 34679999999999999999999976 7999999988643 245667788999999999999999999999876543
Q ss_pred --CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 102 --KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 102 --~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
..+|+|||||.|++|.+++.. .+++..++.|+.||+.||.|||+++ ||||||||+|||++. +.+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~--~~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECS--SCEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeC--CcEEEEecccc
Confidence 127999999999999987755 7999999999999999999999998 999999999999984 48999999999
Q ss_pred hhhcccccccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 180 TIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 180 ~~~~~~~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
...... ...+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+... .+..........++.+
T Consensus 229 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l 297 (681)
T 2pzi_A 229 SRINSF--GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSY 297 (681)
T ss_dssp EETTCC--SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHH
T ss_pred hhcccC--CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHH
Confidence 876543 56789999999999887789999999999999999999999865210 0110000111135789
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.+||.+||. +|.+||++.+.+.|+|+..
T Consensus 298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 999999996 8999999999999999853
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=310.79 Aligned_cols=190 Identities=14% Similarity=0.053 Sum_probs=139.3
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccC------CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeE
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ------SPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~------s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~ 104 (670)
..++.|+.|.+..++....|..||+|++....... .....+.+.+|+++|+++ .|+||+++++++.++. .+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~--~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ--SG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS--EE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC--EE
Confidence 34677888888888888899999999998643211 133456799999999999 8999999999987655 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|||||||+||+|.+++...+++++. .|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEEC-TTSCEEECCCTTEESCC-
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEEC-CCCCEEEeecccCeeCCC
Confidence 9999999999999999999999875 47899999999999999 99999999999998 678999999999987754
Q ss_pred c--ccccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCC
Q 005916 185 A--NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPY 229 (670)
Q Consensus 185 ~--~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf 229 (670)
. ...+.+|||.|||||++.+.+..++|+||+|+++++|.++..|+
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred CCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence 3 34668899999999999998999999999999999998776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-27 Score=269.56 Aligned_cols=185 Identities=21% Similarity=0.209 Sum_probs=144.7
Q ss_pred EEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC----HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS----PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 29 r~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s----~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
...++||+|+||+||+| ...+..+++|.+..+..... ....+++.+|+++|++|+||||+++..++.+.. ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NK 414 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TT
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--cc
Confidence 44679999999999999 55688899998765433211 122456899999999999999995555445444 46
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|+|||||.||+|.+++.. +..|+.||+.||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTTCEECCC
T ss_pred EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECccCEECCC
Confidence 899999999999999875 6789999999999999998 999999999999983 999999999988754
Q ss_pred cc---------cccccCCCccCCCcccc---CCCCccceeeeccchhhhhhhccCCCC
Q 005916 185 AN---------AKSVIGTPEFMAPELYD---ENYNELADIYSFGMCMLEMVTFEYPYS 230 (670)
Q Consensus 185 ~~---------~~~~~GTp~YmAPEvl~---~~ys~~~DIWSLGvilyeLltG~~Pf~ 230 (670)
.. ..+.+||+.|||||++. ..|+..+|+||..+-.++.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32 24678999999999886 468889999999988888887777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.5e-24 Score=221.82 Aligned_cols=150 Identities=14% Similarity=0.148 Sum_probs=117.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC-----H---------HHHHHHHHHHHHHHhCCCCCee
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-----P---------EDLERLYSEVHLLKSLKHNNII 90 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s-----~---------~~~e~l~~Ei~iLk~L~HpNIV 90 (670)
+..|.+.+.||+|+||.||+|.+ .+|..||+|.++....... . .....+.+|+.+|+.|+ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 34455669999999999999999 8899999999975321100 0 24567899999999998 4 5
Q ss_pred eeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCc
Q 005916 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGE 170 (670)
Q Consensus 91 kl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~ 170 (670)
++++++.. . ..|+|||||.||+|.+ +. ......++.||+.||.|||+++ |+||||||+|||++ +|.
T Consensus 165 ~v~~~~~~-~--~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~ 230 (282)
T 1zar_A 165 AVPKVYAW-E--GNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEG 230 (282)
T ss_dssp SSCCEEEE-E--TTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTE
T ss_pred CcCeEEec-c--ceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCc
Confidence 55554432 2 4689999999999987 31 2345679999999999999998 99999999999998 689
Q ss_pred EEEeeccchhhhcccccccccCCCccCCCcccc
Q 005916 171 VKIGDLGLATIMEQANAKSVIGTPEFMAPELYD 203 (670)
Q Consensus 171 vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl~ 203 (670)
+||+|||++.. +..++|||++.
T Consensus 231 vkl~DFG~a~~-----------~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVE-----------VGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEE-----------TTSTTHHHHHH
T ss_pred EEEEECCCCeE-----------CCCCCHHHHHH
Confidence 99999999853 45678999774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=7.8e-20 Score=187.48 Aligned_cols=145 Identities=19% Similarity=0.181 Sum_probs=111.4
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeE--EEEEEEeeccccCC--------------------HHHHHHHHHHHHHH
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLE--VAWCQVRIDDVLQS--------------------PEDLERLYSEVHLL 81 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~--vAiK~v~~~~~~~s--------------------~~~~e~l~~Ei~iL 81 (670)
.+..|.+.+.||+|+||.||+|.+..+|.. ||+|+++....... ......+.+|+.+|
T Consensus 45 ~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp TTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred CCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 355689999999999999999998788999 99998764321100 11224678999999
Q ss_pred HhCCCCCe--eeeeeEEEeCCCCeEEEEEecCCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhh-cCCCCee
Q 005916 82 KSLKHNNI--IRFYNSWIDDQNKTVNIITELFTS-G----SLRQYRKKHKKVDMKAVKGWARQILSGLIYLH-SHDPPII 153 (670)
Q Consensus 82 k~L~HpNI--Vkl~~~~~d~~~~~~~lVmEy~~g-G----sL~~~i~~~~~lse~~i~~i~~QIl~aL~yLH-s~g~~II 153 (670)
+.|.|++| ..++.. . ..++||||+.+ | +|.++... .++..+..++.||+.||.||| .++ |+
T Consensus 125 ~~l~~~~i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--iv 193 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LV 193 (258)
T ss_dssp HHHHHTTCCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EE
T ss_pred HHHHhCCCCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EE
Confidence 99988764 334432 1 35799999942 3 77766432 335578899999999999999 888 99
Q ss_pred eecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 154 HRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 154 HrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC---cEEEEECcccccC
Confidence 9999999999983 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=7.6e-16 Score=167.38 Aligned_cols=142 Identities=18% Similarity=0.172 Sum_probs=100.3
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc-----------C--CH-H--HHH--HHHHHHHHHHhCCCCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL-----------Q--SP-E--DLE--RLYSEVHLLKSLKHNN 88 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~-----------~--s~-~--~~e--~l~~Ei~iLk~L~HpN 88 (670)
-|++...||.|+||.||+|.+. +|+.||+|+++..... . .. . ... ....|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4889999999999999999874 7999999988642110 0 00 0 011 1235777888885554
Q ss_pred eeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC
Q 005916 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ 168 (670)
Q Consensus 89 IVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~ 168 (670)
+....-+... . .+|||||+.|++|.++. ....+..++.||+.+|.|||.+| ||||||||.|||++ ++
T Consensus 175 v~vp~p~~~~-~---~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~-~d 241 (397)
T 4gyi_A 175 FPVPEPIAQS-R---HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIR-EE 241 (397)
T ss_dssp CSCCCEEEEE-T---TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-EE
T ss_pred CCCCeeeecc-C---ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe-CC
Confidence 4222111111 1 36999999999886432 22345678999999999999998 99999999999998 33
Q ss_pred C----------cEEEeeccchhhh
Q 005916 169 G----------EVKIGDLGLATIM 182 (670)
Q Consensus 169 g----------~vKL~DFGla~~~ 182 (670)
| .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 3 3899999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=8.2e-11 Score=119.28 Aligned_cols=140 Identities=15% Similarity=0.032 Sum_probs=105.3
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~~~l 106 (670)
|++...+|.|+.+.||++.. .|..+++|....... .. ..++.+|+.+|+.| .+..+.+++.++.+. +..|+
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~l 87 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNL 87 (263)
T ss_dssp SEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEE
T ss_pred ceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEE
Confidence 67888899999999999964 367899998864211 11 23578899999999 467788888877653 47899
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCC-------------------------------------
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD------------------------------------- 149 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g------------------------------------- 149 (670)
|||++.|.+|.+.. .+......++.++..+|..||+..
T Consensus 88 v~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999999997652 122334578889999999999811
Q ss_pred --------------------CCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 150 --------------------PPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 150 --------------------~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+.++|+|++|.|||++ +.+.+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEEEchhccc
Confidence 3389999999999997 334456999987643
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.60 E-value=2.4e-11 Score=104.30 Aligned_cols=63 Identities=29% Similarity=0.390 Sum_probs=58.7
Q ss_pred ccchhhhheeecC---CCcee---eeecccccCCCCcCcchHHHHhcccccccChHHHHHHHHHHHHHh
Q 005916 376 EYSVSLILRIADQ---SGRLR---NIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLLNL 438 (670)
Q Consensus 376 ~~~I~liLri~D~---~g~i~---~ieF~f~~d~Dta~~Ia~EmV~~l~l~~~d~~~iA~~Id~~i~~l 438 (670)
...|+|+||+.|+ .|+.+ +|+|+|++++||+.+||+|||++++|.++|+..||+||+.-+..+
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~ 91 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLI 91 (98)
Confidence 4789999999996 48998 999999999999999999999999999999999999999987654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.94 E-value=3.6e-09 Score=105.87 Aligned_cols=135 Identities=13% Similarity=0.029 Sum_probs=93.8
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC--eeeeeeEEEeCCCCeEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN--IIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN--IVkl~~~~~d~~~~~~~ 105 (670)
+.+..+.+.|..+.||++. ..+|..+++|...... ...+.+|+.+++.|.+.+ +.+++.+..+. +..+
T Consensus 22 ~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~ 91 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDW 91 (264)
T ss_dssp CEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEE
T ss_pred CceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCE
Confidence 4554444466679999985 4567789999865321 234678999999995434 45677765543 3589
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCC------------------------------------
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD------------------------------------ 149 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g------------------------------------ 149 (670)
+||||+.|.+|. . ...+ ...++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999998884 1 1122 2356777777888887643
Q ss_pred --------------------CCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 150 --------------------PPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 150 --------------------~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+.++|+|++|.|||++ +++.+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-CCcEEEEEcchhccc
Confidence 1299999999999998 444566999997643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.91 E-value=2.3e-09 Score=114.12 Aligned_cols=144 Identities=15% Similarity=0.186 Sum_probs=102.3
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEe--eccccCCHHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEeCCC-CeEE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVR--IDDVLQSPEDLERLYSEVHLLKSLK--HNNIIRFYNSWIDDQN-KTVN 105 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~--~~~~~~s~~~~e~l~~Ei~iLk~L~--HpNIVkl~~~~~d~~~-~~~~ 105 (670)
.+.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+|+.|. +..+.+++.++.+... +..|
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 467899999999998643 4567777654 32211 12346788999999996 4557788876654321 3578
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC-------------------------------------
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH------------------------------------- 148 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~------------------------------------- 148 (670)
+||||+.|..+.+. ....++......++.+++.+|..||..
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999877431 123477888889999999999999973
Q ss_pred -------------------CCCeeeecCccccEEEeCCCCc-EEEeeccchhh
Q 005916 149 -------------------DPPIIHRDLKCDNIFINGNQGE-VKIGDLGLATI 181 (670)
Q Consensus 149 -------------------g~~IIHrDLKpeNILl~~~~g~-vKL~DFGla~~ 181 (670)
.+.++|+|++|.|||++.+.+. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 1359999999999999844323 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.70 E-value=4.8e-09 Score=109.09 Aligned_cols=184 Identities=18% Similarity=0.187 Sum_probs=119.3
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCC--eeeeeeEEEeCCC-CeEEEE
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNN--IIRFYNSWIDDQN-KTVNII 107 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpN--IVkl~~~~~d~~~-~~~~lV 107 (670)
+.++.|.+..||++. ..+++|.... .....++.+|+.+|+.| .+.. +.+++....+... ...|+|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 458999999999872 3477776432 24467789999999988 4433 2334432211111 235789
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCC--------------------------------------
Q 005916 108 TELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD-------------------------------------- 149 (670)
Q Consensus 108 mEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g-------------------------------------- 149 (670)
|+++.|..|..... ..++..+...++.|++..|..||+..
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865332 34677778888888888888888621
Q ss_pred ------------------CCeeeecCccccEEEeCC-CCcEEEeeccchhhhcccccccccCCCcc---CCCcccc---C
Q 005916 150 ------------------PPIIHRDLKCDNIFINGN-QGEVKIGDLGLATIMEQANAKSVIGTPEF---MAPELYD---E 204 (670)
Q Consensus 150 ------------------~~IIHrDLKpeNILl~~~-~g~vKL~DFGla~~~~~~~~~~~~GTp~Y---mAPEvl~---~ 204 (670)
+.++|+|++|.||+++.+ .+.+.|+||+.+..-.... .......+ ..|+... .
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHHHHHhhccccCHHHHHHHHH
Confidence 247999999999999843 4467899999876432210 00000111 2232211 1
Q ss_pred CC------------CccceeeeccchhhhhhhccCCCC
Q 005916 205 NY------------NELADIYSFGMCMLEMVTFEYPYS 230 (670)
Q Consensus 205 ~y------------s~~~DIWSLGvilyeLltG~~Pf~ 230 (670)
.| ..-.+.|++|.++|.+.+|..+|.
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 122578999999999999998873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=4.5e-06 Score=87.13 Aligned_cols=136 Identities=21% Similarity=0.156 Sum_probs=90.6
Q ss_pred EEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCC---CeeeeeeEEEeCCCCeEEEEE
Q 005916 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN---NIIRFYNSWIDDQNKTVNIIT 108 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~Hp---NIVkl~~~~~d~~~~~~~lVm 108 (670)
+.++.|....||+. |..+++|.-. ......++.+|+.+|+.|.+. .|.+.+.+... ..+..++||
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~ 92 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGY 92 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEE
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEE
Confidence 45789999999988 4567777632 234567889999999999642 24455554432 334678999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC----------------------------------------
Q 005916 109 ELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH---------------------------------------- 148 (670)
Q Consensus 109 Ey~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~---------------------------------------- 148 (670)
|++.|..|....- ..++......++.|+...|..||+.
T Consensus 93 e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 93 RKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp ECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9999988865321 2234444455555555555555432
Q ss_pred ------------------CCCeeeecCccccEEEeC--CCCc-EEEeeccchhh
Q 005916 149 ------------------DPPIIHRDLKCDNIFING--NQGE-VKIGDLGLATI 181 (670)
Q Consensus 149 ------------------g~~IIHrDLKpeNILl~~--~~g~-vKL~DFGla~~ 181 (670)
.+.++|+|++|.|||++. .++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 223699999999999984 1345 48999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=8.2e-06 Score=82.52 Aligned_cols=146 Identities=16% Similarity=0.093 Sum_probs=96.3
Q ss_pred cccCCCCCeEEEEEEecccCCe-EEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEE
Q 005916 19 LETDPTCRYIRYKEVIGKGAFK-TVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSW 96 (670)
Q Consensus 19 ~e~dp~gr~yr~~~~LG~G~fG-~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~ 96 (670)
+..+..|..+. .+..|..+ .||+......+..+.+|.-.. .....+.+|..+|+.|. +--+.+++.++
T Consensus 20 l~~~l~g~~~~---~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~ 89 (272)
T 4gkh_A 20 LDADLYGYRWA---RDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFI 89 (272)
T ss_dssp HHHHHTTCEEE---EEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred HhccccCCeEE---EccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEE
Confidence 33344444333 34455555 689987777777888887652 23556788999999883 33356677766
Q ss_pred EeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCC---------------------------
Q 005916 97 IDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD--------------------------- 149 (670)
Q Consensus 97 ~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g--------------------------- 149 (670)
.+.. ..++|||++.|.++.+..... ......++.++...|.-||...
T Consensus 90 ~~~~--~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (272)
T 4gkh_A 90 RTPD--DAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVD 163 (272)
T ss_dssp EETT--EEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCC
T ss_pred EECC--eEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhh
Confidence 6553 689999999998887654432 1223345555556666655321
Q ss_pred -----------------------------CCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 150 -----------------------------PPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 150 -----------------------------~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+.++|+|+.+.|||++ +.+.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 164 ASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVGI 223 (272)
T ss_dssp GGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred hhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECccccc
Confidence 1279999999999998 445566999987653
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.19 E-value=9.8e-07 Score=75.03 Aligned_cols=59 Identities=25% Similarity=0.406 Sum_probs=56.5
Q ss_pred chhhhheeecCCCceeeeecccccCCCCcCcchHHHHhcccccccChHHHHHHHHHHHH
Q 005916 378 SVSLILRIADQSGRLRNIHFLFYLDSDTAFSVSSEMVEQLELADQNVTFIAELIDLLLL 436 (670)
Q Consensus 378 ~I~liLri~D~~g~i~~ieF~f~~d~Dta~~Ia~EmV~~l~l~~~d~~~iA~~Id~~i~ 436 (670)
+|+++||++|.+.+++.|.|.|...+||+..||+|||..+.+.-.|+..+|..++.+|.
T Consensus 2 pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 2 PISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 57899999999999999999999999999999999999999999999999999998886
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=2.1e-05 Score=84.60 Aligned_cols=80 Identities=18% Similarity=0.214 Sum_probs=49.6
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC---HHHHHHHHHHHHHHHhCC-C-CC-eeeeeeEEEeCCCCeE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS---PEDLERLYSEVHLLKSLK-H-NN-IIRFYNSWIDDQNKTV 104 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s---~~~~e~l~~Ei~iLk~L~-H-pN-IVkl~~~~~d~~~~~~ 104 (670)
.+.||.|.++.||++.....+..+++|+......... +...+++..|.++|+.+. + |. +.++|. .+.. ..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~--~d~~--~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTE--MA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETT--TT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE--EcCC--cc
Confidence 4589999999999997666678899998653211000 012346678999998883 2 33 345654 2333 35
Q ss_pred EEEEecCCCC
Q 005916 105 NIITELFTSG 114 (670)
Q Consensus 105 ~lVmEy~~gG 114 (670)
++|||++.|.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=5.3e-05 Score=79.98 Aligned_cols=86 Identities=6% Similarity=-0.078 Sum_probs=53.6
Q ss_pred EEEEEEe-cccCCeEEEEEEEc--C----CCeEEEEEEEeeccc--cCCHHHHHHHHHHHHHHHhCC-C--CCeeeeeeE
Q 005916 28 IRYKEVI-GKGAFKTVYKAFDE--V----NGLEVAWCQVRIDDV--LQSPEDLERLYSEVHLLKSLK-H--NNIIRFYNS 95 (670)
Q Consensus 28 yr~~~~L-G~G~fG~Vy~a~d~--~----tg~~vAiK~v~~~~~--~~s~~~~e~l~~Ei~iLk~L~-H--pNIVkl~~~ 95 (670)
....+.| +.|....+|+.... . +|..+++|....... ... ...+.+|+.+|+.|. + -.+.+++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 4445678 89999999988543 1 256788886543220 000 134667888888883 3 346667765
Q ss_pred EEeCC-CCeEEEEEecCCCCCH
Q 005916 96 WIDDQ-NKTVNIITELFTSGSL 116 (670)
Q Consensus 96 ~~d~~-~~~~~lVmEy~~gGsL 116 (670)
..+.. .+..++|||++.|..|
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCC
T ss_pred ccCCCccCCceEEEEecCCCCh
Confidence 43321 0346799999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00027 Score=73.30 Aligned_cols=30 Identities=20% Similarity=0.416 Sum_probs=25.3
Q ss_pred CCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 150 ~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
+.++|+|+++.|||++ .++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~-~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG-ENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEEC-GGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEe-CCCcEEEEehhhcc
Confidence 4599999999999997 34689999998663
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0011 Score=71.78 Aligned_cols=30 Identities=17% Similarity=0.359 Sum_probs=24.9
Q ss_pred CCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 150 ~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+.++|+|++|.|||++. ++ ++|+||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECS-SC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeC-CC-CEEEeCccccc
Confidence 45999999999999983 33 99999987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0017 Score=68.13 Aligned_cols=75 Identities=15% Similarity=0.041 Sum_probs=55.3
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC---CCCeeeeeeEEEeCCCCeEEEE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK---HNNIIRFYNSWIDDQNKTVNII 107 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~---HpNIVkl~~~~~d~~~~~~~lV 107 (670)
.+.|+.|.+..+|+... .+..+++|+.... ....+..|...|+.|. ...+.+.+.+..+. +..++|
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lv 109 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLL 109 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEE
Confidence 46789999999999853 4667888876532 2456788999998883 35677777765443 478999
Q ss_pred EecCCCCCH
Q 005916 108 TELFTSGSL 116 (670)
Q Consensus 108 mEy~~gGsL 116 (670)
||+++|..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0028 Score=64.79 Aligned_cols=82 Identities=15% Similarity=0.001 Sum_probs=55.0
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-C-C-CeeeeeeEEEeCC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-H-N-NIIRFYNSWIDDQ 100 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-H-p-NIVkl~~~~~d~~ 100 (670)
.|+...-.+.+|.|..+.||+... .+|+.|.+|+-..... .....+..|+..|+.|. . + .+.+++.+ +.
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~- 84 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP----ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD- 84 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET-
T ss_pred cCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc----chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC-
Confidence 355566678899999999999864 5788999886543221 11234678999999883 2 1 23444442 22
Q ss_pred CCeEEEEEecCCCCCH
Q 005916 101 NKTVNIITELFTSGSL 116 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL 116 (670)
-++|||++.++..
T Consensus 85 ---~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 ---RTLAMEWVDERPP 97 (288)
T ss_dssp ---TEEEEECCCCCCC
T ss_pred ---ceEEEEeecccCC
Confidence 3689999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0052 Score=63.25 Aligned_cols=71 Identities=8% Similarity=0.036 Sum_probs=41.4
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCCeEEEEEe
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-Vkl~~~~~d~~~~~~~lVmE 109 (670)
.+.|+.|....+|++ ..+++|+...... ......+|+.+++.+..-++ .+++. .+... -++|+|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-----~~~~r~~E~~~l~~l~~~g~~P~~~~--~~~~~--~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-----EYINRANEAVAAREAAKAGVSPEVLH--VDPAT--GVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEE--ECTTT--CCEEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc-----ceeCHHHHHHHHHHHHHcCCCCceEE--EECCC--CEEEEe
Confidence 568899999999998 3477776653210 11112457777777732222 34544 23332 358999
Q ss_pred cC-CCCCH
Q 005916 110 LF-TSGSL 116 (670)
Q Consensus 110 y~-~gGsL 116 (670)
|+ .|.+|
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0071 Score=63.00 Aligned_cols=32 Identities=22% Similarity=0.310 Sum_probs=25.8
Q ss_pred CCeeeecCccccEEEeCC---CCcEEEeeccchhh
Q 005916 150 PPIIHRDLKCDNIFINGN---QGEVKIGDLGLATI 181 (670)
Q Consensus 150 ~~IIHrDLKpeNILl~~~---~g~vKL~DFGla~~ 181 (670)
+.++|||+.+.|||++.+ .+.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 359999999999999742 15799999987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0054 Score=63.32 Aligned_cols=141 Identities=16% Similarity=0.133 Sum_probs=72.7
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC--eeeeeeE----EEeCCCCeE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN--IIRFYNS----WIDDQNKTV 104 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN--IVkl~~~----~~d~~~~~~ 104 (670)
.+.|+.|....+|++... .| .+++|...... ..+.+..|+.+++.|...+ +.+++.. ......+..
T Consensus 27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 457888999999998643 34 57788776421 1234556888887773211 2333321 000012357
Q ss_pred EEEEecCCCCCHH-----HH---------HHh-cCCC--------CHHHHHHHH---------------HHHHHHHhhhh
Q 005916 105 NIITELFTSGSLR-----QY---------RKK-HKKV--------DMKAVKGWA---------------RQILSGLIYLH 146 (670)
Q Consensus 105 ~lVmEy~~gGsL~-----~~---------i~~-~~~l--------se~~i~~i~---------------~QIl~aL~yLH 146 (670)
+++|++++|..+. .+ +.. ...+ ........+ ..+...+.+|+
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999886431 11 111 0011 111000000 01233344443
Q ss_pred cC-----CCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 147 SH-----DPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 147 s~-----g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.. ...++|+|+.+.|||+++ ++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~-~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLG-DELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeC-CceEEEecchhcc
Confidence 21 124899999999999983 3345799998664
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.22 E-value=0.02 Score=59.14 Aligned_cols=75 Identities=8% Similarity=0.011 Sum_probs=45.3
Q ss_pred EecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCC--CeeeeeeE----EEeCCCCeEEE
Q 005916 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN--NIIRFYNS----WIDDQNKTVNI 106 (670)
Q Consensus 33 ~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~Hp--NIVkl~~~----~~d~~~~~~~l 106 (670)
.|+ |....||++.. .+|..+++|....... + .+.+..|..+++.|... .+.+++.. +.. ..+..++
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~--~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~-~~g~~~~ 104 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN-HQGFYFA 104 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE-ETTEEEE
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCC--C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEE-ECCEEEE
Confidence 566 88889998743 3566788898763221 2 34566788888887321 23444432 011 1236788
Q ss_pred EEecCCCCC
Q 005916 107 ITELFTSGS 115 (670)
Q Consensus 107 VmEy~~gGs 115 (670)
+|+++.|..
T Consensus 105 l~~~i~G~~ 113 (328)
T 1zyl_A 105 VFPSVGGRQ 113 (328)
T ss_dssp EEECCCCEE
T ss_pred EEEecCCCC
Confidence 999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.18 E-value=0.018 Score=57.45 Aligned_cols=120 Identities=17% Similarity=0.187 Sum_probs=78.9
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhh-hcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccccccccC
Q 005916 115 SLRQYRKKH-KKVDMKAVKGWARQILSGLIYL-HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIG 192 (670)
Q Consensus 115 sL~~~i~~~-~~lse~~i~~i~~QIl~aL~yL-Hs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~~~~~~G 192 (670)
+|.+.++.. .+++|+++|.++.|.+.+|.-+ +...+ ..+=+-|..|++. .+|.|-+.+ +.+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVW-RDGAVTLAP-AADD----------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEE-TTSCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEe-cCCceeccc-cccc----------cc
Confidence 688887754 6899999999999999998776 22221 2334457899998 678877653 1110 12
Q ss_pred CCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC
Q 005916 193 TPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV 268 (670)
Q Consensus 193 Tp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~ 268 (670)
...+.|||......+.+.=|||||+++|.-+--..|= ......++.+.+||..|..
T Consensus 100 ~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e--------------------~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 100 EPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE--------------------NEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp -------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT--------------------TEEECCCHHHHHHHHHHTT
T ss_pred ccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc--------------------ccchhhCHHHHHHHHHHHh
Confidence 3356788877656678889999999999987544332 2344567888888888874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.11 E-value=0.02 Score=62.41 Aligned_cols=73 Identities=12% Similarity=0.099 Sum_probs=47.2
Q ss_pred EEEecccCCeEEEEEEEcC-------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCC
Q 005916 31 KEVIGKGAFKTVYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNK 102 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~-------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-Vkl~~~~~d~~~~ 102 (670)
.+.|+.|....||++.... .+..+.+|+.... .. .+.+.+|+.+++.|...++ .++++.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC--
Confidence 3578899999999997542 2567888876321 11 1345579999998843333 5666644 22
Q ss_pred eEEEEEecCCCCC
Q 005916 103 TVNIITELFTSGS 115 (670)
Q Consensus 103 ~~~lVmEy~~gGs 115 (670)
.+|+||++|..
T Consensus 148 --g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 --GRLEEYIPSRP 158 (429)
T ss_dssp --EEEECCCCEEE
T ss_pred --CEEEEEeCCcc
Confidence 28999998633
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.90 E-value=0.01 Score=63.97 Aligned_cols=139 Identities=16% Similarity=0.187 Sum_probs=79.2
Q ss_pred EEecccCCeEEEEEEEcC-------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCe
Q 005916 32 EVIGKGAFKTVYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~-------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~ 103 (670)
+.|..|-...+|++.... .+..|.+++... ... ....+.+|..+++.|. +.-..+++..+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~--- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQ---GVDSLVLESVMFAILAERSLGPQLYGVF--PE--- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC---
Confidence 467778888999986532 346787776421 111 2344568999998883 32235566543 33
Q ss_pred EEEEEecCCCCCHHH--------------HHHh-c-------CCC--CHHHHHHHHHHHHHH------------------
Q 005916 104 VNIITELFTSGSLRQ--------------YRKK-H-------KKV--DMKAVKGWARQILSG------------------ 141 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~--------------~i~~-~-------~~l--se~~i~~i~~QIl~a------------------ 141 (670)
.+||||++|..|.. .+.+ | +.. -..++..|..++-..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 18999998855421 1111 1 111 246677777665321
Q ss_pred -Hhhh----hcC--CCCeeeecCccccEEEeCC---CCcEEEeeccchhh
Q 005916 142 -LIYL----HSH--DPPIIHRDLKCDNIFINGN---QGEVKIGDLGLATI 181 (670)
Q Consensus 142 -L~yL----Hs~--g~~IIHrDLKpeNILl~~~---~g~vKL~DFGla~~ 181 (670)
+..| ... ...++|+|+.+.||+++.+ .+.+.|+||..+..
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 222 2248999999999999854 36899999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.81 E-value=0.063 Score=59.21 Aligned_cols=75 Identities=17% Similarity=0.103 Sum_probs=46.5
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-eeeeeEEEeCCCCeEEEEEe
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-IRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-Vkl~~~~~d~~~~~~~lVmE 109 (670)
.+.|+.|-...+|++.....+..+++|+...... ...+ -.+|..+++.|...++ .++++.+ .. . +|||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~----~~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~--G--~v~e 181 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD----EIIN-REREKKISCILYNKNIAKKIYVFF--TN--G--RIEE 181 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC----SCSC-HHHHHHHHHHHTTSSSBCCEEEEE--TT--E--EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh----hhcC-HHHHHHHHHHHHhcCCCCCEEEEe--CC--e--EEEE
Confidence 3578899999999997654457888887643210 0011 1479999999955444 4667654 22 1 4999
Q ss_pred cCCCCCH
Q 005916 110 LFTSGSL 116 (670)
Q Consensus 110 y~~gGsL 116 (670)
|++|..|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.28 E-value=0.068 Score=56.14 Aligned_cols=31 Identities=19% Similarity=0.355 Sum_probs=25.4
Q ss_pred CCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 150 ~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..++|+|+.+.||+++ .++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~-~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVG-NEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEEC-GGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEe-CCCeEEEEECCCCee
Confidence 3499999999999997 446799999976543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.11 E-value=0.026 Score=59.75 Aligned_cols=73 Identities=14% Similarity=0.133 Sum_probs=40.9
Q ss_pred EEecccCCeEEEEEEEcC--------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC-eeeeeeEEEeCCCC
Q 005916 32 EVIGKGAFKTVYKAFDEV--------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN-IIRFYNSWIDDQNK 102 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~--------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN-IVkl~~~~~d~~~~ 102 (670)
+.|+.|....+|++.... .+..+++|+..... ........|..+++.|...+ +.+++..+ ..
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 478889899999986543 12567777654211 11112356888888883323 34566533 21
Q ss_pred eEEEEEecCCCCC
Q 005916 103 TVNIITELFTSGS 115 (670)
Q Consensus 103 ~~~lVmEy~~gGs 115 (670)
++||||++|..
T Consensus 110 --~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 --GRIEEWLYGDP 120 (369)
T ss_dssp --EEEEECCCSEE
T ss_pred --cEEEEEecCCc
Confidence 57999998753
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=94.65 E-value=0.0011 Score=64.21 Aligned_cols=82 Identities=22% Similarity=0.283 Sum_probs=50.8
Q ss_pred chhhhhcccCccccccCCCCCccchhhhheeec--CCCceeeeecc-------------------cccCCCCcCcchHHH
Q 005916 355 SIEVRRSKRGNFFLLKGESNDEYSVSLILRIAD--QSGRLRNIHFL-------------------FYLDSDTAFSVSSEM 413 (670)
Q Consensus 355 ~i~~~~l~~~~~~~~~g~~~~~~~I~liLri~D--~~g~i~~ieF~-------------------f~~d~Dta~~Ia~Em 413 (670)
.++.+++..+ +...|....+..+..+++..| .+|.|.+-||+ ..+|+|..|.|+.++
T Consensus 73 ~Is~~El~~~--l~~~g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~E 150 (197)
T 3pm8_A 73 TLSSQEILDG--LKKIGYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLKKEVCLIPFKFFDIDGNGKISVEE 150 (197)
T ss_dssp EECHHHHHHH--HHHHC----CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCSHHHHHHHHHHHCTTCSSEECHHH
T ss_pred cCCHHHHHHH--HHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhhHHHHHHHHHHHCCCCCCCCCHHH
Confidence 4667777655 333466677889999999998 46799999997 357999999999999
Q ss_pred Hhccccccc--ChHHHHHHHHHHHHHhC
Q 005916 414 VEQLELADQ--NVTFIAELIDLLLLNLI 439 (670)
Q Consensus 414 V~~l~l~~~--d~~~iA~~Id~~i~~l~ 439 (670)
+..+. ... ....-.+.|+.++..+=
T Consensus 151 l~~~l-~~~~~~~~~~~~~~~~l~~~~D 177 (197)
T 3pm8_A 151 LKRIF-GRDDIENPLIDKAIDSLLQEVD 177 (197)
T ss_dssp HHHHH-C----CCHHHHHHHHHHHHHHC
T ss_pred HHHHH-HhcccCCCCCHHHHHHHHHHHc
Confidence 99843 332 22233344566666553
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=90.60 E-value=0.024 Score=53.86 Aligned_cols=61 Identities=16% Similarity=0.111 Sum_probs=48.1
Q ss_pred hhhhhcccCccccccCCCCCccchhhhheeecC--CCceeeeecc--------------------cccCCCCcCcchHHH
Q 005916 356 IEVRRSKRGNFFLLKGESNDEYSVSLILRIADQ--SGRLRNIHFL--------------------FYLDSDTAFSVSSEM 413 (670)
Q Consensus 356 i~~~~l~~~~~~~~~g~~~~~~~I~liLri~D~--~g~i~~ieF~--------------------f~~d~Dta~~Ia~Em 413 (670)
++..++... +...|...++..+..+++.+|. +|.|.+.+|. ..||+|.+|+|+.++
T Consensus 28 I~~~El~~~--l~~lg~~~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~~~~~l~~aF~~fD~d~~G~I~~~e 105 (176)
T 2lhi_A 28 ISSSELATV--MRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAE 105 (176)
T ss_dssp BCHHHHHHH--HHHHTCCCCHHHHHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSHHHHHHHHHHHHHCSSCSSSBCHHH
T ss_pred CCHHHHHHH--HHHcCCChhHHHHHHHHHHhCcCCCccchHHHHHHHHHHhcccCCcHHHHHHHHHHhCCCCCCcCcHHH
Confidence 666666554 4456777788899999999885 5689988887 457999999999999
Q ss_pred Hhccc
Q 005916 414 VEQLE 418 (670)
Q Consensus 414 V~~l~ 418 (670)
++++.
T Consensus 106 l~~~l 110 (176)
T 2lhi_A 106 LKHVL 110 (176)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98854
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=89.76 E-value=0.86 Score=49.63 Aligned_cols=73 Identities=10% Similarity=0.033 Sum_probs=44.1
Q ss_pred EEecccCCeEEEEEEEcCC-------CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCe
Q 005916 32 EVIGKGAFKTVYKAFDEVN-------GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 32 ~~LG~G~fG~Vy~a~d~~t-------g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~ 103 (670)
+.|..|-...+|++..... +..|++++..... +..-...+|..+++.|. +.-..++++.+ ..
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--- 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--- 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC---
Confidence 4677888999999876421 5678777653221 11111246888888873 32234555432 22
Q ss_pred EEEEEecCCCCC
Q 005916 104 VNIITELFTSGS 115 (670)
Q Consensus 104 ~~lVmEy~~gGs 115 (670)
++||||++|..
T Consensus 146 -~~I~efI~G~~ 156 (424)
T 3mes_A 146 -GRIEEFIDGEP 156 (424)
T ss_dssp -EEEEECCCSEE
T ss_pred -CEEEEEeCCcc
Confidence 57899999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.94 E-value=1.2 Score=47.74 Aligned_cols=30 Identities=17% Similarity=0.289 Sum_probs=24.4
Q ss_pred eeeecCccccEEEeC-----CCCcEEEeeccchhh
Q 005916 152 IIHRDLKCDNIFING-----NQGEVKIGDLGLATI 181 (670)
Q Consensus 152 IIHrDLKpeNILl~~-----~~g~vKL~DFGla~~ 181 (670)
++|+|+.+.|||+.. ..+.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 579999999999942 346799999987754
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=84.53 E-value=0.024 Score=61.69 Aligned_cols=61 Identities=16% Similarity=0.198 Sum_probs=48.6
Q ss_pred chhhhhcccCccccccCCCCCccchhhhheeecC--CCceeeeecc--------------------cccCCCCcCcchHH
Q 005916 355 SIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQ--SGRLRNIHFL--------------------FYLDSDTAFSVSSE 412 (670)
Q Consensus 355 ~i~~~~l~~~~~~~~~g~~~~~~~I~liLri~D~--~g~i~~ieF~--------------------f~~d~Dta~~Ia~E 412 (670)
.++.+++... +...|...++.+|..+|+..|. +|.|++-||+ ..||+|.+|.|+.+
T Consensus 318 ~IS~eELk~a--LrsLG~~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms~~lk~~d~eeeLreAFk~fDkDgdG~IS~e 395 (440)
T 3u0k_A 318 TITTKELGTV--MRSLGQNPTEAELQDMINEVDADGDGTIDFPEFLIMMARKMKDTDSEEEIREAFRVFDKDGNGYISAA 395 (440)
T ss_dssp EECHHHHHHH--HHHTTCCCCHHHHHHHHHHHCSSCSSSEEHHHHHHHHHTC------CHHHHHHHHHHCTTCSSEECHH
T ss_pred EECHHHHHHH--HHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCChHHHHHHHHHHHCCCCcCcCCHH
Confidence 4667777654 4445777788899999999884 6799999997 34699999999999
Q ss_pred HHhcc
Q 005916 413 MVEQL 417 (670)
Q Consensus 413 mV~~l 417 (670)
+++++
T Consensus 396 ELr~v 400 (440)
T 3u0k_A 396 ELRHV 400 (440)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=83.60 E-value=0.2 Score=47.51 Aligned_cols=91 Identities=19% Similarity=0.198 Sum_probs=57.1
Q ss_pred hhhhhcccCccccccCCCCCccchhhhheeecC--CCceeeeecc-------------------cccCCCCcCcchHHHH
Q 005916 356 IEVRRSKRGNFFLLKGESNDEYSVSLILRIADQ--SGRLRNIHFL-------------------FYLDSDTAFSVSSEMV 414 (670)
Q Consensus 356 i~~~~l~~~~~~~~~g~~~~~~~I~liLri~D~--~g~i~~ieF~-------------------f~~d~Dta~~Ia~EmV 414 (670)
++..++... +...|....+..+..+++..|. +|.|.+-||. ..+|+|..|.|+.+++
T Consensus 27 I~~~E~~~~--l~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El 104 (188)
T 1s6i_A 27 ITFDELKDG--LKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEI 104 (188)
T ss_dssp EEHHHHHHH--HTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCCSTHHHHHHTTTTCSSEEEHHHH
T ss_pred CCHHHHHHH--HHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCHHHHHHHHHHHHCCCCCCcCcHHHH
Confidence 666666543 3334656677889999999884 5789988887 3468999999999999
Q ss_pred hcccccccChHHHHHHHHHHHHHhCCCCCCCcccccc
Q 005916 415 EQLELADQNVTFIAELIDLLLLNLIPGWKPCVRIDHL 451 (670)
Q Consensus 415 ~~l~l~~~d~~~iA~~Id~~i~~l~p~w~~~~~~~~~ 451 (670)
..+.- ..... .+.++.++..+=++-...+..++.
T Consensus 105 ~~~l~-~~g~~--~~~~~~~~~~~D~d~dG~Is~~EF 138 (188)
T 1s6i_A 105 QQACK-DFGLD--DIHIDDMIKEIDQDNDGQIDYGEF 138 (188)
T ss_dssp HHTTT-TTTCC--TTHHHHHHHHHCSSSSSEEETTHH
T ss_pred HHHHH-HcCCC--HHHHHHHHHHHCCCCCCcEeHHHH
Confidence 98532 22111 123455555554443333344443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 670 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-85 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-53 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-49 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-49 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-41 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-17 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (681), Expect = 5e-85
Identities = 140/271 (51%), Positives = 186/271 (68%), Gaps = 5/271 (1%)
Query: 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEV 78
+ R++++ IG+G+FKTVYK D +EVAWC + D + + +R E
Sbjct: 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWC--ELQDRKLTKSERQRFKEEA 59
Query: 79 HLLKSLKHNNIIRFYNSWID--DQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWAR 136
+LK L+H NI+RFY+SW K + ++TEL TSG+L+ Y K+ K + +K ++ W R
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 119
Query: 137 QILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEF 196
QIL GL +LH+ PPIIHRDLKCDNIFI G G VKIGDLGLAT+ + AK+VIGTPEF
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF 179
Query: 197 MAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256
MAPE+Y+E Y+E D+Y+FGMCMLEM T EYPYSEC+N+AQIY++V+SG+KPA+ KV
Sbjct: 180 MAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 257 PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
PEVK IE C+ +R S K+LL F Q
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (530), Expect = 2e-62
Identities = 85/300 (28%), Positives = 136/300 (45%), Gaps = 24/300 (8%)
Query: 15 DPDVLET----DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
DPDV E DP + +E IG G+F VY A D N VA ++ QS E
Sbjct: 1 DPDVAELFFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEK 58
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA 130
+ + EV L+ L+H N I++ ++ + ++ E + K +
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVE 116
Query: 131 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 190
+ L GL YLHSH +IHRD+K NI ++ G VK+GD G A+IM AN S
Sbjct: 117 IAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPAN--SF 171
Query: 191 IGTPEFMAPELY----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI 246
+GTP +MAPE+ + Y+ D++S G+ +E+ + P N+ ++
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNE 230
Query: 247 KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIVLPR 305
PA S ++F++ CL R +++ LL F+ + RP + ++ R
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV-----LRERPPTVIMDLIQR 285
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-62
Identities = 78/265 (29%), Positives = 130/265 (49%), Gaps = 16/265 (6%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
IG G++ K + +G + W ++ + + + + L SEV+LL+ LKH NI+R
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK----VDMKAVKGWARQILSGLIYLHS 147
+Y+ ID N T+ I+ E G L K K +D + V Q+ L H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 148 H---DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPE-L 201
++HRDLK N+F++G VK+GD GLA I+ + + AK+ +GTP +M+PE +
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 202 YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
+YNE +DI+S G + E+ P+ + ++ K+ G K + E+
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNE 244
Query: 262 FIEKCLVP-ASQRLSAKELLMDPFL 285
I + L R S +E+L +P +
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-60
Identities = 65/259 (25%), Positives = 118/259 (45%), Gaps = 11/259 (4%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+GKG F VY A ++ + +A + L+ +L EV + L+H NI+R
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
Y + D V +I E G++ + +K K D + + ++ + L Y HS
Sbjct: 71 LYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--R 126
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELA 210
+IHRD+K +N+ + GE+KI D G + + ++ GT +++ PE + ++E
Sbjct: 127 VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
Query: 211 DIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP- 269
D++S G+ E + + P+ E + YK++S + I + L
Sbjct: 186 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKHN 242
Query: 270 ASQRLSAKELLMDPFLQVN 288
SQR +E+L P++ N
Sbjct: 243 PSQRPMLREVLEHPWITAN 261
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-60
Identities = 85/282 (30%), Positives = 139/282 (49%), Gaps = 15/282 (5%)
Query: 11 MEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPED 70
+E V DP +Y R+++ IG+GA TVY A D G EVA Q+ LQ
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMN----LQQQPK 60
Query: 71 LERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKA 130
E + +E+ +++ K+ NI+ + +S++ + ++ E GSL + D
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCM-DEGQ 117
Query: 131 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAK 188
+ R+ L L +LHS+ +IHRD+K DNI + + G VK+ D G + EQ+
Sbjct: 118 IAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS 174
Query: 189 SVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK 247
+++GTP +MAPE + + Y DI+S G+ +EM+ E PY +Y ++G
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
Query: 248 PAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVN 288
+ + F+ +CL +R SAKELL FL++
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-59
Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 20/287 (6%)
Query: 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH 79
+ +P + +G GAF VYKA ++ + A + +S E+LE E+
Sbjct: 7 DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVID----TKSEEELEDYMVEID 61
Query: 80 LLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQI 138
+L S H NI++ +++ + N + I+ E G++ + + + ++ +Q
Sbjct: 62 ILASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEF 196
L L YLH + IIHRDLK NI + G++K+ D G++ + + S IGTP +
Sbjct: 120 LDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 197 MAPELY------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA 250
MAPE+ D Y+ AD++S G+ ++EM E P+ E + K S A
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236
Query: 251 LSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPL 296
K F++KCL R + +LL PF+ V+ R L
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-58
Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+G G V+K + +GL +A + ++ P ++ E+ +L I+
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
FY ++ D ++I E GSL Q KK ++ + + + ++ GL YL
Sbjct: 69 FYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 125
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELA 210
I+HRD+K NI +N GE+K+ D G++ + + A S +GT +M+PE L +Y+ +
Sbjct: 126 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 211 DIYSFGMCMLEMVTFEYPYS---------------------------------------- 230
DI+S G+ ++EM YP
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 231 -ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
++ + + P S V E + F+ KCL+ ++R K+L++ F++
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 3e-57
Identities = 64/262 (24%), Positives = 119/262 (45%), Gaps = 15/262 (5%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+ +G+GA+ V A + V VA V + + PE++++ E+ + K L H N+++
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVK 67
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
FY + + E + G L + + + + Q+++G++YLH
Sbjct: 68 FYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIM----EQANAKSVIGTPEFMAPELY--DEN 205
I HRD+K +N+ ++ +KI D GLAT+ + + GT ++APEL E
Sbjct: 124 ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 206 YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265
+ E D++S G+ + M+ E P+ + +S Q Y K D + + K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 266 CLVP-ASQRLSAKELLMDPFLQ 286
LV S R++ ++ D +
Sbjct: 243 ILVENPSARITIPDIKKDRWYN 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 8e-56
Identities = 82/266 (30%), Positives = 131/266 (49%), Gaps = 24/266 (9%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
I + IG G+F TVYK +VA + + +P+ L+ +EV +L+ +H
Sbjct: 10 ITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHV 64
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLH 146
NI+ F Q + I+T+ SL + K +M + ARQ G+ YLH
Sbjct: 65 NILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA----KSVIGTPEFMAPELY 202
+ IIHRDLK +NIF++ + VKIGD GLAT+ + + + + G+ +MAPE+
Sbjct: 122 AK--SIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 203 ----DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD-- 256
Y+ +D+Y+FG+ + E++T + PYS N QI V G LSKV+
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 257 -PEVKSFIEKCLVP-ASQRLSAKELL 280
+K + +CL +R ++L
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQIL 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 8e-54
Identities = 66/264 (25%), Positives = 130/264 (49%), Gaps = 15/264 (5%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
++ +++G+G+F TV A + E A + + + + E ++ L H
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRH-IIKENKVPYVTRERDVMSRLDHPF 69
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 148
++ Y ++ DD+ + +G L +Y +K D + + +I+S L YLH
Sbjct: 70 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM----EQANAKSVIGTPEFMAPE-LYD 203
IIHRDLK +NI +N + ++I D G A ++ +QA A S +GT ++++PE L +
Sbjct: 128 --GIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 204 ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFI 263
++ + +D+++ G + ++V P+ N I++K+ + K P+ + +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKL-EYDFPEKF-FPKARDLV 241
Query: 264 EKCLVP-ASQRLSAKELLMDPFLQ 286
EK LV A++RL +E+ L+
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 185 bits (471), Expect = 1e-53
Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 16/290 (5%)
Query: 16 PDVLETDPTCRYIRYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLER 73
P +E Y Y E +G GAF V++ ++ G + P D
Sbjct: 17 PQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYT 72
Query: 74 LYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVK 132
+ +E+ ++ L H +I ++++ D + +I E + G L + K+ V
Sbjct: 73 VKNEISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVI 130
Query: 133 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ-GEVKIGDLGLATIMEQAN-AKSV 190
+ RQ GL ++H H I+H D+K +NI + VKI D GLAT + K
Sbjct: 131 NYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 188
Query: 191 IGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-P 248
T EF APE+ D E D+++ G+ +++ P++ + + +
Sbjct: 189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 248
Query: 249 AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLP 297
PE K FI+ L +RL+ + L P+L+ + + +P
Sbjct: 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 184 bits (469), Expect = 3e-53
Identities = 70/304 (23%), Positives = 127/304 (41%), Gaps = 17/304 (5%)
Query: 10 KMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPE 69
K P P ++ D + E +G GAF V++ + G A V
Sbjct: 10 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ES 65
Query: 70 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDM 128
D E + E+ + L+H ++ ++++ DD + +I E + G L + +H K+
Sbjct: 66 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSE 123
Query: 129 KAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ-GEVKIGDLGLATIM-EQAN 186
+ RQ+ GL ++H ++ +H DLK +NI + E+K+ D GL + + +
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
Query: 187 AKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG 245
K GT EF APE + D++S G+ +++ P+ N + + V S
Sbjct: 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSC 240
Query: 246 IKPAALSKVKD--PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDIV 302
S + K FI K L+ + R++ + L P+L G R +P
Sbjct: 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT-PGNAPGRDSQIPSSR 299
Query: 303 LPRV 306
++
Sbjct: 300 YTKI 303
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (458), Expect = 3e-52
Identities = 57/284 (20%), Positives = 118/284 (41%), Gaps = 15/284 (5%)
Query: 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL 81
D Y +++V+G GAF V A D+ VA + + +E E+ +L
Sbjct: 6 DIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMEN---EIAVL 61
Query: 82 KSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSG 141
+KH NI+ + + + + +I +L + G L + + Q+L
Sbjct: 62 HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 142 LIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMA 198
+ YLH I+HRDLK +N+ ++ I D GL+ + + + + GTP ++A
Sbjct: 120 VKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177
Query: 199 P-ELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKD 256
P L + Y++ D +S G+ ++ P+ + ++ + + + + +
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 257 PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLP 299
K FI + +R + ++ L P++ T ++ +
Sbjct: 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQS 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-51
Identities = 58/267 (21%), Positives = 112/267 (41%), Gaps = 21/267 (7%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV--LQSPEDLERLYSEVHLLKSL 84
+Y+ ++G G F +VY + L VA V D + + R+ EV LLK +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 85 K--HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
+ +IR + W + + V I+ L + + + + + + Q+L +
Sbjct: 65 SSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY 202
+ H+ ++HRD+K +NI I+ N+GE+K+ D G +++ GT + PE
Sbjct: 124 RHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 181
Query: 203 --DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260
+ A ++S G+ + +MV + P+ + + E +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSECQ 232
Query: 261 SFIEKCLVP-ASQRLSAKELLMDPFLQ 286
I CL S R + +E+ P++Q
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 176 bits (447), Expect = 5e-51
Identities = 64/277 (23%), Positives = 120/277 (43%), Gaps = 25/277 (9%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL-----QSPEDLERLYSEVHLL 81
Y+ E++G+G V + + E A + + + E E EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 82 KSLK-HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILS 140
+ + H NII+ +++ + ++ +L G L Y + + K + R +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121
Query: 141 GLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAP 199
+ LH + I+HRDLK +NI ++ + +K+ D G + ++ + V GTP ++AP
Sbjct: 122 VICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 200 ELY-------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALS 252
E+ Y + D++S G+ M ++ P+ R + + + SG
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSP 237
Query: 253 KVKD--PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+ D VK + + LV +R +A+E L PF Q
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-50
Identities = 54/267 (20%), Positives = 117/267 (43%), Gaps = 19/267 (7%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
+Y E +G+G F V++ + + V++ D + E+ +L +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARH 60
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYL 145
NI+ + S+ + + +I E + + + +++ + + + Q+ L +L
Sbjct: 61 RNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 146 HSHDPPIIHRDLKCDNIFI-NGNQGEVKIGDLGLATIMEQA-NAKSVIGTPEFMAPELY- 202
HSH I H D++ +NI +KI + G A ++ N + + PE+ APE++
Sbjct: 119 HSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD--PEVK 260
+ + D++S G + +++ P+ + QI + + + K+ E
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 261 SFIEKCLVP-ASQRLSAKELLMDPFLQ 286
F+++ LV R++A E L P+L+
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-49
Identities = 53/257 (20%), Positives = 110/257 (42%), Gaps = 18/257 (7%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
++ + IGKG F V G +VA V+ +++ + +E ++ L+H+
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY--RGNKVA---VK---CIKNDATAQAFLAEASVMTQLRHS 60
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYL 145
N+++ ++++ + I+TE GSL Y + + + ++ + + YL
Sbjct: 61 NLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDE 204
+ +HRDL N+ ++ + K+ D GL + ++ APE L ++
Sbjct: 120 EGN--NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASS-TQDTGKLPVKWTAPEALREK 175
Query: 205 NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264
++ +D++SFG+ + E+ +F + +V G K A P V ++
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMK 234
Query: 265 KCLVP-ASQRLSAKELL 280
C A+ R S +L
Sbjct: 235 NCWHLDAAMRPSFLQLR 251
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-49
Identities = 68/305 (22%), Positives = 122/305 (40%), Gaps = 42/305 (13%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDL-ERLYSEVHLLKSLKHNNII 90
+ +G+G F TVYKA D+ VA ++++ ++ + + E+ LL+ L H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDP 150
+++ N ++++ + + + + +K + L GL YLH H
Sbjct: 64 GLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELY--DENY 206
I+HRDLK +N+ ++ N G +K+ D GLA N + T + APEL Y
Sbjct: 120 WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK-------------------------K 241
D+++ G + E++ + Q+ + K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 242 VSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
GI + ++ I+ + R++A + L + NRP P P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF------SNRPGPTPG 292
Query: 301 IVLPR 305
LPR
Sbjct: 293 CQLPR 297
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 6e-49
Identities = 70/269 (26%), Positives = 126/269 (46%), Gaps = 15/269 (5%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL--QSPEDLERLYSEVHLLKSL 84
Y E +G G F V K ++ GL+ A ++ + E + EV +LK +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
+H N+I + + + + V +I EL G L + + + + + + +QIL+G+ Y
Sbjct: 71 QHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 145 LHSHDPPIIHRDLKCDNIFI---NGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPE 200
LHS I H DLK +NI + N + +KI D GLA ++ N K++ GTPEF+APE
Sbjct: 129 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 201 LYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAALSKVKDPE 258
+ + E AD++S G+ +++ P+ + + +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 259 VKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
K FI + LV +R++ ++ L P+++
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 169 bits (430), Expect = 1e-48
Identities = 62/273 (22%), Positives = 110/273 (40%), Gaps = 15/273 (5%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ E++G G V+ A D +VA +R D + + P R E +L H
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNH 66
Query: 87 NNIIRFYNSWIDD--QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
I+ Y++ + I+ E +LR + K L +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPE 200
H + IIHRD+K NI I+ + I + N +VIGT ++++PE
Sbjct: 127 SHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 201 -LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG-IKPAALSKVKDPE 258
++ + +D+YS G + E++T E P++ + Y+ V I P+A + +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 259 VKSFIEKCLVP-ASQRLSAKELLMDPFLQV-NG 289
+ + + K L R + ++V NG
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 277
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 3e-48
Identities = 50/264 (18%), Positives = 100/264 (37%), Gaps = 16/264 (6%)
Query: 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
++ ++VIG G F V ++ G + ++ + + SE ++ H
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYL 145
N+I V IITE +GSL + R+ + + + G R I +G+ YL
Sbjct: 87 PNVIHLEGVVTKSTP--VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV-------IGTPEFMA 198
+HRDL NI +N N K+ D GL+ +E + + A
Sbjct: 145 ADM--NYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 199 PE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257
PE + + +D++S+G+ M E++++ + + + +
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-PS 260
Query: 258 EVKSFIEKCLVP-ASQRLSAKELL 280
+ + C + R +++
Sbjct: 261 ALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 5e-48
Identities = 51/259 (19%), Positives = 103/259 (39%), Gaps = 18/259 (6%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
+ + + IG G F V+ + N +VA +R + E E ++ L H
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHP 60
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLH 146
+++ Y ++ + ++ E G L Y R + + + G + G+ YL
Sbjct: 61 KLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK---SVIGTPEFMAPE-LY 202
+IHRDL N + N +K+ D G+ + ++ +PE
Sbjct: 119 EA--CVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262
Y+ +D++SFG+ M E+ + E R+++++ + +S+G + ++ V
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQI 234
Query: 263 IEKCLVP-ASQRLSAKELL 280
+ C R + LL
Sbjct: 235 MNHCWKERPEDRPAFSRLL 253
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 8e-48
Identities = 59/285 (20%), Positives = 115/285 (40%), Gaps = 20/285 (7%)
Query: 11 MEPPDPDVLE------TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDV 64
+ +P++++ P+ + + EVIG+G F VY N + C V+ +
Sbjct: 6 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 65
Query: 65 LQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRK-KH 123
+ ++ + +E ++K H N++ + + + ++ G LR + + +
Sbjct: 66 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNET 124
Query: 124 KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183
+K + G+ Q+ G+ +HRDL N ++ VK+ D GLA M
Sbjct: 125 HNPTVKDLIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMY 181
Query: 184 QANAKS------VIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSA 236
S ++MA E L + + +D++SFG+ + E++T P N+
Sbjct: 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241
Query: 237 QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 280
I + G + + + KC P A R S EL+
Sbjct: 242 DITVYLLQGRRLLQPEYC-PDPLYEVMLKCWHPKAEMRPSFSELV 285
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 56/260 (21%), Positives = 107/260 (41%), Gaps = 20/260 (7%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
++ E +G G F V+ + +VA ++ Q + +E +L+K L+H
Sbjct: 15 LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQ 68
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYL 145
++R Y + + IITE +GSL + K K+ + + A QI G+ ++
Sbjct: 69 RLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA---KSVIGTPEFMAP-EL 201
IHRDL+ NI ++ + KI D GLA ++E + ++ AP +
Sbjct: 126 EER--NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 202 YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
+ +D++SFG+ + E+VT + ++ + + G + E+
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQ 241
Query: 262 FIEKCLVP-ASQRLSAKELL 280
+ C R + L
Sbjct: 242 LMRLCWKERPEDRPTFDYLR 261
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-46
Identities = 59/262 (22%), Positives = 111/262 (42%), Gaps = 15/262 (5%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
R + IG+G F V++ ++ S E+ E ++ H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYL 145
+I++ ++ V II EL T G LR + + + +D+ ++ +A Q+ + L YL
Sbjct: 68 PHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN---AKSVIGTPEFMAPE-L 201
S +HRD+ N+ ++ VK+GD GL+ ME + A ++MAPE +
Sbjct: 125 ESK--RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 202 YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
+ +D++ FG+CM E++ + + + ++ +G + P + S
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYS 240
Query: 262 FIEKCLVP-ASQRLSAKELLMD 282
+ KC S+R EL
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-46
Identities = 59/292 (20%), Positives = 114/292 (39%), Gaps = 28/292 (9%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH-LLKSL 84
Y +V+G G V + F++ + A ++ D + EV ++
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRAS 62
Query: 85 KHNNIIRFYNSWID--DQNKTVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILS 140
+ +I+R + + + K + I+ E G L + + + + I
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 141 GLIYLHSHDPPIIHRDLKCDNIFIN--GNQGEVKIGDLGLATIMEQANA-KSVIGTPEFM 197
+ YLHS + I HRD+K +N+ +K+ D G A N+ + TP ++
Sbjct: 123 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180
Query: 198 APELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK------PAA 250
APE+ E Y++ D++S G+ M ++ P+ + I + + I+ P
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNP 239
Query: 251 LSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPDI 301
EVK I L +QR++ E + P++ + PL +
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 291
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 4e-46
Identities = 48/265 (18%), Positives = 103/265 (38%), Gaps = 17/265 (6%)
Query: 33 VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92
+G G F TV K + ++ + + + P + L +E ++++ L + I+R
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPI 152
+ + ++ E+ G L +Y ++++ V K + Q+ G+ YL
Sbjct: 74 IGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--NF 128
Query: 153 IHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-----AKSVIGTPEFMAPE-LYDENY 206
+HRDL N+ + Q KI D GL+ + ++ APE + +
Sbjct: 129 VHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 266
+ +D++SFG+ M E ++ +++ + G + + E+ + C
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNLC 246
Query: 267 LVP-ASQRLSAKEL---LMDPFLQV 287
R + L + + V
Sbjct: 247 WTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (415), Expect = 4e-46
Identities = 63/262 (24%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
+G G+F V+ NG A ++ +++ + +E E +L + H IIR
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPP 151
+ ++ D Q + +I + G L +K ++ K +A ++ L YLHS
Sbjct: 69 MWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK--D 124
Query: 152 IIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPE-LYDENYNELA 210
II+RDLK +NI ++ N G +KI D G A + ++ GTP+++APE + + YN+
Sbjct: 125 IIYRDLKPENILLDKN-GHIKITDFGFAKYVPD-VTYTLCGTPDYIAPEVVSTKPYNKSI 182
Query: 211 DIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-- 268
D +SFG+ + EM+ P+ + N+ + Y+K+ + + +VK + + +
Sbjct: 183 DWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRD 239
Query: 269 ----PASQRLSAKELLMDPFLQ 286
+ + +++ P+ +
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (411), Expect = 6e-46
Identities = 67/279 (24%), Positives = 116/279 (41%), Gaps = 22/279 (7%)
Query: 11 MEP--PDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP 68
M+P P+ D E + T I K +G G + VY+ + L VA ++ D
Sbjct: 2 MDPSSPNYDKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----T 54
Query: 69 EDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHKKV 126
++E E ++K +KH N+++ + IITE T G+L Y ++V
Sbjct: 55 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP--FYIITEFMTYGNLLDYLRECNRQEV 112
Query: 127 DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186
+ A QI S + YL IHRDL N + N VK+ D GL+ +M
Sbjct: 113 SAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT 169
Query: 187 AKSVIGT---PEFMAP-ELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242
+ G ++ AP L ++ +D+++FG+ + E+ T+ + +Q+Y+ +
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229
Query: 243 SSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 280
+ +V + C S R S E+
Sbjct: 230 EKDYRMERPEGC-PEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-45
Identities = 65/262 (24%), Positives = 126/262 (48%), Gaps = 15/262 (5%)
Query: 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLL-KSLKHNNI 89
+++GKG+F V+ A + A ++ DV+ +D+E E +L + +H +
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
+ ++ +N + + E G L + + K D+ +A +I+ GL +LHS
Sbjct: 66 THMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPE-LYDENY 206
I++RDLK DNI ++ + G +KI D G+ +AK + GTP+++APE L + Y
Sbjct: 124 --IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKC 266
N D +SFG+ + EM+ + P+ ++ +++ + + + E K + K
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKL 237
Query: 267 LVP-ASQRLSAK-ELLMDPFLQ 286
V +RL + ++ P +
Sbjct: 238 FVREPEKRLGVRGDIRQHPLFR 259
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-45
Identities = 68/322 (21%), Positives = 121/322 (37%), Gaps = 58/322 (18%)
Query: 23 PTCRYI-RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVH 79
P C + +Y+ IG+G F V+KA G +VA +V +++ + E+
Sbjct: 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIK 61
Query: 80 LLKSLKHNNIIRFYNSWIDDQNK------TVNIITELFTSGSLRQYRKKHKKVDMKAVKG 133
+L+ LKH N++ + ++ ++ + K + +K
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 134 WARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA------ 187
+ +L+GL Y+H + I+HRD+K N+ I + G +K+ D GLA A
Sbjct: 122 VMQMLLNGLYYIHRN--KILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRY 178
Query: 188 KSVIGTPEFMAPE--LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIY------ 239
+ + T + PE L + +Y D++ G M EM T Q+
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 240 -----------------------KKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLS 275
K +K + V+DP I+K LV +QR+
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 276 AKELLMDPFLQVNGTTKNRPLP 297
+ + L F + P+P
Sbjct: 299 SDDALNHDFFW------SDPMP 314
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-45
Identities = 61/267 (22%), Positives = 120/267 (44%), Gaps = 18/267 (6%)
Query: 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
Y +++GKG F V ++ G A +R +V+ + +++ +E +L++ +H
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 148
+ ++ + + E G L + + + + + + +I+S L YLHS
Sbjct: 67 LTALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS--VIGTPEFMAPELY-DEN 205
+++RD+K +N+ ++ + G +KI D GL A GTPE++APE+ D +
Sbjct: 125 --DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 206 YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265
Y D + G+ M EM+ P+ ++ ++++ + + PE KS +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILME--EIRFPRTLSPEAKSLLAG 238
Query: 266 CLVP-ASQRLS-----AKELLMDPFLQ 286
L QRL AKE++ F
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-45
Identities = 53/268 (19%), Positives = 109/268 (40%), Gaps = 22/268 (8%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
+R + +G+G F V+ VA ++ E E ++K L+H
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHE 72
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQY--RKKHKKVDMKAVKGWARQILSGLIYL 145
+++ Y ++ + I+TE + GSL + + K + + + A QI SG+ Y+
Sbjct: 73 KLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA---KSVIGTPEFMAPE-L 201
+HRDL+ NI + N K+ D GLA ++E + ++ APE
Sbjct: 130 ERM--NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 202 YDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261
+ +D++SFG+ + E+ T + ++ +V G + + +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHD 245
Query: 262 FIEKCLVP-ASQRLSAKELL--MDPFLQ 286
+ +C +R + + L ++ +
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-45
Identities = 64/259 (24%), Positives = 122/259 (47%), Gaps = 15/259 (5%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAW-CQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNII 90
+V+G GAF TVYK G +V ++ SP+ + + E +++ S+ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 91 RFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-VDMKAVKGWARQILSGLIYLHSHD 149
R + TV +IT+L G L Y ++HK + + + W QI G+ YL
Sbjct: 75 RLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM----EQANAKSVIGTPEFMAPE-LYDE 204
++HRDL N+ + VKI D GLA ++ ++ +A+ ++MA E +
Sbjct: 131 -RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 205 NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264
Y +D++S+G+ + E++TF + +++I + G + +V +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-TIDVYMIMV 247
Query: 265 KCLVP-ASQRLSAKELLMD 282
KC + A R +EL+++
Sbjct: 248 KCWMIDADSRPKFRELIIE 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-45
Identities = 52/259 (20%), Positives = 106/259 (40%), Gaps = 18/259 (6%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHN 87
+ + + +G G F V +VA ++ + + + E ++ +L H
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHE 59
Query: 88 NIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGLIYLH 146
+++ Y + + IITE +G L Y R+ + + + + + + YL
Sbjct: 60 KLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS---VIGTPEFMAPE-LY 202
S +HRDL N +N G VK+ D GL+ + S + PE L
Sbjct: 118 SK--QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262
++ +DI++FG+ M E+ + E +++ + ++ G++ + +V +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTI 233
Query: 263 IEKCLVP-ASQRLSAKELL 280
+ C A +R + K LL
Sbjct: 234 MYSCWHEKADERPTFKILL 252
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-45
Identities = 67/264 (25%), Positives = 114/264 (43%), Gaps = 18/264 (6%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEV---NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL 84
+R E +G G+F V + + + VA ++ DVL PE ++ EV+ + SL
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIREVNAMHSL 68
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLI 143
H N+IR Y + + ++TEL GSL +KH+ + + +A Q+ G+
Sbjct: 69 DHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 144 YLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-----AKSVIGTPEFMA 198
YL S IHRDL N+ + VKIGD GL + Q + + + A
Sbjct: 126 YLESK--RFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 199 PE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257
PE L ++ +D + FG+ + EM T+ N +QI K+ + +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242
Query: 258 EVKSFIEKCLVP-ASQRLSAKELL 280
++ + + +C R + L
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-44
Identities = 45/265 (16%), Positives = 105/265 (39%), Gaps = 20/265 (7%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEV--NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS 83
+ +G G F +V + + ++VA +++ D E + E ++
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 84 LKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQILSGL 142
L + I+R Q + + ++ E+ G L ++ K +++ + V Q+ G+
Sbjct: 66 LDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-----KSVIGTPEFM 197
YL +HRDL N+ + KI D GL+ + ++ + ++
Sbjct: 123 KYLEEK--NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 198 APE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256
APE + ++ +D++S+G+ M E +++ + ++ + G + +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-P 238
Query: 257 PEVKSFIEKCLVP-ASQRLSAKELL 280
PE+ + + C + R +
Sbjct: 239 PELYALMSDCWIYKWEDRPDFLTVE 263
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 6e-44
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 27/273 (9%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KH 86
I++++VIG+G F V KA + +GL + R+ + S +D E+ +L L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHH 70
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH----------------KKVDMKA 130
NII + + + E G+L + +K + +
Sbjct: 71 PNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 131 VKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSV 190
+ +A + G+ YL IHRDL NI + N KI D GL+ E K++
Sbjct: 129 LLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTM 185
Query: 191 I-GTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248
+MA E L Y +D++S+G+ + E+V+ A++Y+K+ G +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245
Query: 249 AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 280
D EV + +C +R S ++L
Sbjct: 246 EKPLNC-DDEVYDLMRQCWREKPYERPSFAQIL 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (401), Expect = 1e-43
Identities = 59/265 (22%), Positives = 113/265 (42%), Gaps = 15/265 (5%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL--QSPEDLERLYSEVHLLKSLKHNNI 89
+IG+G F VY G A + + Q + L+ + I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 90 IRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD 149
+ ++ ++ I +L G L + +H ++ +A +I+ GL ++H+
Sbjct: 70 VCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 150 PPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELYDEN--YN 207
+++RDLK NI ++ G V+I DLGLA + + +GT +MAPE+ + Y+
Sbjct: 128 --VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 208 ELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCL 267
AD +S G + +++ P+ + + + + L PE++S +E L
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 268 VP-ASQRLS-----AKELLMDPFLQ 286
++RL A+E+ PF +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-43
Identities = 56/270 (20%), Positives = 115/270 (42%), Gaps = 17/270 (6%)
Query: 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAW-CQVRIDDVLQSPEDLERLYSEV 78
E P+C + ++VIG G F VYK + + + ++ + + E
Sbjct: 3 EIHPSC--VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 79 HLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWARQ 137
++ H+NIIR + + IITE +G+L ++ R+K + + + G R
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS-----VIG 192
I +G + + +HRDL NI +N N K+ D GL+ ++E +
Sbjct: 119 IAAG--MKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 193 TPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 251
+ APE + + +D++SFG+ M E++T+ ++ ++ K ++ G +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235
Query: 252 SKVKDPEVKSFIEKCLVP-ASQRLSAKELL 280
+ + +C ++R +++
Sbjct: 236 MDC-PSAIYQLMMQCWQQERARRPKFADIV 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-43
Identities = 60/286 (20%), Positives = 110/286 (38%), Gaps = 39/286 (13%)
Query: 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ--SPEDLERLYSEVHLLKSL- 84
+ + +V+G GAF V A QV + + + + E L SE+ ++ L
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 85 KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK------------------- 125
H NI+ + + +I E G L Y + ++
Sbjct: 99 SHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 126 ----VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181
+ + + +A Q+ G+ +L +HRDL N+ + VKI D GLA
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHG-KVVKICDFGLARD 213
Query: 182 MEQAN----AKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTF-EYPYSECRNS 235
+ + + ++MAPE L++ Y +D++S+G+ + E+ + PY
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 236 AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 280
A YK + +G K E+ ++ C + +R S L
Sbjct: 274 ANFYKLIQNGFKMDQPFYA-TEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 8e-43
Identities = 72/304 (23%), Positives = 126/304 (41%), Gaps = 45/304 (14%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIR 91
E IG+G + VYKA +++ G VA ++R+D ++ E+ LLK L H NI++
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 92 FYNSWIDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDP 150
+ + + ++ E + + + +K + Q+L GL + HSH
Sbjct: 66 LLDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-- 121
Query: 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLATIM--EQANAKSVIGTPEFMAPELY--DENY 206
++HRDLK N+ IN G +K+ D GLA + T + APE+ + Y
Sbjct: 122 RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 207 NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP------------------ 248
+ DI+S G EMVT + Q+++ + P
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 249 --------AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLP 299
+ + D + +S + + L ++R+SAK L PF ++ P+P
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF------QDVTKPVP 294
Query: 300 DIVL 303
+ L
Sbjct: 295 HLRL 298
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 8e-43
Identities = 65/310 (20%), Positives = 119/310 (38%), Gaps = 45/310 (14%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY IG+GA+ V A+D VN + VA ++ + +R E+ +L +H
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 87 NNIIRFYNSWIDDQNKT-VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL 145
NII + + ++ G+ K + + + + QIL GL Y+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK-----SVIGTPEFMAPE 200
HS ++HRDLK N+ +N ++KI D GLA + + + + T + APE
Sbjct: 126 HSA--NVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 201 LYDEN--YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA-------- 250
+ + Y + DI+S G + EM++ + Q+ + P+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 251 --------------------LSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNG 289
L D + ++K L +R+ ++ L P+L+
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
Query: 290 TTKNRPLPLP 299
+ P+
Sbjct: 303 DPSDEPIAEA 312
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (387), Expect = 1e-42
Identities = 68/291 (23%), Positives = 117/291 (40%), Gaps = 41/291 (14%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
+Y E IG+G + VYKA + G A ++R++ + E+ +LK LKH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK--EDEGIPSTTIREISILKELKH 59
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
+NI++ Y+ + + ++ E + ++ K + Q+L+G+ Y H
Sbjct: 60 SNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAK--SVIGTPEFMAPELY-- 202
++HRDLK N+ IN GE+KI D GLA K I T + AP++
Sbjct: 118 DR--RVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK---------------------- 240
+ Y+ DI+S G EMV + + Q+ +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 241 ----KVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
V + + K D + K L +QR++AK+ L + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-42
Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 39/298 (13%)
Query: 25 CRYI-RYK--EVIGKGAFKTVYKAFD-EVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVH 79
CR +Y+ IG+GA+ V+KA D + G VA +VR+ + P R + +
Sbjct: 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62
Query: 80 LLKSLKHNNIIRFYNSWID---DQNKTVNIITELFTSGSLRQY-RKKHKKVDMKAVKGWA 135
L++ +H N++R ++ D+ + ++ E + V + +K
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 136 RQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTP 194
Q+L GL +LHSH ++HRDLK NI + + G++K+ D GLA I A SV+ T
Sbjct: 123 FQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTL 179
Query: 195 EFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSK 253
+ APE L +Y D++S G EM + + + Q+ K + P
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 254 VKD------------------------PEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+D K + KCL ++R+SA L P+ Q
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 8e-42
Identities = 74/342 (21%), Positives = 132/342 (38%), Gaps = 53/342 (15%)
Query: 28 IRYKE--VIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
+ Y + VIG G+F VY+A +G VA +V +D E+ +++ L
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--------QDKRFKNRELQIMRKLD 71
Query: 86 HNNIIR----FYNSWIDDQNKTVNIITELFTSG---SLRQYRKKHKKVDMKAVKGWARQI 138
H NI+R FY+S +N++ + R Y + + + + VK + Q+
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 139 LSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANA-KSVIGTPEFM 197
L Y+HS I HRD+K N+ ++ + +K+ D G A + + S I + +
Sbjct: 132 FRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 198 APELY--DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS------------ 243
APEL +Y D++S G + E++ + + Q+ + +
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 244 ----------SGIKPAALSKVK----DPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVN 288
IK +KV PE + + L + RL+ E F
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD-- 307
Query: 289 GTTKNRPLPLPDIV-LPRVGAFGDRCLMSEGPASVRNKHPSM 329
++ + LP+ P + F + L S P + P
Sbjct: 308 -ELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHA 348
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (385), Expect = 1e-41
Identities = 61/292 (20%), Positives = 128/292 (43%), Gaps = 21/292 (7%)
Query: 2 ESSEDGAAKMEPPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRI 61
++ ED K E P + + D ++ + +G G+F V + +G A +
Sbjct: 21 KAKEDFLKKWETPSQNTAQLD---QF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 62 DDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRK 121
+ + +E +E +L+++ +++ S+ D+ N + ++ E G + + +
Sbjct: 77 QK-VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLR 133
Query: 122 KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181
+ + + +A QI+ YLHS D +I+RDLK +N+ I+ G +++ D G A
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKR 190
Query: 182 MEQANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK 240
++ ++ GTPE +APE + + YN+ D ++ G+ + EM P+ QIY+
Sbjct: 191 VKG-RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYE 248
Query: 241 KVSSGIKPAALSKVKDPEVKSFIEKCLV------PASQRLSAKELLMDPFLQ 286
K+ SG ++K + L + + ++ +
Sbjct: 249 KIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 3e-41
Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 41/292 (14%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
+Y+ E IG+G + TV+KA + VA +VR+DD E+ LLK LKH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKH 60
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
NI+R ++ D+ ++ E + + + +D + VK + Q+L GL + H
Sbjct: 61 KNIVRLHDVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 147 SHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--AKSVIGTPEFMAPELY-- 202
S ++HRDLK N+ IN N GE+K+ + GLA + + T + P++
Sbjct: 119 SR--NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI---------------- 246
+ Y+ D++S G E+ P + K++ +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 247 -----------KPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+ + + ++ L QR+SA+E L P+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 151 bits (381), Expect = 3e-41
Identities = 55/300 (18%), Positives = 119/300 (39%), Gaps = 54/300 (18%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK- 85
Y+ +G+G + V++A + N +V ++ P +++ E+ +L++L+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRG 88
Query: 86 HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYL 145
NII + D ++T ++ E + +Q ++ + ++ + +IL L Y
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYC 145
Query: 146 HSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKS-VIGTPEFMAPELY-- 202
HS I+HRD+K N+ I+ ++++ D GLA + + + F PEL
Sbjct: 146 HSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVS------------------- 243
+ Y+ D++S G + M+ + P+ ++ +++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 244 ----------------SGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQ 286
+ + PE F++K L RL+A+E + P+
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 4e-41
Identities = 57/283 (20%), Positives = 101/283 (35%), Gaps = 32/283 (11%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ IG G+F +Y D G EVA + +L+ E + K ++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLHIESKIYKMMQG 61
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
I W + ++ EL + +K +K V A Q++S + Y+H
Sbjct: 62 GVGIPTIR-WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 147 SHDPPIIHRDLKCDNIFI--NGNQGEVKIGDLGLATIMEQAN---------AKSVIGTPE 195
S + IHRD+K DN + V I D GLA A K++ GT
Sbjct: 121 SKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 196 FMAPELY-DENYNELADIYSFGMCMLEMVT--FEYPYSECRNSAQIYKKVSSG---IKPA 249
+ + + + D+ S G ++ + + Q Y+++S
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 250 ALSKVKDPEVKSFIEKCLVP-ASQRLSA---KELLMDPFLQVN 288
L K E +++ C + ++L + F +
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 69/296 (23%), Positives = 110/296 (37%), Gaps = 50/296 (16%)
Query: 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK 85
R I +E IGKG F V++ G EVA + E +E++ L+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLR 55
Query: 86 HNNIIRFYNSWIDDQN--KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLI 143
H NI+ F + D + ++++ GSL Y ++ +K A SGL
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLA 114
Query: 144 YLHS------HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN------AKSVI 191
+LH P I HRDLK NI + N G I DLGLA + A +
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 192 GTPEFMAPELYDEN-------YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS 244
GT +MAPE+ D++ + ADIY+ G+ E+ + Y +
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 245 G------IKPAALSKVKDP-------------EVKSFIEKCLVP-ASQRLSAKELL 280
++ + P + + +C + RL+A +
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 62/273 (22%), Positives = 122/273 (44%), Gaps = 24/273 (8%)
Query: 32 EVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88
+V+G GA+ V+ G A ++ ++Q + E +E +L+ ++ +
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH 148
+ + + K +++I + G L + + ++ V+ + +I+ L +LH
Sbjct: 90 FLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 148
Query: 149 DPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI---MEQANAKSVIGTPEFMAPELY--- 202
II+RD+K +NI ++ N G V + D GL+ E A GT E+MAP++
Sbjct: 149 --GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPY---SECRNSAQIYKKVSSGIKPAALSKVKDPEV 259
D +++ D +S G+ M E++T P+ E + A+I +++ P +
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALA 263
Query: 260 KSFIEKCLVP-ASQRLS-----AKELLMDPFLQ 286
K I++ L+ +RL A E+ F Q
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-40
Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 41/302 (13%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
Y+ + +G GA+ V A D G +VA ++ QS +R Y E+ LLK ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRH 76
Query: 87 NNIIRFYNSWIDDQNKT--VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
N+I + + D+ + + G+ KH+K+ ++ Q+L GL Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-- 202
+H+ HRDLK N+ +N + E+KI D GLA + + T + APE+
Sbjct: 137 IHAAGII--HRDLKPGNLAVNED-CELKILDFGLARQADS-EMTGYVVTRWYRAPEVILN 192
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-------------- 248
Y + DI+S G M EM+T + + + Q+ + + P
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 249 --------------AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKN 293
A++ P + +EK LV A QR++A E L P+ + T++
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312
Query: 294 RP 295
P
Sbjct: 313 EP 314
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 8e-40
Identities = 52/288 (18%), Positives = 100/288 (34%), Gaps = 44/288 (15%)
Query: 28 IRYKEVIGKGAFKTVYKA-----FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK 82
I Y IG+GAF V++A VA ++ + S + E L+
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMA 71
Query: 83 SLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK----------------- 125
+ NI++ + + ++ E G L ++ +
Sbjct: 72 EFDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 126 -------VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178
+ ARQ+ +G+ YL +HRDL N + N VKI D GL
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGEN-MVVKIADFGL 186
Query: 179 ATIMEQANAK----SVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECR 233
+ + A+ + +M PE ++ Y +D++++G+ + E+ ++
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 234 NSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 280
++ V G A E+ + + C + R S +
Sbjct: 247 AHEEVIYYVRDGNILACPENC-PLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 59/299 (19%), Positives = 114/299 (38%), Gaps = 38/299 (12%)
Query: 15 DPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQSPE 69
PD E I +G+G+F VY+ + VA ++ + S
Sbjct: 11 VPDEWEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA---IKTVNEAASMR 65
Query: 70 DLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKV--- 126
+ +E ++K ++++R Q +I EL T G L+ Y + +
Sbjct: 66 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 127 -------DMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179
+ + A +I G+ YL+++ +HRDL N + + VKIGD G+
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAED-FTVKIGDFGMT 180
Query: 180 TIMEQANAK----SVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRN 234
+ + + + +M+PE L D + +D++SFG+ + E+ T + +
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240
Query: 235 SAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL------MDPFLQ 286
+ Q+ + V G + + C R S E++ M+P +
Sbjct: 241 NEQVLRFVMEGGLLDKPDNC-PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 58/284 (20%), Positives = 116/284 (40%), Gaps = 40/284 (14%)
Query: 28 IRYKEVIGKGAFKTVYKA-----FDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK 82
+ + + +G GAF V +A + VA V++ + E L SE+ +L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA---VKMLKPSAHLTEREALMSELKVLS 81
Query: 83 SLK-HNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK----------------- 124
L H NI+ + +ITE G L + ++ +
Sbjct: 82 YLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 125 -KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183
+D++ + ++ Q+ G+ +L S + IHRDL NI + KI D GLA ++
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIK 196
Query: 184 QANAKSV----IGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNS-AQ 237
+ V ++MAPE +++ Y +D++S+G+ + E+ + ++
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 238 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 280
YK + G + + E+ ++ C +R + K+++
Sbjct: 257 FYKMIKEGFRMLSPEHA-PAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 2e-39
Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 39/285 (13%)
Query: 28 IRYKEVIGKGAFKTVYKAFD-------EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHL 80
+ + +G+GAF V A +VA ++ D + +DL L SE+ +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEM 71
Query: 81 LKSL-KHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHK--------------- 124
+K + KH NII + D + +I E + G+LR+Y + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 125 -KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183
++ K + A Q+ G+ YL S IHRDL N+ + + +KI D GLA +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTED-NVMKIADFGLARDIH 186
Query: 184 Q----ANAKSVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQI 238
+ ++MAPE L+D Y +D++SFG+ + E+ T ++
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 239 YKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMD 282
+K + G + S E+ + C SQR + K+L+ D
Sbjct: 247 FKLLKEGHRMDKPSNC-TNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-39
Identities = 65/306 (21%), Positives = 119/306 (38%), Gaps = 39/306 (12%)
Query: 13 PPDPDVLETDPTCRYIRYKEVIGKGAFKTVYKAFD-----EVNGLEVAWCQVRIDDVLQS 67
P D E R + + +G+GAF V +A VA V++ +
Sbjct: 2 PYDASKWEFPRD-RL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVA---VKMLKEGAT 56
Query: 68 PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKK-- 125
+ L SE+ +L + H+ + + +I E G+L Y + +
Sbjct: 57 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116
Query: 126 --------------VDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEV 171
+ ++ + ++ Q+ G+ +L S IHRDL NI ++ V
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEK-NVV 173
Query: 172 KIGDLGLATIM----EQANAKSVIGTPEFMA-PELYDENYNELADIYSFGMCMLEMVTF- 225
KI D GLA + + ++MA ++D Y +D++SFG+ + E+ +
Sbjct: 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233
Query: 226 EYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL--MD 282
PY + + +++ G + A PE+ + C SQR + EL+ +
Sbjct: 234 ASPYPGVKIDEEFCRRLKEGTRMRAPDYT-TPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 283 PFLQVN 288
LQ N
Sbjct: 293 NLLQAN 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-38
Identities = 80/306 (26%), Positives = 128/306 (41%), Gaps = 41/306 (13%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ +G GA+ +V AFD GL VA ++ QS +R Y E+ LLK +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKH 76
Query: 87 NNIIRFYNSWIDDQNKT--VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIY 144
N+I + + ++ ++ G+ K +K+ V+ QIL GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 145 LHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-- 202
+HS D IIHRDLK N+ +N E+KI D GLA + + T + APE+
Sbjct: 137 IHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLN 192
Query: 203 DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-------------- 248
+YN+ DI+S G M E++T + + Q+ + P
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 249 --------------AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELLMDPFLQVNGTTKN 293
A + +P +EK LV + +R++A + L + +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 294 RPLPLP 299
P+ P
Sbjct: 313 EPVADP 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 4e-37
Identities = 77/321 (23%), Positives = 124/321 (38%), Gaps = 56/321 (17%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY+ + IG GA V A+D V VA ++ Q+ +R Y E+ L+K + H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNH 75
Query: 87 NNIIRFYNSWIDDQ----NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGL 142
NII N + + + V ++ EL + + + + D + + Q+L G+
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGI 132
Query: 143 IYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPE- 200
+LHS IHRDLK NI + + +KI D GLA + + T + APE
Sbjct: 133 KHLHSAGI--IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 201 LYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP------------ 248
+ Y E DI+S G M EMV + + Q K + P
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 249 ---------------------------AALSKVKDPEVKSFIEKCLVP-ASQRLSAKELL 280
+ +K+K + + + K LV ++R+S + L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 281 MDPFLQVNGTTKNRPLPLPDI 301
P++ V P P I
Sbjct: 310 QHPYINVWYDPAEVEAPPPQI 330
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (344), Expect = 1e-36
Identities = 40/260 (15%), Positives = 93/260 (35%), Gaps = 30/260 (11%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
YK IG+G+F +++ + +N +VA ++ + L Y LL
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 87 NNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLH 146
+ ++ + ++ +L +K +K V A+Q+L+ + +H
Sbjct: 63 IPNVYYF----GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 147 SHDPPIIHRDLKCDNIFIN----GNQGEVKIGDLGLATIME---------QANAKSVIGT 193
+++RD+K DN I N + + D G+ K++ GT
Sbjct: 119 EKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 194 PEFMAPELY-DENYNELADIYSFGMCMLEMVT--FEYPYSECRNSAQIYKKVSSGIKPAA 250
+M+ + + D+ + G + + + + + Q Y+++ +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236
Query: 251 LSKVKD---PEVKSFIEKCL 267
L ++ E ++
Sbjct: 237 LRELCAGFPEEFYKYMHYAR 256
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (286), Expect = 3e-28
Identities = 69/339 (20%), Positives = 124/339 (36%), Gaps = 75/339 (22%)
Query: 29 RYK--EVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH 86
RY +G G F TV+ A D VN VA VR D V E E+ LL+ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRVND 68
Query: 87 -----------NNIIRFYNSWIDDQNKTVNIITELFTSG---SLRQYRKKHKKVDMKAVK 132
N+I++ + + V+++ G + +H+ + + VK
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 133 GWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI----MEQANAK 188
++Q+L GL Y+H IIH D+K +N+ + + + +A + +
Sbjct: 129 QISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 189 SVIGTPEFMAPE-LYDENYNELADIYSFGMCMLEMVTFEYPYS----------------- 230
+ I T E+ +PE L + ADI+S + E++T ++ +
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 231 -------------------ECRNSAQIYKKVSSG---------IKPAALSKVKDPEVKSF 262
NS + + +S + SK + E+ F
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 263 IEKCLVP-ASQRLSAKELLMDPFLQVNGTTKNRPLPLPD 300
+ L +R A L+ P+L+ T + +PD
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLK--DTLGMEEIRVPD 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 4e-17
Identities = 29/204 (14%), Positives = 65/204 (31%), Gaps = 32/204 (15%)
Query: 32 EVIGKGAFKTVYKAFDEVNGLEVA--------------WCQVRIDDVLQSPEDLERLYSE 77
+++G+G V+ + E E + D+ S + +E
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 78 VHLLKSLKHNNIIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQ 137
L+ L+ + + Y ++ EL + L + R ++
Sbjct: 65 FRALQKLQGLAVPKVY-----AWEGNA-VLMELIDAKELYRVRVENPD-------EVLDM 111
Query: 138 ILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQANAKSVIGTPEFM 197
IL + + I+H DL N+ ++ + I D + + + + ++
Sbjct: 112 ILEEVAKFYHR--GIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRN 167
Query: 198 APELYDENYNELADIYSFGMCMLE 221
+ Y DI S +L+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 670 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.9 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.86 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.29 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.51 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.83 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 80.87 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 80.53 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-61 Score=495.29 Aligned_cols=266 Identities=52% Similarity=0.967 Sum_probs=244.5
Q ss_pred cccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEe
Q 005916 19 LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWID 98 (670)
Q Consensus 19 ~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d 98 (670)
+.+.+.||||++.+.||+|+||+||+|+++.+|..||+|.+..... .....+++.+|+++|++|+|||||++|++|.+
T Consensus 2 ~g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79 (270)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Confidence 3567789999999999999999999999999999999999986543 45667889999999999999999999999876
Q ss_pred C--CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 99 D--QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 99 ~--~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
. .+..+|+|||||.||+|.+++.+.+.+++..++.|++||+.||.|||+++++|+||||||+|||++..++.+||+||
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 3 34578999999999999999999999999999999999999999999998889999999999999866789999999
Q ss_pred cchhhhcccccccccCCCccCCCccccCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 177 GLATIMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 177 Gla~~~~~~~~~~~~GTp~YmAPEvl~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
|+|+........+.+|||.|||||++.+.|+.++|||||||++|+|++|..||.+..+...+++.+..+..|..++...+
T Consensus 160 Gla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 160 GLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred CcceeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 99988766667788999999999999999999999999999999999999999988888999999999888888888889
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
+++++||.+||. +|.+|||+.|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999996 799999999999999996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-57 Score=466.97 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=218.6
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|+++.+|+.||+|++..... .+..+++.+|+.+|++|+|||||++|++|.+.. .+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~--~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETT--EEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--eeE
Confidence 469999999999999999999999999999999986542 234567889999999999999999999998765 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+|||||.||+|.+++...+.+++..++.|++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEET
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEEC-CCCCEEEccchhheeeccC
Confidence 99999999999999988889999999999999999999999998 99999999999998 5689999999999877543
Q ss_pred c----cccccCCCccCCCcccc-CCC-CccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 186 N----AKSVIGTPEFMAPELYD-ENY-NELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 186 ~----~~~~~GTp~YmAPEvl~-~~y-s~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
. ....+||+.|||||++. ..| +.++|||||||++|+|+||.+||.........+..+.............++++
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence 2 45678999999999874 444 67899999999999999999999876666666666655544433445568999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
++||.+||. +|.+|||++|+|+||||+.
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 999999996 8999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-57 Score=463.49 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=225.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|+++.+|+.||+|++...... .....+.+.+|+.+|+.++|||||+++++|.+.. .+|+
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i 83 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT--RVYL 83 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC--EEEE
Confidence 589999999999999999999999999999999754321 1233567889999999999999999999997654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
|||||.||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|.......
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCCC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceec-CCCCEeecccceeeecCCCc
Confidence 9999999999999999999999999999999999999999998 99999999999998 66899999999998877666
Q ss_pred cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHH
Q 005916 187 AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEK 265 (670)
Q Consensus 187 ~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~k 265 (670)
....+||+.|||||++. ..|+.++|||||||++|+|++|.+||.+ .+..+++..+..+.. .++...++++++||.+
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISR 237 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHH
Confidence 67789999999999875 4689999999999999999999999977 677778888877643 3456678999999999
Q ss_pred cCC-CCCCCCCHHHHhcCcccccc
Q 005916 266 CLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 266 cL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
||. +|.+|||++|+|+||||+.+
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCCc
Confidence 997 89999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-56 Score=457.16 Aligned_cols=254 Identities=30% Similarity=0.495 Sum_probs=211.5
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|+++.+|+.||+|.+..... .....+.+.+|+++|++|+|||||++|++|.+..+..+|+
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 48999999999999999999999999999999986543 4566788999999999999999999999998876668999
Q ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHhhhhcCC---CCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 107 ITELFTSGSLRQYRKK----HKKVDMKAVKGWARQILSGLIYLHSHD---PPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g---~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
|||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ .+||||||||+|||++ .+|.+||+|||++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeeccce
Confidence 9999999999998764 467999999999999999999999864 2499999999999998 6689999999999
Q ss_pred hhhcccc--cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 180 TIMEQAN--AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 180 ~~~~~~~--~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
+.+.... ....+|||.|||||++. ..|+.++|||||||++|+|+||.+||.+ .+..+++..+..+..+ .++...+
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~s 239 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYS 239 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSC
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccC
Confidence 9876532 45688999999999874 5799999999999999999999999987 6777888888877654 3455678
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFL 285 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~ 285 (670)
+++++||.+||. +|.+|||+.|+|+|||+
T Consensus 240 ~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 240 DELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999996 89999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-56 Score=461.72 Aligned_cols=257 Identities=29% Similarity=0.513 Sum_probs=220.5
Q ss_pred cCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 21 TDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 21 ~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
++|.. .|++.+.||+|+||+||+|+++.+|..||+|++.... ....+++.+|+++|++|+|||||+++++|.+..
T Consensus 8 ~~p~d-~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 8 LNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp SCGGG-TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CCccc-CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 44543 5799999999999999999999999999999997542 344677889999999999999999999998765
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 101 NKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
.+|+|||||.||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|
T Consensus 83 --~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~a 157 (288)
T d2jfla1 83 --NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVS 157 (288)
T ss_dssp --EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTC
T ss_pred --eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeEC-CCCCEEEEechhh
Confidence 79999999999999998765 467999999999999999999999998 99999999999998 6789999999999
Q ss_pred hhhccc--ccccccCCCccCCCccc------cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC-CCc
Q 005916 180 TIMEQA--NAKSVIGTPEFMAPELY------DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK-PAA 250 (670)
Q Consensus 180 ~~~~~~--~~~~~~GTp~YmAPEvl------~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~-p~~ 250 (670)
...... ...+.+||+.|||||++ ...|+.++|||||||++|+|+||.+||.+. +..+++..+..+.. ...
T Consensus 158 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~~~ 236 (288)
T d2jfla1 158 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLA 236 (288)
T ss_dssp EECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCCCS
T ss_pred hccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCCCCC
Confidence 766443 24578899999999976 345899999999999999999999999884 44455555555443 233
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+...++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 445678999999999997 89999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-56 Score=463.23 Aligned_cols=255 Identities=31% Similarity=0.514 Sum_probs=222.4
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
||.. +|++.+.||+|+||+||+|+++.+|+.||+|++..... ...+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 17 dp~~-~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 90 (293)
T d1yhwa1 17 DPKK-KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD- 90 (293)
T ss_dssp CTTT-TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred Cccc-ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-
Confidence 4543 57888999999999999999999999999999986542 22467899999999999999999999998765
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+|||||.||+|.+++.+ +.+++..++.|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+.
T Consensus 91 -~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 91 -ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQ 165 (293)
T ss_dssp -EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEE
T ss_pred -EEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEEC-CCCcEeeccchhhee
Confidence 79999999999999998765 46999999999999999999999998 99999999999998 678999999999987
Q ss_pred hccc--ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChH
Q 005916 182 MEQA--NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPE 258 (670)
Q Consensus 182 ~~~~--~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~ 258 (670)
+... .....+||+.|||||++. +.|+.++|||||||++|+|+||.+||.+......++..+..+..+...+...+++
T Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 245 (293)
T d1yhwa1 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (293)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHH
T ss_pred eccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHH
Confidence 7543 345678999999999775 5699999999999999999999999988655566666666655445556667899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 9999999996 8999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=466.35 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=216.6
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
.+.|++.+.||+|+||+||+|+++.+|..||+|+++... .....+++.+|+.+|++|+|||||+++++|.+.. .+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--EE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EE
Confidence 456999999999999999999999999999999997542 3455678999999999999999999999998665 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 105 NIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||+|+.+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHH
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeEC-CCCCEEEeeCCCccccC
Confidence 9999999999999999999999999999999999999999997 57 99999999999998 67899999999999887
Q ss_pred ccccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHH-------------------------
Q 005916 184 QANAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ------------------------- 237 (670)
Q Consensus 184 ~~~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~------------------------- 237 (670)
.....+.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+......
T Consensus 157 ~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 76677889999999999774 5799999999999999999999999976332211
Q ss_pred ----------------HHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 238 ----------------IYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 238 ----------------i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
....+.....+.......++++++||.+||. ||.+||||+|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0111111112222223467899999999997 89999999999999999854
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-55 Score=460.98 Aligned_cols=256 Identities=30% Similarity=0.480 Sum_probs=223.8
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
||. +.|+..+.||+|+||+||+|+++.+|..||+|++..... ......+++.+|+++|++|+|||||+++++|.+..
T Consensus 12 dp~-~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 88 (309)
T d1u5ra_ 12 DPE-KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 88 (309)
T ss_dssp CHH-HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred CcH-HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-
Confidence 443 458899999999999999999999999999999986433 33556778999999999999999999999998764
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+|||||.+|+|..++..++.+++..++.|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|..
T Consensus 89 -~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 89 -TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASI 164 (309)
T ss_dssp -EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBS
T ss_pred -EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEC-CCCCEEEeecccccc
Confidence 79999999999999988888899999999999999999999999998 99999999999998 678999999999987
Q ss_pred hcccccccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCCh
Q 005916 182 MEQANAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDP 257 (670)
Q Consensus 182 ~~~~~~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~ 257 (670)
... ....+||+.|||||++. +.|+.++|||||||++|+|++|..||.+. +..+.+..+..+..+.......++
T Consensus 165 ~~~--~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~ 241 (309)
T d1u5ra_ 165 MAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSE 241 (309)
T ss_dssp SSS--BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCH
T ss_pred cCC--CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCCCCCH
Confidence 654 35678999999999873 35899999999999999999999999874 445555555555555555566789
Q ss_pred HHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 258 EVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 258 ~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 242 ~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 99999999997 8999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=457.34 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=221.9
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.++||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|+++|++|+|||||++|++|.+.. .+|+
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~i 85 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KLYF 85 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS--EEEE
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC--EEEE
Confidence 499999999999999999999999999999999854321 1234567899999999999999999999987654 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc-
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA- 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~- 185 (670)
|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC---
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccC-CCceEEecccccceecccCC
Confidence 9999999999999999999999999999999999999999999 99999999999998 6789999999999877532
Q ss_pred ---ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 186 ---NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 186 ---~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
...+.+||+.|||||++. ..|+.++|||||||++|+|++|.+||.+ .+...++..+..+.. .++...++++++
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKARD 239 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHHH
Confidence 235678999999999874 5799999999999999999999999987 677788888877643 345667899999
Q ss_pred HHHHcCC-CCCCCCCHHH------HhcCccccccCCC
Q 005916 262 FIEKCLV-PASQRLSAKE------LLMDPFLQVNGTT 291 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~e------lL~hpf~~~~~~~ 291 (670)
||.+||. +|.+|||++| +++||||+...|.
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 9999996 8999999988 5789999865443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-55 Score=458.12 Aligned_cols=255 Identities=22% Similarity=0.380 Sum_probs=206.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|++.+.||+|+||+||+|+++.+|+.||+|++..... ......+.+|+.+|++|+|||||+++++|.+.. .+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIKHPNIVALDDIYESGG--HLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSS--EEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEE
Confidence 459999999999999999999999999999999986543 223456889999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DFGla~~~~ 183 (670)
+|||||.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+.. .+|.+||+|||+++...
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999999999999999999999999999999999998 999999999999962 46899999999998775
Q ss_pred ccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC--CcccCCCChHH
Q 005916 184 QAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP--AALSKVKDPEV 259 (670)
Q Consensus 184 ~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~s~~~ 259 (670)
... ..+.+||+.|||||++. +.|+.++|||||||++|+|++|.+||.+ .+...++..+..+..+ .......++++
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 543 45678999999999775 5699999999999999999999999987 5666777777776543 23345678999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
++||.+||. +|.+|||+.|+|+||||+..
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999997 89999999999999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=462.84 Aligned_cols=256 Identities=23% Similarity=0.428 Sum_probs=226.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.++||+|+||+||+|+++.+|+.||+|++++.... .....+++.+|+.+|+.++|||||+++++|.+.. .+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~ 81 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLC 81 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc--ccc
Confidence 3599999999999999999999999999999999864322 1234677889999999999999999999998765 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+|||||.||+|.+++.+.+.+++..++.+++||+.||+|||+++ ||||||||+|||++ .+|.+||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEec-CCCCEEEeecccccccccC
Confidence 99999999999999999999999999999999999999999999 99999999999998 6689999999999876432
Q ss_pred --ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 --NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 --~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
.....+|||.|||||++. +.|+.++|||||||++|+|++|.+||.+ .+...+++.+..+.. .++...++++++|
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dl 235 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHH
Confidence 346789999999999874 6799999999999999999999999987 677788888877653 3566788999999
Q ss_pred HHHcCC-CCCCCCC-----HHHHhcCccccccCC
Q 005916 263 IEKCLV-PASQRLS-----AKELLMDPFLQVNGT 290 (670)
Q Consensus 263 I~kcL~-dP~~RpS-----a~elL~hpf~~~~~~ 290 (670)
|.+||. +|.+|++ +.++++||||+...+
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 999997 8999994 999999999986544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=450.11 Aligned_cols=261 Identities=28% Similarity=0.423 Sum_probs=226.1
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS--PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ 100 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s--~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~ 100 (670)
...++|++.+.||+|+||+||+|+++.+|+.||+|++........ ....+.+.+|+.+|++|+|||||+++++|.+..
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 345689999999999999999999999999999999986543221 224677899999999999999999999997654
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCC---CcEEEeecc
Q 005916 101 NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQ---GEVKIGDLG 177 (670)
Q Consensus 101 ~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~---g~vKL~DFG 177 (670)
.+|+|||||.||+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++.++ +.+||+|||
T Consensus 87 --~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 87 --DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred --EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchh
Confidence 79999999999999999999899999999999999999999999998 99999999999998332 259999999
Q ss_pred chhhhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccC
Q 005916 178 LATIMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSK 253 (670)
Q Consensus 178 la~~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~ 253 (670)
++....... ..+..||+.|||||++. +.|+.++|||||||++|+|++|..||.+ .+..+.+..+..+.. +.....
T Consensus 163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcC
Confidence 998876543 45678999999999875 4699999999999999999999999987 567777777777653 233445
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..++++++||.+||. +|.+|||++|+|+||||+..
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 678999999999997 89999999999999999854
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.7e-54 Score=458.45 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=223.1
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
-..|++.+.||+|+||+||+|+++.+|..||+|++.... ....+.+.+|+.+|++|+|||||+++++|.+.. .+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~ 98 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--EM 98 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT--EE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EE
Confidence 346999999999999999999999999999999997532 455678999999999999999999999998754 79
Q ss_pred EEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC-CCCcEEEeeccchhhh
Q 005916 105 NIITELFTSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-NQGEVKIGDLGLATIM 182 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~-~~g~vKL~DFGla~~~ 182 (670)
|+|||||.||+|.+++. ..+.+++..++.|++||+.||.|||++| ||||||||+|||++. .+|.+||+|||+++.+
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999999999999985 4567999999999999999999999999 999999999999973 3578999999999887
Q ss_pred cccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCCChH
Q 005916 183 EQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPE 258 (670)
Q Consensus 183 ~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~s~~ 258 (670)
.... ..+..||+.|||||++. ..|+.++|||||||++|+|++|.+||.+ .+..+++..+..+.. +.......+++
T Consensus 177 ~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred ccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 6543 45678999999999875 5699999999999999999999999987 566777777776543 23333457899
Q ss_pred HHHHHHHcCC-CCCCCCCHHHHhcCccccccC
Q 005916 259 VKSFIEKCLV-PASQRLSAKELLMDPFLQVNG 289 (670)
Q Consensus 259 ~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~~ 289 (670)
+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999996 899999999999999998543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-53 Score=457.90 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=223.4
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
....+|++.+.||+|+||+||+|+++.+|+.||+|+++... ....+.+.+|+.+|++|+|||||+++++|.+..
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-- 99 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-- 99 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 34457999999999999999999999999999999987543 345677889999999999999999999997654
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC-CCCcEEEeeccchh
Q 005916 103 TVNIITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-NQGEVKIGDLGLAT 180 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~-~~g~vKL~DFGla~ 180 (670)
.+|+|||||.||+|.+++...+ ++++..++.|++||+.||.|||++| ||||||||+|||++. ..|.+||+|||+|.
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccce
Confidence 7999999999999999876654 6999999999999999999999998 999999999999973 46899999999998
Q ss_pred hhcccc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCCC
Q 005916 181 IMEQAN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKD 256 (670)
Q Consensus 181 ~~~~~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~s 256 (670)
.+.... ..+..||+.|||||++. ..|+.++|||||||++|+|+||.+||.+ .+...++..+..+.. +.......+
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCC
Confidence 876543 45678999999999775 5699999999999999999999999987 556666666666543 333445678
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 257 ~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999997 89999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-53 Score=451.73 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=224.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|++.+.||+|+||+||+|+++.+|+.||+|+++..... .....+++.+|+.+|+.++|||||+++++|.+.. .+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ--QIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS--EEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC--eee
Confidence 3599999999999999999999999999999999754321 1234677899999999999999999999997654 899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+|||||.||+|..++...+.+++..++.|++||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEc-CCCCEEEecCccceEeccc
Confidence 99999999999999999999999999999999999999999998 99999999999998 6789999999999877543
Q ss_pred ccccccCCCccCCCccccC-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 186 NAKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 186 ~~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
..+.+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+.. .++...+++++++|.
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLS 233 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence 456889999999998754 699999999999999999999999987 677777777777643 345567899999999
Q ss_pred HcCC-CCCCCC-----CHHHHhcCccccccCC
Q 005916 265 KCLV-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 265 kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
+||. +|.+|+ |++++|+||||+...|
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 9996 799996 9999999999987544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.4e-53 Score=457.29 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=217.7
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL--QSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~--~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
+.|++.++||+|+||+||+|+++.+|+.||+|++...... .......+...|+.+++.++|||||+++++|.+.. .
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~--~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--K 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--E
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC--E
Confidence 3599999999999999999999999999999999754321 11222233344577788889999999999997654 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||.||+|.+++.+++.+++..++.|++||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+.+.
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc-CCCcEEEeeeceeeecC
Confidence 9999999999999999999999999999999999999999999999 99999999999998 67899999999999887
Q ss_pred ccccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCC--HHHHHHHHhcCCCCCcccCCCChHH
Q 005916 184 QANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRN--SAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 184 ~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~--~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
.......+||+.|||||++. ..|+.++|||||||++|+|+||..||.+... ...+.+.+.. .+..++...++++
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPEL 236 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--CCCCCCSSSCHHH
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--CCCCCCCCCCHHH
Confidence 76677889999999999774 3589999999999999999999999976432 2233333222 3344556678999
Q ss_pred HHHHHHcCC-CCCCCCC-----HHHHhcCccccccCC
Q 005916 260 KSFIEKCLV-PASQRLS-----AKELLMDPFLQVNGT 290 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpS-----a~elL~hpf~~~~~~ 290 (670)
++||.+||. +|.+||| |+++++||||+...|
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 999999996 8999999 899999999986544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-53 Score=454.33 Aligned_cols=255 Identities=22% Similarity=0.381 Sum_probs=224.5
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
+.|++.+.||+|+||+||+|+++.+|+.||+|++...... .....+++.+|+++|+.++|||||+++++|.+.. .+|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~ 117 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLY 117 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeeccccccccc--ccc
Confidence 4699999999999999999999999999999999754321 1234577899999999999999999999987654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+|||||.||+|..++.+.+.+++..++.|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccC-CCCCEEeeeceeeeecccc
Confidence 99999999999999999999999999999999999999999999 99999999999998 6789999999999877543
Q ss_pred ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHH
Q 005916 186 NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIE 264 (670)
Q Consensus 186 ~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~ 264 (670)
..+.+||+.|||||++. +.|+.++|||||||++|+|+||.+||.+ .+...++..+..+.. ..+...++++++||.
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLR 270 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHH
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHHH
Confidence 45678999999999774 5699999999999999999999999987 567777777777643 234567899999999
Q ss_pred HcCC-CCCCCC-----CHHHHhcCccccccCC
Q 005916 265 KCLV-PASQRL-----SAKELLMDPFLQVNGT 290 (670)
Q Consensus 265 kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~ 290 (670)
+||. ||.+|+ |++++|+||||+...|
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 9996 898885 9999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-52 Score=433.60 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=222.6
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC-----HHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-----PEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDD 99 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s-----~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~ 99 (670)
..|.+.+.||+|+||+||+|+++.+|+.||+|++........ ....+++.+|+.+|++|+ |||||+++++|.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 458999999999999999999999999999999986543221 223457889999999996 99999999999765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
. .+|||||||.||+|.++++.++++++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 83 ~--~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 T--FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFS 157 (277)
T ss_dssp S--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred c--ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-CCCCeEEccchhe
Confidence 4 89999999999999999999999999999999999999999999998 99999999999998 6789999999999
Q ss_pred hhhccc-ccccccCCCccCCCcccc-------CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CC
Q 005916 180 TIMEQA-NAKSVIGTPEFMAPELYD-------ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PA 249 (670)
Q Consensus 180 ~~~~~~-~~~~~~GTp~YmAPEvl~-------~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~ 249 (670)
..+... .....+||+.|+|||++. ..|+.++||||+||++|+|++|..||.+ .+...++..+..+.. +.
T Consensus 158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCT
T ss_pred eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCCC
Confidence 887654 345678999999999763 3478899999999999999999999987 566667777776643 23
Q ss_pred cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 250 ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 250 ~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 3334578999999999996 8999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=443.12 Aligned_cols=252 Identities=21% Similarity=0.349 Sum_probs=220.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
+|++.+.||+|+||+||+|+++.+|+.||+|+++... .....+.+|+++|+.++|||||+++++|.+.. .+|+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~l 78 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESME--ELVM 78 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEE
Confidence 4899999999999999999999999999999997542 33456889999999999999999999998765 7999
Q ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC-CCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKHK-KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING-NQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~-~~g~vKL~DFGla~~~~~ 184 (670)
|||||.||+|.+++...+ .+++..++.|+.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++.....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999999998765 7999999999999999999999998 999999999999973 345899999999987755
Q ss_pred cc-cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCC--CCcccCCCChHHH
Q 005916 185 AN-AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIK--PAALSKVKDPEVK 260 (670)
Q Consensus 185 ~~-~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~s~~~k 260 (670)
.. .....||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+ .+...++..+..+.. +.......+++++
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 43 45678999999999764 5689999999999999999999999987 567777777777653 2233345789999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 261 SFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
+||.+||. +|.+|||+.|+|+||||+..
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999997 89999999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=444.61 Aligned_cols=254 Identities=24% Similarity=0.447 Sum_probs=220.7
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHH-hCCCCCeeeeeeEEEeCCCCeEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLK-SLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk-~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
.|++.++||+|+||+||+|.++.+|+.||+|++++..... ....+.+..|+.++. .++|||||+++++|.+.. .+|
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~--~~y 79 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--NLF 79 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC--cee
Confidence 4899999999999999999999999999999998543221 233456667777665 689999999999997654 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+|||||.||+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+++.....
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeec-CCCceeccccchhhhcccc
Confidence 99999999999999999999999999999999999999999998 99999999999998 6789999999999876432
Q ss_pred --ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 186 --NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 186 --~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
.....+||+.|+|||++ .+.|+.++|||||||++|+|++|..||.+ .+..+++..+..+.. .++...++++++|
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dl 233 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDL 233 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHH
Confidence 34567899999999976 45799999999999999999999999987 677778888877643 4556678999999
Q ss_pred HHHcCC-CCCCCCCHH-HHhcCccccccC
Q 005916 263 IEKCLV-PASQRLSAK-ELLMDPFLQVNG 289 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~-elL~hpf~~~~~ 289 (670)
|.+||. +|.+|||+. ++++||||+.-.
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 999996 899999995 899999998643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=440.21 Aligned_cols=252 Identities=22% Similarity=0.350 Sum_probs=204.5
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEEEEe
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQS-PEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s-~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~lVmE 109 (670)
.++||+|+||+||+|+++.+|+.||+|+++....... ....+++.+|+++|++++|||||+++++|.+.. .+|+|||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ivmE 80 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVFD 80 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeehhh
Confidence 5789999999999999999999999999976543221 122456889999999999999999999987654 6999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc--c
Q 005916 110 LFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN--A 187 (670)
Q Consensus 110 y~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~--~ 187 (670)
||.|+++..+....+.+++..++.|++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+++...... .
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEec-CCCccccccCccccccCCCcccc
Confidence 9999888877777788999999999999999999999999 99999999999998 67899999999998775533 3
Q ss_pred ccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-CC-CCC--------------
Q 005916 188 KSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI-KPA-------------- 249 (670)
Q Consensus 188 ~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g~-~p~-------------- 249 (670)
...+||+.|||||++. ..|+.++|||||||++|+|+||.+||.+.....++.+.... +. ...
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 5678999999999764 45899999999999999999999999875444443332211 00 000
Q ss_pred ---------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 250 ---------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 250 ---------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
......++++++||.+||+ ||.+||||+|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0112357899999999997 8999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=433.27 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=214.7
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCH--HHHHHHHHHHHHHHhCC--CCCeeeeeeEEEe
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSP--EDLERLYSEVHLLKSLK--HNNIIRFYNSWID 98 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~--~~~e~l~~Ei~iLk~L~--HpNIVkl~~~~~d 98 (670)
|...+|++.++||+|+||+||+|+++.+|+.||+|++......... ....++.+|+.+|++++ |||||+++++|.+
T Consensus 1 pl~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 1 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 4566799999999999999999999999999999999864332111 12234678999999996 8999999999876
Q ss_pred CCCCeEEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeecc
Q 005916 99 DQNKTVNIITELFTS-GSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLG 177 (670)
Q Consensus 99 ~~~~~~~lVmEy~~g-GsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFG 177 (670)
.. .+|+||||+.+ +++.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+.+.+||+|||
T Consensus 81 ~~--~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 81 PD--SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp SS--EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CC--eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccc
Confidence 54 79999999976 688899998899999999999999999999999998 99999999999999667899999999
Q ss_pred chhhhcccccccccCCCccCCCcccc-CC-CCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCC
Q 005916 178 LATIMEQANAKSVIGTPEFMAPELYD-EN-YNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 178 la~~~~~~~~~~~~GTp~YmAPEvl~-~~-ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
+|+........+.+||+.|||||++. .. ++.++|||||||++|+|++|..||.. .. .+..+. ..++...
T Consensus 157 ~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~----~i~~~~--~~~~~~~ 227 (273)
T d1xwsa_ 157 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DE----EIIRGQ--VFFRQRV 227 (273)
T ss_dssp TCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HH----HHHHCC--CCCSSCC
T ss_pred cceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC---ch----HHhhcc--cCCCCCC
Confidence 99887766667889999999999874 33 56789999999999999999999975 22 233332 2345567
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
++++++||.+||. +|.+|||++|+|+||||+.
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 8999999999996 8999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-52 Score=440.06 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=207.0
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHh-CCCCCeeeeeeEEEe--CCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKS-LKHNNIIRFYNSWID--DQN 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~-L~HpNIVkl~~~~~d--~~~ 101 (670)
++|+.+.++||+|+||+||+|+++.+|+.||+|+++.. ..+.+|+.++.+ ++|||||+++++|.+ ..+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 34444557899999999999999999999999998632 346789998765 489999999999876 234
Q ss_pred CeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeecc
Q 005916 102 KTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLG 177 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DFG 177 (670)
.++|+|||||.||+|.+++.++ ..+++..++.|++||+.||.|||+++ |+||||||+|||++. ..+.+||+|||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccc
Confidence 5799999999999999999875 36999999999999999999999998 999999999999984 35679999999
Q ss_pred chhhhcccc-cccccCCCccCCCccccC-CCCccceeeeccchhhhhhhccCCCCCCCCHHH---HHHHHhcCCC--CCc
Q 005916 178 LATIMEQAN-AKSVIGTPEFMAPELYDE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQ---IYKKVSSGIK--PAA 250 (670)
Q Consensus 178 la~~~~~~~-~~~~~GTp~YmAPEvl~~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~---i~~~i~~g~~--p~~ 250 (670)
+|+...... ....+|||.|||||++.+ .|+.++|||||||++|+|+||.+||.+...... +...+..+.. |..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 998775533 466789999999998754 699999999999999999999999976433222 2222222221 222
Q ss_pred ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 251 LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 251 ~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 223468899999999996 89999999999999999754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-51 Score=424.24 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=220.9
Q ss_pred CCCCCCCC--cccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCC
Q 005916 11 MEPPDPDV--LETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNN 88 (670)
Q Consensus 11 ~~~~~~~~--~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpN 88 (670)
|.|+.|.+ +|+++ ..|++.+.||+|+||+||+|.++.+|+.||+|+++... ...+++.+|+.+|++|+|||
T Consensus 2 ~~p~~p~~~~wei~~--~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~Hpn 74 (287)
T d1opja_ 2 MDPSSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPN 74 (287)
T ss_dssp CCTTSTTCCTTBCCG--GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTT
T ss_pred cCCCCCCCcccEecH--HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCC
Confidence 45666654 55554 46999999999999999999999999999999986432 23567899999999999999
Q ss_pred eeeeeeEEEeCCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC
Q 005916 89 IIRFYNSWIDDQNKTVNIITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166 (670)
Q Consensus 89 IVkl~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~ 166 (670)
||++|++|.+.. .+|+|||||.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 75 Iv~~~~~~~~~~--~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~- 149 (287)
T d1opja_ 75 LVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG- 149 (287)
T ss_dssp BCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-
T ss_pred EecCCccEeeCC--eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEEC-
Confidence 999999987654 689999999999999998764 57899999999999999999999998 99999999999998
Q ss_pred CCCcEEEeeccchhhhcccc---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHH
Q 005916 167 NQGEVKIGDLGLATIMEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKV 242 (670)
Q Consensus 167 ~~g~vKL~DFGla~~~~~~~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i 242 (670)
.++.+||+|||+|+...... .....||+.|||||++ .+.|+.++|||||||++|||++|..||....+..++++.+
T Consensus 150 ~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i 229 (287)
T d1opja_ 150 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229 (287)
T ss_dssp GGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH
Confidence 56899999999998875543 2345689999999976 5789999999999999999999887776667888888888
Q ss_pred hcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 243 SSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 243 ~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+..+ ..+...++++++||.+||. +|.+|||+.++++
T Consensus 230 ~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 230 EKDYRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCC-CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 777544 3455678999999999996 8999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=421.94 Aligned_cols=254 Identities=28% Similarity=0.431 Sum_probs=206.3
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.++.+|+.||+|+++.... .....+++.+|+++|++++|||||+++++|.+.. .+|+
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~--~~~i 78 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYL 78 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEecccccccc--ceeE
Confidence 58999999999999999999999999999999975432 2234567889999999999999999999998765 7999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||||.++.+...... .+.+++..++.++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+|+.....
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCCC
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeec-ccCcceeccCCcceeccCC
Confidence 9999976544433333 467999999999999999999999998 99999999999998 6689999999999887543
Q ss_pred c--cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCC------------
Q 005916 186 N--AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPA------------ 249 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~------------ 249 (670)
. ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+++.+.....+.
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 2 45668999999999653 3468899999999999999999999988555555554433211000
Q ss_pred --------------cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 250 --------------ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 250 --------------~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 0012346889999999997 8999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-50 Score=417.81 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=211.4
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC--C
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--K 102 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--~ 102 (670)
..+|++.+.||+|+||+||+|.+..+|+.||+|+++... .......+++.+|+++|+.++|||||++++++.+... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhh-ccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 356899999999999999999999999999999997543 3456777889999999999999999999999876543 4
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.+|+|||||.||+|.+++...+.+++..++.|++||+.||.|||+++ ||||||||+|||++ .++.++|+|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccC-ccccceeehhhhhhhh
Confidence 68999999999999999999999999999999999999999999998 99999999999998 6689999999988655
Q ss_pred ccc-----ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC-CcccCCC
Q 005916 183 EQA-----NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP-AALSKVK 255 (670)
Q Consensus 183 ~~~-----~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~~ 255 (670)
... .....+||+.|||||++. +.|+.++|||||||++|+|+||.+||.+........+.+.....+ .......
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 332 235678999999999875 469999999999999999999999998744444455555554433 3344567
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCcccc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDPFLQ 286 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~ 286 (670)
++++++||.+||. +|.+||+..+.|.|+|++
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 8999999999996 899999444445577765
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-50 Score=417.06 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=208.2
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
+|++.++||+|+||+||+|+++ +|+.||+|+++.... .....+++.+|+.+|++++|||||+++++|.+.. ..++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i 77 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVL 77 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEE
T ss_pred CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--ceeE
Confidence 6899999999999999999986 789999999976532 2334577899999999999999999999998765 6899
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcccc
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQAN 186 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~~ 186 (670)
+|||+.++.+..+....+.+++..++.+++||+.||+|||+++ ||||||||+|||++ .++.+||+|||++.......
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC--
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEc-CCCCEEecccccceecccCc
Confidence 9999998888888777889999999999999999999999998 99999999999998 57899999999998875432
Q ss_pred --cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-CC---------------
Q 005916 187 --AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-GI--------------- 246 (670)
Q Consensus 187 --~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g~--------------- 246 (670)
.....||+.|+|||++. ..++.++|||||||++|+|++|.+||.+......+.+.... +.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 34567999999999764 45799999999999999999999999875444443332210 00
Q ss_pred -------C---CCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 247 -------K---PAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 247 -------~---p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
. ........++.+++||.+||+ ||++||||.|+|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0 011223457899999999997 8999999999999999973
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=416.43 Aligned_cols=258 Identities=28% Similarity=0.385 Sum_probs=206.6
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCC-CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC---CCCCeeeeeeEEEeC-
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVN-GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL---KHNNIIRFYNSWIDD- 99 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~t-g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L---~HpNIVkl~~~~~d~- 99 (670)
..+|++.+.||+|+||+||+|++..+ ++.||+|+++..... ......+.+|+.+|+.| +|||||+++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc--chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 35799999999999999999999765 678999999864322 11123355677777666 899999999998643
Q ss_pred --CCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 100 --QNKTVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 100 --~~~~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
....++++||||.+|.+...... ...+++..++.++.||+.||+|||+++ ||||||||+|||++ ..|.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc-CCCCeeecch
Confidence 33478999999988877655443 467999999999999999999999999 99999999999998 6689999999
Q ss_pred cchhhhccc-ccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC--C------
Q 005916 177 GLATIMEQA-NAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG--I------ 246 (670)
Q Consensus 177 Gla~~~~~~-~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g--~------ 246 (670)
|++...... .....+||+.|||||++ ...|+.++|||||||++|+|++|.+||.+. +.......+... .
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhhCCCchhcc
Confidence 998876543 34678899999999976 567999999999999999999999999874 444433333210 0
Q ss_pred -----------------CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 247 -----------------KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 247 -----------------~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
....+....++.+++||.+||. ||.+||||.|+|+||||+.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0011233467899999999996 89999999999999999854
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=415.56 Aligned_cols=250 Identities=20% Similarity=0.348 Sum_probs=209.6
Q ss_pred eEEEE-EEecccCCeEEEEEEEc--CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCe
Q 005916 27 YIRYK-EVIGKGAFKTVYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 27 ~yr~~-~~LG~G~fG~Vy~a~d~--~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~ 103 (670)
++.+. +.||+|+||+||+|.+. .+++.||+|+++... .++...+++.+|+.+|++|+|||||+++++|.++ .
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~ 81 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---S 81 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---S
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---C
Confidence 34554 47999999999999764 456889999986432 2355677899999999999999999999988543 3
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|+|||||++|+|.+++.+.+.+++..+..|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+++.+.
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccc-ccCcccccchhhhhhcc
Confidence 7899999999999999999999999999999999999999999998 99999999999998 66899999999998764
Q ss_pred ccc-----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 184 QAN-----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 184 ~~~-----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
... .....||+.|||||++ .+.|+.++|||||||++|||+| |.+||.+ .+..++...+..+..+ ..+...+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~ 236 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCP 236 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCC
T ss_pred ccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccC
Confidence 322 2346799999999976 5679999999999999999998 8999987 5667788888887644 3456678
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHH---hcCcccc
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKEL---LMDPFLQ 286 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~el---L~hpf~~ 286 (670)
+++++||.+||. +|.+|||+.++ |+|+|+.
T Consensus 237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 999999999996 89999999998 5677764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=423.43 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=209.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCC-----eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNG-----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD 99 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg-----~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~ 99 (670)
..|++.++||+|+||+||+|++..++ ..||+|.+.... .......+.+|+.+|+++ +|||||++|++|.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 46899999999999999999987654 368999886432 234456788999999998 899999999999765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeec
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHK-----------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRD 156 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~-----------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrD 156 (670)
. .+|+|||||.+|+|.+++..+. .+++..++.|+.||+.||.|||+++ |||||
T Consensus 114 ~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRD 189 (325)
T d1rjba_ 114 G--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRD 189 (325)
T ss_dssp S--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred C--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 5 6899999999999999997642 4899999999999999999999998 99999
Q ss_pred CccccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCC
Q 005916 157 LKCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYS 230 (670)
Q Consensus 157 LKpeNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~ 230 (670)
|||+|||++ .++.+||+|||+|+...... ..+..||+.|||||++ .+.|+.++|||||||++|||+| |.+||.
T Consensus 190 lKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 190 LAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp CSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred Cchhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999998 66899999999998765533 2356789999999966 5789999999999999999997 899998
Q ss_pred CCCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 231 ECRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 231 ~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+......+.+.+..+..+ ..+...++++++||.+||. +|.+|||++||++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 866667777777666543 4556678999999999996 89999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=418.12 Aligned_cols=246 Identities=31% Similarity=0.470 Sum_probs=207.0
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|+.. ..||||+++... .+....+.+.+|+.+|++++|||||++++++.+ ..++
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~ 79 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLA 79 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS--CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEE
Confidence 34778899999999999999643 359999987543 234567889999999999999999999997643 2589
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 106 IITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
+|||||.||+|.+++... +.+++..+..|+.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+|+....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC---
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEc-CCCCEEEccccceeeccc
Confidence 999999999999999765 56999999999999999999999998 99999999999998 678999999999987653
Q ss_pred c----ccccccCCCccCCCcccc----CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCc---ccC
Q 005916 185 A----NAKSVIGTPEFMAPELYD----ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAA---LSK 253 (670)
Q Consensus 185 ~----~~~~~~GTp~YmAPEvl~----~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~---~~~ 253 (670)
. ...+..||+.|||||++. ..|+.++|||||||++|||+||+.||.+..+...+...+..+..+.. .+.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 236 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence 2 235678999999999874 35899999999999999999999999987778888888877764432 344
Q ss_pred CCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 254 VKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 254 ~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
..++++++||.+||. +|.+|||+.+++.+
T Consensus 237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 567899999999996 89999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-49 Score=417.62 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=210.9
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCCe
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNKT 103 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~~ 103 (670)
.+.|++.++||+|+||+||+|+++.+|+.||+|+++... .+++.+|+.+|+.| .||||++++++|.......
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 356999999999999999999999999999999986432 45688999999999 5999999999998777678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 104 VNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 104 ~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+++|||||.+|+|..+ .+.+++..++.+++||+.||.|||++| |+||||||+|||++.+++.+||+|||+|....
T Consensus 107 ~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 107 PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999999999765 357999999999999999999999999 99999999999999666679999999998776
Q ss_pred cc-ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-------------C-C
Q 005916 184 QA-NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-------------G-I 246 (670)
Q Consensus 184 ~~-~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-------------g-~ 246 (670)
.. .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||....+.......+.. . .
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 54 356778999999999764 35899999999999999999999999775554433222211 0 0
Q ss_pred ---------------------CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 247 ---------------------KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 247 ---------------------~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
.+.......++++++||++||. +|.+||||+|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0011123357899999999997 89999999999999999853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=421.43 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=207.7
Q ss_pred CCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC--
Q 005916 22 DPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD-- 99 (670)
Q Consensus 22 dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~-- 99 (670)
-|..-.|+..++||+|+||+||+|+++.+|+.||+|++...... ..+|+.+|++|+|||||+++++|...
T Consensus 16 ~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp CCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 34344699999999999999999999999999999999865432 23699999999999999999998653
Q ss_pred --CCCeEEEEEecCCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 100 --QNKTVNIITELFTSGSLRQ---YRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 100 --~~~~~~lVmEy~~gGsL~~---~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
+..++|+|||||.+|.+.. +......+++..++.|++||+.||+|||++| |+||||||+|||++.+...+||+
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~ 165 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLC 165 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEEC
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEe
Confidence 3347899999998764333 3345567999999999999999999999998 99999999999998555689999
Q ss_pred eccchhhhcccc-cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-C-----
Q 005916 175 DLGLATIMEQAN-AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-G----- 245 (670)
Q Consensus 175 DFGla~~~~~~~-~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g----- 245 (670)
|||++..+.... ..+.+||+.|+|||++. ..|+.++|||||||++|+|++|.+||........+.+.+.. +
T Consensus 166 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 999998775433 46678999999999653 46899999999999999999999999875444444332211 0
Q ss_pred ------------CCC----C----cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 246 ------------IKP----A----ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 246 ------------~~p----~----~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+ . ......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000 0 1123467899999999997 89999999999999999753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=406.78 Aligned_cols=255 Identities=26% Similarity=0.377 Sum_probs=217.9
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
++|++.+.||+|+||+||+|+++.+|+.||||+++.... ......++.+|+.+|+.++|||||+++++|.+.. .++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--cee
Confidence 369999999999999999999999999999999976542 3456788999999999999999999999997765 789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 106 IITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
+||+++.+++|..++..++.+++..++.+++|++.||+|||+++ |+||||||+|||++ ..+.+||+|||.+......
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSC
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccc-cCCceeeeecchhhcccCC
Confidence 99999999999999999999999999999999999999999998 99999999999998 5679999999999877543
Q ss_pred c--cccccCCCccCCCccccC--CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC---------------
Q 005916 186 N--AKSVIGTPEFMAPELYDE--NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI--------------- 246 (670)
Q Consensus 186 ~--~~~~~GTp~YmAPEvl~~--~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~--------------- 246 (670)
. .....+++.|+|||++.. .++.++|||||||++|+|++|..||....+..+.+..+....
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 3 344567899999997643 479999999999999999999999866667666665543210
Q ss_pred ------------CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 247 ------------KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 247 ------------~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.........++.+++||.+||. ||.+||||+|+|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0111223457899999999997 8999999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=411.27 Aligned_cols=248 Identities=23% Similarity=0.407 Sum_probs=212.2
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVN 105 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~ 105 (670)
..|++.+.||+|+||+||+|.++ ++..||||+++... ...+.+.+|+.+|++|+|||||++++++.+. .+|
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~ 83 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIY 83 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC---CeE
Confidence 46999999999999999999875 67889999987432 1245689999999999999999999987532 478
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhc
Q 005916 106 IITELFTSGSLRQYRKKH--KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIME 183 (670)
Q Consensus 106 lVmEy~~gGsL~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~ 183 (670)
+|||||.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|+.+.
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeee-cccceeeccccceEEcc
Confidence 999999999999976543 36999999999999999999999998 99999999999998 67899999999998875
Q ss_pred ccc---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHH
Q 005916 184 QAN---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEV 259 (670)
Q Consensus 184 ~~~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~ 259 (670)
... .....||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++...+..+..+. .+...++++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l 239 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEEL 239 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHH
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccChHHH
Confidence 432 34567999999999775 6799999999999999999997666655577888888888876543 445678999
Q ss_pred HHHHHHcCC-CCCCCCCHHHHhc--Ccccc
Q 005916 260 KSFIEKCLV-PASQRLSAKELLM--DPFLQ 286 (670)
Q Consensus 260 k~fI~kcL~-dP~~RpSa~elL~--hpf~~ 286 (670)
++||.+||. +|.+|||+.++++ |+||.
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999996 7999999999998 78885
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-49 Score=413.76 Aligned_cols=248 Identities=22% Similarity=0.377 Sum_probs=200.4
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCe---EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGL---EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~---~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
..+|++.++||+|+||+||+|.++.+|. .||+|.+... ......+++.+|+++|++|+|||||++++++.+..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~- 100 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST- 100 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-
Confidence 3579999999999999999999987765 5777766532 34566788999999999999999999999986554
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 102 KTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
.+|+|||||.+|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 101 -~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 101 -PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSR 176 (299)
T ss_dssp -SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC----
T ss_pred -EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEEC-CCCcEEECCcccce
Confidence 689999999999999988774 57999999999999999999999998 99999999999998 67899999999998
Q ss_pred hhcccc-------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcc
Q 005916 181 IMEQAN-------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAAL 251 (670)
Q Consensus 181 ~~~~~~-------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~ 251 (670)
.+.... .....||+.|||||++ .+.|+.++|||||||++|||+| |.+||.+ .+..++...+..+..+. .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~ 254 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP-P 254 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-C
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-C
Confidence 775432 1224679999999976 4679999999999999999998 8999987 56677777787765443 3
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+...++++++||.+||. +|.+|||+.|++++
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 45578999999999996 89999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=411.14 Aligned_cols=251 Identities=18% Similarity=0.376 Sum_probs=213.0
Q ss_pred CeEEEEEE-ecccCCeEEEEEEEc--CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRYKEV-IGKGAFKTVYKAFDE--VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~~~~-LG~G~fG~Vy~a~d~--~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
..+.+.+. ||+|+||+||+|.++ .++..||||+++.. ......+++.+|+++|++|+|||||++++++.++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--- 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--- 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---
Confidence 35777775 999999999999775 45668999998743 2466778899999999999999999999988643
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+|||||++|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKA 158 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeec-cCCceeeccchhhhc
Confidence 489999999999999997654 67999999999999999999999998 99999999999998 578999999999987
Q ss_pred hcccc-----cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 182 MEQAN-----AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 182 ~~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
+.... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+. +..++...+..+..+. .+..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~ 236 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRME-CPPE 236 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCCC-CCTT
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCc
Confidence 65432 23457899999999774 679999999999999999998 89999874 4567777888876543 4556
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHH---hcCccccc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKEL---LMDPFLQV 287 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~el---L~hpf~~~ 287 (670)
.++++.+||.+||. +|.+|||+.++ |+|+|+..
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 78999999999996 89999999887 67888753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=406.74 Aligned_cols=244 Identities=20% Similarity=0.397 Sum_probs=200.0
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||+|+||+||+|.+. ++..||||+++.... ..+.+.+|+++|++++|||||+++++|.+.. .+|+
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~l 77 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICL 77 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEE
T ss_pred HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-----cHHHHHHHHHHHHhcCCCCcccccceeccCC--ceEE
Confidence 5899999999999999999876 678899999874321 2356889999999999999999999987654 6899
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||||.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC--------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeec-CCCCeEecccchheeccCC
Confidence 99999999999998765 56899999999999999999999998 99999999999998 5689999999999877543
Q ss_pred c---cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHH
Q 005916 186 N---AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKS 261 (670)
Q Consensus 186 ~---~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~ 261 (670)
. .....||+.|||||++. +.|+.++|||||||++|||+|+..|+....+..+++..+..+..+. .+...++++.+
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~~ 233 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVYQ 233 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-CCTTSCHHHHH
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-CccccCHHHHH
Confidence 3 23467899999999775 5799999999999999999996555445477788888888875443 45667899999
Q ss_pred HHHHcCC-CCCCCCCHHHHhcC
Q 005916 262 FIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 262 fI~kcL~-dP~~RpSa~elL~h 282 (670)
||.+||. +|.+|||++++|+|
T Consensus 234 li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 234 IMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHH
Confidence 9999996 79999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=415.89 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=205.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC---C
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---K 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~---~ 102 (670)
.+|++.+.||+|+||+||+|.+..+|+.||||+++... .....+++.+|+.+|++|+|||||++++++..... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 45999999999999999999999999999999997533 45667889999999999999999999999865432 2
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
.+|++| ++.||+|.+++..+ ++++..++.++.||+.||+|||+++ ||||||||+|||++ ++|.+||+|||++...
T Consensus 85 ~~~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 85 DVYLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVA 159 (345)
T ss_dssp CEEEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred eEEEEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCceeec
Confidence 355555 55699999998764 6999999999999999999999998 99999999999998 6789999999999776
Q ss_pred cccc-----cccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcC----------
Q 005916 183 EQAN-----AKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSG---------- 245 (670)
Q Consensus 183 ~~~~-----~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g---------- 245 (670)
.... ....+||+.|+|||++. ..|+.++||||+||++|+|++|.+||............+...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 4432 35568999999999763 457899999999999999999999997744333322221110
Q ss_pred ---------------CCCC---cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 246 ---------------IKPA---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 246 ---------------~~p~---~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
..+. ......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0001 1123457899999999996 89999999999999999854
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=416.50 Aligned_cols=255 Identities=30% Similarity=0.432 Sum_probs=205.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC----
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN---- 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~---- 101 (670)
.+|++.+.||+|+||+||+|.++.+|+.||+|+++... .+....+++.+|+++|+.|+|||||+++++|.....
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 56899999999999999999999999999999987432 345677889999999999999999999999876532
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|+||||| +++|..+++ ++.+++..++.+++||+.||.|||++| ||||||||+|||++ .++.+||+|||++..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcc-cccccccccccceec
Confidence 3579999999 667777654 567999999999999999999999999 99999999999998 678999999999987
Q ss_pred hcccccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc-C-------------
Q 005916 182 MEQANAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS-G------------- 245 (670)
Q Consensus 182 ~~~~~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~-g------------- 245 (670)
.... ....+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+......+...... +
T Consensus 171 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 171 ADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp CCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cCCc-cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 6543 45678999999999763 35789999999999999999999999874433332221110 0
Q ss_pred -----------CCC---CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 246 -----------IKP---AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 246 -----------~~p---~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
... .......++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 001 11223457899999999997 89999999999999999853
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=413.31 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=205.6
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC-----
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ----- 100 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~----- 100 (670)
.+|++.+.||+|+||+||+|++..+|+.||||++..... ......++.+|+++|+.|+||||+++++++....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 468999999999999999999999999999999876543 2334567889999999999999999999986532
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccch
Q 005916 101 -NKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLA 179 (670)
Q Consensus 101 -~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla 179 (670)
...+|+|||||.++.+..+......+++..++.+++||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeec-CCCcEEeeeccee
Confidence 2368999999988877766666778999999999999999999999998 99999999999998 6789999999999
Q ss_pred hhhccc------ccccccCCCccCCCcccc--CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc---CCCC
Q 005916 180 TIMEQA------NAKSVIGTPEFMAPELYD--ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS---GIKP 248 (670)
Q Consensus 180 ~~~~~~------~~~~~~GTp~YmAPEvl~--~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~---g~~p 248 (670)
...... ...+.+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+. +.......+.. ...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-CHHHHHHHHHHhcCCCCh
Confidence 766432 134568999999999763 46899999999999999999999999873 44333332222 1111
Q ss_pred Cccc---------------------------CCCChHHHHHHHHcCC-CCCCCCCHHHHhcCccccc
Q 005916 249 AALS---------------------------KVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQV 287 (670)
Q Consensus 249 ~~~~---------------------------~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~ 287 (670)
.... ...++++++||.+||. ||.+||||+|+|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 1110 1136788999999997 8999999999999999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-50 Score=422.30 Aligned_cols=275 Identities=21% Similarity=0.341 Sum_probs=221.7
Q ss_pred CeEEEEEEecccCCeEEEEEEE---cCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEeCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFD---EVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDDQN 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d---~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H-pNIVkl~~~~~d~~~ 101 (670)
..|++.+.||+|+||+||+|++ +.+|+.||+|+++...........+++.+|+++|++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~- 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET- 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence 4599999999999999999987 457999999999765433223345667889999999966 89999999987765
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.++++||||.+|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++.
T Consensus 103 -~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 -KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKE 178 (322)
T ss_dssp -EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEE
T ss_pred -ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeec-CCCCEEEeeccchhh
Confidence 79999999999999999999999999999999999999999999999 99999999999998 568999999999987
Q ss_pred hccc---ccccccCCCccCCCccccC---CCCccceeeeccchhhhhhhccCCCCCCC---CHHHHHHHHhcCCCCCccc
Q 005916 182 MEQA---NAKSVIGTPEFMAPELYDE---NYNELADIYSFGMCMLEMVTFEYPYSECR---NSAQIYKKVSSGIKPAALS 252 (670)
Q Consensus 182 ~~~~---~~~~~~GTp~YmAPEvl~~---~ys~~~DIWSLGvilyeLltG~~Pf~~~~---~~~~i~~~i~~g~~p~~~~ 252 (670)
+... ...+..||+.|+|||++.. .|+.++|||||||++|+|++|..||.+.. ....+.+...... ..++
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--~~~~ 256 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYP 256 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCCC
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--CCCc
Confidence 6432 2456789999999997642 47889999999999999999999997643 2334444444432 2344
Q ss_pred CCCChHHHHHHHHcCC-CCCCCC-----CHHHHhcCccccccCCCCCCCCCCCCCcCCCcc
Q 005916 253 KVKDPEVKSFIEKCLV-PASQRL-----SAKELLMDPFLQVNGTTKNRPLPLPDIVLPRVG 307 (670)
Q Consensus 253 ~~~s~~~k~fI~kcL~-dP~~Rp-----Sa~elL~hpf~~~~~~~~~~~~~~~~~~~~~~~ 307 (670)
...++++++||.+||. +|.+|| ||+|+|+||||+...+........+.+.+|.+.
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~ 317 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIR 317 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCC
Confidence 5678999999999997 799999 589999999998755432222223344455543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=401.33 Aligned_cols=251 Identities=22% Similarity=0.396 Sum_probs=206.5
Q ss_pred ccCCCCCeEEEEEEecccCCeEEEEEEEcCCC----eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeE
Q 005916 20 ETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNG----LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNS 95 (670)
Q Consensus 20 e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg----~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~ 95 (670)
|++|. .|.+.++||+|+||+||+|.++.++ ..||+|++... ........+.+|+.+|++|+|||||+++++
T Consensus 3 ei~~~--~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPS--CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTT--TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHH--HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc---cChHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 34454 3889999999999999999887655 57999988643 245566789999999999999999999999
Q ss_pred EEeCCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 96 WIDDQNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 96 ~~d~~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
+.+.. .+++|||||.+|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+||||+ .++.+||+
T Consensus 78 ~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~ 152 (283)
T d1mqba_ 78 ISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVS 152 (283)
T ss_dssp ECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEEC
T ss_pred EecCC--ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEEC-CCCeEEEc
Confidence 87554 689999999999999987655 67999999999999999999999998 99999999999998 67899999
Q ss_pred eccchhhhcccc-----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCC
Q 005916 175 DLGLATIMEQAN-----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKP 248 (670)
Q Consensus 175 DFGla~~~~~~~-----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p 248 (670)
|||+++.+.... .....||+.|||||++ .+.|+.++|||||||++|||++|..||....+..++++.+..+..+
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC
Confidence 999998765432 2335689999999976 5679999999999999999999776666667888888888887654
Q ss_pred CcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 249 AALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 249 ~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
. .+...++.++++|.+||. +|.+|||+.++++
T Consensus 233 ~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 P-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp C-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 4 445577899999999996 8999999999987
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=399.37 Aligned_cols=243 Identities=21% Similarity=0.408 Sum_probs=210.7
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|.+.+.||+|+||+||+|+++ ++..||||.++.... ..+.+.+|+.++++++|||||++|++|.+.. .+++
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~--~~~i 76 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR--PIFI 76 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS--SEEE
T ss_pred HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--ceEE
Confidence 4678899999999999999975 788999999985432 2356889999999999999999999987654 6999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhccc
Q 005916 107 ITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQA 185 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~~ 185 (670)
|||||.+|+|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+...
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSS
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEc-CCCcEEECcchhheeccCC
Confidence 9999999999998665 467999999999999999999999998 99999999999998 6789999999999876543
Q ss_pred c---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHH
Q 005916 186 N---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVK 260 (670)
Q Consensus 186 ~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k 260 (670)
. .....||+.|+|||++ ...|+.++|||||||++|||+| |..||.+ .+..++...+..+..+ ..+...+++++
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~ 231 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKVY 231 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC-CCHHHHHHHHHhCCCC-CCcccccHHHH
Confidence 3 2346789999999976 4679999999999999999998 8999987 4567788888887644 35567789999
Q ss_pred HHHHHcCC-CCCCCCCHHHHhcC
Q 005916 261 SFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 261 ~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+||.+||. +|.+|||+.++|+|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999997 79999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=399.37 Aligned_cols=246 Identities=26% Similarity=0.422 Sum_probs=199.8
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
..|++.+.||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.+|++++|||||++|+++.+ .
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---S
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---C
Confidence 3699999999999999999998754 456788776432 345667889999999999999999999998843 3
Q ss_pred eEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+|+|||||.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++.
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRY 157 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeec-CCCcEEEccchhhee
Confidence 58999999999999998665 457999999999999999999999998 99999999999998 568999999999987
Q ss_pred hcccc---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCC
Q 005916 182 MEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKD 256 (670)
Q Consensus 182 ~~~~~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s 256 (670)
+.... .....||+.|+|||++ .+.|+.++|||||||++|||+| |.+||.+ .+..+++..+..+..+. .+...+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~ 235 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNCP 235 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CCTTCC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCC
Confidence 65432 3456789999999977 4689999999999999999988 8999977 56667777788776543 455678
Q ss_pred hHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 257 PEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 257 ~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+++++||.+||. +|.+|||+.|+++|
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999996 89999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=411.13 Aligned_cols=255 Identities=29% Similarity=0.408 Sum_probs=205.6
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCC---CC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQ---NK 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~---~~ 102 (670)
.+|++.+.||+|+||+||+|+++.+|+.||+|+++... .+....+++.+|+++|++|+|||||+++++|.... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 45999999999999999999999999999999987532 34566778999999999999999999999986432 12
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhh
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIM 182 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~ 182 (670)
..+++|++|.||+|.+++.. +++++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+|++|||++...
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHT 171 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----CC
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccc-ccccccccccchhccc
Confidence 34556677789999998854 57999999999999999999999998 99999999999998 6789999999999766
Q ss_pred cccccccccCCCccCCCccc-cC-CCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCC-CC-----------
Q 005916 183 EQANAKSVIGTPEFMAPELY-DE-NYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGI-KP----------- 248 (670)
Q Consensus 183 ~~~~~~~~~GTp~YmAPEvl-~~-~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~-~p----------- 248 (670)
... ..+..||+.|+|||++ .. .++.++|||||||++|+|++|.+||.+. +.......+.... .+
T Consensus 172 ~~~-~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 172 DDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-DHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp TGG-GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred Ccc-cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChHHhhhccch
Confidence 443 4567899999999965 33 4689999999999999999999999874 3333333332110 00
Q ss_pred --------------C---cccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 249 --------------A---ALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 249 --------------~---~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
. ......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0 0112357899999999996 89999999999999999854
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=403.76 Aligned_cols=246 Identities=27% Similarity=0.453 Sum_probs=203.8
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCe----EEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGL----EVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~----~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
.|++.++||+|+||+||+|.+..+|+ .||+|.++.. .+....+++.+|+.+|++|+|||||+++++|.+.
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--- 83 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 83 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 49999999999999999999988876 4677766532 2234467899999999999999999999998764
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+++||+|.+|+|.+++..+ ..+++..++.|+.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++.
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKL 160 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCCSHHHH
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeC-CCCCeEeecccccee
Confidence 378899999999999887664 67999999999999999999999998 99999999999998 568999999999988
Q ss_pred hcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCC
Q 005916 182 MEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVK 255 (670)
Q Consensus 182 ~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 255 (670)
+.... .....||+.|||||++ .+.|+.++|||||||++|||+| |.+||.+ .+..++...+..+..+. .+...
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~~ 238 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPIC 238 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTTB
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccc
Confidence 75432 2345789999999965 5679999999999999999998 7888876 55667778887776543 44567
Q ss_pred ChHHHHHHHHcCC-CCCCCCCHHHHhcCc
Q 005916 256 DPEVKSFIEKCLV-PASQRLSAKELLMDP 283 (670)
Q Consensus 256 s~~~k~fI~kcL~-dP~~RpSa~elL~hp 283 (670)
++.+++||.+||. +|.+|||+.+++.|.
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 8999999999996 899999999999883
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=400.65 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=203.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcC-----CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEV-----NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD 99 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~-----tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~ 99 (670)
..|++.+.||+|+||+||+|.+.. +++.||+|+++... .....+.+.+|..++.++ +|||||.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 469999999999999999998754 45789999986432 345567788888888887 789999999987654
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEE
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIF 163 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNIL 163 (670)
. ..+++|||||.+|+|.+++... ..+++..++.|+.||+.||.|||+++ ||||||||+|||
T Consensus 90 ~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NIL 166 (299)
T d1ywna1 90 G-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNIL 166 (299)
T ss_dssp T-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred C-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCcccee
Confidence 4 4689999999999999998754 24899999999999999999999998 999999999999
Q ss_pred EeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhc-cCCCCCCCCHHH
Q 005916 164 INGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTF-EYPYSECRNSAQ 237 (670)
Q Consensus 164 l~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG-~~Pf~~~~~~~~ 237 (670)
++ .++.+||+|||+|+...... .....||+.|||||++ .+.|+.++|||||||++|||+|| .+||.+......
T Consensus 167 l~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 167 LS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp EC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred EC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 98 66899999999998764432 3456899999999976 56799999999999999999986 568887666777
Q ss_pred HHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 238 IYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 238 i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+.+.+..+..+. .+...++++++||.+||. +|.+|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 246 FCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 777777776543 455678999999999996 89999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=408.48 Aligned_cols=254 Identities=29% Similarity=0.391 Sum_probs=197.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC----CC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD----QN 101 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~----~~ 101 (670)
++|++.++||+|+||+||+|.++.+|+.||||++.... .+.....++.+|+.+|++++|||||+++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh--cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 45999999999999999999999999999999997543 3466778899999999999999999999998654 23
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 102 KTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
..+|+|||||.++.+ +.+ ...+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+|++|||++..
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLART 168 (355)
T ss_dssp CEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC---
T ss_pred ceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc-cccceeeechhhhhc
Confidence 589999999976544 433 457999999999999999999999998 99999999999998 568999999999887
Q ss_pred hcccc-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhc---------------
Q 005916 182 MEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSS--------------- 244 (670)
Q Consensus 182 ~~~~~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~--------------- 244 (670)
..... ....+||+.|+|||++ +..|+.++||||+||++|+|++|.+||.+.. .......+..
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-HHHHHHHHHHhccCCCHHHHHHhhh
Confidence 76543 4567899999999976 4679999999999999999999999998743 3333222211
Q ss_pred -------CCCCC-----------c-------ccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcCcccccc
Q 005916 245 -------GIKPA-----------A-------LSKVKDPEVKSFIEKCLV-PASQRLSAKELLMDPFLQVN 288 (670)
Q Consensus 245 -------g~~p~-----------~-------~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~hpf~~~~ 288 (670)
...+. . .....++++++||.+||. +|++||||+|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 00000 0 001124678999999996 89999999999999999853
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=396.24 Aligned_cols=255 Identities=21% Similarity=0.359 Sum_probs=209.6
Q ss_pred CcccCCCCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Q 005916 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWI 97 (670)
Q Consensus 18 ~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~ 97 (670)
-+++++ ..|++.+.||+|+||+||+|+++.+ ..||+|+++.... ..+.+.+|+.+|++++|||||++|+++.
T Consensus 11 ~~~i~~--~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 11 AWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp CSBCCG--GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ceEcCH--HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-----CHHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 344443 4699999999999999999998755 5799999864321 2367899999999999999999999875
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEee
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKK--HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGD 175 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~D 175 (670)
+. .+++|||||.+|+|..++.. .+.+++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|
T Consensus 83 ~~---~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~D 156 (285)
T d1fmka3 83 EE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVAD 156 (285)
T ss_dssp SS---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECC
T ss_pred cC---CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEEC-CCCcEEEcc
Confidence 32 47899999999999988654 467999999999999999999999998 99999999999998 568999999
Q ss_pred ccchhhhcccc---cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcc
Q 005916 176 LGLATIMEQAN---AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 251 (670)
Q Consensus 176 FGla~~~~~~~---~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~ 251 (670)
||+++...... .....||+.|+|||++ .+.|+.++|||||||++|||+||..||.......+++..+..+..+. .
T Consensus 157 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~ 235 (285)
T d1fmka3 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-C 235 (285)
T ss_dssp CCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-C
T ss_pred cchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-C
Confidence 99998765432 3446799999999976 56899999999999999999997777666677888888888775443 4
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhc--Cccccc
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLM--DPFLQV 287 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~--hpf~~~ 287 (670)
+...++++++||.+||. +|++|||+.+++. ++||..
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 56678999999999996 8999999999987 788863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=392.13 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=197.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~ 102 (670)
+.|++.+.||+|+||+||+|....+ +..||+|++..... ...+..+++.+|+.+|++|+|||||++|+++.+.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---
Confidence 4599999999999999999986533 34789998875433 3456678899999999999999999999988643
Q ss_pred eEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 103 TVNIITELFTSGSLRQYRKK-HKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
.+++|||||.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~-~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRA 160 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEE
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccc-cccceeeccchhhhh
Confidence 47899999999999987665 467999999999999999999999998 99999999999999 567999999999987
Q ss_pred hcccc-----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCC
Q 005916 182 MEQAN-----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKV 254 (670)
Q Consensus 182 ~~~~~-----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 254 (670)
+.... .....||+.|+|||++ ...|+.++|||||||++|||+| |..||.+ .+..++...+.........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCccc
Confidence 74432 2345688899999976 4568999999999999999998 8999987 5666666666655444445566
Q ss_pred CChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 255 KDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 255 ~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.++.+++||.+||. +|.+|||+.++++
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999996 8999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=396.17 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=206.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCCeE--EEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeCCCC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNGLE--VAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDDQNK 102 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg~~--vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~~~~ 102 (670)
+.|++.++||+|+||+||+|+++.+|.. ||||.++.. ...+..+.+.+|+++|+++ +|||||++|++|.+..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-- 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-- 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc---cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--
Confidence 4588999999999999999999999876 455555422 2344567799999999999 7999999999998754
Q ss_pred eEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC
Q 005916 103 TVNIITELFTSGSLRQYRKKH----------------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING 166 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~ 166 (670)
.+|+|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~- 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG- 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc-
Confidence 799999999999999998754 57999999999999999999999998 99999999999998
Q ss_pred CCCcEEEeeccchhhhcccc-cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccC-CCCCCCCHHHHHHHHh
Q 005916 167 NQGEVKIGDLGLATIMEQAN-AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEY-PYSECRNSAQIYKKVS 243 (670)
Q Consensus 167 ~~g~vKL~DFGla~~~~~~~-~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~-Pf~~~~~~~~i~~~i~ 243 (670)
.++.+||+|||+++...... .....||+.|+|||.+ .+.|+.++|||||||++|||++|.. ||.+ .+..+++..+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i~ 240 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLP 240 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-CCHHHHHHHHH
Confidence 56799999999998765543 3456799999999976 5679999999999999999999764 5654 78888888888
Q ss_pred cCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 244 SGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 244 ~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.+..+. .+...++++++||.+||. +|++|||+.++++|
T Consensus 241 ~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 876544 445568999999999996 89999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-46 Score=390.54 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=209.5
Q ss_pred eEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN 101 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~ 101 (670)
.|++.+.||+|+||+||+|+.+ .++..||+|+++.. ......+++.+|+.+|++|+||||++++++|.+..
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~- 89 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK- 89 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh---cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC-
Confidence 4889999999999999999875 35689999988643 24566788999999999999999999999987654
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecC
Q 005916 102 KTVNIITELFTSGSLRQYRKKHK------------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDL 157 (670)
Q Consensus 102 ~~~~lVmEy~~gGsL~~~i~~~~------------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDL 157 (670)
.+++|||||.+|+|.+++.... .+++..+..++.||+.||+|||+++ ||||||
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDl 166 (301)
T d1lufa_ 90 -PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDL 166 (301)
T ss_dssp -SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred -ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEE
Confidence 6899999999999999986532 4889999999999999999999998 999999
Q ss_pred ccccEEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhcc-CCCCC
Q 005916 158 KCDNIFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFE-YPYSE 231 (670)
Q Consensus 158 KpeNILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~-~Pf~~ 231 (670)
||+|||++ .++.+||+|||+++.+.... ..+..||+.|||||++ ...|+.++|||||||++|||++|. +||.+
T Consensus 167 Kp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 167 ATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp SGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999998 56899999999998775432 2456789999999976 457999999999999999999996 56766
Q ss_pred CCCHHHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 232 CRNSAQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 232 ~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+..++...+..+..+. .+...++++.+||.+||. +|.+|||+.|+++
T Consensus 246 -~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 -MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp -SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 67778888888877543 455678999999999996 8999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=387.28 Aligned_cols=241 Identities=22% Similarity=0.395 Sum_probs=200.1
Q ss_pred eEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeEEE
Q 005916 27 YIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 27 ~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~~l 106 (670)
.|++.+.||+|+||+||+|.+ .|..||+|.++.. ...+.+.+|+++|++|+|||||++|+++.+..+ .+|+
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-~~~l 78 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYI 78 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred HeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC-cEEE
Confidence 488999999999999999987 4889999998643 234678899999999999999999998865443 5799
Q ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccchhhhcc
Q 005916 107 ITELFTSGSLRQYRKKHK--KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGLATIMEQ 184 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~~~~ 184 (670)
|||||.+|+|.+++.+++ .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheec-CCCCEeecccccceecCC
Confidence 999999999999987643 5899999999999999999999998 99999999999998 678999999999987654
Q ss_pred cccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCHHHHHHHHhcCCCCCcccCCCChHHHHH
Q 005916 185 ANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNSAQIYKKVSSGIKPAALSKVKDPEVKSF 262 (670)
Q Consensus 185 ~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~s~~~k~f 262 (670)
. .....+|+.|+|||++ ++.|+.++|||||||++|||+| |.+||.. .+..+++..+..+..+. .+...++++++|
T Consensus 156 ~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~l 232 (262)
T d1byga_ 156 T-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYEV 232 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHHH
T ss_pred C-CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHH
Confidence 3 3456789999999976 5789999999999999999998 6777766 57778888888876654 455678999999
Q ss_pred HHHcCC-CCCCCCCHHHHhcC
Q 005916 263 IEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 263 I~kcL~-dP~~RpSa~elL~h 282 (670)
|.+||. +|.+|||+.+++++
T Consensus 233 i~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 233 MKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcccCHhHCcCHHHHHHH
Confidence 999996 79999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=389.04 Aligned_cols=246 Identities=28% Similarity=0.430 Sum_probs=207.1
Q ss_pred CeEEEEEEecccCCeEEEEEEEcCCC-------eEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEE
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDEVNG-------LEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWI 97 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~~tg-------~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~ 97 (670)
+.|++++.||+|+||+||+|++..++ ..||+|+++... .......+.+|+.+++++ +|||||+++++|.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 47999999999999999999876554 479999886432 355667889999999988 8999999999997
Q ss_pred eCCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCcccc
Q 005916 98 DDQNKTVNIITELFTSGSLRQYRKKHK----------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 161 (670)
Q Consensus 98 d~~~~~~~lVmEy~~gGsL~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeN 161 (670)
+.. .+++|||||.+|+|.+++..+. .+++..++.|+.||+.||+|||+++ ||||||||+|
T Consensus 90 ~~~--~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~N 165 (299)
T d1fgka_ 90 QDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARN 165 (299)
T ss_dssp SSS--SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred cCC--eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccc
Confidence 654 6999999999999999997553 5899999999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCH
Q 005916 162 IFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNS 235 (670)
Q Consensus 162 ILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~ 235 (670)
||++ .++.+||+|||++....... .....||+.|+|||++ .+.|+.++|||||||++|+|++ |.+||.+ .+.
T Consensus 166 iLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~~ 243 (299)
T d1fgka_ 166 VLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPV 243 (299)
T ss_dssp EEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCH
T ss_pred eeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-CCH
Confidence 9998 67899999999998775543 3446799999999966 5789999999999999999998 6888866 677
Q ss_pred HHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 236 AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 236 ~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
.+++..+..+..+. .+...++.+++||.+||. +|++|||+.|+|+
T Consensus 244 ~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 EELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCC-CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 78888888876543 456678999999999996 8999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=390.50 Aligned_cols=252 Identities=22% Similarity=0.351 Sum_probs=209.3
Q ss_pred CCCCeEEEEEEecccCCeEEEEEEEcCC---CeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeC
Q 005916 23 PTCRYIRYKEVIGKGAFKTVYKAFDEVN---GLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDD 99 (670)
Q Consensus 23 p~gr~yr~~~~LG~G~fG~Vy~a~d~~t---g~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~ 99 (670)
+....+.+.++||+|+||+||+|.+..+ ...||||.++.. .+....+++.+|+++|++|+|||||++++++.+.
T Consensus 24 ~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 100 (311)
T d1r0pa_ 24 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100 (311)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET
T ss_pred hHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec
Confidence 3444556689999999999999998654 346899988632 3567788999999999999999999999998765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEeeccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIGDLGL 178 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~DFGl 178 (670)
. ..+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 101 ~-~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DFG~ 176 (311)
T d1r0pa_ 101 E-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGL 176 (311)
T ss_dssp T-TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSSGG
T ss_pred C-CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeEC-CCCCEEEecccc
Confidence 4 3789999999999999988754 45788899999999999999999998 99999999999998 668999999999
Q ss_pred hhhhcccc------cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHHHHhcCCCCCcc
Q 005916 179 ATIMEQAN------AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYKKVSSGIKPAAL 251 (670)
Q Consensus 179 a~~~~~~~------~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~~i~~g~~p~~~ 251 (670)
++...... .....||+.|+|||++ .+.|+.++|||||||++|||+||..||....+..++...+..+..+. .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~ 255 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-Q 255 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-C
T ss_pred hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-C
Confidence 98765432 2345789999999976 56899999999999999999998888877667777778888876543 4
Q ss_pred cCCCChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 252 SKVKDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 252 ~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
+...++++.+||.+||. +|.+|||+.|+++|
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 55678999999999996 89999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=385.70 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=213.7
Q ss_pred CcccCCCCCeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeee
Q 005916 18 VLETDPTCRYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRF 92 (670)
Q Consensus 18 ~~e~dp~gr~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl 92 (670)
-+++++ ..|.+.+.||+|+||+||+|.+. .++..||||+++.. ........+.+|++++++++|||||++
T Consensus 14 ~~ei~~--~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~ 88 (308)
T d1p4oa_ 14 EWEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRL 88 (308)
T ss_dssp TTBCCG--GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ceeecH--HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc---cChHHHHHHHHHHHHHHHcCCCCEeee
Confidence 456664 57889999999999999999875 34678999998643 245566789999999999999999999
Q ss_pred eeEEEeCCCCeEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccE
Q 005916 93 YNSWIDDQNKTVNIITELFTSGSLRQYRKKH----------KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNI 162 (670)
Q Consensus 93 ~~~~~d~~~~~~~lVmEy~~gGsL~~~i~~~----------~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNI 162 (670)
+++|.... .+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 89 ~~~~~~~~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~Ni 164 (308)
T d1p4oa_ 89 LGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNC 164 (308)
T ss_dssp EEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGE
T ss_pred eeEEecCC--ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCce
Confidence 99886544 689999999999999987643 34789999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhcc-CCCCCCCCHH
Q 005916 163 FINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFE-YPYSECRNSA 236 (670)
Q Consensus 163 Ll~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~-~Pf~~~~~~~ 236 (670)
|++ .++.+||+|||+++.+.... .....||+.|+|||.+ .+.|+.++|||||||++|||+||. +||.+ .+..
T Consensus 165 Lld-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~ 242 (308)
T d1p4oa_ 165 MVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNE 242 (308)
T ss_dssp EEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHH
T ss_pred eec-CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHH
Confidence 998 67899999999998775432 3445789999999976 567999999999999999999985 66765 6778
Q ss_pred HHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 237 QIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 237 ~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
+++..+..+..+. .+...++.++++|.+||. +|.+|||+.++++
T Consensus 243 ~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 243 QVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8888888876543 345577999999999996 8999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=385.67 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=210.4
Q ss_pred CeEEEEEEecccCCeEEEEEEEc-----CCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEeC
Q 005916 26 RYIRYKEVIGKGAFKTVYKAFDE-----VNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSL-KHNNIIRFYNSWIDD 99 (670)
Q Consensus 26 r~yr~~~~LG~G~fG~Vy~a~d~-----~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~~~d~ 99 (670)
..|++.++||+|+||.||+|+.. .++..||+|+++... .......+.+|+.+++.| +|||||++|+++.+.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 47899999999999999999863 577899999987543 356677899999999999 799999999998765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCcccc
Q 005916 100 QNKTVNIITELFTSGSLRQYRKKHK------------------KVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDN 161 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL~~~i~~~~------------------~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeN 161 (670)
. .+|+|||||.+|+|.+++.... .+++..+..|+.||+.||.|||+++ ||||||||+|
T Consensus 100 ~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~N 175 (311)
T d1t46a_ 100 G--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARN 175 (311)
T ss_dssp S--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred C--EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccccc
Confidence 4 6899999999999999987643 5899999999999999999999998 9999999999
Q ss_pred EEEeCCCCcEEEeeccchhhhcccc----cccccCCCccCCCccc-cCCCCccceeeeccchhhhhhh-ccCCCCCCCCH
Q 005916 162 IFINGNQGEVKIGDLGLATIMEQAN----AKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVT-FEYPYSECRNS 235 (670)
Q Consensus 162 ILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLlt-G~~Pf~~~~~~ 235 (670)
||++ .++.+||+|||+++...... .....||+.|+|||++ .+.|+.++|||||||++|||+| |.+||......
T Consensus 176 Il~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 176 ILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9998 57899999999998775432 2456889999999976 4678999999999999999998 56667665555
Q ss_pred HHHHHHHhcCCCCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 236 AQIYKKVSSGIKPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 236 ~~i~~~i~~g~~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
..+.+.+..+..+ ..+...++.+++||.+||. +|.+|||+.++|+
T Consensus 255 ~~~~~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 255 SKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6666666666544 3445678999999999996 8999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-44 Score=376.41 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=196.8
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCCCeE
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~~~~ 104 (670)
|.+|++.+.||+|+||+||+|++..+|+.||+|++...... +++..|+++++.++|+|+|..+..+.... ...
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~-~~~ 78 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEG-DYN 78 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEET-TEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEecC-CEE
Confidence 56799999999999999999999999999999998764321 34778999999998777666555544433 478
Q ss_pred EEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC--CCCcEEEeeccchhh
Q 005916 105 NIITELFTSGSLRQYRK-KHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING--NQGEVKIGDLGLATI 181 (670)
Q Consensus 105 ~lVmEy~~gGsL~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~--~~g~vKL~DFGla~~ 181 (670)
++||||| +|+|.+++. ..+.+++..+..++.||+.||+|||+++ ||||||||+|||++. .+..+||+|||+|+.
T Consensus 79 ~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 9999999 556666554 4568999999999999999999999999 999999999999862 345799999999987
Q ss_pred hcccc---------cccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCCCHHHHHH--HHhcC---C
Q 005916 182 MEQAN---------AKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECRNSAQIYK--KVSSG---I 246 (670)
Q Consensus 182 ~~~~~---------~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~~~i~~--~i~~g---~ 246 (670)
+.... ....+||+.|||||++. ..|+.++|||||||++|+|+||..||........... ..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 75432 24568999999999765 4699999999999999999999999977443322211 11111 1
Q ss_pred CCCcccCCCChHHHHHHHHcCC-CCCCCCCHH---HHhcCcccc
Q 005916 247 KPAALSKVKDPEVKSFIEKCLV-PASQRLSAK---ELLMDPFLQ 286 (670)
Q Consensus 247 ~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~---elL~hpf~~ 286 (670)
.........++++.+||.+||. +|.+||++. ++|+|+|.+
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 1122344567999999999995 899999986 557888764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=376.09 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=192.7
Q ss_pred CCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEeCCC--C
Q 005916 25 CRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNIIRFYNSWIDDQN--K 102 (670)
Q Consensus 25 gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~~~d~~~--~ 102 (670)
.|.|.+.+.||+|+||+||+|+. +|..||+|+++... ........|+..++.++|||||++|+++.+... .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 46799999999999999999975 68999999886432 122222345556677899999999999987654 3
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcC------CCCeeeecCccccEEEeCCCCcEEEeec
Q 005916 103 TVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSH------DPPIIHRDLKCDNIFINGNQGEVKIGDL 176 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~------g~~IIHrDLKpeNILl~~~~g~vKL~DF 176 (670)
.+|+|||||.+|+|.+++++. .+++..+..++.|++.||.|||+. .++||||||||+||||+ .++.+||+||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DF 152 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADL 152 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCC
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEec
Confidence 689999999999999999875 699999999999999999999974 23499999999999998 6789999999
Q ss_pred cchhhhcccc------cccccCCCccCCCccccCC-------CCccceeeeccchhhhhhhccCCCCCC-----------
Q 005916 177 GLATIMEQAN------AKSVIGTPEFMAPELYDEN-------YNELADIYSFGMCMLEMVTFEYPYSEC----------- 232 (670)
Q Consensus 177 Gla~~~~~~~------~~~~~GTp~YmAPEvl~~~-------ys~~~DIWSLGvilyeLltG~~Pf~~~----------- 232 (670)
|+++...... ....+||+.|||||++... |+.++|||||||++|||+||..||...
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 9998764422 2457899999999987543 567899999999999999998877421
Q ss_pred ---CCHHHHHHHHhcCCCCCcccCC-----CChHHHHHHHHcCC-CCCCCCCHHHHhcC
Q 005916 233 ---RNSAQIYKKVSSGIKPAALSKV-----KDPEVKSFIEKCLV-PASQRLSAKELLMD 282 (670)
Q Consensus 233 ---~~~~~i~~~i~~g~~p~~~~~~-----~s~~~k~fI~kcL~-dP~~RpSa~elL~h 282 (670)
.....+...+........++.. ....+.+++.+||+ +|.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1233444444433322222211 12358899999996 79999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-42 Score=360.25 Aligned_cols=247 Identities=18% Similarity=0.223 Sum_probs=201.1
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEeCCCC
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH-NNIIRFYNSWIDDQNK 102 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H-pNIVkl~~~~~d~~~~ 102 (670)
.|.+|++.+.||+|+||+||+|++..+|+.||+|++..... ...+.+|+++++.|.| +||+.+++++.+..
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-- 74 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-- 74 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC--
Confidence 46789999999999999999999999999999998865332 2346789999999955 89999999886544
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeC----CCCcEEEeecc
Q 005916 103 TVNIITELFTSGSLRQYRKKH-KKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFING----NQGEVKIGDLG 177 (670)
Q Consensus 103 ~~~lVmEy~~gGsL~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~----~~g~vKL~DFG 177 (670)
..++||||| +|+|.+++... ..+++..+..++.|++.||.|||++| ||||||||+|||++. ..+.+||+|||
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccc
Confidence 789999999 78999988765 46999999999999999999999999 999999999999973 35789999999
Q ss_pred chhhhccc---------ccccccCCCccCCCcccc-CCCCccceeeeccchhhhhhhccCCCCCCC--CHHHHHHHHhcC
Q 005916 178 LATIMEQA---------NAKSVIGTPEFMAPELYD-ENYNELADIYSFGMCMLEMVTFEYPYSECR--NSAQIYKKVSSG 245 (670)
Q Consensus 178 la~~~~~~---------~~~~~~GTp~YmAPEvl~-~~ys~~~DIWSLGvilyeLltG~~Pf~~~~--~~~~i~~~i~~g 245 (670)
+|+.+... .....+|||.|||||++. ..|+.++|||||||++|+|+||..||.+.. +....+..+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 99876432 134568999999999764 569999999999999999999999997533 333344433322
Q ss_pred C---CCCcccCCCChHHHHHHHHcCC-CCCCCCCHHHHhc
Q 005916 246 I---KPAALSKVKDPEVKSFIEKCLV-PASQRLSAKELLM 281 (670)
Q Consensus 246 ~---~p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa~elL~ 281 (670)
. .+..+....++++.+|+..|+. +|.+||+.+.+.+
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1 1223344567899999999995 8999998776644
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-42 Score=366.09 Aligned_cols=256 Identities=26% Similarity=0.350 Sum_probs=196.2
Q ss_pred CCCeEEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-----------CCCeeee
Q 005916 24 TCRYIRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-----------HNNIIRF 92 (670)
Q Consensus 24 ~gr~yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-----------HpNIVkl 92 (670)
.+.+|++.++||+|+||+||+|+++.+|+.||+|+++.. ....+.+.+|+.+|+.++ |||||++
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 334599999999999999999999999999999999753 334567788999998885 5789999
Q ss_pred eeEEEeCCCCeEEEEEecCCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHhhhhc-CCCCeeeecCccccEEEeCCC
Q 005916 93 YNSWIDDQNKTVNIITELFTSGSLRQY---RKKHKKVDMKAVKGWARQILSGLIYLHS-HDPPIIHRDLKCDNIFINGNQ 168 (670)
Q Consensus 93 ~~~~~d~~~~~~~lVmEy~~gGsL~~~---i~~~~~lse~~i~~i~~QIl~aL~yLHs-~g~~IIHrDLKpeNILl~~~~ 168 (670)
++++........+++|+++..+..... ......+++..++.+++||+.||.|||+ +| |+||||||+|||++..+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccC
Confidence 999876655577778877766543332 2334679999999999999999999998 77 99999999999997322
Q ss_pred -----CcEEEeeccchhhhcccccccccCCCccCCCccc-cCCCCccceeeeccchhhhhhhccCCCCCCCCH------H
Q 005916 169 -----GEVKIGDLGLATIMEQANAKSVIGTPEFMAPELY-DENYNELADIYSFGMCMLEMVTFEYPYSECRNS------A 236 (670)
Q Consensus 169 -----g~vKL~DFGla~~~~~~~~~~~~GTp~YmAPEvl-~~~ys~~~DIWSLGvilyeLltG~~Pf~~~~~~------~ 236 (670)
..+|++|||.+..... .....+||+.|+|||++ ...|+.++||||+||++++|++|..||...... .
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cccccceeeEeeccccccccc-ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 2499999999876544 34567899999999965 567999999999999999999999999652211 1
Q ss_pred HHHHHHhc-CC--------------------C------------------CCcccCCCChHHHHHHHHcCC-CCCCCCCH
Q 005916 237 QIYKKVSS-GI--------------------K------------------PAALSKVKDPEVKSFIEKCLV-PASQRLSA 276 (670)
Q Consensus 237 ~i~~~i~~-g~--------------------~------------------p~~~~~~~s~~~k~fI~kcL~-dP~~RpSa 276 (670)
.+...+.. +. . ........++++++||.+||. ||.+||||
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11111100 00 0 000111234689999999997 89999999
Q ss_pred HHHhcCccccc
Q 005916 277 KELLMDPFLQV 287 (670)
Q Consensus 277 ~elL~hpf~~~ 287 (670)
+|+|+||||+.
T Consensus 323 ~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 323 GGLVNHPWLKD 333 (362)
T ss_dssp HHHHTCGGGTT
T ss_pred HHHhcCcccCC
Confidence 99999999983
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.3e-24 Score=209.03 Aligned_cols=170 Identities=16% Similarity=0.190 Sum_probs=123.7
Q ss_pred EEEEEecccCCeEEEEEEEcCCCeEEEEEEEeecccc----C----------CHHHHHHHHHHHHHHHhCCCCCeeeeee
Q 005916 29 RYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVL----Q----------SPEDLERLYSEVHLLKSLKHNNIIRFYN 94 (670)
Q Consensus 29 r~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~----~----------s~~~~e~l~~Ei~iLk~L~HpNIVkl~~ 94 (670)
-+++.||+|+||+||+|.+. +|..||+|+++..... . ..........|..++.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 47899999999999999885 7999999987642110 0 0112234567899999999999999886
Q ss_pred EEEeCCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCCCCeeeecCccccEEEeCCCCcEEEe
Q 005916 95 SWIDDQNKTVNIITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHDPPIIHRDLKCDNIFINGNQGEVKIG 174 (670)
Q Consensus 95 ~~~d~~~~~~~lVmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g~~IIHrDLKpeNILl~~~~g~vKL~ 174 (670)
+. . .+++|||+.++.+. .+++..+..++.||+.+|.|||+++ |+||||||+|||++ + +.++|+
T Consensus 82 ~~--~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~li 144 (191)
T d1zara2 82 WE--G----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWII 144 (191)
T ss_dssp EE--T----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEEC
T ss_pred ec--C----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeee-C-CCEEEE
Confidence 43 1 36999999886653 3556667889999999999999998 99999999999998 3 469999
Q ss_pred eccchhhhcccccccccC-CCccCCCccccCCCCccceeeeccc
Q 005916 175 DLGLATIMEQANAKSVIG-TPEFMAPELYDENYNELADIYSFGM 217 (670)
Q Consensus 175 DFGla~~~~~~~~~~~~G-Tp~YmAPEvl~~~ys~~~DIWSLGv 217 (670)
|||+|............. ... .-.+.+.+.|+..+|+||+.-
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~-~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR-NIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH-HHHHHHHHHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH-HHHHHHcCCCCCcccHHHHHH
Confidence 999987665433211100 000 001234577899999999653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.90 E-value=1.3e-05 Score=78.17 Aligned_cols=140 Identities=14% Similarity=0.015 Sum_probs=83.6
Q ss_pred EEEEEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeCCCCeEEE
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDDQNKTVNI 106 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~~~~~~~l 106 (670)
|+..+..+.++.+.||+.. ..+..+.+|........ ....+.+|..+++.|. +--+.+++.+..+. +..++
T Consensus 16 ~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~l 87 (263)
T d1j7la_ 16 YRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNL 87 (263)
T ss_dssp SEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEE
T ss_pred eEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc----chhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEE
Confidence 4555554445557899873 45666777876533211 1234667888888773 32345555544433 47899
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHhhhhcCC-------------------------------------
Q 005916 107 ITELFTSGSLRQYRKKHKKVDMKAVKGWARQILSGLIYLHSHD------------------------------------- 149 (670)
Q Consensus 107 VmEy~~gGsL~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g------------------------------------- 149 (670)
||+++.|..+...... ......++.++...|..||+..
T Consensus 88 v~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 9999999887543211 1112223334444444444221
Q ss_pred --------------------CCeeeecCccccEEEeCCCCcEEEeeccchhh
Q 005916 150 --------------------PPIIHRDLKCDNIFINGNQGEVKIGDLGLATI 181 (670)
Q Consensus 150 --------------------~~IIHrDLKpeNILl~~~~g~vKL~DFGla~~ 181 (670)
+.++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec-CCceEEEeechhccc
Confidence 1279999999999998 444456999987643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.86 E-value=2e-05 Score=82.84 Aligned_cols=82 Identities=17% Similarity=0.206 Sum_probs=51.4
Q ss_pred EEEecccCCeEEEEEEEcCCCeEEEEEEEeeccccC---CHHHHHHHHHHHHHHHhC-CC--CCeeeeeeEEEeCCCCeE
Q 005916 31 KEVIGKGAFKTVYKAFDEVNGLEVAWCQVRIDDVLQ---SPEDLERLYSEVHLLKSL-KH--NNIIRFYNSWIDDQNKTV 104 (670)
Q Consensus 31 ~~~LG~G~fG~Vy~a~d~~tg~~vAiK~v~~~~~~~---s~~~~e~l~~Ei~iLk~L-~H--pNIVkl~~~~~d~~~~~~ 104 (670)
.+.||.|....||++.+...|+.+++|+-....... .+...+|...|+..|+.+ .+ ..+.++|. .+.. ..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~--~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTE--MA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETT--TT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCC--CC
Confidence 346899999999999887778889999765321111 112345667788888877 33 34556664 3444 34
Q ss_pred EEEEecCCCCCH
Q 005916 105 NIITELFTSGSL 116 (670)
Q Consensus 105 ~lVmEy~~gGsL 116 (670)
++|||++.+..+
T Consensus 107 ~lvmE~L~~~~~ 118 (392)
T d2pula1 107 VTVMEDLSHLKI 118 (392)
T ss_dssp EEEECCCTTSEE
T ss_pred EEEEeccCCccc
Confidence 689999977543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.29 E-value=0.00042 Score=66.70 Aligned_cols=74 Identities=11% Similarity=-0.041 Sum_probs=46.9
Q ss_pred EecccCC-eEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEeCCCCeEEEEEe
Q 005916 33 VIGKGAF-KTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKH--NNIIRFYNSWIDDQNKTVNIITE 109 (670)
Q Consensus 33 ~LG~G~f-G~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~H--pNIVkl~~~~~d~~~~~~~lVmE 109 (670)
.+..|.. +.||+... ..|..+.+|...... ...+..|...|+.|.. -.+.+++.+..+. +..++||+
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~ 86 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLG 86 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEE
Confidence 4455554 68898853 456667778655332 1236678888887732 2345666654443 46889999
Q ss_pred cCCCCCH
Q 005916 110 LFTSGSL 116 (670)
Q Consensus 110 y~~gGsL 116 (670)
+++|-++
T Consensus 87 ~i~G~~~ 93 (255)
T d1nd4a_ 87 EVPGQDL 93 (255)
T ss_dssp CCSSEET
T ss_pred eeecccc
Confidence 9988654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.52 E-value=0.015 Score=58.23 Aligned_cols=69 Identities=10% Similarity=0.116 Sum_probs=41.5
Q ss_pred CeEEEEEEEcCCCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCCCe-----eeee-eEEEeCCCCeEEEEEecCC
Q 005916 39 FKTVYKAFDEVNGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLKHNNI-----IRFY-NSWIDDQNKTVNIITELFT 112 (670)
Q Consensus 39 fG~Vy~a~d~~tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI-----Vkl~-~~~~d~~~~~~~lVmEy~~ 112 (670)
--.||++.. .+|..|++|+.+.... + .+.+..|...|..|....| +..- +.... .....+.+++++.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~--s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~-~~~~~~~l~~~~~ 107 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN-HQGFYFAVFPSVG 107 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE-ETTEEEEEEECCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC--C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeee-eeeEEEEEEeecC
Confidence 468999854 5788899998774321 2 3456778888888732221 1111 01111 2346788999987
Q ss_pred CC
Q 005916 113 SG 114 (670)
Q Consensus 113 gG 114 (670)
|.
T Consensus 108 G~ 109 (325)
T d1zyla1 108 GR 109 (325)
T ss_dssp CE
T ss_pred Cc
Confidence 64
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.51 E-value=0.026 Score=58.04 Aligned_cols=76 Identities=14% Similarity=0.152 Sum_probs=47.5
Q ss_pred EEEEEEecccCCeEEEEEEEcC-------CCeEEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEeC
Q 005916 28 IRYKEVIGKGAFKTVYKAFDEV-------NGLEVAWCQVRIDDVLQSPEDLERLYSEVHLLKSLK-HNNIIRFYNSWIDD 99 (670)
Q Consensus 28 yr~~~~LG~G~fG~Vy~a~d~~-------tg~~vAiK~v~~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~~~d~ 99 (670)
+++ +.|+.|-.-.+|++.... .+..|.+++.- .. .. . ....+|..+++.+. +.-..++|.++ +
T Consensus 45 l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~~--~-idr~~E~~i~~~ls~~gl~Pkll~~~--~ 115 (395)
T d1nw1a_ 45 LRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--ET--E-SHLVAESVIFTLLSERHLGPKLYGIF--S 115 (395)
T ss_dssp EEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC--CC--H-HHHHHHHHHHHHHHHTTSSSCEEEEE--T
T ss_pred eEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc--ch--h-hHHHHHHHHHHHHHhCCCCCeEEEEc--C
Confidence 554 578999999999987643 23455555443 11 11 2 23457999999884 43334677655 3
Q ss_pred CCCeEEEEEecCCCCCH
Q 005916 100 QNKTVNIITELFTSGSL 116 (670)
Q Consensus 100 ~~~~~~lVmEy~~gGsL 116 (670)
+ .+||||+.|..|
T Consensus 116 ~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 G----GRLEEYIPSRPL 128 (395)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----ceEEEEeccccC
Confidence 2 478999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.83 E-value=0.15 Score=49.92 Aligned_cols=29 Identities=34% Similarity=0.429 Sum_probs=23.9
Q ss_pred CeeeecCccccEEEeCCCCcEEEeeccchh
Q 005916 151 PIIHRDLKCDNIFINGNQGEVKIGDLGLAT 180 (670)
Q Consensus 151 ~IIHrDLKpeNILl~~~~g~vKL~DFGla~ 180 (670)
++||+|+.++||++++ +...-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~-~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLG-DELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred ccccCCcchhhhhccc-ccceeEecccccc
Confidence 4999999999999984 4455799999764
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=80.87 E-value=0.17 Score=42.45 Aligned_cols=75 Identities=19% Similarity=0.240 Sum_probs=55.4
Q ss_pred chhhhhcccCccccccCCCCCccchhhhheeecC--CCceeeeecc----------------------cccCCCCcCcch
Q 005916 355 SIEVRRSKRGNFFLLKGESNDEYSVSLILRIADQ--SGRLRNIHFL----------------------FYLDSDTAFSVS 410 (670)
Q Consensus 355 ~i~~~~l~~~~~~~~~g~~~~~~~I~liLri~D~--~g~i~~ieF~----------------------f~~d~Dta~~Ia 410 (670)
.++..++... +...|...++..+..+++..|. +|+|++-||. ..+|.|..+.|+
T Consensus 16 ~is~~E~~~~--l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~ 93 (134)
T d1jfja_ 16 AVSYEEVKAF--VSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLYKLMDVDGDGKLT 93 (134)
T ss_dssp EEEHHHHHHH--HHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHHHHHCCSSSSEEE
T ss_pred CCcHHHHHHH--HHHcCCCCCHHHHHHHHHHhhhcccccccccccccccccccccccccccccccccccccccccCCccc
Confidence 4777776644 4445666677889999999994 5799999986 567789999999
Q ss_pred HHHHhcccccccChHHHHHHHH
Q 005916 411 SEMVEQLELADQNVTFIAELID 432 (670)
Q Consensus 411 ~EmV~~l~l~~~d~~~iA~~Id 432 (670)
.+++..+ +.......+.+++.
T Consensus 94 ~~el~~~-~~~~~~~~~~~~~~ 114 (134)
T d1jfja_ 94 KEEVTSF-FKKHGIEKVAEQVM 114 (134)
T ss_dssp HHHHHHH-HTTTTCHHHHHHHH
T ss_pred HHHHHHH-HHhcCcHHHHHHHH
Confidence 9999984 55666555555543
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=80.53 E-value=0.17 Score=42.33 Aligned_cols=43 Identities=14% Similarity=0.220 Sum_probs=36.2
Q ss_pred CccchhhhheeecCCCceeeeecc-----------------cccCCCCcCcchHHHHhcc
Q 005916 375 DEYSVSLILRIADQSGRLRNIHFL-----------------FYLDSDTAFSVSSEMVEQL 417 (670)
Q Consensus 375 ~~~~I~liLri~D~~g~i~~ieF~-----------------f~~d~Dta~~Ia~EmV~~l 417 (670)
.+.+|...+...|.+|.|++-||. ..+|+|..|.|+.++++.+
T Consensus 7 ~~eeI~~~~~~~d~dG~idf~EF~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~ 66 (109)
T d1pvaa_ 7 KADDIKKALDAVKAEGSFNHKKFFALVGLKAMSANDVKKVFKAIDADASGFIEEEELKFV 66 (109)
T ss_dssp CHHHHHHHHHHTCSTTCCCHHHHHHHHTCTTSCHHHHHHHHHHHCTTCSSSBCHHHHHTG
T ss_pred CHHHHHHHHHhcCCCCCCcHHHHHHHHHHccCCHHHHHHHhhCccCCCcCeEcHHHHHHH
Confidence 356778888888889999999996 5689999999999998874
|